country,term,count
AL,CONDITION AGGRAVATED,1
AL,JOINT EFFUSION,1
AL,PSORIATIC ARTHROPATHY,1
DZ,VASCULITIS,2
DZ,C-REACTIVE PROTEIN INCREASED,1
DZ,DYSPNOEA,1
DZ,HYPERLEUKOCYTOSIS,1
DZ,HYPERTENSIVE CRISIS,1
DZ,INFECTION,1
DZ,LYMPHADENOPATHY,1
DZ,NECK PAIN,1
DZ,PARAESTHESIA,1
DZ,PRURITUS,1
DZ,PURPURA,1
DZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
DZ,RENAL FAILURE ACUTE,1
DZ,WHIPPLE^S DISEASE,1
AR,PAIN,433
AR,RHEUMATOID ARTHRITIS,345
AR,ARTHROPATHY,249
AR,ABASIA,228
AR,CONDITION AGGRAVATED,214
AR,FALL,209
AR,ARTHRALGIA,206
AR,MALAISE,189
AR,PNEUMONIA,187
AR,DRUG INEFFECTIVE,180
AR,PAIN IN EXTREMITY,180
AR,GAIT DISTURBANCE,166
AR,MOBILITY DECREASED,134
AR,ARTHRITIS,126
AR,DEATH,126
AR,DECREASED IMMUNE RESPONSIVENESS,126
AR,PYREXIA,122
AR,INFECTION,93
AR,INFLUENZA,87
AR,URINARY TRACT INFECTION,81
AR,CATARACT,74
AR,ANAEMIA,72
AR,DIABETES MELLITUS,72
AR,OSTEOARTHRITIS,70
AR,INFLAMMATION,68
AR,JOINT SWELLING,68
AR,MUSCULOSKELETAL DISORDER,67
AR,CEREBROVASCULAR ACCIDENT,64
AR,FOOT DEFORMITY,64
AR,PERIPHERAL SWELLING,59
AR,BRONCHITIS,58
AR,PSORIASIS,56
AR,INJECTION SITE PAIN,51
AR,LUNG DISORDER,50
AR,PSORIATIC ARTHROPATHY,49
AR,GAIT INABILITY,48
AR,PRODUCT USE ISSUE,48
AR,NASOPHARYNGITIS,47
AR,COUGH,46
AR,DYSPNOEA,45
AR,HYPERSENSITIVITY,43
AR,CHOLELITHIASIS,42
AR,HIP FRACTURE,42
AR,LIVER DISORDER,41
AR,CARDIAC DISORDER,40
AR,ASTHENIA,39
AR,VISUAL IMPAIRMENT,39
AR,BONE DISORDER,38
AR,DEPRESSION,37
AR,FEELING ABNORMAL,37
AR,LOCAL SWELLING,37
AR,NERVOUSNESS,37
AR,VOMITING,37
AR,FATIGUE,36
AR,PULMONARY FIBROSIS,36
AR,VISUAL ACUITY REDUCED,36
AR,BACK PAIN,35
AR,HAND DEFORMITY,35
AR,HEADACHE,35
AR,SPINAL DISORDER,35
AR,BONE PAIN,33
AR,SWELLING,33
AR,HAEMORRHAGE,32
AR,LOCALISED INFECTION,32
AR,MUSCULOSKELETAL STIFFNESS,32
AR,MYOCARDIAL INFARCTION,32
AR,ACCIDENT,31
AR,HYPOKINESIA,31
AR,ACTIVITIES OF DAILY LIVING IMPAIRED,30
AR,BREAST CANCER,30
AR,EYE DISORDER,30
AR,GALLBLADDER DISORDER,30
AR,LIMB INJURY,30
AR,UPPER LIMB FRACTURE,30
AR,JOINT DISLOCATION,29
AR,LABORATORY TEST ABNORMAL,29
AR,WEIGHT DECREASED,29
AR,FEMUR FRACTURE,28
AR,GENERAL PHYSICAL HEALTH DETERIORATION,28
AR,MUSCULOSKELETAL PAIN,28
AR,STRESS,28
AR,THROMBOSIS,28
AR,BLINDNESS,27
AR,BRONCHOSPASM,27
AR,DISEASE PROGRESSION,27
AR,DIZZINESS,27
AR,MEMORY IMPAIRMENT,27
AR,RENAL DISORDER,27
AR,GASTROINTESTINAL DISORDER,26
AR,HYPERTENSION,26
AR,INFARCTION,26
AR,INTERVERTEBRAL DISC PROTRUSION,26
AR,LOWER LIMB FRACTURE,26
AR,ARTHRITIS INFECTIVE,25
AR,BLOOD PRESSURE INCREASED,24
AR,DYSSTASIA,24
AR,OSTEOPOROSIS,24
AR,LOSS OF CONSCIOUSNESS,23
AR,FINGER DEFORMITY,22
AR,UVEITIS,22
AR,DEVICE RELATED INFECTION,21
AR,ERYSIPELAS,21
AR,FRACTURE,21
AR,ABDOMINAL PAIN UPPER,20
AR,CARDIO-RESPIRATORY ARREST,20
AR,DEAFNESS,20
AR,DIARRHOEA,20
AR,OSTEOMYELITIS,20
AR,SKIN ULCER,20
AR,WEIGHT INCREASED,20
AR,BEDRIDDEN,19
AR,CELLULITIS,19
AR,DEHYDRATION,19
AR,INJECTION SITE ERYTHEMA,19
AR,JOINT EFFUSION,19
AR,MENISCUS INJURY,19
AR,NEPHROLITHIASIS,19
AR,PRURITUS,19
AR,INJURY,18
AR,LIMB DISCOMFORT,18
AR,PULMONARY MASS,18
AR,TUBERCULOSIS,18
AR,WRIST FRACTURE,18
AR,ABDOMINAL PAIN,17
AR,ARRHYTHMIA,17
AR,CARDIAC FAILURE,17
AR,DRY EYE,17
AR,GASTRIC DISORDER,17
AR,NEOPLASM MALIGNANT,17
AR,RASH,17
AR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,17
AR,SPINAL FRACTURE,17
AR,AGITATION,16
AR,BRONCHIAL DISORDER,16
AR,IMMUNOSUPPRESSION,16
AR,MUSCULAR WEAKNESS,16
AR,RENAL FAILURE,16
AR,ROAD TRAFFIC ACCIDENT,16
AR,BACTERIAL INFECTION,15
AR,BLOOD PRESSURE DECREASED,15
AR,CHONDROPATHY,15
AR,CYST,15
AR,DEVICE DISLOCATION,15
AR,IMPAIRED HEALING,15
AR,JOINT INJURY,15
AR,PNEUMONITIS,15
AR,SENSITIVITY TO WEATHER CHANGE,15
AR,SYSTEMIC LUPUS ERYTHEMATOSUS,15
AR,THYROID DISORDER,15
AR,WHITE BLOOD CELL COUNT DECREASED,15
AR,COLITIS,14
AR,FOOT FRACTURE,14
AR,HAEMATOMA,14
AR,HEPATITIS,14
AR,INJECTION SITE HAEMATOMA,14
AR,INJECTION SITE PRURITUS,14
AR,INSOMNIA,14
AR,OEDEMA PERIPHERAL,14
AR,PHARYNGITIS,14
AR,RESPIRATORY DISORDER,14
AR,TOOTH DISORDER,14
AR,ULCER,14
AR,ABDOMINAL DISCOMFORT,13
AR,AMNESIA,13
AR,ANKYLOSING SPONDYLITIS,13
AR,BLISTER,13
AR,BONE EROSION,13
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,13
AR,DISEASE RECURRENCE,13
AR,DRUG DOSE OMISSION,13
AR,GLAUCOMA,13
AR,HERNIA,13
AR,HERPES ZOSTER,13
AR,KNEE DEFORMITY,13
AR,LYMPHOMA,13
AR,MENTAL DISORDER,13
AR,MOVEMENT DISORDER,13
AR,NEOPLASM,13
AR,PULMONARY OEDEMA,13
AR,RIB FRACTURE,13
AR,TIBIA FRACTURE,13
AR,ABORTION SPONTANEOUS,12
AR,ANXIETY,12
AR,APHONIA,12
AR,ASTHMA,12
AR,CARDIAC ARREST,12
AR,DEPRESSED MOOD,12
AR,DRUG INTOLERANCE,12
AR,ERYTHEMA,12
AR,GASTRITIS,12
AR,HYPOAESTHESIA,12
AR,INJECTION SITE HAEMORRHAGE,12
AR,JOINT STIFFNESS,12
AR,LIGAMENT SPRAIN,12
AR,LUNG INFECTION,12
AR,NECK PAIN,12
AR,PANCREATITIS,12
AR,SYNCOPE,12
AR,URTICARIA,12
AR,VARICOSE VEIN,12
AR,ACNE,11
AR,BLOOD PRESSURE ABNORMAL,11
AR,BREAST CANCER FEMALE,11
AR,BUNION,11
AR,CHEST PAIN,11
AR,FEAR,11
AR,FIBULA FRACTURE,11
AR,HAEMORRHOIDS,11
AR,NODULE,11
AR,PLATELET COUNT DECREASED,11
AR,PLEURAL EFFUSION,11
AR,SPEECH DISORDER,11
AR,SYNOVIAL CYST,11
AR,TONSILLITIS,11
AR,VIRAL INFECTION,11
AR,ANKLE FRACTURE,10
AR,BLINDNESS UNILATERAL,10
AR,DEFORMITY,10
AR,DYSPHONIA,10
AR,EMPHYSEMA,10
AR,HEPATIC STEATOSIS,10
AR,INJECTION SITE URTICARIA,10
AR,KIDNEY INFECTION,10
AR,LIMB DEFORMITY,10
AR,MACULOPATHY,10
AR,OSTEONECROSIS,10
AR,OVERWEIGHT,10
AR,POISONING,10
AR,RED BLOOD CELL COUNT DECREASED,10
AR,RED BLOOD CELL COUNT INCREASED,10
AR,RENAL IMPAIRMENT,10
AR,SKIN DISORDER,10
AR,SPINAL PAIN,10
AR,TENDON DISORDER,10
AR,TENDON RUPTURE,10
AR,WALKING DISABILITY,10
AR,ALOPECIA,9
AR,ANGINA PECTORIS,9
AR,APPLICATION SITE PAIN,9
AR,BONE FISSURE,9
AR,COLON CANCER,9
AR,COMA,9
AR,CONTUSION,9
AR,EAR INFECTION,9
AR,EMOTIONAL DISORDER,9
AR,FLUID RETENTION,9
AR,HYPOTENSION,9
AR,LEUKOPENIA,9
AR,LUNG NEOPLASM MALIGNANT,9
AR,NAUSEA,9
AR,ORAL INFECTION,9
AR,PERICARDIAL EFFUSION,9
AR,SCIATICA,9
AR,SINUSITIS,9
AR,SJOGREN^S SYNDROME,9
AR,SOMNOLENCE,9
AR,ARTHRITIS BACTERIAL,8
AR,CARDIOMEGALY,8
AR,CONFUSIONAL STATE,8
AR,CRYING,8
AR,DISCOMFORT,8
AR,DIVERTICULUM,8
AR,EAR DISORDER,8
AR,FEELING COLD,8
AR,HAND FRACTURE,8
AR,HIATUS HERNIA,8
AR,HYPERKERATOSIS,8
AR,HYPOACUSIS,8
AR,IMMOBILE,8
AR,INGUINAL HERNIA,8
AR,INJECTION SITE REACTION,8
AR,MUSCLE SPASMS,8
AR,MUSCULOSKELETAL DISCOMFORT,8
AR,OVARIAN CANCER,8
AR,PANIC ATTACK,8
AR,POST PROCEDURAL COMPLICATION,8
AR,RENAL NEOPLASM,8
AR,SEPSIS,8
AR,SKIN DISCOLOURATION,8
AR,TYPE 2 DIABETES MELLITUS,8
AR,UMBILICAL HERNIA,8
AR,UTERINE LEIOMYOMA,8
AR,VISION BLURRED,8
AR,ANEURYSM,7
AR,ARTERIAL OCCLUSIVE DISEASE,7
AR,CONJUNCTIVITIS,7
AR,DECREASED APPETITE,7
AR,DRUG EFFECT DECREASED,7
AR,FIBROMYALGIA,7
AR,FURUNCLE,7
AR,GASTROENTERITIS,7
AR,GASTROINTESTINAL INFECTION,7
AR,HEPATIC CIRRHOSIS,7
AR,HEPATITIS C,7
AR,HUMERUS FRACTURE,7
AR,LIGAMENT RUPTURE,7
AR,LYMPHADENOPATHY,7
AR,MYALGIA,7
AR,NEUROPATHY PERIPHERAL,7
AR,OVARIAN CYST,7
AR,PARALYSIS,7
AR,PRODUCT QUALITY ISSUE,7
AR,RENAL COLIC,7
AR,RESPIRATORY FAILURE,7
AR,SKIN CANCER,7
AR,SPINAL DEFORMITY,7
AR,TUBERCULIN TEST POSITIVE,7
AR,WHITE BLOOD CELL COUNT INCREASED,7
AR,AORTIC ANEURYSM,6
AR,ARTHROPOD BITE,6
AR,BALANCE DISORDER,6
AR,BILE DUCT STONE,6
AR,BLOOD DISORDER,6
AR,BLOOD GLUCOSE INCREASED,6
AR,BONE DEFORMITY,6
AR,BREAST DISORDER,6
AR,CARPAL TUNNEL SYNDROME,6
AR,CATARRH,6
AR,COAGULOPATHY,6
AR,CONSTIPATION,6
AR,CYSTITIS,6
AR,DISLOCATION OF VERTEBRA,6
AR,DRUG EFFECT INCOMPLETE,6
AR,DRUG HYPERSENSITIVITY,6
AR,DRUG-INDUCED LIVER INJURY,6
AR,DRY MOUTH,6
AR,EXOSTOSIS,6
AR,FUNGAL INFECTION,6
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
AR,INJECTION SITE SWELLING,6
AR,INJECTION SITE WARMTH,6
AR,INTESTINAL HAEMORRHAGE,6
AR,IRRITABLE BOWEL SYNDROME,6
AR,LISTLESS,6
AR,NOSOCOMIAL INFECTION,6
AR,OEDEMA,6
AR,OROPHARYNGEAL PAIN,6
AR,PELVIC FRACTURE,6
AR,POST PROCEDURAL INFECTION,6
AR,PURULENT DISCHARGE,6
AR,SEIZURE,6
AR,SPINAL COMPRESSION FRACTURE,6
AR,TOOTH INFECTION,6
AR,UTERINE CANCER,6
AR,VASCULITIS,6
AR,VIITH NERVE PARALYSIS,6
AR,WOUND INFECTION,6
AR,ANGIOPATHY,5
AR,BRAIN NEOPLASM,5
AR,BREAST MASS,5
AR,BREAST NEOPLASM,5
AR,BURNING SENSATION,5
AR,BURSITIS,5
AR,CARDIOVASCULAR DISORDER,5
AR,CARTILAGE INJURY,5
AR,CLAVICLE FRACTURE,5
AR,DEMENTIA ALZHEIMER^S TYPE,5
AR,EATING DISORDER,5
AR,EYE INFECTION,5
AR,EYE PAIN,5
AR,FEELING HOT,5
AR,FISTULA,5
AR,GASTRIC ULCER,5
AR,HEMIPLEGIA,5
AR,HIP DEFORMITY,5
AR,HYPERHIDROSIS,5
AR,HYPOTONIA,5
AR,INJECTION SITE HYPERSENSITIVITY,5
AR,INJECTION SITE MASS,5
AR,INTERVERTEBRAL DISC DISORDER,5
AR,INTESTINAL PERFORATION,5
AR,JUVENILE IDIOPATHIC ARTHRITIS,5
AR,KERATITIS,5
AR,LACERATION,5
AR,MUSCLE RIGIDITY,5
AR,NASAL CONGESTION,5
AR,NERVOUS SYSTEM DISORDER,5
AR,NO ADVERSE EVENT,5
AR,OCULAR HYPERAEMIA,5
AR,OSTEOPENIA,5
AR,PARAESTHESIA,5
AR,POLYP,5
AR,PROCEDURAL HAEMORRHAGE,5
AR,PULMONARY THROMBOSIS,5
AR,RESPIRATORY ARREST,5
AR,SKIN INFECTION,5
AR,SKIN LESION,5
AR,SKIN PAPILLOMA,5
AR,STOMATITIS,5
AR,TACHYCARDIA,5
AR,TENDON INJURY,5
AR,TOOTH FRACTURE,5
AR,TREMOR,5
AR,WRIST DEFORMITY,5
AR,ABDOMINAL DISTENSION,4
AR,ANGINA UNSTABLE,4
AR,ANKLE DEFORMITY,4
AR,APPENDICITIS,4
AR,ASCITES,4
AR,ASTHMATIC CRISIS,4
AR,BACK DISORDER,4
AR,BLOOD CREATININE INCREASED,4
AR,BLOOD PRESSURE FLUCTUATION,4
AR,BRONCHIOLITIS,4
AR,CAROTID ARTERY OCCLUSION,4
AR,CEREBRAL INFARCTION,4
AR,CHEST DISCOMFORT,4
AR,CHEST INJURY,4
AR,CHILLS,4
AR,CHRONIC SINUSITIS,4
AR,CONJUNCTIVITIS VIRAL,4
AR,CORONARY ARTERY DISEASE,4
AR,DEVICE BREAKAGE,4
AR,DIVERTICULITIS,4
AR,DIVERTICULUM INTESTINAL,4
AR,DRY SKIN,4
AR,ENTEROCOLITIS,4
AR,FEELING OF DESPAIR,4
AR,GASTROOESOPHAGEAL REFLUX DISEASE,4
AR,GROIN PAIN,4
AR,HAEMATEMESIS,4
AR,HEAD INJURY,4
AR,HEARING IMPAIRED,4
AR,HYPERGLYCAEMIA,4
AR,HYPOGLYCAEMIA,4
AR,HYPOTHYROIDISM,4
AR,IMMUNE SYSTEM DISORDER,4
AR,INCREASED UPPER AIRWAY SECRETION,4
AR,INJECTION SITE ABSCESS,4
AR,INJECTION SITE INFECTION,4
AR,LIPOMA,4
AR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,4
AR,MASS,4
AR,MONOPLEGIA,4
AR,MOTOR DYSFUNCTION,4
AR,MUSCLE ATROPHY,4
AR,MUSCLE STRAIN,4
AR,NAIL DISORDER,4
AR,NEPHROTIC SYNDROME,4
AR,NERVE COMPRESSION,4
AR,NEUTROPENIA,4
AR,ORAL DISORDER,4
AR,ORAL MUCOSAL BLISTERING,4
AR,PALPITATIONS,4
AR,PATIENT-DEVICE INCOMPATIBILITY,4
AR,PERITONITIS,4
AR,POLYNEUROPATHY,4
AR,POSTOPERATIVE WOUND INFECTION,4
AR,PROSTATIC DISORDER,4
AR,PULMONARY EMBOLISM,4
AR,PULMONARY PAIN,4
AR,RASH GENERALISED,4
AR,RASH MACULAR,4
AR,RENAL CANCER,4
AR,RESPIRATORY TRACT INFECTION,4
AR,ROTATOR CUFF SYNDROME,4
AR,SCIATIC NERVE NEUROPATHY,4
AR,SECRETION DISCHARGE,4
AR,SENILE DEMENTIA,4
AR,SKIN FISSURES,4
AR,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,4
AR,SPINAL COLUMN INJURY,4
AR,SWELLING FACE,4
AR,SYNOVITIS,4
AR,THYROID CANCER,4
AR,TOXICITY TO VARIOUS AGENTS,4
AR,TRANSIENT ISCHAEMIC ATTACK,4
AR,TRAUMATIC LUNG INJURY,4
AR,ULCERATIVE KERATITIS,4
AR,URINARY INCONTINENCE,4
AR,ABSCESS LIMB,3
AR,ACCIDENT AT WORK,3
AR,AMERICAN TRYPANOSOMIASIS,3
AR,ANGER,3
AR,APHAGIA,3
AR,APPLICATION SITE ERYTHEMA,3
AR,APPLICATION SITE PRURITUS,3
AR,APPLICATION SITE SWELLING,3
AR,ARTERIAL RUPTURE,3
AR,ASPHYXIA,3
AR,BACTERAEMIA,3
AR,BARTHOLINITIS,3
AR,BILIARY COLIC,3
AR,BLADDER CANCER,3
AR,BLADDER DISORDER,3
AR,BLOOD CHOLESTEROL DECREASED,3
AR,BLOOD ERYTHROPOIETIN INCREASED,3
AR,BLOOD GLUCOSE ABNORMAL,3
AR,BLOOD POTASSIUM DECREASED,3
AR,BLOOD TEST ABNORMAL,3
AR,BONE DECALCIFICATION,3
AR,BONE INFARCTION,3
AR,BREAST CYST,3
AR,BRONCHITIS CHRONIC,3
AR,C-REACTIVE PROTEIN INCREASED,3
AR,CARDIOMYOPATHY,3
AR,CAUDA EQUINA SYNDROME,3
AR,CEREBRAL ISCHAEMIA,3
AR,CERVIX DISORDER,3
AR,CHOKING,3
AR,CHOLECYSTITIS,3
AR,COELIAC DISEASE,3
AR,COGNITIVE DISORDER,3
AR,COLON NEOPLASM,3
AR,CORONARY ARTERY OCCLUSION,3
AR,DEAFNESS UNILATERAL,3
AR,DEEP VEIN THROMBOSIS,3
AR,DEMENTIA,3
AR,DEMYELINATION,3
AR,DENGUE FEVER,3
AR,DERMAL CYST,3
AR,DERMATITIS,3
AR,DEVICE FAILURE,3
AR,DRUG ADMINISTRATION ERROR,3
AR,DRUG DEPENDENCE,3
AR,DYSKINESIA,3
AR,DYSPHAGIA,3
AR,EMBOLISM,3
AR,ENTERITIS,3
AR,EPILEPSY,3
AR,EYE HAEMORRHAGE,3
AR,GASTRIC HAEMORRHAGE,3
AR,GASTRIC POLYPS,3
AR,GASTROINTESTINAL HAEMORRHAGE,3
AR,GASTROINTESTINAL PAIN,3
AR,GRIP STRENGTH DECREASED,3
AR,HAEMATOCRIT DECREASED,3
AR,HEAT STROKE,3
AR,HEPATIC ENZYME INCREASED,3
AR,HERPES VIRUS INFECTION,3
AR,INFECTED BUNION,3
AR,INJECTION SITE BRUISING,3
AR,INJECTION SITE INDURATION,3
AR,INJECTION SITE INFLAMMATION,3
AR,INJECTION SITE RASH,3
AR,INTENTIONAL PRODUCT MISUSE,3
AR,INTESTINAL OBSTRUCTION,3
AR,ISCHAEMIC STROKE,3
AR,JOINT RANGE OF MOTION DECREASED,3
AR,LARGE INTESTINE POLYP,3
AR,LEUKAEMIA,3
AR,LIGAMENT DISORDER,3
AR,LIVER INJURY,3
AR,LUNG NEOPLASM,3
AR,MATERNAL EXPOSURE DURING PREGNANCY,3
AR,MIGRAINE,3
AR,MUSCLE CONTRACTURE,3
AR,MYOPATHY,3
AR,NERVE INJURY,3
AR,OSTEITIS,3
AR,OSTEOPOROTIC FRACTURE,3
AR,PANCREATIC DISORDER,3
AR,PARKINSON^S DISEASE,3
AR,PATELLA FRACTURE,3
AR,PERIPHERAL VASCULAR DISORDER,3
AR,POSTOPERATIVE WOUND COMPLICATION,3
AR,RED BLOOD CELL ABNORMALITY,3
AR,RESPIRATORY TRACT CONGESTION,3
AR,RETINAL DETACHMENT,3
AR,RHEUMATOID FACTOR INCREASED,3
AR,SCIATIC NERVE INJURY,3
AR,SCLERODERMA,3
AR,SCOLIOSIS,3
AR,SENSORY LOSS,3
AR,SKIN EXFOLIATION,3
AR,SPINAL CORD DISORDER,3
AR,SUICIDAL IDEATION,3
AR,SURGERY,3
AR,TENDONITIS,3
AR,THROAT TIGHTNESS,3
AR,THYROID NEOPLASM,3
AR,TOOTH LOSS,3
AR,TRANSAMINASES INCREASED,3
AR,ULCER HAEMORRHAGE,3
AR,UTERINE DISORDER,3
AR,UTERINE POLYP,3
AR,VAGINAL HAEMORRHAGE,3
AR,VERTIGO,3
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
AR,ABDOMINAL CAVITY DRAINAGE,2
AR,ABNORMAL SENSATION IN EYE,2
AR,ABSCESS,2
AR,ACUTE MYOCARDIAL INFARCTION,2
AR,AKINESIA,2
AR,ANAL HAEMORRHAGE,2
AR,ANGIOEDEMA,2
AR,ANTIPHOSPHOLIPID SYNDROME,2
AR,APPENDIX DISORDER,2
AR,APPLICATION SITE BRUISE,2
AR,ARTERIAL DISORDER,2
AR,ASTIGMATISM,2
AR,AUTOIMMUNE DISORDER,2
AR,BASAL CELL CARCINOMA,2
AR,BILIARY TRACT DISORDER,2
AR,BLADDER PROLAPSE,2
AR,BLOOD CALCIUM DECREASED,2
AR,BLOOD CHOLESTEROL ABNORMAL,2
AR,BLOOD CHOLESTEROL INCREASED,2
AR,BLOOD GLUCOSE DECREASED,2
AR,BLOOD MAGNESIUM DECREASED,2
AR,BLOOD SODIUM DECREASED,2
AR,BLOOD TRIGLYCERIDES ABNORMAL,2
AR,BLOOD TRIGLYCERIDES DECREASED,2
AR,BODY TEMPERATURE INCREASED,2
AR,BONE CANCER,2
AR,BONE MARROW DISORDER,2
AR,BREAST CALCIFICATIONS,2
AR,BRONCHIECTASIS,2
AR,BRONCHOPNEUMONIA,2
AR,C-REACTIVE PROTEIN ABNORMAL,2
AR,C-REACTIVE PROTEIN DECREASED,2
AR,CALCULUS BLADDER,2
AR,CARDIAC MURMUR,2
AR,CARDIAC VALVE DISEASE,2
AR,CARTILAGE ATROPHY,2
AR,CENTRAL NERVOUS SYSTEM LESION,2
AR,CEREBRAL DISORDER,2
AR,CERUMEN IMPACTION,2
AR,CERVICAL VERTEBRAL FRACTURE,2
AR,COLON DYSPLASIA,2
AR,COMPLICATION OF DEVICE REMOVAL,2
AR,CONVULSION,2
AR,CROHN^S DISEASE,2
AR,CYTOMEGALOVIRUS INFECTION,2
AR,DENTAL CARIES,2
AR,DEPENDENCE,2
AR,DEVICE ISSUE,2
AR,DEVICE LOOSENING,2
AR,DEVICE OCCLUSION,2
AR,DISORIENTATION,2
AR,DRUG TOLERANCE,2
AR,DUODENAL ULCER,2
AR,DYSGRAPHIA,2
AR,DYSURIA,2
AR,EAR PAIN,2
AR,ECHINOCOCCIASIS,2
AR,ECZEMA,2
AR,EFFUSION,2
AR,EMOTIONAL DISTRESS,2
AR,ENDOCARDITIS,2
AR,ENDOCRINE DISORDER,2
AR,EPISTAXIS,2
AR,ESCHERICHIA INFECTION,2
AR,EYE ALLERGY,2
AR,EYE INFLAMMATION,2
AR,EYE IRRITATION,2
AR,FACIAL PAIN,2
AR,FOREIGN BODY,2
AR,FRACTURE MALUNION,2
AR,FRACTURED COCCYX,2
AR,GASTRIC CANCER,2
AR,GASTRITIS EROSIVE,2
AR,GASTROINTESTINAL CARCINOMA,2
AR,GASTROINTESTINAL NECROSIS,2
AR,GASTROINTESTINAL NEOPLASM,2
AR,GASTROINTESTINAL OEDEMA,2
AR,GENITAL INFECTION FEMALE,2
AR,GRANULOMA,2
AR,H1N1 INFLUENZA,2
AR,HAEMATOCHEZIA,2
AR,HAEMATURIA,2
AR,HAEMOPTYSIS,2
AR,HAEMORRHAGE URINARY TRACT,2
AR,HAEMORRHOIDS THROMBOSED,2
AR,HEPATITIS A,2
AR,HEPATITIS B,2
AR,HEPATITIS TOXIC,2
AR,HEPATOMEGALY,2
AR,HEPATOTOXICITY,2
AR,HERNIAL EVENTRATION,2
AR,HODGKIN^S DISEASE,2
AR,HYPERCHOLESTEROLAEMIA,2
AR,HYPERCOAGULATION,2
AR,HYPOPHAGIA,2
AR,IMMUNODEFICIENCY,2
AR,INCONTINENCE,2
AR,INCORRECT DOSE ADMINISTERED,2
AR,INFECTED BITES,2
AR,INFLAMMATORY BOWEL DISEASE,2
AR,INJECTION SITE CELLULITIS,2
AR,INJECTION SITE INJURY,2
AR,INJECTION SITE VESICLES,2
AR,INNER EAR DISORDER,2
AR,INTERVERTEBRAL DISC DISPLACEMENT,2
AR,INTESTINAL ULCER,2
AR,INTRACRANIAL ANEURYSM,2
AR,INTRAOCULAR PRESSURE INCREASED,2
AR,JOINT INSTABILITY,2
AR,KNEE ARTHROPLASTY,2
AR,LACRIMAL DISORDER,2
AR,LARGE INTESTINAL HAEMORRHAGE,2
AR,LARGE INTESTINAL ULCER,2
AR,LARYNGITIS,2
AR,LETHARGY,2
AR,LIMB OPERATION,2
AR,LIVER FUNCTION TEST ABNORMAL,2
AR,LOOSE TOOTH,2
AR,LOW BIRTH WEIGHT BABY,2
AR,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,2
AR,LUNG ADENOCARCINOMA,2
AR,LYMPHATIC DISORDER,2
AR,LYMPHOPENIA,2
AR,MALNUTRITION,2
AR,MASTICATION DISORDER,2
AR,MEGACOLON,2
AR,MENINGIOMA,2
AR,METASTASES TO LUNG,2
AR,MULTI-ORGAN FAILURE,2
AR,MULTIPLE FRACTURES,2
AR,MUSCULOSKELETAL CHEST PAIN,2
AR,MYCOSIS FUNGOIDES,2
AR,MYELITIS,2
AR,MYOPIA,2
AR,NAIL DISCOLOURATION,2
AR,NERVE ROOT COMPRESSION,2
AR,NUCHAL RIGIDITY,2
AR,OBESITY,2
AR,OCULAR HYPERTENSION,2
AR,OCULAR NEOPLASM,2
AR,OCULAR VASCULAR DISORDER,2
AR,OESOPHAGEAL CARCINOMA,2
AR,ORAL CANDIDIASIS,2
AR,OVARIAN DISORDER,2
AR,OVERLAP SYNDROME,2
AR,OXYGEN SATURATION DECREASED,2
AR,PAIN IN JAW,2
AR,PALLOR,2
AR,PANCREATIC CARCINOMA,2
AR,PANCREATIC NEOPLASM,2
AR,PANCYTOPENIA,2
AR,PAROTITIS,2
AR,PATHOGEN RESISTANCE,2
AR,PATHOLOGICAL FRACTURE,2
AR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
AR,PHARYNGEAL DISORDER,2
AR,PHARYNGEAL OEDEMA,2
AR,PHLEBITIS,2
AR,PLATELET COUNT INCREASED,2
AR,PLEURISY,2
AR,POLYMYOSITIS,2
AR,POST PROCEDURAL HAEMORRHAGE,2
AR,PREMATURE BABY,2
AR,PROCEDURAL COMPLICATION,2
AR,PROSTATE CANCER,2
AR,PROTEIN C INCREASED,2
AR,PULMONARY CONGESTION,2
AR,PULMONARY FUNCTION TEST DECREASED,2
AR,PULMONARY HYPERTENSION,2
AR,PULSE ABSENT,2
AR,PURPURA,2
AR,PURULENCE,2
AR,RASH PUSTULAR,2
AR,RECTAL HAEMORRHAGE,2
AR,RENAL FAILURE CHRONIC,2
AR,RESPIRATORY DISTRESS,2
AR,RESPIRATORY RATE INCREASED,2
AR,RETINAL INFARCTION,2
AR,RHINITIS,2
AR,RHINORRHOEA,2
AR,SALIVARY GLAND CYST,2
AR,SCAB,2
AR,SCLERITIS,2
AR,SEASONAL ALLERGY,2
AR,SHOCK,2
AR,SKIN ABRASION,2
AR,SKIN HAEMORRHAGE,2
AR,SKIN INJURY,2
AR,SKIN REACTION,2
AR,SKIN SENSITISATION,2
AR,SLEEP DISORDER,2
AR,SPINAL CORD OEDEMA,2
AR,STAPHYLOCOCCAL INFECTION,2
AR,SUDDEN DEATH,2
AR,SUICIDE ATTEMPT,2
AR,SWOLLEN TONGUE,2
AR,TERMINAL STATE,2
AR,THERAPY PARTIAL RESPONDER,2
AR,THERMAL BURN,2
AR,THROAT IRRITATION,2
AR,TINNITUS,2
AR,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,2
AR,TREATMENT FAILURE,2
AR,TRIGEMINAL PALSY,2
AR,TRISMUS,2
AR,TYPE 1 DIABETES MELLITUS,2
AR,UNDERWEIGHT,2
AR,UPPER RESPIRATORY TRACT INFECTION,2
AR,UTERINE HAEMORRHAGE,2
AR,UTERINE INFECTION,2
AR,VARICOSE ULCERATION,2
AR,VISUAL FIELD DEFECT,2
AR,WALKING AID USER,2
AR,WHEELCHAIR USER,2
AR,WOUND,2
AR,WOUND COMPLICATION,2
AR,WOUND DEHISCENCE,2
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
AR,XEROPHTHALMIA,2
AR,YELLOW SKIN,2
AR,ABDOMINAL ABSCESS,1
AR,ABDOMINAL HERNIA,1
AR,ABDOMINAL INFECTION,1
AR,ABDOMINAL WALL DISORDER,1
AR,ABULIA,1
AR,ACCIDENT AT HOME,1
AR,ACCIDENTAL EXPOSURE TO PRODUCT,1
AR,ACQUIRED CLAW TOE,1
AR,ACUTE HEPATIC FAILURE,1
AR,ACUTE LEUKAEMIA,1
AR,ADENOCARCINOMA OF COLON,1
AR,ADENOIDAL DISORDER,1
AR,ADENOMA BENIGN,1
AR,ADRENAL GLAND CANCER,1
AR,ADVERSE EVENT,1
AR,AFFECT LABILITY,1
AR,AFFECTIVE DISORDER,1
AR,AGGRESSION,1
AR,ALLERGY TO ARTHROPOD BITE,1
AR,AMYOTROPHIC LATERAL SCLEROSIS,1
AR,ANAEMIA POSTOPERATIVE,1
AR,ANAL ABSCESS,1
AR,ANAL ULCER,1
AR,ANAPHYLACTIC REACTION,1
AR,ANAPHYLACTIC SHOCK,1
AR,ANIMAL BITE,1
AR,ANOSMIA,1
AR,ANTIBODY TEST POSITIVE,1
AR,ANTICOAGULATION DRUG LEVEL ABNORMAL,1
AR,ANTINUCLEAR ANTIBODY INCREASED,1
AR,ANTINUCLEAR ANTIBODY POSITIVE,1
AR,AORTIC DILATATION,1
AR,AORTIC DISORDER,1
AR,AORTIC ELONGATION,1
AR,APATHY,1
AR,APHASIA,1
AR,APHTHOUS STOMATITIS,1
AR,APNOEA,1
AR,APPETITE DISORDER,1
AR,APPLICATION SITE CELLULITIS,1
AR,APPLICATION SITE DISCOLOURATION,1
AR,APPLICATION SITE DISCOMFORT,1
AR,APPLICATION SITE ECZEMA,1
AR,APPLICATION SITE HAEMATOMA,1
AR,APPLICATION SITE HYPERSENSITIVITY,1
AR,APPLICATION SITE INDURATION,1
AR,APPLICATION SITE INFECTION,1
AR,APPLICATION SITE INFLAMMATION,1
AR,APPLICATION SITE OEDEMA,1
AR,APPLICATION SITE RASH,1
AR,APPLICATION SITE WARMTH,1
AR,ARTERIAL INJURY,1
AR,ARTERITIS,1
AR,ARTHRODESIS,1
AR,ASPERGILLUS INFECTION,1
AR,ASPERGILLUS TEST POSITIVE,1
AR,ASTHENOPIA,1
AR,ATROPHY,1
AR,ATYPICAL PNEUMONIA,1
AR,AUTISM,1
AR,AUTOIMMUNE PANCREATITIS,1
AR,AUTOIMMUNE THYROIDITIS,1
AR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
AR,B-CELL LYMPHOMA,1
AR,BACILLUS INFECTION,1
AR,BACK INJURY,1
AR,BACTERIAL TEST POSITIVE,1
AR,BARTONELLA TEST POSITIVE,1
AR,BEHCET^S SYNDROME,1
AR,BENIGN NEOPLASM OF THYROID GLAND,1
AR,BICUSPID AORTIC VALVE,1
AR,BICYTOPENIA,1
AR,BILIARY CIRRHOSIS,1
AR,BILIARY CIRRHOSIS PRIMARY,1
AR,BILIARY NEOPLASM,1
AR,BIOPSY TESTES ABNORMAL,1
AR,BIPOLAR DISORDER,1
AR,BLADDER PAIN,1
AR,BLASTOCYSTIS INFECTION,1
AR,BLINDNESS TRANSIENT,1
AR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AR,BLOOD BILIRUBIN INCREASED,1
AR,BLOOD CALCIUM INCREASED,1
AR,BLOOD INSULIN DECREASED,1
AR,BLOOD PHOSPHORUS INCREASED,1
AR,BLOOD TEST NORMAL,1
AR,BLOOD URIC ACID ABNORMAL,1
AR,BLOOD URINE,1
AR,BLOOD URINE PRESENT,1
AR,BONE CYST,1
AR,BONE DENSITY DECREASED,1
AR,BONE DENSITY INCREASED,1
AR,BONE FORMATION INCREASED,1
AR,BONE LOSS,1
AR,BONE MARROW FAILURE,1
AR,BONE MARROW TRANSPLANT REJECTION,1
AR,BONE NEOPLASM,1
AR,BOVINE TUBERCULOSIS,1
AR,BRAIN DEATH,1
AR,BREAST CELLULITIS,1
AR,BREAST INFLAMMATION,1
AR,BREAST INJURY,1
AR,BREAST PAIN,1
AR,BRONCHIAL OBSTRUCTION,1
AR,BRONCHOPULMONARY DISEASE,1
AR,BURN INFECTION,1
AR,BURSITIS INFECTIVE,1
AR,CALCIPHYLAXIS,1
AR,CALCIUM METABOLISM DISORDER,1
AR,CALCULUS URETERIC,1
AR,CALCULUS URINARY,1
AR,CALLUS FORMATION DELAYED,1
AR,CANDIDA INFECTION,1
AR,CAPILLARY FRAGILITY,1
AR,CARCINOID TUMOUR OF THE PROSTATE,1
AR,CARDIAC FAILURE CONGESTIVE,1
AR,CARDIOVASCULAR INSUFFICIENCY,1
AR,CAROTID ARTERY ANEURYSM,1
AR,CAVERNOUS SINUS THROMBOSIS,1
AR,CELLULITIS STAPHYLOCOCCAL,1
AR,CENTRAL NERVOUS SYSTEM NEOPLASM,1
AR,CEREBRAL HAEMATOMA,1
AR,CEREBRAL HAEMORRHAGE,1
AR,CERVICAL CORD COMPRESSION,1
AR,CERVICAL RADICULOPATHY,1
AR,CESTODE INFECTION,1
AR,CHOKING SENSATION,1
AR,CHOLANGIOCARCINOMA,1
AR,CHOLECYSTITIS ACUTE,1
AR,CHOLECYSTITIS INFECTIVE,1
AR,CHOLESTASIS,1
AR,CHONDRITIS,1
AR,CHRONIC GASTRITIS,1
AR,CHRONIC MYELOID LEUKAEMIA,1
AR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
AR,COLITIS ULCERATIVE,1
AR,COLON INJURY,1
AR,COMMUNICATION DISORDER,1
AR,COMPLETED SUICIDE,1
AR,CONCOMITANT DISEASE AGGRAVATED,1
AR,CONGENITAL DIAPHRAGMATIC HERNIA,1
AR,CONGESTIVE CARDIOMYOPATHY,1
AR,CORNEAL DISORDER,1
AR,CORNEAL LESION,1
AR,COXSACKIE VIRAL INFECTION,1
AR,CRYPTOSPORIDIOSIS INFECTION,1
AR,CUTANEOUS TUBERCULOSIS,1
AR,DACRYOCANALICULITIS,1
AR,DACRYOSTENOSIS ACQUIRED,1
AR,DEAFNESS BILATERAL,1
AR,DEAFNESS NEUROSENSORY,1
AR,DECREASED ACTIVITY,1
AR,DECUBITUS ULCER,1
AR,DEFORMITY THORAX,1
AR,DENTAL CYST,1
AR,DENTAL FISTULA,1
AR,DEPRESSION SUICIDAL,1
AR,DERMATITIS ALLERGIC,1
AR,DERMATITIS EXFOLIATIVE,1
AR,DERMATOMYOSITIS,1
AR,DERMATOSIS,1
AR,DEVICE MALFUNCTION,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIABETIC COMPLICATION,1
AR,DIAPHRAGM MUSCLE WEAKNESS,1
AR,DIARRHOEA HAEMORRHAGIC,1
AR,DIET REFUSAL,1
AR,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
AR,DIPLEGIA,1
AR,DISABILITY,1
AR,DIVERTICULAR PERFORATION,1
AR,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
AR,DRUG DISPENSING ERROR,1
AR,DRUG LEVEL INCREASED,1
AR,DRUG SPECIFIC ANTIBODY PRESENT,1
AR,DRY THROAT,1
AR,DYSARTHRIA,1
AR,DYSPLASIA,1
AR,DYSTHYMIC DISORDER,1
AR,EAR DISCOMFORT,1
AR,EAR HAEMORRHAGE,1
AR,EAR INJURY,1
AR,EAR NEOPLASM,1
AR,ECCHYMOSIS,1
AR,ELBOW DEFORMITY,1
AR,EMPYEMA,1
AR,ENCEPHALITIS,1
AR,ENDOCARDITIS BACTERIAL,1
AR,ENDOMETRIAL DISORDER,1
AR,ENDOMETRIAL DYSPLASIA,1
AR,ENDOMETRIAL HYPERTROPHY,1
AR,ENDOMETRIOSIS,1
AR,ENZYME LEVEL INCREASED,1
AR,EOSINOPHILIC COLITIS,1
AR,EPICONDYLITIS,1
AR,EPIGASTRIC DISCOMFORT,1
AR,ERYTHEMA NODOSUM,1
AR,EYE INFECTION BACTERIAL,1
AR,EYE PRURITUS,1
AR,EYE SWELLING,1
AU,MALAISE,30
AU,RHEUMATOID ARTHRITIS,28
AU,DRUG INEFFECTIVE,25
AU,CONDITION AGGRAVATED,17
AU,DYSPNOEA,16
AU,PAIN,16
AU,LOWER RESPIRATORY TRACT INFECTION,15
AU,PNEUMONIA,15
AU,PYREXIA,14
AU,RASH,13
AU,HEADACHE,12
AU,PRODUCT QUALITY ISSUE,12
AU,ARTHRALGIA,11
AU,INFECTION,11
AU,INJECTION SITE PAIN,11
AU,NAUSEA,11
AU,ARTHROPATHY,10
AU,DIARRHOEA,10
AU,INJECTION SITE REACTION,10
AU,ARTHRITIS,9
AU,HYPERSENSITIVITY,9
AU,PAIN IN EXTREMITY,9
AU,ANAPHYLACTIC REACTION,8
AU,DRUG DOSE OMISSION,8
AU,INJECTION SITE ERYTHEMA,8
AU,INJECTION SITE MASS,8
AU,UVEITIS,8
AU,FATIGUE,7
AU,MYOCARDIAL INFARCTION,7
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,7
AU,URTICARIA,7
AU,WEIGHT DECREASED,7
AU,EYE PAIN,6
AU,FEELING ABNORMAL,6
AU,INJECTION SITE PRURITUS,6
AU,INJECTION SITE SWELLING,6
AU,OSTEOARTHRITIS,6
AU,PANCYTOPENIA,6
AU,PROSTATE CANCER,6
AU,PSORIATIC ARTHROPATHY,6
AU,SWELLING,6
AU,URINARY TRACT INFECTION,6
AU,ABDOMINAL PAIN UPPER,5
AU,ASTHENIA,5
AU,BREAST CANCER,5
AU,CHEST PAIN,5
AU,ERYTHEMA,5
AU,FALL,5
AU,GAIT DISTURBANCE,5
AU,MOBILITY DECREASED,5
AU,MYALGIA,5
AU,NASOPHARYNGITIS,5
AU,PRURITUS,5
AU,THROMBOCYTOPENIC PURPURA,5
AU,VOMITING,5
AU,ABDOMINAL DISTENSION,4
AU,ALOPECIA,4
AU,BRONCHITIS,4
AU,CEREBROVASCULAR ACCIDENT,4
AU,CHILLS,4
AU,COUGH,4
AU,DEATH,4
AU,DECREASED APPETITE,4
AU,DISEASE PROGRESSION,4
AU,EYE IRRITATION,4
AU,GASTROOESOPHAGEAL REFLUX DISEASE,4
AU,HAEMORRHAGE,4
AU,HERPES ZOSTER DISSEMINATED,4
AU,INJECTION SITE BRUISING,4
AU,INJECTION SITE HAEMORRHAGE,4
AU,INJECTION SITE WARMTH,4
AU,LIVER FUNCTION TEST ABNORMAL,4
AU,LOSS OF CONSCIOUSNESS,4
AU,MALIGNANT HYPERTENSION,4
AU,OCULAR HYPERAEMIA,4
AU,PARAESTHESIA,4
AU,STRESS,4
AU,VISUAL IMPAIRMENT,4
AU,WEIGHT INCREASED,4
AU,ABASIA,3
AU,ABDOMINAL DISCOMFORT,3
AU,ABDOMINAL PAIN,3
AU,BASAL CELL CARCINOMA,3
AU,BLADDER CANCER,3
AU,CARDIAC DISORDER,3
AU,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
AU,CONFUSIONAL STATE,3
AU,CONSTIPATION,3
AU,CONTUSION,3
AU,CROHN^S DISEASE,3
AU,DEHYDRATION,3
AU,DEVICE RELATED SEPSIS,3
AU,DISCOMFORT,3
AU,EYE HAEMORRHAGE,3
AU,GASTROINTESTINAL HAEMORRHAGE,3
AU,GENERAL PHYSICAL HEALTH DETERIORATION,3
AU,HEPATIC CIRRHOSIS,3
AU,HEPATOSPLENIC T-CELL LYMPHOMA,3
AU,HYPERTENSION,3
AU,INFLUENZA,3
AU,INFLUENZA LIKE ILLNESS,3
AU,INJECTION SITE RASH,3
AU,INJECTION SITE URTICARIA,3
AU,INTESTINAL PERFORATION,3
AU,KERATITIS,3
AU,LUNG INFECTION,3
AU,MOUTH ULCERATION,3
AU,MUSCULOSKELETAL STIFFNESS,3
AU,NIGHT SWEATS,3
AU,OSTEOPOROSIS,3
AU,PERIPHERAL SWELLING,3
AU,PRODUCT USE ISSUE,3
AU,PSORIASIS,3
AU,PULMONARY EMBOLISM,3
AU,RASH ERYTHEMATOUS,3
AU,RASH MACULAR,3
AU,RENAL CANCER,3
AU,RENAL FAILURE,3
AU,SKIN CANCER,3
AU,SKIN ULCER,3
AU,TONSILLITIS,3
AU,UNDERDOSE,3
AU,VIRAL INFECTION,3
AU,WHITE BLOOD CELL COUNT DECREASED,3
AU,ACNE,2
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,2
AU,ANAEMIA,2
AU,ANAPHYLACTIC SHOCK,2
AU,ANKYLOSING SPONDYLITIS,2
AU,APHASIA,2
AU,ARRHYTHMIA,2
AU,ARTHRITIS BACTERIAL,2
AU,ASPERGILLUS INFECTION,2
AU,BACK DISORDER,2
AU,BACK PAIN,2
AU,BACTERIAL INFECTION,2
AU,BLOOD PRESSURE DECREASED,2
AU,CANDIDA INFECTION,2
AU,CANDIDA OSTEOMYELITIS,2
AU,CARDIAC ARREST,2
AU,CATARACT,2
AU,CHRONIC GRAFT VERSUS HOST DISEASE,2
AU,COLITIS,2
AU,COLITIS ULCERATIVE,2
AU,DEEP VEIN THROMBOSIS,2
AU,DEPRESSION,2
AU,DEVICE ISSUE,2
AU,DIVERTICULITIS,2
AU,DIVERTICULUM,2
AU,DRUG EFFECT DECREASED,2
AU,DRUG HYPERSENSITIVITY,2
AU,DRUG INTOLERANCE,2
AU,DRY SKIN,2
AU,DYSPNOEA EXERTIONAL,2
AU,ENTERITIS INFECTIOUS,2
AU,EYE DISORDER,2
AU,FEELING HOT,2
AU,FLATULENCE,2
AU,FOOD ALLERGY,2
AU,FOOD POISONING,2
AU,FOREIGN BODY REACTION,2
AU,GASTRIC DISORDER,2
AU,GASTRIC ULCER,2
AU,GASTROENTERITIS,2
AU,GASTROINTESTINAL DISORDER,2
AU,GASTROINTESTINAL PAIN,2
AU,HEART RATE INCREASED,2
AU,HYPERHIDROSIS,2
AU,INFLAMMATORY MARKER INCREASED,2
AU,INJECTION SITE EXTRAVASATION,2
AU,INSOMNIA,2
AU,INTRAOCULAR PRESSURE INCREASED,2
AU,KIDNEY INFECTION,2
AU,LACERATION,2
AU,LETHARGY,2
AU,LIP HAEMORRHAGE,2
AU,LIP SWELLING,2
AU,LOWER LIMB FRACTURE,2
AU,LUPUS-LIKE SYNDROME,2
AU,LYMPHOCYTIC LEUKAEMIA,2
AU,LYMPHOMA,2
AU,MACULAR DEGENERATION,2
AU,MENOPAUSE,2
AU,MENORRHAGIA,2
AU,METASTATIC MALIGNANT MELANOMA,2
AU,MICROSPORIDIA INFECTION,2
AU,MOUTH HAEMORRHAGE,2
AU,MUSCLE SPASMS,2
AU,MUSCULOSKELETAL DISORDER,2
AU,MYOSITIS,2
AU,NEOPLASM MALIGNANT,2
AU,NEUROPATHY PERIPHERAL,2
AU,NON-HODGKIN^S LYMPHOMA,2
AU,OBLITERATIVE BRONCHIOLITIS,2
AU,OSTEONECROSIS OF JAW,2
AU,PANCREATITIS,2
AU,PLATELET COUNT DECREASED,2
AU,PNEUMOCOCCAL SEPSIS,2
AU,PNEUMONITIS,2
AU,POLLAKIURIA,2
AU,RASH PRURITIC,2
AU,RENAL PAIN,2
AU,RESPIRATORY FAILURE,2
AU,RETINAL VASCULITIS,2
AU,RIB FRACTURE,2
AU,SACROILIITIS,2
AU,SARCOIDOSIS,2
AU,SKIN EXFOLIATION,2
AU,SKIN WARM,2
AU,STAPHYLOCOCCAL INFECTION,2
AU,SUBCUTANEOUS EMPHYSEMA,2
AU,SWELLING FACE,2
AU,SWOLLEN TONGUE,2
AU,TONGUE DISCOMFORT,2
AU,TOXICITY TO VARIOUS AGENTS,2
AU,TREMOR,2
AU,UPPER LIMB FRACTURE,2
AU,VISUAL ACUITY REDUCED,2
AU,ABDOMINAL ADHESIONS,1
AU,ABDOMINAL INFECTION,1
AU,ABDOMINAL SEPSIS,1
AU,ABNORMAL SENSATION IN EYE,1
AU,ABORTION SPONTANEOUS,1
AU,ACROCHORDON,1
AU,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
AU,ACUTE HIV INFECTION,1
AU,ACUTE KIDNEY INJURY,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,AGGRESSION,1
AU,AGITATION,1
AU,ALCOHOLIC LIVER DISEASE,1
AU,ALOPECIA TOTALIS,1
AU,ALVEOLITIS ALLERGIC,1
AU,AMNESIA,1
AU,ANGIOEDEMA,1
AU,ANTINUCLEAR ANTIBODY POSITIVE,1
AU,AORTIC ANEURYSM,1
AU,APATHY,1
AU,APHAGIA,1
AU,ARTHRITIS INFECTIVE,1
AU,ASTHMA,1
AU,ATAXIA,1
AU,ATRIAL FIBRILLATION,1
AU,BARRETT^S OESOPHAGUS,1
AU,BILIARY DILATATION,1
AU,BLADDER CANCER RECURRENT,1
AU,BLADDER DISORDER,1
AU,BLINDNESS,1
AU,BLINDNESS UNILATERAL,1
AU,BLOOD ELECTROLYTES ABNORMAL,1
AU,BODY MASS INDEX INCREASED,1
AU,BONE CANCER,1
AU,BONE LESION,1
AU,BONE LOSS,1
AU,BONE MARROW DISORDER,1
AU,BRAIN NEOPLASM,1
AU,BREAST CANCER FEMALE,1
AU,BREAST CANCER STAGE I,1
AU,BREAST PAIN,1
AU,BRONCHIECTASIS,1
AU,BURSA DISORDER,1
AU,C-REACTIVE PROTEIN INCREASED,1
AU,CARDIAC FAILURE,1
AU,CD4 LYMPHOCYTES DECREASED,1
AU,CELLULITIS,1
AU,CEREBRAL ISCHAEMIA,1
AU,CHOLANGITIS,1
AU,CHOLELITHIASIS,1
AU,CHONDROPATHY,1
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,1
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
AU,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AU,CIRCULATORY COLLAPSE,1
AU,CLOSTRIDIUM DIFFICILE COLITIS,1
AU,CLUMSINESS,1
AU,COAGULOPATHY,1
AU,COLD SWEAT,1
AU,COMPLICATION OF PREGNANCY,1
AU,COMPRESSION FRACTURE,1
AU,COORDINATION ABNORMAL,1
AU,CREPITATIONS,1
AU,CROUP INFECTIOUS,1
AU,CUTANEOUS LUPUS ERYTHEMATOSUS,1
AU,CUTANEOUS SARCOIDOSIS,1
AU,CYST,1
AU,CYSTITIS,1
AU,CYTOMEGALOVIRUS INFECTION,1
AU,DEAFNESS,1
AU,DEFORMITY,1
AU,DELIRIUM,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DEMYELINATING POLYNEUROPATHY,1
AU,DEMYELINATION,1
AU,DERMATITIS,1
AU,DERMATITIS BULLOUS,1
AU,DEVICE COLOUR ISSUE,1
AU,DEVICE LEAKAGE,1
AU,DEVICE RELATED INFECTION,1
AU,DIABETES INSIPIDUS,1
AU,DIABETES MELLITUS,1
AU,DISEASE RECURRENCE,1
AU,DISTURBANCE IN ATTENTION,1
AU,DIVERTICULAR PERFORATION,1
AU,DIZZINESS,1
AU,DRUG ADMINISTRATION ERROR,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG EFFECT INCOMPLETE,1
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
AU,DRY MOUTH,1
AU,DYSARTHRIA,1
AU,DYSPHAGIA,1
AU,DYSPHONIA,1
AU,EAR HAEMORRHAGE,1
AU,EAR INFECTION STAPHYLOCOCCAL,1
AU,ECTOPIC PREGNANCY,1
AU,ECZEMA,1
AU,EMOTIONAL DISTRESS,1
AU,ENCEPHALITIS,1
AU,ENDOMETRITIS,1
AU,ENTEROCOCCAL SEPSIS,1
AU,EPIDERMAL NECROSIS,1
AU,EPISCLERITIS,1
AU,ESCHERICHIA URINARY TRACT INFECTION,1
AU,EXERCISE TOLERANCE DECREASED,1
AU,EXPOSED BONE IN JAW,1
AU,EXTRADURAL ABSCESS,1
AU,EXTRASYSTOLES,1
AU,EXTREMITY CONTRACTURE,1
AU,EYE DISCHARGE,1
AU,EYE INFECTION BACTERIAL,1
AU,EYE PRURITUS,1
AU,EYE SWELLING,1
AU,EYE ULCER,1
AU,EYELID PTOSIS,1
AU,FACIAL PAIN,1
AU,FACIAL PARALYSIS,1
AU,FEEDING DISORDER,1
AU,FEELING COLD,1
AU,FINE MOTOR SKILL DYSFUNCTION,1
AU,FLUSHING,1
AU,FOOT DEFORMITY,1
AU,FOREIGN BODY,1
AU,FORMICATION,1
AU,FRACTURE,1
AU,FREQUENT BOWEL MOVEMENTS,1
AU,FUNDOSCOPY ABNORMAL,1
AU,FURUNCLE,1
AU,GASTRIC INFECTION,1
AU,GASTRIC MUCOSAL HYPERTROPHY,1
AU,GASTRITIS BACTERIAL,1
AU,GLOMERULONEPHRITIS,1
AU,GLOMERULONEPHRITIS PROLIFERATIVE,1
AU,GOUT,1
AU,GRAFT VERSUS HOST DISEASE IN EYE,1
AU,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
AU,GRAFT VERSUS HOST DISEASE IN LUNG,1
AU,GRAFT VERSUS HOST DISEASE IN SKIN,1
AU,GROIN PAIN,1
AU,GUILLAIN-BARRE SYNDROME,1
AU,HAEMATOCHEZIA,1
AU,HAEMATOMA,1
AU,HAIR TEXTURE ABNORMAL,1
AU,HALLUCINATION,1
AU,HEAD DISCOMFORT,1
AU,HEAD INJURY,1
AU,HENOCH-SCHONLEIN PURPURA,1
AU,HEPATIC CYST,1
AU,HEPATIC ENZYME ABNORMAL,1
AU,HEPATIC FUNCTION ABNORMAL,1
AU,HEPATIC STEATO-FIBROSIS,1
AU,HEPATIC STEATOSIS,1
AU,HEPATITIS B REACTIVATION,1
AU,HEPATOTOXICITY,1
AU,HERPES ZOSTER,1
AU,HIP FRACTURE,1
AU,HYDRONEPHROSIS,1
AU,HYPERAESTHESIA,1
AU,HYPERCALCAEMIA,1
AU,HYPERPARATHYROIDISM,1
AU,HYPERPHOSPHATAEMIA,1
AU,HYPERSENSITIVITY VASCULITIS,1
AU,HYPERTONIC BLADDER,1
AU,HYPOMAGNESAEMIA,1
AU,HYPONATRAEMIA,1
AU,HYPOTENSION,1
AU,HYPOTHYROIDISM,1
AU,HYPOTRICHOSIS,1
AU,HYPOXIA,1
AU,ILEUS PARALYTIC,1
AU,IMMUNE-MEDIATED ADVERSE REACTION,1
AU,IMMUNODEFICIENCY,1
AU,IMMUNOSUPPRESSION,1
AU,IMPAIRED DRIVING ABILITY,1
AU,IMPAIRED WORK ABILITY,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INFECTION PARASITIC,1
AU,INFECTION SUSCEPTIBILITY INCREASED,1
AU,INFECTIVE MYOSITIS,1
AU,INFLAMMATION,1
AU,INJECTION SITE CELLULITIS,1
AU,INJECTION SITE HYPERSENSITIVITY,1
AU,INJECTION SITE INFECTION,1
AU,INJECTION SITE RECALL REACTION,1
AU,INTERSTITIAL LUNG DISEASE,1
AU,INTERVERTEBRAL DISC DISORDER,1
AU,INTESTINAL HAEMORRHAGE,1
AU,INTRACRANIAL ANEURYSM,1
AU,IRIDOCYCLITIS,1
AU,ISCHAEMIC STROKE,1
AU,JAUNDICE,1
AU,JOINT ARTHROPLASTY,1
AU,JOINT STIFFNESS,1
AU,JOINT SWELLING,1
AU,JUVENILE IDIOPATHIC ARTHRITIS,1
AU,KNEE ARTHROPLASTY,1
AU,LACRIMATION INCREASED,1
AU,LEUKOCYTOCLASTIC VASCULITIS,1
AU,LIP INJURY,1
AU,LOCAL REACTION,1
AU,LOCAL SWELLING,1
AU,LUMBAR RADICULOPATHY,1
AU,LUMBAR VERTEBRAL FRACTURE,1
AU,LUNG ABSCESS,1
AU,LUNG DISORDER,1
AU,LUNG NEOPLASM MALIGNANT,1
AU,LYME DISEASE,1
AU,LYMPHADENOPATHY,1
AU,MALIGNANT MELANOMA,1
AU,MEDICATION RESIDUE PRESENT,1
AU,MELANOCYTIC NAEVUS,1
AU,MEMORY IMPAIRMENT,1
AU,MENINGOCOCCAL INFECTION,1
AU,MENINGOENCEPHALITIS HERPETIC,1
AU,MENTAL IMPAIRMENT,1
AU,METASTATIC GASTRIC CANCER,1
AU,MIGRAINE,1
AU,MONOCLONAL B-CELL LYMPHOCYTOSIS,1
AU,MUCOSAL INFLAMMATION,1
AU,MUCOSAL ULCERATION,1
AU,MULTIFOCAL MOTOR NEUROPATHY,1
AU,MULTIPLE FRACTURES,1
AU,MUSCLE RUPTURE,1
AU,MUSCULAR WEAKNESS,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MUSCULOSKELETAL PAIN,1
AU,MYELITIS TRANSVERSE,1
AU,MYOPATHY,1
AU,NAIL DISORDER,1
AU,NASAL DISORDER,1
AU,NECK DEFORMITY,1
AU,NECK PAIN,1
AU,NECROSIS,1
AU,NEMATODIASIS,1
AU,NEPHROTIC SYNDROME,1
AU,NERVE COMPRESSION,1
AU,NEURALGIA,1
AU,NEUROBLASTOMA,1
AU,NEUROTOXICITY,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,NO ADVERSE EVENT,1
AU,NORMAL TENSION GLAUCOMA,1
AU,NORMOCYTIC ANAEMIA,1
AU,NOSOCOMIAL INFECTION,1
AU,NYSTAGMUS,1
AU,OBESITY,1
AU,OBSTRUCTIVE AIRWAYS DISORDER,1
AU,OEDEMA PERIPHERAL,1
AU,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
AU,OPTIC NEURITIS,1
AU,ORAL MUCOSAL ERYTHEMA,1
AU,OROPHARYNGEAL PAIN,1
AU,OVERDOSE,1
AU,OXYGEN SATURATION ABNORMAL,1
AU,OXYGEN SATURATION DECREASED,1
AU,PANCREATIC CARCINOMA,1
AU,PANCREATIC MASS,1
AU,PEPTIC ULCER,1
AU,PERICARDIAL EFFUSION,1
AU,PERICARDITIS,1
AU,PERITONITIS,1
AU,PERIVASCULAR DERMATITIS,1
AU,PERONEAL NERVE PALSY,1
AU,PERTUSSIS,1
AU,PHARYNGEAL OEDEMA,1
AU,PHARYNGITIS,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PIGMENTATION DISORDER,1
AU,PLASMA CELL MYELOMA,1
AU,PLEURAL EFFUSION,1
AU,PLEURITIC PAIN,1
AU,PNEUMONIA MYCOPLASMAL,1
AU,PNEUMOTHORAX,1
AU,POLYMORPHIC LIGHT ERUPTION,1
AU,POOR QUALITY DRUG ADMINISTERED,1
AU,POOR QUALITY SLEEP,1
AU,PORTAL HYPERTENSION,1
AU,POST PROCEDURAL INFECTION,1
AU,POSTPARTUM HAEMORRHAGE,1
AU,PRIMARY SEQUESTRUM,1
AU,PRODUCT STORAGE ERROR,1
AU,PRODUCTIVE COUGH,1
AU,PROGRESSIVE MULTIPLE SCLEROSIS,1
AU,PROSTATE INFECTION,1
AU,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
AU,PULMONARY AIR LEAKAGE,1
AU,PULMONARY MASS,1
AU,PULMONARY TOXICITY,1
AU,PUSTULAR PSORIASIS,1
AU,QUADRIPLEGIA,1
AU,QUALITY OF LIFE DECREASED,1
AU,RASH MACULO-PAPULAR,1
AU,RASH PUSTULAR,1
AU,RENAL CELL CARCINOMA,1
AU,RENAL COLIC,1
AU,RENAL HAEMORRHAGE,1
AU,RENAL NEOPLASM,1
AU,RESPIRATORY DISORDER,1
AU,RESPIRATORY TRACT ULCERATION,1
AU,RETINAL VEIN OCCLUSION,1
AU,RETROPERITONEAL LYMPHADENOPATHY,1
AU,RETROPERITONEAL MASS,1
AU,RHEUMATOID LUNG,1
AU,RHEUMATOID NODULE,1
AU,RHINITIS,1
AU,RHINORRHOEA,1
AU,ROAD TRAFFIC ACCIDENT,1
AU,ROSACEA,1
AU,ROTATOR CUFF SYNDROME,1
AU,SCAR,1
AU,SEASONAL ALLERGY,1
AU,SEIZURE,1
AU,SEPSIS,1
AU,SEPTIC SHOCK,1
AU,SINUS DISORDER,1
AU,SINUS HEADACHE,1
AU,SINUSITIS,1
AU,SJOGREN^S SYNDROME,1
AU,SKIN DISCOLOURATION,1
AU,SKIN IRRITATION,1
AU,SKIN LESION,1
AU,SKIN TEXTURE ABNORMAL,1
AU,SLEEP APNOEA SYNDROME,1
AU,SOCIAL AVOIDANT BEHAVIOUR,1
AU,SPINAL DISORDER,1
AU,SPINAL LAMINECTOMY,1
AU,SPINAL PAIN,1
AU,SPLENOMEGALY,1
AU,SPONDYLITIS,1
AU,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
AU,STAPHYLOCOCCAL SEPSIS,1
AU,STAPHYLOCOCCAL SKIN INFECTION,1
AU,STIFF PERSON SYNDROME,1
AU,STOMA SITE REACTION,1
AU,STRABISMUS,1
AU,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
AU,SUBARACHNOID HAEMORRHAGE,1
AU,SUNBURN,1
AU,SYNCOPE,1
AU,TACHYCARDIA,1
AU,TENOSYNOVITIS,1
AU,THERAPEUTIC RESPONSE SHORTENED,1
AU,THERAPY PARTIAL RESPONDER,1
AU,THORACIC VERTEBRAL FRACTURE,1
AU,THROAT IRRITATION,1
AU,THROMBOSIS,1
AU,THYROID CANCER,1
AU,TOOTH LOSS,1
AU,TRANSIENT ISCHAEMIC ATTACK,1
AU,TRAUMATIC LUNG INJURY,1
AU,TRIPLE NEGATIVE BREAST CANCER,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,TYPE 2 DIABETES MELLITUS,1
AU,URINARY INCONTINENCE,1
AU,UROSEPSIS,1
AU,UTERINE POLYP,1
AU,VAGINAL HAEMORRHAGE,1
AU,VASCULITIC RASH,1
AU,VASCULITIS,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VENTRICULAR FIBRILLATION,1
AU,VERTIGO,1
AU,VIITH NERVE PARALYSIS,1
AU,VIRAEMIA,1
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
AU,VISION BLURRED,1
AU,WALDENSTROM^S MACROGLOBULINAEMIA,1
AU,WOUND,1
AU,WOUND COMPLICATION,1
AU,WRIST FRACTURE,1
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
AT,ERYSIPELAS,8
AT,PNEUMONIA,7
AT,ARTHRALGIA,4
AT,DEMYELINATION,4
AT,DRUG INEFFECTIVE,4
AT,INJECTION SITE ERYTHEMA,4
AT,ACUTE RESPIRATORY DISTRESS SYNDROME,3
AT,CAROTID ARTERY STENOSIS,3
AT,CIRCULATORY COLLAPSE,3
AT,DIARRHOEA,3
AT,ERYTHEMA,3
AT,FALL,3
AT,INFLUENZA,3
AT,MATERNAL EXPOSURE DURING PREGNANCY,3
AT,RESPIRATORY TRACT INFECTION,3
AT,SEPSIS,3
AT,AMAUROSIS,2
AT,AMNIORRHEXIS,2
AT,ANKYLOSING SPONDYLITIS,2
AT,ANURIA,2
AT,BLADDER TRANSITIONAL CELL CARCINOMA,2
AT,BLISTER,2
AT,BRADYCARDIA FOETAL,2
AT,BREAST CANCER FEMALE,2
AT,BRONCHIAL CARCINOMA,2
AT,CENTRAL NERVOUS SYSTEM LESION,2
AT,CHOLELITHIASIS,2
AT,CLEAR CELL RENAL CELL CARCINOMA,2
AT,CLINICALLY ISOLATED SYNDROME,2
AT,COLD URTICARIA,2
AT,CONDITION AGGRAVATED,2
AT,COORDINATION ABNORMAL,2
AT,DIPLOPIA,2
AT,FACIAL PARESIS,2
AT,GAIT DISTURBANCE,2
AT,GASTROOESOPHAGEAL REFLUX DISEASE,2
AT,HEMIPARESIS,2
AT,HEPATITIS TOXIC,2
AT,HYPONATRAEMIA,2
AT,IMPAIRED HEALING,2
AT,INFECTION,2
AT,INJECTION RELATED REACTION,2
AT,LEUKOCYTOSIS,2
AT,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AT,MULTIPLE FRACTURES,2
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AT,PARONYCHIA,2
AT,PNEUMOTHORAX,2
AT,PREMATURE BABY,2
AT,PREMATURE DELIVERY,2
AT,PROSTATE CANCER,2
AT,PSORIASIS,2
AT,PYREXIA,2
AT,SYNCOPE,2
AT,TONSILLITIS,2
AT,TRANSIENT ISCHAEMIC ATTACK,2
AT,URINARY TRACT INFECTION,2
AT,VISUAL FIELD DEFECT,2
AT,ABNORMAL BEHAVIOUR,1
AT,ACUTE BIPHENOTYPIC LEUKAEMIA,1
AT,ACUTE CORONARY SYNDROME,1
AT,ACUTE MYELOID LEUKAEMIA,1
AT,ACUTE MYOCARDIAL INFARCTION,1
AT,ACUTE PRERENAL FAILURE,1
AT,AGGRESSION,1
AT,ANAPHYLACTIC SHOCK,1
AT,ANASTOMOTIC ULCER PERFORATION,1
AT,ANGINA PECTORIS,1
AT,ANOMALY OF EXTERNAL EAR CONGENITAL,1
AT,AORTIC STENOSIS,1
AT,ARTHRITIS,1
AT,ATELECTASIS,1
AT,ATRIAL FIBRILLATION,1
AT,AUTOIMMUNE THYROIDITIS,1
AT,BACTERAEMIA,1
AT,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AT,BILE DUCT STONE,1
AT,BRAIN STEM SYNDROME,1
AT,BREAST CANCER,1
AT,BREAST CANCER METASTATIC,1
AT,BRONCHIAL NEOPLASM,1
AT,BRONCHIOLITIS,1
AT,BRONCHOPULMONARY ASPERGILLOSIS,1
AT,BURNING SENSATION,1
AT,BURSITIS,1
AT,CARDIOVASCULAR DISORDER,1
AT,CEREBRAL HAEMATOMA,1
AT,CHOLECYSTITIS,1
AT,CLAVICLE FRACTURE,1
AT,CLOSTRIDIUM DIFFICILE COLITIS,1
AT,CONJUNCTIVAL HYPERAEMIA,1
AT,CORONA VIRUS INFECTION,1
AT,CRANIAL NERVE DISORDER,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,DEAFNESS,1
AT,DEATH,1
AT,DECREASED APPETITE,1
AT,DEHYDRATION,1
AT,DEMYELINATING POLYNEUROPATHY,1
AT,DEPRESSION,1
AT,DERMAL CYST,1
AT,DERMATITIS,1
AT,DERMATOFIBROSARCOMA PROTUBERANS,1
AT,DIFFUSE LARGE B-CELL LYMPHOMA,1
AT,DIVERTICULITIS,1
AT,DYSGEUSIA,1
AT,DYSPNOEA,1
AT,DYSPNOEA EXERTIONAL,1
AT,DYSSTASIA,1
AT,EATING DISORDER,1
AT,EMPHYSEMA,1
AT,ENCEPHALITIS,1
AT,END STAGE RENAL DISEASE,1
AT,ENDOMETRIAL CANCER METASTATIC,1
AT,ENDOMETRIOSIS,1
AT,EPICONDYLITIS,1
AT,EPISTAXIS,1
AT,ESCHERICHIA INFECTION,1
AT,EXPOSURE DURING BREAST FEEDING,1
AT,FATIGUE,1
AT,FEMORAL NECK FRACTURE,1
AT,FLUSHING,1
AT,GASTRIC ULCER,1
AT,GASTRIC ULCER HAEMORRHAGE,1
AT,GOUT,1
AT,GOUTY TOPHUS,1
AT,GUILLAIN-BARRE SYNDROME,1
AT,HEADACHE,1
AT,HEPATOTOXICITY,1
AT,HUMAN BOCAVIRUS INFECTION,1
AT,HYPOAESTHESIA,1
AT,HYPOTENSION,1
AT,IMMUNOSUPPRESSION,1
AT,IMPLANT SITE INFECTION,1
AT,INFLAMMATORY MARKER INCREASED,1
AT,INJECTION SITE INDURATION,1
AT,INJECTION SITE PRURITUS,1
AT,INJURY,1
AT,INTERSTITIAL LUNG DISEASE,1
AT,INTESTINAL FISTULA,1
AT,INVASIVE DUCTAL BREAST CARCINOMA,1
AT,JOINT SWELLING,1
AT,LACUNAR STROKE,1
AT,LIPIDOSIS,1
AT,LIVER FUNCTION TEST INCREASED,1
AT,LOCALISED INFECTION,1
AT,MALIGNANT MELANOMA,1
AT,MALIGNANT MELANOMA IN SITU,1
AT,MALIGNANT MELANOMA STAGE I,1
AT,METASTASES TO LYMPH NODES,1
AT,MITRAL VALVE INCOMPETENCE,1
AT,MORPHOEA,1
AT,MULTIPLE SCLEROSIS,1
AT,MUSCLE STRAIN,1
AT,MUSCLE TWITCHING,1
AT,MUSCULAR WEAKNESS,1
AT,MUSCULOSKELETAL DISORDER,1
AT,MUSCULOSKELETAL PAIN,1
AT,MYASTHENIA GRAVIS,1
AT,NECROTISING FASCIITIS,1
AT,NEOPLASM MALIGNANT,1
AT,NEURALGIA,1
AT,NO ADVERSE EVENT,1
AT,OEDEMA PERIPHERAL,1
AT,OPTIC NERVE INJURY,1
AT,OPTIC NEURITIS,1
AT,ORGANISING PNEUMONIA,1
AT,OSTEOCHONDROSIS,1
AT,PAGET^S DISEASE OF NIPPLE,1
AT,PAIN,1
AT,PANCREATITIS,1
AT,PANOPHTHALMITIS,1
AT,PAPILLARY THYROID CANCER,1
AT,PARAESTHESIA,1
AT,PEMPHIGUS,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PERIPHERAL ARTERY BYPASS,1
AT,PERIPROSTHETIC FRACTURE,1
AT,POLYARTHRITIS,1
AT,PROCEDURAL COMPLICATION,1
AT,PRODUCT USE ISSUE,1
AT,PRODUCTIVE COUGH,1
AT,PRURITUS GENERALISED,1
AT,PSYCHOTIC DISORDER,1
AT,PULMONARY EMBOLISM,1
AT,PULMONARY FUNCTION TEST DECREASED,1
AT,PULMONARY SARCOIDOSIS,1
AT,PUPILS UNEQUAL,1
AT,RASH,1
AT,RASH PAPULAR,1
AT,RASH VESICULAR,1
AT,RENAL CELL CARCINOMA RECURRENT,1
AT,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
AT,RHEUMATOID LUNG,1
AT,RHONCHI,1
AT,ROAD TRAFFIC ACCIDENT,1
AT,SACROILIITIS,1
AT,SENSORY DISTURBANCE,1
AT,SICK SINUS SYNDROME,1
AT,SPONDYLOLISTHESIS,1
AT,STOMATITIS,1
AT,STRESS,1
AT,SYSTEMIC CANDIDA,1
AT,TEMPERATURE REGULATION DISORDER,1
AT,TENDERNESS,1
AT,THYMOMA,1
AT,THYROID CANCER,1
AT,TINNITUS,1
AT,TOOTH EXTRACTION,1
AT,TRANSAMINASES INCREASED,1
AT,UROSEPSIS,1
AT,URTICARIA,1
AT,UTERINE LEIOMYOMA,1
AT,VEIN DISORDER,1
AT,VESTIBULAR NEURONITIS,1
AT,VIITH NERVE INJURY,1
AT,VISION BLURRED,1
AT,VISUAL ACUITY REDUCED,1
AT,VISUAL IMPAIRMENT,1
AT,WEIGHT DECREASED,1
BH,BREAST CANCER FEMALE,1
BH,COMPLICATION OF PREGNANCY,1
BH,CONDITION AGGRAVATED,1
BH,CONGESTIVE CARDIOMYOPATHY,1
BH,DEATH NEONATAL,1
BH,DRUG EFFECT DECREASED,1
BH,FOETAL EXPOSURE DURING PREGNANCY,1
BH,HEPATIC ENZYME INCREASED,1
BH,INJECTION SITE CELLULITIS,1
BH,INJECTION SITE ERYTHEMA,1
BH,INJECTION SITE INDURATION,1
BH,INJECTION SITE INFLAMMATION,1
BH,INJECTION SITE SWELLING,1
BH,LEUKOPENIA,1
BH,MONOCYTE COUNT INCREASED,1
BH,NAIL BED BLEEDING,1
BH,NAIL INFECTION,1
BH,NEUTROPENIA,1
BH,PAPILLARY THYROID CANCER,1
BH,PSORIASIS,1
BH,PULMONARY OEDEMA,1
BH,PYOGENIC GRANULOMA,1
BH,SKIN HAEMORRHAGE,1
BH,SKIN PAPILLOMA,1
BH,SUBCUTANEOUS ABSCESS,1
BH,VASCULAR NEOPLASM,1
BE,CONDITION AGGRAVATED,16
BE,ARTHRALGIA,11
BE,FATIGUE,11
BE,PSORIASIS,11
BE,DRUG INEFFECTIVE,10
BE,HEADACHE,10
BE,PAIN,9
BE,ERYTHEMA,7
BE,PAIN IN EXTREMITY,7
BE,PYREXIA,7
BE,BACK PAIN,6
BE,BRONCHITIS,6
BE,DIVERTICULITIS,6
BE,PRURITUS,6
BE,CELLULITIS,5
BE,FALL,5
BE,LUNG INFECTION,5
BE,MUSCULOSKELETAL STIFFNESS,5
BE,MYALGIA,5
BE,NAUSEA,5
BE,PNEUMONIA,5
BE,POLYCHONDRITIS,5
BE,RHEUMATOID ARTHRITIS,5
BE,VERTIGO,5
BE,ARRHYTHMIA,4
BE,CEREBROVASCULAR ACCIDENT,4
BE,COLON CANCER,4
BE,DYSPNOEA,4
BE,EYE PAIN,4
BE,GAIT DISTURBANCE,4
BE,HAEMORRHAGE,4
BE,HYPERSENSITIVITY,4
BE,INFLUENZA LIKE ILLNESS,4
BE,INJECTION SITE ERYTHEMA,4
BE,JOINT DISLOCATION,4
BE,MALIGNANT MELANOMA,4
BE,PARAESTHESIA,4
BE,PERIPHERAL SWELLING,4
BE,ABDOMINAL DISCOMFORT,3
BE,ANAEMIA,3
BE,ASTHENIA,3
BE,BREAST CANCER,3
BE,BURSITIS,3
BE,CERVICAL DYSPLASIA,3
BE,CYTOMEGALOVIRUS INFECTION,3
BE,DEATH,3
BE,DIARRHOEA,3
BE,EPILEPSY,3
BE,ERYTHEMA INFECTIOSUM,3
BE,FEELING HOT,3
BE,FOOT FRACTURE,3
BE,GASTROINTESTINAL DISORDER,3
BE,HIP FRACTURE,3
BE,HYPERTENSION,3
BE,INSOMNIA,3
BE,IRIDOCYCLITIS,3
BE,LEUKOPENIA,3
BE,MALAISE,3
BE,MOBILITY DECREASED,3
BE,NASOPHARYNGITIS,3
BE,NEUTROPENIA,3
BE,OROPHARYNGEAL PAIN,3
BE,OSTEITIS,3
BE,PANCREATITIS ACUTE,3
BE,POLYARTHRITIS,3
BE,PULMONARY EMBOLISM,3
BE,RESPIRATORY DISTRESS,3
BE,SARCOIDOSIS,3
BE,STAPHYLOCOCCAL INFECTION,3
BE,THROMBOCYTOPENIA,3
BE,VISCERAL LEISHMANIASIS,3
BE,ABSCESS,2
BE,ALOPECIA,2
BE,ANGINA PECTORIS,2
BE,ANGIOEDEMA,2
BE,ANKLE FRACTURE,2
BE,ARTHRITIS,2
BE,ARTHROPATHY,2
BE,ARTHROPOD BITE,2
BE,ATRIAL FIBRILLATION,2
BE,AUTOIMMUNE HEPATITIS,2
BE,BALANCE DISORDER,2
BE,CARDIAC FAILURE,2
BE,CARDIO-RESPIRATORY ARREST,2
BE,CARPAL TUNNEL SYNDROME,2
BE,CHOLECYSTITIS,2
BE,COGNITIVE DISORDER,2
BE,CONTUSION,2
BE,CROHN^S DISEASE,2
BE,DEEP VEIN THROMBOSIS,2
BE,DEPRESSION,2
BE,DIZZINESS,2
BE,DRUG EFFECT INCOMPLETE,2
BE,FACE OEDEMA,2
BE,FEELING ABNORMAL,2
BE,FLUID RETENTION,2
BE,GASTROINTESTINAL INFLAMMATION,2
BE,HAEMORRHAGE SUBCUTANEOUS,2
BE,HAIRY CELL LEUKAEMIA,2
BE,HEPATITIS,2
BE,HODGKIN^S DISEASE,2
BE,HYPERTHYROIDISM,2
BE,HYPOAESTHESIA,2
BE,INFLAMMATION,2
BE,INJECTION SITE HAEMATOMA,2
BE,INJECTION SITE INFLAMMATION,2
BE,INJECTION SITE PAIN,2
BE,INJECTION SITE REACTION,2
BE,JOINT SWELLING,2
BE,KERATITIS,2
BE,LUNG ADENOCARCINOMA,2
BE,LYME DISEASE,2
BE,METASTASES TO BONE,2
BE,MONOPLEGIA,2
BE,MUCOCUTANEOUS LEISHMANIASIS,2
BE,MULTIPLE SCLEROSIS,2
BE,MUSCULOSKELETAL PAIN,2
BE,NECK PAIN,2
BE,OEDEMA PERIPHERAL,2
BE,PANCREATIC CARCINOMA,2
BE,PNEUMOTHORAX,2
BE,PROSTATE CANCER,2
BE,PSORIATIC ARTHROPATHY,2
BE,PULMONARY FIBROSIS,2
BE,PULMONARY FUNCTION TEST DECREASED,2
BE,RASH,2
BE,RENAL FAILURE,2
BE,SEPSIS,2
BE,SINUSITIS,2
BE,SJOGREN^S SYNDROME,2
BE,SKIN ATROPHY,2
BE,SKIN DISCOLOURATION,2
BE,SKIN IRRITATION,2
BE,SPINAL CORD INFECTION,2
BE,SPINAL DISORDER,2
BE,SPINAL PAIN,2
BE,SQUAMOUS CELL CARCINOMA,2
BE,STRESS,2
BE,TOXICITY TO VARIOUS AGENTS,2
BE,TREMOR,2
BE,TUBERCULOSIS,2
BE,VISUAL IMPAIRMENT,2
BE,WEIGHT DECREASED,2
BE,WEIGHT INCREASED,2
BE,ABDOMINAL DISTENSION,1
BE,ABDOMINAL PAIN,1
BE,ABDOMINAL PAIN UPPER,1
BE,ABNORMAL BEHAVIOUR,1
BE,ABNORMAL LOSS OF WEIGHT,1
BE,ABSCESS LIMB,1
BE,ABSCESS NECK,1
BE,ACCOMMODATION DISORDER,1
BE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
BE,ACUTE KIDNEY INJURY,1
BE,ACUTE LEUKAEMIA,1
BE,ADENOCARCINOMA,1
BE,ADENOCARCINOMA OF COLON,1
BE,ADENOID CYSTIC CARCINOMA,1
BE,ALTERED STATE OF CONSCIOUSNESS,1
BE,ANAL ABSCESS,1
BE,ANAPHYLACTOID REACTION,1
BE,ANTIBODY TEST POSITIVE,1
BE,ANXIETY,1
BE,AORTIC VALVE INCOMPETENCE,1
BE,ARTHRODESIS,1
BE,ASPHYXIA,1
BE,ATYPICAL FEMUR FRACTURE,1
BE,AUTOIMMUNE THYROIDITIS,1
BE,BLISTER,1
BE,BLOOD GLUCOSE ABNORMAL,1
BE,BLOOD PRESSURE DECREASED,1
BE,BONE DISORDER,1
BE,BONE MARROW OEDEMA,1
BE,BREATH ODOUR,1
BE,BRONCHIAL OBSTRUCTION,1
BE,BURSITIS INFECTIVE,1
BE,BURSITIS INFECTIVE STAPHYLOCOCCAL,1
BE,C-REACTIVE PROTEIN INCREASED,1
BE,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
BE,CARDIAC DISORDER,1
BE,CARDIAC FAILURE ACUTE,1
BE,CARDIAC FUNCTION TEST ABNORMAL,1
BE,CARDIOGENIC SHOCK,1
BE,CELLULITIS STAPHYLOCOCCAL,1
BE,CEREBRAL ATROPHY,1
BE,CHEST PAIN,1
BE,CHILLS,1
BE,CHOLANGITIS CHRONIC,1
BE,CHOLELITHIASIS,1
BE,CHORIORETINITIS,1
BE,CHRONIC KIDNEY DISEASE,1
BE,CLEAR CELL RENAL CELL CARCINOMA,1
BE,COLITIS,1
BE,CORNEAL EROSION,1
BE,CORONARY ARTERY OCCLUSION,1
BE,COUGH,1
BE,DECREASED APPETITE,1
BE,DEJA VU,1
BE,DEMYELINATION,1
BE,DENTAL CARIES,1
BE,DENTAL NECROSIS,1
BE,DEPRESSED MOOD,1
BE,DEPRESSION SUICIDAL,1
BE,DERMATITIS BULLOUS,1
BE,DERMATITIS PSORIASIFORM,1
BE,DIARRHOEA HAEMORRHAGIC,1
BE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BE,DRUG DOSE OMISSION,1
BE,DRUG EFFECT DELAYED,1
BE,DUODENITIS,1
BE,DYSGEUSIA,1
BE,DYSPHONIA,1
BE,DYSPHORIA,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSTONIA,1
BE,ECTHYMA,1
BE,ECZEMA,1
BE,EMBOLISM,1
BE,ENDOCARDITIS,1
BE,ENDOCRINE NEOPLASM,1
BE,ENDOMETRIAL ADENOCARCINOMA,1
BE,ENTEROCOCCAL INFECTION,1
BE,EPISCLERITIS,1
BE,EROSIVE DUODENITIS,1
BE,ERYSIPELAS,1
BE,EYE INFLAMMATION,1
BE,EYE INJURY,1
BE,EYE SWELLING,1
BE,EYELID OEDEMA,1
BE,FEEDING DISORDER,1
BE,FEELING OF BODY TEMPERATURE CHANGE,1
BE,FISTULA,1
BE,FOLATE DEFICIENCY,1
BE,FORMICATION,1
BE,FUNGAL INFECTION,1
BE,GANGLIONEUROMA,1
BE,GASTROENTERITIS,1
BE,GENERAL PHYSICAL HEALTH DETERIORATION,1
BE,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
BE,GLOMERULONEPHRITIS MEMBRANOUS,1
BE,GOUT,1
BE,HALLUCINATION,1
BE,HAND FRACTURE,1
BE,HEART RATE DECREASED,1
BE,HEPATIC CIRRHOSIS,1
BE,HEPATOSPLENOMEGALY,1
BE,HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME,1
BE,HERPES ZOSTER MENINGOENCEPHALITIS,1
BE,HIATUS HERNIA,1
BE,HIP ARTHROPLASTY,1
BE,HODGKIN^S DISEASE NODULAR SCLEROSIS,1
BE,HOT FLUSH,1
BE,HUMERUS FRACTURE,1
BE,HYDRONEPHROSIS,1
BE,HYPERCALCAEMIA,1
BE,HYPERHIDROSIS,1
BE,HYPERKALAEMIA,1
BE,HYPERTHERMIA,1
BE,HYPERVENTILATION,1
BE,HYPOTENSION,1
BE,HYPOVITAMINOSIS,1
BE,IMMOBILE,1
BE,IMMUNOSUPPRESSION,1
BE,IMPAIRED DRIVING ABILITY,1
BE,IMPAIRED HEALING,1
BE,IMPLANT SITE INFLAMMATION,1
BE,INFARCTION,1
BE,INFECTION,1
BE,INFLUENZA,1
BE,INJECTION SITE DISCOLOURATION,1
BE,INJECTION SITE OEDEMA,1
BE,INJECTION SITE PLAQUE,1
BE,INJECTION SITE PRURITUS,1
BE,INJURY,1
BE,INTENTIONAL PRODUCT USE ISSUE,1
BE,INTERCEPTED DRUG DISPENSING ERROR,1
BE,INTERNAL FIXATION OF FRACTURE,1
BE,INTERSTITIAL LUNG DISEASE,1
BE,INTERVERTEBRAL DISC PROTRUSION,1
BE,INTERVERTEBRAL DISCITIS,1
BE,INTESTINAL OPERATION,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,IRRITABILITY,1
BE,JOINT CREPITATION,1
BE,KERATITIS HERPETIC,1
BE,KIDNEY INFECTION,1
BE,LACERATION,1
BE,LACRIMATION INCREASED,1
BE,LARGE CELL LUNG CANCER STAGE II,1
BE,LARGE INTESTINE PERFORATION,1
BE,LEIOMYOSARCOMA,1
BE,LEUKAEMIA,1
BE,LEUKOENCEPHALOPATHY,1
BE,LIGAMENT INJURY,1
BE,LIMB INJURY,1
BE,LIPOMA,1
BE,LIVER DISORDER,1
BE,LOCAL REACTION,1
BE,LOCAL SWELLING,1
BE,LOSS OF CONSCIOUSNESS,1
BE,LUNG DISORDER,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LYMPHADENOPATHY,1
BE,LYMPHADENOPATHY MEDIASTINAL,1
BE,MACULE,1
BE,MALNUTRITION,1
BE,MEMORY IMPAIRMENT,1
BE,MENIERE^S DISEASE,1
BE,MENINGIOMA,1
BE,MENINGITIS ASEPTIC,1
BE,MENISCUS INJURY,1
BE,METASTASES TO LIVER,1
BE,METASTASES TO LUNG,1
BE,METASTASES TO THE MEDIASTINUM,1
BE,MITRAL VALVE DISEASE,1
BE,MOOD ALTERED,1
BE,MUCOSAL INFLAMMATION,1
BE,MUCOUS MEMBRANE DISORDER,1
BE,MUSCLE ATROPHY,1
BE,MUSCLE SPASMS,1
BE,MYCOBACTERIUM CHELONAE INFECTION,1
BE,MYELODYSPLASTIC SYNDROME,1
BE,MYOCARDIAL INFARCTION,1
BE,NASAL POLYPS,1
BE,NECK DEFORMITY,1
BE,NEPHROGENIC ANAEMIA,1
BE,NEPHROLITHIASIS,1
BE,NEPHROTIC SYNDROME,1
BE,NEURALGIA,1
BE,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
BE,NEUROGENIC BLADDER,1
BE,NIGHT SWEATS,1
BE,NODULAR REGENERATIVE HYPERPLASIA,1
BE,NON-ALCOHOLIC STEATOHEPATITIS,1
BE,NON-HODGKIN^S LYMPHOMA,1
BE,OBLITERATIVE BRONCHIOLITIS,1
BE,OBSTRUCTIVE UROPATHY,1
BE,OCULAR HYPERTENSION,1
BE,OPHTHALMIC HERPES ZOSTER,1
BE,ORAL FUNGAL INFECTION,1
BE,ORAL NEOPLASM,1
BE,OSTEONECROSIS,1
BE,OSTEONECROSIS OF JAW,1
BE,OVARIAN ADENOMA,1
BE,OVERDOSE,1
BE,PALLOR,1
BE,PANCREATIC CARCINOMA METASTATIC,1
BE,PANCREATIC CARCINOMA STAGE III,1
BE,PANCREATITIS,1
BE,PARONYCHIA,1
BE,PARTIAL SEIZURES,1
BE,PATHOGEN RESISTANCE,1
BE,PATHOLOGICAL FRACTURE,1
BE,PELVI-URETERIC OBSTRUCTION,1
BE,PELVIC FRACTURE,1
BE,PELVIC PAIN,1
BE,PERICARDITIS,1
BE,PHLEBITIS,1
BE,PHOTOSENSITIVITY REACTION,1
BE,PLASMA CELL MYELOMA,1
BE,PLATELET COUNT DECREASED,1
BE,PLEURAL NEOPLASM,1
BE,PLEURISY,1
BE,PNEUMONITIS,1
BE,POLYMYALGIA RHEUMATICA,1
BE,POLYNEUROPATHY,1
BE,POST PROCEDURAL INFECTION,1
BE,POST PROCEDURAL PNEUMONIA,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PRODUCT USE ISSUE,1
BE,PRODUCTIVE COUGH,1
BE,PSEUDOMONAL SEPSIS,1
BE,PSYCHIATRIC DECOMPENSATION,1
BE,PUBIS FRACTURE,1
BE,PULMONARY GRANULOMA,1
BE,PULMONARY TUBERCULOSIS,1
BE,PURULENT DISCHARGE,1
BE,PYELONEPHRITIS,1
BE,QUADRIPLEGIA,1
BE,RASH ERYTHEMATOUS,1
BE,RASH MACULAR,1
BE,RASH MACULO-PAPULAR,1
BE,RASH PRURITIC,1
BE,RAYNAUD^S PHENOMENON,1
BE,REACTION TO DRUG EXCIPIENTS,1
BE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BE,RENAL CELL CARCINOMA,1
BE,RENAL FAILURE ACUTE,1
BE,REPRODUCTIVE TRACT DISORDER,1
BE,RESPIRATORY DISORDER,1
BE,RESPIRATORY FAILURE,1
BE,RESPIRATORY TRACT INFECTION,1
BE,RETROPERITONEAL LYMPHADENOPATHY,1
BE,ROAD TRAFFIC ACCIDENT,1
BE,RUBBER SENSITIVITY,1
BE,SALMONELLA SEPSIS,1
BE,SCEDOSPORIUM INFECTION,1
BE,SCLERITIS,1
BE,SEPTIC SHOCK,1
BE,SHOCK,1
BE,SKIN WARM,1
BE,SMALL CELL LUNG CANCER METASTATIC,1
BE,SPINAL FRACTURE,1
BE,SPLENOMEGALY,1
BE,SPONDYLOARTHROPATHY,1
BE,SQUAMOUS CELL CARCINOMA OF SKIN,1
BE,STAPHYLOCOCCAL BACTERAEMIA,1
BE,STAPHYLOCOCCAL OSTEOMYELITIS,1
BE,STREPTOCOCCAL SEPSIS,1
BE,STRESS FRACTURE,1
BE,SUBCUTANEOUS ABSCESS,1
BE,SUDDEN DEATH,1
BE,SWELLING FACE,1
BE,SYRINGOMYELIA,1
BE,SYSTEMIC MYCOSIS,1
BE,TACHYCARDIA,1
BE,TENOSYNOVITIS,1
BE,THERAPEUTIC RESPONSE DECREASED,1
BE,THROAT IRRITATION,1
BE,THROMBOCYTOSIS,1
BE,THROMBOSIS,1
BE,THYROIDITIS,1
BE,TONGUE DISORDER,1
BE,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
BE,TONGUE SPASM,1
BE,TONSILLITIS,1
BE,TOOTH INFECTION,1
BE,TOOTHACHE,1
BE,TOXIC SHOCK SYNDROME,1
BE,TRACHEAL PAIN,1
BE,TRACHEITIS,1
BE,TRANSIENT ISCHAEMIC ATTACK,1
BE,TREATMENT NONCOMPLIANCE,1
BE,TUBULOINTERSTITIAL NEPHRITIS,1
BE,URETERIC STENOSIS,1
BE,URETEROLITHIASIS,1
BE,UROSEPSIS,1
BE,URTICARIA,1
BE,UTERINE HAEMORRHAGE,1
BE,UVEITIS,1
BE,VARICOSE VEIN,1
BE,VASCULITIS,1
BE,VASCULITIS GASTROINTESTINAL,1
BE,VENTRICULAR TACHYCARDIA,1
BE,VISUAL ACUITY REDUCED,1
BE,WALDENSTROM^S MACROGLOBULINAEMIA,1
BE,WHITE MATTER LESION,1
BE,WOUND INFECTION,1
BO,FAECALOMA,1
BO,HYPERTHYROIDISM,1
BO,INTESTINAL OBSTRUCTION,1
BO,INTESTINAL PERFORATION,1
BO,PAIN,1
BO,TACHYCARDIA,1
BO,URINARY TRACT INFECTION,1
BA,C-REACTIVE PROTEIN INCREASED,1
BA,CONDITION AGGRAVATED,1
BA,HAEMOGLOBIN DECREASED,1
BA,JUVENILE IDIOPATHIC ARTHRITIS,1
BA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BA,URTICARIA,1
BR,PAIN,465
BR,DRUG INEFFECTIVE,348
BR,INJECTION SITE PAIN,344
BR,ARTHRALGIA,298
BR,INJECTION SITE ERYTHEMA,256
BR,PAIN IN EXTREMITY,220
BR,INJECTION SITE PRURITUS,184
BR,DEATH,177
BR,PYREXIA,172
BR,RHEUMATOID ARTHRITIS,166
BR,PNEUMONIA,152
BR,INFLUENZA,149
BR,GAIT DISTURBANCE,144
BR,HEADACHE,143
BR,CONDITION AGGRAVATED,138
BR,URINARY TRACT INFECTION,135
BR,HYPERSENSITIVITY,134
BR,FEELING ABNORMAL,132
BR,FALL,129
BR,PRURITUS,123
BR,DYSPNOEA,116
BR,ASTHENIA,115
BR,COUGH,114
BR,MALAISE,114
BR,DIABETES MELLITUS,107
BR,WEIGHT DECREASED,102
BR,INJECTION SITE SWELLING,98
BR,SWELLING,97
BR,ARTHROPATHY,96
BR,ERYTHEMA,95
BR,JOINT SWELLING,91
BR,HYPERTENSION,88
BR,PERIPHERAL SWELLING,85
BR,BACK PAIN,84
BR,INFECTION,83
BR,PSORIASIS,81
BR,ARTHRITIS,75
BR,DECREASED IMMUNE RESPONSIVENESS,74
BR,FATIGUE,74
BR,DIZZINESS,70
BR,INJECTION SITE WARMTH,70
BR,VOMITING,69
BR,NAUSEA,66
BR,WEIGHT INCREASED,66
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,65
BR,INJECTION SITE MASS,64
BR,WOUND,64
BR,NASOPHARYNGITIS,63
BR,INFARCTION,62
BR,ABASIA,60
BR,DRUG EFFECT INCOMPLETE,60
BR,BLOOD PRESSURE INCREASED,58
BR,CARDIAC DISORDER,58
BR,DIARRHOEA,58
BR,MOBILITY DECREASED,55
BR,ANAEMIA,54
BR,PRODUCT USE ISSUE,53
BR,DEPRESSION,52
BR,DENGUE FEVER,50
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,50
BR,INJECTION SITE HAEMATOMA,49
BR,CATARACT,48
BR,INFLAMMATION,48
BR,PRODUCT QUALITY ISSUE,48
BR,OSTEOARTHRITIS,47
BR,ABDOMINAL PAIN,46
BR,LUNG DISORDER,46
BR,DECREASED APPETITE,45
BR,ANKYLOSING SPONDYLITIS,43
BR,ANXIETY,43
BR,IMMUNODEFICIENCY,43
BR,INJECTION SITE DISCOLOURATION,43
BR,INSOMNIA,43
BR,CEREBROVASCULAR ACCIDENT,41
BR,TUBERCULOSIS,41
BR,VISUAL IMPAIRMENT,41
BR,ARRHYTHMIA,40
BR,RASH MACULAR,40
BR,ALOPECIA,39
BR,NERVOUSNESS,39
BR,FEMUR FRACTURE,38
BR,INJECTION SITE HYPERSENSITIVITY,38
BR,JOINT INJURY,38
BR,MEMORY IMPAIRMENT,38
BR,NECK PAIN,38
BR,SINUSITIS,38
BR,BEDRIDDEN,37
BR,OEDEMA PERIPHERAL,37
BR,CHEST PAIN,36
BR,HYPOAESTHESIA,36
BR,DYSPHONIA,35
BR,SPINAL PAIN,35
BR,HAEMORRHAGE,34
BR,INJECTION SITE INDURATION,34
BR,SKIN DISCOLOURATION,34
BR,LOCAL SWELLING,33
BR,MUSCULOSKELETAL STIFFNESS,33
BR,NEPHROLITHIASIS,33
BR,OROPHARYNGEAL PAIN,33
BR,ABDOMINAL PAIN UPPER,32
BR,BONE PAIN,32
BR,LIMB INJURY,32
BR,PRURITUS GENERALISED,32
BR,PSORIATIC ARTHROPATHY,31
BR,SOMNOLENCE,31
BR,CARDIAC ARREST,30
BR,CHOLELITHIASIS,30
BR,DRUG HYPERSENSITIVITY,30
BR,FOOT DEFORMITY,30
BR,MUSCULOSKELETAL PAIN,30
BR,SYNCOPE,29
BR,UVEITIS,29
BR,BLISTER,28
BR,FEAR,28
BR,SKIN EXFOLIATION,28
BR,BLOOD CHOLESTEROL INCREASED,27
BR,DRY MOUTH,27
BR,INTENTIONAL PRODUCT MISUSE,27
BR,RENAL DISORDER,27
BR,SEPSIS,27
BR,TREMOR,27
BR,FEELING HOT,26
BR,IMMUNOSUPPRESSION,26
BR,NODULE,26
BR,RHINITIS,26
BR,FINGER DEFORMITY,25
BR,HYPERHIDROSIS,25
BR,INJECTION SITE HAEMORRHAGE,25
BR,INJECTION SITE REACTION,25
BR,LIVER DISORDER,25
BR,MOVEMENT DISORDER,25
BR,RASH,25
BR,BURNING SENSATION,24
BR,OSTEOPOROSIS,24
BR,SLUGGISHNESS,24
BR,THROMBOSIS,24
BR,BONE DISORDER,23
BR,DEPRESSED MOOD,23
BR,INCORRECT PRODUCT STORAGE,23
BR,SWELLING FACE,23
BR,BLOOD PRESSURE DECREASED,22
BR,DISEASE RECURRENCE,22
BR,DYSSTASIA,22
BR,EYE PAIN,22
BR,HAND DEFORMITY,22
BR,INTERVERTEBRAL DISC PROTRUSION,22
BR,SPINAL DISORDER,22
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,21
BR,CHILLS,21
BR,DISEASE PROGRESSION,21
BR,ERYSIPELAS,21
BR,RHEUMATIC DISORDER,21
BR,ROAD TRAFFIC ACCIDENT,21
BR,GALLBLADDER DISORDER,20
BR,LUNG INFECTION,20
BR,NEOPLASM MALIGNANT,20
BR,OCULAR HYPERAEMIA,20
BR,ABDOMINAL DISTENSION,19
BR,BLOOD PRESSURE ABNORMAL,19
BR,GAIT INABILITY,19
BR,HAEMATOMA,19
BR,LOWER LIMB FRACTURE,19
BR,MUSCULAR WEAKNESS,19
BR,PARAESTHESIA,19
BR,PHARYNGITIS,19
BR,RENAL FAILURE,19
BR,RETCHING,19
BR,APPLICATION SITE PAIN,18
BR,DIVERTICULITIS,18
BR,EATING DISORDER,18
BR,INJECTION SITE OEDEMA,18
BR,LIMB DISCOMFORT,18
BR,MASS,18
BR,MUSCLE SPASMS,18
BR,PULMONARY FIBROSIS,18
BR,STRESS,18
BR,TACHYCARDIA,18
BR,COMA,17
BR,FEEDING DISORDER,17
BR,FEELING COLD,17
BR,HERPES ZOSTER,17
BR,HYPOKINESIA,17
BR,INJECTION SITE DISCOMFORT,17
BR,SECRETION DISCHARGE,17
BR,THROAT IRRITATION,17
BR,VIRAL INFECTION,17
BR,CRYING,16
BR,DRUG ADMINISTRATION ERROR,16
BR,DRUG-INDUCED LIVER INJURY,16
BR,FIBROMYALGIA,16
BR,PRODUCTIVE COUGH,16
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,16
BR,BACTERIAL INFECTION,15
BR,BRONCHITIS,15
BR,HAEMATOCHEZIA,15
BR,HERNIA,15
BR,HYPOTENSION,15
BR,IMMUNE SYSTEM DISORDER,15
BR,LABYRINTHITIS,15
BR,MUSCLE RIGIDITY,15
BR,NEEDLE ISSUE,15
BR,PULMONARY MASS,15
BR,SKIN DISORDER,15
BR,VISION BLURRED,15
BR,ACCIDENT,14
BR,ARTHRITIS INFECTIVE,14
BR,ASTHMA,14
BR,BLOOD PRESSURE FLUCTUATION,14
BR,GASTRIC DISORDER,14
BR,GASTROINTESTINAL DISORDER,14
BR,GLAUCOMA,14
BR,IMPAIRED HEALING,14
BR,LOCALISED INFECTION,14
BR,MUSCULOSKELETAL DISORDER,14
BR,NOSOCOMIAL INFECTION,14
BR,RESPIRATORY FAILURE,14
BR,SKIN LESION,14
BR,THYROID DISORDER,14
BR,TOOTH INFECTION,14
BR,UPPER LIMB FRACTURE,14
BR,ABDOMINAL DISCOMFORT,13
BR,APPLICATION SITE ERYTHEMA,13
BR,BLINDNESS,13
BR,CHONDROPATHY,13
BR,DRY SKIN,13
BR,EYE DISORDER,13
BR,LOSS OF CONSCIOUSNESS,13
BR,PALPITATIONS,13
BR,PULMONARY EMBOLISM,13
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,13
BR,SPINAL FRACTURE,13
BR,TOOTH DISORDER,13
BR,VISUAL ACUITY REDUCED,13
BR,ACUTE MYOCARDIAL INFARCTION,12
BR,ATROPHY,12
BR,BALANCE DISORDER,12
BR,CATARRH,12
BR,CYST,12
BR,DEAFNESS,12
BR,DRUG DOSE OMISSION,12
BR,DYSENTERY,12
BR,EMOTIONAL DISORDER,12
BR,EYE IRRITATION,12
BR,FORMICATION,12
BR,GASTROINTESTINAL INFECTION,12
BR,HEPATIC STEATOSIS,12
BR,JUVENILE IDIOPATHIC ARTHRITIS,12
BR,MYOCARDIAL INFARCTION,12
BR,NEOPLASM,12
BR,PLEURAL EFFUSION,12
BR,RESPIRATORY DISORDER,12
BR,TUBERCULIN TEST POSITIVE,12
BR,WOUND HAEMORRHAGE,12
BR,APPLICATION SITE PRURITUS,11
BR,BLOOD CHOLESTEROL ABNORMAL,11
BR,BLOOD GLUCOSE INCREASED,11
BR,BREAST CANCER,11
BR,CARDIOMEGALY,11
BR,DEHYDRATION,11
BR,FOOT FRACTURE,11
BR,INJECTION SITE URTICARIA,11
BR,IRRITABILITY,11
BR,JOINT EFFUSION,11
BR,MUSCULOSKELETAL CHEST PAIN,11
BR,PARALYSIS,11
BR,PLATELET COUNT DECREASED,11
BR,SLEEP DISORDER,11
BR,THERAPEUTIC RESPONSE DECREASED,11
BR,WOUND INFECTION,11
BR,ANGIOPATHY,10
BR,BREAST MASS,10
BR,CELLULITIS,10
BR,CHEST DISCOMFORT,10
BR,CONFUSIONAL STATE,10
BR,DRUG DEPENDENCE,10
BR,DRUG EFFECT DECREASED,10
BR,DYSGEUSIA,10
BR,DYSPHAGIA,10
BR,EPISTAXIS,10
BR,GASTRIC ULCER,10
BR,GASTRITIS,10
BR,HEAD DISCOMFORT,10
BR,HEPATIC CIRRHOSIS,10
BR,HEPATITIS,10
BR,HERPES VIRUS INFECTION,10
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,10
BR,JOINT LOCK,10
BR,JOINT STIFFNESS,10
BR,LARYNGEAL OEDEMA,10
BR,LIGAMENT SPRAIN,10
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,10
BR,MATERNAL EXPOSURE DURING PREGNANCY,10
BR,MYALGIA,10
BR,NAIL DISORDER,10
BR,PALLOR,10
BR,POOR QUALITY DRUG ADMINISTERED,10
BR,RESPIRATORY TRACT INFECTION,10
BR,RHINORRHOEA,10
BR,SENSITIVITY TO WEATHER CHANGE,10
BR,SKIN SENSITISATION,10
BR,SPEECH DISORDER,10
BR,THROAT TIGHTNESS,10
BR,VARICOSE VEIN,10
BR,VASCULITIS,10
BR,WALKING DISABILITY,10
BR,ANAL HAEMORRHAGE,9
BR,CHIKUNGUNYA VIRUS INFECTION,9
BR,EMPHYSEMA,9
BR,GENERALISED ERYTHEMA,9
BR,HEART RATE INCREASED,9
BR,KIDNEY INFECTION,9
BR,LIMB DEFORMITY,9
BR,RESPIRATORY ARREST,9
BR,RETINAL DETACHMENT,9
BR,RHEUMATIC FEVER,9
BR,SEIZURE,9
BR,SKIN INFECTION,9
BR,SKIN IRRITATION,9
BR,SUICIDAL IDEATION,9
BR,TENDON RUPTURE,9
BR,TOXICITY TO VARIOUS AGENTS,9
BR,URTICARIA,9
BR,ARTERIAL OCCLUSIVE DISEASE,8
BR,CROHN^S DISEASE,8
BR,CYSTITIS,8
BR,DIABETES MELLITUS INADEQUATE CONTROL,8
BR,DRY EYE,8
BR,DRY THROAT,8
BR,DYSPEPSIA,8
BR,DYSURIA,8
BR,FURUNCLE,8
BR,HEAD INJURY,8
BR,HYPERKERATOSIS,8
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,8
BR,JOINT DISLOCATION,8
BR,KNEE DEFORMITY,8
BR,MENTAL DISORDER,8
BR,NASAL CONGESTION,8
BR,PULMONARY OEDEMA,8
BR,RASH PUSTULAR,8
BR,RENAL PAIN,8
BR,SCIATICA,8
BR,SKIN FISSURES,8
BR,SKIN HAEMORRHAGE,8
BR,SYNOVITIS,8
BR,UTERINE DISORDER,8
BR,WHEELCHAIR USER,8
BR,WHEEZING,8
BR,ANKLE FRACTURE,7
BR,APPLICATION SITE SWELLING,7
BR,ASPARTATE AMINOTRANSFERASE INCREASED,7
BR,BLINDNESS UNILATERAL,7
BR,C-REACTIVE PROTEIN INCREASED,7
BR,CARTILAGE INJURY,7
BR,CONJUNCTIVITIS,7
BR,DEVICE RELATED INFECTION,7
BR,EAR INFECTION,7
BR,EAR PAIN,7
BR,FACE INJURY,7
BR,FEAR OF INJECTION,7
BR,GASTROOESOPHAGEAL REFLUX DISEASE,7
BR,HYPOGLYCAEMIA,7
BR,INCORRECT DOSE ADMINISTERED,7
BR,INJECTION SITE PAPULE,7
BR,INJECTION SITE VESICLES,7
BR,INJURY,7
BR,JOINT RANGE OF MOTION DECREASED,7
BR,MOUTH INJURY,7
BR,MULTI-ORGAN FAILURE,7
BR,PHARYNGEAL INFLAMMATION,7
BR,POST PROCEDURAL COMPLICATION,7
BR,SEPTIC SHOCK,7
BR,SKIN BURNING SENSATION,7
BR,SNEEZING,7
BR,THERAPEUTIC RESPONSE UNEXPECTED,7
BR,THROMBOCYTOPENIA,7
BR,THYROID NEOPLASM,7
BR,TINNITUS,7
BR,TONSILLITIS,7
BR,TOOTHACHE,7
BR,UMBILICAL HERNIA,7
BR,VENOUS OCCLUSION,7
BR,ALANINE AMINOTRANSFERASE INCREASED,6
BR,ALLERGIC COUGH,6
BR,APHONIA,6
BR,BLOOD GLUCOSE ABNORMAL,6
BR,BLOOD URIC ACID INCREASED,6
BR,BREAST CANCER FEMALE,6
BR,BRONCHOPNEUMONIA,6
BR,BURSITIS,6
BR,CARDIO-RESPIRATORY ARREST,6
BR,CAROTID ARTERY OCCLUSION,6
BR,CONVULSION,6
BR,DEEP VEIN THROMBOSIS,6
BR,DEMENTIA ALZHEIMER^S TYPE,6
BR,DERMATITIS ALLERGIC,6
BR,EYE SWELLING,6
BR,GENERAL PHYSICAL HEALTH DETERIORATION,6
BR,HAEMOGLOBIN DECREASED,6
BR,HAEMORRHOIDS,6
BR,HEPATIC CANCER,6
BR,HYPERTENSIVE CRISIS,6
BR,INFLUENZA LIKE ILLNESS,6
BR,LEUKOPENIA,6
BR,LUNG NEOPLASM MALIGNANT,6
BR,LYMPHADENITIS BACTERIAL,6
BR,LYMPHADENOPATHY,6
BR,LYMPHOMA,6
BR,OEDEMA,6
BR,ORAL HERPES,6
BR,OSTEOPENIA,6
BR,PANIC DISORDER,6
BR,PELVIC FRACTURE,6
BR,POISONING,6
BR,POOR PERIPHERAL CIRCULATION,6
BR,PRODUCT STORAGE ERROR,6
BR,PROSTATE CANCER,6
BR,PULMONARY PAIN,6
BR,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,6
BR,TENDONITIS,6
BR,THYROID MASS,6
BR,TOOTH FRACTURE,6
BR,UTERINE LEIOMYOMA,6
BR,WRIST FRACTURE,6
BR,YELLOW SKIN,6
BR,BLISTER INFECTED,5
BR,BLOOD CREATININE INCREASED,5
BR,BLOOD TEST ABNORMAL,5
BR,BLOOD TRIGLYCERIDES INCREASED,5
BR,BODY HEIGHT DECREASED,5
BR,BONE EROSION,5
BR,CANDIDA INFECTION,5
BR,CONSTIPATION,5
BR,CYANOSIS,5
BR,DEFORMITY,5
BR,DISCOMFORT,5
BR,DYSLIPIDAEMIA,5
BR,EPILEPSY,5
BR,EYE HAEMORRHAGE,5
BR,FLUID RETENTION,5
BR,GASTRIC HAEMORRHAGE,5
BR,GASTROINTESTINAL CARCINOMA,5
BR,GROIN PAIN,5
BR,HEPATIC NEOPLASM,5
BR,HIP ARTHROPLASTY,5
BR,HIP FRACTURE,5
BR,INGUINAL HERNIA,5
BR,INJECTION SITE INFECTION,5
BR,INJECTION SITE RASH,5
BR,ISCHAEMIC STROKE,5
BR,LACRIMATION INCREASED,5
BR,MENISCUS INJURY,5
BR,MONOPLEGIA,5
BR,MOUTH HAEMORRHAGE,5
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
BR,NECROSIS,5
BR,NERVOUS SYSTEM DISORDER,5
BR,NEUROPATHY PERIPHERAL,5
BR,OBESITY,5
BR,OESOPHAGITIS,5
BR,ORAL DISORDER,5
BR,PAPULE,5
BR,PERIPHERAL COLDNESS,5
BR,PURULENT DISCHARGE,5
BR,RENAL CYST,5
BR,RENAL IMPAIRMENT,5
BR,RHEUMATOID FACTOR INCREASED,5
BR,SENSORY DISTURBANCE,5
BR,SKIN ATROPHY,5
BR,SKIN INJURY,5
BR,SKIN REACTION,5
BR,SKIN WOUND,5
BR,SPINAL OSTEOARTHRITIS,5
BR,SYNOVIAL CYST,5
BR,THYROID CANCER,5
BR,TONGUE DISORDER,5
BR,URINARY RETENTION,5
BR,VITAMIN D DECREASED,5
BR,WOUND COMPLICATION,5
BR,ADVERSE EVENT,4
BR,AGITATION,4
BR,AMERICAN TRYPANOSOMIASIS,4
BR,AMNESIA,4
BR,ANAPHYLACTIC REACTION,4
BR,APATHY,4
BR,APNOEA,4
BR,APPENDICITIS,4
BR,APPLICATION SITE HYPERSENSITIVITY,4
BR,ASTHMATIC CRISIS,4
BR,BLADDER CANCER,4
BR,BLADDER DISORDER,4
BR,BLOOD DISORDER,4
BR,BODY TEMPERATURE DECREASED,4
BR,BONE DEFORMITY,4
BR,BRAIN NEOPLASM,4
BR,CARDIOVASCULAR DISORDER,4
BR,COLD SWEAT,4
BR,CORNEAL DISORDER,4
BR,DANDRUFF,4
BR,DELIRIUM,4
BR,DEMYELINATING POLYNEUROPATHY,4
BR,DEVICE DISLOCATION,4
BR,DEVICE ISSUE,4
BR,DRUG DISPENSING ERROR,4
BR,DRUG EFFECT DELAYED,4
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
BR,DRUG PRESCRIBING ERROR,4
BR,EMBOLISM,4
BR,ENTERITIS INFECTIOUS,4
BR,EXOSTOSIS,4
BR,EXPIRED PRODUCT ADMINISTERED,4
BR,FLAVIVIRUS INFECTION,4
BR,FRACTURE,4
BR,GASTRIC CANCER,4
BR,GLUCOSE TOLERANCE IMPAIRED,4
BR,GRIP STRENGTH DECREASED,4
BR,H1N1 INFLUENZA,4
BR,HAEMATURIA,4
BR,HAEMOPTYSIS,4
BR,HALLUCINATION,4
BR,HAND FRACTURE,4
BR,HIP DEFORMITY,4
BR,HYPERTHYROIDISM,4
BR,HYPOTHERMIA,4
BR,INCORRECT STORAGE OF DRUG,4
BR,INJECTION SITE BRUISING,4
BR,INJECTION SITE EXTRAVASATION,4
BR,INJECTION SITE INFLAMMATION,4
BR,INJECTION SITE IRRITATION,4
BR,INJECTION SITE NODULE,4
BR,INTESTINAL PERFORATION,4
BR,LABORATORY TEST ABNORMAL,4
BR,LACERATION,4
BR,LEIOMYOMA,4
BR,LEUKOCYTOSIS,4
BR,LIVER INJURY,4
BR,LUMBAR VERTEBRAL FRACTURE,4
BR,MALIGNANT MELANOMA,4
BR,MOTOR DYSFUNCTION,4
BR,NEPHRITIS,4
BR,NERVE INJURY,4
BR,OCULAR VASCULAR DISORDER,4
BR,OPTIC NEURITIS,4
BR,ORAL DISCOMFORT,4
BR,PANCREATITIS,4
BR,PHARYNGEAL DISORDER,4
BR,PIGMENTATION DISORDER,4
BR,PLATELET DISORDER,4
BR,POSTOPERATIVE WOUND INFECTION,4
BR,RHEUMATOID LUNG,4
BR,RHINITIS ALLERGIC,4
BR,SJOGREN^S SYNDROME,4
BR,SKIN HYPERTROPHY,4
BR,SKIN MASS,4
BR,SKIN PAPILLOMA,4
BR,SPONDYLITIS,4
BR,STOMATITIS,4
BR,SUFFOCATION FEELING,4
BR,SYSTEMIC INFECTION,4
BR,TIBIA FRACTURE,4
BR,UNINTENDED PREGNANCY,4
BR,UTERINE CANCER,4
BR,VIITH NERVE PARALYSIS,4
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,4
BR,WALKING AID USER,4
BR,WHITE BLOOD CELL COUNT DECREASED,4
BR,ABDOMINAL RIGIDITY,3
BR,ABORTION,3
BR,ABORTION SPONTANEOUS,3
BR,ACUTE RESPIRATORY FAILURE,3
BR,ALANINE AMINOTRANSFERASE ABNORMAL,3
BR,ANAL SQUAMOUS CELL CARCINOMA,3
BR,ANGINA PECTORIS,3
BR,APPARENT DEATH,3
BR,ARTHRODESIS,3
BR,AUTOIMMUNE HEPATITIS,3
BR,AXILLARY MASS,3
BR,BACK DISORDER,3
BR,BENIGN MUSCLE NEOPLASM,3
BR,BILE DUCT STONE,3
BR,BLOOD POTASSIUM DECREASED,3
BR,BLOOD URINE PRESENT,3
BR,BODY TEMPERATURE INCREASED,3
BR,BONE CANCER,3
BR,BONE LOSS,3
BR,BONE MARROW DISORDER,3
BR,BRAIN NEOPLASM BENIGN,3
BR,BRONCHIECTASIS,3
BR,BRONCHOSPASM,3
BR,CARDIAC FAILURE,3
BR,CHOKING,3
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
BR,CONJUNCTIVITIS BACTERIAL,3
BR,CONTUSION,3
BR,DEAFNESS UNILATERAL,3
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
BR,DERMATITIS,3
BR,DEVICE BREAKAGE,3
BR,DIARRHOEA HAEMORRHAGIC,3
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,3
BR,EAR DISCOMFORT,3
BR,EMOTIONAL DISTRESS,3
BR,ENTERITIS,3
BR,EYELID DISORDER,3
BR,FACIAL PAIN,3
BR,FACIAL PARALYSIS,3
BR,FAECES DISCOLOURED,3
BR,FIBULA FRACTURE,3
BR,FUNGAL INFECTION,3
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
BR,GASTRIC NEOPLASM,3
BR,HAEMATOCRIT DECREASED,3
BR,HEARING IMPAIRED,3
BR,HEART RATE IRREGULAR,3
BR,HEPATIC ENZYME INCREASED,3
BR,HEPATIC INFECTION,3
BR,HEPATIC PAIN,3
BR,HIATUS HERNIA,3
BR,HIGH DENSITY LIPOPROTEIN DECREASED,3
BR,HYPERAEMIA,3
BR,HYPERAESTHESIA,3
BR,HYPERPYREXIA,3
BR,HYPOTHYROIDISM,3
BR,IMMOBILE,3
BR,INCREASED APPETITE,3
BR,INFREQUENT BOWEL MOVEMENTS,3
BR,INJECTION SITE INJURY,3
BR,INTERSTITIAL LUNG DISEASE,3
BR,INTESTINAL HAEMORRHAGE,3
BR,INTRACRANIAL PRESSURE INCREASED,3
BR,JAUNDICE,3
BR,LEUKAEMIA,3
BR,LIGAMENT RUPTURE,3
BR,LIMB ASYMMETRY,3
BR,LIPOMA,3
BR,LUNG INFILTRATION,3
BR,LUPUS-LIKE SYNDROME,3
BR,MALNUTRITION,3
BR,MIGRAINE,3
BR,MITRAL VALVE DISEASE,3
BR,MOOD ALTERED,3
BR,MOUTH SWELLING,3
BR,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,3
BR,MYELODYSPLASTIC SYNDROME,3
BR,NEURALGIA,3
BR,OBSTRUCTIVE AIRWAYS DISORDER,3
BR,ONYCHOCLASIS,3
BR,ORAL CANDIDIASIS,3
BR,OSTEOMYELITIS,3
BR,OVARIAN CYST,3
BR,OVERWEIGHT,3
BR,PAIN IN JAW,3
BR,PANCREATIC NEOPLASM,3
BR,PATIENT-DEVICE INCOMPATIBILITY,3
BR,PERICARDIAL EFFUSION,3
BR,PETECHIAE,3
BR,PHARYNGEAL HAEMORRHAGE,3
BR,PHARYNGEAL OEDEMA,3
BR,PHOTOPHOBIA,3
BR,PLASMA CELL MYELOMA,3
BR,PNEUMONIA BACTERIAL,3
BR,POLYNEUROPATHY,3
BR,POST PROCEDURAL INFECTION,3
BR,PRE-EXISTING CONDITION IMPROVED,3
BR,PREMATURE BABY,3
BR,PRESYNCOPE,3
BR,PROCEDURAL PAIN,3
BR,PROSTATOMEGALY,3
BR,PROTEINURIA,3
BR,PSYCHOTIC DISORDER,3
BR,PULPITIS DENTAL,3
BR,PYELONEPHRITIS,3
BR,RASH PAPULAR,3
BR,RECTAL NEOPLASM,3
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,3
BR,RENAL CANCER,3
BR,RIB FRACTURE,3
BR,SACROILIITIS,3
BR,SCLERITIS,3
BR,SCRATCH,3
BR,SCREAMING,3
BR,SENSORY LOSS,3
BR,SHOCK,3
BR,SINUSITIS FUNGAL,3
BR,SKELETAL INJURY,3
BR,SKIN CANCER,3
BR,SKIN PLAQUE,3
BR,SKIN ULCER,3
BR,SPINAL COLUMN INJURY,3
BR,SUBCUTANEOUS ABSCESS,3
BR,TEARFULNESS,3
BR,THIRST,3
BR,ULCER,3
BR,URINARY INCONTINENCE,3
BR,URINARY TRACT INFECTION BACTERIAL,3
BR,URINARY TRACT PAIN,3
BR,VAGINAL DISCHARGE,3
BR,VARICOSE ULCERATION,3
BR,VASCULAR OCCLUSION,3
BR,VENOUS INJURY,3
BR,ZIKA VIRUS INFECTION,3
BR,ABDOMINAL HERNIA,2
BR,ABDOMINAL NEOPLASM,2
BR,ABNORMAL BEHAVIOUR,2
BR,ABNORMAL FAECES,2
BR,ABSCESS,2
BR,ACUTE LYMPHOCYTIC LEUKAEMIA,2
BR,AMENORRHOEA,2
BR,ANAESTHETIC COMPLICATION,2
BR,ANAL ABSCESS,2
BR,ANAL FISSURE,2
BR,ANEURYSM,2
BR,ANKLE DEFORMITY,2
BR,ANOGENITAL WARTS,2
BR,ANORECTAL DISCOMFORT,2
BR,ANTINUCLEAR ANTIBODY POSITIVE,2
BR,APHAGIA,2
BR,APHASIA,2
BR,APHTHOUS ULCER,2
BR,APPENDIX CANCER,2
BR,APPLICATION SITE HAEMATOMA,2
BR,APPLICATION SITE MASS,2
BR,ARTERIOSCLEROSIS,2
BR,ARTERIOSCLEROSIS CORONARY ARTERY,2
BR,ARTHRITIS REACTIVE,2
BR,ARTHROPOD BITE,2
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
BR,ATRIAL FIBRILLATION,2
BR,AUTOIMMUNE DISORDER,2
BR,BASAL CELL CARCINOMA,2
BR,BENIGN NEOPLASM,2
BR,BENIGN PROSTATIC HYPERPLASIA,2
BR,BLADDER NEOPLASM,2
BR,BLADDER PROLAPSE,2
BR,BLOOD BILIRUBIN INCREASED,2
BR,BLOOD BLISTER,2
BR,BLOOD TRIGLYCERIDES ABNORMAL,2
BR,BLOOD UREA ABNORMAL,2
BR,BODY TEMPERATURE ABNORMAL,2
BR,BONE FRAGMENTATION,2
BR,BRAIN NEOPLASM MALIGNANT,2
BR,BREAST PAIN,2
BR,BRONCHIAL SECRETION RETENTION,2
BR,C-REACTIVE PROTEIN ABNORMAL,2
BR,CALCINOSIS,2
BR,CAPILLARY FRAGILITY,2
BR,CARDIAC TAMPONADE,2
BR,CARDIAC VALVE DISEASE,2
BR,CAROTID ARTERY STENOSIS,2
BR,CEREBRAL THROMBOSIS,2
BR,CERVICAL VERTEBRAL FRACTURE,2
BR,CERVIX CARCINOMA,2
BR,CHRONIC SINUSITIS,2
BR,COLITIS,2
BR,CONTRAINDICATION TO MEDICAL TREATMENT,2
BR,CORONARY ARTERY INSUFFICIENCY,2
BR,CRANIOCEREBRAL INJURY,2
BR,DACTYLITIS,2
BR,DEMENTIA,2
BR,DEMYELINATION,2
BR,DEVELOPMENTAL DELAY,2
BR,DIABETIC COMPLICATION,2
BR,DIABETIC FOOT INFECTION,2
BR,DIABETIC METABOLIC DECOMPENSATION,2
BR,DIPLOPIA,2
BR,DISSEMINATED TUBERCULOSIS,2
BR,DISTURBANCE IN ATTENTION,2
BR,DNA ANTIBODY POSITIVE,2
BR,DRUG INTOLERANCE,2
BR,DRUG WITHDRAWAL SYNDROME,2
BR,EAR PRURITUS,2
BR,ELBOW DEFORMITY,2
BR,ERYTHEMA MULTIFORME,2
BR,EXCORIATION,2
BR,EXPIRED DRUG ADMINISTERED,2
BR,EXPOSURE DURING BREAST FEEDING,2
BR,EXTRAPULMONARY TUBERCULOSIS,2
BR,EXTREMITY NECROSIS,2
BR,EYE INFECTION,2
BR,EYE INFLAMMATION,2
BR,EYE MOVEMENT DISORDER,2
BR,EYE PRURITUS,2
BR,EYE ULCER,2
BR,FACIAL BONES FRACTURE,2
BR,FAHR^S DISEASE,2
BR,FAT TISSUE INCREASED,2
BR,FEELING OF DESPAIR,2
BR,FLUSHING,2
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,2
BR,GALLBLADDER NEOPLASM,2
BR,GASTRIC INFECTION,2
BR,GASTROENTERITIS,2
BR,GASTROINTESTINAL HAEMORRHAGE,2
BR,GASTROINTESTINAL MOTILITY DISORDER,2
BR,GENERAL PHYSICAL CONDITION ABNORMAL,2
BR,GENERALISED OEDEMA,2
BR,GENITAL HERPES,2
BR,GINGIVAL PAIN,2
BR,GOITRE,2
BR,HAEMANGIOMA,2
BR,HAEMARTHROSIS,2
BR,HAEMATEMESIS,2
BR,HAIR COLOUR CHANGES,2
BR,HAIR TEXTURE ABNORMAL,2
BR,HELICOBACTER GASTRITIS,2
BR,HELLP SYNDROME,2
BR,HELMINTHIC INFECTION,2
BR,HEPATIC ENZYME ABNORMAL,2
BR,HEPATITIS B,2
BR,HEPATITIS C,2
BR,HEPATOMEGALY,2
BR,HEPATOTOXICITY,2
BR,HISTIOCYTOSIS,2
BR,HOT FLUSH,2
BR,HUNGER,2
BR,HYDROCEPHALUS,2
BR,HYDRONEPHROSIS,2
BR,HYPERGLYCAEMIA,2
BR,HYPERSENSITIVITY VASCULITIS,2
BR,ILL-DEFINED DISORDER,2
BR,IMPAIRED WORK ABILITY,2
BR,INCREASED BRONCHIAL SECRETION,2
BR,INCREASED UPPER AIRWAY SECRETION,2
BR,INDURATION,2
BR,INFLAMMATORY MARKER INCREASED,2
BR,INFUSION RELATED REACTION,2
BR,INJECTION SITE LACERATION,2
BR,INJECTION SITE MACULE,2
BR,INJECTION SITE PUSTULE,2
BR,INJECTION SITE RECALL REACTION,2
BR,INJECTION SITE ULCER,2
BR,INTERVERTEBRAL DISC SPACE NARROWING,2
BR,INTESTINAL FISTULA,2
BR,INTESTINAL ISCHAEMIA,2
BR,INTESTINAL POLYP,2
BR,ISCHAEMIA,2
BR,JOINT CREPITATION,2
BR,JOINT DESTRUCTION,2
BR,KIDNEY ENLARGEMENT,2
BR,LACK OF INJECTION SITE ROTATION,2
BR,LARYNGITIS,2
BR,LEPROSY,2
BR,LIBIDO DECREASED,2
BR,LIVER FUNCTION TEST ABNORMAL,2
BR,LOW DENSITY LIPOPROTEIN ABNORMAL,2
BR,LOW DENSITY LIPOPROTEIN DECREASED,2
BR,LOWER EXTREMITY MASS,2
BR,LOWER RESPIRATORY TRACT INFLAMMATION,2
BR,LYMPH NODE CALCIFICATION,2
BR,LYMPHOCYTOSIS,2
BR,LYMPHOPROLIFERATIVE DISORDER,2
BR,MALARIA,2
BR,MEASLES,2
BR,MENINGIOMA,2
BR,MENOPAUSE,2
BR,MENORRHAGIA,2
BR,MENSTRUAL DISORDER,2
BR,METASTASES TO CENTRAL NERVOUS SYSTEM,2
BR,METASTASES TO LUNG,2
BR,METASTASES TO SPINE,2
BR,MINERAL DEFICIENCY,2
BR,MULTIPLE FRACTURES,2
BR,MUSCLE ATROPHY,2
BR,MUSCLE DISORDER,2
BR,MUSCLE OEDEMA,2
BR,MUSCULOSKELETAL DISCOMFORT,2
BR,MYELITIS,2
BR,MYOCARDIAL ISCHAEMIA,2
BR,MYOCARDITIS,2
BR,NAIL INFECTION,2
BR,NASAL DISCOMFORT,2
BR,NEOPLASM SKIN,2
BR,NIGHT SWEATS,2
BR,NIGHTMARE,2
BR,NO ADVERSE EVENT,2
BR,NUCHAL RIGIDITY,2
BR,ODYNOPHAGIA,2
BR,OEDEMA MOUTH,2
BR,OESOPHAGEAL ULCER,2
BR,ONYCHOMADESIS,2
BR,ORAL MUCOSAL ERYTHEMA,2
BR,ORAL PAIN,2
BR,ORGAN FAILURE,2
BR,OROPHARYNGEAL BLISTERING,2
BR,OSTEITIS,2
BR,OSTEONECROSIS,2
BR,OVARIAN DISORDER,2
BR,OVARIAN NEOPLASM,2
BR,PAIN OF SKIN,2
BR,PANCREATIC CARCINOMA,2
BR,PANCREATIC CYST,2
BR,PANCREATIC DISORDER,2
BR,PANCREATITIS ACUTE,2
BR,PAPILLOMA VIRAL INFECTION,2
BR,PAROTITIS,2
BR,PATHOGEN RESISTANCE,2
BR,PEMPHIGOID,2
BR,PERICARDITIS,2
BR,PERIPHERAL VASCULAR DISORDER,2
BR,PHARYNGEAL ERYTHEMA,2
BR,PHLEBITIS,2
BR,PLANTAR FASCIITIS,2
BR,PNEUMONITIS,2
BR,POLLAKIURIA,2
BR,POLYURIA,2
BR,PORTAL VEIN THROMBOSIS,2
BR,POST PROCEDURAL DISCHARGE,2
BR,PROCTALGIA,2
BR,PROSTATIC DISORDER,2
BR,PROSTHESIS USER,2
BR,PRURITUS GENITAL,2
BR,PULMONARY CALCIFICATION,2
BR,PULMONARY CAVITATION,2
BR,PULMONARY HYPERTENSION,2
BR,PULMONARY THROMBOSIS,2
BR,PULMONARY TUBERCULOSIS,2
BR,PURULENCE,2
BR,PYODERMA,2
BR,RADIUS FRACTURE,2
BR,RASH GENERALISED,2
BR,RAYNAUD^S PHENOMENON,2
BR,REBOUND PSORIASIS,2
BR,REFLUX GASTRITIS,2
BR,RENAL NEOPLASM,2
BR,RENAL TUBERCULOSIS,2
BR,RESTLESSNESS,2
BR,ROTATOR CUFF SYNDROME,2
BR,SALIVARY GLAND NEOPLASM,2
BR,SARCOIDOSIS,2
BR,SCAB,2
BR,SCLERODERMA,2
BR,SEBORRHOEA,2
BR,SKIN DEPIGMENTATION,2
BR,SKIN EROSION,2
BR,SKIN INDURATION,2
BR,SKIN SWELLING,2
BR,SKIN WARM,2
BR,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
BR,SMALL INTESTINE CARCINOMA,2
BR,SPINAL CORD DISORDER,2
BR,SPLEEN DISORDER,2
BR,SPOROTRICHOSIS,2
BR,STEVENS-JOHNSON SYNDROME,2
BR,STRANGULATED HERNIA,2
BR,SURGERY,2
BR,SWOLLEN TONGUE,2
BR,SYRINGE ISSUE,2
BR,TENSION,2
BR,THERMAL BURN,2
BR,THROAT CANCER,2
BR,THROMBOPHLEBITIS,2
BR,TONGUE INJURY,2
BR,TOOTH LOSS,2
BR,TRANSAMINASES INCREASED,2
BR,TRANSIENT ISCHAEMIC ATTACK,2
BR,TREATMENT FAILURE,2
BR,TREATMENT NONCOMPLIANCE,2
BR,TRIGGER FINGER,2
BR,TYPE 2 DIABETES MELLITUS,2
BR,UNEVALUABLE EVENT,2
BR,URETHRAL OBSTRUCTION,2
BR,URINE ANALYSIS ABNORMAL,2
BR,UTERINE PROLAPSE,2
BR,VERTIGO,2
BR,VOCAL CORD DISORDER,2
BR,VOCAL CORD PARALYSIS,2
BR,WOUND SECRETION,2
BR,WRONG DRUG ADMINISTERED,2
BR,ABDOMINAL ABSCESS,1
BR,ABDOMINAL ADHESIONS,1
BR,ABDOMINAL INJURY,1
BR,ABDOMINAL MASS,1
BR,ABNORMAL LOSS OF WEIGHT,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ABSCESS INTESTINAL,1
BR,ABSCESS LIMB,1
BR,ACCIDENT AT HOME,1
BR,ACCIDENT AT WORK,1
BR,ACIDOSIS,1
BR,ACNE,1
BR,ACNE PUSTULAR,1
BR,ACUTE CORONARY SYNDROME,1
BR,ACUTE KIDNEY INJURY,1
BR,ACUTE MYELOID LEUKAEMIA,1
BR,ADENOCARCINOMA,1
BR,ADENOCARCINOMA GASTRIC,1
BR,ADHESION,1
BR,ADVERSE DRUG REACTION,1
BR,AGEUSIA,1
BR,ALLERGIC BRONCHITIS,1
BR,ALLERGIC PHARYNGITIS,1
BR,ALLERGY TO CHEMICALS,1
BR,ALOPECIA UNIVERSALIS,1
BR,AMYLOIDOSIS,1
BR,ANAL INFECTION,1
BR,ANAL NEOPLASM,1
BR,ANAL PRURITUS,1
BR,ANGER,1
BG,ARTHRALGIA,5
BG,BODY TEMPERATURE INCREASED,3
BG,GENERAL PHYSICAL HEALTH DETERIORATION,3
BG,ASTHENIA,2
BG,CHEST DISCOMFORT,2
BG,DRUG INEFFECTIVE,2
BG,DYSPNOEA,2
BG,JOINT DESTRUCTION,2
BG,JOINT SWELLING,2
BG,PULMONARY EMBOLISM,2
BG,RHEUMATOID ARTHRITIS,2
BG,STAPHYLOCOCCAL INFECTION,2
BG,STAPHYLOCOCCAL SEPSIS,2
BG,ABDOMINAL PAIN,1
BG,BACTERIAL SEPSIS,1
BG,BILE DUCT STONE,1
BG,C-REACTIVE PROTEIN INCREASED,1
BG,CERVIX CARCINOMA,1
BG,CONSTIPATION,1
BG,COUGH,1
BG,DISEASE RECURRENCE,1
BG,EYELID OEDEMA,1
BG,FASCIITIS,1
BG,FATIGUE,1
BG,FEMORAL NECK FRACTURE,1
BG,HEMIPLEGIA,1
BG,HEPATIC ENZYME INCREASED,1
BG,INJECTION SITE ERYTHEMA,1
BG,INJURY,1
BG,IRIDOCYCLITIS,1
BG,ISCHAEMIC STROKE,1
BG,JOINT RANGE OF MOTION DECREASED,1
BG,LATENT TUBERCULOSIS,1
BG,LIP SWELLING,1
BG,LUNG ADENOCARCINOMA,1
BG,MALAISE,1
BG,METASTASES TO BONE,1
BG,METASTASES TO LIVER,1
BG,METASTASES TO LUNG,1
BG,METASTASES TO LYMPH NODES,1
BG,MUSCULOSKELETAL CHEST PAIN,1
BG,MUSCULOSKELETAL STIFFNESS,1
BG,MYALGIA,1
BG,MYOCARDIAL INFARCTION,1
BG,NON-HODGKIN^S LYMPHOMA,1
BG,PANCYTOPENIA,1
BG,PNEUMONIA,1
BG,PRODUCTIVE COUGH,1
BG,PULMONARY TUBERCULOSIS,1
BG,PUSTULAR PSORIASIS,1
BG,PYREXIA,1
BG,RASH ERYTHEMATOUS,1
BG,SALIVARY GLAND CANCER STAGE I,1
BG,SPUTUM RETENTION,1
BG,SQUAMOUS CELL CARCINOMA OF SKIN,1
BG,SWELLING FACE,1
BG,TACHYCARDIA,1
BG,VIRAL INFECTION,1
BG,VISUAL ACUITY REDUCED,1
BG,WHITE BLOOD CELL COUNT DECREASED,1
CM,ABDOMINAL DISCOMFORT,1
CM,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CM,COELIAC DISEASE,1
CM,DRUG INEFFECTIVE,1
CM,GRIP STRENGTH DECREASED,1
CM,HEADACHE,1
CM,INJECTION SITE REACTION,1
CM,NAIL DISORDER,1
CM,ONYCHOMADESIS,1
CM,ONYCHOMYCOSIS,1
CA,DRUG INEFFECTIVE,5974
CA,RHEUMATOID ARTHRITIS,3724
CA,PAIN,1868
CA,DRUG INTOLERANCE,1649
CA,JOINT SWELLING,1529
CA,ARTHRALGIA,1429
CA,NAUSEA,1201
CA,FATIGUE,1186
CA,CONDITION AGGRAVATED,1059
CA,DRUG HYPERSENSITIVITY,961
CA,TREATMENT FAILURE,948
CA,SYNOVITIS,925
CA,HEADACHE,834
CA,PERIPHERAL SWELLING,808
CA,DRUG EFFECT DECREASED,807
CA,PAIN IN EXTREMITY,765
CA,RASH,724
CA,ABDOMINAL DISCOMFORT,699
CA,ALOPECIA,671
CA,DEATH,653
CA,ARTHROPATHY,634
CA,MUSCULOSKELETAL STIFFNESS,592
CA,MALAISE,583
CA,DIARRHOEA,569
CA,MOBILITY DECREASED,538
CA,INFECTION,532
CA,SWELLING,530
CA,VOMITING,516
CA,PNEUMONIA,497
CA,C-REACTIVE PROTEIN ABNORMAL,476
CA,GAIT DISTURBANCE,465
CA,DRUG EFFECT INCOMPLETE,464
CA,DYSPNOEA,455
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,446
CA,HYPERSENSITIVITY,426
CA,WEIGHT DECREASED,413
CA,DIZZINESS,396
CA,ARTHRITIS,387
CA,HEPATIC ENZYME INCREASED,385
CA,ASTHENIA,369
CA,C-REACTIVE PROTEIN INCREASED,327
CA,NASOPHARYNGITIS,327
CA,MUSCULOSKELETAL PAIN,320
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,310
CA,PSORIASIS,309
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,302
CA,FALL,300
CA,HYPERTENSION,300
CA,KNEE ARTHROPLASTY,296
CA,OSTEOARTHRITIS,296
CA,INSOMNIA,271
CA,BACK PAIN,268
CA,PRURITUS,267
CA,DECREASED APPETITE,256
CA,ABDOMINAL PAIN UPPER,255
CA,GASTROINTESTINAL DISORDER,253
CA,PEMPHIGUS,251
CA,INFLAMMATION,250
CA,COUGH,247
CA,THERAPEUTIC RESPONSE DECREASED,247
CA,DEPRESSION,246
CA,BONE EROSION,245
CA,HERPES ZOSTER,245
CA,URTICARIA,233
CA,SINUSITIS,232
CA,DIVERTICULITIS,230
CA,HAND DEFORMITY,228
CA,RHEUMATOID FACTOR POSITIVE,221
CA,HYPOAESTHESIA,217
CA,PSORIATIC ARTHROPATHY,217
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,213
CA,INJECTION SITE REACTION,212
CA,LUNG DISORDER,212
CA,CONTRAINDICATED PRODUCT ADMINISTERED,209
CA,PYREXIA,205
CA,MUSCULOSKELETAL DISORDER,204
CA,DIABETES MELLITUS,201
CA,LOWER RESPIRATORY TRACT INFECTION,201
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,201
CA,MYOCARDIAL INFARCTION,194
CA,FIBROMYALGIA,188
CA,ADVERSE DRUG REACTION,187
CA,BRONCHITIS,186
CA,GLOSSODYNIA,185
CA,IMPAIRED WORK ABILITY,184
CA,EAR INFECTION,179
CA,PHARYNGITIS,176
CA,URINARY TRACT INFECTION,174
CA,HIP ARTHROPLASTY,172
CA,MUSCLE SPASMS,171
CA,INFLUENZA,169
CA,NEOPLASM MALIGNANT,165
CA,ANXIETY,164
CA,DISABILITY,163
CA,CHEST PAIN,162
CA,PARAESTHESIA,162
CA,NEPHROLITHIASIS,161
CA,OSTEOPOROSIS,161
CA,SLEEP DISORDER,161
CA,INJECTION SITE PAIN,157
CA,ERYTHEMA,152
CA,STRESS,152
CA,EYE DISORDER,151
CA,LIVER FUNCTION TEST ABNORMAL,150
CA,RENAL FAILURE,150
CA,ACNE,149
CA,JOINT STIFFNESS,149
CA,LOSS OF CONSCIOUSNESS,149
CA,INJECTION SITE ERYTHEMA,148
CA,FEELING ABNORMAL,147
CA,TRANSPLANT DYSFUNCTION,147
CA,INTERSTITIAL LUNG DISEASE,146
CA,FOOT DEFORMITY,145
CA,HOSPITALISATION,145
CA,BLOOD PRESSURE INCREASED,144
CA,BREAST CANCER,144
CA,STOMATITIS,144
CA,OVARIAN CYST,139
CA,ABDOMINAL PAIN,138
CA,GRIP STRENGTH DECREASED,138
CA,NECK PAIN,138
CA,LIVER DISORDER,137
CA,TRANSPLANT REJECTION,134
CA,JOINT RANGE OF MOTION DECREASED,133
CA,PULMONARY FIBROSIS,133
CA,RENAL IMPAIRMENT,131
CA,SURGERY,131
CA,SKIN ULCER,130
CA,ANAEMIA,129
CA,SEPSIS,128
CA,CEREBROVASCULAR ACCIDENT,127
CA,WEIGHT INCREASED,127
CA,IMPAIRED HEALING,124
CA,INFUSION RELATED REACTION,122
CA,WHITE BLOOD CELL COUNT DECREASED,120
CA,FEMUR FRACTURE,119
CA,LIVER FUNCTION TEST INCREASED,119
CA,LOCAL SWELLING,116
CA,ALANINE AMINOTRANSFERASE INCREASED,115
CA,GLAUCOMA,114
CA,JOINT INJURY,114
CA,BLOOD CHOLESTEROL INCREASED,113
CA,DRUG DOSE OMISSION,113
CA,INJECTION SITE SWELLING,112
CA,VISUAL IMPAIRMENT,112
CA,NAIL DISORDER,111
CA,BURNING SENSATION,110
CA,BASAL CELL CARCINOMA,107
CA,SHOULDER ARTHROPLASTY,107
CA,MUSCULAR WEAKNESS,106
CA,PULMONARY MASS,105
CA,ASPARTATE AMINOTRANSFERASE INCREASED,104
CA,DEAFNESS,104
CA,NODULE,104
CA,ADVERSE EVENT,103
CA,ANAPHYLACTIC REACTION,103
CA,DYSPEPSIA,101
CA,LEUKOPENIA,101
CA,LUNG INFECTION,101
CA,DRUG ERUPTION,100
CA,HEPATITIS,99
CA,FINE MOTOR SKILL DYSFUNCTION,98
CA,LOCALISED INFECTION,98
CA,PULMONARY EMBOLISM,96
CA,TENDERNESS,96
CA,CYSTITIS,95
CA,GASTROINTESTINAL PAIN,93
CA,NEUTROPENIA,92
CA,CATARACT,91
CA,CHILLS,90
CA,CONTUSION,90
CA,INJECTION SITE BRUISING,90
CA,AMNESIA,89
CA,ILL-DEFINED DISORDER,89
CA,PNEUMONITIS,89
CA,HYPERHIDROSIS,88
CA,MEMORY IMPAIRMENT,88
CA,MYALGIA,88
CA,ABASIA,87
CA,COELIAC DISEASE,87
CA,FINGER DEFORMITY,87
CA,GAIT INABILITY,87
CA,SOMNOLENCE,87
CA,ANKYLOSING SPONDYLITIS,86
CA,LYMPHADENOPATHY,86
CA,THROMBOSIS,86
CA,DRY EYE,85
CA,DRY MOUTH,85
CA,FOOT OPERATION,85
CA,ONYCHOMYCOSIS,85
CA,TOXICITY TO VARIOUS AGENTS,85
CA,OEDEMA PERIPHERAL,84
CA,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,82
CA,IMMOBILE,82
CA,NEUROPATHY PERIPHERAL,82
CA,OROPHARYNGEAL PAIN,82
CA,THERAPY NON-RESPONDER,82
CA,LIMB DISCOMFORT,81
CA,INJECTION SITE PRURITUS,80
CA,LYMPHOMA,80
CA,CROHN^S DISEASE,79
CA,GASTRIC DISORDER,79
CA,GASTROOESOPHAGEAL REFLUX DISEASE,79
CA,MIGRAINE,79
CA,NON-HODGKIN^S LYMPHOMA,79
CA,SCIATICA,79
CA,SWELLING FACE,79
CA,UNEVALUABLE EVENT,79
CA,PAIN IN JAW,78
CA,PRODUCT USE ISSUE,78
CA,HAEMOGLOBIN DECREASED,76
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,76
CA,HEPATOTOXICITY,75
CA,PALPITATIONS,75
CA,RHEUMATOID NODULE,74
CA,CARDIAC DISORDER,72
CA,SENSITIVITY TO WEATHER CHANGE,72
CA,SPINAL COLUMN STENOSIS,72
CA,RASH PRURITIC,71
CA,MOUTH ULCERATION,70
CA,FEEDING DISORDER,69
CA,MASS,69
CA,BLOOD CREATININE INCREASED,68
CA,DEEP VEIN THROMBOSIS,68
CA,MALIGNANT MELANOMA,68
CA,RHINORRHOEA,68
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,68
CA,INFLUENZA LIKE ILLNESS,67
CA,MATERNAL EXPOSURE DURING PREGNANCY,67
CA,ULCER,66
CA,ATRIAL FIBRILLATION,65
CA,BLOOD IRON ABNORMAL,65
CA,HYPOPHAGIA,65
CA,RENAL DISORDER,65
CA,COLITIS MICROSCOPIC,64
CA,DERMATITIS ALLERGIC,64
CA,DISEASE PROGRESSION,63
CA,SYNCOPE,63
CA,TYPE 2 DIABETES MELLITUS,62
CA,APPARENT DEATH,61
CA,ASTHMA,61
CA,DYSPHAGIA,61
CA,HYPOTENSION,61
CA,NERVE INJURY,61
CA,PRODUCTIVE COUGH,61
CA,DEAFNESS TRANSITORY,60
CA,LUNG NEOPLASM MALIGNANT,60
CA,SYNOVIAL CYST,60
CA,ADVERSE REACTION,59
CA,LABORATORY TEST ABNORMAL,59
CA,SECRETION DISCHARGE,59
CA,CELLULITIS,58
CA,CHEST DISCOMFORT,58
CA,TENOSYNOVITIS,58
CA,CARPAL TUNNEL SYNDROME,57
CA,OBESITY,57
CA,ADRENAL INSUFFICIENCY,56
CA,EPISTAXIS,56
CA,GENERAL PHYSICAL HEALTH DETERIORATION,56
CA,PNEUMONIA VIRAL,56
CA,CRYING,55
CA,DEFORMITY,55
CA,THYROID DISORDER,55
CA,WOUND,55
CA,BEDRIDDEN,54
CA,JUVENILE IDIOPATHIC ARTHRITIS,54
CA,SEPTIC SHOCK,54
CA,BONE PAIN,53
CA,NIGHT SWEATS,53
CA,IMMUNE SYSTEM DISORDER,52
CA,NASAL CONGESTION,52
CA,WALKING AID USER,52
CA,ABDOMINAL DISTENSION,51
CA,BONE DISORDER,51
CA,DEPRESSED MOOD,51
CA,HEPATIC CIRRHOSIS,51
CA,PANNICULITIS,51
CA,DEMYELINATION,50
CA,DISCOMFORT,50
CA,DRUG DEPENDENCE,50
CA,HYPERCALCAEMIA,50
CA,JOINT EFFUSION,50
CA,WRIST DEFORMITY,50
CA,CONSTIPATION,48
CA,EYE PAIN,48
CA,FEELING HOT,48
CA,HEPATIC STEATOSIS,48
CA,MULTIPLE SCLEROSIS,48
CA,PHARYNGEAL OEDEMA,48
CA,SKIN DISCOLOURATION,48
CA,VERTIGO,48
CA,BLOOD PARATHYROID HORMONE DECREASED,47
CA,MUSCULOSKELETAL DISCOMFORT,47
CA,RESPIRATORY DISORDER,47
CA,OSTEOPENIA,46
CA,SKIN LESION,46
CA,TREMOR,46
CA,UPPER RESPIRATORY TRACT INFECTION,46
CA,HEPATIC ENZYME ABNORMAL,45
CA,IMMUNODEFICIENCY,45
CA,HEPATIC FUNCTION ABNORMAL,44
CA,INJECTION SITE HAEMORRHAGE,44
CA,JOINT DISLOCATION,44
CA,KIDNEY INFECTION,44
CA,SKIN REACTION,44
CA,BACK DISORDER,43
CA,DYSPHONIA,43
CA,HIP FRACTURE,43
CA,BALANCE DISORDER,42
CA,BRONCHITIS CHRONIC,42
CA,PLATELET COUNT DECREASED,42
CA,BONE DENSITY DECREASED,41
CA,ENTHESOPATHY,41
CA,PROSTATE CANCER,41
CA,PRURITUS GENERALISED,41
CA,SCAR,41
CA,SWOLLEN TONGUE,41
CA,VIRAL INFECTION,40
CA,BREAST CANCER STAGE III,39
CA,COLITIS,39
CA,EXPOSURE DURING PREGNANCY,39
CA,HYPOTHYROIDISM,39
CA,OSTEOMYELITIS,39
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,38
CA,EPICONDYLITIS,38
CA,HYPOACUSIS,38
CA,MOOD SWINGS,38
CA,PELVIC FRACTURE,38
CA,PHOTOPHOBIA,38
CA,UPPER LIMB FRACTURE,38
CA,ANKLE DEFORMITY,37
CA,CYST,37
CA,DEHYDRATION,37
CA,ELBOW DEFORMITY,37
CA,FOOT FRACTURE,37
CA,HAEMATOCHEZIA,37
CA,HAEMORRHAGE,37
CA,JOINT ARTHROPLASTY,37
CA,NECK MASS,37
CA,SPINAL FRACTURE,37
CA,DYSSTASIA,36
CA,JOINT DESTRUCTION,36
CA,NERVOUS SYSTEM DISORDER,36
CA,ONYCHOMADESIS,36
CA,SKIN EXFOLIATION,36
CA,WOUND INFECTION,36
CA,BLOOD PRESSURE ABNORMAL,35
CA,FRACTURE,35
CA,LACERATION,35
CA,PLEURAL EFFUSION,35
CA,SKIN NECROSIS,35
CA,THROMBOCYTOPENIA,35
CA,BURSITIS,34
CA,ENCEPHALITIS,34
CA,HOT FLUSH,34
CA,LOWER LIMB FRACTURE,34
CA,POST PROCEDURAL INFECTION,34
CA,SEIZURE,34
CA,SKIN DISORDER,34
CA,SUICIDAL IDEATION,34
CA,ANGINA PECTORIS,33
CA,CANDIDA INFECTION,33
CA,CHOLELITHIASIS,33
CA,EAR PAIN,33
CA,EATING DISORDER,33
CA,GRANULOMA SKIN,33
CA,HEART RATE INCREASED,33
CA,RESPIRATORY TRACT CONGESTION,33
CA,TENDONITIS,33
CA,THROAT IRRITATION,33
CA,TONGUE DISORDER,33
CA,TREATMENT NONCOMPLIANCE,33
CA,ANAPHYLACTIC SHOCK,32
CA,BODY HEIGHT BELOW NORMAL,32
CA,HERNIA,32
CA,HYPERCHOLESTEROLAEMIA,32
CA,POLYARTHRITIS,32
CA,TEMPERATURE INTOLERANCE,32
CA,VISION BLURRED,32
CA,BRONCHIECTASIS,31
CA,CARDIAC FAILURE CONGESTIVE,31
CA,CARDIOVASCULAR DISORDER,31
CA,CLOSTRIDIUM DIFFICILE INFECTION,31
CA,EMOTIONAL DISORDER,31
CA,HUMAN ANTICHIMERIC ANTIBODY POSITIVE,31
CA,ORAL MUCOSAL EXFOLIATION,31
CA,PERICARDITIS,31
CA,POST PROCEDURAL COMPLICATION,31
CA,RASH ERYTHEMATOUS,31
CA,SOFT TISSUE DISORDER,31
CA,CONFUSIONAL STATE,30
CA,CUTANEOUS VASCULITIS,30
CA,EYE HAEMORRHAGE,30
CA,GASTRIC ULCER,30
CA,GENERALISED OEDEMA,30
CA,HYPOKINESIA,30
CA,INJECTION SITE RASH,30
CA,INTERVERTEBRAL DISC DEGENERATION,30
CA,LIMB DEFORMITY,30
CA,ABORTION SPONTANEOUS,29
CA,BLOOD TEST ABNORMAL,29
CA,GENERALISED ERYTHEMA,29
CA,IMMUNOSUPPRESSION,29
CA,IMPAIRED GASTRIC EMPTYING,29
CA,INJECTION SITE WARMTH,29
CA,MOTOR DYSFUNCTION,29
CA,NO ADVERSE EVENT,29
CA,OVERDOSE,29
CA,RESPIRATORY TRACT INFECTION,29
CA,RETINAL TOXICITY,29
CA,TENDON DISORDER,29
CA,TOOTH INFECTION,29
CA,BLOOD PRESSURE FLUCTUATION,28
CA,BODY TEMPERATURE INCREASED,28
CA,DEAFNESS NEUROSENSORY,28
CA,GROIN PAIN,28
CA,LACRIMATION INCREASED,28
CA,OEDEMA,28
CA,ORAL PAIN,28
CA,TOOTH LOSS,28
CA,ALANINE AMINOTRANSFERASE ABNORMAL,27
CA,ANTINUCLEAR ANTIBODY POSITIVE,27
CA,ARTHRODESIS,27
CA,COGNITIVE DISORDER,27
CA,GINGIVAL BLEEDING,27
CA,LIVER INJURY,27
CA,ORAL CANDIDIASIS,27
CA,PRESBYACUSIS,27
CA,SLE ARTHRITIS,27
CA,THYROID NEOPLASM,27
CA,WHEELCHAIR USER,27
CA,ARTHRITIS INFECTIVE,26
CA,BLADDER CANCER,26
CA,DELIRIUM,26
CA,DYSPNOEA EXERTIONAL,26
CA,EYE IRRITATION,26
CA,FLUID RETENTION,26
CA,GASTROINTESTINAL HAEMORRHAGE,26
CA,INTENTIONAL PRODUCT MISUSE,26
CA,LIMB OPERATION,26
CA,ONYCHOCLASIS,26
CA,PANCREATITIS,26
CA,PULMONARY THROMBOSIS,26
CA,SQUAMOUS CELL CARCINOMA,26
CA,WHEEZING,26
CA,ANKLE OPERATION,25
CA,DRUG SPECIFIC ANTIBODY PRESENT,25
CA,DRUG USE DISORDER,25
CA,EPIGASTRIC DISCOMFORT,25
CA,EXERCISE TOLERANCE DECREASED,25
CA,OVARIAN NEOPLASM,25
CA,PHYSICAL DISABILITY,25
CA,PLEURAL FIBROSIS,25
CA,PULMONARY TOXICITY,25
CA,PUSTULAR PSORIASIS,25
CA,PYELONEPHRITIS,25
CA,RHEUMATOID FACTOR NEGATIVE,25
CA,SINUS DISORDER,25
CA,ACUTE KIDNEY INJURY,24
CA,BLINDNESS,24
CA,DRUG RESISTANCE,24
CA,GALLBLADDER DISORDER,24
CA,HEPATIC FIBROSIS,24
CA,INJECTION SITE MASS,24
CA,IRRITABLE BOWEL SYNDROME,24
CA,PRERENAL FAILURE,24
CA,PULMONARY OEDEMA,24
CA,RECTAL HAEMORRHAGE,24
CA,STAPHYLOCOCCAL INFECTION,24
CA,TOOTHACHE,24
CA,UNDERDOSE,24
CA,UVEITIS,24
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,24
CA,ACNE CYSTIC,23
CA,BLISTER,23
CA,BRAIN NEOPLASM,23
CA,INJURY,23
CA,LUPUS-LIKE SYNDROME,23
CA,MUCOSAL INFLAMMATION,23
CA,ORAL DISORDER,23
CA,OSTEOPOROTIC FRACTURE,23
CA,PHOTOSENSITIVITY REACTION,23
CA,SCOLIOSIS,23
CA,ARRHYTHMIA,22
CA,BONE CYST,22
CA,EYE OPERATION,22
CA,FEAR OF INJECTION,22
CA,JOINT LAXITY,22
CA,JOINT LOCK,22
CA,OXYGEN SATURATION DECREASED,22
CA,RETINITIS,22
CA,SARCOIDOSIS,22
CA,SJOGREN^S SYNDROME,22
CA,SPINAL DISORDER,22
CA,SPINAL FUSION SURGERY,22
CA,SPINAL OPERATION,22
CA,TERMINAL STATE,22
CA,TOOTH ABSCESS,22
CA,TUBERCULIN TEST POSITIVE,22
CA,BACK INJURY,21
CA,BLOOD IRON DECREASED,21
CA,BONE DENSITY ABNORMAL,21
CA,CREPITATIONS,21
CA,DECREASED IMMUNE RESPONSIVENESS,21
CA,DISLOCATION OF VERTEBRA,21
CA,INFECTION SUSCEPTIBILITY INCREASED,21
CA,INTERVERTEBRAL DISC DISORDER,21
CA,INTRAOCULAR PRESSURE INCREASED,21
CA,MOVEMENT DISORDER,21
CA,MUSCLE FATIGUE,21
CA,QUALITY OF LIFE DECREASED,21
CA,THERAPEUTIC RESPONSE UNEXPECTED,21
CA,ANGIOEDEMA,20
CA,BLOOD GLUCOSE INCREASED,20
CA,BRONCHOSPASM,20
CA,DERMATITIS,20
CA,DRY SKIN,20
CA,EXOSTOSIS,20
CA,FLATULENCE,20
CA,HEAD INJURY,20
CA,INCORRECT DOSAGE ADMINISTERED,20
CA,INJECTION SITE URTICARIA,20
CA,MUSCLE SPASTICITY,20
CA,OCULAR HYPERAEMIA,20
CA,SPINAL PAIN,20
CA,THROAT TIGHTNESS,20
CA,TOE AMPUTATION,20
CA,VEIN RUPTURE,20
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,20
CA,ANGER,19
CA,BREAST MASS,19
CA,COLITIS ULCERATIVE,19
CA,COLON CANCER,19
CA,CONJUNCTIVITIS,19
CA,ECZEMA,19
CA,EXTREMITY CONTRACTURE,19
CA,EYE PRURITUS,19
CA,FUNGAL INFECTION,19
CA,GASTROINTESTINAL TOXICITY,19
CA,HEPATIC FAILURE,19
CA,INTERVERTEBRAL DISC COMPRESSION,19
CA,INTERVERTEBRAL DISC SPACE NARROWING,19
CA,IRRITABILITY,19
CA,MULTIPLE ALLERGIES,19
CA,ROAD TRAFFIC ACCIDENT,19
CA,SPEECH DISORDER,19
CA,ANKLE FRACTURE,18
CA,BLOOD ALBUMIN DECREASED,18
CA,COORDINATION ABNORMAL,18
CA,DRUG EFFECT VARIABLE,18
CA,DRUG TOLERANCE DECREASED,18
CA,FURUNCLE,18
CA,INJECTION SITE DISCOLOURATION,18
CA,INJECTION SITE HYPERSENSITIVITY,18
CA,INTERVERTEBRAL DISC PROTRUSION,18
CA,IRITIS,18
CA,LIP SWELLING,18
CA,LOOSE BODY IN JOINT,18
CA,MUSCLE STRAIN,18
CA,NASAL ULCER,18
CA,NERVOUSNESS,18
CA,PAIN OF SKIN,18
CA,PANCYTOPENIA,18
CA,PHARYNGITIS STREPTOCOCCAL,18
CA,POSTOPERATIVE WOUND INFECTION,18
CA,PULMONARY CONGESTION,18
CA,STRESS FRACTURE,18
CA,UPPER-AIRWAY COUGH SYNDROME,18
CA,WHITE BLOOD CELL COUNT INCREASED,18
CA,ACCIDENT,17
CA,C-REACTIVE PROTEIN,17
CA,COMA,17
CA,FEAR,17
CA,HAEMOPTYSIS,17
CA,HYPERKERATOSIS,17
CA,MENOPAUSE,17
CA,NECK DEFORMITY,17
CA,PROCEDURAL PAIN,17
CA,SINUS CONGESTION,17
CA,SKIN PAPILLOMA,17
CA,SLEEP APNOEA SYNDROME,17
CA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,17
CA,THROMBOCYTOSIS,17
CA,TRANSIENT ISCHAEMIC ATTACK,17
CA,X-RAY ABNORMAL,17
CA,ANKLE ARTHROPLASTY,16
CA,ANTIBODY TEST POSITIVE,16
CA,APHONIA,16
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,16
CA,BLOOD POTASSIUM INCREASED,16
CA,BREAST CANCER FEMALE,16
CA,CARDIAC FAILURE,16
CA,DACTYLITIS,16
CA,EMPHYSEMA,16
CA,EYE INFECTION,16
CA,HEPATOSPLENIC T-CELL LYMPHOMA,16
CA,HIP SURGERY,16
CA,INCORRECT DOSE ADMINISTERED,16
CA,LIMB INJURY,16
CA,PLEURITIC PAIN,16
CA,PRE-EXISTING CONDITION IMPROVED,16
CA,RASH GENERALISED,16
CA,RESPIRATORY FAILURE,16
CA,RIB FRACTURE,16
CA,SHOULDER OPERATION,16
CA,SKIN CANCER,16
CA,SKIN HAEMORRHAGE,16
CA,SPINAL OSTEOARTHRITIS,16
CA,WRIST SURGERY,16
CA,AFFECT LABILITY,15
CA,ASCITES,15
CA,BONE SWELLING,15
CA,C-REACTIVE PROTEIN DECREASED,15
CA,CARDIAC MURMUR,15
CA,CARDIOMYOPATHY,15
CA,CHRONIC SINUSITIS,15
CA,ELECTRIC SHOCK,15
CA,EMBOLISM,15
CA,EMOTIONAL DISTRESS,15
CA,FEELING JITTERY,15
CA,HELICOBACTER INFECTION,15
CA,HYSTERECTOMY,15
CA,INFLAMMATORY MARKER INCREASED,15
CA,INTERVERTEBRAL DISCITIS,15
CA,INTESTINAL POLYP,15
CA,JOINT CREPITATION,15
CA,MEDICAL DEVICE IMPLANTATION,15
CA,MULTIPLE FRACTURES,15
CA,NEURALGIA,15
CA,ORAL HERPES,15
CA,PLEURAL THICKENING,15
CA,POST-TRAUMATIC STRESS DISORDER,15
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,15
CA,RHEUMATIC FEVER,15
CA,SENSORY LOSS,15
CA,SKIN PLAQUE,15
CA,SPUTUM DISCOLOURED,15
CA,TRANSAMINASES ABNORMAL,15
CA,ABSCESS LIMB,14
CA,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,14
CA,ATELECTASIS,14
CA,BACTERIAL INFECTION,14
CA,BLOOD POTASSIUM DECREASED,14
CA,BLOOD URINE PRESENT,14
CA,DECREASED ACTIVITY,14
CA,DRUG-INDUCED LIVER INJURY,14
CA,FAECES SOFT,14
CA,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,14
CA,GRAFT VERSUS HOST DISEASE IN SKIN,14
CA,HYPERAESTHESIA,14
CA,INCREASED UPPER AIRWAY SECRETION,14
CA,INJECTION SITE INDURATION,14
CA,INVESTIGATION ABNORMAL,14
CA,JOINT ANKYLOSIS,14
CA,LARYNGEAL DISORDER,14
CA,MACULAR DEGENERATION,14
CA,MIDDLE INSOMNIA,14
CA,NO THERAPEUTIC RESPONSE,14
CA,PREGNANCY,14
CA,RED BLOOD CELL COUNT DECREASED,14
CA,ROTATOR CUFF SYNDROME,14
CA,SERONEGATIVE ARTHRITIS,14
CA,TACHYCARDIA,14
CA,THYROID CANCER,14
CA,TINNITUS,14
CA,TRANSAMINASES INCREASED,14
CA,VASCULITIS,14
CA,BUNION OPERATION,13
CA,DISEASE SUSCEPTIBILITY,13
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,13
CA,GASTROINTESTINAL INFECTION,13
CA,HYPERSOMNIA,13
CA,INGUINAL HERNIA,13
CA,LYMPHOEDEMA,13
CA,ORAL SURGERY,13
CA,SCLERITIS,13
CA,SPINAL COMPRESSION FRACTURE,13
CA,STENT PLACEMENT,13
CA,TINEA PEDIS,13
CA,UTERINE DISORDER,13
CA,ABSCESS,12
CA,AGGRESSION,12
CA,CARDIAC ARREST,12
CA,CHOLECYSTECTOMY,12
CA,CUSHINGOID,12
CA,CYSTITIS INTERSTITIAL,12
CA,DEPENDENCE,12
CA,DIPLOPIA,12
CA,ELBOW OPERATION,12
CA,FUNGAL SKIN INFECTION,12
CA,GOITRE,12
CA,HALLUCINATION,12
CA,INJECTION SITE INFLAMMATION,12
CA,LATENT TUBERCULOSIS,12
CA,LIP ULCERATION,12
CA,ORAL DISCOMFORT,12
CA,PANIC ATTACK,12
CA,PSEUDOMONAS INFECTION,12
CA,SACROILIITIS,12
CA,SKIN FISSURES,12
CA,SKIN INFECTION,12
CA,TENOSYNOVITIS STENOSANS,12
CA,THERAPY PARTIAL RESPONDER,12
CA,URINE ABNORMALITY,12
CA,URINE ODOUR ABNORMAL,12
CA,UROSEPSIS,12
CA,ARTHROPOD BITE,11
CA,BREAST NEOPLASM,11
CA,CORONARY ARTERY OCCLUSION,11
CA,CYTOLOGY ABNORMAL,11
CA,CYTOMEGALOVIRUS INFECTION,11
CA,DEMENTIA,11
CA,DIVERTICULUM,11
CA,DYSURIA,11
CA,ECCHYMOSIS,11
CA,FEELING COLD,11
CA,FLANK PAIN,11
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,11
CA,INTERNAL HAEMORRHAGE,11
CA,JOINT CONTRACTURE,11
CA,LYME DISEASE,11
CA,MENOPAUSAL SYMPTOMS,11
CA,MUSCLE DISORDER,11
CA,OSTEOSCLEROSIS,11
CA,PANCREATIC DISORDER,11
CA,PARALYSIS,11
CA,PERICARDIAL EFFUSION,11
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,11
CA,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,11
CA,RAYNAUD^S PHENOMENON,11
CA,ROSACEA,11
CA,SERUM FERRITIN DECREASED,11
CA,SKIN ATROPHY,11
CA,SKIN MASS,11
CA,STREPTOCOCCAL INFECTION,11
CA,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,11
CA,TENDON RUPTURE,11
CA,TOOTH FRACTURE,11
CA,TUBERCULOSIS,11
CA,VITAMIN D DEFICIENCY,11
CA,ADENOVIRUS INFECTION,10
CA,ANAL ABSCESS,10
CA,ANGIOPATHY,10
CA,APHTHOUS ULCER,10
CA,BLADDER DISORDER,10
CA,BLOOD COUNT ABNORMAL,10
CA,BLOOD MAGNESIUM INCREASED,10
CA,BREAST PAIN,10
CA,CATARACT OPERATION,10
CA,CONCUSSION,10
CA,DEMENTIA ALZHEIMER^S TYPE,10
CA,DISEASE RECURRENCE,10
CA,DRUG EFFECT DELAYED,10
CA,DRY THROAT,10
CA,EFFUSION,10
CA,ENCEPHALOPATHY,10
CA,EYE SWELLING,10
CA,EYELID EXFOLIATION,10
CA,GINGIVITIS,10
CA,HAEMATOCRIT DECREASED,10
CA,HEART RATE DECREASED,10
CA,HERPES VIRUS INFECTION,10
CA,HIATUS HERNIA,10
CA,HUMAN HERPESVIRUS 6 INFECTION,10
CA,HYPOAESTHESIA ORAL,10
CA,IMMUNISATION REACTION,10
CA,INTESTINAL OBSTRUCTION,10
CA,INVESTIGATION,10
CA,JOINT WARMTH,10
CA,KNEE OPERATION,10
CA,LYMPHADENECTOMY,10
CA,MENTAL DISORDER,10
CA,MOOD ALTERED,10
CA,MUSCLE ATROPHY,10
CA,OCULAR VASCULAR DISORDER,10
CA,PERIPHERAL VENOUS DISEASE,10
CA,PSYCHIATRIC SYMPTOM,10
CA,RESPIRATORY ARREST,10
CA,SCLERODACTYLIA,10
CA,SKIN BURNING SENSATION,10
CA,STRESS AT WORK,10
CA,SYNOVIAL DISORDER,10
CA,SYNOVIAL FLUID ANALYSIS,10
CA,TELANGIECTASIA,10
CA,TONGUE DISCOLOURATION,10
CA,TOOTH DISORDER,10
CA,VASCULAR GRAFT,10
CA,ANAL FISSURE,9
CA,AORTIC BRUIT,9
CA,APHASIA,9
CA,BLADDER NEOPLASM,9
CA,CARDIAC FLUTTER,9
CA,CERVICAL VERTEBRAL FRACTURE,9
CA,DEVICE ISSUE,9
CA,DYSGEUSIA,9
CA,EYE DISCHARGE,9
CA,FREQUENT BOWEL MOVEMENTS,9
CA,GASTROENTERITIS,9
CA,HEPATITIS C,9
CA,HLA MARKER STUDY POSITIVE,9
CA,HUNGER,9
CA,IMMUNE THROMBOCYTOPENIC PURPURA,9
CA,KYPHOSIS,9
CA,LARYNGITIS,9
CA,LEUKAEMIA,9
CA,LICHEN PLANUS,9
CA,MIXED CONNECTIVE TISSUE DISEASE,9
CA,MUSCULOSKELETAL CHEST PAIN,9
CA,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,9
CA,NEUTROPHIL COUNT DECREASED,9
CA,OVARIAN CANCER,9
CA,PHARYNGEAL ULCERATION,9
CA,PNEUMOTHORAX,9
CA,PRECANCEROUS CELLS PRESENT,9
CA,PRESYNCOPE,9
CA,PSYCHOMOTOR HYPERACTIVITY,9
CA,PURULENT DISCHARGE,9
CA,RASH MACULAR,9
CA,RENAL FAILURE ACUTE,9
CA,SCLERODERMA,9
CA,SCRATCH,9
CA,SKIN HYPERTROPHY,9
CA,SKIN IRRITATION,9
CA,SKIN SWELLING,9
CA,SNEEZING,9
CA,SPLENOMEGALY,9
CA,TOE OPERATION,9
CA,UTERINE LEIOMYOMA,9
CA,VAGINAL HAEMORRHAGE,9
CA,VERTEBRAL FORAMINAL STENOSIS,9
CA,VISUAL ACUITY REDUCED,9
CA,VITAMIN D DECREASED,9
CA,VULVOVAGINAL MYCOTIC INFECTION,9
CA,ACCIDENTAL EXPOSURE TO PRODUCT,8
CA,ANEURYSM,8
CA,ARTHRITIS BACTERIAL,8
CA,BONE GRAFT,8
CA,BREAST CYST EXCISION,8
CA,CEREBRAL HAEMORRHAGE,8
CA,CHANGE OF BOWEL HABIT,8
CA,CHOKING,8
CA,CHONDROPATHY,8
CA,COLITIS ISCHAEMIC,8
CA,CONTRAST MEDIA ALLERGY,8
CA,DISTURBANCE IN ATTENTION,8
CA,ENCEPHALITIS BRAIN STEM,8
CA,ENCEPHALITIS VIRAL,8
CA,ENDODONTIC PROCEDURE,8
CA,EPILEPSY,8
CA,FACIAL PAIN,8
CA,FEELING DRUNK,8
CA,FRACTURE DELAYED UNION,8
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
CA,GRAFT VERSUS HOST DISEASE,8
CA,HAEMATURIA,8
CA,HEPATIC CANCER,8
CA,HYPERTROPHIC CARDIOMYOPATHY,8
CA,INCISION SITE INFECTION,8
CA,INJECTION SITE EXTRAVASATION,8
CA,INTESTINAL PERFORATION,8
CA,LIGAMENT SPRAIN,8
CA,LIP DRY,8
CA,MESENTERITIS,8
CA,MOUTH HAEMORRHAGE,8
CA,MYOFASCIAL PAIN SYNDROME,8
CA,NASAL DRYNESS,8
CA,OCULAR HYPERTENSION,8
CA,OPHTHALMIC VEIN THROMBOSIS,8
CA,OSTEONECROSIS,8
CA,PAPILLARY THYROID CANCER,8
CA,PARAPLEGIA,8
CA,PLANTAR FASCIITIS,8
CA,RASH PAPULAR,8
CA,RENAL CANCER,8
CA,RESTLESS LEGS SYNDROME,8
CA,RETINAL DEPOSITS,8
CA,RETINOPATHY,8
CA,SPINAL COLUMN INJURY,8
CA,SQUAMOUS CELL CARCINOMA OF SKIN,8
CA,STAPHYLOCOCCAL ABSCESS,8
CA,SURGICAL FAILURE,8
CA,TOOTH EXTRACTION,8
CA,UTERINE CANCER,8
CA,WRIST FRACTURE,8
CA,ACUTE MYOCARDIAL INFARCTION,7
CA,ANAL INCONTINENCE,7
CA,BACTERAEMIA,7
CA,BLOOD PRESSURE DIASTOLIC DECREASED,7
CA,BLOOD PRESSURE DIASTOLIC INCREASED,7
CA,BONE MARROW FAILURE,7
CA,BUTTERFLY RASH,7
CA,CEREBRAL DISORDER,7
CA,COMPRESSION FRACTURE,7
CA,DENTAL CARIES,7
CA,DERMATITIS PSORIASIFORM,7
CA,DEVICE RELATED INFECTION,7
CA,DIARRHOEA HAEMORRHAGIC,7
CA,DISTURBANCE IN SOCIAL BEHAVIOUR,7
CA,DIZZINESS POSTURAL,7
CA,EXPOSURE TO COMMUNICABLE DISEASE,7
CA,GASTRIC HAEMORRHAGE,7
CA,GASTROENTERITIS VIRAL,7
CA,GASTROINTESTINAL INFLAMMATION,7
CA,GLUCOSE TOLERANCE IMPAIRED,7
CA,GRANULOMA,7
CA,HEART RATE IRREGULAR,7
CA,HEPATIC NEOPLASM,7
CA,HERPES OPHTHALMIC,7
CA,INJECTION RELATED REACTION,7
CA,JAUNDICE,7
CA,JOINT FLUID DRAINAGE,7
CA,KYPHOSCOLIOSIS,7
CA,LUMBAR VERTEBRAL FRACTURE,7
CA,MASS EXCISION,7
CA,MENINGITIS,7
CA,MENORRHAGIA,7
CA,MULTI-ORGAN FAILURE,7
CA,NERVE COMPRESSION,7
CA,OBSTRUCTIVE AIRWAYS DISORDER,7
CA,OPTIC NEURITIS,7
CA,OSTEITIS,7
CA,OSTEOLYSIS,7
CA,PALLOR,7
CA,PANCREATIC CARCINOMA,7
CA,PAPULE,7
CA,PATHOLOGICAL FRACTURE,7
CA,PELVIC PAIN,7
CA,PERIARTHRITIS,7
CA,POLLAKIURIA,7
CA,POOR QUALITY SLEEP,7
CA,POOR VENOUS ACCESS,7
CA,POST PROCEDURAL CONTUSION,7
CA,PRODUCT QUALITY ISSUE,7
CA,PRODUCT STORAGE ERROR,7
CA,PRURITUS ALLERGIC,7
CA,PULMONARY SARCOIDOSIS,7
CA,RASH PUSTULAR,7
CA,RESTRICTIVE PULMONARY DISEASE,7
CA,SEXUAL ABUSE,7
CA,SKIN DEPIGMENTATION,7
CA,STAPHYLOCOCCAL BACTERAEMIA,7
CA,THROAT CANCER,7
CA,TYPE 1 DIABETES MELLITUS,7
CA,ULCERATIVE KERATITIS,7
CA,URINARY INCONTINENCE,7
CA,VAGINAL INFECTION,7
CA,VIITH NERVE PARALYSIS,7
CA,WOUND COMPLICATION,7
CA,ABDOMINAL MASS,6
CA,ABDOMINAL TENDERNESS,6
CA,ARTERIAL OCCLUSIVE DISEASE,6
CA,ARTERIOSPASM CORONARY,6
CA,BLADDER OPERATION,6
CA,BLINDNESS UNILATERAL,6
CA,BLOOD DISORDER,6
CA,BLOOD GLUCOSE DECREASED,6
CA,BOWEL MOVEMENT IRREGULARITY,6
CA,BREATH SOUNDS ABNORMAL,6
CA,CARDIAC OPERATION,6
CA,CLOSTRIDIUM DIFFICILE COLITIS,6
CA,DERMATITIS CONTACT,6
CA,DEVICE OCCLUSION,6
CA,DIAPHRAGMATIC RUPTURE,6
CA,DISSEMINATED INTRAVASCULAR COAGULATION,6
CA,DIVERTICULAR PERFORATION,6
CA,DRUG PRESCRIBING ERROR,6
CA,DRUG TOLERANCE,6
CA,ERYTHEMA OF EYELID,6
CA,EYE INFLAMMATION,6
CA,FAECES DISCOLOURED,6
CA,FLUSHING,6
CA,FOOD POISONING,6
CA,FULL BLOOD COUNT DECREASED,6
CA,GASTRIC ULCER HAEMORRHAGE,6
CA,GENITAL CYST,6
CA,GENITAL HERPES,6
CA,HEAD DISCOMFORT,6
CA,HYPERSENSITIVITY VASCULITIS,6
CA,JAW DISORDER,6
CA,JOINT SURGERY,6
CA,KERATITIS,6
CA,LEG AMPUTATION,6
CA,LOCALISED OEDEMA,6
CA,LYMPHADENITIS,6
CA,MAJOR DEPRESSION,6
CA,METASTASES TO BONE,6
CA,METASTASES TO LIVER,6
CA,MONOCYTOSIS,6
CA,NASAL DISCOMFORT,6
CA,NECROTISING SCLERITIS,6
CA,NODAL OSTEOARTHRITIS,6
CA,OESOPHAGITIS,6
CA,PARAESTHESIA ORAL,6
CA,PREMATURE DELIVERY,6
CA,PROCEDURAL ANXIETY,6
CA,PROSTATOMEGALY,6
CA,RESPIRATORY DISTRESS,6
CA,SINUSITIS BACTERIAL,6
CL,VARICELLA ZOSTER VIRUS INFECTION,5
CL,HYPERSENSITIVITY,3
CL,SJOGREN^S SYNDROME,3
CL,ARTHROPATHY,2
CL,BONE DISORDER,2
CL,CUSHING^S SYNDROME,2
CL,DRUG INEFFECTIVE,2
CL,DYSPNOEA,2
CL,EYE DISORDER,2
CL,GASTRITIS,2
CL,INFECTION,2
CL,INTESTINAL PERFORATION,2
CL,PRODUCT QUALITY ISSUE,2
CL,SEPTIC SHOCK,2
CL,ABDOMINAL ABSCESS,1
CL,ABDOMINAL WOUND DEHISCENCE,1
CL,ACUTE ABDOMEN,1
CL,AMYOTROPHIC LATERAL SCLEROSIS,1
CL,ARTHRALGIA,1
CL,BACK PAIN,1
CL,BRONCHITIS,1
CL,CANDIDA INFECTION,1
CL,CHONDROPATHY,1
CL,COMA,1
CL,CUTANEOUS VASCULITIS,1
CL,DEMYELINATION,1
CL,DIABETIC METABOLIC DECOMPENSATION,1
CL,DRUG DOSE OMISSION,1
CL,EATING DISORDER,1
CL,ENCEPHALITIS AUTOIMMUNE,1
CL,ERYTHEMA,1
CL,FATIGUE,1
CL,GENITAL HAEMORRHAGE,1
CL,HAEMATOCHEZIA,1
CL,HEADACHE,1
CL,HERPES ZOSTER,1
CL,HIDRADENITIS,1
CL,INCORRECT DOSE ADMINISTERED,1
CL,INJECTION SITE ERYTHEMA,1
CL,INJECTION SITE HAEMORRHAGE,1
CL,INJECTION SITE INFLAMMATION,1
CL,INJECTION SITE MASS,1
CL,INJECTION SITE PAIN,1
CL,INJECTION SITE PRURITUS,1
CL,INJECTION SITE URTICARIA,1
CL,INTENTIONAL UNDERDOSE,1
CL,JUVENILE PSORIATIC ARTHRITIS,1
CL,LEUKOPENIA,1
CL,MALNUTRITION,1
CL,MOBILITY DECREASED,1
CL,MUSCULOSKELETAL STIFFNESS,1
CL,NASOPHARYNGITIS,1
CL,NEPHROLITHIASIS,1
CL,OCULAR HYPERAEMIA,1
CL,PAIN,1
CL,PERITONITIS,1
CL,PNEUMONIA,1
CL,POST PROCEDURAL HAEMORRHAGE,1
CL,PRURITUS,1
CL,PSORIASIS,1
CL,PYREXIA,1
CL,RHEUMATOID ARTHRITIS,1
CL,ROTAVIRUS INFECTION,1
CL,SINUSITIS,1
CL,STOMATITIS,1
CL,SUPERINFECTION,1
CL,SUPERINFECTION BACTERIAL,1
CL,SWELLING,1
CL,THERAPEUTIC RESPONSE DECREASED,1
CL,THERAPY NON-RESPONDER,1
CL,URTICARIA,1
CL,UVEITIS,1
CL,VARICELLA,1
CN,RASH,6
CN,LUNG NEOPLASM MALIGNANT,4
CN,PYREXIA,4
CN,CHEST DISCOMFORT,3
CN,DRUG ERUPTION,3
CN,DRUG INEFFECTIVE,3
CN,HEADACHE,3
CN,NAUSEA,3
CN,PAIN,3
CN,PRURITUS,3
CN,WHITE BLOOD CELL COUNT INCREASED,3
CN,ALANINE AMINOTRANSFERASE INCREASED,2
CN,ARTHRALGIA,2
CN,ARTHRITIS,2
CN,ASCITES,2
CN,CEREBRAL INFARCTION,2
CN,DECREASED APPETITE,2
CN,DIZZINESS,2
CN,DYSPNOEA,2
CN,ERYTHEMA,2
CN,HEPATOCELLULAR INJURY,2
CN,HYPERTENSION,2
CN,LIVER DISORDER,2
CN,MENINGIOMA,2
CN,PLATELET COUNT DECREASED,2
CN,PRODUCT USE ISSUE,2
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CN,VOMITING,2
CN,ABASIA,1
CN,ABORTION THREATENED,1
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CN,AGGRESSION,1
CN,ALOPECIA,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,ANAL CANCER,1
CN,ANGINA PECTORIS,1
CN,APATHY,1
CN,ARTHROPATHY,1
CN,ASPARTATE AMINOTRANSFERASE INCREASED,1
CN,BLOOD ALBUMIN DECREASED,1
CN,BLOOD FIBRINOGEN INCREASED,1
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CN,BLOOD PRESSURE DECREASED,1
CN,BONE MARROW FAILURE,1
CN,BREATH SOUNDS ABNORMAL,1
CN,C-REACTIVE PROTEIN INCREASED,1
CN,CARDIAC DISCOMFORT,1
CN,CEREBROVASCULAR ACCIDENT,1
CN,CHOLELITHIASIS,1
CN,CONDITION AGGRAVATED,1
CN,CUSHINGOID,1
CN,CYST,1
CN,DEHYDRATION,1
CN,DELUSION,1
CN,DISCOMFORT,1
CN,DISORIENTATION,1
CN,DISSEMINATED TUBERCULOSIS,1
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CN,DYSCALCULIA,1
CN,DYSPHONIA,1
CN,DYSSTASIA,1
CN,EYELID OEDEMA,1
CN,FREQUENT BOWEL MOVEMENTS,1
CN,FUNGAL INFECTION,1
CN,GENERALISED OEDEMA,1
CN,HAEMATOCHEZIA,1
CN,HEART RATE DECREASED,1
CN,HEART RATE INCREASED,1
CN,HEPATIC ENZYME INCREASED,1
CN,HEPATOTOXICITY,1
CN,HISTIOCYTOSIS HAEMATOPHAGIC,1
CN,HYPERSENSITIVITY,1
CN,HYPOPHAGIA,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CN,INFLUENZA,1
CN,INFLUENZA LIKE ILLNESS,1
CN,INJECTION SITE PRURITUS,1
CN,INTERSTITIAL LUNG DISEASE,1
CN,INTRACRANIAL PRESSURE INCREASED,1
CN,JOINT CONTRACTURE,1
CN,JOINT SWELLING,1
CN,LARYNGEAL OEDEMA,1
CN,LIVER INJURY,1
CN,LOWER RESPIRATORY TRACT INFECTION,1
CN,LUNG INFILTRATION,1
CN,LYMPHADENOPATHY,1
CN,MEASLES,1
CN,MEMORY IMPAIRMENT,1
CN,MOUTH ULCERATION,1
CN,MYCOSIS FUNGOIDES,1
CN,NATURAL KILLER CELL COUNT DECREASED,1
CN,NEOPLASM MALIGNANT,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,ORAL BACTERIAL INFECTION,1
CN,ORAL FUNGAL INFECTION,1
CN,OTITIS MEDIA,1
CN,PALPITATIONS,1
CN,PERINEAL INFECTION,1
CN,PERITONEAL TUBERCULOSIS,1
CN,PHARYNGEAL OEDEMA,1
CN,PNEUMONIA,1
CN,PNEUMONIA ASPIRATION,1
CN,POISONING,1
CN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
CN,PROCALCITONIN INCREASED,1
CN,PRODUCT USE IN UNAPPROVED INDICATION,1
CN,PSORIATIC ARTHROPATHY,1
CN,PULMONARY FIBROSIS,1
CN,PULMONARY TUBERCULOSIS,1
CN,RASH GENERALISED,1
CN,RESPIRATORY RATE INCREASED,1
CN,RHINITIS,1
CN,SERUM FERRITIN INCREASED,1
CN,SHOCK,1
CN,SKIN INFECTION,1
CN,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
CN,SPEECH DISORDER,1
CN,SYNOVIAL CYST,1
CN,TINNITUS,1
CN,TOOTH DISORDER,1
CN,TUBERCULOSIS,1
CN,TUBERCULOUS PLEURISY,1
CN,TUMOUR MARKER INCREASED,1
CN,ULCER,1
CN,UPPER RESPIRATORY TRACT INFECTION,1
CN,URINARY TRACT INFECTION,1
CN,WEIGHT DECREASED,1
CO,ARTHRALGIA,204
CO,INFLUENZA,144
CO,PAIN IN EXTREMITY,138
CO,DRUG INEFFECTIVE,111
CO,HEADACHE,107
CO,PAIN,106
CO,GAIT DISTURBANCE,84
CO,ARTHROPATHY,81
CO,PYREXIA,80
CO,JOINT SWELLING,78
CO,COUGH,70
CO,URINARY TRACT INFECTION,69
CO,FALL,60
CO,MALAISE,56
CO,DIZZINESS,55
CO,RHEUMATOID ARTHRITIS,54
CO,DECREASED IMMUNE RESPONSIVENESS,53
CO,VOMITING,52
CO,CONDITION AGGRAVATED,50
CO,HYPERTENSION,44
CO,PERIPHERAL SWELLING,44
CO,DEATH,43
CO,FATIGUE,41
CO,BACK PAIN,38
CO,PNEUMONIA,37
CO,CATARACT,36
CO,DIARRHOEA,36
CO,PSORIASIS,35
CO,ABASIA,34
CO,HYPERSENSITIVITY,34
CO,MOBILITY DECREASED,34
CO,INJECTION SITE PAIN,33
CO,ARTHRITIS,32
CO,INJECTION SITE ERYTHEMA,29
CO,OSTEOARTHRITIS,29
CO,OSTEOPOROSIS,29
CO,ASTHENIA,28
CO,FOOT DEFORMITY,28
CO,PRURITUS,28
CO,MUSCULOSKELETAL PAIN,27
CO,DYSPNOEA,26
CO,TUBERCULIN TEST POSITIVE,26
CO,ABDOMINAL PAIN UPPER,25
CO,DEPRESSION,25
CO,BONE PAIN,24
CO,MYOCARDIAL INFARCTION,24
CO,SWELLING,24
CO,BRONCHITIS,23
CO,HYPOAESTHESIA,23
CO,NAUSEA,23
CO,TUBERCULOSIS,23
CO,CARDIAC DISORDER,22
CO,DIABETES MELLITUS,22
CO,WEIGHT DECREASED,22
CO,CHILLS,21
CO,GAIT INABILITY,21
CO,IMMUNODEFICIENCY,21
CO,LUNG DISORDER,21
CO,BLINDNESS,20
CO,CELLULITIS,20
CO,FEELING ABNORMAL,20
CO,INFLAMMATION,20
CO,RASH,20
CO,DRUG DOSE OMISSION,19
CO,GASTRITIS,19
CO,IMMUNE SYSTEM DISORDER,19
CO,INJECTION SITE PRURITUS,19
CO,LOCAL SWELLING,19
CO,PRODUCT USE ISSUE,19
CO,BLOOD PRESSURE INCREASED,18
CO,DECREASED APPETITE,18
CO,DISCOMFORT,18
CO,DISEASE RECURRENCE,18
CO,MUSCULOSKELETAL STIFFNESS,18
CO,NEPHROLITHIASIS,18
CO,URTICARIA,18
CO,ERYTHEMA,17
CO,BLOOD GLUCOSE INCREASED,16
CO,HAND DEFORMITY,16
CO,IMMUNOSUPPRESSION,16
CO,INFECTION,16
CO,INJECTION SITE SWELLING,16
CO,JOINT INJURY,16
CO,RASH GENERALISED,16
CO,SPINAL PAIN,16
CO,THROMBOSIS,16
CO,ALOPECIA,15
CO,GENERAL PHYSICAL HEALTH DETERIORATION,15
CO,INSOMNIA,15
CO,JOINT DISLOCATION,15
CO,OEDEMA PERIPHERAL,15
CO,OROPHARYNGEAL PAIN,15
CO,PRODUCT QUALITY ISSUE,15
CO,VISUAL IMPAIRMENT,15
CO,ABDOMINAL PAIN,14
CO,CHEST PAIN,14
CO,DRY SKIN,14
CO,FINGER DEFORMITY,14
CO,MUSCLE SPASMS,14
CO,SJOGREN^S SYNDROME,14
CO,ASPHYXIA,13
CO,CEREBROVASCULAR ACCIDENT,13
CO,CHOLELITHIASIS,13
CO,DRY MOUTH,13
CO,HIP FRACTURE,13
CO,KIDNEY INFECTION,13
CO,MUSCULAR WEAKNESS,13
CO,VAGINAL HAEMORRHAGE,13
CO,VERTIGO,13
CO,GALLBLADDER DISORDER,12
CO,GLAUCOMA,12
CO,HAEMORRHAGE,12
CO,HEPATITIS,12
CO,INTERVERTEBRAL DISC PROTRUSION,12
CO,NECK PAIN,12
CO,PRURITUS GENERALISED,12
CO,SINUSITIS,12
CO,SOMNOLENCE,12
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,12
CO,WOUND,12
CO,ANAEMIA,11
CO,DEAFNESS,11
CO,DRY EYE,11
CO,DYSPHONIA,11
CO,FEELING HOT,11
CO,INJECTION SITE URTICARIA,11
CO,PRODUCTIVE COUGH,11
CO,VIRAL INFECTION,11
CO,WEIGHT INCREASED,11
CO,AMNESIA,10
CO,CARDIAC FAILURE,10
CO,FLUID RETENTION,10
CO,HYPERHIDROSIS,10
CO,INJECTION SITE BRUISING,10
CO,LUNG INFECTION,10
CO,RENAL DISORDER,10
CO,RESPIRATORY ARREST,10
CO,TACHYCARDIA,10
CO,THYROID DISORDER,10
CO,VISUAL ACUITY REDUCED,10
CO,ANKYLOSING SPONDYLITIS,9
CO,APHONIA,9
CO,ARRHYTHMIA,9
CO,BLISTER,9
CO,BONE DISORDER,9
CO,CONJUNCTIVITIS,9
CO,CYSTITIS,9
CO,DEPRESSED MOOD,9
CO,EYE DISORDER,9
CO,FEMUR FRACTURE,9
CO,HAEMOGLOBIN DECREASED,9
CO,INCREASED UPPER AIRWAY SECRETION,9
CO,INFARCTION,9
CO,INJECTION SITE HAEMATOMA,9
CO,INJURY,9
CO,LIVER DISORDER,9
CO,NASOPHARYNGITIS,9
CO,PLATELET COUNT DECREASED,9
CO,PSORIATIC ARTHROPATHY,9
CO,ROAD TRAFFIC ACCIDENT,9
CO,SKIN ULCER,9
CO,ABDOMINAL DISCOMFORT,8
CO,ABDOMINAL DISTENSION,8
CO,ACNE,8
CO,BURNING SENSATION,8
CO,CARDIAC ARREST,8
CO,CEREBRAL ISCHAEMIA,8
CO,DENGUE FEVER,8
CO,DISEASE PROGRESSION,8
CO,EYE PAIN,8
CO,FIBROMYALGIA,8
CO,HEPATIC STEATOSIS,8
CO,HERPES ZOSTER,8
CO,INGUINAL HERNIA,8
CO,INJECTION SITE HAEMORRHAGE,8
CO,LIMB DISCOMFORT,8
CO,LOCALISED INFECTION,8
CO,LOSS OF CONSCIOUSNESS,8
CO,MENISCUS INJURY,8
CO,MUSCULOSKELETAL DISORDER,8
CO,NASAL CONGESTION,8
CO,PARAESTHESIA,8
CO,PULMONARY OEDEMA,8
CO,RENAL FAILURE,8
CO,RHINITIS,8
CO,RHINORRHOEA,8
CO,SPINAL DISORDER,8
CO,SWELLING FACE,8
CO,UPPER LIMB FRACTURE,8
CO,VISION BLURRED,8
CO,WOUND INFECTION,8
CO,ANXIETY,7
CO,BLOOD CHOLESTEROL INCREASED,7
CO,CHIKUNGUNYA VIRUS INFECTION,7
CO,CONSTIPATION,7
CO,DRUG EFFECT INCOMPLETE,7
CO,EPISTAXIS,7
CO,FISTULA,7
CO,FUNGAL SKIN INFECTION,7
CO,HYPERKERATOSIS,7
CO,HYPOACUSIS,7
CO,JOINT RANGE OF MOTION DECREASED,7
CO,LARYNGITIS,7
CO,MIGRAINE,7
CO,MOVEMENT DISORDER,7
CO,OCULAR HYPERAEMIA,7
CO,PERITONITIS,7
CO,PHARYNGITIS,7
CO,PROSTATIC DISORDER,7
CO,PULMONARY MASS,7
CO,SKIN DISCOLOURATION,7
CO,SPEECH DISORDER,7
CO,SYNCOPE,7
CO,VAGINAL DISCHARGE,7
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,6
CO,APPENDICITIS,6
CO,ARTERIAL OCCLUSIVE DISEASE,6
CO,ASTHMA,6
CO,BACTERIAL INFECTION,6
CO,BEDRIDDEN,6
CO,BLINDNESS UNILATERAL,6
CO,BLOOD PRESSURE DECREASED,6
CO,BLOOD TRIGLYCERIDES INCREASED,6
CO,CARPAL TUNNEL SYNDROME,6
CO,CHEST DISCOMFORT,6
CO,CONTUSION,6
CO,DRUG HYPERSENSITIVITY,6
CO,DRUG INTOLERANCE,6
CO,DYSPEPSIA,6
CO,ENDOMETRIOSIS,6
CO,EYE IRRITATION,6
CO,FURUNCLE,6
CO,GASTRIC ULCER,6
CO,GASTROENTERITIS,6
CO,GASTROINTESTINAL INFECTION,6
CO,HERNIA,6
CO,HYPOTHYROIDISM,6
CO,INJECTION SITE RASH,6
CO,INJECTION SITE WARMTH,6
CO,LIMB INJURY,6
CO,MUSCULOSKELETAL DISCOMFORT,6
CO,MYALGIA,6
CO,NEOPLASM MALIGNANT,6
CO,OSTEOMYELITIS,6
CO,OVARIAN CYST,6
CO,PTERYGIUM,6
CO,RESPIRATORY FAILURE,6
CO,SEPSIS,6
CO,SKIN LESION,6
CO,STRESS,6
CO,THROAT IRRITATION,6
CO,THROMBOPHLEBITIS,6
CO,UTERINE LEIOMYOMA,6
CO,VARICOSE VEIN,6
CO,ARTHRITIS INFECTIVE,5
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
CO,DYSSTASIA,5
CO,EAR PAIN,5
CO,EYE DISCHARGE,5
CO,EYE INFLAMMATION,5
CO,EYE PRURITUS,5
CO,EYE SWELLING,5
CO,FLAVIVIRUS INFECTION,5
CO,GASTRIC INFECTION,5
CO,HERPES VIRUS INFECTION,5
CO,HYPOTENSION,5
CO,IMMOBILE,5
CO,INJECTION SITE HYPERSENSITIVITY,5
CO,LIVER INJURY,5
CO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,5
CO,MEMORY IMPAIRMENT,5
CO,NERVOUSNESS,5
CO,PERIPHERAL COLDNESS,5
CO,POST PROCEDURAL INFECTION,5
CO,POSTOPERATIVE WOUND INFECTION,5
CO,RESPIRATORY DISORDER,5
CO,RESPIRATORY TRACT INFECTION,5
CO,ROTATOR CUFF SYNDROME,5
CO,SCOLIOSIS,5
CO,SKIN EXFOLIATION,5
CO,THYROID CANCER,5
CO,TOOTH LOSS,5
CO,TRANSAMINASES INCREASED,5
CO,TREMOR,5
CO,URINARY INCONTINENCE,5
CO,UTERINE DISORDER,5
CO,UVEITIS,5
CO,ABDOMINAL HERNIA,4
CO,ABDOMINAL PAIN LOWER,4
CO,ABSCESS,4
CO,ABSCESS LIMB,4
CO,ACCIDENT,4
CO,BLOOD CALCIUM DECREASED,4
CO,BLOOD GLUCOSE ABNORMAL,4
CO,BLOOD POTASSIUM DECREASED,4
CO,BLOOD URINE PRESENT,4
CO,BONE DEFORMITY,4
CO,BRAIN NEOPLASM,4
CO,BREAST CANCER,4
CO,BUNION,4
CO,CARDIOMEGALY,4
CO,CHOKING,4
CO,COLITIS,4
CO,COLON CANCER,4
CO,COMA,4
CO,CONTRAINDICATED PRODUCT ADMINISTERED,4
CO,DEAFNESS UNILATERAL,4
CO,DEVICE RELATED INFECTION,4
CO,DISTURBANCE IN ATTENTION,4
CO,DIVERTICULITIS,4
CO,DRUG ADMINISTRATION ERROR,4
CO,DRUG DEPENDENCE,4
CO,DYSURIA,4
CO,ERYSIPELAS,4
CO,EYE INFECTION,4
CO,FACIAL PAIN,4
CO,FIBULA FRACTURE,4
CO,GASTROINTESTINAL DISORDER,4
CO,HAEMATOMA,4
CO,HAEMORRHOIDS,4
CO,HEART RATE INCREASED,4
CO,HUMERUS FRACTURE,4
CO,HYPOKINESIA,4
CO,INCORRECT PRODUCT STORAGE,4
CO,INJECTION SITE INDURATION,4
CO,INJECTION SITE REACTION,4
CO,JOINT STIFFNESS,4
CO,KNEE DEFORMITY,4
CO,LACRIMATION INCREASED,4
CO,LATENT TUBERCULOSIS,4
CO,LEIOMYOMA,4
CO,LIP DRY,4
CO,LOWER LIMB FRACTURE,4
CO,MENOPAUSE,4
CO,NODULE,4
CO,OBESITY,4
CO,PALLOR,4
CO,PANCREATITIS,4
CO,PELVIC FRACTURE,4
CO,PIGMENTATION DISORDER,4
CO,PRODUCT USE IN UNAPPROVED INDICATION,4
CO,PURULENT DISCHARGE,4
CO,RASH ERYTHEMATOUS,4
CO,RASH MACULAR,4
CO,RASH PRURITIC,4
CO,REFLUX GASTRITIS,4
CO,SKIN DISORDER,4
CO,SKIN PLAQUE,4
CO,SPINAL COLUMN INJURY,4
CO,SPINAL FRACTURE,4
CO,STOMACH MASS,4
CO,SUICIDAL IDEATION,4
CO,SYNOVITIS,4
CO,TONSILLITIS,4
CO,TOOTHACHE,4
CO,TOXICITY TO VARIOUS AGENTS,4
CO,TRANSIENT ISCHAEMIC ATTACK,4
CO,UMBILICAL HERNIA,4
CO,WHEELCHAIR USER,4
CO,YELLOW SKIN,4
CO,ANKLE FRACTURE,3
CO,BLOOD CREATININE INCREASED,3
CO,BLOOD PRESSURE ABNORMAL,3
CO,BONE DECALCIFICATION,3
CO,BRONCHOPNEUMONIA,3
CO,C-REACTIVE PROTEIN DECREASED,3
CO,CARDIOVASCULAR DISORDER,3
CO,CEREBRAL INFARCTION,3
CO,CHRONIC GASTRITIS,3
CO,CRYING,3
CO,CYST,3
CO,DIARRHOEA HAEMORRHAGIC,3
CO,EAR DISORDER,3
CO,EAR INFECTION,3
CO,FEELING COLD,3
CO,FEELING OF DESPAIR,3
CO,FOOT FRACTURE,3
CO,FUNGAL INFECTION,3
CO,GASTRIC DISORDER,3
CO,GASTRITIS BACTERIAL,3
CO,GLUCOSE TOLERANCE IMPAIRED,3
CO,GRIP STRENGTH DECREASED,3
CO,HAND FRACTURE,3
CO,HEAD DISCOMFORT,3
CO,HEAD INJURY,3
CO,HEMIPLEGIA,3
CO,HEPATIC ENZYME INCREASED,3
CO,HEPATOTOXICITY,3
CO,HIP DEFORMITY,3
CO,HYPERTHYROIDISM,3
CO,INJECTION SITE DISCOLOURATION,3
CO,INTENTIONAL PRODUCT MISUSE,3
CO,INTESTINAL OBSTRUCTION,3
CO,IRRITABLE BOWEL SYNDROME,3
CO,JOINT DESTRUCTION,3
CO,JUVENILE IDIOPATHIC ARTHRITIS,3
CO,LEUKOPENIA,3
CO,MATERNAL EXPOSURE DURING PREGNANCY,3
CO,MENINGITIS BACTERIAL,3
CO,MENSTRUATION IRREGULAR,3
CO,NASAL DRYNESS,3
CO,NEOPLASM,3
CO,OCULAR DISCOMFORT,3
CO,ONYCHOMYCOSIS,3
CO,ORAL HERPES,3
CO,ORAL INFECTION,3
CO,OVARIAN DISORDER,3
CO,OVARIAN NEOPLASM,3
CO,OVERDOSE,3
CO,PAIN OF SKIN,3
CO,PELVIC PAIN,3
CO,PLEURAL EFFUSION,3
CO,POISONING,3
CO,PULMONARY FIBROSIS,3
CO,RHEUMATIC FEVER,3
CO,SALIVA ALTERED,3
CO,SEIZURE,3
CO,SKIN BURNING SENSATION,3
CO,SKIN DEPIGMENTATION,3
CO,SKIN HAEMORRHAGE,3
CO,SKIN INFECTION,3
CO,SKIN PAPILLOMA,3
CO,STOMATITIS,3
CO,SUBCUTANEOUS ABSCESS,3
CO,TENDON INJURY,3
CO,TIBIA FRACTURE,3
CO,TINNITUS,3
CO,TOOTH ABSCESS,3
CO,TOOTH DISORDER,3
CO,TOXIC SKIN ERUPTION,3
CO,UNDERWEIGHT,3
CO,URINARY RETENTION,3
CO,URINE ODOUR ABNORMAL,3
CO,VEIN DISORDER,3
CO,VIITH NERVE PARALYSIS,3
CO,VULVOVAGINAL BURNING SENSATION,3
CO,VULVOVAGINAL DRYNESS,3
CO,WOUND COMPLICATION,3
CO,WOUND INFECTION BACTERIAL,3
CO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
CO,ADVERSE EVENT,2
CO,AGGRESSION,2
CO,AMOEBIASIS,2
CO,ANAL ABSCESS,2
CO,ANEURYSM,2
CO,ANGER,2
CO,ANGINA UNSTABLE,2
CO,ANKLE DEFORMITY,2
CO,APNOEA,2
CO,APPLICATION SITE WARMTH,2
CO,ASPARTATE AMINOTRANSFERASE INCREASED,2
CO,ASTHMATIC CRISIS,2
CO,ASTIGMATISM,2
CO,AUTOIMMUNE HEPATITIS,2
CO,BACTERAEMIA,2
CO,BASAL CELL CARCINOMA,2
CO,BLADDER CANCER,2
CO,BLADDER PROLAPSE,2
CO,BLOOD CHOLESTEROL ABNORMAL,2
CO,BLOOD CREATINE INCREASED,2
CO,BLOOD IRON DECREASED,2
CO,BLOODY DISCHARGE,2
CO,BRADYCARDIA,2
CO,BRONCHIAL DISORDER,2
CO,BRONCHOSPASM,2
CO,CALCULUS URETHRAL,2
CO,CALCULUS URINARY,2
CO,CARDIO-RESPIRATORY ARREST,2
CO,CARTILAGE INJURY,2
CO,CERVIX CARCINOMA,2
CO,CHOKING SENSATION,2
CO,CHOLECYSTITIS,2
CO,CHONDROPATHY,2
CO,CHROMATURIA,2
CO,CLAVICLE FRACTURE,2
CO,COAGULOPATHY,2
CO,COLON NEOPLASM,2
CO,CONVULSION,2
CO,CORONARY ARTERY OCCLUSION,2
CO,DANDRUFF,2
CO,DEHYDRATION,2
CO,DEMENTIA ALZHEIMER^S TYPE,2
CO,DERMATITIS,2
CO,DERMATITIS ALLERGIC,2
CO,DROWNING,2
CO,DRUG DISPENSING ERROR,2
CO,DRUG PRESCRIBING ERROR,2
CO,DRUG RESISTANCE,2
CO,DYSARTHRIA,2
CO,DYSGEUSIA,2
CO,DYSPHAGIA,2
CO,EATING DISORDER,2
CO,EMBOLISM,2
CO,EMOTIONAL DISORDER,2
CO,ENTERITIS,2
CO,EPISCLERITIS,2
CO,ESCHERICHIA URINARY TRACT INFECTION,2
CO,EXPOSURE DURING PREGNANCY,2
CO,EYE ULCER,2
CO,FACE INJURY,2
CO,FISTULA DISCHARGE,2
CO,FLATULENCE,2
CO,FLUSHING,2
CO,FOETAL DEATH,2
CO,GASTROINTESTINAL HAEMORRHAGE,2
CO,GASTROINTESTINAL PAIN,2
CO,GASTROOESOPHAGEAL REFLUX DISEASE,2
CO,GRANULOMA,2
CO,GUN SHOT WOUND,2
CO,HAEMATEMESIS,2
CO,HAEMATOCHEZIA,2
CO,HAEMATURIA,2
CO,HELICOBACTER GASTRITIS,2
CO,HEPATIC CIRRHOSIS,2
CO,HIATUS HERNIA,2
CO,HORMONE LEVEL ABNORMAL,2
CO,HOT FLUSH,2
CO,HYPERTHERMIA,2
CO,HYPOKALAEMIA,2
CO,HYPOVITAMINOSIS,2
CO,IMPAIRED HEALING,2
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
CO,INFECTED SKIN ULCER,2
CO,INFLUENZA LIKE ILLNESS,2
CO,INJECTION SITE CELLULITIS,2
CO,INJECTION SITE INFLAMMATION,2
CO,INJECTION SITE INJURY,2
CO,INJECTION SITE MACULE,2
CO,INJECTION SITE MASS,2
CO,INJECTION SITE OEDEMA,2
CO,INTERSTITIAL LUNG DISEASE,2
CO,INTERVERTEBRAL DISC DISORDER,2
CO,INTESTINAL POLYP,2
CO,INTRACRANIAL ANEURYSM,2
CO,IRIDOCYCLITIS,2
CO,JAW DISORDER,2
CO,JOINT ABSCESS,2
CO,JOINT EFFUSION,2
CO,KERATITIS,2
CO,KNEE ARTHROPLASTY,2
CO,LACERATION,2
CO,LIGAMENT DISORDER,2
CO,LIGAMENT INJURY,2
CO,LIGAMENT SPRAIN,2
CO,LIP PAIN,2
CO,LIP PRURITUS,2
CO,LIP SWELLING,2
CO,LYMPHOMA,2
CO,MACULE,2
CO,MALNUTRITION,2
CO,MASS,2
CO,MENTAL RETARDATION,2
CO,MICTURITION DISORDER,2
CO,MULTIPLE INJURIES,2
CO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
CO,NAIL INFECTION,2
CO,NASAL SEPTUM DISORDER,2
CO,NECK MASS,2
CO,NERVE INJURY,2
CO,NERVOUS SYSTEM DISORDER,2
CO,NEURALGIA,2
CO,NIPPLE DISORDER,2
CO,NO ADVERSE EVENT,2
CO,OEDEMA,2
CO,ONYCHOCLASIS,2
CO,OPHTHALMIC HERPES ZOSTER,2
CO,ORAL PAIN,2
CO,OSTEOPENIA,2
CO,OXYGEN SATURATION DECREASED,2
CO,PAIN IN JAW,2
CO,PARALYSIS,2
CO,PARKINSON^S DISEASE,2
CO,PERIPHERAL VASCULAR DISORDER,2
CO,PNEUMONIA BACTERIAL,2
CO,PRESCRIBED UNDERDOSE,2
CO,PROCEDURAL COMPLICATION,2
CO,PROCEDURAL DIZZINESS,2
CO,PROCEDURAL PAIN,2
CO,PULMONARY CONGESTION,2
CO,PYELONEPHRITIS,2
CO,RECTAL CANCER,2
CO,RECTAL HAEMORRHAGE,2
CO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CO,RENAL NEOPLASM,2
CO,RENAL PAIN,2
CO,RIB FRACTURE,2
CO,SCIATICA,2
CO,SCRATCH,2
CO,SENSORY DISTURBANCE,2
CO,SEPTIC SHOCK,2
CO,SKIN ABRASION,2
CO,SKIN HYPERPIGMENTATION,2
CO,SKIN WOUND,2
CO,SLEEP APNOEA SYNDROME,2
CO,SPINAL OSTEOARTHRITIS,2
CO,SPONDYLITIS,2
CO,SUTURE RUPTURE,2
CO,TENDON DISORDER,2
CO,TENDON RUPTURE,2
CO,TESTICULAR DISORDER,2
CO,THERAPEUTIC RESPONSE DECREASED,2
CO,THERAPEUTIC RESPONSE UNEXPECTED,2
CO,TONSILLAR DISORDER,2
CO,TONSILLAR HYPERTROPHY,2
CO,TOOTH INFECTION,2
CO,ULCER,2
CO,ULCERATIVE KERATITIS,2
CO,URETEROLITHIASIS,2
CO,URINARY TRACT OBSTRUCTION,2
CO,URINE ANALYSIS ABNORMAL,2
CO,UTERINE CANCER,2
CO,VASCULAR CALCIFICATION,2
CO,VULVOVAGINAL PRURITUS,2
CO,WALKING DISABILITY,2
CO,WOUND HAEMORRHAGE,2
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CO,ABDOMINAL SEPSIS,1
CO,ABNORMAL LOSS OF WEIGHT,1
CO,ABORTION COMPLICATED,1
CO,ABORTION THREATENED,1
CO,ABSCESS NECK,1
CO,ACCIDENT AT HOME,1
CO,ACCIDENT AT WORK,1
CO,ACCIDENTAL EXPOSURE TO PRODUCT,1
CO,ACTINIC ELASTOSIS,1
CO,ACTINIC KERATOSIS,1
CO,ACTIVATED PROTEIN C RESISTANCE TEST POSITIVE,1
CO,ACUTE MYOCARDIAL INFARCTION,1
CO,ACUTE RESPIRATORY FAILURE,1
CO,ACUTE SINUSITIS,1
CO,ADENOIDITIS,1
CO,ALANINE AMINOTRANSFERASE INCREASED,1
CO,ALLERGIC BRONCHITIS,1
CO,ALLERGIC COUGH,1
CO,ALLERGIC RESPIRATORY DISEASE,1
CO,AMERICAN TRYPANOSOMIASIS,1
CO,AMYLASE INCREASED,1
CO,ANAL FISSURE,1
CO,ANAL FISTULA,1
CO,ANAL INJURY,1
CO,ANDROGEN DEFICIENCY,1
CO,ANGINA PECTORIS,1
CO,ANIMAL BITE,1
CO,AORTIC ANEURYSM,1
CO,AORTIC DILATATION,1
CO,AORTIC RUPTURE,1
CO,AORTIC THROMBOSIS,1
CO,APALLIC SYNDROME,1
CO,APHAGIA,1
CO,APHASIA,1
CO,APPENDIX DISORDER,1
CO,APPLICATION SITE CELLULITIS,1
CO,APPLICATION SITE ERYTHEMA,1
CO,APPLICATION SITE OEDEMA,1
CO,APPLICATION SITE PRURITUS,1
CO,APTYALISM,1
CO,ARTHRODESIS,1
CO,ARTHROPOD BITE,1
CO,ASPIRATION BRONCHIAL,1
CO,ATRIAL SEPTAL DEFECT,1
CO,ATROPHY,1
CO,ATYPICAL PNEUMONIA,1
CO,AURICULAR SWELLING,1
CO,BACK DISORDER,1
CO,BACTERIAL PYELONEPHRITIS,1
CO,BENIGN BREAST NEOPLASM,1
CO,BILE DUCT OBSTRUCTION,1
CO,BILIARY COLIC,1
CO,BILIRUBIN EXCRETION DISORDER,1
CO,BIPOLAR DISORDER,1
CO,BLADDER DILATATION,1
CO,BLADDER DISORDER,1
CO,BLADDER GRANULOMA,1
CO,BLADDER INJURY,1
CO,BLADDER PAIN,1
CO,BLEPHARITIS,1
CO,BLISTER INFECTED,1
CO,BLOOD BILIRUBIN INCREASED,1
CO,BLOOD CORTICOSTERONE DECREASED,1
CO,BLOOD DISORDER,1
CO,BLOOD GLUCOSE DECREASED,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD POTASSIUM ABNORMAL,1
CO,BLOOD PRESSURE,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD URIC ACID INCREASED,1
CO,BLOOD URINE,1
CO,BONE ABSCESS,1
CO,BONE CANCER,1
CO,BONE CYST,1
CO,BONE DENSITY ABNORMAL,1
CO,BONE EROSION,1
CO,BONE FISSURE,1
CO,BONE LOSS,1
CO,BONE MARROW FAILURE,1
CO,BONE MARROW OEDEMA,1
CO,BONE NEOPLASM,1
CO,BOREDOM,1
CO,BRAIN HYPOXIA,1
CO,BRAIN NEOPLASM BENIGN,1
CO,BREAST CANCER FEMALE,1
CO,BREAST CELLULITIS,1
CO,BREAST MASS,1
CO,BREAST PAIN,1
CO,BREAST TENDERNESS,1
CO,BRONCHIECTASIS,1
CO,BRONCHIOLITIS,1
CO,CANDIDIASIS,1
CO,CARDIAC DISCOMFORT,1
CO,CARDIAC MURMUR,1
CO,CARDIAC VALVE DISEASE,1
CO,CATARACT OPERATION,1
CO,CATHETER SITE HAEMORRHAGE,1
CO,CENTRAL OBESITY,1
CO,CEREBRAL HAEMORRHAGE,1
CO,CEREBRAL THROMBOSIS,1
CO,CERVICITIS,1
CO,CHEILITIS,1
CO,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,1
CO,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
CO,CLAUSTROPHOBIA,1
CO,COITAL BLEEDING,1
CO,COLD SWEAT,1
CO,COLON INJURY,1
CO,COMPLICATION OF PREGNANCY,1
CO,CONJUNCTIVAL HAEMORRHAGE,1
CO,CONJUNCTIVAL HYPERAEMIA,1
CO,CONJUNCTIVITIS ALLERGIC,1
CO,CONJUNCTIVITIS BACTERIAL,1
CO,CORNEAL DISORDER,1
CO,COSTOCHONDRITIS,1
CO,CROHN^S DISEASE,1
CO,CUSHING^S SYNDROME,1
CO,CUTANEOUS TUBERCULOSIS,1
CO,CYCLOTHYMIC DISORDER,1
CO,CYSTITIS ESCHERICHIA,1
CO,CYSTOCELE,1
CO,DACRYOSTENOSIS ACQUIRED,1
CO,DARK CIRCLES UNDER EYES,1
CO,DEATH OF RELATIVE,1
CO,DECUBITUS ULCER,1
CO,DEEP VEIN THROMBOSIS,1
CO,DEFORMITY,1
CO,DELIRIUM,1
CO,DELIRIUM FEBRILE,1
CO,DEPRESSIVE SYMPTOM,1
CO,DERMATITIS ACNEIFORM,1
CO,DERMATITIS EXFOLIATIVE,1
CO,DERMATOFIBROSARCOMA PROTUBERANS,1
CO,DEVELOPMENTAL HIP DYSPLASIA,1
CO,DEVICE BREAKAGE,1
CO,DEVICE FAILURE,1
CO,DEVICE ISSUE,1
CO,DEVICE LOOSENING,1
CO,DIABETIC FOOT,1
CO,DIABETIC RETINOPATHY,1
CO,DIAPHRAGMALGIA,1
CO,DIARRHOEA INFECTIOUS,1
CO,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
CO,DIPLEGIA,1
CO,DISEASE COMPLICATION,1
CO,DISLOCATION OF VERTEBRA,1
CO,DISORIENTATION,1
CO,DISSOCIATION,1
CO,DIVERTICULUM INTESTINAL,1
CO,DRUG EFFECT DECREASED,1
CO,DRUG USE DISORDER,1
CO,DRUG-INDUCED LIVER INJURY,1
CO,DRY GANGRENE,1
CO,DRY THROAT,1
CO,DYSBACTERIOSIS,1
CO,DYSKINESIA,1
CO,DYSPAREUNIA,1
CO,EAR INJURY,1
CO,ECCHYMOSIS,1
CO,EFFUSION,1
CO,ELBOW DEFORMITY,1
CO,ELECTROCARDIOGRAM ABNORMAL,1
CO,EMOTIONAL DISTRESS,1
CO,EMPHYSEMA,1
CO,ENCEPHALITIC INFECTION,1
CO,ENCEPHALITIS,1
CO,ENCEPHALITIS VIRAL,1
CO,ENCHONDROMA,1
CO,ENDOMETRIAL THICKENING,1
CO,ENDOPHTHALMITIS,1
CO,EPHELIDES,1
CO,EPICONDYLITIS,1
CO,EROSIVE OESOPHAGITIS,1
CO,ERYTHEMA OF EYELID,1
CO,ESCHERICHIA SEPSIS,1
CO,EXCESSIVE CERUMEN PRODUCTION,1
CO,EXCESSIVE SKIN,1
CO,EXERCISE TOLERANCE DECREASED,1
CO,EXOPHTHALMOS,1
CO,EXOSTOSIS,1
CO,EXPIRED PRODUCT ADMINISTERED,1
CO,EXPOSURE DURING BREAST FEEDING,1
CO,EXTREMITY NECROSIS,1
CO,EYE BURNS,1
CO,EYE CONTUSION,1
CO,EYE HAEMORRHAGE,1
CO,EYE INJURY,1
CO,EYE OEDEMA,1
CO,EYE OPERATION COMPLICATION,1
CO,EYELID DISORDER,1
CO,EYELID OEDEMA,1
CO,EYELID PAIN,1
CO,FACE OEDEMA,1
CO,FAECAL INCONTINENCE,1
CO,FALLOPIAN TUBE DISORDER,1
CO,FAT TISSUE INCREASED,1
CO,FEAR,1
CO,FOOD POISONING,1
CO,FOOT OPERATION,1
CO,FOREIGN BODY,1
CO,FRACTURE,1
CO,FRACTURED COCCYX,1
CO,GALLBLADDER PAIN,1
CO,GANGRENE,1
CO,GASTRIC CANCER,1
CO,GASTRIC HAEMORRHAGE,1
CO,GASTRIC ULCER HAEMORRHAGE,1
CO,GASTRITIS EROSIVE,1
CO,GASTRITIS HAEMORRHAGIC,1
CO,GASTRODUODENITIS,1
CO,GASTROENTERITIS VIRAL,1
CO,GASTROINTESTINAL BACTERIAL INFECTION,1
CO,GASTROINTESTINAL FISTULA,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GASTROINTESTINAL OBSTRUCTION,1
CO,GASTROINTESTINAL STROMAL TUMOUR,1
CO,GASTROLITHIASIS,1
CO,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
CO,GENITAL DISCHARGE,1
CO,GENITAL DISCOMFORT,1
CO,GENITAL HERPES,1
CO,GENITAL RASH,1
CO,GINGIVAL BLEEDING,1
CO,GINGIVAL DISORDER,1
CO,GINGIVAL SWELLING,1
CO,GOUT,1
CO,GOUTY ARTHRITIS,1
CO,GUILLAIN-BARRE SYNDROME,1
CO,HAEMANGIOMA,1
CO,HAEMODYNAMIC INSTABILITY,1
CO,HAEMOPTYSIS,1
CO,HAEMORRHAGE SUBCUTANEOUS,1
CO,HAEMORRHAGE URINARY TRACT,1
CO,HALLUCINATION,1
CO,HEAD TITUBATION,1
CO,HEARING DISABILITY,1
CO,HEART DISEASE CONGENITAL,1
CO,HEART INJURY,1
CO,HELICOBACTER INFECTION,1
CO,HEPATIC CANCER,1
CO,HEPATIC FAILURE,1
CO,HEPATIC FUNCTION ABNORMAL,1
CO,HEPATIC NEOPLASM,1
CO,HEPATIC PAIN,1
CO,HEPATITIS A,1
CO,HEPATITIS TOXIC,1
CO,HERPES ZOSTER DISSEMINATED,1
CO,HYDRONEPHROSIS,1
CO,HYPERTENSIVE CRISIS,1
CO,HYPOAESTHESIA ORAL,1
CO,HYPOGLYCAEMIA,1
CO,HYPONATRAEMIA,1
CO,HYPOXIA,1
CO,IMPLANT SITE ABSCESS,1
CO,INCORRECT DOSAGE ADMINISTERED,1
CO,INCORRECT DRUG ADMINISTRATION RATE,1
CO,INCREASED APPETITE,1
CO,INFECTED CYST,1
CO,INFECTED VARICOSE VEIN,1
CO,INFECTION SUSCEPTIBILITY INCREASED,1
CO,INFECTIVE THROMBOSIS,1
CO,INFLAMMATION OF WOUND,1
CO,INITIAL INSOMNIA,1
CO,INJECTION SITE ABSCESS,1
CO,INJECTION SITE ANAESTHESIA,1
CO,INJECTION SITE INFECTION,1
CO,INJECTION SITE PLAQUE,1
CO,INJECTION SITE VESICLES,1
CO,INTENTIONAL PRODUCT USE ISSUE,1
CO,INTENTIONAL SELF-INJURY,1
CO,INTENTIONAL UNDERDOSE,1
CO,INTERNAL HAEMORRHAGE,1
CO,INTRACRANIAL MASS,1
CO,IRON DEFICIENCY,1
CO,IRRITABILITY,1
CO,ISCHAEMIA,1
CO,JOINT PROSTHESIS USER,1
CO,JOINT WARMTH,1
CO,KERATOCONUS,1
CO,KIDNEY ENLARGEMENT,1
CO,KNEE OPERATION,1
CO,LABORATORY TEST ABNORMAL,1
CO,LACRIMATION DECREASED,1
CO,LARGE INTESTINAL HAEMORRHAGE,1
CO,LARGE INTESTINAL OBSTRUCTION,1
CO,LARGE INTESTINE POLYP,1
CO,LARYNGEAL CANCER,1
CO,LAZINESS,1
CO,LEG AMPUTATION,1
CO,LEISHMANIASIS,1
CO,LENS DISLOCATION,1
CO,LENTICULAR PIGMENTATION,1
CO,LICHEN PLANUS,1
CO,LIGAMENT RUPTURE,1
CO,LIMB ASYMMETRY,1
CO,LIMB CRUSHING INJURY,1
CO,LIMB DEFORMITY,1
CO,LIMB PROSTHESIS USER,1
CO,LIP INFECTION,1
CO,LIP ULCERATION,1
CO,LIVER ABSCESS,1
CO,LIVER FUNCTION TEST ABNORMAL,1
CO,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
CO,LUMBAR VERTEBRAL FRACTURE,1
CO,LUNG ABSCESS,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LUPUS-LIKE SYNDROME,1
CO,LYMPHADENOPATHY,1
CO,LYMPHADENOPATHY MEDIASTINAL,1
CO,MALIGNANT MELANOMA,1
CO,MANTLE CELL LYMPHOMA,1
CO,MECONIUM ASPIRATION SYNDROME,1
CO,MEDIASTINUM NEOPLASM,1
CO,MEDICAL DEVICE REMOVAL,1
CO,MELANOCYTIC NAEVUS,1
CO,MENINGITIS,1
CO,MENORRHAGIA,1
CO,MENSTRUAL DISORDER,1
CO,MENTAL DISORDER,1
CO,METASTASIS,1
CO,METATARSALGIA,1
CO,MIDDLE EAR INFLAMMATION,1
CO,MITRAL VALVE DISEASE,1
CO,MONOPLEGIA,1
CO,MOUTH HAEMORRHAGE,1
CO,MUCOSAL DISCOLOURATION,1
CO,MUCOSAL DRYNESS,1
CO,MULTI-ORGAN DISORDER,1
CO,MULTI-ORGAN FAILURE,1
CO,MULTIPLE FRACTURES,1
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CO,MUSCLE ATROPHY,1
CO,MUSCLE TIGHTNESS,1
CO,MYCOBACTERIAL INFECTION,1
CO,MYOCARDIAL ISCHAEMIA,1
CO,MYOPIA,1
CO,NASAL DISORDER,1
CO,NASAL SEPTAL OPERATION,1
CO,NEOPLASM PROGRESSION,1
CO,NEOPLASM PROSTATE,1
CO,NEOPLASM SKIN,1
CO,NERVE COMPRESSION,1
CO,NEURITIS,1
CO,NEUROLOGICAL INFECTION,1
CO,NEUTROPENIA,1
CO,NEUTROPENIC COLITIS,1
CO,NEUTROPHIL COUNT DECREASED,1
CO,NIGHT SWEATS,1
CO,NON-CARDIAC CHEST PAIN,1
CO,NOSE DEFORMITY,1
CO,OBLITERATIVE BRONCHIOLITIS,1
CO,OBSTRUCTIVE AIRWAYS DISORDER,1
CO,OCCULT BLOOD,1
CO,OCULAR HYPERTENSION,1
CO,OCULAR ICTERUS,1
CO,OCULAR VASCULAR DISORDER,1
CO,ODYNOPHAGIA,1
CO,OESOPHAGEAL CANDIDIASIS,1
CO,OESOPHAGITIS,1
CO,ONCOLOGIC COMPLICATION,1
CO,ONYCHOMADESIS,1
CO,OPEN FRACTURE,1
CO,OPHTHALMIC HERPES SIMPLEX,1
CO,OPTIC NERVE DISORDER,1
CO,OPTIC NEURITIS,1
CO,ORAL MUCOSAL BLISTERING,1
CO,ORAL NEOPLASM,1
CO,ORGANISING PNEUMONIA,1
CO,OROPHARYNGEAL DISCOMFORT,1
CO,OROPHARYNGEAL SQUAMOUS CELL CARCINOMA,1
CO,OSTEOARTHROPATHY,1
CO,OSTEONECROSIS OF JAW,1
CO,OVARIAN CANCER,1
CO,PANNICULITIS,1
CO,PAPILLARY THYROID CANCER,1
CO,PAPULE,1
CO,PARAESTHESIA ORAL,1
CO,PARATHYROID DISORDER,1
CO,PATHOGEN RESISTANCE,1
CO,PATHOLOGICAL FRACTURE,1
CO,PEAU D^ORANGE,1
CR,DEATH,6
CR,CEREBROVASCULAR ACCIDENT,2
CR,DRUG EFFECT INCOMPLETE,2
CR,DRUG INTOLERANCE,2
CR,HYPERSENSITIVITY,2
CR,OEDEMA,2
CR,OTITIS MEDIA,2
CR,PNEUMONIA,2
CR,RASH,2
CR,SKIN LESION,2
CR,ACUTE MYELOID LEUKAEMIA,1
CR,ANAEMIA,1
CR,ANGIOEDEMA,1
CR,ANOGENITAL WARTS,1
CR,APNOEA,1
CR,ARTHRALGIA,1
CR,ARTHRITIS,1
CR,ARTHRITIS BACTERIAL,1
CR,BEDRIDDEN,1
CR,BLOOD PRESSURE INCREASED,1
CR,COUGH,1
CR,DERMATITIS ALLERGIC,1
CR,DYSURIA,1
CR,ERYTHEMA,1
CR,EYE INFECTION TOXOPLASMAL,1
CR,FACE OEDEMA,1
CR,GASTRIC CANCER,1
CR,HAEMORRHAGIC STROKE,1
CR,HEPATIC STEATOSIS,1
CR,HEPATITIS,1
CR,HEPATOMEGALY,1
CR,HODGKIN^S DISEASE,1
CR,IMPAIRED HEALING,1
CR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CR,INFECTION,1
CR,INSOMNIA,1
CR,LUNG INFECTION,1
CR,LYMPHOCYTOSIS,1
CR,MALIGNANT MELANOMA,1
CR,MOBILITY DECREASED,1
CR,MYALGIA,1
CR,MYOCARDIAL INFARCTION,1
CR,NASOPHARYNGITIS,1
CR,NEUTROPENIA,1
CR,ONYCHOMADESIS,1
CR,PAPILLOMA,1
CR,PEMPHIGUS,1
CR,POLYP,1
CR,PRURITUS,1
CR,RECTAL HAEMORRHAGE,1
CR,RECTAL ULCER,1
CR,RESPIRATORY TRACT INFECTION,1
CR,SEPSIS,1
CR,SKIN ULCER,1
CR,ULCERATIVE KERATITIS,1
HR,RHEUMATOID ARTHRITIS,8
HR,ABDOMINAL PAIN,6
HR,BONE EROSION,5
HR,DRUG INEFFECTIVE,5
HR,HEPATIC ENZYME INCREASED,5
HR,INFUSION RELATED REACTION,5
HR,MOBILITY DECREASED,5
HR,POLYARTHRITIS,5
HR,PYREXIA,5
HR,SUICIDE ATTEMPT,5
HR,ARTHRALGIA,4
HR,DISEASE PROGRESSION,4
HR,C-REACTIVE PROTEIN INCREASED,3
HR,CONDITION AGGRAVATED,3
HR,EYE SWELLING,3
HR,GENERAL PHYSICAL HEALTH DETERIORATION,3
HR,HEPATOTOXICITY,3
HR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
HR,RENAL CANCER,3
HR,ANKYLOSING SPONDYLITIS,2
HR,ARTHROPATHY,2
HR,BURSITIS,2
HR,DIARRHOEA,2
HR,DIVERTICULITIS,2
HR,EYE OEDEMA,2
HR,HEPATIC LESION,2
HR,JOINT EFFUSION,2
HR,JOINT SWELLING,2
HR,LOSS OF CONSCIOUSNESS,2
HR,MYOCARDIAL INFARCTION,2
HR,PERFORMANCE STATUS DECREASED,2
HR,RHEUMATIC DISORDER,2
HR,SYNOVIAL CYST,2
HR,SYNOVIAL RUPTURE,2
HR,ABDOMINAL MASS,1
HR,ABDOMINAL PAIN LOWER,1
HR,ACUTE PSYCHOSIS,1
HR,ANGIOMYOLIPOMA,1
HR,BALANCE DISORDER,1
HR,CEREBRAL INFARCTION,1
HR,CHOLECYSTITIS ACUTE,1
HR,CHONDROSARCOMA,1
HR,CLEAR CELL RENAL CELL CARCINOMA,1
HR,COLITIS ULCERATIVE,1
HR,DEPRESSION,1
HR,EPSTEIN-BARR VIRUS INFECTION,1
HR,EYE MOVEMENT DISORDER,1
HR,FEELING HOT,1
HR,GASTROINTESTINAL DISORDER,1
HR,HYPERSPLENISM,1
HR,IRIDOCYCLITIS,1
HR,JUVENILE IDIOPATHIC ARTHRITIS,1
HR,LEUKOPENIA,1
HR,LUNG CANCER METASTATIC,1
HR,LUNG NEOPLASM MALIGNANT,1
HR,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
HR,MENINGIOMA,1
HR,METASTASES TO BONE,1
HR,NASAL DISCOMFORT,1
HR,OCULAR DISCOMFORT,1
HR,OSTEOCHONDROMA,1
HR,OSTEOSARCOMA,1
HR,PARAESTHESIA,1
HR,PRODUCT USE ISSUE,1
HR,RENAL HAEMANGIOMA,1
HR,RENAL LIPOMATOSIS,1
HR,SPLENOMEGALY,1
HR,SUBCUTANEOUS ABSCESS,1
HR,SYNCOPE,1
HR,THROMBOCYTOPENIA,1
HR,ULCERATIVE KERATITIS,1
HR,VASCULAR NEOPLASM,1
HR,WEIGHT DECREASED,1
CY,PROSTATE CANCER,2
CY,BREAST CANCER,1
CY,CHOLECYSTITIS,1
CY,EXPOSURE VIA FATHER,1
CY,GUILLAIN-BARRE SYNDROME,1
CY,JAW DISORDER,1
CY,NEUROPATHY PERIPHERAL,1
CY,PANCREATITIS,1
CY,PHOTOSENSITIVITY REACTION,1
CY,POLYNEUROPATHY,1
CY,PREMATURE BABY,1
CY,PSEUDOCYST,1
CY,THYROID CANCER,1
CY,TOOTH DISORDER,1
CY,UTERINE CANCER,1
CZ,DRUG INEFFECTIVE,10
CZ,DEATH,5
CZ,C-REACTIVE PROTEIN INCREASED,4
CZ,RHEUMATOID ARTHRITIS,4
CZ,ACUTE MYOCARDIAL INFARCTION,3
CZ,ARTHROPATHY,3
CZ,DYSPNOEA,3
CZ,IRIDOCYCLITIS,3
CZ,PNEUMONIA,3
CZ,PSORIASIS,3
CZ,PSORIATIC ARTHROPATHY,3
CZ,SPINAL PAIN,3
CZ,ABORTION,2
CZ,ANAEMIA,2
CZ,ARTHRITIS,2
CZ,ATRIAL FIBRILLATION,2
CZ,BRAIN NEOPLASM,2
CZ,BREAST CANCER,2
CZ,BRONCHOPLEURAL FISTULA,2
CZ,CARDIAC FAILURE,2
CZ,CELL-MEDIATED IMMUNE DEFICIENCY,2
CZ,CONDITION AGGRAVATED,2
CZ,DEEP VEIN THROMBOSIS,2
CZ,DISEASE PROGRESSION,2
CZ,FALL,2
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,2
CZ,INFECTIOUS PLEURAL EFFUSION,2
CZ,INFLAMMATION,2
CZ,LIVER DISORDER,2
CZ,LIVER FUNCTION TEST ABNORMAL,2
CZ,MYOCARDIAL INFARCTION,2
CZ,NON-HODGKIN^S LYMPHOMA,2
CZ,PLEURAL EFFUSION,2
CZ,PNEUMOTHORAX,2
CZ,PULMONARY EMBOLISM,2
CZ,PYREXIA,2
CZ,RASH,2
CZ,TUBERCULOUS PLEURISY,2
CZ,UPPER RESPIRATORY TRACT INFECTION,2
CZ,ABDOMINAL SEPSIS,1
CZ,ABSCESS LIMB,1
CZ,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CZ,ACUTE RESPIRATORY FAILURE,1
CZ,ADENOCARCINOMA OF COLON,1
CZ,ANAPLASTIC ASTROCYTOMA,1
CZ,ANAPLASTIC OLIGODENDROGLIOMA,1
CZ,ANKYLOSING SPONDYLITIS,1
CZ,AORTIC DILATATION,1
CZ,APPENDICITIS,1
CZ,ARTERIOSCLEROSIS CORONARY ARTERY,1
CZ,ARTHRITIS BACTERIAL,1
CZ,ASTHENIA,1
CZ,ASTHMA,1
CZ,BACK PAIN,1
CZ,BARRETT^S OESOPHAGUS,1
CZ,BLOOD PRESSURE INCREASED,1
CZ,BONE RESORPTION TEST ABNORMAL,1
CZ,BUNDLE BRANCH BLOCK,1
CZ,CANDIDA INFECTION,1
CZ,CHOLANGIOCARCINOMA,1
CZ,CHOLECYSTITIS ACUTE,1
CZ,CHOLELITHIASIS,1
CZ,CHRONIC HEPATITIS,1
CZ,COAGULOPATHY,1
CZ,COLON CANCER,1
CZ,COLORECTAL CANCER,1
CZ,CONTUSION,1
CZ,CONVULSION,1
CZ,COR PULMONALE ACUTE,1
CZ,CORONARY ARTERY DISEASE,1
CZ,CROHN^S DISEASE,1
CZ,DECUBITUS ULCER,1
CZ,DERMATITIS ALLERGIC,1
CZ,DERMATITIS EXFOLIATIVE,1
CZ,DIABETES MELLITUS,1
CZ,DIARRHOEA,1
CZ,DIPLOPIA,1
CZ,DIVERTICULITIS,1
CZ,DRUG ERUPTION,1
CZ,ENTERITIS NECROTICANS,1
CZ,EPILEPSY,1
CZ,ERYSIPELAS,1
CZ,ESCHERICHIA INFECTION,1
CZ,EXTRADURAL ABSCESS,1
CZ,EYE CONTUSION,1
CZ,FACIAL PARESIS,1
CZ,FISTULA,1
CZ,GASTRITIS EROSIVE,1
CZ,GASTROOESOPHAGEAL REFLUX DISEASE,1
CZ,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
CZ,GRAND MAL CONVULSION,1
CZ,HAEMATOMA,1
CZ,HEADACHE,1
CZ,HEPATIC CIRRHOSIS,1
CZ,HEPATIC STEATOSIS,1
CZ,HEPATOSPLENOMEGALY,1
CZ,HERPES VIRUS INFECTION,1
CZ,HERPES ZOSTER,1
CZ,HYDROTHORAX,1
CZ,HYPOAESTHESIA,1
CZ,IGA NEPHROPATHY,1
CZ,INCARCERATED HERNIA,1
CZ,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CZ,INFECTION,1
CZ,INTENTIONAL PRODUCT MISUSE,1
CZ,INTERSTITIAL LUNG DISEASE,1
CZ,INTERVERTEBRAL DISC DISORDER,1
CZ,INTERVERTEBRAL DISCITIS,1
CZ,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
CZ,INVASIVE BREAST CARCINOMA,1
CZ,INVASIVE DUCTAL BREAST CARCINOMA,1
CZ,JUVENILE IDIOPATHIC ARTHRITIS,1
CZ,LISTERIA SEPSIS,1
CZ,LOWER RESPIRATORY TRACT INFECTION,1
CZ,LUNG NEOPLASM MALIGNANT,1
CZ,LYMPHOMA,1
CZ,MACULAR DEGENERATION,1
CZ,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
CZ,MENINGIOMA,1
CZ,MENINGIOMA BENIGN,1
CZ,MUSCULAR WEAKNESS,1
CZ,MUSCULOSKELETAL DISORDER,1
CZ,MYOPATHY,1
CZ,MYOSITIS,1
CZ,NASOPHARYNGITIS,1
CZ,NAUSEA,1
CZ,NEOPLASM PROGRESSION,1
CZ,NEPHROSCLEROSIS,1
CZ,NEPHROTIC SYNDROME,1
CZ,NERVOUS SYSTEM DISORDER,1
CZ,OLIGODENDROGLIOMA,1
CZ,OROPHARYNGEAL PAIN,1
CZ,OVARIAN CYST,1
CZ,OVARIAN EPITHELIAL CANCER,1
CZ,PALPITATIONS,1
CZ,PANCREATITIS CHRONIC,1
CZ,PARAESTHESIA,1
CZ,PARTIAL SEIZURES,1
CZ,PELVIC ABSCESS,1
CZ,PERIPHERAL ARTERY THROMBOSIS,1
CZ,PERITONITIS,1
CZ,PLASMA CELL MYELOMA,1
CZ,PLEURISY,1
CZ,POLYARTHRITIS,1
CZ,POLYMYOSITIS,1
CZ,POST PROCEDURAL HAEMATOMA,1
CZ,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA,1
CZ,PROSTATE CANCER,1
CZ,PRURITUS,1
CZ,PRURITUS GENERALISED,1
CZ,PULMONARY INFARCTION,1
CZ,RASH GENERALISED,1
CZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CZ,RESPIRATORY TRACT INFECTION,1
CZ,RETINAL DETACHMENT,1
CZ,RHEUMATOID LUNG,1
CZ,RICHTER^S HERNIA,1
CZ,ROTATOR CUFF SYNDROME,1
CZ,SALMONELLA SEPSIS,1
CZ,SALMONELLA TEST POSITIVE,1
CZ,SCHIZOPHRENIA,1
CZ,SECRETION DISCHARGE,1
CZ,SEPSIS,1
CZ,SPINAL COLUMN STENOSIS,1
CZ,SQUAMOUS CELL CARCINOMA OF LUNG,1
CZ,STRANGULATED HERNIA,1
CZ,STREPTOCOCCAL SEPSIS,1
CZ,STRESS URINARY INCONTINENCE,1
CZ,SUBDIAPHRAGMATIC ABSCESS,1
CZ,TRANSAMINASES INCREASED,1
CZ,TRANSIENT ISCHAEMIC ATTACK,1
CZ,TREATMENT NONCOMPLIANCE,1
CZ,URINARY TRACT INFECTION,1
CZ,UVEITIS,1
CZ,VARICES OESOPHAGEAL,1
CZ,VENOUS THROMBOSIS LIMB,1
CZ,VIITH NERVE PARALYSIS,1
CZ,VISUAL IMPAIRMENT,1
CZ,VOMITING,1
CZ,WEIGHT INCREASED,1
DK,LUNG NEOPLASM MALIGNANT,13
DK,PNEUMONIA,12
DK,ARTHRITIS,11
DK,DRUG INEFFECTIVE,11
DK,OEDEMA PERIPHERAL,11
DK,WEIGHT DECREASED,11
DK,SPLENOMEGALY,10
DK,SYNOVITIS,10
DK,COUGH,9
DK,DYSPNOEA,9
DK,GAIT DISTURBANCE,9
DK,BONE ATROPHY,8
DK,BONE DISORDER,8
DK,CARTILAGE ATROPHY,8
DK,BLADDER TRANSITIONAL CELL CARCINOMA STAGE II,7
DK,FATIGUE,7
DK,INTERSTITIAL LUNG DISEASE,7
DK,MALAISE,7
DK,RENAL CANCER,7
DK,BREAST CANCER,6
DK,HAEMATURIA,6
DK,PARAESTHESIA,6
DK,PYREXIA,6
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,5
DK,ARTHRALGIA,5
DK,ASCITES,5
DK,BILIARY CIRRHOSIS,5
DK,CHRONIC HEPATIC FAILURE,5
DK,CONDITION AGGRAVATED,5
DK,DIZZINESS,5
DK,HEPATIC CIRRHOSIS,5
DK,KNEE OPERATION,5
DK,PAIN IN EXTREMITY,5
DK,PANCYTOPENIA,5
DK,PROSTATE CANCER,5
DK,RHEUMATOID ARTHRITIS,5
DK,VARICES OESOPHAGEAL,5
DK,ALOPECIA,4
DK,ANAEMIA,4
DK,BLADDER CANCER,4
DK,CERVIX CARCINOMA,4
DK,DEMYELINATION,4
DK,DRUG EFFECT INCOMPLETE,4
DK,HYPERHIDROSIS,4
DK,JOINT INJURY,4
DK,LIVER DISORDER,4
DK,MALIGNANT MELANOMA,4
DK,MYALGIA,4
DK,NEOBLADDER SURGERY,4
DK,PANCREATIC CARCINOMA,4
DK,PULMONARY FIBROSIS,4
DK,SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED,4
DK,URINARY CYSTECTOMY,4
DK,URINARY INCONTINENCE,4
DK,URINARY TRACT INFECTION,4
DK,VISUAL IMPAIRMENT,4
DK,ALANINE AMINOTRANSFERASE INCREASED,3
DK,ANAL INCONTINENCE,3
DK,ANGIOEDEMA,3
DK,BURNING SENSATION,3
DK,CARDIAC ARREST,3
DK,CLONUS,3
DK,DISCOMFORT,3
DK,DRY SKIN,3
DK,DYSPNOEA EXERTIONAL,3
DK,ERYTHEMA,3
DK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
DK,GASTRIC CANCER,3
DK,HYPERREFLEXIA,3
DK,INJECTION SITE REACTION,3
DK,METASTASES TO LYMPH NODES,3
DK,MUSCLE SPASMS,3
DK,MYELITIS TRANSVERSE,3
DK,NEURITIS,3
DK,PAIN IN JAW,3
DK,PARAPARESIS,3
DK,PNEUMOTHORAX,3
DK,PULMONARY FUNCTION TEST DECREASED,3
DK,SEPTIC SHOCK,3
DK,SJOGREN^S SYNDROME,3
DK,SKIN BURNING SENSATION,3
DK,SKIN EXFOLIATION,3
DK,TENDON INJURY,3
DK,VOMITING,3
DK,ABDOMINAL PAIN,2
DK,ADVERSE DRUG REACTION,2
DK,ATAXIA,2
DK,BALANCE DISORDER,2
DK,BLADDER PAIN,2
DK,CONNECTIVE TISSUE DISORDER,2
DK,DRUG EFFECT DECREASED,2
DK,DYSARTHRIA,2
DK,DYSPHAGIA,2
DK,FEELING HOT,2
DK,GAIT INABILITY,2
DK,GASTRIC ULCER HAEMORRHAGE,2
DK,GROIN PAIN,2
DK,HIDRADENITIS,2
DK,HYPERTENSION,2
DK,HYPERTONIA,2
DK,INFECTION,2
DK,INFLUENZA,2
DK,INJURY,2
DK,INSOMNIA,2
DK,INVASIVE DUCTAL BREAST CARCINOMA,2
DK,IRITIS,2
DK,LIMB INJURY,2
DK,LUNG DISORDER,2
DK,LUNG INFILTRATION,2
DK,MASS,2
DK,MATERNAL EXPOSURE DURING PREGNANCY,2
DK,MENINGITIS TUBERCULOUS,2
DK,METASTASES TO BONE,2
DK,METASTASES TO PERITONEUM,2
DK,MUCOSAL DRYNESS,2
DK,MUSCLE FATIGUE,2
DK,MUSCLE INJURY,2
DK,MUSCULOSKELETAL DISCOMFORT,2
DK,MYELITIS,2
DK,MYELODYSPLASTIC SYNDROME,2
DK,NAIL INJURY,2
DK,NEOPLASM MALIGNANT,2
DK,NO ADVERSE EVENT,2
DK,OEDEMA,2
DK,OPTIC NEURITIS,2
DK,PAIN,2
DK,PAIN OF SKIN,2
DK,PERIPHERAL SWELLING,2
DK,PNEUMONITIS,2
DK,PROCEDURAL PAIN,2
DK,PSORIASIS,2
DK,PSYCHOTIC DISORDER,2
DK,PUSTULAR PSORIASIS,2
DK,RASH PUSTULAR,2
DK,RHEUMATOID FACTOR INCREASED,2
DK,SENSORY DISTURBANCE,2
DK,SKELETAL INJURY,2
DK,SKIN DISORDER,2
DK,SUPERINFECTION,2
DK,TENDONITIS,2
DK,TENOSYNOVITIS,2
DK,VASCULITIS,2
DK,WHEELCHAIR USER,2
DK,WOUND,2
DK,ABDOMINAL DISCOMFORT,1
DK,ABDOMINAL DISTENSION,1
DK,ACUTE MYOCARDIAL INFARCTION,1
DK,ACUTE POLYNEUROPATHY,1
DK,ADENOCARCINOMA OF COLON,1
DK,AGGRESSION,1
DK,AMYLASE INCREASED,1
DK,ANAPHYLACTIC REACTION,1
DK,ANGINA PECTORIS,1
DK,ANKYLOSING SPONDYLITIS,1
DK,APOCRINE BREAST CARCINOMA,1
DK,APPENDICITIS PERFORATED,1
DK,AREFLEXIA,1
DK,ARTHROPATHY,1
DK,ARTHROSCOPY,1
DK,ASTHENIA,1
DK,ATYPICAL PNEUMONIA,1
DK,AXONAL NEUROPATHY,1
DK,B-CELL LYMPHOMA,1
DK,BACK PAIN,1
DK,BASAL CELL CARCINOMA,1
DK,BLINDNESS,1
DK,BLOOD CHOLESTEROL INCREASED,1
DK,BLOOD PRESSURE ABNORMAL,1
DK,BODY TEMPERATURE DECREASED,1
DK,BONE PAIN,1
DK,BRAIN MASS,1
DK,BRAIN STEM THROMBOSIS,1
DK,C-REACTIVE PROTEIN INCREASED,1
DK,CAPILLARY LEAK SYNDROME,1
DK,CARDIAC DISORDER,1
DK,CARTILAGE INJURY,1
DK,CATARACT,1
DK,CENTRAL NERVOUS SYSTEM LESION,1
DK,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
DK,CEREBRAL THROMBOSIS,1
DK,CHONDROPATHY,1
DK,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DK,COGNITIVE DISORDER,1
DK,COLLOID BRAIN CYST,1
DK,COLON CANCER,1
DK,CONGENITAL ANOMALY,1
DK,COORDINATION ABNORMAL,1
DK,CORNEAL DISORDER,1
DK,CORYNEBACTERIUM INFECTION,1
DK,CYSTITIS ESCHERICHIA,1
DK,DEATH,1
DK,DELUSION,1
DK,DERMATITIS,1
DK,DIFFUSE LARGE B-CELL LYMPHOMA,1
DK,DIPLOPIA,1
DK,DISTURBANCE IN ATTENTION,1
DK,DRY EYE,1
DK,DRY MOUTH,1
DK,DRY THROAT,1
DK,DUODENAL ULCER,1
DK,DYSGEUSIA,1
DK,ENCEPHALITIS,1
DK,ENDOCARDITIS STAPHYLOCOCCAL,1
DK,ENDOMETRIAL ADENOCARCINOMA,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EXPOSURE VIA FATHER,1
DK,EYE DISORDER,1
DK,EYELID PTOSIS,1
DK,FAECAL INCONTINENCE,1
DK,FEEDING DISORDER,1
DK,FEELING COLD,1
DK,FOLATE DEFICIENCY,1
DK,GASTROINTESTINAL DISORDER,1
DK,GLOMERULONEPHRITIS PROLIFERATIVE,1
DK,GOITRE,1
DK,GRAFT INFECTION,1
DK,HAEMORRHAGE,1
DK,HAEMORRHAGE NEONATAL,1
DK,HAEMORRHAGIC DIATHESIS,1
DK,HAIR DISORDER,1
DK,HAIR INJURY,1
DK,HALLUCINATION,1
DK,HAND-FOOT-AND-MOUTH DISEASE,1
DK,HEADACHE,1
DK,HEPATITIS TOXIC,1
DK,HERPES ZOSTER,1
DK,HIP ARTHROPLASTY,1
DK,HODGKIN^S DISEASE,1
DK,HYPERCALCAEMIA,1
DK,HYPERCHOLESTEROLAEMIA,1
DK,HYPERSENSITIVITY,1
DK,HYPOAESTHESIA,1
DK,HYPONATRAEMIA,1
DK,INFLUENZA LIKE ILLNESS,1
DK,INJECTION SITE PAIN,1
DK,INTENTIONAL PRODUCT MISUSE,1
DK,INTERVERTEBRAL DISC PROTRUSION,1
DK,INTRAOCULAR MELANOMA,1
DK,JOINT SWELLING,1
DK,JUVENILE IDIOPATHIC ARTHRITIS,1
DK,LEUKOPENIA,1
DK,LHERMITTE^S SIGN,1
DK,LOSS OF EMPLOYMENT,1
DK,LUNG INFECTION,1
DK,LYMPHOCYTIC INFILTRATION,1
DK,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
DK,MEMORY IMPAIRMENT,1
DK,MENINGIOMA,1
DK,METASTASES TO ADRENALS,1
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DK,METASTASES TO LUNG,1
DK,METASTASES TO NERVOUS SYSTEM,1
DK,METASTATIC MALIGNANT MELANOMA,1
DK,MILLER FISHER SYNDROME,1
DK,MOBILITY DECREASED,1
DK,MOVEMENT DISORDER,1
DK,MULTI-ORGAN FAILURE,1
DK,MULTIPLE SCLEROSIS,1
DK,MUSCLE CONTRACTIONS INVOLUNTARY,1
DK,MUSCLE TIGHTNESS,1
DK,MUSCULAR WEAKNESS,1
DK,MUSCULOSKELETAL PAIN,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,MYELOFIBROSIS,1
DK,NASAL CAVITY CANCER,1
DK,NASAL DRYNESS,1
DK,NASAL MUCOSAL ULCER,1
DK,NAUSEA,1
DK,NECROTISING SOFT TISSUE INFECTION,1
DK,NEONATAL ASPIRATION,1
DK,NEPHROLITHIASIS,1
DK,NERVE INJURY,1
DK,NEUROENDOCRINE TUMOUR,1
DK,NEUROPATHY PERIPHERAL,1
DK,NIGHT SWEATS,1
DK,NODULE,1
DK,NON-SMALL CELL LUNG CANCER METASTATIC,1
DK,NUTRITIONAL CONDITION ABNORMAL,1
DK,OESOPHAGEAL ADENOCARCINOMA,1
DK,OESOPHAGEAL CANCER METASTATIC,1
DK,ORAL FUNGAL INFECTION,1
DK,OVARIAN CANCER,1
DK,PANCREATITIS ACUTE,1
DK,PAPILLOEDEMA,1
DK,PARALYSIS,1
DK,PAROTID GLAND INFLAMMATION,1
DK,PAROTITIS,1
DK,PERIPHERAL NERVE INJURY,1
DK,PERIPHERAL SENSORY NEUROPATHY,1
DK,PERITONSILLAR ABSCESS,1
DK,POSTOPERATIVE ABSCESS,1
DK,PRODUCT QUALITY ISSUE,1
DK,PRODUCT USE ISSUE,1
DK,PROTEINURIA,1
DK,PSYCHOLOGICAL FACTOR AFFECTING MEDICAL CONDITION,1
DK,RASH,1
DK,RECTAL CANCER STAGE II,1
DK,RECTAL STENOSIS,1
DK,RECTAL ULCER,1
DK,RENAL CELL CARCINOMA,1
DK,RENAL IMPAIRMENT,1
DK,RESUSCITATION,1
DK,RETINAL VASCULAR THROMBOSIS,1
DK,RHINITIS,1
DK,SALIVA ALTERED,1
DK,SALIVARY GLAND DISORDER,1
DK,SALIVARY GLAND ENLARGEMENT,1
DK,SALIVARY GLAND PAIN,1
DK,SENSORY LOSS,1
DK,SINUSITIS,1
DK,SMALL FIBRE NEUROPATHY,1
DK,SPINDLE CELL SARCOMA,1
DK,SQUAMOUS CELL CARCINOMA,1
DK,STAPHYLOCOCCAL ABSCESS,1
DK,STRESS,1
DK,SWELLING,1
DK,SYSTEMIC LUPUS ERYTHEMATOSUS,1
DK,T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA,1
DK,THROMBOCYTOPENIA,1
DK,THROMBOSIS,1
DK,THYROID CANCER,1
DK,TONGUE MOVEMENT DISTURBANCE,1
DK,TREMOR,1
DK,URINARY RETENTION,1
DK,UVEITIS,1
DK,VISUAL ACUITY REDUCED,1
DK,VITAMIN B12 DEFICIENCY,1
DK,VULVOVAGINAL MYCOTIC INFECTION,1
DK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
DO,DEATH,3
DO,ACCIDENT,1
DO,AGGRESSION,1
DO,ARTHRALGIA,1
DO,BREAST CANCER FEMALE,1
DO,CANDIDIASIS,1
DO,CHIKUNGUNYA VIRUS INFECTION,1
DO,CORNEAL PERFORATION,1
DO,DEPRESSION,1
DO,DYSLIPIDAEMIA,1
DO,ENCEPHALITIS,1
DO,GOITRE,1
DO,HEPATIC STEATOSIS,1
DO,HERPES VIRUS INFECTION,1
DO,HYPERTRANSAMINASAEMIA,1
DO,INFECTION,1
DO,INFLUENZA,1
DO,LOWER LIMB FRACTURE,1
DO,MOBILITY DECREASED,1
DO,MYALGIA,1
DO,NEOPLASM,1
DO,NEUTROPENIA,1
DO,PHARYNGOTONSILLITIS,1
DO,PNEUMONIA VIRAL,1
DO,PULMONARY TUBERCULOSIS,1
DO,RESPIRATORY TRACT INFECTION,1
DO,SUICIDAL IDEATION,1
DO,TONSILLITIS STREPTOCOCCAL,1
DO,TRANSAMINASES INCREASED,1
DO,TYMPANIC MEMBRANE PERFORATION,1
DO,VARICELLA,1
DO,WALKING DISABILITY,1
EC,ANGIOEDEMA,1
EC,BLINDNESS TRANSIENT,1
EC,DISEASE PROGRESSION,1
EC,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
EC,JUVENILE IDIOPATHIC ARTHRITIS,1
EC,LYMPHOMA,1
EC,PRODUCT QUALITY ISSUE,1
EG,BONE MARROW FAILURE,2
EG,LEUKOPENIA,2
EG,PRODUCT USE ISSUE,2
EG,RASH,2
EG,SEPSIS,2
EG,THROMBOCYTOPENIA,2
EG,ABDOMINAL PAIN,1
EG,ABDOMINAL PAIN UPPER,1
EG,ANAPHYLACTIC SHOCK,1
EG,ARTHRALGIA,1
EG,CARDIAC DISORDER,1
EG,CUTANEOUS LEISHMANIASIS,1
EG,DEATH,1
EG,DIARRHOEA,1
EG,DRUG INEFFECTIVE,1
EG,ENDOMETRIAL CANCER STAGE III,1
EG,EYE INFECTION,1
EG,GIARDIASIS,1
EG,HAEMOLYTIC ANAEMIA,1
EG,HEPATIC ENZYME INCREASED,1
EG,HEPATIC FIBROSIS,1
EG,HEPATITIS C,1
EG,INCORRECT DOSE ADMINISTERED,1
EG,INJECTION SITE HAEMORRHAGE,1
EG,INJECTION SITE OEDEMA,1
EG,INJECTION SITE REACTION,1
EG,LIVER FUNCTION TEST INCREASED,1
EG,LOSS OF CONSCIOUSNESS,1
EG,LUMBAR VERTEBRAL FRACTURE,1
EG,NO THERAPEUTIC RESPONSE,1
EG,PYREXIA,1
EG,RASH ERYTHEMATOUS,1
EG,RENAL IMPAIRMENT,1
EG,RHEUMATOID ARTHRITIS,1
EG,SEIZURE,1
EG,SKIN ULCER,1
EG,STEVENS-JOHNSON SYNDROME,1
EG,SUDDEN DEATH,1
EG,THERAPEUTIC RESPONSE UNEXPECTED,1
EG,THORACIC VERTEBRAL FRACTURE,1
EG,TOXICITY TO VARIOUS AGENTS,1
EG,UTERINE HAEMORRHAGE,1
EG,VASCULITIS,1
SV,DEATH,1
SV,TESTIS CANCER,1
EE,PNEUMONIA,3
EE,RENAL FAILURE,3
EE,ACUTE RESPIRATORY FAILURE,2
EE,CARDIAC FAILURE ACUTE,2
EE,CHRONIC MYELOID LEUKAEMIA,2
EE,MYOCARDIAL INFARCTION,2
EE,PULMONARY EMBOLISM,2
EE,SEPSIS,2
EE,APGAR SCORE LOW,1
EE,DEMYELINATION,1
EE,DIPLOPIA,1
EE,DRUG INEFFECTIVE,1
EE,DYSPNOEA,1
EE,HAEMATOMA,1
EE,HISTIOCYTOSIS HAEMATOPHAGIC,1
EE,HYPERSENSITIVITY,1
EE,INJECTION SITE ERYTHEMA,1
EE,INJECTION SITE OEDEMA,1
EE,INJECTION SITE PRURITUS,1
EE,INJECTION SITE REACTION,1
EE,LOCAL REACTION,1
EE,LOCALISED OEDEMA,1
EE,MATERNAL EXPOSURE DURING PREGNANCY,1
EE,MECONIUM ASPIRATION SYNDROME,1
EE,MULTIPLE SCLEROSIS,1
EE,PRODUCT USE ISSUE,1
EE,RECTAL ADENOCARCINOMA,1
EE,RENAL TUBULAR NECROSIS,1
EE,TUBULOINTERSTITIAL NEPHRITIS,1
FI,IRITIS,9
FI,FATIGUE,8
FI,DIZZINESS,6
FI,DRUG INEFFECTIVE,6
FI,HEPATITIS C,6
FI,PYREXIA,6
FI,CONDITION AGGRAVATED,5
FI,DRUG EFFECT INCOMPLETE,5
FI,LIVER FUNCTION TEST INCREASED,5
FI,RHEUMATOID ARTHRITIS,5
FI,SEXUALLY TRANSMITTED DISEASE,5
FI,ABORTION SPONTANEOUS,4
FI,CONTUSION,4
FI,INFECTION,4
FI,INFLUENZA,4
FI,LEUKOPENIA,4
FI,LOSS OF CONSCIOUSNESS,4
FI,NEUTROPENIA,4
FI,ARTHRALGIA,3
FI,ARTHROPATHY,3
FI,BLOOD PRESSURE INCREASED,3
FI,BREAST CANCER,3
FI,C-REACTIVE PROTEIN INCREASED,3
FI,CONTRAINDICATED PRODUCT ADMINISTERED,3
FI,DEMYELINATION,3
FI,DIPLOPIA,3
FI,DYSPNOEA,3
FI,EPILEPSY,3
FI,FALL,3
FI,HEADACHE,3
FI,HYPOGLYCAEMIA,3
FI,INTRAOCULAR PRESSURE INCREASED,3
FI,LETHARGY,3
FI,MATERNAL EXPOSURE DURING PREGNANCY,3
FI,MEMORY IMPAIRMENT,3
FI,MENTAL DISORDER,3
FI,PNEUMONIA,3
FI,PSORIASIS,3
FI,WOUND,3
FI,ABDOMINAL PAIN,2
FI,ALANINE AMINOTRANSFERASE ABNORMAL,2
FI,ALANINE AMINOTRANSFERASE INCREASED,2
FI,ANGER,2
FI,ANKYLOSING SPONDYLITIS,2
FI,ANTERIOR CHAMBER CELL,2
FI,ARTHRITIS,2
FI,ARTHRITIS BACTERIAL,2
FI,BALANCE DISORDER,2
FI,BREAST CANCER FEMALE,2
FI,BRUXISM,2
FI,CATARACT,2
FI,CEREBRAL INFARCTION,2
FI,COUGH,2
FI,DEEP VEIN THROMBOSIS,2
FI,DERMATITIS PSORIASIFORM,2
FI,DRUG EFFECT DECREASED,2
FI,ERYTHEMA,2
FI,GAMBLING DISORDER,2
FI,H1N1 INFLUENZA,2
FI,HYPERCALCAEMIA,2
FI,HYPERTENSION,2
FI,HYPOAESTHESIA,2
FI,ILEAL ULCER,2
FI,INTERSTITIAL LUNG DISEASE,2
FI,INVASIVE DUCTAL BREAST CARCINOMA,2
FI,IRRITABILITY,2
FI,JOINT EFFUSION,2
FI,METASTASES TO LIVER,2
FI,MUSCLE TWITCHING,2
FI,MUSCULOSKELETAL STIFFNESS,2
FI,MYELITIS,2
FI,NASOPHARYNGITIS,2
FI,NAUSEA,2
FI,OSTEOMYELITIS,2
FI,PAIN IN EXTREMITY,2
FI,PANCREATIC CARCINOMA,2
FI,PETIT MAL EPILEPSY,2
FI,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
FI,PREMATURE BABY,2
FI,PRODUCT USE ISSUE,2
FI,PSORIATIC ARTHROPATHY,2
FI,PSYCHOTIC DISORDER,2
FI,RENAL CANCER,2
FI,RESPIRATORY TRACT INFECTION,2
FI,RESTLESSNESS,2
FI,SARCOIDOSIS,2
FI,SENSORY DISTURBANCE,2
FI,SUPERFICIAL SPREADING MELANOMA STAGE II,2
FI,TEARFULNESS,2
FI,TENDONITIS,2
FI,TONSILLITIS,2
FI,UPPER RESPIRATORY TRACT INFECTION,2
FI,UVEITIS,2
FI,VOMITING,2
FI,WEIGHT INCREASED,2
FI,ABDOMINAL DISTENSION,1
FI,ABDOMINAL PAIN UPPER,1
FI,ABSCESS,1
FI,ABSCESS LIMB,1
FI,ACTIVITIES OF DAILY LIVING IMPAIRED,1
FI,ADENOCARCINOMA,1
FI,ADENOMA BENIGN,1
FI,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
FI,AGGRESSION,1
FI,ALCOHOL ABUSE,1
FI,ANAEMIA,1
FI,ANAPHYLACTIC REACTION,1
FI,AORTITIS,1
FI,APGAR SCORE LOW,1
FI,AQUEDUCTAL STENOSIS,1
FI,ASCITES,1
FI,ASPARTATE AMINOTRANSFERASE INCREASED,1
FI,ASTHENIA,1
FI,ASTHMA,1
FI,ATRIAL FIBRILLATION,1
FI,AUTOIMMUNE HEPATITIS,1
FI,BASAL CELL CARCINOMA,1
FI,BLINDNESS,1
FI,BLOOD BILIRUBIN INCREASED,1
FI,BLOOD CREATININE INCREASED,1
FI,BODY TEMPERATURE INCREASED,1
FI,BONE MARROW FAILURE,1
FI,BRAIN SCAN ABNORMAL,1
FI,BRONCHIECTASIS,1
FI,BURSA DISORDER,1
FI,CALCULUS URINARY,1
FI,CARDIAC ARREST,1
FI,CARDIAC DISORDER,1
FI,CARDIAC FAILURE,1
FI,CHEST PAIN,1
FI,CHILLS,1
FI,CHROMATOPSIA,1
FI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FI,CLOSTRIDIUM TEST POSITIVE,1
FI,COAGULATION FACTOR VIII LEVEL INCREASED,1
FI,COLD SWEAT,1
FI,COLITIS ULCERATIVE,1
FI,COLORECTAL ADENOCARCINOMA,1
FI,CONGESTIVE CARDIOMYOPATHY,1
FI,CONNECTIVE TISSUE DISORDER,1
FI,CROHN^S DISEASE,1
FI,CSF IMMUNOGLOBULIN INCREASED,1
FI,CSF OLIGOCLONAL BAND PRESENT,1
FI,CYANOSIS,1
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FI,DERMATITIS EXFOLIATIVE,1
FI,DEVICE MALFUNCTION,1
FI,DEVICE RELATED INFECTION,1
FI,DIARRHOEA,1
FI,DILATATION VENTRICULAR,1
FI,DISEASE RECURRENCE,1
FI,DRUG ADMINISTRATION ERROR,1
FI,DRUG PRESCRIBING ERROR,1
FI,DRUG-INDUCED LIVER INJURY,1
FI,DUODENAL ULCER,1
FI,DYSPEPSIA,1
FI,DYSPHONIA,1
FI,DYSSTASIA,1
FI,EAR INFECTION,1
FI,ELECTROCARDIOGRAM ABNORMAL,1
FI,ENCEPHALOPATHY,1
FI,ENDOCARDITIS,1
FI,EOSINOPHILIC PNEUMONIA,1
FI,ERYSIPELAS,1
FI,ERYTHEMA ELEVATUM DIUTINUM,1
FI,ESCHERICHIA BACTERAEMIA,1
FI,EXPOSURE VIA FATHER,1
FI,EXPOSURE VIA PARTNER,1
FI,EYE DISCHARGE,1
FI,EYE MOVEMENT DISORDER,1
FI,EYELID OEDEMA,1
FI,FEEDING DISORDER,1
FI,FEELING ABNORMAL,1
FI,FLANK PAIN,1
FI,FLUID RETENTION,1
FI,FOETAL MALPOSITION,1
FI,FOREIGN BODY REACTION,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC DILATATION,1
FI,GENERAL PHYSICAL CONDITION ABNORMAL,1
FI,GESTATIONAL DIABETES,1
FI,HAEMATOMA,1
FI,HAND-FOOT-AND-MOUTH DISEASE,1
FI,HEPATIC CIRRHOSIS,1
FI,HEPATIC FAILURE,1
FI,HEPATIC FIBROSIS,1
FI,HEPATIC STEATOSIS,1
FI,HEPATITIS ALCOHOLIC,1
FI,HERPES VIRUS INFECTION,1
FI,HYDROCEPHALUS,1
FI,HYPERPARATHYROIDISM PRIMARY,1
FI,HYPERVITAMINOSIS D,1
FI,HYPOVOLAEMIA,1
FI,HYPOXIA,1
FI,IMPATIENCE,1
FI,INFECTION REACTIVATION,1
FI,INFECTION SUSCEPTIBILITY INCREASED,1
FI,INJECTION SITE BRUISING,1
FI,INJECTION SITE ERYTHEMA,1
FI,INJECTION SITE EXTRAVASATION,1
FI,INJECTION SITE HAEMORRHAGE,1
FI,INJECTION SITE HYPERSENSITIVITY,1
FI,INJECTION SITE INJURY,1
FI,INJECTION SITE PARAESTHESIA,1
FI,INJECTION SITE SWELLING,1
FI,INTERNATIONAL NORMALISED RATIO INCREASED,1
FI,INTESTINAL OBSTRUCTION,1
FI,INTRA-ABDOMINAL HAEMATOMA,1
FI,IRON DEFICIENCY ANAEMIA,1
FI,JOINT ABSCESS,1
FI,JOINT INJURY,1
FI,JOINT RANGE OF MOTION DECREASED,1
FI,JOINT SWELLING,1
FI,JUVENILE IDIOPATHIC ARTHRITIS,1
FI,LEG AMPUTATION,1
FI,LEGIONELLA INFECTION,1
FI,LIMB DEFORMITY,1
FI,LIP SWELLING,1
FI,LOCALISED INFECTION,1
FI,LUNG ABSCESS,1
FI,LUNG DISORDER,1
FI,LUNG INFILTRATION,1
FI,LYMPHOCYTOSIS,1
FI,MALAISE,1
FI,MALIGNANT MELANOMA,1
FI,METASTASES TO BREAST,1
FI,METASTASES TO LUNG,1
FI,METASTASES TO LYMPH NODES,1
FI,METASTASES TO SPLEEN,1
FI,MIGRAINE,1
FI,MUSCLE RIGIDITY,1
FI,MUSCULAR WEAKNESS,1
FI,MYELODYSPLASTIC SYNDROME,1
FI,NEOPLASM MALIGNANT,1
FI,NEUROPATHY PERIPHERAL,1
FI,NEUROSARCOIDOSIS,1
FI,NO ADVERSE EVENT,1
FI,NODULE,1
FI,OEDEMA PERIPHERAL,1
FI,OESOPHAGEAL IRRITATION,1
FI,OPTIC NEURITIS,1
FI,ORTHOSIS USER,1
FI,OSTEOARTHRITIS,1
FI,OSTEOPOROSIS,1
FI,PAIN,1
FI,PALPITATIONS,1
FI,PANCREATITIS,1
FI,PAPILLARY THYROID CANCER,1
FI,PARAESTHESIA,1
FI,PARALYSIS,1
FI,PARESIS,1
FI,PEMPHIGOID,1
FI,PERIPHERAL COLDNESS,1
FI,PERIPHERAL SWELLING,1
FI,PERIPHERAL VASCULAR DISORDER,1
FI,PERITONEAL HAEMORRHAGE,1
FI,PLANTAR FASCIITIS,1
FI,PNEUMONIA BACTERIAL,1
FI,PNEUMONIA STAPHYLOCOCCAL,1
FI,POLYNEUROPATHY,1
FI,POLYP,1
FI,PRE-ECLAMPSIA,1
FI,PREMATURE DELIVERY,1
FI,PROSTATE CANCER,1
FI,PROTEINURIA,1
FI,PSYCHIATRIC SYMPTOM,1
FI,PSYCHOMOTOR HYPERACTIVITY,1
FI,PULMONARY TOXICITY,1
FI,PURPURA,1
FI,PYELONEPHRITIS,1
FI,PYODERMA GANGRENOSUM,1
FI,RADICULOPATHY,1
FI,RASH,1
FI,RECTAL ADENOCARCINOMA,1
FI,RECTAL CANCER METASTATIC,1
FI,RECTAL HAEMORRHAGE,1
FI,RENAL CYST,1
FI,RENAL DISORDER,1
FI,RENAL FAILURE,1
FI,RESPIRATORY FAILURE,1
FI,RESUSCITATION,1
FI,RHEUMATIC DISORDER,1
FI,ROTATOR CUFF SYNDROME,1
FI,SCAR,1
FI,SEPSIS,1
FI,SEPTIC ARTHRITIS STAPHYLOCOCCAL,1
FI,SINGLE UMBILICAL ARTERY,1
FI,SJOGREN^S SYNDROME,1
FI,SKIN DISORDER,1
FI,SKIN INFECTION,1
FI,SMALL FOR DATES BABY,1
FI,SOCIAL PROBLEM,1
FI,SQUAMOUS CELL CARCINOMA,1
FI,STAPHYLOCOCCAL ABSCESS,1
FI,STAPHYLOCOCCAL INFECTION,1
FI,STAPHYLOCOCCAL SEPSIS,1
FI,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
FI,SWELLING FACE,1
FI,SYNCOPE,1
FI,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FI,TENDERNESS,1
FI,THORACIC VERTEBRAL FRACTURE,1
FI,THROAT TIGHTNESS,1
FI,THROMBOSIS,1
FI,TINNITUS,1
FI,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
FI,TOURETTE^S DISORDER,1
FI,TRANSIENT ISCHAEMIC ATTACK,1
FI,TREMOR,1
FI,TRISOMY 8,1
FI,TYMPANIC MEMBRANE PERFORATION,1
FI,URTICARIA,1
FI,VASCULITIS,1
FI,VERTIGO,1
FI,VESTIBULAR NEURONITIS,1
FI,WEIGHT DECREASED,1
FI,WHITE BLOOD CELL COUNT DECREASED,1
FR,DRUG INEFFECTIVE,84
FR,ASTHENIA,48
FR,CONDITION AGGRAVATED,39
FR,HEPATOCELLULAR INJURY,39
FR,PSORIASIS,38
FR,PYREXIA,38
FR,BREAST CANCER,32
FR,RHEUMATOID ARTHRITIS,32
FR,ANKYLOSING SPONDYLITIS,31
FR,ARTHRALGIA,30
FR,HEADACHE,30
FR,DIARRHOEA,28
FR,DYSPNOEA,28
FR,PRODUCT USE ISSUE,28
FR,PNEUMONIA,26
FR,SARCOIDOSIS,26
FR,NEUTROPENIA,25
FR,UVEITIS,25
FR,COUGH,24
FR,WEIGHT DECREASED,24
FR,PAIN,23
FR,BASAL CELL CARCINOMA,22
FR,DEPRESSION,22
FR,INJECTION SITE ERYTHEMA,21
FR,PULMONARY EMBOLISM,21
FR,HYPERSENSITIVITY,20
FR,INFECTION,20
FR,MALIGNANT MELANOMA,20
FR,FATIGUE,19
FR,INTERSTITIAL LUNG DISEASE,19
FR,PRURITUS,19
FR,GENERAL PHYSICAL HEALTH DETERIORATION,18
FR,MALAISE,18
FR,ADENOCARCINOMA OF COLON,17
FR,ANXIETY,17
FR,DECREASED APPETITE,17
FR,MYOCARDIAL INFARCTION,17
FR,SEPTIC SHOCK,17
FR,ABDOMINAL PAIN,16
FR,DEMYELINATION,16
FR,DISTURBANCE IN ATTENTION,16
FR,ECZEMA,16
FR,ACUTE MYELOID LEUKAEMIA,15
FR,ANGIOEDEMA,15
FR,INJECTION SITE REACTION,15
FR,METASTASES TO LIVER,15
FR,SYNCOPE,15
FR,IRIDOCYCLITIS,14
FR,MULTIPLE SCLEROSIS,14
FR,NAUSEA,14
FR,RASH,14
FR,URINARY TRACT INFECTION,14
FR,INJECTION SITE PAIN,13
FR,LUNG DISORDER,13
FR,LYMPHOMA,13
FR,PANCYTOPENIA,13
FR,PLEURAL EFFUSION,13
FR,PSORIATIC ARTHROPATHY,13
FR,VOMITING,13
FR,ACUTE KIDNEY INJURY,12
FR,BRONCHITIS,12
FR,CHILLS,12
FR,ERYSIPELAS,12
FR,ERYTHEMA,12
FR,HYPOTENSION,12
FR,PARAESTHESIA,12
FR,POLYNEUROPATHY,12
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,12
FR,URTICARIA,12
FR,VASCULITIS,12
FR,ABDOMINAL PAIN UPPER,11
FR,AGRANULOCYTOSIS,11
FR,BALANCE DISORDER,11
FR,CHOLESTASIS,11
FR,DERMATITIS BULLOUS,11
FR,HYPERTENSION,11
FR,INFLAMMATION,11
FR,INVASIVE DUCTAL BREAST CARCINOMA,11
FR,LUNG ADENOCARCINOMA,11
FR,LYMPHADENOPATHY,11
FR,OPTIC NEURITIS,11
FR,THROMBOCYTOPENIA,11
FR,TREATMENT FAILURE,11
FR,BREAST CANCER FEMALE,10
FR,DIZZINESS,10
FR,INJECTION SITE PLAQUE,10
FR,INJECTION SITE PRURITUS,10
FR,LYMPHOPENIA,10
FR,NEOPLASM MALIGNANT,10
FR,OEDEMA PERIPHERAL,10
FR,PROSTATE CANCER,10
FR,RECTAL HAEMORRHAGE,10
FR,TUBERCULOSIS,10
FR,VERTIGO,10
FR,VIITH NERVE PARALYSIS,10
FR,ARTHROPATHY,9
FR,CARDIAC FAILURE,9
FR,CEREBROVASCULAR ACCIDENT,9
FR,CONGESTIVE CARDIOMYOPATHY,9
FR,DEHYDRATION,9
FR,DIPLOPIA,9
FR,DRUG EFFECT INCOMPLETE,9
FR,DRUG INTOLERANCE,9
FR,FALL,9
FR,GAIT DISTURBANCE,9
FR,IRON DEFICIENCY ANAEMIA,9
FR,ISCHAEMIC STROKE,9
FR,MUSCULAR WEAKNESS,9
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,9
FR,SUICIDAL IDEATION,9
FR,VISUAL ACUITY REDUCED,9
FR,ARTHRITIS,8
FR,COLITIS,8
FR,COLON CANCER,8
FR,DISEASE RECURRENCE,8
FR,DRUG EFFECT DECREASED,8
FR,HEPATIC STEATOSIS,8
FR,HYPOAESTHESIA,8
FR,INJECTION SITE SWELLING,8
FR,LUNG NEOPLASM MALIGNANT,8
FR,MAJOR DEPRESSION,8
FR,MEMORY IMPAIRMENT,8
FR,METASTASES TO BONE,8
FR,MYALGIA,8
FR,NEUROPATHY PERIPHERAL,8
FR,PUSTULAR PSORIASIS,8
FR,SUICIDE ATTEMPT,8
FR,TOOTH ABSCESS,8
FR,ABORTION SPONTANEOUS,7
FR,AFFECTIVE DISORDER,7
FR,ANAEMIA,7
FR,ASTHMA,7
FR,BACK PAIN,7
FR,CROHN^S DISEASE,7
FR,DELIRIUM,7
FR,DIABETES MELLITUS INADEQUATE CONTROL,7
FR,DYSKINESIA,7
FR,EPISTAXIS,7
FR,EYE PAIN,7
FR,INJECTION SITE INFLAMMATION,7
FR,INTRADUCTAL PROLIFERATIVE BREAST LESION,7
FR,LUNG INFECTION,7
FR,METASTASES TO LYMPH NODES,7
FR,NON-HODGKIN^S LYMPHOMA,7
FR,PHLEBITIS,7
FR,PULMONARY MASS,7
FR,RENAL FAILURE,7
FR,RESPIRATORY DISTRESS,7
FR,RHEUMATIC DISORDER,7
FR,SINUS NODE DYSFUNCTION,7
FR,SKIN LESION,7
FR,TOXIC SKIN ERUPTION,7
FR,TREMOR,7
FR,VIRAL INFECTION,7
FR,WHIPPLE^S DISEASE,7
FR,ACUTE CORONARY SYNDROME,6
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,6
FR,ALOPECIA,6
FR,B-CELL LYMPHOMA,6
FR,BRADYCARDIA,6
FR,CARDIAC ARREST,6
FR,CHEST PAIN,6
FR,CLEAR CELL RENAL CELL CARCINOMA,6
FR,DEEP VEIN THROMBOSIS,6
FR,DERMO-HYPODERMITIS,6
FR,DISSEMINATED LARGE CELL LYMPHOMA,6
FR,DRUG HYPERSENSITIVITY,6
FR,ENCEPHALOPATHY,6
FR,ESCHERICHIA URINARY TRACT INFECTION,6
FR,FOETAL DEATH,6
FR,GLIOBLASTOMA,6
FR,HERPES ZOSTER,6
FR,HODGKIN^S DISEASE,6
FR,LIVER FUNCTION TEST ABNORMAL,6
FR,MYCOSIS FUNGOIDES,6
FR,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,6
FR,PAIN IN EXTREMITY,6
FR,PERITONITIS,6
FR,PRODUCT QUALITY ISSUE,6
FR,RHINITIS,6
FR,SINUS BRADYCARDIA,6
FR,SJOGREN^S SYNDROME,6
FR,SLEEP DISORDER,6
FR,SQUAMOUS CELL CARCINOMA,6
FR,TONSILLITIS,6
FR,UTERINE CANCER,6
FR,WEIGHT INCREASED,6
FR,AORTIC VALVE STENOSIS,5
FR,ATRIAL FIBRILLATION,5
FR,BACTERIAL SEPSIS,5
FR,BREAST CANCER METASTATIC,5
FR,BRONCHIAL DISORDER,5
FR,BRONCHOPNEUMONIA,5
FR,CONFUSIONAL STATE,5
FR,CONSTIPATION,5
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,5
FR,DISEASE PROGRESSION,5
FR,DIVERTICULITIS,5
FR,DRY SKIN,5
FR,DYSGEUSIA,5
FR,ERYTHEMA NODOSUM,5
FR,EXPOSURE DURING PREGNANCY,5
FR,EXPOSURE VIA FATHER,5
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
FR,GASTROINTESTINAL INFECTION,5
FR,HAEMOPTYSIS,5
FR,HEPATIC ENZYME INCREASED,5
FR,HEPATITIS,5
FR,HYPERTHERMIA,5
FR,HYPERTHYROIDISM,5
FR,HYPONATRAEMIA,5
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
FR,INFUSION RELATED REACTION,5
FR,LEUKOPENIA,5
FR,LUPUS-LIKE SYNDROME,5
FR,LYMPHADENOPATHY MEDIASTINAL,5
FR,MYELITIS,5
FR,MYOSITIS,5
FR,NASOPHARYNGITIS,5
FR,NIGHT SWEATS,5
FR,PANCREATIC CARCINOMA METASTATIC,5
FR,PARADOXICAL DRUG REACTION,5
FR,PEMPHIGOID,5
FR,PERITONEAL DIALYSIS COMPLICATION,5
FR,PRODUCT USE IN UNAPPROVED INDICATION,5
FR,PULMONARY OEDEMA,5
FR,PULMONARY SARCOIDOSIS,5
FR,PURPURA,5
FR,RECTAL ADENOCARCINOMA,5
FR,SEPSIS,5
FR,SKIN EXFOLIATION,5
FR,SKIN PLAQUE,5
FR,STAPHYLOCOCCAL INFECTION,5
FR,STOMATITIS,5
FR,TACHYCARDIA,5
FR,TINNITUS,5
FR,TOOTH INFECTION,5
FR,TOXICITY TO VARIOUS AGENTS,5
FR,TRANSIENT ISCHAEMIC ATTACK,5
FR,VISION BLURRED,5
FR,ABASIA,4
FR,AGEUSIA,4
FR,ALVEOLITIS,4
FR,ANGIOCENTRIC LYMPHOMA,4
FR,ANOSMIA,4
FR,AORTITIS,4
FR,ARRHYTHMIA,4
FR,ARTHRITIS BACTERIAL,4
FR,ASPARTATE AMINOTRANSFERASE INCREASED,4
FR,ATAXIA,4
FR,BACTERAEMIA,4
FR,BLINDNESS,4
FR,BLOOD CREATININE INCREASED,4
FR,BREAST CALCIFICATIONS,4
FR,BRONCHIAL CARCINOMA,4
FR,CARDIAC DISORDER,4
FR,CATARACT,4
FR,COGNITIVE DISORDER,4
FR,COLITIS ULCERATIVE,4
FR,COLONIC ABSCESS,4
FR,COMPLETED SUICIDE,4
FR,CONTRAINDICATED PRODUCT ADMINISTERED,4
FR,CYSTITIS,4
FR,DERMATITIS ALLERGIC,4
FR,DIFFUSE LARGE B-CELL LYMPHOMA,4
FR,DIVERTICULAR PERFORATION,4
FR,DRUG RESISTANCE,4
FR,DYSPHAGIA,4
FR,DYSURIA,4
FR,ENCEPHALITIS,4
FR,EOSINOPHILIA,4
FR,EXPOSURE VIA PARTNER,4
FR,FACIAL SPASM,4
FR,FEELING ABNORMAL,4
FR,FOETAL EXPOSURE DURING PREGNANCY,4
FR,GASTROENTERITIS,4
FR,GASTROINTESTINAL DISORDER,4
FR,HAEMATOMA,4
FR,HAEMATURIA,4
FR,HALLUCINATION_ VISUAL,4
FR,HEMIPARESIS,4
FR,HEPATIC CANCER,4
FR,HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE III,4
FR,HYPERHIDROSIS,4
FR,HYPERSENSITIVITY VASCULITIS,4
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
FR,INFLUENZA,4
FR,INJECTION SITE HYPERSENSITIVITY,4
FR,INSOMNIA,4
FR,LARGE INTESTINE POLYP,4
FR,METASTASES TO LUNG,4
FR,MIGRAINE,4
FR,MULTI-ORGAN FAILURE,4
FR,MUSCULOSKELETAL DISORDER,4
FR,MUSCULOSKELETAL STIFFNESS,4
FR,MYELODYSPLASTIC SYNDROME,4
FR,NECROSIS,4
FR,NEUTROPHIL COUNT DECREASED,4
FR,OESOPHAGEAL ADENOCARCINOMA,4
FR,OSTEOARTHRITIS,4
FR,OSTEONECROSIS OF JAW,4
FR,PARAPARESIS,4
FR,PHOTOSENSITIVITY REACTION,4
FR,RASH ERYTHEMATOUS,4
FR,RENAL CANCER,4
FR,RENAL CYST,4
FR,RENAL NEOPLASM,4
FR,RESPIRATORY FAILURE,4
FR,RHEUMATOID LUNG,4
FR,SECOND PRIMARY MALIGNANCY,4
FR,SHOCK,4
FR,SINUS TACHYCARDIA,4
FR,SINUSITIS,4
FR,SKIN INFECTION,4
FR,SKIN REACTION,4
FR,SOMNOLENCE,4
FR,TESTICULAR SEMINOMA (PURE),4
FR,THROMBOPHLEBITIS SUPERFICIAL,4
FR,TOOTH HYPOPLASIA,4
FR,TRANSAMINASES INCREASED,4
FR,UPPER RESPIRATORY TRACT INFECTION,4
FR,URINARY INCONTINENCE,4
FR,UTERINE CARCINOMA IN SITU,4
FR,VISUAL IMPAIRMENT,4
FR,ABSCESS,3
FR,ACTINIC KERATOSIS,3
FR,ADENOCARCINOMA,3
FR,ADENOCARCINOMA GASTRIC,3
FR,ADRENAL INSUFFICIENCY,3
FR,AGGRESSION,3
FR,ALANINE AMINOTRANSFERASE INCREASED,3
FR,ANORECTAL DISCOMFORT,3
FR,APHASIA,3
FR,APPENDICITIS,3
FR,ARTHRITIS INFECTIVE,3
FR,ASPERGILLUS INFECTION,3
FR,AXONAL NEUROPATHY,3
FR,BACTERIAL PYELONEPHRITIS,3
FR,BONE MARROW FAILURE,3
FR,CARDIOGENIC SHOCK,3
FR,CARPAL TUNNEL SYNDROME,3
FR,CEREBELLAR SYNDROME,3
FR,CHOLECYSTITIS,3
FR,CHOLECYSTITIS ACUTE,3
FR,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,3
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,3
FR,CHRONIC MYELOID LEUKAEMIA,3
FR,COLITIS ISCHAEMIC,3
FR,CONJUNCTIVITIS,3
FR,CORONARY ARTERY STENOSIS,3
FR,CYTOMEGALOVIRUS INFECTION,3
FR,DEAFNESS NEUROSENSORY,3
FR,DEATH,3
FR,DEVICE RELATED INFECTION,3
FR,DIABETES MELLITUS,3
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,3
FR,DRUG-INDUCED LIVER INJURY,3
FR,DRY EYE,3
FR,DYSARTHRIA,3
FR,EAR INFECTION,3
FR,EMPHYSEMA,3
FR,ENCOPRESIS,3
FR,ENDOCARDITIS,3
FR,ENDOMETRIAL ADENOCARCINOMA,3
FR,ENTEROBACTER SEPSIS,3
FR,EPSTEIN-BARR VIRUS INFECTION,3
FR,ERECTILE DYSFUNCTION,3
FR,ERYTHEMA MULTIFORME,3
FR,EYE IRRITATION,3
FR,FACE OEDEMA,3
FR,FEELING HOT,3
FR,FORMICATION,3
FR,FUNGAL INFECTION,3
FR,GASTRITIS,3
FR,GASTROINTESTINAL ANGIODYSPLASIA,3
FR,GASTROINTESTINAL HAEMORRHAGE,3
FR,GASTROINTESTINAL INFLAMMATION,3
FR,GENITAL HAEMORRHAGE,3
FR,GUILLAIN-BARRE SYNDROME,3
FR,HEAD TITUBATION,3
FR,HEPATIC CIRRHOSIS,3
FR,HEPATIC FAILURE,3
FR,HEPATOCELLULAR CARCINOMA,3
FR,HICCUPS,3
FR,HYPOGLYCAEMIC COMA,3
FR,HYPOVOLAEMIC SHOCK,3
FR,IMMUNE THROMBOCYTOPENIC PURPURA,3
FR,IMMUNOSUPPRESSION,3
FR,IMPAIRED HEALING,3
FR,INFECTION SUSCEPTIBILITY INCREASED,3
FR,INFECTIOUS COLITIS,3
FR,INFERTILITY,3
FR,INFLAMMATORY BOWEL DISEASE,3
FR,INFLUENZA LIKE ILLNESS,3
FR,INJECTION SITE INDURATION,3
FR,INJECTION SITE OEDEMA,3
FR,INJECTION SITE WARMTH,3
FR,INTERVERTEBRAL DISC DEGENERATION,3
FR,JOINT EFFUSION,3
FR,JOINT SWELLING,3
FR,LOSS OF CONSCIOUSNESS,3
FR,LOSS OF LIBIDO,3
FR,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,3
FR,LYMPHADENITIS,3
FR,LYMPHOEDEMA,3
FR,MALIGNANT MELANOMA IN SITU,3
FR,MANTLE CELL LYMPHOMA,3
FR,MIDDLE INSOMNIA,3
FR,MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA,3
FR,MOBILITY DECREASED,3
FR,MONOCYTOPENIA,3
FR,MORGANELLA INFECTION,3
FR,MUCOSAL INFLAMMATION,3
FR,MUSCLE ABSCESS,3
FR,MYOCARDITIS,3
FR,NAIL DISORDER,3
FR,NASAL CONGESTION,3
FR,NEOPLASM,3
FR,NEURALGIA,3
FR,NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC,3
FR,NODULE,3
FR,OEDEMA,3
FR,OROPHARYNGEAL PAIN,3
FR,OSTEITIS,3
FR,PALPITATIONS,3
FR,PANCREATIC CARCINOMA,3
FR,PAPILLOMA VIRAL INFECTION,3
FR,PERICARDITIS,3
FR,PERIPHERAL SENSORIMOTOR NEUROPATHY,3
FR,PLASMA CELL MYELOMA,3
FR,PLEURISY,3
FR,PNEUMONIA LEGIONELLA,3
FR,POLYARTHRITIS,3
FR,POST PROCEDURAL COMPLICATION,3
FR,POST PROCEDURAL INFECTION,3
FR,PREMATURE BABY,3
FR,PRODUCTIVE COUGH,3
FR,PROSTATE CANCER METASTATIC,3
FR,PRURIGO,3
FR,PULMONARY TUBERCULOSIS,3
FR,PYELONEPHRITIS,3
FR,PYODERMA GANGRENOSUM,3
FR,RASH GENERALISED,3
FR,RASH MACULO-PAPULAR,3
FR,RASH PAPULAR,3
FR,RASH PUSTULAR,3
FR,RECTAL CANCER,3
FR,RENAL COLIC,3
FR,RENAL FAILURE ACUTE,3
FR,RESPIRATORY DISORDER,3
FR,RETINAL OEDEMA,3
FR,RETINAL VEIN OCCLUSION,3
FR,RETINOIC ACID SYNDROME,3
FR,SINOATRIAL BLOCK,3
FR,SKIN DISORDER,3
FR,SKIN IRRITATION,3
FR,SKIN ULCER,3
FR,SPINAL PAIN,3
FR,SPLEEN DISORDER,3
FR,STEVENS-JOHNSON SYNDROME,3
FR,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
FR,SUBCUTANEOUS ABSCESS,3
FR,TENDON DISORDER,3
FR,THROMBOPHLEBITIS,3
FR,TOOTH DISORDER,3
FR,URINARY TRACT INFECTION ENTEROCOCCAL,3
FR,VASCULAR PURPURA,3
FR,WHITE BLOOD CELL COUNT DECREASED,3
FR,ABORTION INDUCED,2
FR,ABULIA,2
FR,ACARODERMATITIS,2
FR,ACINETOBACTER INFECTION,2
FR,ACUTE LYMPHOCYTIC LEUKAEMIA,2
FR,ACUTE RESPIRATORY FAILURE,2
FR,ADENOMA BENIGN,2
FR,ADENOMYOSIS,2
FR,AGITATION,2
FR,AMYLOIDOSIS,2
FR,ANGINA PECTORIS,2
FR,ANGIOTENSIN CONVERTING ENZYME INCREASED,2
FR,ANHEDONIA,2
FR,ANXIETY DISORDER,2
FR,APLASIA,2
FR,AREFLEXIA,2
FR,ASCITES,2
FR,ASPHYXIA,2
FR,ASPIRATION,2
FR,ATELECTASIS,2
FR,ATRIOVENTRICULAR BLOCK,2
FR,BACTERIAL INFECTION,2
FR,BASEDOW^S DISEASE,2
FR,BLADDER CANCER,2
FR,BLISTER,2
FR,BLOOD CREATINE INCREASED,2
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
FR,BONE TUBERCULOSIS,2
FR,BRADYARRHYTHMIA,2
FR,BRONCHIECTASIS,2
FR,BURNING SENSATION,2
FR,BURSITIS,2
FR,BUTTERFLY RASH,2
FR,C-REACTIVE PROTEIN INCREASED,2
FR,CAMPYLOBACTER GASTROENTERITIS,2
FR,CARTILAGE INJURY,2
FR,CELL DEATH,2
FR,CELLULITIS,2
FR,CENTRAL NERVOUS SYSTEM LESION,2
FR,CEREBRAL HAEMORRHAGE,2
FR,CEREBRAL INFARCTION,2
FR,CERVICOBRACHIAL SYNDROME,2
FR,CESTODE INFECTION,2
FR,CHEST DISCOMFORT,2
FR,CHILLBLAINS,2
FR,CHOKING SENSATION,2
FR,CHOLANGIOCARCINOMA,2
FR,CHOLELITHIASIS,2
FR,CHOLELITHIASIS OBSTRUCTIVE,2
FR,CHORIORETINITIS,2
FR,CHRONIC PIGMENTED PURPURA,2
FR,CHRONIC SINUSITIS,2
FR,CLOSTRIDIUM DIFFICILE COLITIS,2
FR,COLON CANCER METASTATIC,2
FR,COLORECTAL CANCER,2
FR,COMA,2
FR,COMA SCALE ABNORMAL,2
FR,CONGENITAL EYE DISORDER,2
FR,CORONARY ARTERY OCCLUSION,2
FR,CRYOGLOBULINAEMIA,2
FR,CUTANEOUS VASCULITIS,2
FR,CYTOMEGALOVIRUS COLITIS,2
FR,DEAFNESS BILATERAL,2
FR,DELUSION,2
FR,DEMENTIA ALZHEIMER^S TYPE,2
FR,DEPERSONALISATION/DEREALISATION DISORDER,2
FR,DEPRESSED MOOD,2
FR,DERMATITIS PSORIASIFORM,2
FR,DIVERTICULUM,2
FR,DRUG ERUPTION,2
FR,DYSAESTHESIA,2
FR,DYSPEPSIA,2
FR,DYSPHONIA,2
FR,DYSPNOEA EXERTIONAL,2
FR,DYSSTASIA,2
FR,ENDOCARDITIS NONINFECTIVE,2
FR,ENDOCARDITIS STAPHYLOCOCCAL,2
FR,ENDOMETRIAL CANCER,2
FR,EPILEPSY,2
FR,ESCHERICHIA INFECTION,2
FR,EXTRAMAMMARY PAGET^S DISEASE,2
FR,EYE DISORDER,2
FR,EYELID OEDEMA,2
FR,FEMUR FRACTURE,2
FR,FOETAL GROWTH RESTRICTION,2
FR,FOOD INTOLERANCE,2
FR,FRACTURE,2
FR,FUNCTIONAL GASTROINTESTINAL DISORDER,2
FR,GASTRITIS EROSIVE,2
FR,GENITAL ULCERATION,2
FR,GLAUCOMA,2
FR,GRANULOMA,2
FR,GRANULOMATOSIS WITH POLYANGIITIS,2
FR,GROIN ABSCESS,2
FR,HAEMOGLOBIN DECREASED,2
FR,HAEMORRHOIDS,2
FR,HALLUCINATION,2
FR,HELICOBACTER INFECTION,2
FR,HEPATIC LESION,2
FR,HEPATOMEGALY,2
FR,HERPES SIMPLEX,2
FR,HERPES VIRUS INFECTION,2
FR,HIDRADENITIS,2
FR,HILAR LYMPHADENOPATHY,2
FR,HODGKIN^S DISEASE MIXED CELLULARITY STAGE UNSPECIFIED,2
FR,HODGKIN^S DISEASE NODULAR SCLEROSIS,2
FR,HYDRONEPHROSIS,2
FR,HYPERSEXUALITY,2
FR,HYPERTHERMIA MALIGNANT,2
FR,HYPOGAMMAGLOBULINAEMIA,2
FR,HYPOREFLEXIA,2
FR,IGA NEPHROPATHY,2
FR,IMMUNODEFICIENCY,2
FR,INCORRECT DOSE ADMINISTERED,2
FR,INFARCTION,2
FR,INGUINAL HERNIA,2
FR,INJECTION RELATED REACTION,2
FR,INJECTION SITE HAEMORRHAGE,2
FR,INJECTION SITE PAPULE,2
FR,INJECTION SITE RASH,2
FR,INJECTION SITE RECALL REACTION,2
FR,INTENTIONAL PRODUCT MISUSE,2
FR,INTERMEDIATE UVEITIS,2
FR,INTERVERTEBRAL DISC PROTRUSION,2
FR,IVTH NERVE PARALYSIS,2
FR,JAUNDICE,2
FR,JOINT ANKYLOSIS,2
FR,JOINT INJURY,2
FR,JUGULAR VEIN THROMBOSIS,2
FR,KAPOSI^S SARCOMA,2
FR,KERATITIS,2
FR,LARYNGEAL DISCOMFORT,2
FR,LARYNGITIS,2
FR,LATENT TUBERCULOSIS,2
FR,LIVEDO RETICULARIS,2
FR,LOCAL SWELLING,2
FR,LUNG ABSCESS,2
FR,LUNG CANCER METASTATIC,2
FR,LYMPHOCYTOSIS,2
FR,MASS,2
FR,MASTICATION DISORDER,2
FR,MATERNAL EXPOSURE DURING PREGNANCY,2
FR,MEDIASTINITIS,2
FR,MEDULLARY THYROID CANCER,2
FR,MENINGIOMA,2
FR,MENINGITIS,2
FR,MENINGITIS STAPHYLOCOCCAL,2
FR,MENTAL DISORDER,2
FR,METABOLIC ACIDOSIS,2
FR,METASTASES TO SPINE,2
FR,METASTATIC BRONCHIAL CARCINOMA,2
FR,MICROCYTIC ANAEMIA,2
FR,MORPHOEA,2
FR,MOUTH ULCERATION,2
FR,MUCOSAL EROSION,2
FR,MUSCULOSKELETAL CHEST PAIN,2
FR,MYCOBACTERIAL INFECTION,2
FR,MYELITIS TRANSVERSE,2
FR,NASAL POLYPS,2
FR,NEPHROTIC SYNDROME,2
FR,NERVOUS SYSTEM DISORDER,2
FR,NEURODEGENERATIVE DISORDER,2
FR,NEURODERMATITIS,2
FR,NEUTROPHIL COUNT INCREASED,2
FR,NON-SMALL CELL LUNG CANCER,2
FR,NYSTAGMUS,2
FR,OBESITY,2
FR,OCULAR HYPERAEMIA,2
FR,OCULAR MYASTHENIA,2
FR,ODYNOPHAGIA,2
FR,OESOPHAGEAL CARCINOMA,2
FR,OESOPHAGEAL PAIN,2
FR,OESOPHAGITIS,2
FR,OPHTHALMIC HERPES ZOSTER,2
FR,OPHTHALMOPLEGIA,2
FR,ORAL CANDIDIASIS,2
FR,ORAL HERPES,2
FR,ORCHITIS,2
FR,OSTEOMYELITIS,2
FR,OSTEONECROSIS,2
FR,OSTEOPOROTIC FRACTURE,2
FR,OXYGEN SATURATION DECREASED,2
FR,PAPILLARY RENAL CELL CARCINOMA,2
FR,PAPILLOEDEMA,2
FR,PARAESTHESIA ORAL,2
FR,PARONYCHIA,2
FR,PELVIC FRACTURE,2
FR,PERICARDIAL EFFUSION,2
FR,PERIORBITAL OEDEMA,2
FR,PERIPHERAL NERVE INJURY,2
FR,PERIPHERAL SWELLING,2
FR,PERIPHLEBITIS,2
FR,PHARYNGEAL OEDEMA,2
FR,PNEUMONIA HAEMOPHILUS,2
FR,PNEUMONIA KLEBSIELLA,2
FR,PNEUMOTHORAX,2
FR,POLYARTERITIS NODOSA,2
FR,POLYP,2
FR,PORTAL HYPERTENSION,2
FR,PREMATURE DELIVERY,2
FR,PROSTATITIS,2
FR,PRURITUS GENERALISED,2
FR,PSOAS ABSCESS,2
FR,PSYCHIATRIC SYMPTOM,2
FR,PULMONARY ARTERIAL HYPERTENSION,2
FR,PULMONARY GRANULOMA,2
FR,PYELONEPHRITIS ACUTE,2
FR,PYOGENIC GRANULOMA,2
FR,RASH PRURITIC,2
FR,RAYNAUD^S PHENOMENON,2
FR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
FR,REITER^S SYNDROME,2
FR,RENAL CELL CARCINOMA,2
FR,RENAL TUBULAR DISORDER,2
FR,RESPIRATORY ARREST,2
FR,RETROPERITONEAL LYMPHADENOPATHY,2
FR,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,2
FR,ROAD TRAFFIC ACCIDENT,2
FR,ROTATOR CUFF SYNDROME,2
FR,RUPTURED CEREBRAL ANEURYSM,2
FR,SARCOMA,2
FR,SARCOMA OF SKIN,2
FR,SCIATICA,2
FR,SEIZURE,2
FR,SENSORY LOSS,2
FR,SERUM SICKNESS,2
FR,SEXUAL DYSFUNCTION,2
FR,SINUS DISORDER,2
FR,SKIN NEOPLASM EXCISION,2
FR,SOFT TISSUE INFECTION,2
FR,SPEECH DISORDER,2
FR,SPLENOMEGALY,2
FR,SPONDYLITIS,2
FR,SQUAMOUS CELL CARCINOMA OF LUNG,2
FR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,2
FR,SQUAMOUS CELL CARCINOMA OF THE TONGUE,2
FR,STAPHYLOCOCCAL SEPSIS,2
FR,STERNAL FRACTURE,2
FR,STRESS,2
FR,SUBARACHNOID HAEMORRHAGE,2
FR,SUDDEN HEARING LOSS,2
FR,SUPERFICIAL SPREADING MELANOMA STAGE I,2
FR,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,2
FR,SUPERINFECTION,2
FR,TESTICULAR SEMINOMA (PURE) STAGE I,2
FR,THROMBOSIS,2
FR,THYROID CANCER,2
FR,THYROID NEOPLASM,2
FR,TONGUE OEDEMA,2
FR,TRANSITIONAL CELL CARCINOMA,2
FR,TRANSITIONAL CELL CARCINOMA URETHRA,2
FR,TRAUMATIC HAEMATOMA,2
FR,ULCERATIVE KERATITIS,2
FR,URETHRAL POLYP,2
FR,URINARY RETENTION,2
FR,UROSEPSIS,2
FR,VARICES OESOPHAGEAL,2
FR,VASCULAR COMPLICATION ASSOCIATED WITH DEVICE,2
FR,VENOUS THROMBOSIS LIMB,2
FR,VENTRICULAR FIBRILLATION,2
FR,VITAMIN B12 DEFICIENCY,2
FR,VITREOUS HAEMORRHAGE,2
FR,VULVAL ULCERATION,2
FR,WHEEZING,2
FR,WHITE MATTER LESION,2
FR,WOUND,2
FR,5-HYDROXYINDOLACETIC ACID INCREASED,1
FR,ABDOMINAL ABSCESS,1
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL HERNIA OBSTRUCTIVE,1
FR,ABNORMAL DREAMS,1
FR,ABSCESS BACTERIAL,1
FR,ABSCESS INTESTINAL,1
FR,ABSCESS LIMB,1
FR,ACNE,1
FR,ACQUIRED HAEMOPHILIA,1
FR,ACTINOMYCOSIS,1
FR,ACTINOMYCOTIC PULMONARY INFECTION,1
FR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
FR,ACUTE LEUKAEMIA,1
FR,ACUTE POLYNEUROPATHY,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ACUTE VESTIBULAR SYNDROME,1
FR,ADENOCARCINOMA OF THE CERVIX,1
FR,ADRENAL NEOPLASM,1
FR,AESTHESIONEUROBLASTOMA,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,ALLERGIC OTITIS MEDIA,1
FR,ALLERGIC SINUSITIS,1
FR,ALOPECIA AREATA,1
FR,ALOPECIA TOTALIS,1
FR,ALOPECIA UNIVERSALIS,1
FR,ALVEOLITIS ALLERGIC,1
FR,AMAUROSIS,1
FR,AMAUROSIS FUGAX,1
FR,AMYOTROPHIC LATERAL SCLEROSIS,1
FR,AMYOTROPHY,1
FR,ANAEMIA MACROCYTIC,1
FR,ANAESTHESIA,1
FR,ANAL ABSCESS,1
FR,ANAL CANCER,1
FR,ANAL FISTULA,1
FR,ANAL HAEMORRHAGE,1
FR,ANAL SPHINCTER ATONY,1
FR,ANAL ULCER,1
FR,ANAPHYLACTIC REACTION,1
FR,ANAPHYLACTIC SHOCK,1
FR,ANDROGENETIC ALOPECIA,1
FR,ANGIOPATHY,1
FR,ANOGENITAL WARTS,1
FR,ANORECTAL DISORDER,1
FR,ANTI FACTOR VIII ANTIBODY TEST,1
FR,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
FR,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
FR,ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE,1
FR,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
FR,ANTINUCLEAR ANTIBODY,1
FR,ANURIA,1
FR,AORTIC VALVE DISEASE,1
FR,APHAGIA,1
FR,APHTHOUS STOMATITIS,1
FR,APHTHOUS ULCER,1
FR,APICAL GRANULOMA,1
FR,APLASTIC ANAEMIA,1
FR,APPENDIX DISORDER,1
FR,APPLICATION SITE ERYTHEMA,1
FR,APRAXIA,1
FR,ARTERIOSCLEROSIS,1
FR,ARTERIOSCLEROSIS CORONARY ARTERY,1
FR,ARTERIOSPASM CORONARY,1
FR,ARTHRODESIS,1
FR,ARTICULAR CALCIFICATION,1
FR,ASTHENOSPERMIA,1
FR,ATRIAL SEPTAL DEFECT,1
FR,ATYPICAL MYCOBACTERIAL INFECTION,1
FR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
FR,AUTOIMMUNE HEPATITIS,1
FR,AUTONOMIC NEUROPATHY,1
FR,AZOOSPERMIA,1
FR,BARRETT^S OESOPHAGUS,1
FR,BENCE JONES PROTEINURIA,1
FR,BENIGN RENAL NEOPLASM,1
FR,BETA 2 MICROGLOBULIN INCREASED,1
FR,BITE,1
FR,BLADDER CANCER STAGE IV,1
FR,BLADDER DYSFUNCTION,1
FR,BLADDER TRANSITIONAL CELL CARCINOMA,1
FR,BLEEDING VARICOSE VEIN,1
FR,BLEPHARITIS,1
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FR,BLOOD BILIRUBIN INCREASED,1
FR,BLOOD CREATINE ABNORMAL,1
FR,BLOOD DISORDER,1
FR,BLOOD PRESSURE INCREASED,1
FR,BONE DENSITY DECREASED,1
FR,BONE FISSURE,1
FR,BONE LESION,1
FR,BOWEN^S DISEASE,1
FR,BRADYCARDIA FOETAL,1
FR,BRAIN ABSCESS,1
FR,BRAIN COMPRESSION,1
FR,BRAIN MASS,1
FR,BREAST CANCER RECURRENT,1
FR,BREAST NECROSIS,1
FR,BREATH SOUNDS ABSENT,1
FR,BRONCHIOLITIS,1
FR,BRONCHITIS BACTERIAL,1
FR,BRONCHITIS FUNGAL,1
FR,BRONCHITIS VIRAL,1
FR,BRONCHOPULMONARY ASPERGILLOSIS,1
FR,BRONCHOSPASM,1
FR,BUNDLE BRANCH BLOCK RIGHT,1
FR,BURNOUT SYNDROME,1
FR,BURSITIS INFECTIVE STAPHYLOCOCCAL,1
FR,CAESAREAN SECTION,1
FR,CALLUS FORMATION DELAYED,1
FR,CARCINOID TUMOUR PULMONARY,1
FR,CARDIAC ANEURYSM,1
FR,CARDIAC DISCOMFORT,1
FR,CARDIAC FAILURE ACUTE,1
FR,CARDIAC GRANULOMA,1
FR,CARDIOMYOPATHY,1
FR,CARDIOMYOPATHY ACUTE,1
FR,CARDIOPULMONARY FAILURE,1
FR,CAROTID ARTERY OCCLUSION,1
FR,CATARACT CONGENITAL,1
FR,CELLULITIS STAPHYLOCOCCAL,1
FR,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
FR,CEREBRAL ATROPHY,1
FR,CEREBRAL ISCHAEMIA,1
FR,CEREBRAL SARCOIDOSIS,1
FR,CEREBRAL TOXOPLASMOSIS,1
FR,CERUMEN IMPACTION,1
FR,CERVICAL DYSPLASIA,1
FR,CERVIX CARCINOMA,1
FR,CERVIX NEOPLASM,1
FR,CHEST X-RAY ABNORMAL,1
FR,CHOLANGITIS,1
FR,CHOLANGITIS ACUTE,1
FR,CHOLECYSTITIS CHRONIC,1
FR,CHOLESTATIC LIVER INJURY,1
FR,CHONDRITIS,1
FR,CHROMATOPSIA,1
FR,CHROMATURIA,1
FR,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,1
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FR,CIRCULATORY COLLAPSE,1
FR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
FR,CLONUS,1
FR,COAGULATION FACTOR DECREASED,1
FR,COAGULATION FACTOR VIII LEVEL INCREASED,1
FR,COELIAC DISEASE,1
FR,COLD SWEAT,1
FR,COLECTOMY,1
FR,COLITIS EROSIVE,1
FR,COLITIS MICROSCOPIC,1
FR,COLON ADENOMA,1
FR,COLON CANCER STAGE II,1
FR,COLORECTAL ADENOCARCINOMA,1
FR,CONJUNCTIVAL DISORDER,1
FR,CONTUSION,1
FR,CORNEAL OEDEMA,1
FR,CORNEAL PERFORATION,1
FR,CORONARY ARTERY DISEASE,1
FR,COSTOCHONDRITIS,1
FR,CRYPTOCOCCOSIS,1
FR,CSF PROTEIN INCREASED,1
FR,CSF TEST ABNORMAL,1
FR,CUTANEOUS CALCIFICATION,1
FR,CYANOSIS,1
FR,CYSTITIS ESCHERICHIA,1
FR,CYTOMEGALOVIRUS TEST POSITIVE,1
FR,CYTOPENIA,1
FR,DACRYOCYSTITIS,1
FR,DEAFNESS,1
FR,DECREASED IMMUNE RESPONSIVENESS,1
FR,DECUBITUS ULCER,1
FR,DEMYELINATING POLYNEUROPATHY,1
FR,DENTAL CARE,1
FR,DENTAL CYST,1
FR,DENTAL NECROSIS,1
FR,DEPILATION,1
FR,DERMAL CYST,1
FR,DERMATITIS,1
FR,DERMATITIS EXFOLIATIVE,1
FR,DERMATOFIBROSARCOMA PROTUBERANS,1
FR,DERMATOMYOSITIS,1
FR,DEVICE RELATED SEPSIS,1
FR,DIABETIC HYPEROSMOLAR COMA,1
FR,DIABETIC KETOACIDOSIS,1
FR,DIAPHRAGM NEOPLASM,1
FR,DISEASE COMPLICATION,1
FR,DISORIENTATION,1
FR,DISSEMINATED INTRAVASCULAR COAGULATION,1
FR,DIVERTICULUM GASTRIC,1
FR,DIVERTICULUM INTESTINAL,1
FR,DIVERTICULUM OESOPHAGEAL,1
FR,DRUG ADMINISTRATION ERROR,1
FR,DRUG DEPENDENCE,1
FR,DRUG DISPENSING ERROR,1
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
FR,DRUG SPECIFIC ANTIBODY PRESENT,1
FR,DRY MOUTH,1
FR,DUPUYTREN^S CONTRACTURE,1
FR,DYSGLOBULINAEMIA,1
FR,DYSGRAPHIA,1
FR,DYSTHYMIC DISORDER,1
FR,EAR DISORDER,1
FR,EAR HAEMORRHAGE,1
FR,EAR PAIN,1
FR,ECCHYMOSIS,1
FR,ECTHYMA,1
FR,ECZEMA NUMMULAR,1
FR,EMBOLISM,1
FR,ENDOCARDITIS ENTEROCOCCAL,1
FR,ENERGY INCREASED,1
FR,ENTEROBACTER INFECTION,1
FR,ENTEROBACTER TEST POSITIVE,1
FR,ENTEROVIRUS INFECTION,1
FR,EOSINOPHIL COUNT INCREASED,1
FR,EPIDURITIS,1
FR,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,1
FR,ERUCTATION,1
FR,ERYTHEMA ANNULARE,1
FR,ERYTHEMA MIGRANS,1
FR,ERYTHRODERMIC PSORIASIS,1
FR,ESCHERICHIA SEPSIS,1
FR,EXECUTIVE DYSFUNCTION,1
FR,EXOMPHALOS,1
FR,EXPOSURE DURING BREAST FEEDING,1
FR,EXPOSURE VIA DIRECT CONTACT,1
FR,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
FR,EXTRAPYRAMIDAL DISORDER,1
FR,EXTRASYSTOLES,1
FR,EXTREMITY NECROSIS,1
FR,EYE HAEMORRHAGE,1
FR,EYE INFLAMMATION,1
FR,FACIAL PARALYSIS,1
FR,FAT EMBOLISM,1
FR,FIBROMA,1
FR,FINGER DEFORMITY,1
FR,FLUSHING,1
FR,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
FR,FOETAL DISTRESS SYNDROME,1
FR,FOLLICULITIS,1
FR,FOOT DEFORMITY,1
FR,FRACTURED SACRUM,1
FR,FULL BLOOD COUNT ABNORMAL,1
FR,GALLBLADDER OEDEMA,1
FR,GASTRIC CANCER,1
FR,GASTRIC DISORDER,1
FR,GASTRIC POLYPS,1
FR,GASTRIC ULCER,1
FR,GASTRITIS HAEMORRHAGIC,1
FR,GASTROENTERITIS VIRAL,1
FR,GASTROINTESTINAL FUNGAL INFECTION,1
FR,GASTROINTESTINAL NEOPLASM,1
FR,GASTROINTESTINAL PAIN,1
FR,GASTROOESOPHAGEAL REFLUX DISEASE,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENERALISED OEDEMA,1
FR,GENERALISED TONIC-CLONIC SEIZURE,1
FR,GENITOURINARY TRACT INFECTION,1
FR,GOITRE,1
FR,GONORRHOEA,1
FR,GOUT,1
FR,GRANULOMATOUS LIVER DISEASE,1
FR,GROIN PAIN,1
GM,DRUG DOSE OMISSION,1
GM,PSORIATIC ARTHROPATHY,1
GE,ANAEMIA,1
GE,GASTROINTESTINAL HAEMORRHAGE,1
GE,INFUSION RELATED REACTION,1
GE,LEUKOPENIA,1
GE,LUPUS-LIKE SYNDROME,1
GE,NEPHROPATHY TOXIC,1
GE,PANCYTOPENIA,1
GE,PNEUMONIA,1
GE,UPPER RESPIRATORY TRACT INFECTION,1
DE,RHEUMATOID ARTHRITIS,217
DE,CONDITION AGGRAVATED,134
DE,DRUG INEFFECTIVE,123
DE,ARTHROPATHY,80
DE,DYSPNOEA,75
DE,PNEUMONIA,63
DE,PAIN,59
DE,ARTHRALGIA,52
DE,NASOPHARYNGITIS,50
DE,FALL,47
DE,DEATH,46
DE,MYOCARDIAL INFARCTION,45
DE,FATIGUE,40
DE,DRUG EFFECT INCOMPLETE,38
DE,PSORIASIS,38
DE,PYREXIA,37
DE,PRURITUS,36
DE,BRONCHITIS,33
DE,NAUSEA,33
DE,PSORIATIC ARTHROPATHY,33
DE,PAIN IN EXTREMITY,32
DE,COUGH,31
DE,DRUG EFFECT DECREASED,31
DE,INJECTION SITE ERYTHEMA,31
DE,CEREBROVASCULAR ACCIDENT,30
DE,OSTEOARTHRITIS,30
DE,RHEUMATIC DISORDER,30
DE,IMPAIRED HEALING,29
DE,INFECTION,29
DE,INJECTION SITE REACTION,29
DE,JOINT SWELLING,28
DE,DIZZINESS,27
DE,ERYTHEMA,27
DE,INFLAMMATION,26
DE,RASH,26
DE,DIARRHOEA,25
DE,ASTHENIA,23
DE,HEADACHE,23
DE,CARDIAC DISORDER,22
DE,INFLUENZA,21
DE,PERIPHERAL SWELLING,21
DE,PRODUCT USE ISSUE,21
DE,IRITIS,20
DE,RENAL FAILURE,19
DE,SEPSIS,19
DE,HYPOAESTHESIA,18
DE,INFECTION SUSCEPTIBILITY INCREASED,18
DE,CATARACT,17
DE,GAIT DISTURBANCE,17
DE,OEDEMA PERIPHERAL,17
DE,URINARY TRACT INFECTION,17
DE,VOMITING,17
DE,ABDOMINAL PAIN UPPER,16
DE,ARTHRITIS,16
DE,BACK PAIN,16
DE,DEPRESSION,16
DE,DRUG INTOLERANCE,16
DE,HYPERTENSION,16
DE,INTERVERTEBRAL DISC PROTRUSION,16
DE,LIVER FUNCTION TEST ABNORMAL,16
DE,POLYNEUROPATHY,16
DE,RESPIRATORY TRACT INFECTION,16
DE,ARRHYTHMIA,15
DE,ATRIAL FIBRILLATION,15
DE,CYSTITIS,15
DE,DIVERTICULITIS,15
DE,INJECTION SITE PAIN,15
DE,INJECTION SITE PRURITUS,15
DE,LUNG DISORDER,15
DE,NEPHROLITHIASIS,15
DE,PANCREATITIS,15
DE,PLEURAL EFFUSION,15
DE,TOOTH DISORDER,15
DE,ACUTE KIDNEY INJURY,14
DE,ANKYLOSING SPONDYLITIS,14
DE,BREAST CANCER,14
DE,FOOT DEFORMITY,14
DE,HERPES ZOSTER,14
DE,HYPERHIDROSIS,14
DE,INFLAMMATORY MARKER INCREASED,14
DE,MALAISE,14
DE,MOBILITY DECREASED,14
DE,NEPHRITIS,14
DE,PARAESTHESIA,14
DE,PULMONARY EMBOLISM,14
DE,PULMONARY FIBROSIS,14
DE,SPINAL DISORDER,14
DE,WEIGHT DECREASED,14
DE,WEIGHT INCREASED,14
DE,BASAL CELL CARCINOMA,13
DE,CARDIAC FAILURE,13
DE,CHILLS,13
DE,ESCHERICHIA INFECTION,13
DE,GLAUCOMA,13
DE,JUVENILE IDIOPATHIC ARTHRITIS,13
DE,MUSCULOSKELETAL DISORDER,13
DE,SWELLING FACE,13
DE,ALOPECIA,12
DE,BREAST CANCER FEMALE,12
DE,BRONCHIAL CARCINOMA,12
DE,CHOLELITHIASIS,12
DE,GENERAL PHYSICAL HEALTH DETERIORATION,12
DE,MALIGNANT MELANOMA,12
DE,MUSCULOSKELETAL STIFFNESS,12
DE,MYALGIA,12
DE,RESPIRATORY FAILURE,12
DE,VISUAL IMPAIRMENT,12
DE,ANGINA PECTORIS,11
DE,ARTHRITIS INFECTIVE,11
DE,BLOOD TEST ABNORMAL,11
DE,C-REACTIVE PROTEIN INCREASED,11
DE,CARPAL TUNNEL SYNDROME,11
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,11
DE,DISEASE RECURRENCE,11
DE,HAEMATOMA,11
DE,HEPATIC CIRRHOSIS,11
DE,HEPATIC ENZYME INCREASED,11
DE,JOINT INJURY,11
DE,LOSS OF CONSCIOUSNESS,11
DE,MENTAL DISORDER,11
DE,MUSCULOSKELETAL PAIN,11
DE,BLOOD PRESSURE INCREASED,10
DE,CARDIOVASCULAR DISORDER,10
DE,CHOLECYSTITIS,10
DE,DEHYDRATION,10
DE,DISCOMFORT,10
DE,FOETAL EXPOSURE DURING PREGNANCY,10
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
DE,GASTRITIS,10
DE,HYPERSENSITIVITY,10
DE,KERATOACANTHOMA,10
DE,LOCAL SWELLING,10
DE,MUSCULAR WEAKNESS,10
DE,OSTEONECROSIS,10
DE,PANCYTOPENIA,10
DE,RASH GENERALISED,10
DE,RENAL CELL CARCINOMA,10
DE,RHEUMATOID NODULE,10
DE,SKIN REACTION,10
DE,SPINAL FRACTURE,10
DE,BLOOD GLUCOSE INCREASED,9
DE,CHEST DISCOMFORT,9
DE,ENDOCARDITIS,9
DE,ERYSIPELAS,9
DE,GASTROENTERITIS,9
DE,GASTROINTESTINAL DISORDER,9
DE,HAEMOGLOBIN DECREASED,9
DE,HAEMORRHAGE,9
DE,INFLUENZA LIKE ILLNESS,9
DE,LOWER LIMB FRACTURE,9
DE,LYMPHADENOPATHY,9
DE,MITRAL VALVE INCOMPETENCE,9
DE,PRURITUS GENERALISED,9
DE,SKIN ULCER,9
DE,TONSILLITIS,9
DE,UPPER LIMB FRACTURE,9
DE,URTICARIA,9
DE,CIRCULATORY COLLAPSE,8
DE,CROHN^S DISEASE,8
DE,CYST,8
DE,DISEASE PROGRESSION,8
DE,DRUG HYPERSENSITIVITY,8
DE,HYPERTENSIVE CRISIS,8
DE,IRIDOCYCLITIS,8
DE,MATERNAL EXPOSURE DURING PREGNANCY,8
DE,PERICARDIAL EFFUSION,8
DE,PULMONARY OEDEMA,8
DE,RENAL FAILURE ACUTE,8
DE,RENAL FUNCTION TEST ABNORMAL,8
DE,SEPTIC SHOCK,8
DE,SUICIDE ATTEMPT,8
DE,SYNCOPE,8
DE,THROMBOCYTOPENIA,8
DE,TINNITUS,8
DE,ABORTION SPONTANEOUS,7
DE,ABSCESS,7
DE,ANKLE FRACTURE,7
DE,BORRELIA INFECTION,7
DE,BURSITIS,7
DE,CHEST PAIN,7
DE,CONGESTIVE CARDIOMYOPATHY,7
DE,EYE DISORDER,7
DE,GALLBLADDER DISORDER,7
DE,GASTRIC ULCER,7
DE,GOITRE,7
DE,INJECTION SITE SWELLING,7
DE,INJECTION SITE WARMTH,7
DE,INTERSTITIAL LUNG DISEASE,7
DE,INTERVERTEBRAL DISC DISORDER,7
DE,JOINT EFFUSION,7
DE,LEUKAEMIA,7
DE,LEUKOPENIA,7
DE,LIPASE INCREASED,7
DE,LIVER DISORDER,7
DE,METASTASES TO LYMPH NODES,7
DE,MUSCLE SPASMS,7
DE,OROPHARYNGEAL PAIN,7
DE,PALPITATIONS,7
DE,SEIZURE,7
DE,SENSITIVITY TO WEATHER CHANGE,7
DE,SKIN DISORDER,7
DE,SQUAMOUS CELL CARCINOMA,7
DE,THROMBOSIS,7
DE,TUBERCULOSIS,7
DE,VISUAL ACUITY REDUCED,7
DE,WHITE BLOOD CELL COUNT INCREASED,7
DE,WOUND INFECTION,7
DE,ABASIA,6
DE,ABDOMINAL DISTENSION,6
DE,ABDOMINAL PAIN,6
DE,ACCIDENT,6
DE,ACUTE MYOCARDIAL INFARCTION,6
DE,ANAEMIA,6
DE,ARTERIOSCLEROSIS,6
DE,ARTHROPOD BITE,6
DE,ASPARTATE AMINOTRANSFERASE INCREASED,6
DE,ASTHMA,6
DE,B-CELL LYMPHOMA,6
DE,BACK DISORDER,6
DE,BOWEN^S DISEASE,6
DE,BRONCHOPNEUMONIA,6
DE,COLITIS,6
DE,COMA,6
DE,CORONARY ARTERY DISEASE,6
DE,DECREASED APPETITE,6
DE,DERMATITIS ALLERGIC,6
DE,DRUG-INDUCED LIVER INJURY,6
DE,DRY SKIN,6
DE,EYE INFLAMMATION,6
DE,FLUID RETENTION,6
DE,LIMB DISCOMFORT,6
DE,LUNG NEOPLASM MALIGNANT,6
DE,MALIGNANT MELANOMA STAGE I,6
DE,MULTI-ORGAN FAILURE,6
DE,MULTIPLE SCLEROSIS,6
DE,NON-HODGKIN^S LYMPHOMA,6
DE,OSTEOMYELITIS,6
DE,OVARIAN CANCER,6
DE,PNEUMONIA ASPIRATION,6
DE,PROSTATE CANCER,6
DE,PULMONARY HYPERTENSION,6
DE,PYELONEPHRITIS,6
DE,PYODERMA GANGRENOSUM,6
DE,RENAL CANCER,6
DE,RENAL DISORDER,6
DE,RIB FRACTURE,6
DE,ROAD TRAFFIC ACCIDENT,6
DE,SINUSITIS,6
DE,SUBCUTANEOUS ABSCESS,6
DE,SWELLING,6
DE,TOXICITY TO VARIOUS AGENTS,6
DE,VIRAL INFECTION,6
DE,WHIPPLE^S DISEASE,6
DE,WOUND,6
DE,ACNE,5
DE,ALANINE AMINOTRANSFERASE INCREASED,5
DE,BALANCE DISORDER,5
DE,BLOOD CHOLESTEROL INCREASED,5
DE,BLOOD CREATININE INCREASED,5
DE,CONTUSION,5
DE,DECREASED IMMUNE RESPONSIVENESS,5
DE,DEEP VEIN THROMBOSIS,5
DE,DEMYELINATION,5
DE,DIFFUSE LARGE B-CELL LYMPHOMA,5
DE,EXPOSURE VIA FATHER,5
DE,FEBRILE INFECTION,5
DE,FEMUR FRACTURE,5
DE,FOOT FRACTURE,5
DE,FRACTURE,5
DE,FUNGAL INFECTION,5
DE,GOUT,5
DE,HAEMATOCHEZIA,5
DE,HEPATIC FAILURE,5
DE,HEPATIC STEATOSIS,5
DE,HISTIOCYTOSIS HAEMATOPHAGIC,5
DE,HYPERKERATOSIS,5
DE,HYPOACUSIS,5
DE,INGUINAL HERNIA,5
DE,INVASIVE DUCTAL BREAST CARCINOMA,5
DE,JOINT STIFFNESS,5
DE,LABORATORY TEST ABNORMAL,5
DE,LEUKOCYTOSIS,5
DE,LUNG INFILTRATION,5
DE,MALIGNANT NEOPLASM OF CONJUNCTIVA,5
DE,METASTASES TO BONE,5
DE,METASTASES TO LUNG,5
DE,MYELODYSPLASTIC SYNDROME,5
DE,NEOPLASM MALIGNANT,5
DE,NERVOUS SYSTEM DISORDER,5
DE,OTITIS MEDIA,5
DE,PALLOR,5
DE,PANCREATIC CARCINOMA,5
DE,PHARYNGEAL OEDEMA,5
DE,PLEURISY,5
DE,PNEUMOTHORAX,5
DE,PREMATURE BABY,5
DE,PRODUCT QUALITY ISSUE,5
DE,RASH PRURITIC,5
DE,RASH PUSTULAR,5
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
DE,RETINAL DETACHMENT,5
DE,SKIN CANCER,5
DE,SPINAL PAIN,5
DE,STAPHYLOCOCCAL SEPSIS,5
DE,STRESS,5
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,5
DE,TACHYCARDIA,5
DE,TENDON RUPTURE,5
DE,THERAPY NON-RESPONDER,5
DE,TRANSAMINASES INCREASED,5
DE,TREMOR,5
DE,UROSEPSIS,5
DE,UVEITIS,5
DE,VERTIGO,5
DE,VIRAL UPPER RESPIRATORY TRACT INFECTION,5
DE,ALVEOLITIS,4
DE,ANAPHYLACTIC REACTION,4
DE,ANXIETY,4
DE,ATRIAL SEPTAL DEFECT,4
DE,ATROPHY,4
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,4
DE,BONE PAIN,4
DE,BUNDLE BRANCH BLOCK RIGHT,4
DE,CERVICAL DYSPLASIA,4
DE,CERVIX CARCINOMA STAGE 0,4
DE,COLON CANCER,4
DE,CONGENITAL CYSTIC LUNG,4
DE,CORONARY ARTERY STENOSIS,4
DE,CYSTITIS NONINFECTIVE,4
DE,DIABETES MELLITUS,4
DE,DIABETIC FOOT,4
DE,DYSPNOEA EXERTIONAL,4
DE,EMPYEMA,4
DE,ENTEROCOCCAL SEPSIS,4
DE,EPENDYMOMA MALIGNANT,4
DE,EPISTAXIS,4
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,4
DE,ESCHERICHIA URINARY TRACT INFECTION,4
DE,EYE HAEMORRHAGE,4
DE,FIBROMYALGIA,4
DE,GLOMERULAR FILTRATION RATE DECREASED,4
DE,HAEMORRHOIDS,4
DE,HAND FRACTURE,4
DE,HEPATIC CYST,4
DE,HEPATITIS,4
DE,HERPES VIRUS INFECTION,4
DE,HODGKIN^S DISEASE,4
DE,HOT FLUSH,4
DE,ILEUS PARALYTIC,4
DE,IMMUNE SYSTEM DISORDER,4
DE,IMMUNODEFICIENCY,4
DE,IMMUNOSUPPRESSION,4
DE,INSOMNIA,4
DE,INTESTINAL HAEMORRHAGE,4
DE,INTRAOCULAR PRESSURE INCREASED,4
DE,LEFT VENTRICULAR FAILURE,4
DE,LUMBAR SPINAL STENOSIS,4
DE,LUMBAR VERTEBRAL FRACTURE,4
DE,LUNG INFECTION,4
DE,LYMPHOMA,4
DE,MENISCUS INJURY,4
DE,MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION,4
DE,METASTASES TO ADRENALS,4
DE,METASTASES TO KIDNEY,4
DE,METASTASES TO LIVER,4
DE,METASTASES TO MENINGES,4
DE,METASTATIC BRONCHIAL CARCINOMA,4
DE,MUCOSAL INFLAMMATION,4
DE,NECK PAIN,4
DE,NEUTROPENIA,4
DE,NIGHT SWEATS,4
DE,NOSOCOMIAL INFECTION,4
DE,OEDEMA,4
DE,OPTIC NEURITIS,4
DE,PATENT DUCTUS ARTERIOSUS,4
DE,PHOTOPHOBIA,4
DE,PILONIDAL CYST,4
DE,PNEUMONITIS,4
DE,POISONING,4
DE,POLYARTHRITIS,4
DE,POST PROCEDURAL HAEMORRHAGE,4
DE,PRODUCT USE IN UNAPPROVED INDICATION,4
DE,PSOAS ABSCESS,4
DE,PURULENCE,4
DE,QUADRIPLEGIA,4
DE,RESPIRATORY DISTRESS,4
DE,ROTATOR CUFF SYNDROME,4
DE,SCAR,4
DE,SCLERAL DISORDER,4
DE,SENSORY DISTURBANCE,4
DE,SKIN MASS,4
DE,SLEEP DISORDER,4
DE,SPINAL COLUMN STENOSIS,4
DE,SPINAL OSTEOARTHRITIS,4
DE,STAPHYLOCOCCAL INFECTION,4
DE,SYMBLEPHARON,4
DE,TENDON DISORDER,4
DE,THROAT TIGHTNESS,4
DE,VARICOSE VEIN,4
DE,WHITE BLOOD CELL COUNT DECREASED,4
DE,WRIST FRACTURE,4
DE,ABDOMINAL DISCOMFORT,3
DE,ABDOMINAL HERNIA,3
DE,ACUTE MYELOID LEUKAEMIA,3
DE,ADENOCARCINOMA,3
DE,ADENOCARCINOMA OF COLON,3
DE,ADRENAL GLAND CANCER,3
DE,ANAPHYLACTIC SHOCK,3
DE,ANGIOEDEMA,3
DE,AORTIC ARTERIOSCLEROSIS,3
DE,ARTHRITIS BACTERIAL,3
DE,BLADDER CANCER,3
DE,BLOOD BILIRUBIN INCREASED,3
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
DE,BONE DISORDER,3
DE,BRAIN NEOPLASM,3
DE,BURNING SENSATION,3
DE,BURSITIS INFECTIVE,3
DE,CARDIAC FAILURE CONGESTIVE,3
DE,CARDIAC VALVE DISEASE,3
DE,CATARACT CONGENITAL,3
DE,CELLULITIS,3
DE,CEREBRAL INFARCTION,3
DE,CHONDROPATHY,3
DE,CHORIORETINITIS,3
DE,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,3
DE,CHRONIC TONSILLITIS,3
DE,CONJUNCTIVITIS,3
DE,CYANOSIS,3
DE,DEAFNESS,3
DE,DEVICE ISSUE,3
DE,DIABETIC FOOT INFECTION,3
DE,DIPLOPIA,3
DE,DISSEMINATED TUBERCULOSIS,3
DE,DIVERTICULUM INTESTINAL,3
DE,DRUG ADMINISTRATION ERROR,3
DE,DRY MOUTH,3
DE,DYSURIA,3
DE,EJECTION FRACTION DECREASED,3
DE,ENDOCARDITIS STAPHYLOCOCCAL,3
DE,ENTERITIS,3
DE,EOSINOPHIL COUNT INCREASED,3
DE,EPILEPSY,3
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,3
DE,EYE SWELLING,3
DE,FEAR OF INJECTION,3
DE,FEMORAL NECK FRACTURE,3
DE,FISTULA,3
DE,FLUSHING,3
DE,GASTRIC DISORDER,3
DE,GASTROENTERITIS NOROVIRUS,3
DE,GASTROINTESTINAL PAIN,3
DE,GINGIVAL BLEEDING,3
DE,HAEMATURIA,3
DE,HAEMOGLOBIN INCREASED,3
DE,HAEMORRHAGIC ANAEMIA,3
DE,HEARING IMPAIRED,3
DE,HEART RATE INCREASED,3
DE,HEMIPARESIS,3
DE,HEPATITIS E,3
DE,HEPATITIS TOXIC,3
DE,HERPES OPHTHALMIC,3
DE,HIP ARTHROPLASTY,3
DE,HYPERSENSITIVITY VASCULITIS,3
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
DE,INFLAMMATORY BOWEL DISEASE,3
DE,INJECTION SITE HAEMORRHAGE,3
DE,INJECTION SITE INDURATION,3
DE,JAUNDICE,3
DE,JOINT RANGE OF MOTION DECREASED,3
DE,LABILE HYPERTENSION,3
DE,LACRIMATION INCREASED,3
DE,LARGE INTESTINE PERFORATION,3
DE,LEIOMYOMA,3
DE,LIGAMENT RUPTURE,3
DE,LIMB INJURY,3
DE,LOW DENSITY LIPOPROTEIN INCREASED,3
DE,LYMPHOPROLIFERATIVE DISORDER,3
DE,MENINGITIS,3
DE,MENORRHAGIA,3
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,3
DE,MIGRAINE,3
DE,MONOCLONAL GAMMOPATHY,3
DE,MONOPLEGIA,3
DE,MOTOR DYSFUNCTION,3
DE,MOVEMENT DISORDER,3
DE,MUSCULOSKELETAL DISCOMFORT,3
DE,MYOCARDITIS,3
DE,NECROTISING FASCIITIS,3
DE,OESOPHAGEAL ADENOCARCINOMA,3
DE,OESOPHAGEAL CARCINOMA,3
DE,OSTEITIS,3
DE,OSTEOPOROSIS,3
DE,OVERWEIGHT,3
DE,PANCREATIC ATROPHY,3
DE,PARONYCHIA,3
DE,PELVIC FRACTURE,3
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
DE,PETECHIAE,3
DE,POLYP,3
DE,POST PROCEDURAL COMPLICATION,3
DE,POST PROCEDURAL INFECTION,3
DE,PREMATURE DELIVERY,3
DE,PRERENAL FAILURE,3
DE,PROSTATE CANCER METASTATIC,3
DE,PULMONARY MASS,3
DE,RASH MACULO-PAPULAR,3
DE,RECTAL CANCER,3
DE,RED BLOOD CELL COUNT DECREASED,3
DE,RED BLOOD CELL COUNT INCREASED,3
DE,RENAL FAILURE CHRONIC,3
DE,RHEUMATOID FACTOR INCREASED,3
DE,SCHIZOPHRENIFORM DISORDER,3
DE,SCIATICA,3
DE,SJOGREN^S SYNDROME,3
DE,SKIN HAEMORRHAGE,3
DE,SKIN LESION,3
DE,SKIN PLAQUE,3
DE,SMALL CELL LUNG CANCER,3
DE,SMALL FOR DATES BABY,3
DE,STOMATITIS,3
DE,STREPTOCOCCAL INFECTION,3
DE,SUDDEN CARDIAC DEATH,3
DE,SUDDEN DEATH,3
DE,SUDDEN HEARING LOSS,3
DE,SUICIDAL IDEATION,3
DE,SUPERINFECTION BACTERIAL,3
DE,SYNOVIAL CYST,3
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,3
DE,TONGUE COATED,3
DE,TONSILLAR DISORDER,3
DE,TRANSIENT ISCHAEMIC ATTACK,3
DE,TRICUSPID VALVE INCOMPETENCE,3
DE,TUBULOINTERSTITIAL NEPHRITIS,3
DE,UTERINE DISORDER,3
DE,UTERINE PROLAPSE,3
DE,VENTRICULAR EXTRASYSTOLES,3
DE,VIITH NERVE PARALYSIS,3
DE,VISION BLURRED,3
DE,WOUND INFECTION STAPHYLOCOCCAL,3
DE,ABORTION,2
DE,ABSCESS BACTERIAL,2
DE,ACCIDENT AT WORK,2
DE,ACUTE ABDOMEN,2
DE,ACUTE RESPIRATORY FAILURE,2
DE,ADVERSE DRUG REACTION,2
DE,ANAL ABSCESS,2
DE,ANAL SQUAMOUS CELL CARCINOMA,2
DE,ANEURYSM,2
DE,ANGIOPATHY,2
DE,AORTIC ANEURYSM,2
DE,APATHY,2
DE,APPENDICITIS,2
DE,APPENDICITIS PERFORATED,2
DE,ARTERIAL OCCLUSIVE DISEASE,2
DE,ARTERIOSCLEROSIS CORONARY ARTERY,2
DE,ATRIAL FLUTTER,2
DE,AUTOIMMUNE HEPATITIS,2
DE,BACTERAEMIA,2
DE,BACTERIAL INFECTION,2
DE,BENIGN NEOPLASM,2
DE,BENIGN OVARIAN TUMOUR,2
DE,BILE DUCT CANCER,2
DE,BLOOD COUNT ABNORMAL,2
DE,BLOOD IRON DECREASED,2
DE,BLOOD PRESSURE ABNORMAL,2
DE,BLOOD PRESSURE DECREASED,2
DE,BLOOD PRESSURE FLUCTUATION,2
DE,BLOOD URIC ACID INCREASED,2
DE,BONE LOSS,2
DE,BONE MARROW OEDEMA,2
DE,BREAST DISORDER,2
DE,BREATH SOUNDS ABNORMAL,2
DE,BRONCHIAL DISORDER,2
DE,BRONCHITIS CHRONIC,2
DE,BRONCHOPULMONARY ASPERGILLOSIS,2
DE,BURSA DISORDER,2
DE,CARDIAC PACEMAKER REMOVAL,2
DE,CARDIAC RESYNCHRONISATION THERAPY,2
DE,CARDIOMYOPATHY,2
DE,CARDIOVASCULAR INSUFFICIENCY,2
DE,CAROTID ARTERY STENOSIS,2
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,2
DE,CENTRAL NERVOUS SYSTEM LESION,2
DE,CEREBROVASCULAR DISORDER,2
DE,CERVICAL VERTEBRAL FRACTURE,2
DE,CHOLANGIOCARCINOMA,2
DE,CHOLANGITIS,2
DE,CHOLANGITIS INFECTIVE,2
DE,CHRONIC KIDNEY DISEASE,2
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
DE,CHRONIC MYELOID LEUKAEMIA,2
DE,COGNITIVE DISORDER,2
DE,COLITIS ULCERATIVE,2
DE,CONCUSSION,2
DE,CONGENITAL PULMONARY HYPERTENSION,2
DE,CONSTIPATION,2
DE,COR PULMONALE,2
DE,DEPRESSED MOOD,2
DE,DERMAL CYST,2
DE,DEVICE ALARM ISSUE,2
DE,DIABETES MELLITUS INADEQUATE CONTROL,2
DE,DIABETIC NEUROPATHY,2
DE,DIARRHOEA HAEMORRHAGIC,2
DE,DIASTOLIC DYSFUNCTION,2
DE,DIFFUSE LARGE B-CELL LYMPHOMA STAGE III,2
DE,DISORIENTATION,2
DE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
DE,DRUG SPECIFIC ANTIBODY PRESENT,2
DE,DYSAESTHESIA,2
DE,DYSPEPSIA,2
DE,DYSPHAGIA,2
DE,DYSPHONIA,2
DE,EAR PAIN,2
DE,ECZEMA,2
DE,ENDOCARDITIS BACTERIAL,2
DE,EOSINOPHILIA,2
DE,EPSTEIN-BARR VIRUS INFECTION,2
DE,ERYTHEMA NODOSUM,2
DE,EXPOSURE VIA PARTNER,2
DE,EYE INFECTION,2
DE,FACE OEDEMA,2
DE,FACIAL PARESIS,2
DE,FEAR,2
DE,FEELING ABNORMAL,2
DE,FEELING HOT,2
DE,FIBULA FRACTURE,2
DE,FOETAL GROWTH RESTRICTION,2
DE,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III,2
DE,FRACTURED SACRUM,2
DE,FURUNCLE,2
DE,GASTRIC CANCER,2
DE,GASTROINTESTINAL CARCINOMA,2
DE,GASTROINTESTINAL INFECTION,2
DE,GASTROINTESTINAL INFLAMMATION,2
DE,GASTROINTESTINAL PERFORATION,2
DE,GASTROOESOPHAGEAL REFLUX DISEASE,2
DE,GENERALISED ERYTHEMA,2
DE,GENITAL ABSCESS,2
DE,GENITAL INFECTION FUNGAL,2
DE,GESTATIONAL DIABETES,2
DE,GLIOBLASTOMA,2
DE,GLOMERULONEPHRITIS PROLIFERATIVE,2
DE,GRANULOCYTOPENIA,2
DE,GUILLAIN-BARRE SYNDROME,2
DE,HAEMANGIOMA,2
DE,HAEMATOCRIT DECREASED,2
DE,HAEMOPTYSIS,2
DE,HAEMORRHAGIC DIATHESIS,2
DE,HEAD INJURY,2
DE,HEART DISEASE CONGENITAL,2
DE,HEAT STROKE,2
DE,HEPATIC FUNCTION ABNORMAL,2
DE,HEPATOMEGALY,2
DE,HEPATOTOXICITY,2
DE,HERPES ZOSTER MENINGITIS,2
DE,HYPERLIPIDAEMIA,2
DE,HYPERTENSIVE HEART DISEASE,2
DE,HYPERTHYROIDISM,2
DE,HYPOGLYCAEMIA,2
DE,HYPOPLASTIC LEFT HEART SYNDROME,2
DE,HYPOTENSION,2
DE,HYPOTHYROIDISM,2
DE,ILEUS,2
DE,IMMOBILE,2
DE,INFECTED BITES,2
DE,INFECTED DERMAL CYST,2
DE,INFECTIOUS PLEURAL EFFUSION,2
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
DE,INJECTION SITE HYPERSENSITIVITY,2
DE,INJECTION SITE INFLAMMATION,2
DE,INJECTION SITE RASH,2
DE,INJURY,2
DE,INTENTIONAL PRODUCT MISUSE,2
DE,INTESTINAL ISCHAEMIA,2
DE,INTRASPINAL ABSCESS,2
DE,IRIS ADHESIONS,2
DE,IRON DEFICIENCY,2
DE,ISCHAEMIC CARDIOMYOPATHY,2
DE,ISCHAEMIC STROKE,2
DE,JAW DISORDER,2
DE,KERATITIS,2
DE,KNEE ARTHROPLASTY,2
DE,LARGE INTESTINE POLYP,2
DE,LARYNGITIS,2
DE,LEFT VENTRICULAR HYPERTROPHY,2
DE,LEG AMPUTATION,2
DE,LIP SQUAMOUS CELL CARCINOMA,2
DE,LUNG ADENOCARCINOMA,2
DE,LUNG NEOPLASM,2
DE,LUPUS-LIKE SYNDROME,2
DE,LYMPHADENITIS,2
DE,LYMPHOCYTE COUNT INCREASED,2
DE,LYMPHOCYTIC LEUKAEMIA,2
DE,LYMPHOEDEMA,2
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,2
DE,MELKERSSON-ROSENTHAL SYNDROME,2
DE,MENINGIOMA,2
DE,MENINGITIS LISTERIA,2
DE,METASTASES TO BONE MARROW,2
DE,METASTASES TO PERITONEUM,2
DE,MOTOR NEURONE DISEASE,2
DE,MUSCLE ATROPHY,2
DE,MUSCLE RUPTURE,2
DE,MYOCLONUS,2
DE,NAIL DISORDER,2
DE,NECROSIS,2
DE,NEOPLASM,2
DE,NEPHROSCLEROSIS,2
DE,NERVE INJURY,2
DE,NEUROENDOCRINE TUMOUR,2
DE,NEUTROPHIL COUNT DECREASED,2
DE,NO ADVERSE EVENT,2
DE,NO THERAPEUTIC RESPONSE,2
DE,NOCTURIA,2
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
DE,OEDEMATOUS PANCREATITIS,2
DE,OLIGOHYDRAMNIOS,2
DE,OPTIC ISCHAEMIC NEUROPATHY,2
DE,OPTIC NERVE INJURY,2
DE,OSTEOPOROTIC FRACTURE,2
DE,OVARIAN MASS,2
DE,OXYGEN SATURATION DECREASED,2
DE,PANCREATIC TOXICITY,2
DE,PANCREATITIS ACUTE,2
DE,PAPILLOEDEMA,2
DE,PARKINSON^S DISEASE,2
DE,PERIODONTITIS,2
DE,PERIPHERAL EMBOLISM,2
DE,PERTUSSIS,2
DE,PHARYNGITIS,2
DE,PIGMENTATION DISORDER,2
DE,PLATELET COUNT DECREASED,2
DE,PLATELET COUNT INCREASED,2
DE,POSTOPERATIVE WOUND INFECTION,2
DE,PSYCHOTIC DISORDER,2
DE,PULMONARY CONGESTION,2
DE,PULPITIS DENTAL,2
DE,PYOPNEUMOTHORAX,2
DE,RASH ERYTHEMATOUS,2
DE,RASH MACULAR,2
DE,RENAL CYST,2
DE,RENAL IMPAIRMENT,2
DE,RHABDOMYOLYSIS,2
DE,RHEUMATIC FEVER,2
DE,RHINITIS,2
DE,RHINORRHOEA,2
DE,SARCOIDOSIS,2
DE,SCAB,2
DE,SCLERITIS,2
DE,SENSORY LOSS,2
DE,SHOULDER OPERATION,2
DE,SINUS TACHYCARDIA,2
DE,SKIN ATROPHY,2
DE,SKIN DISCOLOURATION,2
DE,SKIN FISSURES,2
DE,SKIN INFECTION,2
DE,SKIN IRRITATION,2
DE,SKIN SWELLING,2
DE,SLEEP APNOEA SYNDROME,2
DE,SOMATOFORM DISORDER,2
DE,SPLENOMEGALY,2
DE,SPONDYLITIS,2
DE,SQUAMOUS CELL CARCINOMA OF LUNG,2
DE,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,2
DE,SYNOVITIS,2
DE,T-CELL LYMPHOMA,2
DE,THORACIC VERTEBRAL FRACTURE,2
DE,THROMBOPHLEBITIS,2
DE,THYROID NEOPLASM,2
DE,TONSILLAR HAEMORRHAGE,2
DE,TOOTH INFECTION,2
DE,TRIGEMINAL NEURALGIA,2
DE,ULCERATIVE KERATITIS,2
DE,UMBILICAL HERNIA,2
DE,UNDERDOSE,2
DE,UNEVALUABLE EVENT,2
DE,UPPER RESPIRATORY TRACT INFECTION,2
DE,URINARY TRACT DISORDER,2
DE,UTERINE HAEMATOMA,2
DE,UTERINE LEIOMYOMA,2
DE,VAGINAL HAEMORRHAGE,2
DE,VAGINAL INFECTION,2
DE,VARICELLA,2
DE,VARICES OESOPHAGEAL,2
DE,VASCULITIS,2
DE,VENOUS INJURY,2
DE,VENOUS THROMBOSIS LIMB,2
DE,VERTIGO POSITIONAL,2
DE,VESTIBULAR DISORDER,2
DE,VISUAL FIELD DEFECT,2
DE,WHITE BLOOD CELL COUNT ABNORMAL,2
DE,WOUND INFECTION BACTERIAL,2
DE,WRIST SURGERY,2
DE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
DE,ABDOMINAL ADHESIONS,1
DE,ABDOMINAL NEOPLASM,1
DE,ABDOMINAL OPERATION,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABNORMAL FAECES,1
DE,ABORTED PREGNANCY,1
DE,ABSCESS LIMB,1
DE,ACARODERMATITIS,1
DE,ACCIDENT AT HOME,1
DE,ACCIDENTAL OVERDOSE,1
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
DE,ACUTE CORONARY SYNDROME,1
DE,ACUTE LYMPHOCYTIC LEUKAEMIA,1
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
DE,ACUTE TONSILLITIS,1
DE,ADENOCARCINOMA GASTRIC,1
DE,ADJUSTMENT DISORDER,1
DE,ADVERSE EVENT,1
DE,AGE-RELATED MACULAR DEGENERATION,1
DE,AGITATION,1
DE,AGRANULOCYTOSIS,1
DE,AKATHISIA,1
DE,ALLERGY TO ARTHROPOD BITE,1
DE,ALOPECIA EFFLUVIUM,1
DE,ALPHA 1 GLOBULIN INCREASED,1
DE,ALPHA 2 GLOBULIN INCREASED,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,ALVEOLAR OSTEITIS,1
DE,ALVEOLITIS ALLERGIC,1
DE,AMENORRHOEA,1
DE,AMYLASE ABNORMAL,1
DE,AMYOTROPHIC LATERAL SCLEROSIS,1
DE,ANAL FISSURE,1
DE,ANAL INFLAMMATION,1
DE,ANAL NEOPLASM,1
DE,ANAL SKIN TAGS,1
DE,ANAL SPHINCTER ATONY,1
DE,ANASTOMOTIC LEAK,1
DE,ANGIOCENTRIC LYMPHOMA,1
DE,ANGIOSARCOMA,1
DE,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
DE,ANIMAL SCRATCH,1
DE,ANOGENITAL WARTS,1
DE,ANORECTAL OPERATION,1
DE,ANOREXIA NERVOSA,1
DE,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
DE,ANTIBODY TEST POSITIVE,1
DE,ANTINUCLEAR ANTIBODY POSITIVE,1
DE,ANXIETY DISORDER,1
DE,AORTIC DISORDER,1
DE,AORTIC VALVE SCLEROSIS,1
DE,AORTIC VALVE STENOSIS,1
DE,APLASIA,1
DE,APLASTIC ANAEMIA,1
DE,APPENDIX CANCER,1
DE,APPLICATION SITE ERYTHEMA,1
DE,APPLICATION SITE REACTION,1
DE,ARTERIAL DISORDER,1
DE,ARTERIAL STENOSIS,1
DE,ARTERIOVENOUS MALFORMATION,1
DE,ARTERY DISSECTION,1
DE,ARTHROSCOPY,1
DE,ASCITES,1
DE,ASPARTATE AMINOTRANSFERASE DECREASED,1
DE,ASPERGILLUS INFECTION,1
DE,ASPHYXIA,1
DE,ATRIOVENTRICULAR BLOCK,1
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
DE,ATYPICAL PNEUMONIA,1
DE,AUTOINFLAMMATORY DISEASE,1
DE,AUTOPHOBIA,1
DE,B-CELL SMALL LYMPHOCYTIC LYMPHOMA,1
DE,B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE,1
DE,BACTERIAL TEST POSITIVE,1
DE,BARRETT^S OESOPHAGUS,1
DE,BEHCET^S SYNDROME,1
DE,BENIGN BONE NEOPLASM,1
DE,BENIGN PANCREATIC NEOPLASM,1
DE,BICYTOPENIA,1
DE,BILIARY COLIC,1
DE,BILIRUBIN CONJUGATED INCREASED,1
DE,BINGE DRINKING,1
DE,BIPOLAR I DISORDER,1
DE,BLADDER CANCER RECURRENT,1
DE,BLADDER PAIN,1
DE,BLADDER PROLAPSE,1
DE,BLADDER TRANSITIONAL CELL CARCINOMA,1
DE,BLEPHARITIS,1
DE,BLINDNESS,1
DE,BLINDNESS TRANSIENT,1
DE,BLISTER,1
DE,BLOOD ALKALINE PHOSPHATASE DECREASED,1
DE,BLOOD CALCIUM DECREASED,1
DE,BLOOD CHOLESTEROL ABNORMAL,1
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
DE,BLOOD POTASSIUM DECREASED,1
DE,BLOOD PRESSURE DIASTOLIC INCREASED,1
DE,BLOOD SODIUM DECREASED,1
DE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
DE,BLOOD TRIGLYCERIDES ABNORMAL,1
DE,BLOOD TRIGLYCERIDES INCREASED,1
DE,BLOOD UREA INCREASED,1
DE,BLOOD URINE PRESENT,1
DE,BODY TEMPERATURE INCREASED,1
DE,BONE ABSCESS,1
DE,BONE DEFORMITY,1
DE,BONE EROSION,1
DE,BONE FISSURE,1
DE,BONE GIANT CELL TUMOUR,1
DE,BONE MARROW DISORDER,1
DE,BONE MARROW FAILURE,1
DE,BONE MARROW TOXICITY,1
DE,BONE SWELLING,1
DE,BORDERLINE OVARIAN TUMOUR,1
DE,BORDERLINE PERSONALITY DISORDER,1
DE,BRADYARRHYTHMIA,1
DE,BRADYCARDIA,1
DE,BRAIN INJURY,1
DE,BRAIN NATRIURETIC PEPTIDE INCREASED,1
DE,BRAIN OEDEMA,1
DE,BRAIN STEM STROKE,1
DE,BREAST ABSCESS,1
DE,BREAST CANCER METASTATIC,1
DE,BREAST CANCER RECURRENT,1
DE,BREAST HAEMATOMA,1
DE,BREAST HAEMORRHAGE,1
DE,BREAST MASS,1
DE,BREAST NEOPLASM,1
DE,BREAST TENDERNESS,1
DE,BREECH PRESENTATION,1
DE,BRONCHIECTASIS,1
DE,BUNION OPERATION,1
DE,BURNING FEET SYNDROME,1
DE,BURNS SECOND DEGREE,1
DE,CALCINOSIS,1
DE,CALCULUS URINARY,1
DE,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
DE,CARCINOID TUMOUR,1
DE,CARDIAC ARREST,1
DE,CARDIAC DEATH,1
DE,CARDIAC FAILURE CHRONIC,1
DE,CARDIAC HYPERTROPHY,1
DE,CARDIOMEGALY,1
DE,CARDIOPULMONARY FAILURE,1
DE,CARTILAGE INJURY,1
DE,CEREBELLAR HAEMORRHAGE,1
DE,CEREBRAL ARTERY EMBOLISM,1
DE,CEREBRAL HAEMORRHAGE,1
DE,CERVICAL SPINAL STENOSIS,1
DE,CHEILITIS GRANULOMATOSA,1
DE,CHEST X-RAY ABNORMAL,1
DE,CHOLECYSTITIS ACUTE,1
DE,CHORIORETINOPATHY,1
DE,CHRONIC GASTRITIS,1
DE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
DE,CHRONIC SPONTANEOUS URTICARIA,1
DE,CLAVICLE FRACTURE,1
DE,CLEAR CELL RENAL CELL CARCINOMA,1
DE,CLINICALLY ISOLATED SYNDROME,1
DE,COLITIS ISCHAEMIC,1
DE,COLITIS MICROSCOPIC,1
DE,COLLAGEN DISORDER,1
DE,COLON CANCER METASTATIC,1
DE,COLON NEOPLASM,1
DE,COLORECTAL CANCER,1
DE,COMMINUTED FRACTURE,1
DE,COMPLETED SUICIDE,1
DE,COMPLICATION ASSOCIATED WITH DEVICE,1
DE,CONCOMITANT DISEASE AGGRAVATED,1
DE,CONGENITAL HYDRONEPHROSIS,1
DE,CONJUNCTIVAL DEPOSIT,1
DE,CONJUNCTIVAL OEDEMA,1
DE,CONTRAINDICATED PRODUCT ADMINISTERED,1
DE,CORNEAL DISORDER,1
DE,CORNEAL TRANSPLANT,1
DE,CORONARY ARTERY OCCLUSION,1
DE,COUNTERFEIT DRUG ADMINISTERED,1
DE,CRITICAL ILLNESS POLYNEUROPATHY,1
DE,CUSHINGOID,1
DE,CYSTITIS BACTERIAL,1
DE,CYSTOID MACULAR OEDEMA,1
DE,CYTOMEGALOVIRUS TEST POSITIVE,1
DE,CYTOPENIA,1
DE,DACRYOCYSTITIS,1
DE,DANDRUFF,1
DE,DEAFNESS BILATERAL,1
DE,DEAFNESS UNILATERAL,1
DE,DECREASED VIBRATORY SENSE,1
DE,DEMENTIA,1
DE,DEMYELINATING POLYNEUROPATHY,1
DE,DENTAL CARIES,1
DE,DENTAL PULP DISORDER,1
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DE,DEPRESSION SUICIDAL,1
DE,DERMATITIS,1
DE,DEVELOPMENTAL DELAY,1
DE,DEVICE BREAKAGE,1
DE,DEVICE CONNECTION ISSUE,1
DE,DEVICE DEFECTIVE,1
DE,DEVICE DISLOCATION,1
DE,DEVICE LOOSENING,1
DE,DEVICE MISUSE,1
DE,DEVICE RELATED INFECTION,1
GR,PYREXIA,19
GR,RHEUMATOID ARTHRITIS,16
GR,CONDITION AGGRAVATED,12
GR,DRUG INEFFECTIVE,12
GR,ARTHROPATHY,11
GR,PSORIATIC ARTHROPATHY,11
GR,DEATH,10
GR,URINARY TRACT INFECTION,10
GR,PNEUMONIA,9
GR,DYSPNOEA,8
GR,GAIT DISTURBANCE,7
GR,BREAST CANCER,6
GR,INFECTION,6
GR,ASTHENIA,5
GR,BILIARY TRACT DISORDER,5
GR,DIARRHOEA,5
GR,DIZZINESS,5
GR,FATIGUE,5
GR,HYPERSENSITIVITY,5
GR,INJECTION SITE ERYTHEMA,5
GR,IRIDOCYCLITIS,5
GR,PULMONARY OEDEMA,5
GR,RESPIRATORY TRACT INFECTION,5
GR,CARDIAC ARREST,4
GR,CEREBROVASCULAR ACCIDENT,4
GR,COUGH,4
GR,DEMYELINATION,4
GR,HAEMATOCRIT DECREASED,4
GR,LUNG NEOPLASM MALIGNANT,4
GR,LYMPHOMA,4
GR,MYCOSIS FUNGOIDES,4
GR,NEUTROPENIA,4
GR,PAIN,4
GR,PAIN IN EXTREMITY,4
GR,PRODUCT USE ISSUE,4
GR,PSORIASIS,4
GR,SQUAMOUS CELL CARCINOMA,4
GR,VIRAL INFECTION,4
GR,WHITE BLOOD CELL COUNT DECREASED,4
GR,ARTHRALGIA,3
GR,ATRIAL FIBRILLATION,3
GR,BREAST CANCER FEMALE,3
GR,CARDIAC DISORDER,3
GR,CARDIAC FAILURE,3
GR,DECREASED IMMUNE RESPONSIVENESS,3
GR,DISEASE RECURRENCE,3
GR,EPILEPSY,3
GR,HEADACHE,3
GR,INFLAMMATION,3
GR,INJECTION SITE OEDEMA,3
GR,LEUKOPENIA,3
GR,MYOCARDIAL INFARCTION,3
GR,NASOPHARYNGITIS,3
GR,OSTEOPOROSIS,3
GR,PULMONARY EMBOLISM,3
GR,URTICARIA,3
GR,VOMITING,3
GR,ABASIA,2
GR,ABDOMINAL PAIN UPPER,2
GR,ACUTE MYOCARDIAL INFARCTION,2
GR,ANAEMIA,2
GR,ANAPHYLACTIC SHOCK,2
GR,ANKYLOSING SPONDYLITIS,2
GR,ANTIPHOSPHOLIPID SYNDROME,2
GR,ARTHRITIS,2
GR,BACK DISORDER,2
GR,BACK PAIN,2
GR,BLOOD CREATININE INCREASED,2
GR,BRAIN OEDEMA,2
GR,BREATH SOUNDS ABNORMAL,2
GR,BRONCHOSPASM,2
GR,CHEST PAIN,2
GR,CHOLECYSTITIS,2
GR,CHOLELITHIASIS,2
GR,COMA,2
GR,DECREASED APPETITE,2
GR,ENCEPHALITIS,2
GR,FOOD POISONING,2
GR,GASTROINTESTINAL DISORDER,2
GR,GENERAL PHYSICAL HEALTH DETERIORATION,2
GR,GUILLAIN-BARRE SYNDROME,2
GR,HEPATITIS,2
GR,HERPES ZOSTER,2
GR,HYPOAESTHESIA,2
GR,INJECTION SITE HYPERSENSITIVITY,2
GR,INVASIVE BREAST CARCINOMA,2
GR,LABORATORY TEST ABNORMAL,2
GR,LACRIMATION INCREASED,2
GR,LIMB INJURY,2
GR,LUNG ADENOCARCINOMA,2
GR,LUNG INFECTION,2
GR,MOBILITY DECREASED,2
GR,MOVEMENT DISORDER,2
GR,MUSCULOSKELETAL DISORDER,2
GR,NON-HODGKIN^S LYMPHOMA,2
GR,PARALYSIS,2
GR,PARESIS,2
GR,PLATELET COUNT DECREASED,2
GR,PROSTATE CANCER,2
GR,PROSTATITIS,2
GR,PRURITUS,2
GR,PSEUDOMONAS INFECTION,2
GR,PULMONARY MASS,2
GR,RASH,2
GR,RENAL FAILURE,2
GR,SCLERODERMA,2
GR,SPINAL PAIN,2
GR,STRESS,2
GR,SUDDEN DEATH,2
GR,SYNCOPE,2
GR,THROMBOSIS,2
GR,TONSILLITIS,2
GR,TUBERCULOSIS,2
GR,UPPER RESPIRATORY TRACT INFECTION,2
GR,VISION BLURRED,2
GR,ABDOMINAL DISCOMFORT,1
GR,ABDOMINAL DISTENSION,1
GR,ABDOMINAL MASS,1
GR,ABDOMINAL PAIN,1
GR,ABSCESS,1
GR,ACUTE LEUKAEMIA,1
GR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
GR,ADVERSE DRUG REACTION,1
GR,ADVERSE EVENT,1
GR,ALOPECIA,1
GR,ANEURYSM,1
GR,ANTINUCLEAR ANTIBODY POSITIVE,1
GR,APNOEA,1
GR,ASCITES,1
GR,ASTHMA,1
GR,ATYPICAL PNEUMONIA,1
GR,BENIGN EAR NEOPLASM,1
GR,BENIGN INTRACRANIAL HYPERTENSION,1
GR,BENIGN NEOPLASM,1
GR,BENIGN PROSTATIC HYPERPLASIA,1
GR,BILE DUCT OBSTRUCTION,1
GR,BLADDER CANCER,1
GR,BLEPHARITIS,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD PHOSPHORUS INCREASED,1
GR,BLOOD PRESSURE DECREASED,1
GR,BLOOD PRESSURE INCREASED,1
GR,BLOOD PRESSURE SYSTOLIC INCREASED,1
GR,BONE MARROW EOSINOPHILIC LEUKOCYTE COUNT INCREASED,1
GR,BREAST CANCER METASTATIC,1
GR,BREAST DISORDER,1
GR,BRONCHITIS,1
GR,C-REACTIVE PROTEIN INCREASED,1
GR,CARDIOMYOPATHY,1
GR,CARPAL TUNNEL SYNDROME,1
GR,CATARACT,1
GR,CELLULITIS,1
GR,CEREBELLAR TUMOUR,1
GR,CEREBRAL ISCHAEMIA,1
GR,CERVICAL MYELOPATHY,1
GR,CHORIORETINOPATHY,1
GR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
GR,COLITIS,1
GR,CONCOMITANT DISEASE AGGRAVATED,1
GR,CONGESTIVE CARDIOMYOPATHY,1
GR,CROHN^S DISEASE,1
GR,CSF TEST ABNORMAL,1
GR,CULTURE URINE POSITIVE,1
GR,DACTYLITIS,1
GR,DEAFNESS,1
GR,DIARRHOEA HAEMORRHAGIC,1
GR,DIPLOPIA,1
GR,DISEASE PROGRESSION,1
GR,DIVERTICULUM INTESTINAL,1
GR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GR,DRY MOUTH,1
GR,DYSAESTHESIA,1
GR,DYSGRAPHIA,1
GR,DYSPHAGIA,1
GR,DYSPNOEA EXERTIONAL,1
GR,DYSURIA,1
GR,EAR INFECTION,1
GR,EJECTION FRACTION DECREASED,1
GR,EMBOLISM,1
GR,EOSINOPHIL COUNT INCREASED,1
GR,EPENDYMOMA MALIGNANT,1
GR,EPIDIDYMITIS,1
GR,ERYTHEMA,1
GR,EXPOSURE VIA FATHER,1
GR,EXTRADURAL HAEMATOMA,1
GR,EYE PAIN,1
GR,EYE PRURITUS,1
GR,EYELID OEDEMA,1
GR,EYELID PAIN,1
GR,FALL,1
GR,FEELING ABNORMAL,1
GR,FRACTURE,1
GR,GALLBLADDER DISORDER,1
GR,GASTRIC ULCER,1
GR,GASTRINOMA,1
GR,GASTROINTESTINAL INFLAMMATION,1
GR,GASTROINTESTINAL PAIN,1
GR,GENERAL PHYSICAL CONDITION ABNORMAL,1
GR,GENITAL INFECTION,1
GR,GINGIVAL HYPERTROPHY,1
GR,HAEMORRHAGE,1
GR,HAEMORRHAGE URINARY TRACT,1
GR,HEART RATE INCREASED,1
GR,HEPATIC CANCER,1
GR,HERNIA,1
GR,HIP FRACTURE,1
GR,HODGKIN^S DISEASE,1
GR,HYPERHIDROSIS,1
GR,HYPERPLASIA,1
GR,HYPERSENSITIVITY VASCULITIS,1
GR,HYPERTHYROIDISM,1
GR,HYPORESPONSIVE TO STIMULI,1
GR,HYPOTENSION,1
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
GR,IMMUNE SYSTEM DISORDER,1
GR,IMPAIRED HEALING,1
GR,INFERTILITY MALE,1
GR,INJECTION SITE INDURATION,1
GR,INJECTION SITE PRURITUS,1
GR,INJECTION SITE RASH,1
GR,INJECTION SITE REACTION,1
GR,INJECTION SITE URTICARIA,1
GR,INJECTION SITE WARMTH,1
GR,INTENTIONAL PRODUCT MISUSE,1
GR,ISCHAEMIC STROKE,1
GR,JOINT DISLOCATION,1
GR,JOINT EFFUSION,1
GR,JOINT INJURY,1
GR,LARGE INTESTINAL HAEMORRHAGE,1
GR,LARYNGITIS,1
GR,LEISHMANIASIS,1
GR,LENS DISORDER,1
GR,LICHEN PLANUS,1
GR,LIMB DEFORMITY,1
GR,LIVER DISORDER,1
GR,LIVER FUNCTION TEST ABNORMAL,1
GR,LOCALISED INFECTION,1
GR,LOWER LIMB FRACTURE,1
GR,LUNG DISORDER,1
GR,LYMPHOCYTOSIS,1
GR,LYMPHOPENIA,1
GR,MACULAR HOLE,1
GR,MALAISE,1
GR,MASS,1
GR,MEMORY IMPAIRMENT,1
GR,MENINGITIS,1
GR,MENORRHAGIA,1
GR,MENTAL IMPAIRMENT,1
GR,MONOCYTOSIS,1
GR,MONONEURITIS,1
GR,MONOPLEGIA,1
GR,MULTIPLE SCLEROSIS,1
GR,MUSCLE SPASMS,1
GR,MYCOBACTERIUM KANSASII INFECTION,1
GR,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
GR,MYCOSIS FUNGOIDES STAGE I,1
GR,MYELITIS TRANSVERSE,1
GR,MYELODYSPLASTIC SYNDROME,1
GR,MYOPATHY,1
GR,NAIL PIGMENTATION,1
GR,NECK SURGERY,1
GR,NERVOUS SYSTEM DISORDER,1
GR,NEUROTOXICITY,1
GR,NIGHT SWEATS,1
GR,NIPPLE PAIN,1
GR,OCULAR HYPERAEMIA,1
GR,OEDEMA PERIPHERAL,1
GR,OESOPHAGITIS,1
GR,OSTEONECROSIS OF JAW,1
GR,OVARIAN DISORDER,1
GR,OXYGEN SATURATION DECREASED,1
GR,PANCREATITIS ACUTE,1
GR,PANCYTOPENIA,1
GR,PATHOLOGICAL FRACTURE,1
GR,PEPTIC ULCER,1
GR,PERICARDITIS,1
GR,PERIPHERAL ARTERY THROMBOSIS,1
GR,PERIPHERAL ISCHAEMIA,1
GR,PERIPHERAL SWELLING,1
GR,PHARYNGEAL POLYP,1
GR,PHOTOPHOBIA,1
GR,PITYRIASIS ROSEA,1
GR,POLLAKIURIA,1
GR,POLYARTHRITIS,1
GR,POLYP,1
GR,PSEUDOMONAS TEST POSITIVE,1
GR,PULMONARY FIBROSIS,1
GR,RASH GENERALISED,1
GR,RED BLOOD CELLS URINE POSITIVE,1
GR,RENAL CANCER,1
GR,RENAL FAILURE ACUTE,1
GR,RESPIRATORY DISORDER,1
GR,RETINAL DETACHMENT,1
GR,RHEUMATOID FACTOR POSITIVE,1
GR,SENSITIVITY OF TEETH,1
GR,SEPSIS,1
GR,SEPTIC SHOCK,1
GR,SKIN CANCER,1
GR,SKIN ULCER,1
GR,SPINAL FRACTURE,1
GR,SPINAL MENINGIOMA BENIGN,1
GR,SQUAMOUS CELL CARCINOMA OF SKIN,1
GR,STATUS EPILEPTICUS,1
GR,STOMATITIS,1
GR,SWELLING,1
GR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
GR,TACHYCARDIA,1
GR,TEETH BRITTLE,1
GR,TENDONITIS,1
GR,THERAPEUTIC RESPONSE CHANGED,1
GR,THERAPEUTIC RESPONSE DECREASED,1
GR,THROAT TIGHTNESS,1
GR,THYROID CANCER,1
GR,THYROID DISORDER,1
GR,TINNITUS,1
GR,TOOTH DISORDER,1
GR,TRANSAMINASES INCREASED,1
GR,ULCERATIVE KERATITIS,1
GR,URINARY RETENTION,1
GR,UTERINE DISORDER,1
GR,UVEITIS,1
GR,VARICOCELE,1
GR,VASCULITIS,1
GR,VEIN DISORDER,1
GR,VENOUS INSUFFICIENCY,1
GR,VERTIGO,1
GR,VULVOVAGINAL PAIN,1
GR,WEIGHT DECREASED,1
GR,WHITE BLOOD CELL COUNT INCREASED,1
GR,WRIST FRACTURE,1
GT,DEATH,2
GT,ANAPHYLACTIC REACTION,1
GT,ECCHYMOSIS,1
GT,ERYTHEMA,1
HN,IMMUNE THROMBOCYTOPENIC PURPURA,2
HN,OCCUPATIONAL EXPOSURE TO PRODUCT,2
HN,ARTHROPATHY,1
HN,BLOOD URINE PRESENT,1
HN,BONE DISORDER,1
HN,COUGH,1
HN,DEATH,1
HN,DECREASED APPETITE,1
HN,DEPRESSION,1
HN,DIZZINESS,1
HN,DYSPHONIA,1
HN,EPISTAXIS,1
HN,HEPATITIS,1
HN,INFLUENZA,1
HN,INJECTION SITE ERYTHEMA,1
HN,MENORRHAGIA,1
HN,MOOD ALTERED,1
HN,MOUTH HAEMORRHAGE,1
HN,MUSCLE SPASMS,1
HN,PIGMENTATION DISORDER,1
HN,PLATELET COUNT DECREASED,1
HN,PYREXIA,1
HN,SEPSIS,1
HN,TUBERCULIN TEST POSITIVE,1
HN,VAGINAL HAEMORRHAGE,1
HN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
HN,WEIGHT DECREASED,1
HK,ARTHRALGIA,9
HK,DEATH,6
HK,DRUG INEFFECTIVE,5
HK,DRUG EFFECT INCOMPLETE,4
HK,INFLAMMATION,4
HK,IRITIS,4
HK,INFLUENZA,3
HK,RASH,3
HK,RENAL IMPAIRMENT,3
HK,VISION BLURRED,3
HK,ABASIA,2
HK,ABDOMINAL DISCOMFORT,2
HK,ARTHROPATHY,2
HK,DECREASED IMMUNE RESPONSIVENESS,2
HK,DISCOMFORT,2
HK,ECZEMA,2
HK,EYE PAIN,2
HK,HAEMORRHAGE,2
HK,INFECTION,2
HK,INJECTION SITE ERYTHEMA,2
HK,INJECTION SITE SWELLING,2
HK,INSOMNIA,2
HK,JOINT SWELLING,2
HK,PRODUCT QUALITY ISSUE,2
HK,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
HK,ANAEMIA,1
HK,ARTHRITIS,1
HK,BACK PAIN,1
HK,BLOOD POTASSIUM INCREASED,1
HK,BREAST NEOPLASM,1
HK,CELLULITIS,1
HK,COLD SWEAT,1
HK,CONDITION AGGRAVATED,1
HK,CONTUSION,1
HK,DIABETES MELLITUS,1
HK,DIZZINESS EXERTIONAL,1
HK,DRUG EFFECT DECREASED,1
HK,DRUG ERUPTION,1
HK,DRUG INTOLERANCE,1
HK,DRY SKIN,1
HK,DYSPEPSIA,1
HK,DYSPNOEA,1
HK,DYSPNOEA EXERTIONAL,1
HK,EAR DISCOMFORT,1
HK,ENTERITIS,1
HK,FATIGUE,1
HK,FEELING COLD,1
HK,FUNGAL INFECTION,1
HK,GASTRIC HAEMORRHAGE,1
HK,GASTROOESOPHAGEAL REFLUX DISEASE,1
HK,GINGIVITIS,1
HK,HAND DEFORMITY,1
HK,HEADACHE,1
HK,HYPERSENSITIVITY,1
HK,HYPERTENSION,1
HK,IMMUNE SYSTEM DISORDER,1
HK,INJECTION SITE BRUISING,1
HK,INJECTION SITE HAEMORRHAGE,1
HK,INJECTION SITE PAIN,1
HK,INJECTION SITE PRURITUS,1
HK,INTERNAL HAEMORRHAGE,1
HK,JOINT DESTRUCTION,1
HK,JOINT STIFFNESS,1
HK,LACRIMAL DISORDER,1
HK,LUNG INFECTION,1
HK,LYMPHADENOPATHY,1
HK,MALABSORPTION,1
HK,MYOSITIS,1
HK,NASOPHARYNGITIS,1
HK,NERVOUS SYSTEM DISORDER,1
HK,ORAL INFECTION,1
HK,OROPHARYNGEAL DISCOMFORT,1
HK,OSTEONECROSIS,1
HK,OTITIS MEDIA,1
HK,PERIPHERAL SWELLING,1
HK,PNEUMONIA,1
HK,POLYP,1
HK,POOR VENOUS ACCESS,1
HK,POSTMENOPAUSAL HAEMORRHAGE,1
HK,PRODUCTIVE COUGH,1
HK,PRURITUS,1
HK,PULMONARY FIBROSIS,1
HK,PURULENT DISCHARGE,1
HK,RHINITIS ALLERGIC,1
HK,SARCOIDOSIS,1
HK,SKIN ULCER,1
HK,SMALL INTESTINAL OBSTRUCTION,1
HK,SWELLING FACE,1
HK,TONSILLITIS,1
HK,TOOTHACHE,1
HK,TUBERCULOSIS,1
HK,TUMOUR INVASION,1
HK,VIRAL INFECTION,1
HK,WEIGHT DECREASED,1
HK,WEIGHT INCREASED,1
HU,DRUG INEFFECTIVE,15
HU,CONDITION AGGRAVATED,13
HU,RHEUMATOID ARTHRITIS,7
HU,PNEUMONIA,6
HU,ASTHENIA,5
HU,DEATH,5
HU,MALAISE,5
HU,NAUSEA,5
HU,ARTHRALGIA,4
HU,COUGH,4
HU,MUSCULOSKELETAL PAIN,4
HU,MYOCARDIAL INFARCTION,4
HU,PAIN IN EXTREMITY,4
HU,PYREXIA,4
HU,VOMITING,4
HU,ABDOMINAL PAIN UPPER,3
HU,BRAIN NEOPLASM,3
HU,BRONCHITIS,3
HU,C-REACTIVE PROTEIN INCREASED,3
HU,DIPLOPIA,3
HU,FATIGUE,3
HU,GAIT DISTURBANCE,3
HU,HYPERSENSITIVITY,3
HU,LIVER FUNCTION TEST ABNORMAL,3
HU,NASOPHARYNGITIS,3
HU,PULMONARY EMBOLISM,3
HU,RASH,3
HU,RASH ERYTHEMATOUS,3
HU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
HU,THYROIDITIS SUBACUTE,3
HU,ACUTE MYELOMONOCYTIC LEUKAEMIA,2
HU,ARTERIOSCLEROSIS,2
HU,BACK PAIN,2
HU,BONE MARROW TOXICITY,2
HU,CARDIAC FAILURE,2
HU,COLITIS ULCERATIVE,2
HU,DERMATITIS ALLERGIC,2
HU,DISEASE RECURRENCE,2
HU,DIZZINESS,2
HU,DYSPHAGIA,2
HU,DYSPNOEA,2
HU,EMBOLISM,2
HU,ERYSIPELAS,2
HU,GANGRENE,2
HU,GINGIVAL INFLAMMATION,2
HU,HEPATIC ENZYME DECREASED,2
HU,HEPATORENAL FAILURE,2
HU,INFECTION,2
HU,INJECTION SITE ERYTHEMA,2
HU,INJECTION SITE SWELLING,2
HU,INTRACRANIAL PRESSURE INCREASED,2
HU,JOINT SWELLING,2
HU,LEUKOPENIA,2
HU,LICHEN PLANUS,2
HU,LUNG NEOPLASM MALIGNANT,2
HU,MATERNAL EXPOSURE DURING PREGNANCY,2
HU,METASTASES TO LUNG,2
HU,NODULE,2
HU,OCULAR HYPERAEMIA,2
HU,OSTEOARTHRITIS,2
HU,PANCREATIC NEOPLASM,2
HU,PERIPHERAL SWELLING,2
HU,PRURITUS,2
HU,PULMONARY MASS,2
HU,PULMONARY OEDEMA,2
HU,SKIN DISORDER,2
HU,SKIN EXFOLIATION,2
HU,SQUAMOUS CELL CARCINOMA,2
HU,SWELLING FACE,2
HU,THERAPEUTIC RESPONSE UNEXPECTED,2
HU,TOOTH ABSCESS,2
HU,TUBERCULOSIS,2
HU,UVEITIS,2
HU,VASCULITIS,2
HU,VENOUS THROMBOSIS LIMB,2
HU,VIRAL INFECTION,2
HU,ABDOMINAL PAIN,1
HU,ABDOMINAL PAIN LOWER,1
HU,ABDOMINAL SYMPTOM,1
HU,ABORTION INDUCED,1
HU,ALCOHOL POISONING,1
HU,ALCOHOL WITHDRAWAL SYNDROME,1
HU,ALVEOLITIS,1
HU,AMYLASE INCREASED,1
HU,AMYLOIDOSIS,1
HU,ANAEMIA,1
HU,ANGIOPATHY,1
HU,ANKLE FRACTURE,1
HU,ANKYLOSING SPONDYLITIS,1
HU,ANTIPHOSPHOLIPID SYNDROME,1
HU,ARRHYTHMIA,1
HU,ARTHROPATHY,1
HU,ATRIAL FIBRILLATION,1
HU,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
HU,BACTERIAL TOXAEMIA,1
HU,BASAL CELL CARCINOMA,1
HU,BILIARY POLYP,1
HU,BIPOLAR DISORDER,1
HU,BLADDER CANCER,1
HU,BLOOD CREATININE ABNORMAL,1
HU,BLOOD GLUCOSE INCREASED,1
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
HU,BLOOD OSMOLARITY DECREASED,1
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HU,BLOOD URINE PRESENT,1
HU,BODY TEMPERATURE INCREASED,1
HU,BONE LESION,1
HU,BREAST CANCER,1
HU,CARDIAC ARREST,1
HU,CARDIAC DISORDER,1
HU,CARDIAC FAILURE CONGESTIVE,1
HU,CATARACT,1
HU,CENTRAL NERVOUS SYSTEM LESION,1
HU,CEREBRAL DISORDER,1
HU,CEREBRAL HAEMORRHAGE,1
HU,CERVICAL POLYP,1
HU,CHILLS,1
HU,CHRONIC KIDNEY DISEASE,1
HU,CHRONIC SINUSITIS,1
HU,CONGESTIVE CARDIOMYOPATHY,1
HU,CORONARY ARTERY STENOSIS,1
HU,DEMYELINATION,1
HU,DEPRESSION,1
HU,DIARRHOEA,1
HU,DIARRHOEA HAEMORRHAGIC,1
HU,DISORGANISED SPEECH,1
HU,DISSEMINATED INTRAVASCULAR COAGULATION,1
HU,DRUG EFFECT INCOMPLETE,1
HU,DRY EYE,1
HU,DYSPEPSIA,1
HU,DYSPNOEA EXERTIONAL,1
HU,DYSSTASIA,1
HU,ENDOCARDITIS,1
HU,EOSINOPHILIA,1
HU,ERYTHEMA,1
HU,EXCORIATION,1
HU,EYE DISORDER,1
HU,EYE PAIN,1
HU,FEELING ABNORMAL,1
HU,FLUSHING,1
HU,FOETAL MONITORING ABNORMAL,1
HU,FOOT DEFORMITY,1
HU,GASTRIC CANCER,1
HU,GASTRIC HAEMORRHAGE,1
HU,GASTROENTERITIS,1
HU,GASTROENTERITIS SALMONELLA,1
HU,GASTROINTESTINAL DISORDER,1
HU,GASTROINTESTINAL NEOPLASM,1
HU,GASTROINTESTINAL STROMAL TUMOUR,1
HU,GASTROINTESTINAL TOXICITY,1
HU,GENERALISED ERYTHEMA,1
HU,GRANULOMA,1
HU,HAEMATURIA,1
HU,HAEMOLYSIS,1
HU,HAEMORRHAGE,1
HU,HAEMORRHOIDS,1
HU,HELICOBACTER INFECTION,1
HU,HYPEREOSINOPHILIC SYNDROME,1
HU,HYPOAESTHESIA,1
HU,HYPOAESTHESIA ORAL,1
HU,HYPONATRAEMIA,1
HU,IMMUNE SYSTEM DISORDER,1
HU,IMPETIGO,1
HU,INFESTATION,1
HU,INFLAMMATORY BOWEL DISEASE,1
HU,INFLAMMATORY MARKER INCREASED,1
HU,INFLUENZA,1
HU,INJECTION SITE INFLAMMATION,1
HU,INJECTION SITE PRURITUS,1
HU,INJECTION SITE REACTION,1
HU,INTESTINAL HAEMORRHAGE,1
HU,IRIDOCYCLITIS,1
HU,IRITIS,1
HU,JOINT INJURY,1
HU,JOINT RANGE OF MOTION DECREASED,1
HU,LABORATORY TEST ABNORMAL,1
HU,LETHARGY,1
HU,LIGAMENT RUPTURE,1
HU,LIP SWELLING,1
HU,LIPASE INCREASED,1
HU,LIVER DISORDER,1
HU,LOCAL SWELLING,1
HU,LUNG NEOPLASM,1
HU,LYMPHOMA,1
HU,MALIGNANT GLIOMA,1
HU,MALIGNANT MELANOMA,1
HU,MEMORY IMPAIRMENT,1
HU,MENTAL DISORDER,1
HU,METASTASES TO LYMPH NODES,1
HU,MOBILITY DECREASED,1
HU,MOUTH SWELLING,1
HU,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
HU,NECK PAIN,1
HU,NEOPLASM,1
HU,NEOPLASM MALIGNANT,1
HU,NERVOUS SYSTEM DISORDER,1
HU,NON-HODGKIN^S LYMPHOMA,1
HU,NYSTAGMUS,1
HU,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
HU,PAIN,1
HU,PANCREATIC CARCINOMA,1
HU,PANCREATIC CYST,1
HU,PANCREATIC NECROSIS,1
HU,PANCREATITIS,1
HU,PANCREATITIS ACUTE,1
HU,PAPILLOMA,1
HU,PERITONEAL HAEMORRHAGE,1
HU,POLYP,1
HU,PRODUCT USE ISSUE,1
HU,PULMONARY CONGESTION,1
HU,PULMONARY FIBROSIS,1
HU,PURPURA,1
HU,PYELONEPHRITIS,1
HU,RASH GENERALISED,1
HU,RASH MACULAR,1
HU,RASH PRURITIC,1
HU,RASH PUSTULAR,1
HU,RECTAL ADENOMA,1
HU,RED BLOOD CELL COUNT ABNORMAL,1
HU,RELAPSING FEVER,1
HU,RENAL NEOPLASM,1
HU,RESPIRATORY TRACT INFECTION,1
HU,RHEUMATOID LUNG,1
HU,ROSACEA,1
HU,SEIZURE,1
HU,SELF INJURIOUS BEHAVIOUR,1
HU,SEPSIS,1
HU,SINUSITIS,1
HU,SKIN REACTION,1
HU,SKIN SWELLING,1
HU,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
HU,SMALL INTESTINAL STENOSIS,1
HU,SOFT TISSUE NEOPLASM,1
HU,SPINAL CORD HERNIATION,1
HU,SPLENIC ABSCESS,1
HU,SPLENIC RUPTURE,1
HU,SUBARACHNOID HAEMORRHAGE,1
HU,SUICIDE ATTEMPT,1
HU,THROMBOCYTOPENIA,1
HU,THROMBOSIS,1
HU,TOOTH DISORDER,1
HU,TOOTH LOSS,1
HU,TREMOR,1
HU,TUBERCULIN TEST POSITIVE,1
HU,TUBULOINTERSTITIAL NEPHRITIS,1
HU,TUNNEL VISION,1
HU,UPPER RESPIRATORY TRACT INFECTION,1
HU,URINARY TRACT INFECTION,1
HU,UTERINE NEOPLASM,1
HU,VASCULAR ENCEPHALOPATHY,1
HU,VISUAL IMPAIRMENT,1
HU,WHITE BLOOD CELL COUNT INCREASED,1
HU,WHITE BLOOD CELL DISORDER,1
HU,WOUND,1
HU,WOUND SECRETION,1
IS,DRUG-INDUCED LIVER INJURY,1
IN,IRIDOCYCLITIS,5
IN,DIARRHOEA,4
IN,PYREXIA,4
IN,DRUG INEFFECTIVE,3
IN,VARICELLA,3
IN,DEATH,2
IN,DERMATITIS BULLOUS,2
IN,DYSPNOEA,2
IN,EPSTEIN-BARR VIRUS INFECTION,2
IN,MYXOEDEMA COMA,2
IN,PNEUMONIA CYTOMEGALOVIRAL,2
IN,RESPIRATORY DISTRESS,2
IN,RHEUMATOID ARTHRITIS,2
IN,ROTAVIRUS INFECTION,2
IN,ABDOMINAL PAIN,1
IN,ABORTION SPONTANEOUS,1
IN,ADENOVIRUS INFECTION,1
IN,ANAL FISTULA,1
IN,ANKYLOSING SPONDYLITIS,1
IN,AORTIC ANEURYSM,1
IN,ASTHMA,1
IN,ATRIAL FIBRILLATION,1
IN,BALANCE DISORDER,1
IN,BLOOD CREATININE INCREASED,1
IN,BONE LOSS,1
IN,CARDIAC FAILURE,1
IN,CONDITION AGGRAVATED,1
IN,DEHYDRATION,1
IN,DIABETES MELLITUS INADEQUATE CONTROL,1
IN,DISSEMINATED TUBERCULOSIS,1
IN,ENDOPHTHALMITIS,1
IN,FAECAL VOLUME INCREASED,1
IN,GASTROINTESTINAL INFECTION,1
IN,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
IN,GRAFT VERSUS HOST DISEASE IN LIVER,1
IN,HAEMATEMESIS,1
IN,HEADACHE,1
IN,HEPATITIS A,1
IN,HIATUS HERNIA,1
IN,HYPERBILIRUBINAEMIA,1
IN,HYPERTRIGLYCERIDAEMIA,1
IN,HYPOACUSIS,1
IN,HYPOAESTHESIA,1
IN,IMMUNODEFICIENCY,1
IN,INCORRECT DOSAGE ADMINISTERED,1
IN,INFLAMMATION,1
IN,INFUSION RELATED REACTION,1
IN,INJECTION SITE EXTRAVASATION,1
IN,INTERSTITIAL LUNG DISEASE,1
IN,JAUNDICE,1
IN,LIVER ABSCESS,1
IN,MALARIA,1
IN,MATERNAL EXPOSURE DURING PREGNANCY,1
IN,MENTAL IMPAIRMENT,1
IN,MYOPATHY,1
IN,NEUROPATHY PERIPHERAL,1
IN,NEUTROPENIA,1
IN,OCULAR HYPERAEMIA,1
IN,ORAL CANDIDIASIS,1
IN,OROPHARYNGEAL PAIN,1
IN,OSTEOARTHRITIS,1
IN,PAIN,1
IN,PANCYTOPENIA,1
IN,PHARYNGITIS,1
IN,PNEUMONIA,1
IN,PRODUCT QUALITY ISSUE,1
IN,PRURITUS,1
IN,RASH,1
IN,RHINITIS,1
IN,SEIZURE,1
IN,SINOATRIAL BLOCK,1
IN,SPINAL DEFORMITY,1
IN,SPINAL OSTEOARTHRITIS,1
IN,SWEAT GLAND DISORDER,1
IN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IN,THERAPEUTIC RESPONSE DECREASED,1
IN,TYPE 2 LEPRA REACTION,1
IN,TYPHOID FEVER,1
IN,UVEITIS,1
IR,ANAPHYLACTOID SHOCK,1
IR,RASH GENERALISED,1
IQ,ARTHRITIS BACTERIAL,3
IQ,SJOGREN^S SYNDROME,3
IQ,ARTHRITIS,2
IQ,ERYTHRODERMIC PSORIASIS,2
IQ,JOINT EFFUSION,2
IQ,OEDEMA PERIPHERAL,2
IQ,PYREXIA,2
IQ,ABDOMINAL DISTENSION,1
IQ,ADRENAL INSUFFICIENCY,1
IQ,ANURIA,1
IQ,BLOOD UREA INCREASED,1
IQ,CANDIDA INFECTION,1
IQ,CARDIAC ARREST,1
IQ,CHEST PAIN,1
IQ,CONDITION AGGRAVATED,1
IQ,CUSHING^S SYNDROME,1
IQ,DEATH,1
IQ,DEHYDRATION,1
IQ,ERYTHEMA,1
IQ,MYCOSIS FUNGOIDES,1
IQ,OESOPHAGEAL CANDIDIASIS,1
IQ,OESOPHAGEAL INFECTION,1
IQ,PANCYTOPENIA,1
IQ,PHYSICAL DISABILITY,1
IQ,PNEUMONIA,1
IQ,PRODUCT USE ISSUE,1
IQ,SYNCOPE,1
IQ,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IQ,WEIGHT ABNORMAL,1
IE,LOWER RESPIRATORY TRACT INFECTION,27
IE,MALAISE,13
IE,CONDITION AGGRAVATED,12
IE,HEADACHE,9
IE,DEATH,8
IE,DRUG INEFFECTIVE,8
IE,INJECTION SITE PAIN,6
IE,PRODUCT USE ISSUE,6
IE,PYREXIA,6
IE,SYSTEMIC LUPUS ERYTHEMATOSUS,6
IE,BACK PAIN,5
IE,DEVICE ISSUE,5
IE,DIZZINESS,5
IE,DRUG DOSE OMISSION,5
IE,INFECTION,5
IE,INJECTION SITE SWELLING,5
IE,PSORIASIS,5
IE,INJECTION SITE ERYTHEMA,4
IE,KIDNEY INFECTION,4
IE,NAUSEA,4
IE,OESOPHAGEAL CARCINOMA,4
IE,OROPHARYNGEAL PAIN,4
IE,RHEUMATOID ARTHRITIS,4
IE,ABDOMINAL DISCOMFORT,3
IE,ABDOMINAL PAIN,3
IE,BODY MASS INDEX INCREASED,3
IE,CHEST PAIN,3
IE,COUGH,3
IE,DYSPNOEA,3
IE,FALL,3
IE,FATIGUE,3
IE,GASTROINTESTINAL DISORDER,3
IE,HAEMORRHAGE,3
IE,HEPATIC STEATOSIS,3
IE,INJECTION SITE HAEMORRHAGE,3
IE,LACERATION,3
IE,NEURODERMATITIS,3
IE,PAIN,3
IE,PHARYNGITIS,3
IE,PNEUMONIA,3
IE,PRURITUS,3
IE,RASH,3
IE,SINUSITIS,3
IE,VOMITING,3
IE,ANKYLOSING SPONDYLITIS,2
IE,ANXIETY,2
IE,ARTHRALGIA,2
IE,ARTHROPATHY,2
IE,CARPAL TUNNEL SYNDROME,2
IE,CELLULITIS,2
IE,CONTUSION,2
IE,DEMYELINATION,2
IE,DIARRHOEA,2
IE,DRUG EFFECT DECREASED,2
IE,DRY EYE,2
IE,DYSPHAGIA,2
IE,EMOTIONAL DISTRESS,2
IE,EXPOSURE VIA PARTNER,2
IE,HAEMOGLOBIN DECREASED,2
IE,HYPERHIDROSIS,2
IE,IMMUNOSUPPRESSION,2
IE,INFLUENZA LIKE ILLNESS,2
IE,INJECTION SITE CELLULITIS,2
IE,INJECTION SITE PRURITUS,2
IE,INJECTION SITE RASH,2
IE,INJECTION SITE REACTION,2
IE,INJECTION SITE WARMTH,2
IE,LOSS OF CONSCIOUSNESS,2
IE,LYMPHADENOPATHY,2
IE,MALIGNANT MELANOMA,2
IE,MUSCULOSKELETAL PAIN,2
IE,NASOPHARYNGITIS,2
IE,NON-HODGKIN^S LYMPHOMA,2
IE,PERIPHERAL SWELLING,2
IE,PNEUMONIA KLEBSIELLA,2
IE,PRODUCT QUALITY ISSUE,2
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
IE,PROSTATE CANCER,2
IE,RECTAL ADENOCARCINOMA,2
IE,RETROPERITONEAL FIBROSIS,2
IE,SUICIDAL IDEATION,2
IE,URINARY TRACT INFECTION,2
IE,VIRAL INFECTION,2
IE,WEIGHT DECREASED,2
IE,WOUND INFECTION,2
IE,ABASIA,1
IE,ABDOMINAL DISTENSION,1
IE,ABORTION SPONTANEOUS,1
IE,ABSCESS,1
IE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IE,ACUTE MYELOID LEUKAEMIA,1
IE,AGITATION,1
IE,ALANINE AMINOTRANSFERASE DECREASED,1
IE,AMENORRHOEA,1
IE,ARTHRITIS INFECTIVE,1
IE,ASPERGILLUS INFECTION,1
IE,B-CELL LYMPHOMA,1
IE,BACK DISORDER,1
IE,BASAL CELL CARCINOMA,1
IE,BENIGN HYDATIDIFORM MOLE,1
IE,BENIGN PROSTATIC HYPERPLASIA,1
IE,BLINDNESS,1
IE,BLISTER,1
IE,BLOOD CALCIUM DECREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IE,BLOOD GLUCOSE INCREASED,1
IE,BLOOD IRON DECREASED,1
IE,BLOOD TEST ABNORMAL,1
IE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
IE,BLOOD UREA INCREASED,1
IE,BODY TEMPERATURE INCREASED,1
IE,BONE DISORDER,1
IE,BREAST CANCER FEMALE,1
IE,BRONCHIAL NEOPLASM,1
IE,BUTTERFLY RASH,1
IE,CARDIOMYOPATHY,1
IE,CATARACT,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CERVIX CANCER METASTATIC,1
IE,CHEST DISCOMFORT,1
IE,CHOKING,1
IE,CHOLELITHIASIS,1
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IE,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
IE,CLINICALLY ISOLATED SYNDROME,1
IE,COELIAC DISEASE,1
IE,COLITIS,1
IE,COLOUR BLINDNESS ACQUIRED,1
IE,CONSTIPATION,1
IE,DEAFNESS,1
IE,DECREASED APPETITE,1
IE,DEHYDRATION,1
IE,DEPRESSED MOOD,1
IE,DEPRESSION,1
IE,DEVICE LEAKAGE,1
IE,DEVICE MALFUNCTION,1
IE,DIABETIC RETINOPATHY,1
IE,DIPLOPIA,1
IE,DISCOMFORT,1
IE,DISEASE RECURRENCE,1
IE,DIVERTICULITIS,1
IE,DRUG DISPENSING ERROR,1
IE,DRUG HYPERSENSITIVITY,1
IE,DRUG USE DISORDER,1
IE,DRUG-INDUCED LIVER INJURY,1
IE,DYSKINESIA,1
IE,DYSPNOEA EXERTIONAL,1
IE,EAR DISORDER,1
IE,EATING DISORDER,1
IE,ERECTILE DYSFUNCTION,1
IE,EYE DISORDER,1
IE,EYE SWELLING,1
IE,FAECALOMA,1
IE,FEAR,1
IE,FEAR OF INJECTION,1
IE,FEEDING DISORDER,1
IE,FOAMING AT MOUTH,1
IE,GROIN PAIN,1
IE,HAEMATOCRIT DECREASED,1
IE,HEAD INJURY,1
IE,HERPES ZOSTER,1
IE,HODGKIN^S DISEASE,1
IE,HOT FLUSH,1
IE,HYPERCHOLESTEROLAEMIA,1
IE,HYPERSENSITIVITY,1
IE,HYPERTENSION,1
IE,HYPERTONIA,1
IE,ILEUS,1
IE,IMPAIRED HEALING,1
IE,IMPAIRED WORK ABILITY,1
IE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IE,INCREASED VISCOSITY OF BRONCHIAL SECRETION,1
IE,INFLAMMATION,1
IE,INFLUENZA,1
IE,INJECTION SITE DISCOMFORT,1
IE,INJECTION SITE INDURATION,1
IE,INJECTION SITE INFLAMMATION,1
IE,INJECTION SITE OEDEMA,1
IE,INTERVERTEBRAL DISC PROTRUSION,1
IE,INTERVERTEBRAL DISCITIS,1
IE,JOINT STIFFNESS,1
IE,JOINT SWELLING,1
IE,LARGE INTESTINAL ULCER,1
IE,LETHARGY,1
IE,LIBIDO DECREASED,1
IE,LICHEN PLANUS,1
IE,LUMBAR SPINAL STENOSIS,1
IE,LUNG INFECTION,1
IE,MASTECTOMY,1
IE,MATERNAL EXPOSURE DURING PREGNANCY,1
IE,MEMORY IMPAIRMENT,1
IE,METASTATIC MALIGNANT MELANOMA,1
IE,METASTATIC NEOPLASM,1
IE,MOBILITY DECREASED,1
IE,MULTIPLE FRACTURES,1
IE,MUSCLE SPASMS,1
IE,MUSCLE STRAIN,1
IE,MUSCLE TWITCHING,1
IE,MUSCULAR WEAKNESS,1
IE,MUSCULOSKELETAL STIFFNESS,1
IE,MYOCARDIAL INFARCTION,1
IE,NASAL CONGESTION,1
IE,NEEDLE ISSUE,1
IE,NERVE COMPRESSION,1
IE,NEUTROPENIA,1
IE,NODULAR MELANOMA,1
IE,NODULE,1
IE,NON-CARDIAC CHEST PAIN,1
IE,OCULAR ICTERUS,1
IE,OEDEMA PERIPHERAL,1
IE,OPTIC NEUROPATHY,1
IE,OVERDOSE,1
IE,PAIN OF SKIN,1
IE,PALPITATIONS,1
IE,PANIC ATTACK,1
IE,PARAESTHESIA,1
IE,PERICARDITIS,1
IE,PERINEURIAL CYST,1
IE,PRE-EXISTING CONDITION IMPROVED,1
IE,PRESCRIBED UNDERDOSE,1
IE,PRESYNCOPE,1
IE,PRODUCT CONTAMINATION PHYSICAL,1
IE,PRODUCT STORAGE ERROR,1
IE,PRODUCTIVE COUGH,1
IE,PROTHROMBIN TIME PROLONGED,1
IE,PSORIATIC ARTHROPATHY,1
IE,PULMONARY MASS,1
IE,RASH ERYTHEMATOUS,1
IE,RASH PAPULAR,1
IE,RASH PRURITIC,1
IE,RECTAL HAEMORRHAGE,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IE,RENAL DISORDER,1
IE,RESPIRATORY DISORDER,1
IE,RESPIRATORY TRACT INFECTION,1
IE,RESTLESS LEGS SYNDROME,1
IE,RHONCHI,1
IE,SEIZURE,1
IE,SELF-INJURIOUS IDEATION,1
IE,SENSORY DISTURBANCE,1
IE,SEPSIS,1
IE,SEROSITIS,1
IE,SERUM FERRITIN INCREASED,1
IE,SINUS DISORDER,1
IE,SKIN ABRASION,1
IE,SKIN IRRITATION,1
IE,SKIN PAPILLOMA,1
IE,SLEEP DISORDER,1
IE,SPONDYLITIS,1
IE,SQUAMOUS CELL CARCINOMA,1
IE,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
IE,SWELLING,1
IE,SWELLING FACE,1
IE,SYNCOPE,1
IE,THERAPEUTIC RESPONSE SHORTENED,1
IE,THERAPEUTIC RESPONSE UNEXPECTED,1
IE,THYROID B-CELL LYMPHOMA,1
IE,TINNITUS,1
IE,TONGUE BITING,1
IE,TOOTH DISORDER,1
IE,TRISOMY 21,1
IE,TUBERCULOSIS,1
IE,ULCER,1
IE,UNDERDOSE,1
IE,UPPER LIMB FRACTURE,1
IE,UPPER RESPIRATORY TRACT INFECTION,1
IE,URTICARIA,1
IE,UVEITIS,1
IE,VAGINAL HAEMORRHAGE,1
IE,VISION BLURRED,1
IE,WHITE BLOOD CELL COUNT DECREASED,1
IE,WRIST FRACTURE,1
IE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
IL,PYREXIA,18
IL,CONDITION AGGRAVATED,17
IL,DRUG INEFFECTIVE,15
IL,FALL,9
IL,PNEUMONIA,7
IL,RESPIRATORY TRACT INFECTION,6
IL,RHEUMATOID ARTHRITIS,6
IL,ASTHENIA,5
IL,INFECTION,5
IL,ARTHRALGIA,4
IL,BREAST CANCER,4
IL,DIARRHOEA,4
IL,HYPERTENSION,4
IL,JUVENILE IDIOPATHIC ARTHRITIS,4
IL,LOSS OF CONSCIOUSNESS,4
IL,MYOCARDIAL INFARCTION,4
IL,ABDOMINAL PAIN,3
IL,ARTHRITIS,3
IL,CEREBROVASCULAR ACCIDENT,3
IL,DRUG HYPERSENSITIVITY,3
IL,INJECTION SITE REACTION,3
IL,INTRACRANIAL ANEURYSM,3
IL,PSORIATIC ARTHROPATHY,3
IL,RIB FRACTURE,3
IL,SYSTEMIC LUPUS ERYTHEMATOSUS,3
IL,VOMITING,3
IL,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,2
IL,ARTHROPATHY,2
IL,ASTHMA,2
IL,BRONCHIECTASIS,2
IL,DEEP VEIN THROMBOSIS,2
IL,EAR INFECTION,2
IL,FEELING ABNORMAL,2
IL,HAEMATOMA,2
IL,HEAD INJURY,2
IL,HEADACHE,2
IL,HERNIA,2
IL,HYPERHIDROSIS,2
IL,HYPERSENSITIVITY,2
IL,INJECTION SITE ERYTHEMA,2
IL,INJECTION SITE HAEMORRHAGE,2
IL,INJECTION SITE PRURITUS,2
IL,JOINT SWELLING,2
IL,LYMPHOMA,2
IL,MATERNAL EXPOSURE DURING PREGNANCY,2
IL,MENINGIOMA,2
IL,NAUSEA,2
IL,NEPHRITIS,2
IL,NEUTROPENIA,2
IL,PAIN,2
IL,PAIN IN EXTREMITY,2
IL,PHARYNGITIS,2
IL,PROSTATE CANCER,2
IL,PULMONARY OEDEMA,2
IL,SEPSIS,2
IL,STILL^S DISEASE,2
IL,URINARY TRACT INFECTION,2
IL,WEIGHT INCREASED,2
IL,ABDOMINAL MASS,1
IL,ABORTION SPONTANEOUS,1
IL,ABSCESS,1
IL,ABSCESS LIMB,1
IL,ACCIDENT,1
IL,ALANINE AMINOTRANSFERASE INCREASED,1
IL,ALLERGIC OEDEMA,1
IL,ANAEMIA,1
IL,ANAEMIA MACROCYTIC,1
IL,ANAL FISTULA,1
IL,ANGIOPATHY,1
IL,ANKLE FRACTURE,1
IL,ANKYLOSING SPONDYLITIS,1
IL,ARTHRITIS BACTERIAL,1
IL,ARTHRITIS INFECTIVE,1
IL,B-CELL LYMPHOMA,1
IL,BACK PAIN,1
IL,BALANCE DISORDER,1
IL,BLADDER CANCER,1
IL,BLADDER NEOPLASM,1
IL,BLADDER PROLAPSE,1
IL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD PRESSURE INCREASED,1
IL,BREAST CANCER FEMALE,1
IL,BRONCHITIS,1
IL,BURN INFECTION,1
IL,BURNS SECOND DEGREE,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CARDIAC VALVE DISEASE,1
IL,CARDIOMYOPATHY,1
IL,CELLULITIS,1
IL,CHOLECYSTITIS,1
IL,CHOLELITHIASIS,1
IL,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
IL,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,COAGULOPATHY,1
IL,COGNITIVE DISORDER,1
IL,COLITIS,1
IL,COMPLICATION OF DELIVERY,1
IL,COUGH,1
IL,CROHN^S DISEASE,1
IL,DEAFNESS,1
IL,DEPRESSION,1
IL,DIABETES MELLITUS,1
IL,DIARRHOEA HAEMORRHAGIC,1
IL,DISEASE PROGRESSION,1
IL,DISEASE RECURRENCE,1
IL,DIZZINESS,1
IL,DRUG ADMINISTRATION ERROR,1
IL,DYSPEPSIA,1
IL,DYSPNOEA,1
IL,DYSSTASIA,1
IL,EMOTIONAL DISTRESS,1
IL,EOSINOPHILIA,1
IL,EPILEPSY,1
IL,EPISTAXIS,1
IL,ERYTHEMA,1
IL,EXPOSURE VIA PARTNER,1
IL,EYE DISORDER,1
IL,FACIAL PAIN,1
IL,FACIAL PARALYSIS,1
IL,FATIGUE,1
IL,FEELING HOT,1
IL,FEMORAL NECK FRACTURE,1
IL,FEMUR FRACTURE,1
IL,FOETAL MALPRESENTATION,1
IL,FOOT FRACTURE,1
IL,GAIT DISTURBANCE,1
IL,GASTRIC ULCER,1
IL,GASTROENTERITIS,1
IL,GASTROINTESTINAL CARCINOMA,1
IL,GENE MUTATION,1
IL,GRANULOMA,1
IL,GRANULOMATOSIS WITH POLYANGIITIS,1
IL,HAEMATOCHEZIA,1
IL,HAEMOGLOBIN DECREASED,1
IL,HAEMORRHAGE,1
IL,HAND FRACTURE,1
IL,HELICOBACTER INFECTION,1
IL,HEMIANOPIA,1
IL,HEPATIC STEATOSIS,1
IL,HEPATOCELLULAR CARCINOMA,1
IL,HERPES VIRUS INFECTION,1
IL,HERPES ZOSTER,1
IL,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
IL,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
IL,ILEAL ULCER,1
IL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IL,INFLAMMATION,1
IL,INFLAMMATORY BOWEL DISEASE,1
IL,INJECTION SITE HYPERAESTHESIA,1
IL,INJECTION SITE PAIN,1
IL,INJECTION SITE PARAESTHESIA,1
IL,INJECTION SITE SWELLING,1
IL,INJECTION SITE WARMTH,1
IL,INJURY,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTRACRANIAL PRESSURE INCREASED,1
IL,IRIDOCYCLITIS,1
IL,JOINT INJURY,1
IL,LACERATION,1
IL,LEUKOPENIA,1
IL,LIGAMENT SPRAIN,1
IL,LIMB INJURY,1
IL,LIP SWELLING,1
IL,LIVER FUNCTION TEST INCREASED,1
IL,LOCAL SWELLING,1
IL,LOWER LIMB FRACTURE,1
IL,LUNG INFECTION,1
IL,LUNG NEOPLASM,1
IL,LUNG NEOPLASM MALIGNANT,1
IL,LYMPH GLAND INFECTION,1
IL,LYMPHADENOPATHY,1
IL,MALIGNANT URINARY TRACT NEOPLASM,1
IL,MEDICATION ERROR,1
IL,MENINGITIS,1
IL,MENISCUS INJURY,1
IL,MENSTRUATION DELAYED,1
IL,METASTASES TO LYMPH NODES,1
IL,METASTASES TO PELVIS,1
IL,METASTASES TO RETROPERITONEUM,1
IL,MIGRAINE,1
IL,MITRAL VALVE DISEASE,1
IL,MYASTHENIA GRAVIS,1
IL,MYELITIS,1
IL,MYELOPROLIFERATIVE DISORDER,1
IL,MYOSITIS,1
IL,NASOPHARYNGITIS,1
IL,NEOPLASM MALIGNANT,1
IL,NODULAR REGENERATIVE HYPERPLASIA,1
IL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
IL,NORMOCYTIC ANAEMIA,1
IL,OEDEMA,1
IL,OEDEMA MUCOSAL,1
IL,ORTHOSTATIC HYPOTENSION,1
IL,OSTEONECROSIS,1
IL,OVARIAN CANCER METASTATIC,1
IL,OVARIAN NEOPLASM,1
IL,OVERDOSE,1
IL,OXYGEN SATURATION ABNORMAL,1
IL,PALPITATIONS,1
IL,PANCREATITIS,1
IL,PANCYTOPENIA,1
IL,PAPILLARY THYROID CANCER,1
IL,PARAESTHESIA,1
IL,PARAESTHESIA ORAL,1
IL,PARALYSIS,1
IL,PARASITE STOOL TEST POSITIVE,1
IL,PEMPHIGUS,1
IL,PERICARDIAL EFFUSION,1
IL,PERINEPHRIC ABSCESS,1
IL,PHARYNGITIS BACTERIAL,1
IL,PHARYNGITIS STREPTOCOCCAL,1
IL,PNEUMONITIS,1
IL,PORTAL HYPERTENSION,1
IL,POST HERPETIC NEURALGIA,1
IL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
IL,POSTOPERATIVE WOUND INFECTION,1
IL,PRODUCT QUALITY ISSUE,1
IL,PRURITUS,1
IL,PSORIASIS,1
IL,PULMONARY FIBROSIS,1
IL,PULMONARY HYPERTENSION,1
IL,PULMONARY MASS,1
IL,PYODERMA GANGRENOSUM,1
IL,RASH GENERALISED,1
IL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IL,RENAL CANCER,1
IL,RENAL FAILURE,1
IL,RENAL FAILURE ACUTE,1
IL,RENAL IMPAIRMENT,1
IL,SALMONELLOSIS,1
IL,SARCOIDOSIS,1
IL,SARCOMA,1
IL,SEIZURE,1
IL,SMALL CELL CARCINOMA,1
IL,SPINAL COLUMN STENOSIS,1
IL,SYNCOPE,1
IL,SYNOVIAL CYST,1
IL,TENDON DISORDER,1
IL,THYROID CANCER,1
IL,TOOTH DISORDER,1
IL,TOOTH INFECTION,1
IL,TRANSIENT ISCHAEMIC ATTACK,1
IL,TREATMENT FAILURE,1
IL,TRISOMY 18,1
IL,TUBERCULOSIS,1
IL,UPPER RESPIRATORY TRACT INFECTION,1
IL,URINARY RETENTION,1
IL,UTERINE MASS,1
IL,UTERINE NEOPLASM,1
IL,UVEITIS,1
IL,VAGINAL HAEMORRHAGE,1
IL,VISION BLURRED,1
IL,VISUAL FIELD DEFECT,1
IL,WEIGHT DECREASED,1
IL,WHITE BLOOD CELL COUNT DECREASED,1
IL,WOUND,1
IL,WOUND INFECTION,1
IT,DRUG INEFFECTIVE,78
IT,RHEUMATOID ARTHRITIS,38
IT,ARTHRALGIA,17
IT,PYREXIA,17
IT,ARTHRITIS,14
IT,PSORIATIC ARTHROPATHY,13
IT,BLADDER CANCER,10
IT,COUGH,10
IT,CONDITION AGGRAVATED,9
IT,BREAST CANCER,8
IT,ERYTHEMA,8
IT,ANKYLOSING SPONDYLITIS,7
IT,CHOLANGITIS,7
IT,PSORIASIS,7
IT,TUBERCULOSIS,7
IT,CROHN^S DISEASE,6
IT,INFLAMMATORY BOWEL DISEASE,6
IT,PANCREATITIS ACUTE,6
IT,PAPILLARY CYSTADENOMA LYMPHOMATOSUM,6
IT,PNEUMONIA,6
IT,THYROID CANCER,6
IT,ALANINE AMINOTRANSFERASE INCREASED,5
IT,ASPARTATE AMINOTRANSFERASE INCREASED,5
IT,BRONCHITIS,5
IT,HYPERTENSIVE CRISIS,5
IT,LOCAL SWELLING,5
IT,LYMPHADENOPATHY,5
IT,MALIGNANT MELANOMA,5
IT,NASOPHARYNGITIS,5
IT,PARAESTHESIA,5
IT,PRODUCT USE IN UNAPPROVED INDICATION,5
IT,TACHYCARDIA,5
IT,ASPERGILLUS INFECTION,4
IT,ASTHENIA,4
IT,BLISTER,4
IT,DEEP VEIN THROMBOSIS,4
IT,DEMYELINATION,4
IT,DISEASE PROGRESSION,4
IT,DYSPNOEA,4
IT,EPILEPSY,4
IT,EXPOSURE DURING PREGNANCY,4
IT,HEADACHE,4
IT,HEPATIC STEATOSIS,4
IT,INJECTION SITE ERYTHEMA,4
IT,INVASIVE DUCTAL BREAST CARCINOMA,4
IT,LUNG NEOPLASM MALIGNANT,4
IT,NEUTROPENIA,4
IT,PAIN,4
IT,SQUAMOUS CELL CARCINOMA OF SKIN,4
IT,THROMBOCYTOPENIA,4
IT,URTICARIA,4
IT,UVEITIS,4
IT,VARICELLA,4
IT,ABDOMINAL PAIN,3
IT,ABDOMINAL PAIN UPPER,3
IT,ALTERED STATE OF CONSCIOUSNESS,3
IT,BREAST CANCER FEMALE,3
IT,C-REACTIVE PROTEIN INCREASED,3
IT,CORONARY ARTERY STENOSIS,3
IT,CYSTITIS,3
IT,DIARRHOEA,3
IT,DIPLOPIA,3
IT,FATIGUE,3
IT,GASTROINTESTINAL DISORDER,3
IT,HAEMORRHAGE,3
IT,HEPATOCELLULAR CARCINOMA,3
IT,HODGKIN^S DISEASE,3
IT,HYPERHIDROSIS,3
IT,HYPERPYREXIA,3
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
IT,IRIDOCYCLITIS,3
IT,LEUKOPENIA,3
IT,LOSS OF CONSCIOUSNESS,3
IT,LOWER RESPIRATORY TRACT INFECTION,3
IT,LYMPHOMA,3
IT,MEDIASTINITIS,3
IT,MENINGITIS ASEPTIC,3
IT,MENINGITIS PNEUMOCOCCAL,3
IT,MUSCLE SPASMS,3
IT,MYOCARDIAL INFARCTION,3
IT,NECROTISING FASCIITIS,3
IT,NEOPLASM,3
IT,NO THERAPEUTIC RESPONSE,3
IT,PAPILLOEDEMA,3
IT,PENILE SQUAMOUS CELL CARCINOMA,3
IT,PLEURAL EFFUSION,3
IT,PRURITUS,3
IT,PULMONARY TUBERCULOSIS,3
IT,PURPURA FULMINANS,3
IT,RETROPERITONEAL FIBROSIS,3
IT,STREPTOCOCCAL SEPSIS,3
IT,TRANSAMINASES INCREASED,3
IT,URINARY TRACT INFECTION,3
IT,VERTIGO,3
IT,ABORTION SPONTANEOUS,2
IT,ADENOCARCINOMA,2
IT,ADENOCARCINOMA GASTRIC,2
IT,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,2
IT,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,2
IT,APHASIA,2
IT,ATRIAL FIBRILLATION,2
IT,B-CELL LYMPHOMA,2
IT,BALANCE DISORDER,2
IT,BILIARY HAMARTOMA,2
IT,BLADDER TRANSITIONAL CELL CARCINOMA,2
IT,CARCINOEMBRYONIC ANTIGEN INCREASED,2
IT,CARDIAC FAILURE,2
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
IT,COLITIS ULCERATIVE,2
IT,COLON CANCER,2
IT,CYSTIC FIBROSIS,2
IT,DERMO-HYPODERMITIS,2
IT,DRUG ABUSE,2
IT,DYSARTHRIA,2
IT,DYSGEUSIA,2
IT,DYSPEPSIA,2
IT,ENDOCARDITIS BACTERIAL,2
IT,FEMALE GENITAL TRACT FISTULA,2
IT,FLUSHING,2
IT,GLOMERULONEPHRITIS,2
IT,HEMIPARESIS,2
IT,HEPATIC CANCER,2
IT,HEPATIC CIRRHOSIS,2
IT,HERPES ZOSTER,2
IT,HOT FLUSH,2
IT,HYPERTRANSAMINASAEMIA,2
IT,HYPOACUSIS,2
IT,HYPOPNOEA,2
IT,IGA NEPHROPATHY,2
IT,INCONTINENCE,2
IT,INFLUENZA,2
IT,INJECTION SITE PRURITUS,2
IT,INJECTION SITE URTICARIA,2
IT,INJECTION SITE VESICLES,2
IT,INTESTINAL POLYP,2
IT,ISCHAEMIC STROKE,2
IT,LIVER DISORDER,2
IT,LUNG ADENOCARCINOMA,2
IT,LYMPHOPENIA,2
IT,MELANOCYTIC NAEVUS,2
IT,METASTASES TO LIVER,2
IT,MILLER FISHER SYNDROME,2
IT,MONOCLONAL B-CELL LYMPHOCYTOSIS,2
IT,MOVEMENT DISORDER,2
IT,MULTIPLE SCLEROSIS,2
IT,MYASTHENIA GRAVIS,2
IT,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
IT,NEOPLASM MALIGNANT,2
IT,NEPHROLITHIASIS,2
IT,NEPHROTIC SYNDROME,2
IT,OEDEMA,2
IT,OSTEOARTHRITIS,2
IT,OVARIAN NEOPLASM,2
IT,OVERDOSE,2
IT,PAIN IN EXTREMITY,2
IT,PAPILLARY THYROID CANCER,2
IT,PERITONEAL TUBERCULOSIS,2
IT,PLEURISY,2
IT,PNEUMONITIS,2
IT,POLYARTHRITIS,2
IT,PRODUCT USE ISSUE,2
IT,PRODUCTIVE COUGH,2
IT,PRURITUS GENERALISED,2
IT,PULMONARY MASS,2
IT,PUSTULAR PSORIASIS,2
IT,RECTAL HAEMORRHAGE,2
IT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
IT,SOPOR,2
IT,SPINAL PAIN,2
IT,SPUTUM DISCOLOURED,2
IT,SYNCOPE,2
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
IT,TREATMENT FAILURE,2
IT,TREMOR,2
IT,URINARY INCONTINENCE,2
IT,VOMITING,2
IT,WEIGHT DECREASED,2
IT,WHITE BLOOD CELL COUNT DECREASED,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABDOMINAL DISTENSION,1
IT,ABSCESS RUPTURE,1
IT,ACTINIC KERATOSIS,1
IT,ACUTE CORONARY SYNDROME,1
IT,ACUTE MYOCARDIAL INFARCTION,1
IT,ADENOCARCINOMA PANCREAS,1
IT,ADENOMA BENIGN,1
IT,ADVERSE EVENT,1
IT,AMNESIA,1
IT,AMYOTROPHIC LATERAL SCLEROSIS,1
IT,ANAEMIA,1
IT,ANAPHYLACTIC REACTION,1
IT,ANGINA PECTORIS,1
IT,ANGINA UNSTABLE,1
IT,ANGIOEDEMA,1
IT,ANKLE FRACTURE,1
IT,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY,1
IT,ANTINUCLEAR ANTIBODY INCREASED,1
IT,ANTINUCLEAR ANTIBODY POSITIVE,1
IT,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,1
IT,AORTIC ANEURYSM RUPTURE,1
IT,AORTIC CALCIFICATION,1
IT,AORTIC STENOSIS,1
IT,AORTIC VALVE INCOMPETENCE,1
IT,APHTHOUS STOMATITIS,1
IT,ARTHROPATHY,1
IT,ASTHMATIC CRISIS,1
IT,ASYMPTOMATIC BACTERIURIA,1
IT,ATRIOVENTRICULAR BLOCK,1
IT,BENIGN PROSTATIC HYPERPLASIA,1
IT,BLADDER NEOPLASM,1
IT,BLINDNESS,1
IT,BLOOD PRESSURE INCREASED,1
IT,BLOOD URINE PRESENT,1
IT,BLOODY DISCHARGE,1
IT,BONE CANCER,1
IT,BONE EROSION,1
IT,BONE NEOPLASM,1
IT,BONE PAIN,1
IT,BREAST DISORDER,1
IT,BRONCHOGENIC CYST,1
IT,BRONCHOSTENOSIS,1
IT,CALCULUS URETERIC,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC VALVE RUPTURE,1
IT,CARPAL TUNNEL SYNDROME,1
IT,CATARACT,1
IT,CATARRH,1
IT,CEREBELLAR SYNDROME,1
IT,CEREBRAL DISORDER,1
IT,CEREBRAL HAEMANGIOMA,1
IT,CERVICAL DYSPLASIA,1
IT,CHEST PAIN,1
IT,CHOLESTASIS,1
IT,COELIAC DISEASE,1
IT,COLITIS MICROSCOPIC,1
IT,COLORECTAL CANCER,1
IT,COMPLEMENT FACTOR DECREASED,1
IT,CONFUSIONAL STATE,1
IT,CONJUNCTIVAL HYPERAEMIA,1
IT,CONTUSION,1
IT,CRYOGLOBULINAEMIA,1
IT,CYTOMEGALOVIRUS HEPATITIS,1
IT,DEATH,1
IT,DEPRESSION,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
IT,DISEASE RECURRENCE,1
IT,DIVERTICULAR PERFORATION,1
IT,DIZZINESS,1
IT,DRUG EFFECT DECREASED,1
IT,DRUG INTOLERANCE,1
IT,DYSPHONIA,1
IT,DYSPLASIA,1
IT,DYSPNOEA EXERTIONAL,1
IT,EMPHYSEMA,1
IT,ENCEPHALITIS,1
IT,ENCEPHALOPATHY,1
IT,ENDOMETRIAL CANCER,1
IT,ERUCTATION,1
IT,ERYTHEMA MULTIFORME,1
IT,ESCHERICHIA INFECTION,1
IT,ESCHERICHIA URINARY TRACT INFECTION,1
IT,EXOPHTHALMOS,1
IT,EXTRAOCULAR MUSCLE PARESIS,1
IT,EXTRAPULMONARY TUBERCULOSIS,1
IT,EYE OEDEMA,1
IT,EYE PAIN,1
IT,EYE SWELLING,1
IT,EYELID PAIN,1
IT,EYELID PTOSIS,1
IT,FACIAL PARALYSIS,1
IT,FEEDING DISORDER,1
IT,FEMUR FRACTURE,1
IT,FLATULENCE,1
IT,FLUID RETENTION,1
IT,FOETAL EXPOSURE DURING PREGNANCY,1
IT,GAIT DISTURBANCE,1
IT,GASTRIC CANCER,1
IT,GASTRIC ULCER,1
IT,GASTRITIS EROSIVE,1
IT,GENERALISED ERYTHEMA,1
IT,GLOSSOPHARYNGEAL NEURALGIA,1
IT,HAEMATOCHEZIA,1
IT,HAEMATURIA,1
IT,HAEMODYNAMIC INSTABILITY,1
IT,HAEMOPTYSIS,1
IT,HAEMORRHAGE URINARY TRACT,1
IT,HALLUCINATION_ VISUAL,1
IT,HELICOBACTER GASTRITIS,1
IT,HEMIPLEGIA,1
IT,HEPATIC ENZYME INCREASED,1
IT,HEPATIC LESION,1
IT,HEPATITIS CHOLESTATIC,1
IT,HEPATOMEGALY,1
IT,HEPATORENAL FAILURE,1
IT,HIP FRACTURE,1
IT,HYPERAMYLASAEMIA,1
IT,HYPERHOMOCYSTEINAEMIA,1
IT,HYPERPROLACTINAEMIA,1
IT,HYPERSENSITIVITY,1
IT,HYPOAESTHESIA,1
IT,HYPOGAMMAGLOBULINAEMIA,1
IT,HYPOGLOSSAL NERVE PARALYSIS,1
IT,HYPOTENSION,1
IT,HYPOTHERMIA,1
IT,IMMUNOSUPPRESSION,1
IT,INDURATION,1
IT,INFECTED FISTULA,1
IT,INFECTION,1
IT,INFLAMMATORY MARKER INCREASED,1
IT,INJECTION RELATED REACTION,1
IT,INJECTION SITE OEDEMA,1
IT,INJECTION SITE PAIN,1
IT,INJECTION SITE REACTION,1
IT,INTENTIONAL DRUG MISUSE,1
IT,INTERMITTENT CLAUDICATION,1
IT,INTERVERTEBRAL DISC PROTRUSION,1
IT,INTERVERTEBRAL DISCITIS,1
IT,INTESTINAL HAEMORRHAGE,1
IT,INVASIVE BREAST CARCINOMA,1
IT,JAUNDICE,1
IT,JAUNDICE CHOLESTATIC,1
IT,JOINT EFFUSION,1
IT,JOINT SWELLING,1
IT,KAPOSI^S SARCOMA,1
IT,LACERATION,1
IT,LACRIMATION INCREASED,1
IT,LARYNGEAL CANCER,1
IT,LARYNGEAL OEDEMA,1
IT,LARYNGITIS,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LEUKOCYTOSIS,1
IT,LEUKOCYTURIA,1
IT,LEUKOENCEPHALOPATHY,1
IT,LIP SWELLING,1
IT,LIPOSARCOMA,1
IT,LIVER FUNCTION TEST ABNORMAL,1
IT,LOCALISED INFECTION,1
IT,LUMBOSACRAL RADICULOPATHY,1
IT,LUNG DISORDER,1
IT,LUNG NEOPLASM,1
IT,LYMPH NODE TUBERCULOSIS,1
IT,LYMPHOCYTOSIS,1
IT,LYMPHOID TISSUE HYPERPLASIA,1
IT,LYMPHOMA CUTIS,1
IT,MACULOPATHY,1
IT,MALAISE,1
IT,MALIGNANT MEDIASTINAL NEOPLASM,1
IT,MATERNAL EXPOSURE DURING PREGNANCY,1
IT,MELKERSSON-ROSENTHAL SYNDROME,1
IT,MENSTRUATION IRREGULAR,1
IT,METASTASES TO LYMPH NODES,1
IT,MOBILITY DECREASED,1
IT,MUCOEPIDERMOID CARCINOMA,1
IT,MULTIPLE FRACTURES,1
IT,MUSCULOSKELETAL STIFFNESS,1
IT,MYALGIA,1
IT,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
IT,MYCOSIS FUNGOIDES,1
IT,MYELITIS,1
IT,MYELOID LEUKAEMIA,1
IT,MYELOPROLIFERATIVE NEOPLASM,1
IT,MYOCARDIAL ISCHAEMIA,1
IT,NAUSEA,1
IT,NODULAR MELANOMA,1
IT,NODULE,1
IT,NON-SMALL CELL LUNG CANCER,1
IT,OBSTRUCTIVE UROPATHY,1
IT,OEDEMA PERIPHERAL,1
IT,OPHTHALMIC HERPES ZOSTER,1
IT,ORAL NEOPLASM,1
IT,OSTEITIS,1
IT,OSTEOMYELITIS BACTERIAL,1
IT,OVARIAN CANCER,1
IT,PALATAL OEDEMA,1
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IT,PANCREATIC NEOPLASM,1
IT,PANCREATITIS,1
IT,PANIC ATTACK,1
IT,PARADOXICAL DRUG REACTION,1
IT,PARAINFLUENZAE VIRUS INFECTION,1
IT,PARKINSON^S DISEASE,1
IT,PEMPHIGOID,1
IT,PERICARDIAL EFFUSION,1
IT,PERICARDITIS,1
IT,PERINEAL ABSCESS,1
IT,PERIPHERAL ARTHRITIS,1
IT,PERIPHERAL COLDNESS,1
IT,PERIPHERAL MOTOR NEUROPATHY,1
IT,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
IT,PERIPHERAL SENSORY NEUROPATHY,1
IT,PERIPHERAL SWELLING,1
IT,PERITONSILLAR ABSCESS,1
IT,PHLEBITIS,1
IT,PNEUMONIA PSEUDOMONAL,1
IT,PNEUMOTHORAX,1
IT,POLYCYTHAEMIA VERA,1
IT,POLYMYALGIA RHEUMATICA,1
IT,POLYMYOSITIS,1
IT,POLYNEUROPATHY,1
IT,PRESCRIBED UNDERDOSE,1
IT,PRESYNCOPE,1
IT,PROSTATE CANCER,1
IT,PULMONARY EMBOLISM,1
IT,PULMONARY FIBROSIS,1
IT,PULMONARY MYCOSIS,1
IT,PYOGENIC GRANULOMA,1
IT,PYRAMIDAL TRACT SYNDROME,1
IT,Q FEVER,1
IT,QUALITY OF LIFE DECREASED,1
IT,RASH,1
IT,RASH ERYTHEMATOUS,1
IT,RAYNAUD^S PHENOMENON,1
IT,RECTAL POLYP,1
IT,REFLUX GASTRITIS,1
IT,RENAL CELL CARCINOMA,1
IT,RENAL COLIC,1
IT,RENAL FAILURE,1
IT,RENAL NEOPLASM,1
IT,RESPIRATORY FAILURE,1
IT,RHEUMATOID FACTOR INCREASED,1
IT,RHEUMATOID NODULE,1
IT,RHINITIS,1
IT,RHONCHI,1
IT,ROAD TRAFFIC ACCIDENT,1
IT,SALIVARY HYPERSECRETION,1
IT,SCLERODACTYLIA,1
IT,SENSORY DISTURBANCE,1
IT,SEPTIC SHOCK,1
IT,SKIN DISORDER,1
IT,SKIN EXFOLIATION,1
IT,SKIN NEOPLASM EXCISION,1
IT,SKIN REACTION,1
IT,SMALL CELL CARCINOMA,1
IT,SMALL FIBRE NEUROPATHY,1
IT,SOMNOLENCE,1
IT,SPUTUM PURULENT,1
IT,SQUAMOUS CELL CARCINOMA,1
IT,SQUAMOUS CELL CARCINOMA OF LUNG,1
IT,STOMATITIS,1
IT,STREPTOCOCCAL ENDOCARDITIS,1
IT,SUBCUTANEOUS ABSCESS,1
IT,SUICIDE ATTEMPT,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,SWELLING,1
IT,SYNOVITIS,1
IT,TENDON DISORDER,1
IT,THERAPEUTIC RESPONSE DECREASED,1
IT,THERAPY NON-RESPONDER,1
IT,THROAT TIGHTNESS,1
IT,THROMBOCYTOSIS,1
IT,THYMOMA,1
IT,THYROID MASS,1
IT,THYROID NEOPLASM,1
IT,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
IT,TONIC CONVULSION,1
IT,TOOTH ABSCESS,1
IT,TOOTH INFECTION,1
IT,TOXIC SKIN ERUPTION,1
IT,TRACHEITIS,1
IT,TRANSIENT ISCHAEMIC ATTACK,1
IT,TRANSITIONAL CELL CARCINOMA,1
IT,TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME,1
IT,UPPER RESPIRATORY TRACT INFECTION,1
IT,URETERIC STENOSIS,1
IT,URINARY TRACT INFECTION BACTERIAL,1
IT,UTERINE LEIOMYOMA,1
IT,VANISHING TWIN SYNDROME,1
IT,VARICELLA ZOSTER PNEUMONIA,1
IT,VARICOCELE,1
IT,VISUAL ACUITY REDUCED,1
IT,WEIGHT INCREASED,1
IT,WHEEZING,1
IT,WHITE MATTER LESION,1
IT,WOUND INFECTION,1
JP,RHEUMATOID ARTHRITIS,110
JP,PNEUMONIA,98
JP,INTERSTITIAL LUNG DISEASE,88
JP,CONDITION AGGRAVATED,77
JP,PYREXIA,56
JP,DRUG INEFFECTIVE,46
JP,FALL,41
JP,LYMPHOMA,41
JP,ARTHRALGIA,38
JP,MALAISE,38
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,36
JP,BREAST CANCER,35
JP,LUNG NEOPLASM MALIGNANT,34
JP,LYMPHOPROLIFERATIVE DISORDER,34
JP,ORGANISING PNEUMONIA,32
JP,COLON CANCER,31
JP,FRACTURE,29
JP,COUGH,28
JP,GASTRIC CANCER,27
JP,PRODUCT USE ISSUE,26
JP,RASH,26
JP,SEPSIS,26
JP,THERAPEUTIC RESPONSE DECREASED,26
JP,DIZZINESS,25
JP,RENAL IMPAIRMENT,25
JP,PAIN,24
JP,PANCYTOPENIA,22
JP,CEREBRAL INFARCTION,21
JP,DEATH,21
JP,DIFFUSE LARGE B-CELL LYMPHOMA,21
JP,INJECTION SITE ERYTHEMA,21
JP,WHITE BLOOD CELL COUNT DECREASED,21
JP,ARTHROPATHY,20
JP,CARDIAC FAILURE,20
JP,CATARACT,20
JP,NASOPHARYNGITIS,20
JP,PLEURAL EFFUSION,20
JP,HERPES ZOSTER,19
JP,INFECTION,19
JP,PLATELET COUNT DECREASED,19
JP,ASTHENIA,18
JP,DIARRHOEA,18
JP,DISSEMINATED INTRAVASCULAR COAGULATION,18
JP,NAUSEA,18
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,18
JP,WEIGHT DECREASED,17
JP,ANAEMIA,16
JP,FEMUR FRACTURE,16
JP,HAEMORRHAGE,16
JP,HEPATIC FUNCTION ABNORMAL,16
JP,INJECTION SITE PAIN,16
JP,SEPTIC SHOCK,16
JP,C-REACTIVE PROTEIN INCREASED,15
JP,CELLULITIS,15
JP,PNEUMONIA ASPIRATION,15
JP,RESPIRATORY FAILURE,15
JP,SPINAL COMPRESSION FRACTURE,15
JP,HAEMORRHAGE SUBCUTANEOUS,14
JP,LUNG DISORDER,14
JP,PNEUMONIA BACTERIAL,14
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,13
JP,INJECTION SITE HAEMORRHAGE,13
JP,PRURITUS,13
JP,URINARY TRACT INFECTION,13
JP,GASTRIC ULCER,12
JP,JOINT SWELLING,12
JP,MUSCULAR WEAKNESS,12
JP,NEPHROTIC SYNDROME,12
JP,URTICARIA,12
JP,UTERINE CANCER,12
JP,DECREASED APPETITE,11
JP,HEADACHE,11
JP,MATERNAL EXPOSURE DURING PREGNANCY,11
JP,NEOPLASM,11
JP,NEOPLASM MALIGNANT,11
JP,VOMITING,11
JP,BLADDER CANCER,10
JP,CONSTIPATION,10
JP,DIABETES MELLITUS,10
JP,DRUG ERUPTION,10
JP,GAIT DISTURBANCE,10
JP,HODGKIN^S DISEASE,10
JP,IMMUNOSUPPRESSION,10
JP,INJECTION SITE PRURITUS,10
JP,PANCREATIC CARCINOMA,10
JP,PERITONITIS,10
JP,PLEURISY,10
JP,TUBERCULOSIS,10
JP,ASCITES,9
JP,BLOOD PRESSURE INCREASED,9
JP,BONE MARROW FAILURE,9
JP,BREAST CANCER FEMALE,9
JP,COMPRESSION FRACTURE,9
JP,DISEASE PROGRESSION,9
JP,HYPOAESTHESIA,9
JP,INFLUENZA,9
JP,INTERNAL HAEMORRHAGE,9
JP,LOSS OF CONSCIOUSNESS,9
JP,OROPHARYNGEAL PAIN,9
JP,PULMONARY EMBOLISM,9
JP,PULMONARY TUBERCULOSIS,9
JP,PYELONEPHRITIS,9
JP,SJOGREN^S SYNDROME,9
JP,SUBARACHNOID HAEMORRHAGE,9
JP,CERVIX CARCINOMA,8
JP,CHOLECYSTITIS,8
JP,ECZEMA,8
JP,FEELING ABNORMAL,8
JP,HYPERTENSION,8
JP,INJECTION SITE BRUISING,8
JP,INJECTION SITE SWELLING,8
JP,JOINT DESTRUCTION,8
JP,LIVER DISORDER,8
JP,LUPUS-LIKE SYNDROME,8
JP,MUSCULOSKELETAL PAIN,8
JP,OEDEMA PERIPHERAL,8
JP,PAIN IN EXTREMITY,8
JP,RENAL FAILURE,8
JP,SARCOIDOSIS,8
JP,ACUTE KIDNEY INJURY,7
JP,APLASTIC ANAEMIA,7
JP,ATYPICAL MYCOBACTERIAL INFECTION,7
JP,BACK PAIN,7
JP,CELL MARKER INCREASED,7
JP,DRUG EFFECT DECREASED,7
JP,DYSPNOEA,7
JP,ENCEPHALOPATHY,7
JP,ERYTHEMA,7
JP,FINGER DEFORMITY,7
JP,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,7
JP,METASTASES TO BONE,7
JP,METASTASES TO LIVER,7
JP,MYCOBACTERIAL INFECTION,7
JP,MYCOBACTERIUM AVIUM COMPLEX INFECTION,7
JP,OSTEOMYELITIS,7
JP,PREMATURE BABY,7
JP,RECTAL CANCER,7
JP,RENAL DISORDER,7
JP,STOMATITIS,7
JP,SWELLING,7
JP,ABDOMINAL PAIN,6
JP,AMYLOIDOSIS,6
JP,ARTHRITIS BACTERIAL,6
JP,ASTHMA,6
JP,ATRIAL FIBRILLATION,6
JP,BLOOD PRESSURE DECREASED,6
JP,CYTOMEGALOVIRUS INFECTION,6
JP,DRUG-INDUCED LIVER INJURY,6
JP,FATIGUE,6
JP,FEMORAL NECK FRACTURE,6
JP,INJECTION SITE REACTION,6
JP,INJURY,6
JP,INSOMNIA,6
JP,LARGE INTESTINE POLYP,6
JP,LUPUS NEPHRITIS,6
JP,MUSCULOSKELETAL DISORDER,6
JP,MUSCULOSKELETAL STIFFNESS,6
JP,MYOCARDIAL INFARCTION,6
JP,OSTEOARTHRITIS,6
JP,OSTEONECROSIS OF JAW,6
JP,PALPITATIONS,6
JP,POLYMYOSITIS,6
JP,RHEUMATOID VASCULITIS,6
JP,SKIN ULCER,6
JP,TUBULOINTERSTITIAL NEPHRITIS,6
JP,ABDOMINAL DISCOMFORT,5
JP,ABDOMINAL DISTENSION,5
JP,ABORTION SPONTANEOUS,5
JP,ALTERED STATE OF CONSCIOUSNESS,5
JP,ANAPHYLACTIC REACTION,5
JP,ANXIETY,5
JP,BLOOD CREATININE INCREASED,5
JP,BRAIN NEOPLASM,5
JP,BRONCHIECTASIS,5
JP,BRONCHITIS,5
JP,CANDIDA INFECTION,5
JP,CARDIAC FAILURE CONGESTIVE,5
JP,CHEST PAIN,5
JP,CHILLS,5
JP,CHOLELITHIASIS,5
JP,GASTROINTESTINAL DISORDER,5
JP,GASTROINTESTINAL HAEMORRHAGE,5
JP,GASTROINTESTINAL PERFORATION,5
JP,HENOCH-SCHONLEIN PURPURA,5
JP,HEPATIC FAILURE,5
JP,HISTIOCYTOSIS HAEMATOPHAGIC,5
JP,HYPERSENSITIVITY,5
JP,ILEUS,5
JP,INFUSION RELATED REACTION,5
JP,JOINT DISLOCATION,5
JP,LIVER FUNCTION TEST ABNORMAL,5
JP,LUNG ADENOCARCINOMA,5
JP,NEPHRITIS,5
JP,NERVOUSNESS,5
JP,PNEUMOTHORAX,5
JP,PRODUCTIVE COUGH,5
JP,RENAL CANCER,5
JP,ROAD TRAFFIC ACCIDENT,5
JP,SINUSITIS,5
JP,SOMNOLENCE,5
JP,STAPHYLOCOCCAL SEPSIS,5
JP,STREPTOCOCCAL INFECTION,5
JP,TENDON RUPTURE,5
JP,THROMBOTIC MICROANGIOPATHY,5
JP,UPPER LIMB FRACTURE,5
JP,UVEITIS,5
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
JP,ACUTE HEPATIC FAILURE,4
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,4
JP,ACUTE RESPIRATORY FAILURE,4
JP,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,4
JP,ARRHYTHMIA,4
JP,ARTHRITIS,4
JP,BLOOD TEST ABNORMAL,4
JP,BRONCHOPULMONARY ASPERGILLOSIS,4
JP,COMA HEPATIC,4
JP,CONTUSION,4
JP,CYSTITIS,4
JP,DEHYDRATION,4
JP,DEMENTIA,4
JP,DEMYELINATION,4
JP,DENTAL CARIES,4
JP,DEPRESSION,4
JP,DERMATOMYOSITIS,4
JP,DRUG EFFECT INCOMPLETE,4
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
JP,DRY EYE,4
JP,DYSARTHRIA,4
JP,DYSPHAGIA,4
JP,EPSTEIN-BARR VIRUS INFECTION,4
JP,FOETAL GROWTH RESTRICTION,4
JP,FOOT DEFORMITY,4
JP,HAEMATURIA,4
JP,HAEMOGLOBIN DECREASED,4
JP,HAEMOPTYSIS,4
JP,HOSPITALISATION,4
JP,HUMERUS FRACTURE,4
JP,HYDRONEPHROSIS,4
JP,INFLAMMATION,4
JP,INTENTIONAL UNDERDOSE,4
JP,LEUKOENCEPHALOPATHY,4
JP,MELAENA,4
JP,METASTASES TO LUNG,4
JP,METASTASES TO LYMPH NODES,4
JP,MOBILITY DECREASED,4
JP,MUMPS,4
JP,MUSCLE ABSCESS,4
JP,MYELODYSPLASTIC SYNDROME,4
JP,NEPHRITIC SYNDROME,4
JP,OEDEMA,4
JP,PERIPHERAL SWELLING,4
JP,RASH GENERALISED,4
JP,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
JP,RHEUMATOID LUNG,4
JP,RHINORRHOEA,4
JP,SCIATICA,4
JP,SPINAL COLUMN STENOSIS,4
JP,SPINAL DISORDER,4
JP,SPONDYLITIS,4
JP,SUDDEN HEARING LOSS,4
JP,SUICIDAL IDEATION,4
JP,THYROID CANCER,4
JP,ULCERATIVE KERATITIS,4
JP,UPPER RESPIRATORY TRACT INFLAMMATION,4
JP,VASCULITIS,4
JP,VERTIGO,4
JP,VISUAL ACUITY REDUCED,4
JP,WEIGHT INCREASED,4
JP,WHITE BLOOD CELL COUNT INCREASED,4
JP,ABDOMINAL PAIN LOWER,3
JP,ABDOMINAL PAIN UPPER,3
JP,ABORTION,3
JP,ABSCESS LIMB,3
JP,ACUTE MYELOID LEUKAEMIA,3
JP,ALANINE AMINOTRANSFERASE INCREASED,3
JP,ALVEOLAR PROTEINOSIS,3
JP,ANGINA PECTORIS,3
JP,APPENDICITIS,3
JP,ARTERIAL THROMBOSIS,3
JP,ASPARTATE AMINOTRANSFERASE INCREASED,3
JP,ASPIRATION,3
JP,BACTERIAL INFECTION,3
JP,BEHCET^S SYNDROME,3
JP,BILE DUCT CANCER,3
JP,BLINDNESS UNILATERAL,3
JP,BLOOD BETA-D-GLUCAN INCREASED,3
JP,BLOOD GLUCOSE INCREASED,3
JP,BRAIN ABSCESS,3
JP,BREAST CANCER RECURRENT,3
JP,BRONCHOPNEUMONIA,3
JP,CARDIAC ARREST,3
JP,CARDIOMYOPATHY,3
JP,CARDIOVASCULAR DISORDER,3
JP,CEREBROVASCULAR ACCIDENT,3
JP,CHOLECYSTITIS ACUTE,3
JP,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,3
JP,CONVULSION,3
JP,DEEP VEIN THROMBOSIS,3
JP,DISORIENTATION,3
JP,DISSEMINATED TUBERCULOSIS,3
JP,DIVERTICULITIS,3
JP,DYSPNOEA EXERTIONAL,3
JP,EMPHYSEMA,3
JP,EOSINOPHIL COUNT INCREASED,3
JP,ERYTHEMA MULTIFORME,3
JP,EYELID OEDEMA,3
JP,FACE OEDEMA,3
JP,FUNGAL INFECTION,3
JP,GASTROENTERITIS,3
JP,GENERALISED ERYTHEMA,3
JP,GENITAL HAEMORRHAGE,3
JP,GINGIVAL BLEEDING,3
JP,GLAUCOMA,3
JP,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,3
JP,GLOMERULONEPHRITIS MEMBRANOUS,3
JP,HAEMATEMESIS,3
JP,HEPATITIS B REACTIVATION,3
JP,HYPERTHERMIA,3
JP,IGA NEPHROPATHY,3
JP,INFECTION SUSCEPTIBILITY INCREASED,3
JP,INFECTIVE SPONDYLITIS,3
JP,INJECTION SITE INDURATION,3
JP,INJECTION SITE RASH,3
JP,INTENTIONAL DRUG MISUSE,3
JP,KERATITIS,3
JP,KNEE DEFORMITY,3
JP,LABORATORY TEST ABNORMAL,3
JP,LARGE INTESTINE PERFORATION,3
JP,LARYNGEAL CANCER,3
JP,LEUKOPENIA,3
JP,LUNG NEOPLASM,3
JP,MENINGITIS,3
JP,MOUTH ULCERATION,3
JP,MUSCLE RUPTURE,3
JP,MYALGIA,3
JP,MYASTHENIA GRAVIS,3
JP,NEUTROPHIL COUNT DECREASED,3
JP,NO ADVERSE EVENT,3
JP,OESOPHAGEAL CANDIDIASIS,3
JP,OPTIC NEURITIS,3
JP,OVARIAN CANCER,3
JP,PANCREATITIS,3
JP,PANCREATITIS ACUTE,3
JP,PEMPHIGOID,3
JP,PERICARDITIS,3
JP,PLATELET COUNT INCREASED,3
JP,POLYARTHRITIS,3
JP,PROTEINURIA,3
JP,PRURITUS GENERALISED,3
JP,PULMONARY OEDEMA,3
JP,RASH PUSTULAR,3
JP,RENAL FAILURE ACUTE,3
JP,RESPIRATORY DISORDER,3
JP,RETINAL DETACHMENT,3
JP,RHEUMATIC DISORDER,3
JP,SEASONAL ALLERGY,3
JP,SENSORY DISTURBANCE,3
JP,SKIN DISCOLOURATION,3
JP,SKIN EXFOLIATION,3
JP,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,3
JP,SWELLING FACE,3
JP,THALAMUS HAEMORRHAGE,3
JP,TOOTH DISORDER,3
JP,URINARY RETENTION,3
JP,VIITH NERVE PARALYSIS,3
JP,ACTIVITIES OF DAILY LIVING IMPAIRED,2
JP,ACUTE MYOCARDIAL INFARCTION,2
JP,ADENOCARCINOMA,2
JP,AFFECT LABILITY,2
JP,AGRANULOCYTOSIS,2
JP,ALOPECIA,2
JP,ALVEOLITIS ALLERGIC,2
JP,AMENORRHOEA,2
JP,ANAPHYLACTIC SHOCK,2
JP,ANAPHYLACTOID REACTION,2
JP,ANGIOEDEMA,2
JP,ANTISYNTHETASE SYNDROME,2
JP,AORTIC ANEURYSM,2
JP,AORTIC VALVE STENOSIS,2
JP,APNOEA NEONATAL,2
JP,ARTHRITIS INFECTIVE,2
JP,ATAXIA,2
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
JP,AUTOIMMUNE HEPATITIS,2
JP,AZOTAEMIA,2
JP,BEDRIDDEN,2
JP,BENIGN NEOPLASM,2
JP,BENIGN NEOPLASM OF CHOROID,2
JP,BILE DUCT STONE,2
JP,BILIARY TRACT INFECTION,2
JP,BLISTER,2
JP,BLOOD CHOLESTEROL INCREASED,2
JP,BLOOD UREA INCREASED,2
JP,BLOOD URIC ACID INCREASED,2
JP,BONE DEFORMITY,2
JP,BONE DENSITY DECREASED,2
JP,BONE PAIN,2
JP,C-REACTIVE PROTEIN ABNORMAL,2
JP,CARDIAC DISORDER,2
JP,CHOLANGITIS ACUTE,2
JP,CHRONIC MYELOID LEUKAEMIA,2
JP,CHRONIC MYELOMONOCYTIC LEUKAEMIA,2
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
JP,COGNITIVE DISORDER,2
JP,CUSHINGOID,2
JP,CYANOSIS,2
JP,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,2
JP,CYTOPENIA,2
JP,DEAFNESS,2
JP,DELIRIUM,2
JP,DEMYELINATING POLYNEUROPATHY,2
JP,DEPRESSED MOOD,2
JP,DERMAL CYST,2
JP,DERMATITIS ALLERGIC,2
JP,DEVICE RELATED INFECTION,2
JP,DIABETES MELLITUS INADEQUATE CONTROL,2
JP,DISCOMFORT,2
JP,DISEASE RECURRENCE,2
JP,DRUG DOSE OMISSION,2
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
JP,DRY SKIN,2
JP,DUODENAL ULCER,2
JP,EAR PAIN,2
JP,ENCEPHALITIS AUTOIMMUNE,2
JP,ENDOCARDITIS,2
JP,ENTEROCOLITIS,2
JP,EPIGASTRIC DISCOMFORT,2
JP,EPISTAXIS,2
JP,EPSTEIN-BARR VIRUS TEST POSITIVE,2
JP,EXPOSURE DURING PREGNANCY,2
JP,EXTRADURAL ABSCESS,2
JP,EYE PRURITUS,2
JP,FEBRILE NEUTROPENIA,2
JP,FIBROMYALGIA,2
JP,FOETAL EXPOSURE DURING PREGNANCY,2
JP,FOOT FRACTURE,2
JP,FRACTURE PAIN,2
JP,GASTRIC CANCER STAGE I,2
JP,GASTROINTESTINAL NECROSIS,2
JP,GENERAL PHYSICAL HEALTH DETERIORATION,2
JP,GENERALISED OEDEMA,2
JP,GENERALISED TONIC-CLONIC SEIZURE,2
JP,GESTATIONAL HYPERTENSION,2
JP,GLUCOSE TOLERANCE IMPAIRED,2
JP,GOITRE,2
JP,GUILLAIN-BARRE SYNDROME,2
JP,HEAD INJURY,2
JP,HEART RATE INCREASED,2
JP,HEAT ILLNESS,2
JP,HENOCH-SCHONLEIN PURPURA NEPHRITIS,2
JP,HEPATITIS B,2
JP,HERNIA,2
JP,HYPERBILIRUBINAEMIA NEONATAL,2
JP,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,2
JP,HYPERGLYCAEMIA,2
JP,HYPERHIDROSIS,2
JP,HYPERSENSITIVITY VASCULITIS,2
JP,HYPERURICAEMIA,2
JP,HYPERVENTILATION,2
JP,HYPOCALCAEMIA,2
JP,HYPOGAMMAGLOBULINAEMIA,2
JP,HYPOKALAEMIA,2
JP,HYPONATRAEMIA,2
JP,HYPOPHAGIA,2
JP,IMMUNODEFICIENCY,2
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
JP,INFECTIOUS PLEURAL EFFUSION,2
JP,INFLAMMATORY MARKER INCREASED,2
JP,INGUINAL HERNIA,2
JP,INTENTIONAL PRODUCT USE ISSUE,2
JP,INTESTINAL ISCHAEMIA,2
JP,INTESTINAL OBSTRUCTION,2
JP,INTESTINAL PERFORATION,2
JP,INTRACRANIAL ANEURYSM,2
JP,INTRAOCULAR PRESSURE INCREASED,2
JP,IRON DEFICIENCY ANAEMIA,2
JP,LACUNAR INFARCTION,2
JP,LEUKAEMIA,2
JP,LIMB INJURY,2
JP,LISTERIOSIS,2
JP,LIVER FUNCTION TEST INCREASED,2
JP,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
JP,LUMBAR SPINAL STENOSIS,2
JP,LUNG INFECTION,2
JP,LYMPHADENOPATHY,2
JP,MALIGNANT NEOPLASM OF RENAL PELVIS,2
JP,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
JP,MATRIX METALLOPROTEINASE-3 INCREASED,2
JP,MENIERE^S DISEASE,2
JP,MENINGITIS CRYPTOCOCCAL,2
JP,MENTAL DISORDER,2
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,2
JP,METASTATIC MALIGNANT MELANOMA,2
JP,MITRAL VALVE INCOMPETENCE,2
JP,MUCORMYCOSIS,2
JP,MULTI-ORGAN FAILURE,2
JP,MULTIPLE SCLEROSIS,2
JP,MUSCLE RIGIDITY,2
JP,MYOSITIS,2
JP,NECK PAIN,2
JP,NEPHROGENIC ANAEMIA,2
JP,NERVOUS SYSTEM DISORDER,2
JP,NEUROPATHY PERIPHERAL,2
JP,NEUROPSYCHIATRIC LUPUS,2
JP,OESOPHAGEAL CARCINOMA,2
JP,OPHTHALMIC HERPES SIMPLEX,2
JP,ORAL CANDIDIASIS,2
JP,OROPHARYNGEAL DISCOMFORT,2
JP,OSTEITIS,2
JP,OSTEONECROSIS,2
JP,OSTEOPOROSIS,2
JP,OTITIS MEDIA,2
JP,OVARIAN CYST,2
JP,PACHYMENINGITIS,2
JP,PATENT DUCTUS ARTERIOSUS,2
JP,PELVIC NEOPLASM,2
JP,PERIODONTITIS,2
JP,PETECHIAE,2
JP,PHARYNGEAL CANCER,2
JP,PLASMA CELL MYELOMA,2
JP,PNEUMONIA MYCOPLASMAL,2
JP,PNEUMONITIS,2
JP,POLLAKIURIA,2
JP,POLYNEUROPATHY,2
JP,PRODUCT QUALITY ISSUE,2
JP,PSEUDOMONAS INFECTION,2
JP,PUBIS FRACTURE,2
JP,PURPURA,2
JP,PURULENCE,2
JP,PYELONEPHRITIS ACUTE,2
JP,RASH ERYTHEMATOUS,2
JP,RASH PRURITIC,2
JP,RENAL ABSCESS,2
JP,RESPIRATORY ARREST,2
JP,RESPIRATORY DISTRESS,2
JP,RETROPERITONEAL CANCER,2
JP,RETROPERITONEAL NEOPLASM,2
JP,RHEUMATOID FACTOR INCREASED,2
JP,SACROILIITIS,2
JP,SCLERITIS,2
JP,SECOND PRIMARY MALIGNANCY,2
JP,SEIZURE,2
JP,SENSITIVITY TO WEATHER CHANGE,2
JP,SENSORY LOSS,2
JP,SHOCK,2
JP,SKIN CANCER,2
JP,SKIN INFECTION,2
JP,SMALL CELL LUNG CANCER,2
JP,SOLAR DERMATITIS,2
JP,SPINAL FRACTURE,2
JP,SPINAL OSTEOARTHRITIS,2
JP,SPINAL PAIN,2
JP,SPLENIC ABSCESS,2
JP,SQUAMOUS CELL CARCINOMA,2
JP,STAPHYLOCOCCAL ABSCESS,2
JP,STAPHYLOCOCCAL INFECTION,2
JP,STAPHYLOCOCCUS TEST POSITIVE,2
JP,STILL^S DISEASE ADULT ONSET,2
JP,SUBARACHNOID HAEMORRHAGE NEONATAL,2
JP,SUBDURAL HAEMATOMA,2
JP,SUDDEN DEATH,2
JP,SYNCOPE,2
JP,SYNOVITIS,2
JP,SYSTEMIC CANDIDA,2
JP,T-CELL LYMPHOMA,2
JP,THERMAL BURN,2
JP,THREATENED LABOUR,2
JP,THROMBOCYTOPENIA,2
JP,TOOTHACHE,2
JP,TUBERCULIN TEST POSITIVE,2
JP,TUBULAR BREAST CARCINOMA,2
JP,TUMOUR MARKER ABNORMAL,2
JP,UNDERDOSE,2
JP,UTERINE LEIOMYOMA,2
JP,UTERINE PERFORATION,2
JP,VENOUS THROMBOSIS,2
JP,WOUND INFECTION,2
JP,ABDOMINAL ABSCESS,1
JP,ABDOMINAL LYMPHADENOPATHY,1
JP,ABDOMINAL OPERATION,1
JP,ABDOMINAL WALL HAEMATOMA,1
JP,ABORTION INDUCED,1
JP,ABORTION MISSED,1
JP,ABSCESS,1
JP,ACQUIRED HAEMOPHILIA,1
JP,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
JP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
JP,ACUTE HEPATITIS B,1
JP,ACUTE SINUSITIS,1
JP,ADENOCARCINOMA GASTRIC,1
JP,ADENOCARCINOMA OF COLON,1
JP,ADMINISTRATION SITE REACTION,1
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
JP,ADVERSE EVENT,1
JP,AGEUSIA,1
JP,AGITATION,1
JP,ALANINE AMINOTRANSFERASE ABNORMAL,1
JP,AMNIOTIC FLUID VOLUME DECREASED,1
JP,AMYOTROPHIC LATERAL SCLEROSIS,1
JP,ANAL ABSCESS,1
JP,ANEURYSM,1
JP,ANGINA UNSTABLE,1
JP,ANGIOCENTRIC LYMPHOMA,1
JP,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
JP,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED,1
JP,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
JP,ANTIPHOSPHOLIPID SYNDROME,1
JP,AORTIC ANEURYSM RUPTURE,1
JP,AORTIC OCCLUSION,1
JP,AORTITIS,1
JP,APATHY,1
JP,APHAGIA,1
JP,APHASIA,1
JP,APLASIA PURE RED CELL,1
JP,APPENDICITIS PERFORATED,1
JP,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
JP,ASPERGILLOMA,1
JP,ATONIC SEIZURES,1
JP,ATYPICAL FEMUR FRACTURE,1
JP,ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION,1
JP,ATYPICAL MYCOBACTERIAL PNEUMONIA,1
JP,ATYPICAL PNEUMONIA,1
JP,AUTOIMMUNE DISORDER,1
JP,AXONAL NEUROPATHY,1
JP,AZOOSPERMIA,1
JP,B-CELL LYMPHOMA,1
JP,BACILLUS BACTERAEMIA,1
JP,BACK DISORDER,1
JP,BACTERAEMIA,1
JP,BALANCE DISORDER,1
JP,BASAL CELL CARCINOMA,1
JP,BASEDOW^S DISEASE,1
JP,BASOPHIL PERCENTAGE DECREASED,1
JP,BENIGN PROSTATIC HYPERPLASIA,1
JP,BILE DUCT STENOSIS,1
JP,BIRTH MARK,1
JP,BLADDER TRANSITIONAL CELL CARCINOMA,1
JP,BLOOD ALBUMIN DECREASED,1
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JP,BLOOD BLISTER,1
JP,BLOOD CALCIUM INCREASED,1
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,1
JP,BLOOD PRESSURE SYSTOLIC INCREASED,1
JP,BLOOD TRIGLYCERIDES INCREASED,1
JP,BODY TEMPERATURE DECREASED,1
JP,BODY TEMPERATURE INCREASED,1
JP,BONE ABSCESS,1
JP,BONE CANCER METASTATIC,1
JP,BONE DENSITY ABNORMAL,1
JP,BONE LESION,1
JP,BOWEN^S DISEASE,1
JP,BRADYCARDIA FOETAL,1
JP,BRADYCARDIA NEONATAL,1
JP,BRAIN STEM INFARCTION,1
JP,BREAST CANCER MALE,1
JP,BREAST DISCOMFORT,1
JP,BREAST FEEDING,1
JP,BREAST MASS,1
JP,BREATH SOUNDS ABNORMAL,1
JP,BRONCHIOLITIS,1
JP,BRONCHITIS CHRONIC,1
JP,BUTTERFLY RASH,1
JP,C-REACTIVE PROTEIN DECREASED,1
JP,CACHEXIA,1
JP,CALCULUS URINARY,1
JP,CARBUNCLE,1
JP,CARDIAC VALVE RUPTURE,1
JP,CARDIO-RESPIRATORY ARREST,1
JP,CARDIOMEGALY,1
JP,CAROTID ARTERY THROMBOSIS,1
JP,CATHETERISATION CARDIAC,1
JP,CD20 ANTIGEN POSITIVE,1
JP,CELL-MEDIATED IMMUNE DEFICIENCY,1
JP,CENTRAL NERVOUS SYSTEM LESION,1
JP,CENTRAL OBESITY,1
JP,CEREBELLAR ATROPHY,1
JP,CEREBRAL HAEMORRHAGE,1
JP,CEREBRAL HAEMORRHAGE NEONATAL,1
JP,CEREBROVASCULAR DISORDER,1
JP,CERVICAL DYSPLASIA,1
JP,CERVICAL MYELOPATHY,1
JP,CERVICAL VERTEBRAL FRACTURE,1
JP,CERVIX CARCINOMA STAGE III,1
JP,CHEILITIS,1
JP,CHEST INJURY,1
JP,CHEST X-RAY ABNORMAL,1
JP,CHOKING,1
JP,CHOLANGIOCARCINOMA,1
JP,CHOLANGITIS,1
JP,CHORDAE TENDINAE RUPTURE,1
JP,CHORIORETINOPATHY,1
JP,CHOROID NEOPLASM,1
JP,CHRONIC GASTRITIS,1
JP,CHRONIC RESPIRATORY FAILURE,1
JP,CHRONIC SINUSITIS,1
JP,CIRCULATORY COLLAPSE,1
JP,CLAVICLE FRACTURE,1
JP,COATING IN MOUTH,1
JP,COGAN^S SYNDROME,1
JP,COLD SWEAT,1
JP,COLITIS,1
JP,COLITIS ISCHAEMIC,1
JP,COLITIS ULCERATIVE,1
JP,COLON CANCER METASTATIC,1
JP,COLON CANCER RECURRENT,1
JP,COMMUNICATION DISORDER,1
JP,COMPLEMENT FACTOR C3 DECREASED,1
JP,COMPLICATED FRACTURE,1
JP,COMPUTERISED TOMOGRAM ABNORMAL,1
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
JP,CONGENITAL ANOMALY,1
JP,CONGESTIVE CARDIOMYOPATHY,1
JP,CONJUNCTIVAL HAEMORRHAGE,1
JP,CONJUNCTIVAL NEOPLASM,1
JP,CONJUNCTIVAL ULCER,1
JP,CONJUNCTIVITIS,1
JP,CONJUNCTIVITIS ALLERGIC,1
JP,CONNECTIVE TISSUE DISORDER,1
JP,CORONARY ARTERY STENOSIS,1
JP,CRANIAL NERVE DISORDER,1
JP,CROHN^S DISEASE,1
JP,CRYPTOCOCCOSIS,1
JP,CYSTITIS ESCHERICHIA,1
JP,CYTOMEGALOVIRUS VIRAEMIA,1
JP,DEAFNESS CONGENITAL,1
JP,DEAFNESS UNILATERAL,1
JP,DECREASED IMMUNE RESPONSIVENESS,1
JP,DECUBITUS ULCER,1
JP,DEFORMITY,1
JP,DELUSION,1
JP,DEMENTIA ALZHEIMER^S TYPE,1
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JP,DEPRESSIVE SYMPTOM,1
JP,DERMATITIS,1
JP,DERMATITIS ATOPIC,1
JP,DEVICE FAILURE,1
JP,DEVICE OCCLUSION,1
JP,DIABETIC NEPHROPATHY,1
JP,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
JP,DIFFUSE LARGE B-CELL LYMPHOMA STAGE II,1
JP,DNA ANTIBODY POSITIVE,1
JP,DROWNING,1
JP,DRUG HYPERSENSITIVITY,1
JP,DRUG INTOLERANCE,1
JP,DRUG LEVEL INCREASED,1
JP,DRUG RESISTANCE,1
JP,DRY MOUTH,1
JP,DUODENAL ULCER HAEMORRHAGE,1
JP,DUODENAL ULCER PERFORATION,1
JP,DYSGRAPHIA,1
JP,DYSLIPIDAEMIA,1
JP,DYSPEPSIA,1
JP,DYSPHONIA,1
JP,DYSPNOEA AT REST,1
JP,DYSSTASIA,1
JP,DYSURIA,1
JP,EAR INFECTION,1
JP,EATING DISORDER,1
JP,ELECTROCARDIOGRAM ABNORMAL,1
JP,EMOTIONAL DISTRESS,1
JP,EMPYEMA,1
JP,ENCEPHALITIS,1
JP,ENCEPHALOMYELITIS,1
JP,ENDOMETRIAL ADENOCARCINOMA,1
JP,ENTEROCOLITIS HAEMORRHAGIC,1
JP,ENTEROCOLITIS VIRAL,1
JP,ENTEROVESICAL FISTULA,1
JP,EPHELIDES,1
JP,EPISCLERITIS,1
JP,EPSTEIN-BARR VIRAEMIA,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
JP,ERYSIPELAS,1
JP,ERYTHEMA INDURATUM,1
JP,ERYTHEMA NODOSUM,1
JP,ERYTHEMA OF EYELID,1
JP,EXERCISE TOLERANCE DECREASED,1
JP,EXPIRED DRUG ADMINISTERED,1
JP,EXPOSURE DURING BREAST FEEDING,1
JP,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE I,1
JP,EYE ALLERGY,1
JP,EYE DISCHARGE,1
JP,EYE HAEMORRHAGE,1
JP,EYE PAIN,1
JP,FACIAL PAIN,1
JP,FAECES DISCOLOURED,1
JP,FEAR OF INJECTION,1
JP,FEEDING DISORDER NEONATAL,1
JP,FEELING HOT,1
JP,FELTY^S SYNDROME,1
JP,FEMALE GENITAL TRACT FISTULA,1
JP,FISTULA,1
JP,FISTULA DISCHARGE,1
JP,FLATULENCE,1
JP,FOETAL HEART RATE DECREASED,1
JP,FOETAL HEART RATE INCREASED,1
JP,FOLATE DEFICIENCY,1
JP,FOLLICULITIS,1
JP,FOREARM FRACTURE,1
JP,FOREIGN BODY SENSATION IN EYES,1
JP,FRACTURED ISCHIUM,1
JP,GALLBLADDER CANCER,1
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
JP,GANGRENE,1
JP,GASTRIC ADENOMA,1
JP,GASTRIC POLYPS,1
JP,GASTROENTERITIS NOROVIRUS,1
JP,GASTROINTESTINAL INFECTION,1
JP,GASTROINTESTINAL ULCER,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GENITAL HERPES ZOSTER,1
JP,GENITAL ULCERATION,1
JP,GINGIVAL CANCER,1
JP,GINGIVAL INFECTION,1
JP,GINGIVAL PAIN,1
JP,GINGIVAL SWELLING,1
JP,GLOMERULAR FILTRATION RATE DECREASED,1
JP,GLOMERULONEPHRITIS CHRONIC,1
JP,GLOSSOPTOSIS,1
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
JP,GRANULAR CELL TUMOUR,1
JP,GRANULOCYTOPENIA,1
JP,GRANULOMA,1
JP,GRIP STRENGTH DECREASED,1
JP,HAEMATOCHEZIA,1
JP,HAEMORRHAGIC INFARCTION,1
JP,HAEMORRHOIDS,1
JP,HAIR TEXTURE ABNORMAL,1
JP,HALLUCINATION,1
JP,HALLUCINATION_ VISUAL,1
JP,HAND DEFORMITY,1
JP,HAND FRACTURE,1
JP,HEAD DISCOMFORT,1
JP,HEART INJURY,1
JP,HEART RATE DECREASED,1
JP,HEART RATE IRREGULAR,1
JP,HELICOBACTER INFECTION,1
JP,HEPATIC CANCER,1
JP,HEPATIC CIRRHOSIS,1
JP,HEPATIC NEOPLASM,1
JP,HEPATIC STEATOSIS,1
JP,HEPATITIS ACUTE,1
JP,HEPATITIS ALCOHOLIC,1
JP,HEPATITIS B DNA INCREASED,1
JP,HEPATITIS B VIRUS TEST POSITIVE,1
JP,HEPATITIS C,1
JP,HEPATITIS FULMINANT,1
JP,HEPATOSPLENOMEGALY,1
JP,HERPES VIRUS INFECTION,1
JP,HIP ARTHROPLASTY,1
JP,HIP DEFORMITY,1
JP,HIP FRACTURE,1
JP,HODGKIN^S DISEASE LYMPHOCYTE DEPLETION TYPE STAGE UNSPECIFIED,1
JP,HOT FLUSH,1
JP,HUMAN HERPESVIRUS 6 INFECTION,1
JP,HUMAN PAPILLOMA VIRUS TEST POSITIVE,1
JP,HYPERCALCAEMIA,1
JP,HYPERCHOLESTEROLAEMIA,1
JP,HYPERKALAEMIA,1
JP,HYPERNATRAEMIA,1
JP,HYPERTENSIVE ENCEPHALOPATHY,1
JP,HYPOACUSIS,1
JP,HYPOCOMPLEMENTAEMIA,1
JP,HYPOGLYCAEMIA,1
JP,HYPOKINESIA,1
JP,HYPOPHARYNGEAL CANCER,1
JP,HYPOTHERMIA,1
JP,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
JP,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
JP,IMMUNE SYSTEM DISORDER,1
JP,IMMUNE THROMBOCYTOPENIC PURPURA,1
JP,IMPAIRED HEALING,1
JP,IMPETIGO,1
JP,INCISIONAL HERNIA,1
JP,INCORRECT DOSE ADMINISTERED,1
JP,INCORRECT PRODUCT STORAGE,1
JP,INFARCTION,1
JP,INFECTED CYST,1
JP,INFECTED SKIN ULCER,1
JP,INFECTION REACTIVATION,1
JP,INJECTION SITE DISCOLOURATION,1
JP,INJECTION SITE EXTRAVASATION,1
JP,INJECTION SITE INFLAMMATION,1
JP,INJECTION SITE MASS,1
JP,INJECTION SITE WARMTH,1
JP,INTENTIONAL PRODUCT MISUSE,1
JP,INTERLEUKIN LEVEL INCREASED,1
JP,INTERLEUKIN-2 RECEPTOR INCREASED,1
JP,INTERSTITIAL GRANULOMATOUS DERMATITIS,1
JP,INTERVERTEBRAL DISCITIS,1
JP,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
JP,INTRAVENTRICULAR HAEMORRHAGE,1
JP,INTRAVENTRICULAR HAEMORRHAGE NEONATAL,1
JP,INVASIVE DUCTAL BREAST CARCINOMA,1
JP,IRIDOCYCLITIS,1
JP,IRITIS,1
JP,IRRITABLE BOWEL SYNDROME,1
JP,JAUNDICE,1
JP,JAUNDICE NEONATAL,1
JP,JOINT ARTHROPLASTY,1
JP,JOINT INJURY,1
JP,JUVENILE IDIOPATHIC ARTHRITIS,1
JP,KNEE ARTHROPLASTY,1
JP,KNEE OPERATION,1
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
JP,LARYNGEAL PAIN,1
JP,LARYNGEAL SQUAMOUS CELL CARCINOMA,1
JP,LEUKOCYTOCLASTIC VASCULITIS,1
JP,LIGAMENT RUPTURE,1
JP,LIP AND/OR ORAL CAVITY CANCER,1
JP,LIP DRY,1
JP,LIP SWELLING,1
JP,LIPOMA,1
JP,LISTLESS,1
JP,LIVER ABSCESS,1
JP,LOCAL SWELLING,1
JP,LOW BIRTH WEIGHT BABY,1
JP,LUMBAR VERTEBRAL FRACTURE,1
JP,LUNG ABSCESS,1
JP,LUNG ADENOCARCINOMA STAGE IV,1
JP,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
JP,LUNG CYST,1
JP,LUNG SQUAMOUS CELL CARCINOMA METASTATIC,1
JP,LUPUS CYSTITIS,1
JP,LYMPH NODE TUBERCULOSIS,1
JP,LYMPHANGIOMA,1
JP,LYMPHOCYTE COUNT DECREASED,1
JP,LYMPHOPENIA,1
JP,MALIGNANT MEDIASTINAL NEOPLASM,1
JP,MALIGNANT MELANOMA,1
JP,MALIGNANT NEOPLASM PROGRESSION,1
JP,MALIGNANT PERITONEAL NEOPLASM,1
JP,MALIGNANT PLEURAL EFFUSION,1
JP,MALLORY-WEISS SYNDROME,1
JP,MARASMUS,1
JP,MATERNAL EXPOSURE BEFORE PREGNANCY,1
JP,MEDIASTINAL DISORDER,1
JP,MEDIASTINAL MASS,1
JP,MEDICAL DEVICE SITE JOINT INFECTION,1
JP,MENINGIOMA,1
JP,MENINGITIS ASEPTIC,1
JP,MENINGITIS BACTERIAL,1
JP,MENINGITIS LISTERIA,1
JP,MENINGITIS TUBERCULOUS,1
JP,MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS,1
JP,MESENTERIC NEOPLASM,1
JP,MESENTERIC PANNICULITIS,1
JP,METASTASES TO SPINE,1
JP,METASTASIS,1
JP,METASTATIC CARCINOMA OF THE BLADDER,1
JP,METASTATIC SALIVARY GLAND CANCER,1
JP,METRORRHAGIA,1
JP,MICROSCOPIC POLYANGIITIS,1
JP,MICTURITION URGENCY,1
JP,MOVEMENT DISORDER,1
JP,MUCOSAL INFLAMMATION,1
JP,MULTIPLE FRACTURES,1
JP,MUSCLE SPASMS,1
JP,MYCOBACTERIUM CHELONAE INFECTION,1
JP,MYCOTIC ENDOPHTHALMITIS,1
JP,MYELITIS,1
JP,MYOCARDITIS,1
JP,MYOPATHY,1
JP,NASAL CONGESTION,1
JP,NASAL DRYNESS,1
JP,NEPHROLITHIASIS,1
JP,NEUROMYELITIS OPTICA,1
JP,NEUROPATHIC ARTHROPATHY,1
JP,NEUROSARCOIDOSIS,1
JP,NEUROSIS,1
JP,NEUTROPENIA,1
JP,NODULE,1
JP,NORMAL NEWBORN,1
JP,OBSTRUCTED LABOUR,1
JP,OCULAR HYPERAEMIA,1
JP,OCULAR LYMPHOMA,1
JP,OCULAR NEOPLASM,1
JP,OESOPHAGEAL ULCER,1
JP,OLIGURIA,1
JP,OPHTHALMIC HERPES ZOSTER,1
JP,ORAL MUCOSA EROSION,1
JP,ORAL MUCOSAL ERYTHEMA,1
JP,ORAL PAIN,1
JP,OSTEOPOROTIC FRACTURE,1
JP,OTITIS MEDIA CHRONIC,1
JP,OVARIAN CANCER RECURRENT,1
JP,OVERDOSE,1
JP,OVERLAP SYNDROME,1
JP,PANCREATIC ENZYMES INCREASED,1
JP,PANCREATIC NEOPLASM,1
JP,PANNICULITIS,1
JP,PAPILLARY THYROID CANCER,1
JP,PAPILLOMA VIRAL INFECTION,1
JP,PARATHYROID GLAND ENLARGEMENT,1
JP,PARKINSON^S DISEASE,1
JP,PARONYCHIA,1
JO,MYOCARDIAL INFARCTION,1
KR,CONDITION AGGRAVATED,4
KR,DRUG INEFFECTIVE,4
KR,DEATH,3
KR,PYREXIA,3
KR,TUBERCULOSIS,3
KR,HEPATITIS B DNA INCREASED,2
KR,INTERSTITIAL LUNG DISEASE,2
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
KR,PULMONARY TUBERCULOSIS,2
KR,SWELLING FACE,2
KR,ARTHRITIS BACTERIAL,1
KR,ARTHROPATHY,1
KR,ASPERGILLUS INFECTION,1
KR,ASTHENIA,1
KR,B-CELL LYMPHOMA,1
KR,BACK PAIN,1
KR,BLOOD BILIRUBIN INCREASED,1
KR,BLOOD PRESSURE SYSTOLIC INCREASED,1
KR,CHILLS,1
KR,CYTOMEGALOVIRUS INFECTION,1
KR,DEAFNESS NEUROSENSORY,1
KR,DECREASED APPETITE,1
KR,DECREASED IMMUNE RESPONSIVENESS,1
KR,DISEASE RECURRENCE,1
KR,DYSPNOEA,1
KR,DYSSTASIA,1
KR,EYE PAIN,1
KR,FATIGUE,1
KR,FLANK PAIN,1
KR,GAIT DISTURBANCE,1
KR,GRAFT VERSUS HOST DISEASE,1
KR,HAEMORRHAGE,1
KR,HEADACHE,1
KR,HEPATITIS,1
KR,HEPATITIS B,1
KR,HYPERSENSITIVITY,1
KR,IDIOPATHIC PULMONARY FIBROSIS,1
KR,INFLAMMATION,1
KR,MUSCULAR WEAKNESS,1
KR,NEPHRITIS,1
KR,NODULAR VASCULITIS,1
KR,PAIN,1
KR,PANCYTOPENIA,1
KR,PARAESTHESIA,1
KR,PARALYSIS,1
KR,PRODUCT USE IN UNAPPROVED INDICATION,1
KR,PRODUCT USE ISSUE,1
KR,PRURITUS,1
KR,PULMONARY ALVEOLAR HAEMORRHAGE,1
KR,PYELONEPHRITIS,1
KR,RHEUMATOID ARTHRITIS,1
KR,SECONDARY AMYLOIDOSIS,1
KR,SMALL INTESTINAL OBSTRUCTION,1
KR,SPINAL COLUMN STENOSIS,1
KR,STAPHYLOCOCCAL INFECTION,1
KR,SWELLING,1
KR,THYROID B-CELL LYMPHOMA,1
KR,ULCERATIVE KERATITIS,1
KR,UNEVALUABLE EVENT,1
KR,UTERINE INFLAMMATION,1
KR,VARICELLA ZOSTER VIRUS INFECTION,1
KR,YELLOW SKIN,1
KW,HEPATIC ENZYME INCREASED,2
KW,ASTHENIA,1
KW,BLOOD CHOLESTEROL ABNORMAL,1
KW,BLOOD DISORDER,1
KW,BLOOD PRESSURE ABNORMAL,1
KW,CARDIAC DISORDER,1
KW,COOMBS POSITIVE HAEMOLYTIC ANAEMIA,1
KW,DIZZINESS,1
KW,DYSURIA,1
KW,FALL,1
KW,FEMUR FRACTURE,1
KW,HAEMOGLOBIN DECREASED,1
KW,HAEMOPTYSIS,1
KW,HYPOKINESIA,1
KW,PRODUCT USE ISSUE,1
KW,PROSTATOMEGALY,1
KW,URINARY TRACT INFECTION,1
LV,BLINDNESS TRANSIENT,2
LV,ABDOMINAL DISTENSION,1
LV,ABDOMINAL PAIN,1
LV,ASCITES,1
LV,ATYPICAL PNEUMONIA,1
LV,CHOLANGIOCARCINOMA,1
LV,DNA ANTIBODY POSITIVE,1
LV,DRUG EFFECT INCOMPLETE,1
LV,INFLAMMATORY MARKER INCREASED,1
LV,INTERSTITIAL LUNG DISEASE,1
LV,LEUKOPENIA,1
LV,LYMPHOPENIA,1
LV,MATERNAL EXPOSURE DURING PREGNANCY,1
LV,MITRAL VALVE INCOMPETENCE,1
LV,NECROTISING FASCIITIS,1
LV,PAPILLARY THYROID CANCER,1
LV,PLEURISY,1
LV,PNEUMONIA CHLAMYDIAL,1
LV,POLYSEROSITIS,1
LV,PREMATURE BABY,1
LV,PULMONARY VALVE INCOMPETENCE,1
LV,PYREXIA,1
LV,SPLENOMEGALY,1
LV,SYSTEMIC LUPUS ERYTHEMATOSUS,1
LV,TRANSAMINASES INCREASED,1
LV,TRICUSPID VALVE INCOMPETENCE,1
LB,ANAPHYLACTIC SHOCK,1
LB,ANGIOEDEMA,1
LB,CELLULITIS,1
LB,CONDITION AGGRAVATED,1
LB,DRUG INEFFECTIVE,1
LB,ERECTILE DYSFUNCTION,1
LB,GENERAL PHYSICAL CONDITION ABNORMAL,1
LB,HYPERSENSITIVITY,1
LB,MYALGIA,1
LB,PROCEDURAL PAIN,1
LB,TUMOUR FLARE,1
LT,NEUROENDOCRINE CARCINOMA OF THE SKIN,7
LT,CARDIOVASCULAR INSUFFICIENCY,4
LT,FATIGUE,3
LT,METASTASES TO PANCREAS,2
LT,C-REACTIVE PROTEIN INCREASED,1
LT,DIEULAFOY^S VASCULAR MALFORMATION,1
LT,DRUG INEFFECTIVE,1
LT,DYSPNOEA,1
LT,GASTRIC HAEMORRHAGE,1
LT,METASTASES TO SOFT TISSUE,1
LT,NEUROENDOCRINE CARCINOMA METASTATIC,1
LT,PNEUMONIA,1
LT,PULMONARY TUBERCULOSIS,1
LT,RASH PUSTULAR,1
LT,SKIN DISCOLOURATION,1
LT,SKIN MASS,1
LT,SYNCOPE,1
LT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
LT,WHITE BLOOD CELL COUNT INCREASED,1
LU,ABDOMINAL PAIN,1
LU,AMNESIA,1
LU,ARTHROPOD BITE,1
LU,COLONIC ABSCESS,1
LU,DIVERTICULITIS,1
LU,ERYTHEMA MIGRANS,1
LU,LYME DISEASE,1
LU,RETINAL DETACHMENT,1
MO,ANTIBODY TEST ABNORMAL,2
MO,HEPATITIS B E ANTIBODY POSITIVE,2
MO,LIVER FUNCTION TEST ABNORMAL,2
MO,LOSS OF CONSCIOUSNESS,1
MO,PYREXIA,1
MY,DEATH,2
MY,TENDON RUPTURE,2
MY,TUBERCULOSIS,2
MY,ACUTE PULMONARY OEDEMA,1
MY,ARTHRITIS BACTERIAL,1
MY,COUGH,1
MY,DISEASE PROGRESSION,1
MY,FOETAL EXPOSURE DURING PREGNANCY,1
MY,ILEAL PERFORATION,1
MY,INFECTION,1
MY,LOW BIRTH WEIGHT BABY,1
MY,ORGANISING PNEUMONIA,1
MY,PNEUMONIA,1
MY,PULMONARY TUBERCULOSIS,1
MY,PYREXIA,1
MT,ERYTHEMA,2
MT,ACUTE KIDNEY INJURY,1
MT,ANAL ATRESIA,1
MT,ANAPHYLACTIC SHOCK,1
MT,ATRIAL FIBRILLATION,1
MT,BLOOD DISORDER,1
MT,CARDIOVASCULAR DISORDER,1
MT,CHROMATURIA,1
MT,COLON CANCER,1
MT,DEPRESSED MOOD,1
MT,EMBOLISM,1
MT,ENDOCARDITIS,1
MT,EYE INFLAMMATION,1
MT,HYPERSENSITIVITY,1
MT,INFLUENZA LIKE ILLNESS,1
MT,INJECTION SITE REACTION,1
MT,INTESTINAL MASS,1
MT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
MT,OCULAR HYPERAEMIA,1
MT,PLATELET COUNT INCREASED,1
MT,POLYP,1
MT,POST PROCEDURAL COMPLICATION,1
MT,PROSTATE CANCER,1
MT,PYREXIA,1
MT,RECTAL ADENOCARCINOMA,1
MT,RIGHT ATRIAL DILATATION,1
MT,RIGHT VENTRICULAR DILATATION,1
MT,RIGHT VENTRICULAR DYSFUNCTION,1
MT,SKIN ULCER,1
MT,SPINAL DISORDER,1
MT,SWELLING FACE,1
MT,TRISOMY 21,1
MX,DEATH,5
MX,PAIN,5
MX,BRONCHITIS,3
MX,DEMYELINATING POLYNEUROPATHY,3
MX,PERIPHERAL SWELLING,3
MX,PNEUMONIA,3
MX,VOMITING,3
MX,ARTHRITIS BACTERIAL,2
MX,CONDITION AGGRAVATED,2
MX,DECREASED IMMUNE RESPONSIVENESS,2
MX,DEPRESSION,2
MX,DIZZINESS,2
MX,DRUG INEFFECTIVE,2
MX,DYSPNOEA,2
MX,FATIGUE,2
MX,FEELING ABNORMAL,2
MX,HYPERSENSITIVITY,2
MX,IMMUNE SYSTEM DISORDER,2
MX,IMMUNOSUPPRESSION,2
MX,INFECTION,2
MX,INFLUENZA,2
MX,MALAISE,2
MX,MENINGITIS,2
MX,MYOCARDIAL INFARCTION,2
MX,NAUSEA,2
MX,OCULAR HYPERAEMIA,2
MX,RHEUMATOID ARTHRITIS,2
MX,SJOGREN^S SYNDROME,2
MX,TUBERCULOSIS,2
MX,WEIGHT DECREASED,2
MX,ABASIA,1
MX,ABDOMINAL NEOPLASM,1
MX,ACID PEPTIC DISEASE,1
MX,ALLERGY TO ARTHROPOD BITE,1
MX,ALOPECIA,1
MX,ANAPHYLACTIC SHOCK,1
MX,APNOEA,1
MX,APPENDICITIS,1
MX,ARTHRALGIA,1
MX,ARTHRITIS,1
MX,ARTHRITIS SALMONELLA,1
MX,ARTHROPATHY,1
MX,ASCITES,1
MX,ASTHENOPIA,1
MX,ASTHMATIC CRISIS,1
MX,ATRIAL FIBRILLATION,1
MX,BALANCE DISORDER,1
MX,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MX,BLOOD PRESSURE DECREASED,1
MX,BONE LOSS,1
MX,BONE PAIN,1
MX,BREAST CANCER,1
MX,BREAST CANCER FEMALE,1
MX,CARTILAGE INJURY,1
MX,CELLULITIS,1
MX,CEREBROVASCULAR ACCIDENT,1
MX,CEREBROVASCULAR DISORDER,1
MX,CHEST PAIN,1
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MX,COMA,1
MX,DECREASED APPETITE,1
MX,DELIRIUM,1
MX,DEPRESSED MOOD,1
MX,DEVICE ISSUE,1
MX,DIALYSIS,1
MX,DIPLOPIA,1
MX,DRUG DEPENDENCE,1
MX,DRUG DOSE OMISSION,1
MX,ERYTHEMA,1
MX,EYE PAIN,1
MX,FACE OEDEMA,1
MX,GAIT INABILITY,1
MX,GALLBLADDER CANCER,1
MX,GASTRIC ULCER,1
MX,GASTROINTESTINAL INFECTION,1
MX,GENERAL PHYSICAL HEALTH DETERIORATION,1
MX,GENERALISED ERYTHEMA,1
MX,HEADACHE,1
MX,HEPATIC ENZYME INCREASED,1
MX,HEPATIC VEIN THROMBOSIS,1
MX,HERPES ZOSTER,1
MX,HIP FRACTURE,1
MX,HYPOAESTHESIA,1
MX,IMMUNODEFICIENCY,1
MX,IMPAIRED HEALING,1
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MX,INJECTION SITE DISCOMFORT,1
MX,INJECTION SITE PRURITUS,1
MX,INJURY,1
MX,INSOMNIA,1
MX,INTERSTITIAL LUNG DISEASE,1
MX,JOINT ABSCESS,1
MX,JOINT DESTRUCTION,1
MX,JOINT SWELLING,1
MX,LACRIMATION INCREASED,1
MX,LOSS OF CONSCIOUSNESS,1
MX,LUNG CANCER METASTATIC,1
MX,LUNG NEOPLASM MALIGNANT,1
MX,MEMORY IMPAIRMENT,1
MX,METABOLIC DISORDER,1
MX,MOUTH ULCERATION,1
MX,MUSCULOSKELETAL DISCOMFORT,1
MX,MUSCULOSKELETAL STIFFNESS,1
MX,NASAL CONGESTION,1
MX,NECK PAIN,1
MX,NERVOUS SYSTEM DISORDER,1
MX,NOCTURIA,1
MX,ORAL NEOPLASM,1
MX,ORTHOPNOEA,1
MX,OVERLAP SYNDROME,1
MX,OXYGEN SATURATION ABNORMAL,1
MX,PARAESTHESIA,1
MX,PATERNAL EXPOSURE TIMING UNSPECIFIED,1
MX,PERITONEAL TUBERCULOSIS,1
MX,POST PROCEDURAL COMPLICATION,1
MX,PRODUCT USE ISSUE,1
MX,PRURITUS,1
MX,PRURITUS GENERALISED,1
MX,PSORIATIC ARTHROPATHY,1
MX,PULMONARY EMBOLISM,1
MX,PULMONARY OEDEMA,1
MX,PYREXIA,1
MX,RENAL TUBERCULOSIS,1
MX,RESORPTION BONE INCREASED,1
MX,RESPIRATORY DISORDER,1
MX,SKIN CANCER,1
MX,SKIN ULCER,1
MX,SLEEP APNOEA SYNDROME,1
MX,SOMNOLENCE,1
MX,STATUS EPILEPTICUS,1
MX,SWELLING FACE,1
MX,SWOLLEN TONGUE,1
MX,SYNOVIAL RUPTURE,1
MX,TACHYCARDIA,1
MX,THROAT TIGHTNESS,1
MX,THROMBOSIS,1
MX,TOOTH DISORDER,1
MX,TOOTH INFECTION,1
MX,URINARY TRACT INFECTION,1
MX,VISION BLURRED,1
MX,WHEEZING,1
ME,BACTERIAL TEST POSITIVE,1
ME,EMPHYSEMA,1
ME,MICTURITION DISORDER,1
ME,PNEUMONIA,1
ME,TUBERCULIN TEST POSITIVE,1
MA,SEPTIC SHOCK,3
MA,ABSCESS LIMB,2
MA,OSTEOARTHRITIS,2
MA,ARTHROPOD BITE,1
MA,BODY HEIGHT BELOW NORMAL,1
MA,BRADYCARDIA,1
MA,C-REACTIVE PROTEIN INCREASED,1
MA,CARPAL TUNNEL SYNDROME,1
MA,CELLULITIS,1
MA,CHEST DISCOMFORT,1
MA,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
MA,COMPLEX REGIONAL PAIN SYNDROME,1
MA,CUSHINGOID,1
MA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MA,DYSPNOEA,1
MA,HALLUCINATION,1
MA,HEADACHE,1
MA,HISTIOCYTOSIS HAEMATOPHAGIC,1
MA,HYPERTENSION,1
MA,HYPOAESTHESIA,1
MA,INFECTION,1
MA,JOINT DESTRUCTION,1
MA,LEUKAEMIA,1
MA,LOSS OF CONSCIOUSNESS,1
MA,LUNG INFECTION,1
MA,MALAISE,1
MA,OEDEMA PERIPHERAL,1
MA,OSTEOPOROSIS,1
MA,PERIPHERAL COLDNESS,1
MA,PNEUMONIA,1
MA,PRURITUS,1
MA,SEPSIS,1
MA,STAPHYLOCOCCAL INFECTION,1
MA,TINNITUS,1
NL,RHEUMATOID ARTHRITIS,45
NL,DEATH,29
NL,RESPIRATORY TRACT INFECTION,24
NL,URINARY TRACT INFECTION,20
NL,DRUG INEFFECTIVE,17
NL,PSORIATIC ARTHROPATHY,17
NL,CYTOMEGALOVIRUS INFECTION,15
NL,MYOCARDIAL INFARCTION,15
NL,PNEUMONIA,15
NL,BREAST CANCER,14
NL,FATIGUE,14
NL,PYREXIA,14
NL,CYSTITIS,13
NL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,13
NL,ARTHRITIS,12
NL,BRONCHOPULMONARY ASPERGILLOSIS,12
NL,EPSTEIN-BARR VIRUS INFECTION,12
NL,FALL,12
NL,ARTHRALGIA,11
NL,HEADACHE,11
NL,INFLUENZA,11
NL,INJECTION SITE REACTION,11
NL,NASOPHARYNGITIS,11
NL,RHINOVIRUS INFECTION,11
NL,COUGH,10
NL,HEPATIC ENZYME INCREASED,10
NL,ANKYLOSING SPONDYLITIS,9
NL,ARTHROPATHY,9
NL,ENTEROCOCCAL SEPSIS,9
NL,ESCHERICHIA SEPSIS,9
NL,INFECTION,9
NL,LUNG INFECTION,9
NL,DIARRHOEA,8
NL,LUNG NEOPLASM MALIGNANT,8
NL,PAIN,8
NL,SEPSIS,8
NL,CHEST PAIN,7
NL,CONTUSION,7
NL,DYSPNOEA,7
NL,PRURITUS,7
NL,ABORTION SPONTANEOUS,6
NL,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,6
NL,ASTHMA,6
NL,BK VIRUS INFECTION,6
NL,CARDIAC DISORDER,6
NL,CITROBACTER INFECTION,6
NL,GASTROINTESTINAL DISORDER,6
NL,HYPERTENSION,6
NL,INJECTION SITE PAIN,6
NL,MALAISE,6
NL,RENAL IMPAIRMENT,6
NL,WOUND INFECTION,6
NL,ASPERGILLUS INFECTION,5
NL,CELLULITIS,5
NL,CORONA VIRUS INFECTION,5
NL,CYTOMEGALOVIRUS COLITIS,5
NL,DECREASED IMMUNE RESPONSIVENESS,5
NL,DEVICE RELATED SEPSIS,5
NL,DIABETES MELLITUS,5
NL,DIVERTICULITIS,5
NL,DIZZINESS,5
NL,ERYTHEMA,5
NL,INJECTION SITE ERYTHEMA,5
NL,JAW DISORDER,5
NL,MUCORMYCOSIS,5
NL,OSTEOARTHRITIS,5
NL,PAIN IN EXTREMITY,5
NL,RASH,5
NL,RENAL FAILURE,5
NL,ANAL INFECTION,4
NL,ATRIAL FIBRILLATION,4
NL,BACTERIAL SEPSIS,4
NL,BREAST CANCER FEMALE,4
NL,CARDIAC ARREST,4
NL,CATARACT,4
NL,CEREBROVASCULAR ACCIDENT,4
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
NL,CONDITION AGGRAVATED,4
NL,CROHN^S DISEASE,4
NL,GASTROINTESTINAL CARCINOMA,4
NL,HERPES SIMPLEX,4
NL,HIP FRACTURE,4
NL,HYPERSENSITIVITY,4
NL,INFLAMMATION,4
NL,NEPHROLITHIASIS,4
NL,NEURALGIA,4
NL,OEDEMA PERIPHERAL,4
NL,PERIPHERAL SWELLING,4
NL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,4
NL,PSORIASIS,4
NL,PYELONEPHRITIS,4
NL,SINUSITIS,4
NL,STRESS,4
NL,SYNCOPE,4
NL,TRANSIENT ISCHAEMIC ATTACK,4
NL,VOMITING,4
NL,WEIGHT DECREASED,4
NL,WOUND,4
NL,ABASIA,3
NL,ALANINE AMINOTRANSFERASE INCREASED,3
NL,ALOPECIA,3
NL,ANGINA PECTORIS,3
NL,ARRHYTHMIA,3
NL,ARTHRITIS BACTERIAL,3
NL,CARDIAC FAILURE,3
NL,CEREBRAL INFARCTION,3
NL,COLON CANCER,3
NL,DEHYDRATION,3
NL,ENTEROCOCCAL INFECTION,3
NL,ERYSIPELAS,3
NL,EYE INFECTION,3
NL,FOOT DEFORMITY,3
NL,GENERAL PHYSICAL HEALTH DETERIORATION,3
NL,HEPATITIS E,3
NL,HERNIA,3
NL,HYPOTENSION,3
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
NL,INFECTION SUSCEPTIBILITY INCREASED,3
NL,IRITIS,3
NL,KLEBSIELLA SEPSIS,3
NL,KNEE ARTHROPLASTY,3
NL,LEUKAEMIA,3
NL,LIVER FUNCTION TEST ABNORMAL,3
NL,LOCALISED INFECTION,3
NL,MEMORY IMPAIRMENT,3
NL,MUSCULAR WEAKNESS,3
NL,MUSCULOSKELETAL PAIN,3
NL,NAUSEA,3
NL,NEUROPATHY PERIPHERAL,3
NL,NON-HODGKIN^S LYMPHOMA,3
NL,OSTEITIS,3
NL,OVARIAN DISORDER,3
NL,PHOTOSENSITIVITY REACTION,3
NL,PROSTATE CANCER,3
NL,RECTAL CANCER,3
NL,ROAD TRAFFIC ACCIDENT,3
NL,SARCOIDOSIS,3
NL,SJOGREN^S SYNDROME,3
NL,SPINAL COLUMN STENOSIS,3
NL,SPINAL COMPRESSION FRACTURE,3
NL,TYPE 2 DIABETES MELLITUS,3
NL,WEIGHT INCREASED,3
NL,WHIPPLE^S DISEASE,3
NL,ABDOMINAL ABSCESS,2
NL,ABDOMINAL ADHESIONS,2
NL,ACUTE GRAFT VERSUS HOST DISEASE,2
NL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
NL,ASTHENIA,2
NL,B-CELL LYMPHOMA,2
NL,BACK PAIN,2
NL,BACTERIAL INFECTION,2
NL,BLADDER DISORDER,2
NL,BURNING SENSATION,2
NL,BURSITIS,2
NL,CHOLECYSTITIS,2
NL,CHOLELITHIASIS,2
NL,COGNITIVE DISORDER,2
NL,DEAFNESS,2
NL,DECREASED APPETITE,2
NL,DEMYELINATION,2
NL,DRY EYE,2
NL,DRY SKIN,2
NL,DYSPHONIA,2
NL,DYSPNOEA EXERTIONAL,2
NL,ECZEMA,2
NL,EPILEPSY,2
NL,GAIT DISTURBANCE,2
NL,GASTRIC DISORDER,2
NL,GASTROENTERITIS BACTERIAL,2
NL,GASTROENTERITIS VIRAL,2
NL,GLOMERULONEPHRITIS,2
NL,HAEMATOCHEZIA,2
NL,HAEMATOMA,2
NL,HAEMOGLOBIN DECREASED,2
NL,HEPATIC FUNCTION ABNORMAL,2
NL,HEPATIC STEATOSIS,2
NL,HEPATOTOXICITY,2
NL,HYPOAESTHESIA,2
NL,IMMUNOSUPPRESSION,2
NL,IMPAIRED HEALING,2
NL,INFLAMMATION OF WOUND,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INGROWING NAIL,2
NL,INJECTION SITE WARMTH,2
NL,INSOMNIA,2
NL,INTERVERTEBRAL DISC PROTRUSION,2
NL,INTESTINAL PERFORATION,2
NL,JOINT INJURY,2
NL,LARGE INTESTINE PERFORATION,2
NL,LARYNGITIS,2
NL,LIMB DISCOMFORT,2
NL,LOCAL SWELLING,2
NL,LUNG DISORDER,2
NL,LYMPHADENOPATHY,2
NL,METASTASES TO BONE,2
NL,METASTASES TO LIVER,2
NL,MIGRAINE WITH AURA,2
NL,MOBILITY DECREASED,2
NL,MUSCULOSKELETAL STIFFNESS,2
NL,MYALGIA,2
NL,NECK PAIN,2
NL,NEOPLASM,2
NL,NERVE INJURY,2
NL,NEUTROPENIA,2
NL,OESOPHAGEAL CARCINOMA,2
NL,ORAL PAIN,2
NL,OROPHARYNGEAL PAIN,2
NL,OSTEOPOROSIS,2
NL,PALPITATIONS,2
NL,PANCREATIC CARCINOMA,2
NL,PARAESTHESIA,2
NL,PLASMA CELL MYELOMA,2
NL,PNEUMONITIS,2
NL,PNEUMOTHORAX,2
NL,POLYARTHRITIS,2
NL,PRODUCT USE ISSUE,2
NL,PROSTATE INFECTION,2
NL,PULMONARY EMBOLISM,2
NL,PULMONARY FIBROSIS,2
NL,RED BLOOD CELL COUNT DECREASED,2
NL,RHEUMATOID NODULE,2
NL,RIB FRACTURE,2
NL,SCAR,2
NL,SENSORY DISTURBANCE,2
NL,SENSORY LOSS,2
NL,SKIN DISORDER,2
NL,SKIN REACTION,2
NL,SPINAL FRACTURE,2
NL,STOMATITIS,2
NL,THROMBOSIS,2
NL,TUBERCULOSIS,2
NL,UPPER LIMB FRACTURE,2
NL,URTICARIA,2
NL,VISUAL ACUITY REDUCED,2
NL,WRIST FRACTURE,2
NL,ABDOMINAL INFECTION,1
NL,ABDOMINAL NEOPLASM,1
NL,ABDOMINAL PAIN,1
NL,ABDOMINAL SEPSIS,1
NL,ADENOCARCINOMA OF COLON,1
NL,ADMINISTRATION SITE REACTION,1
NL,ADVERSE DRUG REACTION,1
NL,AGORAPHOBIA,1
NL,AMYOTROPHIC LATERAL SCLEROSIS,1
NL,ANAEMIA,1
NL,ANAL ULCER,1
NL,ANAPHYLACTIC REACTION,1
NL,ANEURYSM,1
NL,AORTIC ANEURYSM,1
NL,AORTIC OCCLUSION,1
NL,AORTIC VALVE INCOMPETENCE,1
NL,APATHY,1
NL,APHASIA,1
NL,ARTHRITIS INFECTIVE,1
NL,ASPARTATE AMINOTRANSFERASE INCREASED,1
NL,ATRIOVENTRICULAR BLOCK,1
NL,BACTEROIDES INFECTION,1
NL,BALANCE DISORDER,1
NL,BARTHOLIN^S CYST,1
NL,BASAL CELL CARCINOMA,1
NL,BASEDOW^S DISEASE,1
NL,BENIGN BONE NEOPLASM,1
NL,BILIARY COLIC,1
NL,BIPOLAR DISORDER,1
NL,BLADDER CANCER,1
NL,BLADDER PROLAPSE,1
NL,BLINDNESS UNILATERAL,1
NL,BLISTER,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BLOOD IRON DECREASED,1
NL,BLOOD PRESSURE DIASTOLIC INCREASED,1
NL,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
NL,BONE DECALCIFICATION,1
NL,BONE DEFORMITY,1
NL,BONE DISORDER,1
NL,BONE PAIN,1
NL,BOWEN^S DISEASE,1
NL,BRADYPHRENIA,1
NL,BRAIN ABSCESS,1
NL,BREAST CANCER METASTATIC,1
NL,BREAST INFLAMMATION,1
NL,BRONCHIECTASIS,1
NL,BRONCHIOLITIS,1
NL,BRONCHITIS,1
NL,BURNS SECOND DEGREE,1
NL,C-REACTIVE PROTEIN INCREASED,1
NL,CARDIAC ASTHMA,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARPAL TUNNEL SYNDROME,1
NL,CEREBRAL ATAXIA,1
NL,CEREBRAL HAEMORRHAGE,1
NL,CERVIX CARCINOMA,1
NL,CHOLECYSTECTOMY,1
NL,CHOLESTEATOMA,1
NL,CIRCULATORY COLLAPSE,1
NL,CLAVICLE FRACTURE,1
NL,COLITIS MICROSCOPIC,1
NL,COMMUNICATION DISORDER,1
NL,COMPLETED SUICIDE,1
NL,CORNEAL DEFECT,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CYST,1
NL,CYSTITIS VIRAL,1
NL,DEAFNESS TRANSITORY,1
NL,DELIRIUM,1
NL,DEMENTIA,1
NL,DENTAL CARIES,1
NL,DEPRESSION,1
NL,DERMATITIS,1
NL,DERMATITIS PSORIASIFORM,1
NL,DISEASE RECURRENCE,1
NL,DISTURBANCE IN ATTENTION,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NL,DRY MOUTH,1
NL,DUODENITIS,1
NL,DYSARTHRIA,1
NL,DYSSTASIA,1
NL,EAR HAEMORRHAGE,1
NL,EAR INFECTION,1
NL,ENDOCARDITIS,1
NL,ENDOCARDITIS Q FEVER,1
NL,ENTERITIS,1
NL,ENTERITIS INFECTIOUS,1
NL,ENTEROVESICAL FISTULA,1
NL,ESCHERICHIA INFECTION,1
NL,ESSENTIAL THROMBOCYTHAEMIA,1
NL,EXERCISE TOLERANCE DECREASED,1
NL,EYE DISORDER,1
NL,EYE INFLAMMATION,1
NL,FEELING ABNORMAL,1
NL,FEMOROACETABULAR IMPINGEMENT,1
NL,FEMUR FRACTURE,1
NL,FLUID RETENTION,1
NL,FRACTURE,1
NL,FUNGAL INFECTION,1
NL,GALLBLADDER CANCER,1
NL,GALLBLADDER DISORDER,1
NL,GASTRIC HAEMORRHAGE,1
NL,GASTRIC PERFORATION,1
NL,GASTROENTERITIS NOROVIRUS,1
NL,GASTROINTESTINAL HAEMORRHAGE,1
NL,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
NL,GENERAL PHYSICAL CONDITION ABNORMAL,1
NL,GINGIVITIS,1
NL,GLIOBLASTOMA,1
NL,GLOSSODYNIA,1
NL,GRAFT VERSUS HOST DISEASE,1
NL,HAEMOLYTIC ANAEMIA,1
NL,HAEMORRHAGE,1
NL,HAEMORRHAGE SUBCUTANEOUS,1
NL,HAEMOTHORAX,1
NL,HEART RATE DECREASED,1
NL,HEMIPARESIS,1
NL,HEPATIC FIBROSIS,1
NL,HERPES OPHTHALMIC,1
NL,HERPES SIMPLEX SEPSIS,1
NL,HICCUPS,1
NL,HIP DEFORMITY,1
NL,HODGKIN^S DISEASE,1
NL,HOT FLUSH,1
NL,HUMERUS FRACTURE,1
NL,HUNGER,1
NL,HYPERCHOLESTEROLAEMIA,1
NL,HYPERHIDROSIS,1
NL,HYPOTHERMIA,1
NL,HYPOXIA,1
NL,IMMUNODEFICIENCY,1
NL,IMMUNOGLOBULINS DECREASED,1
NL,INCREASED APPETITE,1
NL,INCREASED UPPER AIRWAY SECRETION,1
NL,INFESTATION,1
NL,INJECTION SITE INDURATION,1
NL,INJECTION SITE IRRITATION,1
NL,INJECTION SITE SWELLING,1
NL,INTERNAL HAEMORRHAGE,1
NL,INTERVERTEBRAL DISC OPERATION,1
NL,INTESTINAL HAEMORRHAGE,1
NL,INTESTINAL MASS,1
NL,INTESTINAL OBSTRUCTION,1
NL,INTESTINAL POLYP,1
NL,INTRACRANIAL ANEURYSM,1
NL,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
NL,INVASIVE DUCTAL BREAST CARCINOMA,1
NL,INVESTIGATION,1
NL,IRIDOCYCLITIS,1
NL,JOINT ARTHROPLASTY,1
NL,JOINT STIFFNESS,1
NL,JOINT SWELLING,1
NL,KIDNEY INFECTION,1
NL,KLEBSIELLA INFECTION,1
NL,KNEE OPERATION,1
NL,LACERATION,1
NL,LARGE INTESTINAL STENOSIS,1
NL,LARYNGEAL CANCER,1
NL,LARYNGEAL DISORDER,1
NL,LIGAMENT RUPTURE,1
NL,LIMB INJURY,1
NL,LIVER DISORDER,1
NL,LOBULAR BREAST CARCINOMA IN SITU,1
NL,LOSS OF CONSCIOUSNESS,1
NL,LOWER GASTROINTESTINAL HAEMORRHAGE,1
NL,LUNG ADENOCARCINOMA,1
NL,LUNG CANCER METASTATIC,1
NL,LUNG INFILTRATION,1
NL,LUNG NEOPLASM,1
NL,LYME DISEASE,1
NL,LYMPHANGIECTASIA,1
NL,LYMPHANGITIS,1
NL,LYMPHOCYTE PERCENTAGE ABNORMAL,1
NL,LYMPHOMA,1
NL,MALIGNANT MELANOMA,1
NL,MASS,1
NL,MATERNAL EXPOSURE DURING PREGNANCY,1
NL,MEDICAL DEVICE SITE REACTION,1
NL,MENINGITIS,1
NL,MENTAL DISORDER,1
NL,MESOTHELIOMA,1
NL,METASTATIC BRONCHIAL CARCINOMA,1
NL,MIXED CONNECTIVE TISSUE DISEASE,1
NL,MONOPARESIS,1
NL,MOUTH HAEMORRHAGE,1
NL,MOUTH ULCERATION,1
NL,MUCOSAL INFECTION,1
NL,MULTI-ORGAN FAILURE,1
NL,MULTIFOCAL MOTOR NEUROPATHY,1
NL,MULTIPLE SCLEROSIS,1
NL,MUSCLE ATROPHY,1
NL,MUSCLE DISORDER,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MYELOFIBROSIS,1
NL,MYELOPROLIFERATIVE DISORDER,1
NL,NEGATIVE THOUGHTS,1
NL,NEOPLASM MALIGNANT,1
NL,NEOPLASM RECURRENCE,1
NL,NEOPLASM SKIN,1
NL,NEPHROTIC SYNDROME,1
NL,NERVOUS SYSTEM DISORDER,1
NL,NERVOUSNESS,1
NL,NEURITIS,1
NL,NEUROLOGICAL SYMPTOM,1
NL,NEUTROPHIL PERCENTAGE DECREASED,1
NL,OCULAR HYPERAEMIA,1
NL,OESOPHAGEAL CANDIDIASIS,1
NL,OPTIC NEURITIS,1
NL,ORBITAL OEDEMA,1
NL,ORGAN FAILURE,1
NL,ORGANISING PNEUMONIA,1
NL,OSTEOMYELITIS,1
NL,OSTEOPENIA,1
NL,OTITIS MEDIA,1
NL,OXYGEN SATURATION DECREASED,1
NL,PAGET^S DISEASE OF NIPPLE,1
NL,PAIN THRESHOLD DECREASED,1
NL,PANCREATIC CARCINOMA RECURRENT,1
NL,PANCREATIC NEOPLASM,1
NL,PANCREATITIS,1
NL,PARALYSIS,1
NL,PAROSMIA,1
NL,PATHOLOGICAL FRACTURE,1
NL,PERIARTHRITIS,1
NL,PERICARDIAL EFFUSION,1
NL,PERICARDITIS,1
NL,PERIODONTITIS,1
NL,PERIPHERAL VASCULAR DISORDER,1
NL,PERITONEAL MESOTHELIOMA MALIGNANT,1
NL,PETECHIAE,1
NL,PETIT MAL EPILEPSY,1
NL,PHARYNGEAL OEDEMA,1
NL,PHOTOPSIA,1
NL,PIGMENTATION DISORDER,1
NL,PLATELET COUNT ABNORMAL,1
NL,PLEURAL INFECTION,1
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NL,PNEUMONIA VIRAL,1
NL,POLYARTERITIS NODOSA,1
NL,PRODUCT USE IN UNAPPROVED INDICATION,1
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
NL,PROTEIN URINE,1
NL,PROTEINURIA,1
NL,PRURITUS GENERALISED,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY SARCOIDOSIS,1
NL,PULMONARY TUBERCULOSIS,1
NL,PURPURA,1
NL,PUSTULAR PSORIASIS,1
NL,Q FEVER,1
NL,RASH ERYTHEMATOUS,1
NL,RASH GENERALISED,1
NL,RASH MACULAR,1
NL,RECTAL CANCER METASTATIC,1
NL,RECTAL HAEMORRHAGE,1
NL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NL,RENAL ATROPHY,1
NL,RENAL CANCER,1
NL,RENAL CYST,1
NL,RESPIRATORY DISORDER,1
NL,RESPIRATORY FAILURE,1
NL,RESTLESS LEGS SYNDROME,1
NL,RETINAL DETACHMENT,1
NL,RETINAL TEAR,1
NL,RHABDOMYOLYSIS,1
NL,RHEUMATIC DISORDER,1
NL,SALIVARY GLAND ADENOMA,1
NL,SAPHO SYNDROME,1
NL,SCAN ABNORMAL,1
NL,SCRATCH,1
NL,SEASONAL ALLERGY,1
NL,SEBACEOUS GLAND INFECTION,1
NL,SENSITIVITY TO WEATHER CHANGE,1
NL,SKIN DISCOLOURATION,1
NL,SKIN INFECTION,1
NL,SLEEP APNOEA SYNDROME,1
NL,SLEEP DISORDER,1
NL,SOLAR LENTIGO,1
NL,SPEECH DISORDER,1
NL,SPINAL COLUMN INJURY,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STAPHYLOCOCCAL INFECTION,1
NL,STREPTOCOCCAL INFECTION,1
NL,SUBCUTANEOUS ABSCESS,1
NL,SURGERY,1
NL,SWELLING FACE,1
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NL,TENDON INJURY,1
NL,TENDON RUPTURE,1
NL,THROAT CANCER,1
NL,THROMBOCYTOPENIA,1
NL,THYROID DISORDER,1
NL,TINNITUS,1
NL,TOE AMPUTATION,1
NL,TOE OPERATION,1
NL,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NL,TONSILLAR DISORDER,1
NL,TOOTH INFECTION,1
NL,TREMOR,1
NL,UMBILICAL HERNIA,1
NL,UPPER RESPIRATORY TRACT INFECTION,1
NL,URINARY TRACT INFLAMMATION,1
NL,URINE ANALYSIS ABNORMAL,1
NL,UROSEPSIS,1
NL,VAGINAL HAEMORRHAGE,1
NL,VARICELLA,1
NL,VARICOSE VEIN,1
NL,VASCULITIS,1
NL,VASOCONSTRICTION,1
NL,VERTIGO,1
NL,VERTIGO POSITIONAL,1
NL,VIITH NERVE PARALYSIS,1
NL,VIRAL INFECTION,1
NL,VOGT-KOYANAGI-HARADA SYNDROME,1
NL,VULVOVAGINAL MYCOTIC INFECTION,1
NL,WHITE BLOOD CELL COUNT DECREASED,1
NL,WHITE BLOOD CELL COUNT INCREASED,1
NL,WOUND DEHISCENCE,1
NZ,ARTHRITIS,7
NZ,DRUG INEFFECTIVE,7
NZ,CONDITION AGGRAVATED,6
NZ,DISEASE RECURRENCE,4
NZ,PSORIASIS,4
NZ,BRONCHITIS,3
NZ,CARPAL TUNNEL SYNDROME,3
NZ,DEMYELINATION,3
NZ,DEPRESSION,3
NZ,DISEASE PROGRESSION,3
NZ,DRUG EFFECT INCOMPLETE,3
NZ,DYSPNOEA,3
NZ,INTERSTITIAL LUNG DISEASE,3
NZ,JOINT EFFUSION,3
NZ,LOWER RESPIRATORY TRACT INFECTION,3
NZ,MALAISE,3
NZ,MYOCARDIAL INFARCTION,3
NZ,NEUROPATHY PERIPHERAL,3
NZ,PAIN,3
NZ,POLYARTHRITIS,3
NZ,PROSTATISM,3
NZ,PRURITUS,3
NZ,RHEUMATIC DISORDER,3
NZ,SUPRAVENTRICULAR TACHYCARDIA,3
NZ,TREATMENT FAILURE,3
NZ,UVEITIS,3
NZ,COUGH,2
NZ,FATIGUE,2
NZ,FEELING ABNORMAL,2
NZ,GLOMERULONEPHRITIS MEMBRANOUS,2
NZ,NAUSEA,2
NZ,NEPHROTIC SYNDROME,2
NZ,OEDEMA PERIPHERAL,2
NZ,PNEUMONIA,2
NZ,PSORIATIC ARTHROPATHY,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABSCESS,1
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NZ,AGEUSIA,1
NZ,AGITATION,1
NZ,ALOPECIA AREATA,1
NZ,ANAEMIA,1
NZ,ANGINA PECTORIS,1
NZ,ANKYLOSING SPONDYLITIS,1
NZ,ANOSMIA,1
NZ,APHTHOUS STOMATITIS,1
NZ,ARRHYTHMIA,1
NZ,ARTHRALGIA,1
NZ,ATRIAL FIBRILLATION,1
NZ,BLOOD CHOLESTEROL INCREASED,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BLOOD TRIGLYCERIDES INCREASED,1
NZ,C-REACTIVE PROTEIN INCREASED,1
NZ,CARDIAC FAILURE,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CEREBROVASCULAR ACCIDENT,1
NZ,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
NZ,COLITIS,1
NZ,CYST,1
NZ,DEATH,1
NZ,DEHYDRATION,1
NZ,DIABETES MELLITUS,1
NZ,DIARRHOEA,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG EFFECT DECREASED,1
NZ,DRY EYE,1
NZ,DYSPHONIA,1
NZ,ECZEMA,1
NZ,ERECTILE DYSFUNCTION,1
NZ,EXPIRED PRODUCT ADMINISTERED,1
NZ,EXPOSURE DURING PREGNANCY,1
NZ,EYE SWELLING,1
NZ,EYELID OEDEMA,1
NZ,FALL,1
NZ,GAIT DISTURBANCE,1
NZ,H1N1 INFLUENZA,1
NZ,HAEMORRHOIDS,1
NZ,HEART RATE IRREGULAR,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HYPERTENSION,1
NZ,HYPOTENSION,1
NZ,IMPAIRED WORK ABILITY,1
NZ,INFECTION,1
NZ,INFLAMMATORY BOWEL DISEASE,1
NZ,INFUSION,1
NZ,INSOMNIA,1
NZ,IRITIS,1
NZ,JUVENILE IDIOPATHIC ARTHRITIS,1
NZ,LACERATION,1
NZ,LIP BLISTER,1
NZ,LIP EXFOLIATION,1
NZ,LIP SWELLING,1
NZ,LUPUS-LIKE SYNDROME,1
NZ,LYMPHOMA,1
NZ,MACULAR OEDEMA,1
NZ,MASS,1
NZ,METABOLIC SYNDROME,1
NZ,MITRAL VALVE INCOMPETENCE,1
NZ,MOBILITY DECREASED,1
NZ,MOOD ALTERED,1
NZ,MOUTH ULCERATION,1
NZ,MUSCLE RUPTURE,1
NZ,MUSCLE SPASMS,1
NZ,MUSCLE STRAIN,1
NZ,MUSCULOSKELETAL STIFFNESS,1
NZ,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
NZ,NEPHROLITHIASIS,1
NZ,NEUTROPHIL COUNT DECREASED,1
NZ,NODULE,1
NZ,OROPHARYNGEAL PAIN,1
NZ,OSTEOARTHRITIS,1
NZ,PHARYNGEAL OEDEMA,1
NZ,PLACENTA PRAEVIA,1
NZ,PLEURAL EFFUSION,1
NZ,PNEUMOCYSTIS JIROVECII INFECTION,1
NZ,PNEUMONIA INFLUENZAL,1
NZ,POOR QUALITY SLEEP,1
NZ,PRODUCT QUALITY ISSUE,1
NZ,PROSTATE CANCER,1
NZ,RASH,1
NZ,RASH ERYTHEMATOUS,1
NZ,RENAL COLIC,1
NZ,RESPIRATORY FAILURE,1
NZ,SCRATCH,1
NZ,SEPSIS,1
NZ,SEPTIC SHOCK,1
NZ,SINUS CONGESTION,1
NZ,SINUSITIS,1
NZ,SJOGREN^S SYNDROME,1
NZ,SKIN EXFOLIATION,1
NZ,SOMNOLENCE,1
NZ,STAPHYLOCOCCAL ABSCESS,1
NZ,STAPHYLOCOCCAL INFECTION,1
NZ,STEVENS-JOHNSON SYNDROME,1
NZ,STREPTOCOCCAL INFECTION,1
NZ,SUBACUTE ENDOCARDITIS,1
NZ,SUICIDAL IDEATION,1
NZ,SUPERINFECTION BACTERIAL,1
NZ,SURGERY,1
NZ,SWELLING,1
NZ,SWELLING FACE,1
NZ,SWOLLEN TONGUE,1
NZ,SYNCOPE,1
NZ,UNEVALUABLE EVENT,1
NZ,WEIGHT DECREASED,1
NZ,WEIGHT INCREASED,1
NG,DEATH,1
NG,HYPOTENSION,1
NG,MYOCARDIAL INFARCTION,1
NG,PNEUMONIA,1
NG,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
NG,PRURITUS,1
NG,PRURITUS GENERALISED,1
NG,PYREXIA,1
NG,STILL^S DISEASE ADULT ONSET,1
NG,URINARY TRACT INFECTION,1
NO,DRUG EFFECT DECREASED,18
NO,OSTEONECROSIS,13
NO,PSORIASIS,9
NO,BURSITIS,8
NO,CONDITION AGGRAVATED,7
NO,DRUG INEFFECTIVE,7
NO,DRUG RESISTANCE,7
NO,FEMORAL NECK FRACTURE,7
NO,FLATULENCE,7
NO,HYPOAESTHESIA,7
NO,INFECTION,7
NO,RASH,7
NO,RHEUMATIC DISORDER,7
NO,RHEUMATOID ARTHRITIS,7
NO,SWELLING,7
NO,WHITE BLOOD CELL COUNT DECREASED,7
NO,ASTHMA,6
NO,DRUG EFFECT INCOMPLETE,6
NO,GAIT DISTURBANCE,6
NO,ILEUS,6
NO,MIGRAINE,6
NO,SEPSIS,6
NO,VOLVULUS,6
NO,BODY TEMPERATURE FLUCTUATION,5
NO,DYSPNOEA,5
NO,MYELITIS TRANSVERSE,5
NO,OPTIC NEURITIS,5
NO,OSTEOARTHRITIS,5
NO,PERIPHERAL COLDNESS,5
NO,POLYNEUROPATHY,5
NO,PYREXIA,5
NO,RENAL CANCER,5
NO,SPINAL CORD INJURY,5
NO,COUGH,4
NO,DEMYELINATION,4
NO,HYPERTENSION,4
NO,METASTASES TO LIVER,4
NO,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,4
NO,VISUAL IMPAIRMENT,4
NO,ABDOMINAL PAIN UPPER,3
NO,ACUTE RESPIRATORY FAILURE,3
NO,ANAL FISTULA,3
NO,BREAST CANCER,3
NO,COLON CANCER,3
NO,DIFFUSE LARGE B-CELL LYMPHOMA,3
NO,DIZZINESS,3
NO,ERYSIPELAS,3
NO,EYELID PTOSIS,3
NO,FATIGUE,3
NO,HEADACHE,3
NO,HYPERLIPIDAEMIA,3
NO,IIIRD NERVE PARESIS,3
NO,IRIDOCYCLITIS,3
NO,MALAISE,3
NO,NASOPHARYNGITIS,3
NO,NIGHT SWEATS,3
NO,PERIPHERAL SENSORY NEUROPATHY,3
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
NO,PROSTATE CANCER,3
NO,PRURITUS,3
NO,RENAL FAILURE,3
NO,TUBERCULOSIS,3
NO,ABORTION SPONTANEOUS,2
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NO,ADENOCARCINOMA OF COLON,2
NO,ANKYLOSING SPONDYLITIS,2
NO,DEMYELINATING POLYNEUROPATHY,2
NO,ERYTHEMA MULTIFORME,2
NO,EYE PAIN,2
NO,FEELING ABNORMAL,2
NO,GLIOBLASTOMA,2
NO,HAEMOGLOBIN DECREASED,2
NO,HIATUS HERNIA,2
NO,HYPERSENSITIVITY,2
NO,INFLAMMATION,2
NO,INJECTION SITE PAIN,2
NO,LARYNGOSPASM,2
NO,LATENT TUBERCULOSIS,2
NO,METASTASES TO LUNG,2
NO,MOBILITY DECREASED,2
NO,MORPHOEA,2
NO,MULTIPLE SCLEROSIS,2
NO,MUSCULOSKELETAL STIFFNESS,2
NO,OVARIAN CANCER STAGE IV,2
NO,OVERWEIGHT,2
NO,PAIN,2
NO,PAIN IN EXTREMITY,2
NO,PARAESTHESIA,2
NO,PLATELET COUNT DECREASED,2
NO,PORPHYRIA NON-ACUTE,2
NO,PRODUCT USE ISSUE,2
NO,RASH GENERALISED,2
NO,SENSORIMOTOR DISORDER,2
NO,TREMOR,2
NO,VIRAL INFECTION,2
NO,VISUAL ACUITY REDUCED,2
NO,VOMITING,2
NO,WEIGHT DECREASED,2
NO,ABDOMINAL DISTENSION,1
NO,ABSCESS JAW,1
NO,ACUTE MYELOID LEUKAEMIA,1
NO,ADENOCARCINOMA OF APPENDIX,1
NO,ALOPECIA AREATA,1
NO,ALVEOLITIS ALLERGIC,1
NO,ANAPHYLACTIC REACTION,1
NO,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
NO,AORTIC DISORDER,1
NO,AORTIC VALVE INCOMPETENCE,1
NO,APPENDICITIS PERFORATED,1
NO,ARTHRALGIA,1
NO,ARTHROPATHY,1
NO,ATRIAL FIBRILLATION,1
NO,BALANCE DISORDER,1
NO,BASAL CELL CARCINOMA,1
NO,BONE CANCER,1
NO,BONE LESION,1
NO,BRAIN INJURY,1
NO,BREAST CANCER METASTATIC,1
NO,BREAST CANCER RECURRENT,1
NO,BREAST NEOPLASM,1
NO,C-REACTIVE PROTEIN INCREASED,1
NO,CARDIAC FAILURE,1
NO,CARDIAC FAILURE ACUTE,1
NO,CEREBRAL INFARCTION,1
NO,CEREBRAL ISCHAEMIA,1
NO,CHILLS,1
NO,CHRONIC SINUSITIS,1
NO,CIRCULATORY COLLAPSE,1
NO,COGWHEEL RIGIDITY,1
NO,COLITIS ULCERATIVE,1
NO,CONFUSIONAL STATE,1
NO,CORONARY ARTERY DISEASE,1
NO,CYANOSIS,1
NO,DELIRIUM,1
NO,DERMATITIS,1
NO,DIARRHOEA,1
NO,DISEASE RECURRENCE,1
NO,DYSPNOEA EXERTIONAL,1
NO,DYSURIA,1
NO,EMOTIONAL DISORDER,1
NO,ENCEPHALOPATHY,1
NO,EWING^S SARCOMA,1
NO,EXPOSURE DURING BREAST FEEDING,1
NO,EYE INFECTION TOXOPLASMAL,1
NO,FACIAL PAIN,1
NO,FAECES DISCOLOURED,1
NO,FIBROMYALGIA,1
NO,FOETAL MALFORMATION,1
NO,GASTROINTESTINAL DISORDER,1
NO,GRAND MAL CONVULSION,1
NO,HEARING IMPAIRED,1
NO,HEART RATE INCREASED,1
NO,HEPATIC CIRRHOSIS,1
NO,HYPERGLYCAEMIA,1
NO,HYPERHIDROSIS,1
NO,HYPERTENSIVE HEART DISEASE,1
NO,HYPERTHYROIDISM,1
NO,HYPOREFLEXIA,1
NO,IMPAIRED WORK ABILITY,1
NO,INCORRECT PRODUCT STORAGE,1
NO,INFECTION SUSCEPTIBILITY INCREASED,1
NO,INJECTION SITE ERYTHEMA,1
NO,INJECTION SITE INFECTION,1
NO,INJECTION SITE IRRITATION,1
NO,INSOMNIA,1
NO,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
NO,INVASIVE DUCTAL BREAST CARCINOMA,1
NO,JOINT STIFFNESS,1
NO,KETOACIDOSIS,1
NO,LACRIMAL DISORDER,1
NO,LARGE INTESTINE POLYP,1
NO,LIBIDO DECREASED,1
NO,LISTLESS,1
NO,LOCALISED INFECTION,1
NO,LUMBAR VERTEBRAL FRACTURE,1
NO,LUNG DISORDER,1
NO,LUNG INFILTRATION,1
NO,LUNG NEOPLASM,1
NO,LUNG NEOPLASM MALIGNANT,1
NO,LYMPHADENOPATHY,1
NO,MACULAR SCAR,1
NO,MANTLE CELL LYMPHOMA,1
NO,MASKED FACIES,1
NO,MATERNAL EXPOSURE DURING PREGNANCY,1
NO,MEAN CELL VOLUME INCREASED,1
NO,MEMORY IMPAIRMENT,1
NO,METASTASES TO LYMPH NODES,1
NO,MUCOUS STOOLS,1
NO,MULTI-ORGAN FAILURE,1
NO,MUSCLE RIGIDITY,1
NO,MUSCULOSKELETAL PAIN,1
NO,MYELOMALACIA,1
NO,NAUSEA,1
NO,NECK PAIN,1
NO,NERVOUS SYSTEM DISORDER,1
NO,OCULAR HYPERAEMIA,1
NO,OEDEMA MUCOSAL,1
NO,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
NO,ORAL MUCOSAL BLISTERING,1
NO,ORAL PAIN,1
NO,OSTEOLYSIS,1
NO,OSTEOMYELITIS,1
NO,OSTEOPOROSIS,1
NO,PAIN IN JAW,1
NO,PANCREATIC CARCINOMA METASTATIC,1
NO,PAPILLOEDEMA,1
NO,PARKINSON^S DISEASE,1
NO,PAROSMIA,1
NO,PERIORBITAL OEDEMA,1
NO,PERIPHERAL SWELLING,1
NO,PNEUMOCOCCAL SEPSIS,1
NO,PNEUMONIA,1
NO,POOR QUALITY SLEEP,1
NO,PRODUCT QUALITY ISSUE,1
NO,PRODUCT USE IN UNAPPROVED INDICATION,1
NO,PROGRESSIVE SUPRANUCLEAR PALSY,1
NO,PSORIATIC ARTHROPATHY,1
NO,PYELITIS,1
NO,RECTAL CANCER,1
NO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NO,RENAL FAILURE ACUTE,1
NO,RESPIRATORY ARREST,1
NO,RESPIRATORY FAILURE,1
NO,RESPIRATORY TRACT INFECTION,1
NO,RESTLESSNESS,1
NO,SACROILIITIS,1
NO,SENSORY DISTURBANCE,1
NO,SENSORY LOSS,1
NO,SINUS CONGESTION,1
NO,SINUSITIS,1
NO,SLEEP DISORDER,1
NO,SMALL CELL LUNG CANCER,1
NO,SOMNOLENCE,1
NO,SPINAL COLUMN STENOSIS,1
NO,SPONDYLITIS,1
NO,SQUAMOUS CELL CARCINOMA,1
NO,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
NO,T-CELL LYMPHOMA,1
NO,TACHYCARDIA,1
NO,TENDON DISORDER,1
NO,TENDON RUPTURE,1
NO,TESTIS CANCER,1
NO,THYROXINE FREE INCREASED,1
NO,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NO,TONSILLITIS BACTERIAL,1
NO,TOOTH INFECTION,1
NO,TRIGEMINAL NEURALGIA,1
NO,TURNER^S SYNDROME,1
NO,UPPER RESPIRATORY TRACT INFECTION,1
NO,URETERIC CANCER,1
NO,URTICARIA,1
NO,UVEITIS,1
NO,VASCULITIS,1
NO,VENTRICULAR FIBRILLATION,1
NO,VISION BLURRED,1
NO,WEIGHT GAIN POOR,1
OM,CARDIAC ARREST,1
OM,DISORIENTATION,1
OM,DIZZINESS,1
OM,HEADACHE,1
OM,HYPOTENSION,1
OM,LETHARGY,1
OM,LOSS OF CONSCIOUSNESS,1
OM,OTORRHOEA,1
OM,SEPTIC SHOCK,1
OM,STAPHYLOCOCCAL INFECTION,1
OM,VOMITING,1
PK,PYREXIA,2
PK,DERMATITIS EXFOLIATIVE,1
PK,DRUG HYPERSENSITIVITY,1
PK,EOSINOPHIL COUNT INCREASED,1
PK,FIBROSIS,1
PK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PK,INCORRECT DOSE ADMINISTERED,1
PK,LYMPHOCYTIC INFILTRATION,1
PK,MEAN CELL VOLUME INCREASED,1
PK,MEAN PLATELET VOLUME INCREASED,1
PK,MONOCYTE COUNT INCREASED,1
PK,PAIN,1
PK,PNEUMONIA,1
PK,PRURITUS,1
PK,RASH,1
PK,SKIN ATROPHY,1
PS,BLOOD GLUCOSE INCREASED,1
PS,DIABETES MELLITUS,1
PS,DIABETES MELLITUS INADEQUATE CONTROL,1
PS,GASTRIC CANCER,1
PA,ARTHRALGIA,2
PA,ABDOMINAL DISCOMFORT,1
PA,ABDOMINAL PAIN UPPER,1
PA,APPARENT DEATH,1
PA,BALANCE DISORDER,1
PA,BLOOD SODIUM INCREASED,1
PA,BREAST CANCER,1
PA,CEREBROVASCULAR ACCIDENT,1
PA,CHEST PAIN,1
PA,CONDITION AGGRAVATED,1
PA,COUGH,1
PA,DEATH,1
PA,DEPRESSION,1
PA,DIARRHOEA,1
PA,DISABILITY,1
PA,DIVERTICULAR PERFORATION,1
PA,DIVERTICULITIS,1
PA,DIZZINESS,1
PA,DYSAESTHESIA,1
PA,DYSPNOEA,1
PA,EXTRA DOSE ADMINISTERED,1
PA,FACIAL PARALYSIS,1
PA,FATIGUE,1
PA,GASTRITIS BACTERIAL,1
PA,HEMIPLEGIA,1
PA,HYPOGLYCAEMIA,1
PA,IMMUNODEFICIENCY,1
PA,INJECTION SITE DISCOLOURATION,1
PA,INJECTION SITE ERYTHEMA,1
PA,INJECTION SITE HAEMATOMA,1
PA,INJECTION SITE RASH,1
PA,INSOMNIA,1
PA,KERATITIS,1
PA,LYMPHOMA,1
PA,MONOCLONAL GAMMOPATHY,1
PA,MONONEURITIS,1
PA,MYCOBACTERIUM ABSCESSUS INFECTION,1
PA,NAUSEA,1
PA,NECK PAIN,1
PA,OEDEMA,1
PA,OSTEOLYSIS,1
PA,PALPITATIONS,1
PA,POLYARTHRITIS,1
PA,PSORIASIS,1
PA,PSORIATIC ARTHROPATHY,1
PA,PYREXIA,1
PA,RENAL CANCER,1
PA,RHEUMATOID ARTHRITIS,1
PA,SJOGREN^S SYNDROME,1
PA,SKIN DISORDER,1
PA,SPEECH DISORDER,1
PA,SPINAL OSTEOARTHRITIS,1
PA,TUBERCULOSIS,1
PA,UVEITIS,1
PA,VASCULITIS,1
PA,VISUAL IMPAIRMENT,1
PA,VOMITING,1
PA,WALDENSTROM^S MACROGLOBULINAEMIA,1
PA,WEIGHT DECREASED,1
PA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PY,BREAST DISORDER,1
PE,URINARY TRACT INFECTION,9
PE,PYREXIA,5
PE,JOINT SWELLING,4
PE,MALAISE,4
PE,ARTHROPATHY,3
PE,DIARRHOEA,3
PE,HAEMOGLOBIN DECREASED,3
PE,HEADACHE,3
PE,TONSILLITIS,3
PE,ACCIDENT,2
PE,ARTHRALGIA,2
PE,ARTHRITIS,2
PE,BLOOD PRESSURE INCREASED,2
PE,BRONCHITIS,2
PE,CELLULITIS,2
PE,DEATH,2
PE,DRUG INEFFECTIVE,2
PE,FALL,2
PE,HEPATIC CIRRHOSIS,2
PE,HYPERSENSITIVITY,2
PE,LARYNGEAL OEDEMA,2
PE,MATERNAL EXPOSURE DURING PREGNANCY,2
PE,VASCULITIS,2
PE,ABDOMINAL INFECTION,1
PE,ABDOMINAL PAIN,1
PE,ABDOMINAL PAIN UPPER,1
PE,AMENORRHOEA,1
PE,ANGER,1
PE,ANGINA PECTORIS,1
PE,APPARENT DEATH,1
PE,APPENDICITIS,1
PE,BLADDER DISORDER,1
PE,BODY TEMPERATURE INCREASED,1
PE,BONE FISSURE,1
PE,BREAST CANCER FEMALE,1
PE,BRUCELLOSIS,1
PE,CHEST PAIN,1
PE,CHRONIC MYELOID LEUKAEMIA,1
PE,CLEAR CELL RENAL CELL CARCINOMA,1
PE,COMA,1
PE,COMPARTMENT SYNDROME,1
PE,CREATININE RENAL CLEARANCE DECREASED,1
PE,DEVICE DISLOCATION,1
PE,DISEASE PROGRESSION,1
PE,DISEASE RECURRENCE,1
PE,DIZZINESS,1
PE,ENTEROCOLITIS,1
PE,FACIAL BONES FRACTURE,1
PE,GASTRIC INFECTION,1
PE,GASTROINTESTINAL HAEMORRHAGE,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,HAEMATOCHEZIA,1
PE,HEPATIC ENCEPHALOPATHY,1
PE,HEPATITIS,1
PE,HIP FRACTURE,1
PE,HYPERTENSION,1
PE,INCREASED BRONCHIAL SECRETION,1
PE,INFECTION,1
PE,INFLUENZA,1
PE,INJECTION SITE PRURITUS,1
PE,INTRACRANIAL HAEMATOMA,1
PE,KERATITIS,1
PE,LEUKAEMIA,1
PE,LIMB INJURY,1
PE,LIP OEDEMA,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,LYMPHOMA,1
PE,LYMPHOPROLIFERATIVE DISORDER,1
PE,MELAENA,1
PE,MYOCARDIAL INFARCTION,1
PE,NASOPHARYNGITIS,1
PE,NAUSEA,1
PE,NEPHROLITHIASIS,1
PE,OESOPHAGITIS,1
PE,ORAL CANDIDIASIS,1
PE,PALLOR,1
PE,PELVIC NEOPLASM,1
PE,PHARYNGITIS,1
PE,PHARYNGOTONSILLITIS,1
PE,PHLEBITIS,1
PE,PNEUMONIA,1
PE,POLYNEUROPATHY,1
PE,POLYOMAVIRUS TEST POSITIVE,1
PE,PRODUCT STORAGE ERROR,1
PE,PRODUCT USE ISSUE,1
PE,PROSTATE CANCER,1
PE,PSORIATIC ARTHROPATHY,1
PE,RASH,1
PE,RECTAL HAEMORRHAGE,1
PE,RENAL CANCER,1
PE,RHEUMATOID ARTHRITIS,1
PE,RHEUMATOID VASCULITIS,1
PE,SKIN LESION,1
PE,SKIN ULCER,1
PE,SLEEP DISORDER,1
PE,SQUAMOUS CELL CARCINOMA,1
PE,THYROID NEOPLASM,1
PE,TONSILLAR INFLAMMATION,1
PE,TONSILLITIS BACTERIAL,1
PE,TRISOMY 21,1
PE,TUBERCULIN TEST POSITIVE,1
PE,TUBERCULOSIS,1
PE,TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME,1
PE,ULCER,1
PE,UTERINE DISORDER,1
PE,VAGINAL HAEMORRHAGE,1
PE,VOMITING,1
PE,WEIGHT INCREASED,1
PH,TUBERCULOSIS,2
PH,BLOOD PRESSURE INCREASED,1
PH,BRONCHOSPASM,1
PH,COUGH,1
PH,DEATH,1
PH,DRUG HYPERSENSITIVITY,1
PH,HEADACHE,1
PH,HEPATIC CIRRHOSIS,1
PH,HEPATIC ENZYME INCREASED,1
PH,HEPATITIS B,1
PH,HOSPITALISATION,1
PH,HYPERSENSITIVITY,1
PH,HYPERTENSION,1
PH,IMMUNE SYSTEM DISORDER,1
PH,INFECTION,1
PH,INFLUENZA LIKE ILLNESS,1
PH,INJECTION SITE INFECTION,1
PH,LUNG NEOPLASM MALIGNANT,1
PH,MASTOIDITIS,1
PH,MONONEUROPATHY MULTIPLEX,1
PH,PYREXIA,1
PH,RASH PRURITIC,1
PH,STEVENS-JOHNSON SYNDROME,1
PH,TRANSAMINASES INCREASED,1
PH,URINARY TRACT INFECTION,1
PL,CONDITION AGGRAVATED,9
PL,INJECTION SITE ERYTHEMA,9
PL,ERYTHEMA,7
PL,PYREXIA,6
PL,DIARRHOEA,5
PL,DRUG INEFFECTIVE,5
PL,DYSPNOEA,5
PL,LEUKOPENIA,5
PL,STEVENS-JOHNSON SYNDROME,5
PL,ECTHYMA,4
PL,FUSARIUM INFECTION,4
PL,INJECTION SITE EXTRAVASATION,4
PL,PNEUMONIA,4
PL,PSORIASIS,4
PL,RASH GENERALISED,4
PL,RASH PRURITIC,4
PL,RHEUMATOID ARTHRITIS,4
PL,TUBERCULOSIS,4
PL,ASTHENIA,3
PL,ATRIAL FIBRILLATION,3
PL,BRONCHITIS,3
PL,CIRCULATORY COLLAPSE,3
PL,ERYTHEMA NODOSUM,3
PL,FEELING ABNORMAL,3
PL,HAEMORRHAGIC NECROTIC PANCREATITIS,3
PL,INJECTION SITE OEDEMA,3
PL,ORAL MUCOSA EROSION,3
PL,PRURITUS,3
PL,RASH,3
PL,RASH PAPULAR,3
PL,SEPSIS,3
PL,SKIN BURNING SENSATION,3
PL,SKIN LESION,3
PL,ABDOMINAL PAIN,2
PL,ACUTE RESPIRATORY FAILURE,2
PL,ALANINE AMINOTRANSFERASE INCREASED,2
PL,ANAEMIA,2
PL,ANGIOPATHY,2
PL,ANKYLOSING SPONDYLITIS,2
PL,ASPARTATE AMINOTRANSFERASE INCREASED,2
PL,BLOOD PRESSURE INCREASED,2
PL,CELLULITIS,2
PL,CROHN^S DISEASE,2
PL,DEATH,2
PL,DEMYELINATION,2
PL,DERMATITIS ALLERGIC,2
PL,DIVERTICULITIS,2
PL,EPISCLERITIS,2
PL,ESCHERICHIA SEPSIS,2
PL,FACE OEDEMA,2
PL,FATIGUE,2
PL,FRACTURE,2
PL,GRAFT VERSUS HOST DISEASE,2
PL,HEPATIC STEATOSIS,2
PL,HISTIOCYTOSIS HAEMATOPHAGIC,2
PL,HYPERSENSITIVITY,2
PL,INJECTION SITE HYPERSENSITIVITY,2
PL,INJECTION SITE REACTION,2
PL,KERATITIS,2
PL,LUNG NEOPLASM,2
PL,MENINGIOMA,2
PL,MULTI-ORGAN FAILURE,2
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
PL,MYOCARDIAL INFARCTION,2
PL,OEDEMA,2
PL,ORCHITIS NONINFECTIVE,2
PL,OSTEONECROSIS,2
PL,OSTEONECROSIS OF JAW,2
PL,PREGNANCY,2
PL,RASH ERYTHEMATOUS,2
PL,RECTOSIGMOID CANCER,2
PL,SARCOIDOSIS,2
PL,SILENT MYOCARDIAL INFARCTION,2
PL,SKIN NECROSIS,2
PL,SWELLING,2
PL,SYNCOPE,2
PL,TYPE 1 DIABETES MELLITUS,2
PL,UPPER RESPIRATORY TRACT INFECTION,2
PL,UVEITIS,2
PL,VOMITING,2
PL,ABORTION SPONTANEOUS,1
PL,ABSCESS,1
PL,ACNE,1
PL,ACUTE RESPIRATORY DISTRESS SYNDROME,1
PL,AGRANULOCYTOSIS,1
PL,ALTERED STATE OF CONSCIOUSNESS,1
PL,ANAEMIA OF CHRONIC DISEASE,1
PL,ANAL ABSCESS,1
PL,ANGINA PECTORIS,1
PL,ANTINUCLEAR ANTIBODY POSITIVE,1
PL,ANXIETY,1
PL,ARTERIOSCLEROSIS,1
PL,ARTHRALGIA,1
PL,ARTHRITIS,1
PL,ARTHROPATHY,1
PL,ASCITES,1
PL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
PL,BLISTER,1
PL,BLOOD CHOLESTEROL INCREASED,1
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PL,BLOOD CREATINE PHOSPHOKINASE MB,1
PL,BLOOD CREATININE INCREASED,1
PL,BLOOD DISORDER,1
PL,BODY TEMPERATURE INCREASED,1
PL,BRONCHIOLOALVEOLAR CARCINOMA,1
PL,BRONCHITIS BACTERIAL,1
PL,BRONCHOPNEUMONIA,1
PL,C-REACTIVE PROTEIN INCREASED,1
PL,CARDIAC HYPERTROPHY,1
PL,CEREBROVASCULAR INSUFFICIENCY,1
PL,CHEST PAIN,1
PL,CHEST X-RAY ABNORMAL,1
PL,CHILLS,1
PL,COLITIS,1
PL,COLITIS ULCERATIVE,1
PL,CONFUSIONAL STATE,1
PL,COUGH,1
PL,CRANIOCEREBRAL INJURY,1
PL,CUTANEOUS LUPUS ERYTHEMATOSUS,1
PL,DECREASED ACTIVITY,1
PL,DECREASED IMMUNE RESPONSIVENESS,1
PL,DISEASE RECURRENCE,1
PL,DISTURBANCE IN ATTENTION,1
PL,DIVERTICULAR PERFORATION,1
PL,DIZZINESS,1
PL,DRUG INTOLERANCE,1
PL,DRUG-INDUCED LIVER INJURY,1
PL,DYSPHONIA,1
PL,EMPYEMA,1
PL,ENDOMETRIAL ADENOCARCINOMA,1
PL,EPIDURAL HAEMORRHAGE,1
PL,EYE MOVEMENT DISORDER,1
PL,GAIT DISTURBANCE,1
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PL,GENERAL PHYSICAL HEALTH DETERIORATION,1
PL,GIANT CELL TUMOUR OF TENDON SHEATH,1
PL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
PL,GRANULOCYTOPENIA,1
PL,GROIN ABSCESS,1
PL,HAEMATURIA,1
PL,HAEMOGLOBIN DECREASED,1
PL,HALLUCINATION,1
PL,HEPATITIS,1
PL,HEPATITIS ACUTE,1
PL,HIP ARTHROPLASTY,1
PL,HYPERHIDROSIS,1
PL,HYPERTHYROIDISM,1
PL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
PL,INJECTION SITE RASH,1
PL,INJECTION SITE SWELLING,1
PL,INTERSTITIAL LUNG DISEASE,1
PL,IRITIS,1
PL,JOINT SWELLING,1
PL,JUVENILE IDIOPATHIC ARTHRITIS,1
PL,KLEBSIELLA TEST POSITIVE,1
PL,LEUKOCYTOSIS,1
PL,LIVER INJURY,1
PL,LOCAL SWELLING,1
PL,LOSS OF CONSCIOUSNESS,1
PL,LOW DENSITY LIPOPROTEIN INCREASED,1
PL,LOWER RESPIRATORY TRACT INFECTION,1
PL,LUNG ABSCESS,1
PL,LUNG ADENOCARCINOMA,1
PL,LYMPHOPENIA,1
PL,MALAISE,1
PL,MATERNAL EXPOSURE DURING PREGNANCY,1
PL,MUSCULAR WEAKNESS,1
PL,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
PL,MYOCARDIAL FIBROSIS,1
PL,MYOGLOBINAEMIA,1
PL,MYOSITIS,1
PL,NECROLYTIC MIGRATORY ERYTHEMA,1
PL,OEDEMA MUCOSAL,1
PL,OPTIC NEURITIS,1
PL,OROPHARYNGEAL PAIN,1
PL,OSTEOMYELITIS CHRONIC,1
PL,PAIN,1
PL,PALATAL DISORDER,1
PL,PALPITATIONS,1
PL,PANCREATITIS ACUTE,1
PL,PANCREATITIS HAEMORRHAGIC,1
PL,PAPILLOEDEMA,1
PL,PARAPSORIASIS,1
PL,PELVIC ABSCESS,1
PL,PERICARDIAL FIBROSIS,1
PL,PERICARDITIS,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PERITONITIS,1
PL,PETECHIAE,1
PL,PHARYNGEAL CANCER,1
PL,PHARYNGEAL OEDEMA,1
PL,PHLEBITIS,1
PL,PHOTOSENSITIVITY REACTION,1
PL,PNEUMONIA BACTERIAL,1
PL,POLYNEUROPATHY,1
PL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
PL,POSTURE ABNORMAL,1
PL,PULMONARY MASS,1
PL,PULMONARY OEDEMA,1
PL,PULMONARY SARCOIDOSIS,1
PL,PULMONARY TUBERCULOSIS,1
PL,PYELONEPHRITIS,1
PL,RASH FOLLICULAR,1
PL,RASH MACULAR,1
PL,RASH PAPULOSQUAMOUS,1
PL,RED BLOOD CELL ABNORMALITY,1
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PL,RENAL CELL CARCINOMA STAGE I,1
PL,RENAL DISORDER,1
PL,RENAL FAILURE,1
PL,RESPIRATORY TRACT INFECTION,1
PL,RETROPERITONEAL ABSCESS,1
PL,SARCOMA,1
PL,SCRATCH,1
PL,SCROTAL DISORDER,1
PL,SEIZURE,1
PL,SERUM FERRITIN INCREASED,1
PL,SINUSITIS,1
PL,SKIN CANCER,1
PL,SKIN DISORDER,1
PL,SKIN EXFOLIATION,1
PL,SKIN OEDEMA,1
PL,SKIN REACTION,1
PL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
PL,SWELLING FACE,1
PL,THERAPEUTIC RESPONSE DECREASED,1
PL,THROMBOCYTOSIS,1
PL,THROMBOSIS,1
PL,THYROID CANCER,1
PL,THYROID NEOPLASM,1
PL,TRANSIENT ISCHAEMIC ATTACK,1
PL,TREMOR,1
PL,UREAPLASMA TEST POSITIVE,1
PL,URINARY TRACT INFECTION,1
PL,URTICARIA PHYSICAL,1
PL,VASCULITIS,1
PL,VASCULITIS NECROTISING,1
PL,VULVAL CANCER,1
PL,WEIGHT DECREASED,1
PL,WOUND,1
PT,PNEUMONIA,10
PT,INJECTION SITE ERYTHEMA,7
PT,HEADACHE,6
PT,PSORIATIC ARTHROPATHY,5
PT,RESPIRATORY TRACT INFECTION,5
PT,TUBERCULOSIS,5
PT,URINARY TRACT INFECTION,5
PT,COUGH,4
PT,DIARRHOEA,4
PT,FATIGUE,4
PT,INJECTION SITE OEDEMA,4
PT,INJECTION SITE PRURITUS,4
PT,PSORIASIS,4
PT,RASH,4
PT,RHEUMATOID ARTHRITIS,4
PT,UPPER RESPIRATORY TRACT INFECTION,4
PT,ACUTE TONSILLITIS,3
PT,ANKYLOSING SPONDYLITIS,3
PT,CHOLANGITIS,3
PT,CONDITION AGGRAVATED,3
PT,DEATH,3
PT,DIZZINESS,3
PT,DYSPNOEA,3
PT,GENERALISED OEDEMA,3
PT,GRANULOMATOUS LIVER DISEASE,3
PT,PERIPHERAL SWELLING,3
PT,PRODUCT QUALITY ISSUE,3
PT,PULMONARY TUBERCULOSIS,3
PT,PYREXIA,3
PT,RESPIRATORY TRACT INFECTION BACTERIAL,3
PT,TUBERCULIN TEST POSITIVE,3
PT,ABSCESS LIMB,2
PT,ADENOCARCINOMA OF COLON,2
PT,ARTHROPATHY,2
PT,ASTHENIA,2
PT,ASTHMATIC CRISIS,2
PT,ATRIAL FIBRILLATION,2
PT,BILE DUCT OBSTRUCTION,2
PT,BLADDER CANCER,2
PT,BURSITIS INFECTIVE,2
PT,CEREBROVASCULAR ACCIDENT,2
PT,CHOLECYSTITIS,2
PT,DRUG EFFECT INCOMPLETE,2
PT,DRUG INEFFECTIVE,2
PT,ENDOCARDITIS,2
PT,ERYSIPELAS,2
PT,ERYTHEMA,2
PT,ERYTHEMA NODOSUM,2
PT,EXTRAPYRAMIDAL DISORDER,2
PT,FOETAL GROWTH RESTRICTION,2
PT,FOLLICULITIS,2
PT,GENITOURINARY TRACT INFECTION,2
PT,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,2
PT,HAEMORRHAGIC STROKE,2
PT,HEMIPARESIS,2
PT,HENOCH-SCHONLEIN PURPURA,2
PT,HEPATIC STEATOSIS,2
PT,HEPATITIS TOXIC,2
PT,HEPATOTOXICITY,2
PT,HODGKIN^S DISEASE STAGE III,2
PT,HYPERSENSITIVITY VASCULITIS,2
PT,HYPERTENSION,2
PT,INFECTED CYST,2
PT,INFLAMMATION,2
PT,INFLUENZA LIKE ILLNESS,2
PT,INJECTION SITE PAIN,2
PT,INJECTION SITE PAPULE,2
PT,INJECTION SITE RASH,2
PT,INJECTION SITE SWELLING,2
PT,INJECTION SITE WARMTH,2
PT,LUNG NEOPLASM,2
PT,LUNG NEOPLASM MALIGNANT,2
PT,MALAISE,2
PT,MATERNAL EXPOSURE DURING PREGNANCY,2
PT,METASTASES TO CENTRAL NERVOUS SYSTEM,2
PT,METASTASES TO LIVER,2
PT,MYCOSIS FUNGOIDES,2
PT,NAUSEA,2
PT,NEPHROLITHIASIS,2
PT,NON-HODGKIN^S LYMPHOMA,2
PT,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
PT,OCULAR HYPERAEMIA,2
PT,OEDEMA,2
PT,ORGANISING PNEUMONIA,2
PT,PAIN,2
PT,POLYSEROSITIS,2
PT,PREMATURE BABY,2
PT,PRODUCT USE ISSUE,2
PT,PRURITUS,2
PT,PULMONARY FIBROSIS,2
PT,PUSTULAR PSORIASIS,2
PT,RASH ERYTHEMATOUS,2
PT,SARCOIDOSIS,2
PT,SJOGREN^S SYNDROME,2
PT,SMALL CELL LUNG CANCER METASTATIC,2
PT,SQUAMOUS CELL CARCINOMA,2
PT,TRANSAMINASES INCREASED,2
PT,TRAUMATIC LUNG INJURY,2
PT,TUMOUR HAEMORRHAGE,2
PT,UPPER RESPIRATORY TRACT INFECTION BACTERIAL,2
PT,UVEITIS,2
PT,VISUAL IMPAIRMENT,2
PT,WEIGHT DECREASED,2
PT,ABDOMINAL PAIN UPPER,1
PT,ABNORMAL FAECES,1
PT,ABSCESS RUPTURE,1
PT,ACUTE ENDOCARDITIS,1
PT,ACUTE MYOCARDIAL INFARCTION,1
PT,ACUTE SINUSITIS,1
PT,ADENOVIRAL UPPER RESPIRATORY INFECTION,1
PT,ALOPECIA,1
PT,AMNESTIC DISORDER,1
PT,ANTINUCLEAR ANTIBODY POSITIVE,1
PT,APHTHOUS STOMATITIS,1
PT,APPLICATION SITE HYPERSENSITIVITY,1
PT,ARTERIAL OCCLUSIVE DISEASE,1
PT,ARTERIOVENOUS FISTULA OPERATION,1
PT,ARTHRALGIA,1
PT,ARTHRITIS INFECTIVE,1
PT,ASTHMA,1
PT,BACK PAIN,1
PT,BACTERIAL PYELONEPHRITIS,1
PT,BILIARY CIRRHOSIS PRIMARY,1
PT,BLADDER ADENOCARCINOMA STAGE I,1
PT,BLADDER NEOPLASM,1
PT,BLOOD POTASSIUM DECREASED,1
PT,BLOOD PRESSURE DECREASED,1
PT,BONE MARROW FAILURE,1
PT,BREAST ABSCESS,1
PT,BREAST CANCER,1
PT,BREAST NEOPLASM,1
PT,BRONCHOPULMONARY ASPERGILLOSIS,1
PT,CARDIOVASCULAR DISORDER,1
PT,CEREBRAL INFARCTION,1
PT,CERVIX CARCINOMA STAGE 0,1
PT,CHEST PAIN,1
PT,CHOLELITHIASIS,1
PT,CHOLESTASIS,1
PT,CHRONIC MYELOID LEUKAEMIA,1
PT,COLITIS,1
PT,COLITIS ULCERATIVE,1
PT,CONVULSION,1
PT,CROHN^S DISEASE,1
PT,CUTANEOUS VASCULITIS,1
PT,CYST RUPTURE,1
PT,CYSTITIS,1
PT,CYSTITIS ESCHERICHIA,1
PT,CYTOMEGALOVIRUS COLITIS,1
PT,CYTOMEGALOVIRUS MONONUCLEOSIS,1
PT,DACTYLITIS,1
PT,DEMYELINATION,1
PT,DENTAL CARIES,1
PT,DERMATITIS ALLERGIC,1
PT,DERMATOMYOSITIS,1
PT,DERMATOPHYTOSIS,1
PT,DEVICE RELATED INFECTION,1
PT,DIABETES MELLITUS INADEQUATE CONTROL,1
PT,DIPLOPIA,1
PT,DRUG EFFECT DECREASED,1
PT,DYSHIDROTIC ECZEMA,1
PT,DYSPHAGIA,1
PT,ENDOMETRIOSIS,1
PT,ERYTHRODERMIC PSORIASIS,1
PT,ESCHERICHIA INFECTION,1
PT,ESSENTIAL THROMBOCYTHAEMIA,1
PT,EYE HAEMORRHAGE,1
PT,FACE OEDEMA,1
PT,FAECAL CALPROTECTIN INCREASED,1
PT,FEELING ABNORMAL,1
PT,GAIT DISTURBANCE,1
PT,GANGLIONEUROMA,1
PT,GASTRIC SARCOMA,1
PT,GASTRIC ULCER,1
PT,GENERALISED ERYTHEMA,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,GRAND MAL CONVULSION,1
PT,GRANULOMA,1
PT,HAEMATOCHEZIA,1
PT,HAEMATOMA,1
PT,HAEMOGLOBIN DECREASED,1
PT,HAEMORRHAGIC OVARIAN CYST,1
PT,HAIR COLOUR CHANGES,1
PT,HEPATITIS,1
PT,HYPERHIDROSIS,1
PT,IMMUNOSUPPRESSION,1
PT,INFARCTION,1
PT,INFECTED SKIN ULCER,1
PT,INFLAMMATORY BOWEL DISEASE,1
PT,INFLUENZA,1
PT,INFUSION RELATED REACTION,1
PT,INJECTION SITE CELLULITIS,1
PT,INJECTION SITE HYPERSENSITIVITY,1
PT,INJECTION SITE REACTION,1
PT,INJECTION SITE URTICARIA,1
PT,INSOMNIA,1
PT,INTESTINAL ULCER,1
PT,ISCHAEMIC STROKE,1
PT,JOINT RANGE OF MOTION DECREASED,1
PT,JOINT SWELLING,1
PT,LACRIMATION INCREASED,1
PT,LIMB INJURY,1
PT,LIVER FUNCTION TEST ABNORMAL,1
PT,LOCAL SWELLING,1
PT,LOCALISED INFECTION,1
PT,LOSS OF CONSCIOUSNESS,1
PT,LUNG ABSCESS,1
PT,LUNG INFECTION,1
PT,MASTICATION DISORDER,1
PT,MASTITIS,1
PT,MEMORY IMPAIRMENT,1
PT,METASTASES TO BONE,1
PT,MIGRAINE,1
PT,MONOPARESIS,1
PT,MUCOSAL INFLAMMATION,1
PT,MULTIPLE FRACTURES,1
PT,MULTIPLE SCLEROSIS,1
PT,MYCOBACTERIUM TEST POSITIVE,1
PT,MYELITIS TRANSVERSE,1
PT,NASOPHARYNGITIS,1
PT,NECK PAIN,1
PT,NEOPLASM,1
PT,NEUROCYSTICERCOSIS,1
PT,NEUTROPENIA,1
PT,NO THERAPEUTIC RESPONSE,1
PT,NON-HODGKIN^S LYMPHOMA STAGE IV,1
PT,NON-SMALL CELL LUNG CANCER,1
PT,ODYNOPHAGIA,1
PT,OEDEMA PERIPHERAL,1
PT,ORAL MUCOSAL ERUPTION,1
PT,ORBITAL OEDEMA,1
PT,OSTEONECROSIS,1
PT,PAIN IN EXTREMITY,1
PT,PALPABLE PURPURA,1
PT,PANNICULITIS,1
PT,PAPULE,1
PT,PARAESTHESIA,1
PT,PARKINSON^S DISEASE,1
PT,PERIORBITAL OEDEMA,1
PT,PHARYNGEAL OEDEMA,1
PT,PHARYNGITIS,1
PT,PHARYNGOTONSILLITIS,1
PT,PLATELET COUNT DECREASED,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONIA BACTERIAL,1
PT,PNEUMONIA PSEUDOMONAS AERUGINOSA,1
PT,PORTAL FIBROSIS,1
PT,POST PROCEDURAL INFLAMMATION,1
PT,PRODUCTIVE COUGH,1
PT,PRURIGO,1
PT,PRURITUS GENERALISED,1
PT,PRURITUS GENITAL,1
PT,PULMONARY NECROSIS,1
PT,PYELONEPHRITIS,1
PT,RASH MACULO-PAPULAR,1
PT,RASH PRURITIC,1
PT,RASH VESICULAR,1
PT,RECTAL ADENOCARCINOMA,1
PT,RECTAL HAEMORRHAGE,1
PT,RED BLOOD CELL COUNT DECREASED,1
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PT,RENAL CANCER,1
PT,RESPIRATORY FAILURE,1
PT,RETINAL DETACHMENT,1
PT,RETINAL VASCULITIS,1
PT,RHEUMATOID NODULE,1
PT,RIB FRACTURE,1
PT,SARCOMA,1
PT,SEPTIC ARTHRITIS STREPTOCOCCAL,1
PT,SINUSITIS,1
PT,SKIN DISORDER,1
PT,SKIN LESION,1
PT,SPEECH DISORDER,1
PT,SPLENIC ARTERY THROMBOSIS,1
PT,SPONDYLOARTHROPATHY,1
PT,STAPHYLOCOCCAL INFECTION,1
PT,STEATORRHOEA,1
PT,STEVENS-JOHNSON SYNDROME,1
PT,SUPERINFECTION,1
PT,SYNCOPE,1
PT,SYNOVIAL RUPTURE,1
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PT,TENDON DISORDER,1
PT,TENDON RUPTURE,1
PT,TENDONITIS,1
PT,THERAPY NON-RESPONDER,1
PT,THROMBOCYTOPENIA,1
PT,THYMOMA,1
PT,THYROID NEOPLASM,1
PT,TOOTH ABSCESS,1
PT,TOOTHACHE,1
PT,TOXIC SKIN ERUPTION,1
PT,TREATMENT FAILURE,1
PT,URTICARIA,1
PT,VARICOSE ULCERATION,1
PT,VASCULITIS,1
PT,VASCULITIS CEREBRAL,1
PT,VITH NERVE PARESIS,1
PT,VOMITING,1
PT,VULVOVAGINAL PAIN,1
PT,WHITE BLOOD CELL COUNT DECREASED,1
PT,WRIST FRACTURE,1
PR,DRUG INEFFECTIVE,8
PR,NASOPHARYNGITIS,3
PR,FATIGUE,2
PR,LUNG DISORDER,2
PR,PSORIASIS,2
PR,RHEUMATOID ARTHRITIS,2
PR,ABDOMINAL PAIN UPPER,1
PR,AGRAPHIA,1
PR,ANAEMIA,1
PR,APHASIA,1
PR,ARTHRALGIA,1
PR,ASTHMA,1
PR,AUTOIMMUNE HEPATITIS,1
PR,BACK DISORDER,1
PR,BLOOD GLUCOSE INCREASED,1
PR,BLOOD PRESSURE INCREASED,1
PR,BLOOD URINE PRESENT,1
PR,BRAIN NEOPLASM,1
PR,BREAST ABSCESS,1
PR,BREAST DISORDER,1
PR,BRONCHITIS,1
PR,BRONCHITIS CHRONIC,1
PR,CAESAREAN SECTION,1
PR,CERVICAL DYSPLASIA,1
PR,CONDITION AGGRAVATED,1
PR,DEHYDRATION,1
PR,DIABETES MELLITUS,1
PR,DIARRHOEA,1
PR,DIZZINESS,1
PR,DRUG EFFECT INCOMPLETE,1
PR,ENDOTRACHEAL INTUBATION,1
PR,EPILEPSY,1
PR,ERYTHEMA MULTIFORME,1
PR,EYE PRURITUS,1
PR,FALL,1
PR,GAIT DISTURBANCE,1
PR,GASTROINTESTINAL DISORDER,1
PR,GESTATIONAL HYPERTENSION,1
PR,HEADACHE,1
PR,HYPERSENSITIVITY,1
PR,IMMOBILE,1
PR,INTRACRANIAL ANEURYSM,1
PR,MENISCUS INJURY,1
PR,MYOCARDIAL INFARCTION,1
PR,OEDEMA PERIPHERAL,1
PR,OVARIAN CYST,1
PR,PAIN,1
PR,PERIPHERAL SWELLING,1
PR,PRURITUS GENERALISED,1
PR,PSORIATIC ARTHROPATHY,1
PR,PULMONARY FUNCTION TEST DECREASED,1
PR,SNEEZING,1
PR,SOMNOLENCE,1
PR,UTERINE HAEMORRHAGE,1
PR,UTERINE LEIOMYOMA,1
PR,VOMITING,1
QA,LYMPHOMA,2
QA,JAUNDICE CHOLESTATIC,1
QA,RENAL COLIC,1
RO,DEATH,11
RO,CONDITION AGGRAVATED,10
RO,MALAISE,10
RO,ARTHRALGIA,7
RO,ARTHROPATHY,7
RO,CATARACT,7
RO,IRIDOCYCLITIS,7
RO,PSORIASIS,7
RO,TUBERCULOSIS,7
RO,CEREBROVASCULAR ACCIDENT,6
RO,COUGH,6
RO,FALL,6
RO,INTERVERTEBRAL DISC PROTRUSION,6
RO,NASOPHARYNGITIS,6
RO,PAIN,6
RO,PNEUMONIA,6
RO,PRURITUS,6
RO,PYREXIA,6
RO,ASTHENIA,5
RO,DECREASED IMMUNE RESPONSIVENESS,5
RO,DIZZINESS,5
RO,DRUG INEFFECTIVE,5
RO,ERYTHEMA,5
RO,LUNG DISORDER,5
RO,RASH,5
RO,CARDIAC DISORDER,4
RO,CARDIO-RESPIRATORY ARREST,4
RO,HYPERTENSION,4
RO,INFECTION,4
RO,INJECTION SITE ERYTHEMA,4
RO,LOWER LIMB FRACTURE,4
RO,PSORIATIC ARTHROPATHY,4
RO,SKIN DISCOLOURATION,4
RO,ABDOMINAL PAIN,3
RO,ANAEMIA,3
RO,CONFUSIONAL STATE,3
RO,DERMATITIS,3
RO,DRY SKIN,3
RO,DYSPEPSIA,3
RO,HAND FRACTURE,3
RO,HEADACHE,3
RO,HEPATIC CIRRHOSIS,3
RO,LABORATORY TEST ABNORMAL,3
RO,LICHEN PLANUS,3
RO,LOSS OF CONSCIOUSNESS,3
RO,METASTASES TO LIVER,3
RO,NEOPLASM MALIGNANT,3
RO,NON-HODGKIN^S LYMPHOMA,3
RO,OSTEOARTHRITIS,3
RO,PALPITATIONS,3
RO,PERIPHERAL SWELLING,3
RO,POST PROCEDURAL COMPLICATION,3
RO,PRODUCT QUALITY ISSUE,3
RO,PULMONARY FIBROSIS,3
RO,PULMONARY MASS,3
RO,RASH PUSTULAR,3
RO,RENAL FAILURE,3
RO,SKIN EXFOLIATION,3
RO,SQUAMOUS CELL CARCINOMA OF SKIN,3
RO,STAPHYLOCOCCAL INFECTION,3
RO,VISUAL IMPAIRMENT,3
RO,ABDOMINAL DISTENSION,2
RO,ANAPHYLACTIC REACTION,2
RO,ANGINA PECTORIS,2
RO,ARTHRITIS,2
RO,ASTHMA,2
RO,BLISTER,2
RO,BURNING SENSATION,2
RO,CARDIAC ARREST,2
RO,CARDIAC FAILURE,2
RO,CYST,2
RO,DECREASED APPETITE,2
RO,DIABETIC GANGRENE,2
RO,DIARRHOEA,2
RO,DRUG DOSE OMISSION,2
RO,EMOTIONAL DISTRESS,2
RO,GALLBLADDER DISORDER,2
RO,GASTRIC NEOPLASM,2
RO,HEPATITIS,2
RO,HYPERTROPHIC CARDIOMYOPATHY,2
RO,IMMUNOSUPPRESSION,2
RO,INCORRECT DRUG ADMINISTRATION RATE,2
RO,INFARCTION,2
RO,INJECTION SITE INDURATION,2
RO,INSOMNIA,2
RO,INTRACRANIAL PRESSURE INCREASED,2
RO,INVASIVE BREAST CARCINOMA,2
RO,JAUNDICE,2
RO,JOINT SWELLING,2
RO,LIMB INJURY,2
RO,LIVER DISORDER,2
RO,LUNG NEOPLASM,2
RO,LUPUS-LIKE SYNDROME,2
RO,LYMPHOMA,2
RO,METAL POISONING,2
RO,METASTASES TO LUNG,2
RO,MUSCLE FATIGUE,2
RO,MUSCLE INJURY,2
RO,MYOCARDIAL INFARCTION,2
RO,PANCREATITIS ACUTE,2
RO,PLEURAL EFFUSION,2
RO,POST PROCEDURAL INFECTION,2
RO,PULMONARY TUBERCULOSIS,2
RO,RESPIRATORY ARREST,2
RO,RESPIRATORY FAILURE,2
RO,RESPIRATORY TRACT INFECTION,2
RO,TRANSAMINASES INCREASED,2
RO,TREMOR,2
RO,TUBERCULIN TEST POSITIVE,2
RO,URINARY TRACT INFECTION,2
RO,UVEITIS,2
RO,VASCULITIS,2
RO,VOMITING,2
RO,WEIGHT DECREASED,2
RO,WOUND,2
RO,ABSCESS,1
RO,ACCIDENT,1
RO,ACUTE CORONARY SYNDROME,1
RO,ACUTE KIDNEY INJURY,1
RO,ACUTE MYOCARDIAL INFARCTION,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,ADENOCARCINOMA OF COLON,1
RO,AGITATION,1
RO,ANAL FISTULA,1
RO,ANAPLASTIC ASTROCYTOMA,1
RO,ANGIOEDEMA,1
RO,ANKLE FRACTURE,1
RO,ANKYLOSING SPONDYLITIS,1
RO,AORTIC DISSECTION,1
RO,ARTHRITIS BACTERIAL,1
RO,ARTHROPOD BITE,1
RO,ASPHYXIA,1
RO,ASTHMATIC CRISIS,1
RO,ATYPICAL PNEUMONIA,1
RO,AUTOIMMUNE HEPATITIS,1
RO,AXILLARY PAIN,1
RO,BACK PAIN,1
RO,BLADDER CANCER,1
RO,BLADDER NEOPLASM,1
RO,BLINDNESS UNILATERAL,1
RO,BLOOD CHOLESTEROL INCREASED,1
RO,BLOOD CREATININE INCREASED,1
RO,BLOOD IMMUNOGLOBULIN G INCREASED,1
RO,BLOOD PRESSURE ABNORMAL,1
RO,BODY TEMPERATURE INCREASED,1
RO,BORRELIA TEST POSITIVE,1
RO,BRAIN ABSCESS,1
RO,BREAST CANCER,1
RO,BREAST MASS,1
RO,BREAST NEOPLASM,1
RO,BRONCHOPNEUMONIA,1
RO,C-REACTIVE PROTEIN INCREASED,1
RO,CARCINOID TUMOUR,1
RO,CARDIAC MURMUR,1
RO,CARDIOPULMONARY FAILURE,1
RO,CARDIOVASCULAR DISORDER,1
RO,CENTRAL NERVOUS SYSTEM LESION,1
RO,CENTRAL NERVOUS SYSTEM NEOPLASM,1
RO,CHEST PAIN,1
RO,CHILLS,1
RO,CLOSTRIDIAL INFECTION,1
RO,COAGULATION TEST ABNORMAL,1
RO,COLON ADENOMA,1
RO,COLON CANCER,1
RO,COMA,1
RO,COMMUNICATION DISORDER,1
RO,COMPLETED SUICIDE,1
RO,CONGENITAL ANOMALY IN OFFSPRING,1
RO,CROHN^S DISEASE,1
RO,DEEP VEIN THROMBOSIS,1
RO,DEMYELINATION,1
RO,DENTAL CYST,1
RO,DERMATITIS INFECTED,1
RO,DIFFUSE LARGE B-CELL LYMPHOMA,1
RO,DISEASE RECURRENCE,1
RO,DIVERTICULAR PERFORATION,1
RO,DRUG HYPERSENSITIVITY,1
RO,DYSPNOEA,1
RO,EAR INFECTION,1
RO,EXCORIATION,1
RO,EXPOSURE DURING PREGNANCY,1
RO,EXTRAPULMONARY TUBERCULOSIS,1
RO,EYE DISORDER,1
RO,EYE INFECTION,1
RO,EYE PAIN,1
RO,FACIAL PARESIS,1
RO,FATIGUE,1
RO,FEELING ABNORMAL,1
RO,FEELING COLD,1
RO,FEMUR FRACTURE,1
RO,FOOD POISONING,1
RO,FRACTURE,1
RO,GAIT DISTURBANCE,1
RO,GANGRENE,1
RO,GASTRIC CANCER,1
RO,GASTROINTESTINAL HAEMORRHAGE,1
RO,GENERAL PHYSICAL HEALTH DETERIORATION,1
RO,GENERALISED TONIC-CLONIC SEIZURE,1
RO,GLAUCOMA,1
RO,HAEMATOCHEZIA,1
RO,HAEMATOMA,1
RO,HAEMORRHAGE,1
RO,HEAD INJURY,1
RO,HEART RATE DECREASED,1
RO,HEMIPARESIS,1
RO,HEPATIC CYST,1
RO,HEPATIC NEOPLASM,1
RO,HEPATIC PAIN,1
RO,HEPATITIS B ANTIBODY POSITIVE,1
RO,HEPATITIS C,1
RO,HEPATITIS TOXIC,1
RO,HEPATOMEGALY,1
RO,HERNIA,1
RO,HERPES ZOSTER,1
RO,HIATUS HERNIA,1
RO,HIP FRACTURE,1
RO,HUMERUS FRACTURE,1
RO,HYPERGLYCAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPERSENSITIVITY,1
RO,HYPOAESTHESIA ORAL,1
RO,ILIAC ARTERY OCCLUSION,1
RO,IMMUNE SYSTEM DISORDER,1
RO,IMMUNE-MEDIATED ADVERSE REACTION,1
RO,IMMUNODEFICIENCY,1
RO,IMMUNOGLOBULINS INCREASED,1
RO,INCISION SITE INFLAMMATION,1
RO,INCORRECT PRODUCT STORAGE,1
RO,INFECTION SUSCEPTIBILITY INCREASED,1
RO,INFLAMMATION,1
RO,INFLUENZA,1
RO,INJECTION SITE BRUISING,1
RO,INJECTION SITE CELLULITIS,1
RO,INJECTION SITE INFLAMMATION,1
RO,INJECTION SITE INJURY,1
RO,INJECTION SITE OEDEMA,1
RO,INJECTION SITE PAIN,1
RO,INJECTION SITE PLAQUE,1
RO,INJECTION SITE SWELLING,1
RO,INJURY,1
RO,INTENTIONAL PRODUCT MISUSE,1
RO,INTERNAL HAEMORRHAGE,1
RO,INTERVERTEBRAL DISC DEGENERATION,1
RO,INTERVERTEBRAL DISC DISORDER,1
RO,INTERVERTEBRAL DISCITIS,1
RO,IRON DEFICIENCY ANAEMIA,1
RO,JOINT DEPOSIT,1
RO,KERATITIS,1
RO,KYPHOSIS,1
RO,LACK OF SPONTANEOUS SPEECH,1
RO,LARGE INTESTINAL HAEMORRHAGE,1
RO,LARGE INTESTINE POLYP,1
RO,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,1
RO,LEUKAEMIA,1
RO,LOWER RESPIRATORY TRACT INFECTION,1
RO,LUNG ADENOCARCINOMA,1
RO,LUNG INFECTION,1
RO,LUNG NEOPLASM MALIGNANT,1
RO,LYMPHADENOPATHY,1
RO,MAXILLOFACIAL SINUS NEOPLASM,1
RO,MEGACOLON,1
RO,METASTASES TO LYMPH NODES,1
RO,METASTASES TO PERITONEUM,1
RO,MOBILITY DECREASED,1
RO,MUMPS,1
RO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
RO,NASAL SEPTUM DEVIATION,1
RO,NASOPHARYNGEAL CANCER,1
RO,NAUSEA,1
RO,NEOPLASM,1
RO,NEOPLASM OF APPENDIX,1
RO,NERVOUSNESS,1
RO,NO THERAPEUTIC RESPONSE,1
RO,NOSOCOMIAL INFECTION,1
RO,OBSTRUCTIVE UROPATHY,1
RO,OCULAR ICTERUS,1
RO,OPTIC NEURITIS,1
RO,OROPHARYNGEAL PAIN,1
RO,OSTEONECROSIS,1
RO,OSTEOPENIA,1
RO,OSTEOPOROSIS,1
RO,OVARIAN EPITHELIAL CANCER,1
RO,PANCREATIC CARCINOMA,1
RO,PANCYTOPENIA,1
RO,PANIC ATTACK,1
RO,PARALYSIS,1
RO,PERICARDITIS,1
RO,PERINEAL INJURY,1
RO,PERIPHERAL EMBOLISM,1
RO,PERIPHERAL ISCHAEMIA,1
RO,PERIPHERAL VENOUS DISEASE,1
RO,PERITONITIS,1
RO,PLEURISY,1
RO,POST PROCEDURAL HAEMATOMA,1
RO,PRODUCTIVE COUGH,1
RO,PROSTATE CANCER,1
RO,PROSTATIC DISORDER,1
RO,PROSTATIC MASS,1
RO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
RO,PTERYGIUM,1
RO,PULMONARY OEDEMA,1
RO,PUPILLARY DISORDER,1
RO,PURULENT DISCHARGE,1
RO,PUSTULAR PSORIASIS,1
RO,RASH ERYTHEMATOUS,1
RO,RASH GENERALISED,1
RO,RASH VESICULAR,1
RO,RECTAL ADENOCARCINOMA,1
RO,RECTAL CANCER,1
RO,RECTAL NEOPLASM,1
RO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
RO,RENAL COLIC,1
RO,RENAL CYST,1
RO,RENAL DISORDER,1
RO,RENAL NEOPLASM,1
RO,RENAL PAIN,1
RO,RESTLESSNESS,1
RO,RETROPERITONEAL ABSCESS,1
RO,RHEUMATOID NODULE,1
RO,RIB FRACTURE,1
RO,SCIATICA,1
RO,SECRETION DISCHARGE,1
RO,SENSITIVITY TO WEATHER CHANGE,1
RO,SEPSIS,1
RO,SEPTIC SHOCK,1
RO,SINUS NODE DYSFUNCTION,1
RO,SKIN BURNING SENSATION,1
RO,SKIN FISSURES,1
RO,SKIN HYPERTROPHY,1
RO,SKIN PLAQUE,1
RO,SPEECH DISORDER,1
RO,SPINAL FRACTURE,1
RO,SPINAL PAIN,1
RO,SPLEEN DISORDER,1
RO,SPLENOMEGALY,1
RO,SPUTUM DISCOLOURED,1
RO,SPUTUM PURULENT,1
RO,STAPHYLOCOCCAL SKIN INFECTION,1
RO,SWELLING FACE,1
RO,SYNCOPE,1
RO,SYNOVIAL CYST,1
RO,TENDON DISORDER,1
RO,THYROID CANCER,1
RO,THYROID DISORDER,1
RO,TOOTH ABSCESS,1
RO,TOOTH DISORDER,1
RO,TRANSIENT ISCHAEMIC ATTACK,1
RO,URTICARIA,1
RO,UTERINE LEIOMYOMA,1
RO,VARICES OESOPHAGEAL,1
RO,VERTEBRAL LESION,1
RO,VERTIGO,1
RO,VIRAL INFECTION,1
RO,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
RO,VISCERAL PAIN,1
RO,VISUAL ACUITY REDUCED,1
RO,WOUND DEHISCENCE,1
RO,WOUND EVISCERATION,1
RO,WOUND INFECTION,1
RO,WOUND INFECTION STAPHYLOCOCCAL,1
RO,YELLOW SKIN,1
RU,DRUG INEFFECTIVE,5
RU,CONDITION AGGRAVATED,3
RU,THROMBOCYTOPENIA,3
RU,ALANINE AMINOTRANSFERASE INCREASED,2
RU,ANKYLOSING SPONDYLITIS,2
RU,BODY HEIGHT BELOW NORMAL,2
RU,DRUG RESISTANCE,2
RU,GASTROENTERITIS,2
RU,HAEMOGLOBIN DECREASED,2
RU,INJECTION SITE ERYTHEMA,2
RU,INJECTION SITE PAIN,2
RU,JUVENILE IDIOPATHIC ARTHRITIS,2
RU,LOWER LIMB FRACTURE,2
RU,MULTIPLE-DRUG RESISTANCE,2
RU,PRODUCT QUALITY ISSUE,2
RU,PRODUCT USE ISSUE,2
RU,RASH GENERALISED,2
RU,RESPIRATORY FAILURE,2
RU,RESPIRATORY TRACT INFECTION,2
RU,ABORTION MISSED,1
RU,ACUTE KIDNEY INJURY,1
RU,ADVERSE EVENT,1
RU,AGRANULOCYTOSIS,1
RU,ANAPHYLACTIC REACTION,1
RU,ANGIOEDEMA,1
RU,ARTHRALGIA,1
RU,ASPHYXIA,1
RU,ASTHENIA,1
RU,BACTERIAL DISEASE CARRIER,1
RU,BODY TEMPERATURE INCREASED,1
RU,BONE NEOPLASM,1
RU,BREAST FIBROSIS,1
RU,C-REACTIVE PROTEIN INCREASED,1
RU,CARDIAC FAILURE CHRONIC,1
RU,CHOLECYSTITIS CHRONIC,1
RU,COUGH,1
RU,DERMATITIS EXFOLIATIVE,1
RU,DISEASE PROGRESSION,1
RU,DISSEMINATED INTRAVASCULAR COAGULATION,1
RU,DISSEMINATED TUBERCULOSIS,1
RU,DIZZINESS,1
RU,DRUG EFFECT DECREASED,1
RU,DRUG HYPERSENSITIVITY,1
RU,DYSPNOEA,1
RU,ERYTHEMA,1
RU,GENERAL PHYSICAL HEALTH DETERIORATION,1
RU,GROWTH RETARDATION,1
RU,HEPATIC ENZYME INCREASED,1
RU,HYPERBILIRUBINAEMIA,1
RU,INJECTION SITE INDURATION,1
RU,INJECTION SITE PAPULE,1
RU,INJECTION SITE REACTION,1
RU,LEUKOPENIA,1
RU,LUNG NEOPLASM MALIGNANT,1
RU,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
RU,NAUSEA,1
RU,OEDEMA PERIPHERAL,1
RU,OESOPHAGEAL CARCINOMA,1
RU,OSTEOARTHRITIS,1
RU,PANCYTOPENIA,1
RU,PLATELET COUNT DECREASED,1
RU,PROSTATE CANCER,1
RU,PRURITUS GENERALISED,1
RU,PULMONARY EMBOLISM,1
RU,RADIUS FRACTURE,1
RU,RASH ERYTHEMATOUS,1
RU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
RU,RENAL CANCER,1
RU,SKIN EXFOLIATION,1
RU,TIBIA FRACTURE,1
RU,TUBERCULOSIS,1
RU,UTERINE HAEMORRHAGE,1
RU,UVEITIS,1
RU,VOMITING,1
BL,BONE EROSION,1
BL,C-REACTIVE PROTEIN ABNORMAL,1
BL,CONDITION AGGRAVATED,1
BL,DRUG INEFFECTIVE,1
BL,JOINT STIFFNESS,1
BL,JOINT SWELLING,1
BL,MUSCULOSKELETAL STIFFNESS,1
BL,NASOPHARYNGITIS,1
BL,PAIN IN EXTREMITY,1
BL,PERIPHERAL SWELLING,1
BL,RHEUMATOID ARTHRITIS,1
BL,STRESS,1
SA,DRUG DOSE OMISSION,4
SA,DRUG INEFFECTIVE,3
SA,ABORTION SPONTANEOUS,2
SA,ACCIDENTAL OVERDOSE,2
SA,ASTHMA,2
SA,BONE MARROW DISORDER,2
SA,DIZZINESS,2
SA,DRUG ADMINISTRATION ERROR,2
SA,GINGIVAL BLEEDING,2
SA,HAEMORRHAGE,2
SA,HEADACHE,2
SA,INJECTION SITE ERYTHEMA,2
SA,INJECTION SITE PAIN,2
SA,MYCOBACTERIUM ABSCESSUS INFECTION,2
SA,PNEUMONITIS,2
SA,RHINORRHOEA,2
SA,VOMITING,2
SA,ABDOMINAL DISCOMFORT,1
SA,ARTHRALGIA,1
SA,ARTHRITIS,1
SA,BLISTER,1
SA,BREAST CANCER,1
SA,DISEASE RECURRENCE,1
SA,DRUG HYPERSENSITIVITY,1
SA,EPILEPSY,1
SA,EXPOSURE DURING PREGNANCY,1
SA,FATIGUE,1
SA,GAIT INABILITY,1
SA,GASTRIC CANCER,1
SA,GRANULOMA,1
SA,GUILLAIN-BARRE SYNDROME,1
SA,HEPATIC ENZYME INCREASED,1
SA,IMMUNODEFICIENCY,1
SA,IMMUNOSUPPRESSION,1
SA,INFLUENZA,1
SA,INJECTION SITE DRYNESS,1
SA,INJECTION SITE PRURITUS,1
SA,INTENTIONAL PRODUCT MISUSE,1
SA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
SA,LUNG INFECTION,1
SA,NAUSEA,1
SA,OVARIAN NEOPLASM,1
SA,POLYARTHRITIS,1
SA,PYREXIA,1
SA,RETINAL DETACHMENT,1
SA,RHEUMATOID ARTHRITIS,1
SA,SARCOIDOSIS,1
SA,SEPTIC SHOCK,1
SA,SYNOVITIS,1
SA,VISION BLURRED,1
RS,DRUG INEFFECTIVE,7
RS,JOINT SWELLING,7
RS,INJECTION SITE ERYTHEMA,6
RS,ARTHRALGIA,5
RS,IRIDOCYCLITIS,5
RS,EYELID OEDEMA,4
RS,TRANSAMINASES INCREASED,4
RS,ABSCESS LIMB,3
RS,BONE EROSION,3
RS,PNEUMONIA,3
RS,ANAEMIA,2
RS,ARTHRITIS,2
RS,ASPHYXIA,2
RS,C-REACTIVE PROTEIN INCREASED,2
RS,DRUG INTOLERANCE,2
RS,HEREDITARY ANGIOEDEMA,2
RS,HERPES ZOSTER,2
RS,INJECTION SITE PRURITUS,2
RS,INJECTION SITE SWELLING,2
RS,LIMB INJURY,2
RS,LIP SWELLING,2
RS,MASTITIS,2
RS,MULTIPLE FRACTURES,2
RS,PULMONARY FIBROSIS,2
RS,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
RS,ROAD TRAFFIC ACCIDENT,2
RS,URINARY TRACT INFECTION,2
RS,ACCIDENT,1
RS,ACINETOBACTER TEST POSITIVE,1
RS,ALOPECIA,1
RS,ARTHROPATHY,1
RS,BLAU SYNDROME,1
RS,BRONCHITIS,1
RS,CYST,1
RS,DACTYLITIS,1
RS,DERMATITIS EXFOLIATIVE,1
RS,DISEASE PROGRESSION,1
RS,DISSEMINATED INTRAVASCULAR COAGULATION,1
RS,EAR INFECTION,1
RS,ERYTHEMA INDURATUM,1
RS,ERYTHRODERMIC PSORIASIS,1
RS,HEPATORENAL FAILURE,1
RS,HISTIOCYTOSIS HAEMATOPHAGIC,1
RS,INFECTION,1
RS,INJECTION SITE INDURATION,1
RS,JOINT CONTRACTURE,1
RS,JUVENILE IDIOPATHIC ARTHRITIS,1
RS,LUNG DISORDER,1
RS,MALIGNANT MELANOMA,1
RS,MUSCULOSKELETAL PAIN,1
RS,NAIL PITTING,1
RS,NEURALGIA,1
RS,OPHTHALMIC HERPES ZOSTER,1
RS,OTITIS EXTERNA,1
RS,PAIN IN EXTREMITY,1
RS,PLATELET COUNT DECREASED,1
RS,PNEUMOCYSTIS JIROVECII INFECTION,1
RS,PNEUMONIA BACTERIAL,1
RS,PROTEINURIA,1
RS,PRURITUS,1
RS,PRURITUS GENERALISED,1
RS,PSORIASIS,1
RS,PSORIATIC ARTHROPATHY,1
RS,PULMONARY MASS,1
RS,PYREXIA,1
RS,RESPIRATORY DISORDER,1
RS,SARCOIDOSIS,1
RS,SKIN HAEMORRHAGE,1
RS,STAPHYLOCOCCAL INFECTION,1
RS,SYNOVITIS,1
RS,ULCERATIVE KERATITIS,1
SL,ABDOMINAL DISCOMFORT,1
SL,ACCIDENT,1
SL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SL,ANXIETY,1
SL,ARTHRALGIA,1
SL,ARTHRITIS,1
SL,ASTHENIA,1
SL,BONE PAIN,1
SL,BRAIN NEOPLASM,1
SL,BURNOUT SYNDROME,1
SL,CEREBRAL DISORDER,1
SL,CHILLS,1
SL,DEPRESSION,1
SL,DISABILITY,1
SL,DRUG HYPERSENSITIVITY,1
SL,DYSPNOEA,1
SL,EMOTIONAL DISTRESS,1
SL,FALL,1
SL,FATIGUE,1
SL,FEELING ABNORMAL,1
SL,FLATULENCE,1
SL,HEAD INJURY,1
SL,HYPERHIDROSIS,1
SL,INFECTION,1
SL,INSOMNIA,1
SL,INTENTIONAL PRODUCT MISUSE,1
SL,IRRITABILITY,1
SL,JOINT SWELLING,1
SL,LOSS OF CONSCIOUSNESS,1
SL,LOSS OF EMPLOYMENT,1
SL,MALAISE,1
SL,MENTAL FATIGUE,1
SL,MOBILITY DECREASED,1
SL,MUSCLE DISORDER,1
SL,MUSCULAR WEAKNESS,1
SL,MUSCULOSKELETAL PAIN,1
SL,NAUSEA,1
SL,NERVE INJURY,1
SL,PAIN,1
SL,PAIN IN EXTREMITY,1
SL,PARAESTHESIA,1
SL,PERICARDITIS,1
SL,PERIPHERAL SWELLING,1
SL,PRODUCTIVE COUGH,1
SL,PRURITUS,1
SL,PYREXIA,1
SL,SEXUAL ABUSE,1
SL,SKIN ATROPHY,1
SL,SKIN DISCOLOURATION,1
SL,SKIN DISORDER,1
SL,STRESS,1
SL,SWELLING,1
SL,UNDERDOSE,1
SL,URINARY INCONTINENCE,1
SL,URTICARIA,1
SL,VOMITING,1
SL,WALKING AID USER,1
SL,WHITE BLOOD CELL COUNT DECREASED,1
SL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SG,BREAST CANCER,2
SG,DRUG EFFECT INCOMPLETE,2
SG,PNEUMONIA,2
SG,ABDOMINAL PAIN,1
SG,CONDITION AGGRAVATED,1
SG,DEATH,1
SG,DRUG INEFFECTIVE,1
SG,LOSS OF CONSCIOUSNESS,1
SG,NECK PAIN,1
SG,PYREXIA,1
SG,RHEUMATOID ARTHRITIS,1
SG,SPINAL OSTEOARTHRITIS,1
SG,UPPER LIMB FRACTURE,1
SK,UVEITIS,4
SK,CARDIAC FAILURE,3
SK,CEREBROVASCULAR ACCIDENT,3
SK,IRITIS,3
SK,NON-HODGKIN^S LYMPHOMA,3
SK,RHEUMATOID ARTHRITIS,3
SK,BRAIN NEOPLASM,2
SK,CHOLECYSTITIS INFECTIVE,2
SK,GALLBLADDER PERFORATION,2
SK,GENERAL PHYSICAL HEALTH DETERIORATION,2
SK,HENOCH-SCHONLEIN PURPURA,2
SK,SCLERODERMA,2
SK,ACUTE MYOCARDIAL INFARCTION,1
SK,ARTHROPATHY,1
SK,BASAL CELL CARCINOMA,1
SK,BLOOD IMMUNOGLOBULIN A INCREASED,1
SK,BRADYCARDIA,1
SK,BREAST CANCER,1
SK,BREAST CANCER STAGE I,1
SK,C-REACTIVE PROTEIN INCREASED,1
SK,CARDIAC DISORDER,1
SK,CATARACT,1
SK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SK,CONDITION AGGRAVATED,1
SK,CROHN^S DISEASE,1
SK,DEATH,1
SK,DIARRHOEA,1
SK,DISEASE PROGRESSION,1
SK,DIVERTICULITIS,1
SK,DRUG INEFFECTIVE,1
SK,DYSPEPSIA,1
SK,EMBOLISM,1
SK,ENTEROCOLITIS,1
SK,EPSTEIN-BARR VIRUS ANTIBODY POSITIVE,1
SK,HEADACHE,1
SK,HYPERSENSITIVITY,1
SK,HYPERTENSION,1
SK,HYPERTRICHOSIS,1
SK,ILEUS,1
SK,INFECTION,1
SK,IRIDOCYCLITIS,1
SK,LARYNGEAL CANCER,1
SK,MICROEMBOLISM,1
SK,MYASTHENIA GRAVIS,1
SK,NO THERAPEUTIC RESPONSE,1
SK,PANCREATIC CARCINOMA,1
SK,PANCYTOPENIA,1
SK,PETECHIAE,1
SK,POLYNEUROPATHY,1
SK,PULMONARY EMBOLISM,1
SK,PYREXIA,1
SK,RASH,1
SK,RECTAL CANCER,1
SK,RENAL CANCER,1
SK,RENAL FAILURE,1
SK,SQUAMOUS CELL CARCINOMA,1
SK,SUDDEN DEATH,1
SK,SWELLING,1
SK,THROMBOTIC STROKE,1
SK,URINARY TRACT INFECTION,1
SK,UROSEPSIS,1
SK,URTICARIA,1
SK,VASCULITIS,1
SK,VERTIGO,1
SI,INFECTION,3
SI,ACUTE RESPIRATORY FAILURE,2
SI,ANAPHYLACTIC REACTION,2
SI,CEREBROVASCULAR ACCIDENT,2
SI,CONDITION AGGRAVATED,2
SI,DIABETES MELLITUS,2
SI,DRUG RESISTANCE,2
SI,DYSPNOEA,2
SI,HYPERSENSITIVITY,2
SI,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,2
SI,LOWER RESPIRATORY TRACT INFECTION VIRAL,2
SI,PAIN,2
SI,PANCREATIC CYST,2
SI,PRODUCT USE ISSUE,2
SI,RASH PRURITIC,2
SI,ACUTE MYELOID LEUKAEMIA,1
SI,ANGINA PECTORIS,1
SI,APPLICATION SITE PRURITUS,1
SI,APPLICATION SITE RASH,1
SI,ATRIAL FIBRILLATION,1
SI,BACTERIAL INFECTION,1
SI,BLOOD DISORDER,1
SI,BREAST CANCER,1
SI,BURSITIS,1
SI,CELLULITIS,1
SI,CHROMOSOME ANALYSIS ABNORMAL,1
SI,CHRONIC MYELOID LEUKAEMIA,1
SI,COLON CANCER,1
SI,CONTUSION,1
SI,CRYOGLOBULINAEMIA,1
SI,DEHYDRATION,1
SI,DERMATITIS ALLERGIC,1
SI,DRUG-INDUCED LIVER INJURY,1
SI,DYSPHAGIA,1
SI,ECZEMA,1
SI,ENDOMETRIAL ADENOCARCINOMA,1
SI,ERYTHEMA NODOSUM,1
SI,GASTRIC CANCER,1
SI,GENITAL HERPES SIMPLEX,1
SI,GRANULOMATOSIS WITH POLYANGIITIS,1
SI,HAEMORRHAGE,1
SI,HYPOTENSION,1
SI,INJECTION SITE ERYTHEMA,1
SI,INJECTION SITE RASH,1
SI,LOCALISED INFECTION,1
SI,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
SI,LUNG SQUAMOUS CELL CARCINOMA STAGE III,1
SI,MYELOPROLIFERATIVE DISORDER,1
SI,MYELOPROLIFERATIVE NEOPLASM,1
SI,NAIL INFECTION,1
SI,NEUTROPENIA,1
SI,PEPTOSTREPTOCOCCUS INFECTION,1
SI,PHOTOSENSITIVITY REACTION,1
SI,PNEUMONIA,1
SI,PNEUMONIA BACTERIAL,1
SI,PRODUCT QUALITY ISSUE,1
SI,PROSTATE CANCER,1
SI,PRURITUS ALLERGIC,1
SI,PSEUDOMONAS INFECTION,1
SI,PSORIASIS,1
SI,PSORIATIC ARTHROPATHY,1
SI,PULMONARY SARCOIDOSIS,1
SI,PUSTULAR PSORIASIS,1
SI,RASH,1
SI,RASH VESICULAR,1
SI,RECURRENT CANCER,1
SI,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,1
SI,RENAL FAILURE ACUTE,1
SI,RENAL FAILURE CHRONIC,1
SI,RETROPERITONEAL FIBROSIS,1
SI,SACROILIITIS,1
SI,SPINAL PAIN,1
SI,SQUAMOUS CELL CARCINOMA OF SKIN,1
SI,URINARY TRACT INFECTION,1
SI,VITREOUS DETACHMENT,1
SI,WHEEZING,1
ZA,RHEUMATOID ARTHRITIS,15
ZA,CONDITION AGGRAVATED,14
ZA,DRUG INEFFECTIVE,13
ZA,ARTHRALGIA,9
ZA,BACK PAIN,8
ZA,PAIN,8
ZA,DEATH,7
ZA,ARTHRITIS,6
ZA,BRONCHITIS,5
ZA,C-REACTIVE PROTEIN INCREASED,5
ZA,FALL,5
ZA,HEADACHE,5
ZA,JOINT SWELLING,5
ZA,MYOCARDIAL INFARCTION,5
ZA,PNEUMONIA,5
ZA,PULMONARY EMBOLISM,5
ZA,PYREXIA,5
ZA,SINUSITIS,5
ZA,CEREBROVASCULAR ACCIDENT,4
ZA,COUGH,4
ZA,DIZZINESS,4
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,4
ZA,HYPERTENSION,4
ZA,HYPOAESTHESIA,4
ZA,INFECTION,4
ZA,MALAISE,4
ZA,NAUSEA,4
ZA,NEPHROLITHIASIS,4
ZA,SEPSIS,4
ZA,ANKYLOSING SPONDYLITIS,3
ZA,ARTHROPATHY,3
ZA,BREAST CANCER,3
ZA,JOINT INJURY,3
ZA,MACULOPATHY,3
ZA,PALPITATIONS,3
ZA,PANCYTOPENIA,3
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
ZA,PRODUCT QUALITY ISSUE,3
ZA,PSORIASIS,3
ZA,RASH,3
ZA,RENAL IMPAIRMENT,3
ZA,RESPIRATORY TRACT INFECTION,3
ZA,SKIN ULCER,3
ZA,ABASIA,2
ZA,ADVERSE EVENT,2
ZA,ARTHRITIS INFECTIVE,2
ZA,ASTHMA,2
ZA,BLOOD CREATININE INCREASED,2
ZA,CACHEXIA,2
ZA,CHEST DISCOMFORT,2
ZA,CHEST PAIN,2
ZA,DECREASED IMMUNE RESPONSIVENESS,2
ZA,DEEP VEIN THROMBOSIS,2
ZA,DEPRESSION,2
ZA,DIARRHOEA,2
ZA,DISEASE PROGRESSION,2
ZA,DIVERTICULITIS,2
ZA,DYSPNOEA,2
ZA,ENCEPHALITIS VIRAL,2
ZA,ERYTHEMA,2
ZA,FATIGUE,2
ZA,FIBROMYALGIA,2
ZA,GASTROENTERITIS,2
ZA,HAEMOGLOBIN DECREASED,2
ZA,HEPATIC FIBROSIS,2
ZA,HEPATOTOXICITY,2
ZA,HERPES ZOSTER,2
ZA,HYPERSENSITIVITY,2
ZA,INTERSTITIAL LUNG DISEASE,2
ZA,JOINT DISLOCATION,2
ZA,JOINT RANGE OF MOTION DECREASED,2
ZA,JUVENILE IDIOPATHIC ARTHRITIS,2
ZA,LEUKAEMIA,2
ZA,LIP SWELLING,2
ZA,LOCAL SWELLING,2
ZA,LOWER RESPIRATORY TRACT INFECTION,2
ZA,LUNG INFECTION,2
ZA,MELAENA,2
ZA,MUSCLE SPASMS,2
ZA,NIGHT SWEATS,2
ZA,ORGANISING PNEUMONIA,2
ZA,PAIN IN EXTREMITY,2
ZA,PULMONARY HYPERTENSION,2
ZA,PULMONARY TUBERCULOSIS,2
ZA,SPINAL OSTEOARTHRITIS,2
ZA,SPONDYLITIS,2
ZA,SWOLLEN TONGUE,2
ZA,TACHYCARDIA,2
ZA,TENDON RUPTURE,2
ZA,THROMBOSIS,2
ZA,TUBERCULOSIS,2
ZA,UVEITIS,2
ZA,WHITE BLOOD CELL COUNT DECREASED,2
ZA,WHITE BLOOD CELL COUNT INCREASED,2
ZA,ABDOMINAL INFECTION,1
ZA,ABDOMINAL PAIN,1
ZA,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ZA,ACUTE SINUSITIS,1
ZA,ALANINE AMINOTRANSFERASE INCREASED,1
ZA,ALLERGIC OEDEMA,1
ZA,ANAEMIA,1
ZA,ANAL FISSURE,1
ZA,ANION GAP INCREASED,1
ZA,ANXIETY,1
ZA,APHONIA,1
ZA,APHTHOUS ULCER,1
ZA,ASPARTATE AMINOTRANSFERASE DECREASED,1
ZA,ASTHENIA,1
ZA,ATRIAL FIBRILLATION,1
ZA,BIPOLAR DISORDER,1
ZA,BLEPHARITIS,1
ZA,BLOOD ALKALINE PHOSPHATASE,1
ZA,BLOOD CHLORIDE DECREASED,1
ZA,BLOOD CREATINE INCREASED,1
ZA,BLOOD MAGNESIUM DECREASED,1
ZA,BLOOD POTASSIUM DECREASED,1
ZA,BONE DISORDER,1
ZA,BRAIN NEOPLASM MALIGNANT,1
ZA,BREAST CANCER FEMALE,1
ZA,BRONCHIOLITIS,1
ZA,CARBON DIOXIDE DECREASED,1
ZA,CARDIAC DISORDER,1
ZA,CATARACT,1
ZA,CERVICAL RADICULOPATHY,1
ZA,CERVICAL VERTEBRAL FRACTURE,1
ZA,CERVIX CARCINOMA,1
ZA,COMA,1
ZA,CONVULSION,1
ZA,CUTANEOUS VASCULITIS,1
ZA,DECREASED APPETITE,1
ZA,DEFORMITY,1
ZA,DEPRESSED MOOD,1
ZA,DERMATITIS ALLERGIC,1
ZA,DIABETIC FOOT,1
ZA,DRUG DOSE OMISSION,1
ZA,DRUG INTOLERANCE,1
ZA,DRUG RESISTANCE,1
ZA,DRUG TOLERANCE DECREASED,1
ZA,DRUG-INDUCED LIVER INJURY,1
ZA,DYSLIPIDAEMIA,1
ZA,ENCEPHALITIS,1
ZA,EPILEPSY,1
ZA,ESCHERICHIA URINARY TRACT INFECTION,1
ZA,EYE DISORDER,1
ZA,EYE SWELLING,1
ZA,FAECALOMA,1
ZA,FEEDING DISORDER,1
ZA,FLUSHING,1
ZA,GASTRITIS,1
ZA,GLAUCOMA,1
ZA,GOUT,1
ZA,GRANULOMA,1
ZA,HAEMOPTYSIS,1
ZA,HAEMORRHAGE,1
ZA,HIP FRACTURE,1
ZA,HIV TEST POSITIVE,1
ZA,HOSPITALISATION,1
ZA,HYPERVENTILATION,1
ZA,HYPOAESTHESIA ORAL,1
ZA,HYPOTHYROIDISM,1
ZA,IMMOBILE,1
ZA,IMMUNE SYSTEM DISORDER,1
ZA,IMPAIRED WORK ABILITY,1
ZA,INFLAMMATION,1
ZA,INFLAMMATORY MARKER INCREASED,1
ZA,INJECTION SITE DISCOLOURATION,1
ZA,INJECTION SITE ERYTHEMA,1
ZA,INJECTION SITE PAIN,1
ZA,INJECTION SITE PRURITUS,1
ZA,INJECTION SITE REACTION,1
ZA,INJECTION SITE SWELLING,1
ZA,INJECTION SITE WARMTH,1
ZA,INTERVERTEBRAL DISC DEGENERATION,1
ZA,INTESTINAL PERFORATION,1
ZA,IRON DEFICIENCY ANAEMIA,1
ZA,ISCHAEMIC STROKE,1
ZA,JOINT ANKYLOSIS,1
ZA,JOINT EFFUSION,1
ZA,JOINT STIFFNESS,1
ZA,KIDNEY INFECTION,1
ZA,KYPHOSIS,1
ZA,LACERATION,1
ZA,LIMB INJURY,1
ZA,LIVER INJURY,1
ZA,LUNG DISORDER,1
ZA,LYMPHADENOPATHY,1
ZA,LYMPHOCYTE COUNT DECREASED,1
ZA,MALIGNANT MELANOMA,1
ZA,MARFAN^S SYNDROME,1
ZA,MENINGITIS,1
ZA,MENINGITIS TUBERCULOUS,1
ZA,MIGRAINE,1
ZA,MOBILITY DECREASED,1
ZA,MOUTH ULCERATION,1
ZA,MULTI-ORGAN FAILURE,1
ZA,MULTIPLE SCLEROSIS,1
ZA,MUSCULOSKELETAL DISORDER,1
ZA,MUSCULOSKELETAL STIFFNESS,1
ZA,NECK PAIN,1
ZA,NEOPLASM MALIGNANT,1
ZA,NEUROENDOCRINE TUMOUR,1
ZA,NEUTROPENIA,1
ZA,NEUTROPHIL COUNT INCREASED,1
ZA,OCULAR TOXICITY,1
ZA,OROPHARYNGEAL SWELLING,1
ZA,OSTEOARTHRITIS,1
ZA,OSTEOMYELITIS,1
ZA,OSTEOPOROSIS,1
ZA,OSTEOPOROTIC FRACTURE,1
ZA,PACHYMENINGITIS,1
ZA,PANCREATITIS,1
ZA,PARAESTHESIA,1
ZA,PERIARTHRITIS,1
ZA,PERIPHERAL SWELLING,1
ZA,PHYSICAL DISABILITY,1
ZA,PLATELET COUNT DECREASED,1
ZA,PLEURAL EFFUSION,1
ZA,PLEURITIC PAIN,1
ZA,PNEUMOCONIOSIS,1
ZA,PNEUMONIA CYTOMEGALOVIRAL,1
ZA,PNEUMONITIS,1
ZA,PREGNANCY,1
ZA,PRODUCT USE ISSUE,1
ZA,PRURITUS,1
ZA,PSORIATIC ARTHROPATHY,1
ZA,PYELONEPHRITIS,1
ZA,RASH ERYTHEMATOUS,1
ZA,RECTAL HAEMORRHAGE,1
ZA,RED BLOOD CELL COUNT DECREASED,1
ZA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
ZA,RENAL FAILURE,1
ZA,RESPIRATORY DISTRESS,1
ZA,RESPIRATORY FAILURE,1
ZA,RETINAL DETACHMENT,1
ZA,ROAD TRAFFIC ACCIDENT,1
ZA,ROSAI-DORFMAN SYNDROME,1
ZA,RUSSELL^S VIPER VENOM TIME ABNORMAL,1
ZA,SALMONELLOSIS,1
ZA,SARCOIDOSIS,1
ZA,SECRETION DISCHARGE,1
ZA,SEIZURE,1
ZA,SHOULDER DEFORMITY,1
ZA,SKIN LESION,1
ZA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
ZA,SMALL CELL LUNG CANCER,1
ZA,SPEECH DISORDER,1
ZA,STAPHYLOCOCCUS TEST POSITIVE,1
ZA,STEVENS-JOHNSON SYNDROME,1
ZA,STOMA COMPLICATION,1
ZA,SWELLING FACE,1
ZA,TEMPOROMANDIBULAR JOINT SYNDROME,1
ZA,THERAPEUTIC RESPONSE DECREASED,1
ZA,TRANSAMINASES INCREASED,1
ZA,UNDERDOSE,1
ZA,UNEVALUABLE EVENT,1
ZA,UPPER-AIRWAY COUGH SYNDROME,1
ZA,VAGINAL DISCHARGE,1
ZA,VENOUS INJURY,1
ZA,VERTIGO,1
ZA,VOMITING,1
ZA,WEIGHT DECREASED,1
ZA,WEIGHT INCREASED,1
ZA,WHITE BLOOD CELLS URINE POSITIVE,1
ZA,WRIST FRACTURE,1
ES,DRUG INEFFECTIVE,104
ES,CONDITION AGGRAVATED,96
ES,INJECTION SITE ERYTHEMA,88
ES,INJECTION SITE PAIN,84
ES,PAIN IN EXTREMITY,59
ES,INJECTION SITE PRURITUS,58
ES,PAIN,53
ES,ARTHRALGIA,50
ES,RHEUMATOID ARTHRITIS,46
ES,FATIGUE,44
ES,PYREXIA,44
ES,DIZZINESS,39
ES,NASOPHARYNGITIS,39
ES,HEADACHE,37
ES,INJECTION SITE HAEMATOMA,37
ES,INFLAMMATION,35
ES,MALAISE,34
ES,PSORIASIS,29
ES,VOMITING,29
ES,FEELING ABNORMAL,28
ES,INJECTION SITE INFLAMMATION,28
ES,PERIPHERAL SWELLING,27
ES,ARTHRITIS,26
ES,FALL,26
ES,PRURITUS,26
ES,BACK PAIN,25
ES,MOBILITY DECREASED,25
ES,ANKYLOSING SPONDYLITIS,24
ES,ERYTHEMA,24
ES,NAUSEA,24
ES,URINARY TRACT INFECTION,24
ES,INJECTION SITE REACTION,23
ES,DIARRHOEA,22
ES,DRUG EFFECT INCOMPLETE,21
ES,INJECTION SITE URTICARIA,20
ES,COUGH,19
ES,INJECTION SITE WARMTH,19
ES,PSORIATIC ARTHROPATHY,19
ES,ASTHENIA,18
ES,DECREASED IMMUNE RESPONSIVENESS,18
ES,DYSPNOEA,18
ES,GAIT DISTURBANCE,18
ES,INJECTION SITE MASS,17
ES,INJECTION SITE SWELLING,17
ES,PNEUMONIA,17
ES,RASH,17
ES,URTICARIA,17
ES,HYPOAESTHESIA,16
ES,JOINT SWELLING,16
ES,ABASIA,14
ES,INJECTION SITE HAEMORRHAGE,14
ES,DISEASE RECURRENCE,13
ES,HYPERSENSITIVITY,13
ES,ANAEMIA,12
ES,BLOOD PRESSURE INCREASED,12
ES,HYPERHIDROSIS,12
ES,INFECTION,12
ES,MUSCULOSKELETAL PAIN,12
ES,ABDOMINAL DISCOMFORT,11
ES,ABDOMINAL PAIN UPPER,11
ES,MUSCULOSKELETAL STIFFNESS,11
ES,OROPHARYNGEAL PAIN,11
ES,ABDOMINAL PAIN,10
ES,BRONCHITIS,10
ES,DISCOMFORT,10
ES,HAEMATOMA,10
ES,INJECTION SITE DISCOMFORT,10
ES,INJECTION SITE INDURATION,10
ES,NECK PAIN,10
ES,PARAESTHESIA,10
ES,WEIGHT DECREASED,10
ES,ALOPECIA,9
ES,ANXIETY,9
ES,ARTHROPATHY,9
ES,BLOOD CHOLESTEROL INCREASED,9
ES,CATARACT,9
ES,CHEST PAIN,9
ES,FOOT DEFORMITY,9
ES,INFLUENZA,9
ES,MUSCULAR WEAKNESS,9
ES,PRURITUS GENERALISED,9
ES,RESPIRATORY TRACT INFECTION,9
ES,SEPTIC SHOCK,9
ES,CHILLS,8
ES,CONSTIPATION,8
ES,DEPRESSED MOOD,8
ES,FEELING HOT,8
ES,HYPERTENSION,8
ES,INJECTION SITE RASH,8
ES,INSOMNIA,8
ES,LUNG NEOPLASM MALIGNANT,8
ES,NERVOUSNESS,8
ES,PANCYTOPENIA,8
ES,SKIN EXFOLIATION,8
ES,UVEITIS,8
ES,ANGINA PECTORIS,7
ES,BLOOD PRESSURE DECREASED,7
ES,DRUG-INDUCED LIVER INJURY,7
ES,EPISTAXIS,7
ES,HAEMATOCHEZIA,7
ES,HERPES ZOSTER,7
ES,LEUKOPENIA,7
ES,LOCAL SWELLING,7
ES,MUSCLE SPASMS,7
ES,MYALGIA,7
ES,NEPHROLITHIASIS,7
ES,ORAL HERPES,7
ES,PHARYNGITIS,7
ES,RESPIRATORY FAILURE,7
ES,SCIATICA,7
ES,SENSORY LOSS,7
ES,SOMNOLENCE,7
ES,SWELLING,7
ES,TRANSAMINASES INCREASED,7
ES,WOUND,7
ES,ACNE,6
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,6
ES,APHONIA,6
ES,CATARRH,6
ES,CELLULITIS,6
ES,CEREBROVASCULAR ACCIDENT,6
ES,CROHN^S DISEASE,6
ES,DEATH,6
ES,DYSPHAGIA,6
ES,EAR PAIN,6
ES,FEAR OF INJECTION,6
ES,HAEMORRHAGE,6
ES,SECRETION DISCHARGE,6
ES,SEPSIS,6
ES,SPINAL DISORDER,6
ES,TOOTH DISORDER,6
ES,TREMOR,6
ES,VERTIGO,6
ES,VISION BLURRED,6
ES,WEIGHT INCREASED,6
ES,ACUTE MYELOID LEUKAEMIA,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,5
ES,ASTHMA,5
ES,BLOOD GLUCOSE INCREASED,5
ES,BREAST CANCER,5
ES,CARDIAC DISORDER,5
ES,CHEST DISCOMFORT,5
ES,COLON CANCER,5
ES,DECREASED APPETITE,5
ES,DRUG EFFECT DECREASED,5
ES,DRY MOUTH,5
ES,FLUID RETENTION,5
ES,GASTROENTERITIS,5
ES,HEPATOTOXICITY,5
ES,HERPES VIRUS INFECTION,5
ES,HOT FLUSH,5
ES,INJECTION SITE DISCOLOURATION,5
ES,INTERSTITIAL LUNG DISEASE,5
ES,INTERVERTEBRAL DISC PROTRUSION,5
ES,LOSS OF CONSCIOUSNESS,5
ES,MULTI-ORGAN FAILURE,5
ES,ORAL PAIN,5
ES,PRODUCT USE ISSUE,5
ES,PROSTATE CANCER,5
ES,PUSTULAR PSORIASIS,5
ES,RENAL FAILURE,5
ES,SPINAL PAIN,5
ES,SQUAMOUS CELL CARCINOMA,5
ES,SWELLING FACE,5
ES,TENDON RUPTURE,5
ES,UPPER LIMB FRACTURE,5
ES,WHEEZING,5
ES,ALANINE AMINOTRANSFERASE INCREASED,4
ES,ARRHYTHMIA,4
ES,BLINDNESS,4
ES,BLOOD GLUCOSE ABNORMAL,4
ES,BONE PAIN,4
ES,DIABETES MELLITUS,4
ES,DRY SKIN,4
ES,EYE DISORDER,4
ES,EYE PAIN,4
ES,FEELING COLD,4
ES,FOOT FRACTURE,4
ES,GASTROINTESTINAL DISORDER,4
ES,GROIN PAIN,4
ES,HYPERKERATOSIS,4
ES,IMPAIRED HEALING,4
ES,INCREASED APPETITE,4
ES,INFUSION RELATED REACTION,4
ES,JUVENILE IDIOPATHIC ARTHRITIS,4
ES,LOWER RESPIRATORY TRACT INFECTION,4
ES,MALIGNANT MELANOMA,4
ES,MASS,4
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
ES,PRODUCTIVE COUGH,4
ES,RENAL COLIC,4
ES,RHINORRHOEA,4
ES,ROAD TRAFFIC ACCIDENT,4
ES,SEIZURE,4
ES,SENSITIVITY TO WEATHER CHANGE,4
ES,SKIN PAPILLOMA,4
ES,SKIN REACTION,4
ES,TACHYCARDIA,4
ES,TINNITUS,4
ES,TUBERCULOSIS,4
ES,VARICOSE VEIN,4
ES,VASCULITIS,4
ES,VIRAL INFECTION,4
ES,ABDOMINAL DISTENSION,3
ES,ACUTE MYOCARDIAL INFARCTION,3
ES,ARTHRITIS INFECTIVE,3
ES,ASPHYXIA,3
ES,ASTHENOPIA,3
ES,BLOOD PRESSURE FLUCTUATION,3
ES,BLOOD TEST ABNORMAL,3
ES,BLOOD URINE PRESENT,3
ES,BRONCHOSPASM,3
ES,CARDIOVASCULAR DISORDER,3
ES,CHOKING SENSATION,3
ES,CHOLELITHIASIS,3
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA,3
ES,DEAFNESS,3
ES,DEAFNESS UNILATERAL,3
ES,DEPRESSION,3
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
ES,DRUG INTOLERANCE,3
ES,DYSGEUSIA,3
ES,FACE OEDEMA,3
ES,FEMUR FRACTURE,3
ES,FINGER DEFORMITY,3
ES,FOLLICULITIS,3
ES,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,3
ES,HEPATIC STEATOSIS,3
ES,HYPOTENSION,3
ES,IMMUNOSUPPRESSION,3
ES,INTERNAL HAEMORRHAGE,3
ES,INTESTINAL PERFORATION,3
ES,INVASIVE DUCTAL BREAST CARCINOMA,3
ES,ISCHAEMIC STROKE,3
ES,KIDNEY INFECTION,3
ES,LIBIDO DECREASED,3
ES,LIMB INJURY,3
ES,LUNG INFECTION,3
ES,MIGRAINE,3
ES,NEUTROPENIA,3
ES,OEDEMA PERIPHERAL,3
ES,ORAL INFECTION,3
ES,OVARIAN CYST,3
ES,PERIPHERAL SENSORY NEUROPATHY,3
ES,PHARYNGEAL OEDEMA,3
ES,PULMONARY FIBROSIS,3
ES,PULMONARY OEDEMA,3
ES,RASH MACULAR,3
ES,RENAL IMPAIRMENT,3
ES,RHEUMATOID FACTOR INCREASED,3
ES,SKIN DEPIGMENTATION,3
ES,SPINAL COMPRESSION FRACTURE,3
ES,SPINAL FRACTURE,3
ES,THERAPEUTIC RESPONSE UNEXPECTED,3
ES,THROAT IRRITATION,3
ES,VISUAL ACUITY REDUCED,3
ES,VISUAL IMPAIRMENT,3
ES,WOUND INFECTION,3
ES,ABNORMAL SENSATION IN EYE,2
ES,ADENOCARCINOMA OF COLON,2
ES,ADVERSE DRUG REACTION,2
ES,ALANINE AMINOTRANSFERASE ABNORMAL,2
ES,APATHY,2
ES,APPENDICITIS,2
ES,ARTHROPOD BITE,2
ES,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
ES,B-CELL LYMPHOMA,2
ES,BENIGN SALIVARY GLAND NEOPLASM,2
ES,BLISTER,2
ES,BLOOD GLUCOSE DECREASED,2
ES,BLOOD PRESSURE DIASTOLIC INCREASED,2
ES,BLOOD URIC ACID INCREASED,2
ES,BONE MARROW FAILURE,2
ES,BRONCHIAL DISORDER,2
ES,BRONCHIECTASIS,2
ES,BURSITIS,2
ES,C-REACTIVE PROTEIN INCREASED,2
ES,CANDIDA INFECTION,2
ES,CARDIAC FAILURE,2
ES,CARDIAC FAILURE CONGESTIVE,2
ES,CEREBRAL INFARCTION,2
ES,CHOKING,2
ES,CLEAR CELL RENAL CELL CARCINOMA,2
ES,COLITIS,2
ES,CONTUSION,2
ES,CORNEAL PERFORATION,2
ES,COSTOCHONDRITIS,2
ES,CUTANEOUS LUPUS ERYTHEMATOSUS,2
ES,CYTOMEGALOVIRUS INFECTION,2
ES,DEEP VEIN THROMBOSIS,2
ES,DEHYDRATION,2
ES,DERMATITIS,2
ES,DIAPHRAGMATIC DISORDER,2
ES,DIPLOPIA,2
ES,DISEASE PROGRESSION,2
ES,DIVERTICULITIS,2
ES,DIVERTICULUM,2
ES,DRUG DEPENDENCE,2
ES,DYSKINESIA,2
ES,EAR DISCOMFORT,2
ES,EAR PRURITUS,2
ES,EAR SWELLING,2
ES,EMPHYSEMA,2
ES,ENTERITIS INFECTIOUS,2
ES,ERECTILE DYSFUNCTION,2
ES,ERYTHRODERMIC PSORIASIS,2
ES,EYE SWELLING,2
ES,FEAR,2
ES,FEEDING DISORDER,2
ES,FIBULA FRACTURE,2
ES,FLUSHING,2
ES,FOOD CRAVING,2
ES,GALLBLADDER DISORDER,2
ES,GASTRIC DISORDER,2
ES,GASTRIC POLYPS,2
ES,GASTRIC ULCER,2
ES,GASTROINTESTINAL HAEMORRHAGE,2
ES,GASTROINTESTINAL INFLAMMATION,2
ES,GENITAL ABSCESS,2
ES,GINGIVITIS,2
ES,HAEMATEMESIS,2
ES,HAEMOGLOBIN ABNORMAL,2
ES,HEPATIC ENZYME INCREASED,2
ES,HEPATIC NECROSIS,2
ES,HEPATITIS,2
ES,HILAR LYMPHADENOPATHY,2
ES,HUMERUS FRACTURE,2
ES,HYPERTRANSAMINASAEMIA,2
ES,IMMUNODEFICIENCY,2
ES,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
ES,INFLUENZA LIKE ILLNESS,2
ES,INJECTION SITE BRUISING,2
ES,INJECTION SITE IRRITATION,2
ES,INJECTION SITE PLAQUE,2
ES,INJECTION SITE RECALL REACTION,2
ES,INJECTION SITE VESICLES,2
ES,INTERSTITIAL GRANULOMATOUS DERMATITIS,2
ES,INTESTINAL STENOSIS,2
ES,JOINT DISLOCATION,2
ES,JOINT EFFUSION,2
ES,JOINT INJURY,2
ES,JOINT STIFFNESS,2
ES,KYPHOSIS,2
ES,LABORATORY TEST ABNORMAL,2
ES,LIGAMENT SPRAIN,2
ES,LIMB DISCOMFORT,2
ES,LIP DISORDER,2
ES,LIP SWELLING,2
ES,LISTERIOSIS,2
ES,LISTLESS,2
ES,LIVER DISORDER,2
ES,LIVER INJURY,2
ES,LOCALISED INFECTION,2
ES,LOWER LIMB FRACTURE,2
ES,LOWER RESPIRATORY TRACT INFLAMMATION,2
ES,LYMPHOPROLIFERATIVE DISORDER,2
ES,MALIGNANT NEOPLASM OF CONJUNCTIVA,2
ES,MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL,2
ES,MEMORY IMPAIRMENT,2
ES,MOUTH SWELLING,2
ES,MUCOSAL INFLAMMATION,2
ES,MULTIPLE SCLEROSIS,2
ES,MYASTHENIA GRAVIS,2
ES,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
ES,MYOCARDIAL INFARCTION,2
ES,MYOCLONUS,2
ES,NAIL DISORDER,2
ES,NAIL DYSTROPHY,2
ES,NASAL CONGESTION,2
ES,NEOPLASM MALIGNANT,2
ES,NONINFECTIVE GINGIVITIS,2
ES,OCULAR MYASTHENIA,2
ES,OESOPHAGEAL HAEMORRHAGE,2
ES,OESOPHAGITIS,2
ES,OPTIC NEURITIS,2
ES,PALLOR,2
ES,PALPITATIONS,2
ES,PANCREATIC CARCINOMA,2
ES,PANCREATITIS NECROTISING,2
ES,PARKINSON^S DISEASE,2
ES,PELVIC FRACTURE,2
ES,PERIPHERAL COLDNESS,2
ES,PHARYNGEAL ERYTHEMA,2
ES,PHLEBITIS,2
ES,PLATELET COUNT DECREASED,2
ES,PNEUMONITIS,2
ES,POLYP,2
ES,POST-TRAUMATIC NECK SYNDROME,2
ES,PRODUCT QUALITY ISSUE,2
ES,PROSTATITIS,2
ES,PYELONEPHRITIS,2
ES,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
ES,RENAL DISORDER,2
ES,RENAL PAIN,2
ES,RHEUMATOID FACTOR DECREASED,2
ES,RHEUMATOID NODULE,2
ES,SALIVARY HYPERSECRETION,2
ES,SCAB,2
ES,SCRATCH,2
ES,SHOCK HAEMORRHAGIC,2
ES,SINUSITIS,2
ES,SKIN DISCOLOURATION,2
ES,SKIN DISORDER,2
ES,SKIN HAEMORRHAGE,2
ES,SKIN INFECTION,2
ES,SKIN INJURY,2
ES,SKIN ULCER,2
ES,SPEECH DISORDER,2
ES,SPONDYLITIS,2
ES,STAPHYLOCOCCAL INFECTION,2
ES,STRESS,2
ES,SUBCUTANEOUS ABSCESS,2
ES,SWOLLEN TONGUE,2
ES,SYNCOPE,2
ES,TENDONITIS,2
ES,THIRST,2
ES,THYROID NEOPLASM,2
ES,TIBIA FRACTURE,2
ES,TONGUE PRURITUS,2
ES,TONSILLITIS,2
ES,TREATMENT FAILURE,2
ES,TUBULAR BREAST CARCINOMA,2
ES,URINARY INCONTINENCE,2
ES,VENOUS INJURY,2
ES,VENTRICULAR FIBRILLATION,2
ES,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
ES,WHITE BLOOD CELL COUNT DECREASED,2
ES,WRIST FRACTURE,2
ES,ZYGOMYCOSIS,2
ES,ABDOMINAL ABSCESS,1
ES,ABDOMINAL HERNIA,1
ES,ABNORMAL BEHAVIOUR,1
ES,ABSCESS LIMB,1
ES,ACCIDENT AT WORK,1
ES,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ES,ACUTE CORONARY SYNDROME,1
ES,ACUTE SINUSITIS,1
ES,ADENOCARCINOMA GASTRIC,1
ES,ADRENAL ATROPHY,1
ES,ADVERSE EVENT,1
ES,ALOPECIA AREATA,1
ES,AMNESIA,1
ES,AMNIOCENTESIS ABNORMAL,1
ES,AMYOTROPHIC LATERAL SCLEROSIS,1
ES,ANAL ABSCESS,1
ES,ANAL HAEMORRHAGE,1
ES,ANAPHYLACTIC REACTION,1
ES,ANGIOEDEMA,1
ES,ANKLE FRACTURE,1
ES,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
ES,ANTICIPATORY ANXIETY,1
ES,ANTICOAGULATION DRUG LEVEL ABNORMAL,1
ES,APHTHOUS STOMATITIS,1
ES,ARTERIAL DISORDER,1
ES,ARTERIAL OCCLUSIVE DISEASE,1
ES,ASTHMA EXERCISE INDUCED,1
ES,ATRIAL FIBRILLATION,1
ES,AUTOIMMUNE DISORDER,1
ES,AUTOIMMUNE HEPATITIS,1
ES,AUTOIMMUNE PANCREATITIS,1
ES,BACK DISORDER,1
ES,BACTERAEMIA,1
ES,BACTERIAL DISEASE CARRIER,1
ES,BACTERIAL INFECTION,1
ES,BACTERIAL PAROTITIS,1
ES,BALANCE DISORDER,1
ES,BENIGN INTRACRANIAL HYPERTENSION,1
ES,BENIGN NEOPLASM OF BLADDER,1
ES,BLADDER CANCER,1
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE III,1
ES,BLINDNESS TRANSIENT,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD CHOLESTEROL DECREASED,1
ES,BLOOD CHROMOGRANIN A INCREASED,1
ES,BLOOD CORTICOTROPHIN INCREASED,1
ES,BLOOD CORTISOL DECREASED,1
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
ES,BLOOD GLUCOSE FLUCTUATION,1
ES,BLOOD PRESSURE ABNORMAL,1
ES,BLOOD PROLACTIN INCREASED,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BONE FISSURE,1
ES,BONE MARROW OEDEMA,1
ES,BONE MARROW TOXICITY,1
ES,BRAIN DEATH,1
ES,BRAIN HYPOXIA,1
ES,BRAIN NEOPLASM,1
ES,BREAST CANCER RECURRENT,1
ES,BREAST CYST,1
ES,BREAST INFLAMMATION,1
ES,BREAST NEOPLASM,1
ES,BRONCHITIS BACTERIAL,1
ES,BRONCHOPULMONARY ASPERGILLOSIS,1
ES,BURNING SENSATION,1
ES,C-REACTIVE PROTEIN DECREASED,1
ES,CALCIUM DEFICIENCY,1
ES,CALCULUS URINARY,1
ES,CAPILLARY FRAGILITY,1
ES,CARDIAC VALVE DISEASE,1
ES,CAROTID ARTERY OCCLUSION,1
ES,CARPAL TUNNEL SYNDROME,1
ES,CARTILAGE INJURY,1
ES,CEREBELLAR INFARCTION,1
ES,CEREBELLAR SYNDROME,1
ES,CEREBRAL VENOUS THROMBOSIS,1
ES,CERVICOBRACHIAL SYNDROME,1
ES,CHEMICAL PERITONITIS,1
ES,CHEST INJURY,1
ES,CHOLECYSTITIS,1
ES,CHOLECYSTITIS INFECTIVE,1
ES,CHONDROPATHY,1
ES,CHOROIDITIS,1
ES,CHROMATURIA,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,CLUMSINESS,1
ES,COAGULOPATHY,1
ES,COLD SWEAT,1
ES,COLON NEOPLASM,1
ES,COLORECTAL ADENOCARCINOMA,1
ES,CONFUSIONAL STATE,1
ES,CONJUNCTIVAL NEOPLASM,1
ES,CONVULSION,1
ES,CORNEAL ABSCESS,1
ES,CORONARY ARTERY OCCLUSION,1
ES,CRYING,1
ES,CYANOSIS,1
ES,CYST,1
ES,CYST RUPTURE,1
ES,CYSTITIS,1
ES,CYSTITIS HAEMORRHAGIC,1
ES,CYSTOCELE,1
ES,DACRYOLITH,1
ES,DAYDREAMING,1
ES,DEAFNESS BILATERAL,1
ES,DECREASED INTEREST,1
ES,DELIRIUM FEBRILE,1
ES,DEMENTIA,1
ES,DEMYELINATING POLYNEUROPATHY,1
ES,DEMYELINATION,1
ES,DERMATITIS ALLERGIC,1
ES,DERMATITIS EXFOLIATIVE,1
ES,DERMATITIS PSORIASIFORM,1
ES,DERMATOMYOSITIS,1
ES,DEVICE FAILURE,1
ES,DEVICE OCCLUSION,1
ES,DIFFUSE ALOPECIA,1
ES,DIFFUSE LARGE B-CELL LYMPHOMA,1
ES,DISORIENTATION,1
ES,DIVERTICULAR PERFORATION,1
ES,DIVERTICULITIS MECKEL^S,1
ES,DROWNING,1
ES,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
ES,DRUG DOSE OMISSION,1
ES,DRUG EFFECT DELAYED,1
ES,DRUG HYPERSENSITIVITY,1
ES,DRUG WITHDRAWAL SYNDROME,1
ES,DRY THROAT,1
ES,DUST ALLERGY,1
ES,DYSPEPSIA,1
ES,DYSPHONIA,1
ES,DYSPLASIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSSTASIA,1
ES,DYSTONIA,1
ES,DYSURIA,1
ES,EAR INFECTION,1
ES,EATING DISORDER,1
ES,ECZEMA,1
ES,EFFUSION,1
ES,EMBOLISM,1
ES,EMOTIONAL DISORDER,1
ES,EPILEPSY,1
ES,EPSTEIN-BARR VIRUS INFECTION,1
ES,ERYTHEMA MULTIFORME,1
ES,EXCESSIVE CERUMEN PRODUCTION,1
ES,EXERCISE LACK OF,1
ES,EXERCISE TOLERANCE DECREASED,1
ES,EXOSTOSIS,1
ES,EXPOSURE DURING BREAST FEEDING,1
ES,EYE INFECTION,1
ES,EYE INFLAMMATION,1
ES,EYE IRRITATION,1
ES,EYE MOVEMENT DISORDER,1
ES,EYE PRURITUS,1
ES,EYELID OEDEMA,1
ES,EYELID PTOSIS,1
ES,FACE INJURY,1
ES,FACIAL PAIN,1
ES,FACIAL PARALYSIS,1
ES,FAECAL CALPROTECTIN INCREASED,1
ES,FAECES DISCOLOURED,1
ES,FALLOPIAN TUBE DISORDER,1
ES,FEELING OF DESPAIR,1
ES,FIBROMYALGIA,1
ES,FIBROSIS,1
ES,FOOD ALLERGY,1
ES,FORMICATION,1
ES,FUNGAL SKIN INFECTION,1
ES,FURUNCLE,1
ES,FUSARIUM INFECTION,1
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ES,GASTRIC INFECTION,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GASTRITIS EROSIVE,1
ES,GASTROENTERITIS VIRAL,1
ES,GASTROINTESTINAL TRACT ADENOMA,1
ES,GASTROOESOPHAGEAL REFLUX DISEASE,1
ES,GENERALISED ERYTHEMA,1
ES,GENITAL TRACT INFLAMMATION,1
ES,GINGIVAL ABSCESS,1
ES,GINGIVAL BLEEDING,1
ES,GINGIVAL INJURY,1
ES,GINGIVAL PAIN,1
ES,GLAUCOMA,1
ES,GLOMERULONEPHRITIS,1
ES,GLOMERULONEPHRITIS PROLIFERATIVE,1
ES,GLOSSITIS,1
ES,GLUCAGONOMA,1
ES,GONOCOCCAL PELVIC INFLAMMATORY DISEASE,1
ES,GRANULOMA,1
ES,GRANULOMA ANNULARE,1
ES,GRANULOMATOSIS WITH POLYANGIITIS,1
ES,GROWING PAINS,1
ES,HAEMATOTOXICITY,1
ES,HAEMATURIA,1
ES,HAEMOPTYSIS,1
ES,HAEMORRHOIDS,1
ES,HAND DEFORMITY,1
ES,HAND FRACTURE,1
ES,HEAD DISCOMFORT,1
ES,HEART RATE INCREASED,1
ES,HELICOBACTER INFECTION,1
ES,HEMIPLEGIA,1
ES,HEPATIC CYST,1
ES,HEPATIC FIBROSIS,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATITIS B,1
ES,HEPATITIS C,1
ES,HEPATITIS VIRAL,1
ES,HEPATOCELLULAR CARCINOMA,1
ES,HEPATOMEGALY,1
ES,HERPES OPHTHALMIC,1
ES,HIATUS HERNIA,1
ES,HIP DEFORMITY,1
ES,HIP FRACTURE,1
ES,HODGKIN^S DISEASE,1
ES,HUMAN HERPES VIRUS 8 TEST POSITIVE,1
ES,HYPERAESTHESIA,1
ES,HYPERPHAGIA,1
ES,HYPERTENSIVE CRISIS,1
ES,HYPERTENSIVE EMERGENCY,1
ES,HYPOAESTHESIA ORAL,1
ES,HYPOTHERMIA,1
ES,HYPOTONIA,1
ES,IGA NEPHROPATHY,1
ES,ILL-DEFINED DISORDER,1
ES,IMMOBILE,1
ES,INCORRECT PRODUCT STORAGE,1
ES,INCORRECT STORAGE OF DRUG,1
ES,INFARCTION,1
ES,INFECTED CYST,1
ES,INFLAMMATORY MARKER INCREASED,1
ES,INGUINAL HERNIA,1
ES,INJECTION SITE ABSCESS,1
ES,INJECTION SITE CELLULITIS,1
ES,INJECTION SITE ECZEMA,1
ES,INJECTION SITE EXTRAVASATION,1
ES,INJECTION SITE INFECTION,1
ES,INJECTION SITE NECROSIS,1
ES,INJECTION SITE OEDEMA,1
ES,INJECTION SITE PAPULE,1
ES,INTENTIONAL SELF-INJURY,1
ES,INTESTINAL HAEMORRHAGE,1
ES,INTESTINAL OBSTRUCTION,1
ES,INTESTINAL POLYP,1
ES,INTRACRANIAL ANEURYSM,1
ES,INTRAOCULAR PRESSURE INCREASED,1
ES,IRIDOCYCLITIS,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,JOINT RANGE OF MOTION DECREASED,1
ES,KAPOSI^S SARCOMA,1
ES,KNEE IMPINGEMENT SYNDROME,1
ES,LACTOSE INTOLERANCE,1
ES,LARYNGEAL POLYP,1
ES,LEIOMYOMA,1
ES,LIGAMENT RUPTURE,1
ES,LIPIDS ABNORMAL,1
ES,LIPOSARCOMA,1
ES,LISTERIA ENCEPHALITIS,1
ES,LISTERIA SEPSIS,1
ES,LIVER FUNCTION TEST ABNORMAL,1
ES,LOW BIRTH WEIGHT BABY,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III,1
ES,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
ES,LUNG DISORDER,1
ES,LUNG NEOPLASM,1
ES,LYMPHADENOPATHY,1
ES,LYMPHADENOPATHY MEDIASTINAL,1
ES,LYMPHANGIECTASIA,1
ES,LYMPHANGIOMA,1
ES,LYMPHOCYTE PERCENTAGE DECREASED,1
ES,LYMPHOCYTOSIS,1
ES,LYMPHOEDEMA,1
ES,MACULAR DEGENERATION,1
ES,MACULE,1
ES,MASTITIS,1
ES,MATERNAL EXPOSURE DURING PREGNANCY,1
ES,MELAENA,1
ES,MENINGITIS LISTERIA,1
ES,MENINGOENCEPHALITIS HERPETIC,1
ES,MENISCUS INJURY,1
ES,MENOPAUSE,1
ES,MENTAL DISORDER,1
ES,METABOLIC DISORDER,1
ES,METASTASES TO CENTRAL NERVOUS SYSTEM,1
ES,MILLER FISHER SYNDROME,1
ES,MITE ALLERGY,1
ES,MONOPLEGIA,1
ES,MORAXELLA TEST POSITIVE,1
ES,MOTOR DYSFUNCTION,1
ES,MUCOCUTANEOUS RASH,1
ES,MULTIPLE SCLEROSIS RELAPSE,1
ES,MUSCLE CONTRACTIONS INVOLUNTARY,1
ES,MUSCLE CONTRACTURE,1
ES,MUSCLE DISORDER,1
ES,MUSCLE RIGIDITY,1
ES,MUSCLE RUPTURE,1
ES,MUSCULOSKELETAL CHEST PAIN,1
ES,MUSCULOSKELETAL DISORDER,1
ES,MUTISM,1
ES,MYCOBACTERIUM TEST POSITIVE,1
ES,MYELITIS TRANSVERSE,1
ES,MYELOID LEUKAEMIA,1
ES,MYELOPATHY,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOPATHY,1
ES,MYRINGITIS,1
ES,NAIL DISCOLOURATION,1
ES,NASAL OBSTRUCTION,1
ES,NECROTISING FASCIITIS,1
ES,NEOPLASM,1
ES,NEPHROTIC SYNDROME,1
ES,NERVE COMPRESSION,1
ES,NERVE DEGENERATION,1
ES,NEUROPATHY PERIPHERAL,1
ES,NIGHT SWEATS,1
ES,NIGHTMARE,1
ES,NO ADVERSE EVENT,1
ES,NOCTURIA,1
ES,NODULE,1
ES,NON-HODGKIN^S LYMPHOMA STAGE III,1
ES,NON-SMALL CELL LUNG CANCER,1
ES,OESOPHAGEAL MUCOSAL TEAR,1
ES,OLIGODENDROGLIOMA,1
ES,ONYCHOCLASIS,1
ES,ONYCHOMYCOSIS,1
ES,OPTIC NERVE INJURY,1
ES,ORAL DISCOMFORT,1
ES,ORAL DISORDER,1
ES,ORAL FUNGAL INFECTION,1
ES,ORAL PRURITUS,1
ES,ORGANISING PNEUMONIA,1
ES,OROPHARYNGEAL CANDIDIASIS,1
ES,OROPHARYNGEAL DISCOMFORT,1
ES,OROPHARYNGEAL PLAQUE,1
ES,OSTEITIS,1
ES,OSTEOARTHRITIS,1
ES,OSTEOMYELITIS,1
ES,OSTEONECROSIS,1
ES,OSTEOPOROSIS,1
ES,OVARIAN CANCER METASTATIC,1
ES,OVARIAN DISORDER,1
ES,PAIN OF SKIN,1
ES,PANCREATIC INJURY,1
ES,PANNICULITIS,1
ES,PAPILLOEDEMA,1
ES,PARADOXICAL DRUG REACTION,1
ES,PARALYSIS,1
ES,PARKINSONISM,1
ES,PATELLA FRACTURE,1
ES,PENILE ERYTHEMA,1
ES,PENILE PAIN,1
ES,PERIPHERAL ISCHAEMIA,1
ES,PERIPHERAL NERVOUS SYSTEM NEOPLASM,1
ES,PERITONITIS,1
ES,PERSONALITY DISORDER,1
ES,PETECHIAE,1
ES,PETIT MAL EPILEPSY,1
ES,PHARYNGEAL INFLAMMATION,1
ES,PHOTOPSIA,1
ES,PHOTOSENSITIVITY REACTION,1
ES,PIGMENTATION DISORDER,1
ES,PLACENTA PRAEVIA,1
ES,PLATELET COUNT INCREASED,1
ES,PLEOMORPHIC ADENOMA,1
ES,PLEURAL EFFUSION,1
ES,PLICATED TONGUE,1
ES,PNEUMOTHORAX,1
ES,POISONING,1
ES,POLLAKIURIA,1
ES,POLYCHONDRITIS,1
ES,POOR PERIPHERAL CIRCULATION,1
ES,POST PROCEDURAL COMPLICATION,1
ES,POST PROCEDURAL INFECTION,1
ES,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
ES,POSTOPERATIVE WOUND INFECTION,1
ES,PREMATURE BABY,1
ES,PRESYNCOPE,1
ES,PRINZMETAL ANGINA,1
ES,PROCEDURAL PAIN,1
ES,PROLACTINOMA,1
ES,PROSTATIC DISORDER,1
ES,PROTEIN URINE PRESENT,1
ES,PROTEINURIA,1
ES,PRURITUS GENITAL,1
ES,PSITTACOSIS,1
ES,PSYCHOMOTOR HYPERACTIVITY,1
ES,PULMONARY EMBOLISM,1
ES,PULMONARY GRANULOMA,1
ES,PULMONARY MASS,1
ES,PULMONARY SARCOIDOSIS,1
ES,PULMONARY TUBERCULOSIS,1
ES,PYODERMA GANGRENOSUM,1
ES,RADIUS FRACTURE,1
ES,RASH PAPULAR,1
ES,RASH PRURITIC,1
ES,RASH PUSTULAR,1
ES,RAYNAUD^S PHENOMENON,1
ES,RECTAL ADENOCARCINOMA,1
ES,RECTAL HAEMORRHAGE,1
ES,RED BLOOD CELL COUNT DECREASED,1
ES,RED BLOOD CELL SEDIMENTATION RATE DECREASED,1
ES,REFLUX GASTRITIS,1
ES,RENAL CANCER,1
ES,RESPIRATORY DISORDER,1
ES,RESPIRATORY RATE INCREASED,1
ES,RESPIRATORY TRACT CONGESTION,1
ES,RESTLESSNESS,1
ES,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,1
ES,RHINALGIA,1
ES,RIB FRACTURE,1
ES,RUBELLA ANTIBODY POSITIVE,1
ES,SALMONELLOSIS,1
ES,SARCOIDOSIS,1
ES,SEASONAL ALLERGY,1
ES,SEMINOMA,1
ES,SENSE OF OPPRESSION,1
ES,SENSITISATION,1
ES,SENSORY DISTURBANCE,1
ES,SKIN BURNING SENSATION,1
ES,SKIN INDURATION,1
ES,SKIN IRRITATION,1
ES,SKIN TOXICITY,1
ES,SKIN WARM,1
ES,SKIN WOUND,1
ES,SKIN WRINKLING,1
ES,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
ES,SMALL CELL LUNG CANCER EXTENSIVE STAGE,1
ES,SOLAR LENTIGO,1
ES,SPINAL COLUMN STENOSIS,1
ES,SPONTANEOUS HAEMATOMA,1
ES,STATUS MIGRAINOSUS,1
ES,STOMATITIS,1
ES,SUDDEN DEATH,1
ES,SUFFOCATION FEELING,1
ES,SUICIDAL IDEATION,1
ES,SUICIDE ATTEMPT,1
ES,SUPRAVENTRICULAR TACHYCARDIA,1
ES,SYNOVIAL CYST,1
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ES,TELANGIECTASIA,1
ES,TENDON CALCIFICATION,1
ES,TENDON DISORDER,1
ES,TENDON INJURY,1
ES,TENDON PAIN,1
ES,TENOSYNOVITIS,1
ES,TENSION HEADACHE,1
ES,THERAPEUTIC RESPONSE DELAYED,1
ES,THERAPY NON-RESPONDER,1
ES,THROMBOCYTOPENIA,1
ES,THROMBOSIS,1
ES,TONGUE DISORDER,1
ES,TONGUE PARALYSIS,1
ES,TONGUE ULCERATION,1
ES,TOOTH INFECTION,1
ES,TOOTHACHE,1
ES,TOXIC SKIN ERUPTION,1
ES,TOXICITY TO VARIOUS AGENTS,1
ES,TRANSITIONAL CELL CARCINOMA,1
ES,TRIGEMINAL NEURALGIA,1
ES,TUBERCULIN TEST POSITIVE,1
ES,TUBERCULOID LEPROSY,1
ES,TUBERCULOUS PLEURISY,1
ES,TUNNEL VISION,1
ES,TYMPANIC MEMBRANE PERFORATION,1
ES,ULCER,1
ES,UMBILICAL HERNIA,1
ES,UNDERDOSE,1
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ES,UPPER RESPIRATORY TRACT INFECTION,1
ES,URETERIC OBSTRUCTION,1
ES,URINARY BLADDER HAEMORRHAGE,1
ES,URINARY RETENTION,1
ES,URINE ODOUR ABNORMAL,1
ES,UTERINE DISORDER,1
ES,UTERINE LEIOMYOMA,1
ES,VACCINATION COMPLICATION,1
ES,VAGINAL INFECTION,1
ES,VAGINAL ODOUR,1
ES,VASCULAR PURPURA,1
ES,VESSEL PUNCTURE SITE HAEMATOMA,1
ES,VIITH NERVE PARALYSIS,1
ES,VIRAL LOAD INCREASED,1
ES,VISUAL BRIGHTNESS,1
ES,VITAMIN D DEFICIENCY,1
ES,VITREOUS FLOATERS,1
ES,VOCAL CORD INFLAMMATION,1
ES,VOLVULUS,1
ES,VULVOVAGINAL CANDIDIASIS,1
ES,VULVOVAGINAL DISCOMFORT,1
ES,VULVOVAGINAL DRYNESS,1
ES,VULVOVAGINAL MYCOTIC INFECTION,1
ES,VULVOVAGINAL PRURITUS,1
ES,WHIPPLE^S DISEASE,1
ES,WHITE BLOOD CELL COUNT INCREASED,1
ES,WITHDRAWAL SYNDROME,1
ES,WOUND NECROSIS,1
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SE,FATIGUE,18
SE,DRUG INEFFECTIVE,15
SE,PYREXIA,15
SE,DYSPNOEA,14
SE,BREAST CANCER,12
SE,PAIN,11
SE,PNEUMONIA,11
SE,CONDITION AGGRAVATED,9
SE,INJECTION SITE ERYTHEMA,9
SE,NASOPHARYNGITIS,9
SE,BREAST CANCER FEMALE,8
SE,COUGH,8
SE,SEPSIS,8
SE,ARTHRALGIA,7
SE,DIZZINESS,7
SE,HYPERSENSITIVITY,7
SE,INFECTION SUSCEPTIBILITY INCREASED,7
SE,INJECTION SITE REACTION,7
SE,RASH,7
SE,ANAEMIA,6
SE,DEPRESSED MOOD,6
SE,DRUG EFFECT DECREASED,6
SE,DRUG EFFECT INCOMPLETE,6
SE,HYPOAESTHESIA,6
SE,MALAISE,6
SE,MUSCLE SPASMS,6
SE,POLYNEUROPATHY,6
SE,PROSTATE CANCER,6
SE,ARTHROPATHY,5
SE,BACTERIAL INFECTION,5
SE,COMA,5
SE,GAIT DISTURBANCE,5
SE,INJECTION SITE PRURITUS,5
SE,MALIGNANT MELANOMA,5
SE,MUSCULOSKELETAL STIFFNESS,5
SE,PARAESTHESIA,5
SE,PERIPHERAL SWELLING,5
SE,SARCOMA,5
SE,URINARY TRACT INFECTION,5
SE,AMYOTROPHIC LATERAL SCLEROSIS,4
SE,ANXIETY,4
SE,BACK PAIN,4
SE,BLISTER,4
SE,BLOOD PRESSURE INCREASED,4
SE,DIARRHOEA,4
SE,ERYSIPELAS,4
SE,FALL,4
SE,INFECTION,4
SE,INFLUENZA,4
SE,INJECTION SITE PAIN,4
SE,INJECTION SITE SWELLING,4
SE,MULTIPLE SCLEROSIS,4
SE,MUSCULAR WEAKNESS,4
SE,PAIN IN EXTREMITY,4
SE,PRURITUS,4
SE,WEIGHT DECREASED,4
SE,ABDOMINAL PAIN,3
SE,ALVEOLITIS,3
SE,ASTHENIA,3
SE,BALANCE DISORDER,3
SE,C-REACTIVE PROTEIN INCREASED,3
SE,CARDIAC FAILURE,3
SE,CHEST DISCOMFORT,3
SE,CHEST PAIN,3
SE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,3
SE,COGNITIVE DISORDER,3
SE,COLON CANCER,3
SE,DERMATITIS PSORIASIFORM,3
SE,DIVERTICULITIS,3
SE,ERYTHEMA,3
SE,FEELING ABNORMAL,3
SE,GENERAL PHYSICAL HEALTH DETERIORATION,3
SE,HAEMATOCHEZIA,3
SE,HODGKIN^S DISEASE,3
SE,INJECTION SITE RASH,3
SE,INJECTION SITE WARMTH,3
SE,INSOMNIA,3
SE,LYMPHOMA,3
SE,METASTASES TO LYMPH NODES,3
SE,MOTOR NEURONE DISEASE,3
SE,MUSCULOSKELETAL DISORDER,3
SE,MYOCARDIAL INFARCTION,3
SE,NAUSEA,3
SE,OROPHARYNGEAL PAIN,3
SE,PSORIATIC ARTHROPATHY,3
SE,PULMONARY EMBOLISM,3
SE,PULMONARY FIBROSIS,3
SE,STIFF PERSON SYNDROME,3
SE,TREMOR,3
SE,URTICARIA,3
SE,VISUAL ACUITY REDUCED,3
SE,WOUND,3
SE,ADENOCARCINOMA,2
SE,ANAL CANCER,2
SE,ANGIOEDEMA,2
SE,ANOSMIA,2
SE,ANTI-GAD ANTIBODY POSITIVE,2
SE,ARRHYTHMIA,2
SE,ATRIAL FIBRILLATION,2
SE,BIOPSY LYMPH GLAND ABNORMAL,2
SE,BLADDER CANCER,2
SE,BLOOD TEST ABNORMAL,2
SE,BRAIN NEOPLASM,2
SE,BREAST CANCER METASTATIC,2
SE,CARDIAC DISORDER,2
SE,CARDIAC FAILURE ACUTE,2
SE,CARDIAC FIBRILLATION,2
SE,CEREBRAL DISORDER,2
SE,CEREBRAL HAEMORRHAGE,2
SE,CEREBRAL INFARCTION,2
SE,CHOLECYSTITIS,2
SE,CHRONIC MYELOID LEUKAEMIA,2
SE,COMPUTERISED TOMOGRAM ABNORMAL,2
SE,CONFUSIONAL STATE,2
SE,CROHN^S DISEASE,2
SE,CUTANEOUS VASCULITIS,2
SE,DEEP VEIN THROMBOSIS,2
SE,DISEASE PROGRESSION,2
SE,DRUG DOSE OMISSION,2
SE,DRY EYE,2
SE,DRY MOUTH,2
SE,EOSINOPHILIA,2
SE,EPISTAXIS,2
SE,FALLOPIAN TUBE CANCER,2
SE,GASTROINTESTINAL CARCINOMA,2
SE,GASTROINTESTINAL MUCOCOELE,2
SE,HAEMOGLOBIN DECREASED,2
SE,HAEMORRHAGE SUBCUTANEOUS,2
SE,HAMARTOMA,2
SE,HEAD INJURY,2
SE,HEART RATE INCREASED,2
SE,HEPATITIS,2
SE,HERPES ZOSTER,2
SE,HYPERTENSION,2
SE,HYPOACUSIS,2
SE,HYPOKALAEMIA,2
SE,INJECTION SITE HYPERSENSITIVITY,2
SE,INVASIVE DUCTAL BREAST CARCINOMA,2
SE,IRITIS,2
SE,LEUKAEMIA,2
SE,LEUKOPENIA,2
SE,LIPOSARCOMA,2
SE,LOCALISED INFECTION,2
SE,LUNG INFECTION,2
SE,MALIGNANT OLIGODENDROGLIOMA,2
SE,METASTASIS,2
SE,METASTATIC LYMPHOMA,2
SE,MORTON^S NEURALGIA,2
SE,MOVEMENT DISORDER,2
SE,MUCOSAL DRYNESS,2
SE,MYALGIA,2
SE,MYXOFIBROSARCOMA,2
SE,NODULAR MELANOMA,2
SE,OESOPHAGEAL CARCINOMA,2
SE,OSTEITIS,2
SE,OVARIAN CANCER,2
SE,PALPITATIONS,2
SE,PANCREATIC CARCINOMA METASTATIC,2
SE,POSITRON EMISSION TOMOGRAM ABNORMAL,2
SE,PRURITUS GENERALISED,2
SE,PSORIASIS,2
SE,PUSTULAR PSORIASIS,2
SE,PYELONEPHRITIS,2
SE,RASH ERYTHEMATOUS,2
SE,RASH PRURITIC,2
SE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
SE,RESPIRATORY FAILURE,2
SE,RESPIRATORY TRACT INFECTION,2
SE,RHEUMATOID ARTHRITIS,2
SE,SEIZURE,2
SE,SEPTIC SHOCK,2
SE,SKIN CANCER,2
SE,SOFT TISSUE INFECTION,2
SE,SYNCOPE,2
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,2
SE,TACHYCARDIA,2
SE,TESTIS CANCER,2
SE,THROAT IRRITATION,2
SE,THROAT TIGHTNESS,2
SE,TOOTH INFECTION,2
SE,TRANSAMINASES INCREASED,2
SE,TRANSIENT ISCHAEMIC ATTACK,2
SE,TUBERCULOSIS,2
SE,TUBULOINTERSTITIAL NEPHRITIS,2
SE,UROSEPSIS,2
SE,UVEITIS,2
SE,VISION BLURRED,2
SE,WHITE BLOOD CELL COUNT DECREASED,2
SE,WOUND INFECTION,2
SE,ABDOMINAL ABSCESS,1
SE,ABDOMINAL DISCOMFORT,1
SE,ABDOMINAL DISTENSION,1
SE,ABDOMINAL HERNIA,1
SE,ABDOMINAL PAIN UPPER,1
SE,ABORTION SPONTANEOUS,1
SE,ABSCESS,1
SE,ABSCESS LIMB,1
SE,ACNE,1
SE,ACTINIC KERATOSIS,1
SE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SE,ACUTE MONOCYTIC LEUKAEMIA,1
SE,ACUTE MYOCARDIAL INFARCTION,1
SE,ADENOCARCINOMA OF COLON,1
SE,ADRENAL INSUFFICIENCY,1
SE,AGEUSIA,1
SE,AMNESIA,1
SE,ANAL ABSCESS,1
SE,ANGINA PECTORIS,1
SE,ANOXIA,1
SE,ANTIBODY TEST POSITIVE,1
SE,ARTERIAL RUPTURE,1
SE,ARTERIOSCLEROSIS,1
SE,ARTHRITIS,1
SE,ARTHRITIS INFECTIVE,1
SE,ARTHROPOD BITE,1
SE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
SE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
SE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
SE,B-CELL LYMPHOMA,1
SE,B-CELL SMALL LYMPHOCYTIC LYMPHOMA STAGE IV,1
SE,BASAL CELL CARCINOMA,1
SE,BILE DUCT CANCER,1
SE,BLEEDING VARICOSE VEIN,1
SE,BLOOD POTASSIUM INCREASED,1
SE,BLOOD PRESSURE DIASTOLIC INCREASED,1
SE,BORRELIA INFECTION,1
SE,BRADYCARDIA,1
SE,BRAIN NEOPLASM MALIGNANT,1
SE,BRAIN OEDEMA,1
SE,BREAST PAIN,1
SE,BREAST SWELLING,1
SE,BRONCHIOLITIS,1
SE,BRONCHITIS,1
SE,BUNDLE BRANCH BLOCK LEFT,1
SE,BURNING SENSATION,1
SE,CALCULUS URETERIC,1
SE,CARDIAC ARREST,1
SE,CARDIAC DISCOMFORT,1
SE,CARDIOMYOPATHY,1
SE,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
SE,CHILLS,1
SE,CHOLANGITIS SCLEROSING,1
SE,CHRONIC HEPATITIS,1
SE,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
SE,CLAVICLE FRACTURE,1
SE,COLD SWEAT,1
SE,COLITIS,1
SE,COLITIS MICROSCOPIC,1
SE,COLON CANCER METASTATIC,1
SE,CONGENITAL ANOMALY,1
SE,CONGENITAL GENITOURINARY ABNORMALITY,1
SE,CONSTIPATION,1
SE,CRYING,1
SE,CSF IMMUNOGLOBULIN INCREASED,1
SE,CSF OLIGOCLONAL BAND PRESENT,1
SE,DACRYOSTENOSIS ACQUIRED,1
SE,DEAFNESS NEUROSENSORY,1
SE,DEATH,1
SE,DEFAECATION URGENCY,1
SE,DEHYDRATION,1
SE,DEMYELINATION,1
SE,DENTAL FISTULA,1
SE,DEPRESSION,1
SE,DEPRESSION SUICIDAL,1
SE,DEPRESSIVE SYMPTOM,1
SE,DERMATITIS,1
SE,DEVICE RELATED INFECTION,1
SE,DIFFUSE ALOPECIA,1
SE,DIPLOPIA,1
SE,DISSEMINATED TUBERCULOSIS,1
SE,DISTURBANCE IN ATTENTION,1
SE,DIVERTICULUM INTESTINAL,1
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SE,DRUG ERUPTION,1
SE,DRUG SPECIFIC ANTIBODY PRESENT,1
SE,DYSPEPSIA,1
SE,DYSPHAGIA,1
SE,EATING DISORDER,1
SE,EMPYEMA,1
SE,ENCEPHALITIS VIRAL,1
SE,ENDOMETRITIS,1
SE,EPIDIDYMITIS,1
SE,EPILEPSY,1
SE,ERYTHEMA MULTIFORME,1
SE,ESCHERICHIA SEPSIS,1
SE,ESCHERICHIA URINARY TRACT INFECTION,1
SE,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
SE,EXTRASYSTOLES,1
SE,EYE DISORDER,1
SE,EYE INFECTION,1
SE,EYE IRRITATION,1
SE,EYELID PTOSIS,1
SE,FACE OEDEMA,1
SE,FEAR,1
SE,FEBRILE NEUTROPENIA,1
SE,FIBRIN D DIMER INCREASED,1
SE,FIBROMATOSIS,1
SE,FLATULENCE,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,FRACTURED COCCYX,1
SE,FUMBLING,1
SE,FUNGAL INFECTION,1
SE,GALLBLADDER PERFORATION,1
SE,GASTRIC CANCER,1
SE,GASTRIC HAEMORRHAGE,1
SE,GASTRIC INFECTION,1
SE,GASTRIC NEOPLASM,1
SE,GASTROENTERITIS VIRAL,1
SE,GASTROINTESTINAL DISORDER,1
SE,GASTROINTESTINAL HAEMORRHAGE,1
SE,GASTROOESOPHAGEAL CANCER,1
SE,GENERALISED ERYTHEMA,1
SE,GENITAL CANCER MALE,1
SE,GENITAL NEOPLASM MALIGNANT FEMALE,1
SE,GINGIVAL CANCER,1
SE,GLAUCOMA,1
SE,GLIOBLASTOMA,1
SE,GUILLAIN-BARRE SYNDROME,1
SE,HAEMARTHROSIS,1
SE,HAEMOCHROMATOSIS,1
SE,HEADACHE,1
SE,HEART RATE IRREGULAR,1
SE,HEMIPARESIS,1
SE,HEPATIC CIRRHOSIS,1
SE,HEPATITIS CHRONIC ACTIVE,1
SE,HEPATOCELLULAR CARCINOMA,1
SE,HERPES OPHTHALMIC,1
SE,HYDROTHORAX,1
SE,HYPERCHOLESTEROLAEMIA,1
SE,HYPERREFLEXIA,1
SE,HYPERTONIA,1
SE,HYPOTENSION,1
SE,IIIRD NERVE PARESIS,1
SE,ILEUS,1
SE,IMMUNODEFICIENCY,1
SE,IMMUNOGLOBULINS DECREASED,1
SE,IMMUNOSUPPRESSION,1
SE,IMPLANT SITE INFECTION,1
SE,INCREASED TENDENCY TO BRUISE,1
SE,INFECTION IN AN IMMUNOCOMPROMISED HOST,1
SE,INFLAMMATION,1
SE,INFLAMMATION OF WOUND,1
SE,INFLAMMATORY BOWEL DISEASE,1
SE,INJECTION SITE BRUISING,1
SE,INJECTION SITE DISCOMFORT,1
SE,INJECTION SITE INDURATION,1
SE,INTERSTITIAL LUNG DISEASE,1
SE,INTERVERTEBRAL DISCITIS,1
SE,INTESTINAL ADENOCARCINOMA,1
SE,IRIDOCYCLITIS,1
SE,JOINT DISLOCATION,1
SE,JOINT SWELLING,1
SE,KERATITIS INTERSTITIAL,1
SE,KERATORHEXIS,1
SE,KIDNEY INFECTION,1
SE,LIGAMENT SPRAIN,1
SE,LIMB DISCOMFORT,1
SE,LIP AND/OR ORAL CAVITY CANCER,1
SE,LIP ULCERATION,1
SE,LOCAL SWELLING,1
SE,LUMBAR PUNCTURE ABNORMAL,1
SE,LUNG ABSCESS,1
SE,LUNG DISORDER,1
SE,LUNG INFILTRATION,1
SE,LUNG NEOPLASM MALIGNANT,1
SE,LYMPH NODE TUBERCULOSIS,1
SE,LYMPHANGITIS,1
SE,LYMPHOEDEMA,1
SE,MALIGNANT MELANOMA STAGE II,1
SE,MALIGNANT MELANOMA STAGE IV,1
SE,MALIGNANT NEOPLASM OF PLEURA,1
SE,MALIGNANT NEOPLASM OF RENAL PELVIS,1
SE,MALIGNANT PERITONEAL NEOPLASM,1
SE,MALIGNANT RESPIRATORY TRACT NEOPLASM,1
SE,MATERNAL EXPOSURE DURING PREGNANCY,1
SE,MEMORY IMPAIRMENT,1
SE,MENINGITIS,1
SE,MENINGITIS ASEPTIC,1
SE,MENTAL STATUS CHANGES,1
SE,METABOLIC DISORDER,1
SE,METASTASES TO BONE,1
SE,METASTASES TO PERITONEUM,1
SE,MICROSCOPIC POLYANGIITIS,1
SE,MIDDLE INSOMNIA,1
SE,MONOCLONAL IMMUNOGLOBULIN PRESENT,1
SE,MUCOUS MEMBRANE DISORDER,1
SE,MUSCLE ATROPHY,1
SE,MUSCLE RIGIDITY,1
SE,MYASTHENIA GRAVIS,1
SE,MYCOBACTERIUM ABSCESSUS INFECTION,1
SE,MYELITIS,1
SE,MYOPATHY,1
SE,MYOSITIS,1
SE,NAIL DISORDER,1
SE,NASAL DRYNESS,1
SE,NEEDLE ISSUE,1
SE,NEOPLASM,1
SE,NEOPLASM MALIGNANT,1
SE,NERVOUSNESS,1
SE,NEUROPATHY PERIPHERAL,1
SE,NEUTROPENIA,1
SE,NIGHT SWEATS,1
SE,NOCTURNAL DYSPNOEA,1
SE,NON-HODGKIN^S LYMPHOMA,1
SE,NONINFECTIVE GINGIVITIS,1
SE,NUCLEAR MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL,1
SE,OCULAR VASCULITIS,1
SE,ODYNOPHAGIA,1
SE,OEDEMA PERIPHERAL,1
SE,OESOPHAGEAL CANDIDIASIS,1
SE,OLIGODENDROGLIOMA,1
SE,OPTIC ATROPHY,1
SE,ORAL MUCOSAL BLISTERING,1
SE,OROPHARYNGEAL DISCOMFORT,1
SE,OSTEOARTHRITIS,1
SE,OSTEOPOROSIS,1
SE,OTITIS MEDIA,1
SE,OTITIS MEDIA ACUTE,1
SE,PAIN IN JAW,1
SE,PANIC ATTACK,1
SE,PANNICULITIS,1
SE,PARAESTHESIA ORAL,1
SE,PARKINSON^S DISEASE,1
SE,PARTIAL SEIZURES,1
SE,PELVIC INFECTION,1
SE,PELVIC PAIN,1
SE,PENILE SQUAMOUS CELL CARCINOMA,1
SE,PERICARDITIS INFECTIVE,1
SE,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
SE,PERITONITIS,1
SE,PERIVASCULAR DERMATITIS,1
SE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
SE,PNEUMOTHORAX SPONTANEOUS,1
SE,POLYMYOSITIS,1
SE,POOR QUALITY SLEEP,1
SE,POST HERPETIC NEURALGIA,1
SE,POST PROCEDURAL COMPLICATION,1
SE,POST VIRAL FATIGUE SYNDROME,1
SE,PRESYNCOPE,1
SE,PROCTITIS ULCERATIVE,1
SE,PRODUCTIVE COUGH,1
SE,PROSTATIC ABSCESS,1
SE,PROSTATITIS,1
SE,PSEUDODEMENTIA,1
SE,PSYCHOTIC DISORDER,1
SE,PULMONARY AMYLOIDOSIS,1
SE,PULMONARY OEDEMA,1
SE,PYODERMA GANGRENOSUM,1
SE,RECTAL CANCER,1
SE,RECTAL HAEMORRHAGE,1
SE,RECTAL NEOPLASM,1
SE,RECTAL PERFORATION,1
SE,RENAL ABSCESS,1
SE,RENAL AMYLOIDOSIS,1
SE,REPRODUCTIVE TRACT DISORDER,1
SE,RESPIRATORY DISTRESS,1
SE,RESPIRATORY TRACT IRRITATION,1
SE,RESPIRATORY TRACT NEOPLASM,1
SE,RESTLESS LEGS SYNDROME,1
SE,RETINAL ARTERY OCCLUSION,1
SE,SCAR,1
SE,SCLERITIS,1
SE,SENSITISATION,1
SE,SKIN ATROPHY,1
SE,SKIN DISORDER,1
SE,SKIN FISSURES,1
SE,SKIN REACTION,1
SE,SMALL FIBRE NEUROPATHY,1
SE,SPEECH DISORDER,1
SE,SPINAL DISORDER,1
SE,SQUAMOUS CELL CARCINOMA,1
SE,SQUAMOUS CELL CARCINOMA OF SKIN,1
SE,STAPHYLOCOCCAL INFECTION,1
SE,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
SE,SUBARACHNOID HAEMORRHAGE,1
SE,SUBDURAL HAEMATOMA,1
SE,SUICIDAL IDEATION,1
SE,SWELLING FACE,1
SE,SYNOVITIS,1
SE,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
SE,SYSTOLIC DYSFUNCTION,1
SE,T-CELL LYMPHOMA,1
SE,TEMPORAL ARTERITIS,1
SE,TENDON RUPTURE,1
SE,TENDONITIS,1
SE,THORACIC OUTLET SYNDROME,1
SE,THROMBOCYTOPENIA,1
SE,THROMBOSIS,1
SE,THYROIDITIS,1
SE,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
SE,TONSILLITIS STREPTOCOCCAL,1
SE,TOOTH DISORDER,1
SE,TOXIC SKIN ERUPTION,1
SE,TYPE 2 DIABETES MELLITUS,1
SE,UPPER RESPIRATORY TRACT INFECTION,1
SE,URETERIC OBSTRUCTION,1
SE,URETHRAL STENOSIS,1
SE,URINARY RETENTION,1
SE,URINARY TRACT INFECTION NEONATAL,1
SE,UTERINE LEIOMYOMA,1
SE,VAGINAL HAEMORRHAGE,1
SE,VASCULITIS,1
SE,VASCULITIS CEREBRAL,1
SE,VISUAL IMPAIRMENT,1
SE,VOCAL CORD INFLAMMATION,1
SE,VOCAL CORD PARALYSIS,1
SE,VOMITING,1
SE,WEIGHT INCREASED,1
SE,WHEELCHAIR USER,1
SE,WHITE BLOOD CELL COUNT INCREASED,1
SE,WOUND COMPLICATION,1
CH,ACUTE KIDNEY INJURY,5
CH,CONDITION AGGRAVATED,5
CH,DEATH,5
CH,HYPERSENSITIVITY,5
CH,NAUSEA,5
CH,PAIN,5
CH,PRODUCT USE ISSUE,5
CH,DIARRHOEA,4
CH,MALAISE,4
CH,PNEUMONIA,4
CH,VOMITING,4
CH,ACUTE MYELOID LEUKAEMIA,3
CH,ARTHRALGIA,3
CH,CHILLS,3
CH,DEHYDRATION,3
CH,DISEASE RECURRENCE,3
CH,DISSEMINATED INTRAVASCULAR COAGULATION,3
CH,DIZZINESS,3
CH,DRUG INEFFECTIVE,3
CH,FATIGUE,3
CH,HYPOAESTHESIA,3
CH,PAIN IN EXTREMITY,3
CH,PARAESTHESIA,3
CH,PARALYSIS,3
CH,POLYNEUROPATHY,3
CH,PRURITUS,3
CH,RETINOPATHY,3
CH,RHEUMATOID ARTHRITIS,3
CH,ACNE,2
CH,ALCOHOLISM,2
CH,ASTHENIA,2
CH,BRONCHITIS,2
CH,CARDIAC FAILURE,2
CH,COLITIS,2
CH,DERMATOSIS,2
CH,DIVERTICULITIS,2
CH,DRUG INTOLERANCE,2
CH,ERYTHEMA,2
CH,ERYTHROMELALGIA,2
CH,GAIT DISTURBANCE,2
CH,GASTROINTESTINAL DISORDER,2
CH,GASTROINTESTINAL HAEMORRHAGE,2
CH,GENERAL PHYSICAL HEALTH DETERIORATION,2
CH,IGA NEPHROPATHY,2
CH,IMMUNOSUPPRESSION,2
CH,INFECTION IN AN IMMUNOCOMPROMISED HOST,2
CH,INJECTION SITE HYPERSENSITIVITY,2
CH,INJECTION SITE NECROSIS,2
CH,INJECTION SITE REACTION,2
CH,INJECTION SITE URTICARIA,2
CH,INNER EAR DISORDER,2
CH,INTESTINAL ULCER,2
CH,LUNG INFECTION,2
CH,LUNG NEOPLASM MALIGNANT,2
CH,LYMPHOMA,2
CH,MENINGOCOCCAL BACTERAEMIA,2
CH,METASTASES TO LYMPH NODES,2
CH,NEPHROLITHIASIS,2
CH,OTITIS MEDIA,2
CH,PERIPHERAL SENSORY NEUROPATHY,2
CH,PULMONARY EMBOLISM,2
CH,PURPURA FULMINANS,2
CH,PYREXIA,2
CH,RENAL FAILURE ACUTE,2
CH,SACCADIC EYE MOVEMENT,2
CH,SEPSIS,2
CH,SEPTIC SHOCK,2
CH,SKIN NECROSIS,2
CH,STRESS CARDIOMYOPATHY,2
CH,SUBCUTANEOUS ABSCESS,2
CH,TENDON DISORDER,2
CH,TONSILLITIS,2
CH,TRANSIENT ISCHAEMIC ATTACK,2
CH,URINARY TRACT INFECTION,2
CH,UVEITIS,2
CH,WEIGHT INCREASED,2
CH,ABSTAINS FROM ALCOHOL,1
CH,ACUTE HEPATIC FAILURE,1
CH,ALTERED STATE OF CONSCIOUSNESS,1
CH,ALVEOLITIS,1
CH,AMAUROSIS FUGAX,1
CH,AMENORRHOEA,1
CH,AMYLOIDOSIS,1
CH,ANGINA PECTORIS,1
CH,ANGINA UNSTABLE,1
CH,AORTIC VALVE DISEASE,1
CH,APOPTOSIS,1
CH,APPLICATION SITE THROMBOSIS,1
CH,ARTHRITIS BACTERIAL,1
CH,ARTHROPATHY,1
CH,ATRIAL FIBRILLATION,1
CH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
CH,B-CELL LYMPHOMA,1
CH,BACK PAIN,1
CH,BACTERIAL INFECTION,1
CH,BLINDNESS,1
CH,BLISTER,1
CH,BLOOD PRESSURE SYSTOLIC INCREASED,1
CH,BREAST CANCER,1
CH,BREAST CANCER FEMALE,1
CH,BUNDLE BRANCH BLOCK LEFT,1
CH,CARDIAC ARREST,1
CH,CARDIOVASCULAR DISORDER,1
CH,CATARACT,1
CH,CEREBRAL HAEMORRHAGE,1
CH,CEREBRAL INFARCTION,1
CH,CEREBRAL ISCHAEMIA,1
CH,CHOLESTEATOMA,1
CH,CLOSTRIDIUM DIFFICILE INFECTION,1
CH,COMPARTMENT SYNDROME,1
CH,CONDUCTIVE DEAFNESS,1
CH,CONGESTIVE CARDIOMYOPATHY,1
CH,CONTUSION,1
CH,CROHN^S DISEASE,1
CH,DEMYELINATION,1
CH,DEPOSIT EYE,1
CH,DERMAL CYST,1
CH,DERMO-HYPODERMITIS,1
CH,DEVICE ISSUE,1
CH,DEVICE RELATED INFECTION,1
CH,DIPLEGIA,1
CH,DRUG CROSS-REACTIVITY,1
CH,DRUG DOSE OMISSION,1
CH,DRUG HYPERSENSITIVITY,1
CH,DYSPNOEA,1
CH,DYSURIA,1
CH,EJECTION FRACTION DECREASED,1
CH,ELECTROENCEPHALOGRAM ABNORMAL,1
CH,ENDOCARDITIS,1
CH,EPILEPSY,1
CH,ERYSIPELAS,1
CH,ESCHERICHIA SEPSIS,1
CH,FEAR,1
CH,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
CH,FOLATE DEFICIENCY,1
CH,GALLBLADDER DISORDER,1
CH,GANGRENE,1
CH,GASTRIC HAEMORRHAGE,1
CH,GENITAL NEOPLASM MALIGNANT FEMALE,1
CH,GLOSSITIS,1
CH,GRANULOMA,1
CH,GYNAECOMASTIA,1
CH,HAEMATOCHEZIA,1
CH,HAEMOGLOBIN DECREASED,1
CH,HEADACHE,1
CH,HERPES SIMPLEX,1
CH,HYPERTHERMIA,1
CH,IMPAIRED HEALING,1
CH,INFECTION,1
CH,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
CH,INFLUENZA LIKE ILLNESS,1
CH,INJECTION SITE ERYTHEMA,1
CH,INJECTION SITE HAEMATOMA,1
CH,INJECTION SITE INFLAMMATION,1
CH,INJECTION SITE IRRITATION,1
CH,INJECTION SITE OEDEMA,1
CH,INJECTION SITE PAIN,1
CH,INJECTION SITE PLAQUE,1
CH,INJECTION SITE RASH,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,IRITIS,1
CH,IRON DEFICIENCY,1
CH,JOINT RANGE OF MOTION DECREASED,1
CH,LEFT VENTRICULAR DILATATION,1
CH,LIBIDO DISORDER,1
CH,LIP OEDEMA,1
CH,LIVER FUNCTION TEST ABNORMAL,1
CH,LOCAL SWELLING,1
CH,LOCALISED OEDEMA,1
CH,LOSS OF CONSCIOUSNESS,1
CH,LUNG ADENOCARCINOMA,1
CH,LUNG ADENOCARCINOMA METASTATIC,1
CH,MACULAR DEGENERATION,1
CH,MALIGNANT GENITOURINARY TRACT NEOPLASM,1
CH,MALIGNANT MELANOMA,1
CH,MENINGITIS,1
CH,METASTATIC MALIGNANT MELANOMA,1
CH,MONARTHRITIS,1
CH,MUSCULOSKELETAL PAIN,1
CH,MYELITIS,1
CH,MYELOPATHY,1
CH,NECK PAIN,1
CH,NEOPLASM,1
CH,NEOPLASM MALIGNANT,1
CH,NEOPLASM SKIN,1
CH,NEURITIS,1
CH,NEUTROPENIA,1
CH,NIGHT SWEATS,1
CH,NONINFECTIVE ENCEPHALITIS,1
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CH,OCULAR HYPERAEMIA,1
CH,OVARIAN ABSCESS,1
CH,PALLOR,1
CH,PANCREATITIS ACUTE,1
CH,PO2 DECREASED,1
CH,POOR QUALITY DRUG ADMINISTERED,1
CH,PRODUCTIVE COUGH,1
CH,PSORIATIC ARTHROPATHY,1
CH,PULMONARY FIBROSIS,1
CH,PULMONARY HILUM MASS,1
CH,PULMONARY SEPSIS,1
CH,PYODERMA GANGRENOSUM,1
CH,RADICULITIS,1
CH,RASH,1
CH,RENAL FAILURE,1
CH,RESPIRATORY TRACT INFECTION,1
CH,RETROPERITONEAL FIBROSIS,1
CH,RHEUMATOID NODULE,1
CH,ROAD TRAFFIC ACCIDENT,1
CH,SINUSITIS,1
CH,SKIN LESION,1
CH,SKIN PLAQUE,1
CH,SKIN REACTION,1
CH,SKIN ULCER,1
CH,SPLENOMEGALY,1
CH,SPONDYLITIS,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STASIS DERMATITIS,1
CH,STENOTROPHOMONAS INFECTION,1
CH,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
CH,SYNCOPE,1
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CH,TENDON RUPTURE,1
CH,THERMAL BURN,1
CH,THROMBOCYTOPENIA,1
CH,THYROID FUNCTION TEST ABNORMAL,1
CH,TINNITUS,1
CH,TOXIC EPIDERMAL NECROLYSIS,1
CH,TRANSAMINASES INCREASED,1
CH,TUBO-OVARIAN ABSCESS,1
CH,TUBULAR BREAST CARCINOMA,1
CH,TYPE III IMMUNE COMPLEX MEDIATED REACTION,1
CH,UNINTENDED PREGNANCY,1
CH,UROSEPSIS,1
CH,VARICELLA ZOSTER VIRUS INFECTION,1
CH,VENTRICULAR FIBRILLATION,1
CH,VENTRICULAR TACHYCARDIA,1
CH,VIRAL INFECTION,1
CH,VISUAL IMPAIRMENT,1
CH,VULVOVAGINAL MYCOTIC INFECTION,1
CH,WOUND SEPSIS,1
TW,FALL,88
TW,PYREXIA,87
TW,ARTHRALGIA,62
TW,CONDITION AGGRAVATED,60
TW,ROAD TRAFFIC ACCIDENT,54
TW,PRODUCT USE ISSUE,52
TW,DEATH,47
TW,RED BLOOD CELL SEDIMENTATION RATE INCREASED,46
TW,PNEUMONIA,43
TW,C-REACTIVE PROTEIN INCREASED,39
TW,NASOPHARYNGITIS,39
TW,CELLULITIS,38
TW,JOINT SWELLING,37
TW,DYSPNOEA,34
TW,URINARY TRACT INFECTION,30
TW,IRITIS,28
TW,COUGH,27
TW,OSTEOARTHRITIS,27
TW,DRUG INEFFECTIVE,26
TW,CATARACT,23
TW,HAEMOGLOBIN DECREASED,23
TW,GASTRIC ULCER,21
TW,BACK PAIN,20
TW,TUBERCULOSIS,20
TW,ALANINE AMINOTRANSFERASE INCREASED,19
TW,RHEUMATOID ARTHRITIS,19
TW,WHITE BLOOD CELL COUNT DECREASED,19
TW,PAIN,18
TW,VOMITING,18
TW,LOWER LIMB FRACTURE,17
TW,PLEURAL EFFUSION,17
TW,SEPSIS,17
TW,CHEST DISCOMFORT,16
TW,DISEASE RECURRENCE,16
TW,ABDOMINAL PAIN,15
TW,ARTHROPATHY,15
TW,HYPOAESTHESIA,15
TW,WOUND,15
TW,CEREBROVASCULAR ACCIDENT,14
TW,DIZZINESS,14
TW,MYOCARDIAL INFARCTION,14
TW,PULMONARY MASS,14
TW,WOUND INFECTION,14
TW,ASTHENIA,13
TW,DECREASED APPETITE,13
TW,ERYTHEMA,13
TW,HYPOTENSION,13
TW,PAIN IN EXTREMITY,13
TW,ASPARTATE AMINOTRANSFERASE INCREASED,12
TW,BLOOD CREATININE INCREASED,12
TW,BREAST CANCER,12
TW,DIARRHOEA,12
TW,INFECTION,12
TW,INTENTIONAL PRODUCT MISUSE,12
TW,MUSCULAR WEAKNESS,12
TW,NEPHROLITHIASIS,12
TW,ABDOMINAL DISTENSION,11
TW,FEMUR FRACTURE,11
TW,INTERVERTEBRAL DISC PROTRUSION,11
TW,LUNG NEOPLASM MALIGNANT,11
TW,PLATELET COUNT DECREASED,11
TW,CONTUSION,10
TW,DISCOMFORT,10
TW,GASTROOESOPHAGEAL REFLUX DISEASE,10
TW,INFLUENZA,10
TW,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,10
TW,RASH,10
TW,SEPTIC SHOCK,10
TW,ACUTE MYOCARDIAL INFARCTION,9
TW,ACUTE RESPIRATORY FAILURE,9
TW,CHOLELITHIASIS,9
TW,DYSURIA,9
TW,GAIT DISTURBANCE,9
TW,HIP FRACTURE,9
TW,MELAENA,9
TW,MOUTH ULCERATION,9
TW,PRODUCTIVE COUGH,9
TW,PRURITUS,9
TW,PULMONARY FIBROSIS,9
TW,SPINAL COMPRESSION FRACTURE,9
TW,ANAEMIA,8
TW,ASCITES,8
TW,BREAST CANCER FEMALE,8
TW,CARDIAC FAILURE,8
TW,CONSTIPATION,8
TW,FATIGUE,8
TW,HYDRONEPHROSIS,8
TW,LIMB INJURY,8
TW,LOSS OF CONSCIOUSNESS,8
TW,LUNG ADENOCARCINOMA,8
TW,LUNG INFILTRATION,8
TW,NAUSEA,8
TW,RESPIRATORY FAILURE,8
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,8
TW,WHITE BLOOD CELL COUNT INCREASED,8
TW,ABDOMINAL PAIN UPPER,7
TW,COMA,7
TW,DUODENAL ULCER,7
TW,FOOT DEFORMITY,7
TW,HYPERTENSION,7
TW,IMPAIRED HEALING,7
TW,LUNG DISORDER,7
TW,MYCOBACTERIUM TEST POSITIVE,7
TW,OSTEONECROSIS OF JAW,7
TW,PERIPHERAL SWELLING,7
TW,PULMONARY OEDEMA,7
TW,PYELONEPHRITIS ACUTE,7
TW,ABASIA,6
TW,ABORTION SPONTANEOUS,6
TW,ASTHMA,6
TW,CARDIOMEGALY,6
TW,CEREBRAL HAEMORRHAGE,6
TW,CHOLECYSTITIS,6
TW,COLON CANCER,6
TW,COMPRESSION FRACTURE,6
TW,DISLOCATION OF VERTEBRA,6
TW,FOOT FRACTURE,6
TW,HAEMATOCHEZIA,6
TW,HAEMORRHOIDS,6
TW,HEAD INJURY,6
TW,HEPATIC CANCER,6
TW,HEPATITIS B,6
TW,HEPATITIS B DNA INCREASED,6
TW,MASS,6
TW,OROPHARYNGEAL PAIN,6
TW,OSTEONECROSIS,6
TW,PSORIASIS,6
TW,PSORIATIC ARTHROPATHY,6
TW,SKIN ULCER,6
TW,SPINAL OSTEOARTHRITIS,6
TW,SPUTUM DISCOLOURED,6
TW,SWELLING,6
TW,VISION BLURRED,6
TW,ABDOMINAL DISCOMFORT,5
TW,ABDOMINAL PAIN LOWER,5
TW,ANKLE FRACTURE,5
TW,ARTHRITIS,5
TW,BLOOD PRESSURE INCREASED,5
TW,BLOOD UREA INCREASED,5
TW,CHEST PAIN,5
TW,COMMINUTED FRACTURE,5
TW,FRACTURE,5
TW,GASTRIC HAEMORRHAGE,5
TW,GASTROINTESTINAL HAEMORRHAGE,5
TW,HAEMATURIA,5
TW,HAND FRACTURE,5
TW,HEADACHE,5
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
TW,INTERSTITIAL LUNG DISEASE,5
TW,LACERATION,5
TW,LIP AND/OR ORAL CAVITY CANCER,5
TW,LYMPHOMA,5
TW,MUSCULOSKELETAL PAIN,5
TW,POLYARTHRITIS,5
TW,PROSTATE CANCER,5
TW,RENAL IMPAIRMENT,5
TW,RIB FRACTURE,5
TW,SKIN EXFOLIATION,5
TW,SPONDYLOLISTHESIS,5
TW,STAPHYLOCOCCAL INFECTION,5
TW,UPPER LIMB FRACTURE,5
TW,UTERINE LEIOMYOMA,5
TW,WEIGHT DECREASED,5
TW,WOUND COMPLICATION,5
TW,WRIST FRACTURE,5
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,4
TW,ALTERED STATE OF CONSCIOUSNESS,4
TW,BACTERAEMIA,4
TW,BENIGN PROSTATIC HYPERPLASIA,4
TW,BLOOD CREATINE INCREASED,4
TW,BRAIN NEOPLASM,4
TW,BRONCHIECTASIS,4
TW,CHEST X-RAY ABNORMAL,4
TW,CHOLANGITIS,4
TW,COAGULOPATHY,4
TW,CORONARY ARTERY DISEASE,4
TW,DISEASE PROGRESSION,4
TW,DRUG HYPERSENSITIVITY,4
TW,GASTRIC CANCER,4
TW,GASTROENTERITIS,4
TW,GLAUCOMA,4
TW,HAEMATOMA,4
TW,HERPES ZOSTER,4
TW,HUMERUS FRACTURE,4
TW,INFLAMMATION,4
TW,INJURY,4
TW,INSOMNIA,4
TW,JOINT EFFUSION,4
TW,LIGAMENT RUPTURE,4
TW,LOCAL SWELLING,4
TW,LUMBAR SPINAL STENOSIS,4
TW,LUNG INFECTION,4
TW,MALAISE,4
TW,MYCOBACTERIAL INFECTION,4
TW,NEOPLASM MALIGNANT,4
TW,NERVE COMPRESSION,4
TW,OEDEMA,4
TW,OEDEMA PERIPHERAL,4
TW,OSTEOPOROSIS,4
TW,PEPTIC ULCER,4
TW,POST PROCEDURAL INFECTION,4
TW,RED BLOOD CELL COUNT DECREASED,4
TW,RENAL FAILURE ACUTE,4
TW,RHINORRHOEA,4
TW,SHOCK,4
TW,SYNCOPE,4
TW,SYNOVITIS,4
TW,URINE OUTPUT DECREASED,4
TW,WHEEZING,4
TW,WHITE BLOOD CELLS URINE POSITIVE,4
TW,ANAL ABSCESS,3
TW,ARRHYTHMIA,3
TW,ATYPICAL MYCOBACTERIAL INFECTION,3
TW,BACTERIAL TEST POSITIVE,3
TW,BLISTER,3
TW,BLOOD GLUCOSE ABNORMAL,3
TW,BRADYCARDIA,3
TW,CARDIAC ARREST,3
TW,CERVICAL SPINAL STENOSIS,3
TW,CHILLS,3
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
TW,DEHYDRATION,3
TW,DUODENAL ULCER PERFORATION,3
TW,DYSPHAGIA,3
TW,EMPHYSEMA,3
TW,ESCHERICHIA URINARY TRACT INFECTION,3
TW,EXOSTOSIS,3
TW,FAECES DISCOLOURED,3
TW,FEELING HOT,3
TW,FEMORAL NECK FRACTURE,3
TW,GLOMERULAR FILTRATION RATE DECREASED,3
TW,HAEMATEMESIS,3
TW,HAEMATOCRIT DECREASED,3
TW,HAEMOPTYSIS,3
TW,HAEMORRHAGE INTRACRANIAL,3
TW,HAEMORRHOIDAL HAEMORRHAGE,3
TW,HEPATIC NEOPLASM,3
TW,HEPATOCELLULAR CARCINOMA,3
TW,HODGKIN^S DISEASE,3
TW,HYPERGLYCAEMIA,3
TW,HYPOKALAEMIA,3
TW,HYPONATRAEMIA,3
TW,JAUNDICE,3
TW,JOINT STIFFNESS,3
TW,JUVENILE IDIOPATHIC ARTHRITIS,3
TW,LACUNAR INFARCTION,3
TW,LIP SWELLING,3
TW,LIVER FUNCTION TEST ABNORMAL,3
TW,LOCALISED INFECTION,3
TW,LUMBAR VERTEBRAL FRACTURE,3
TW,METASTASIS,3
TW,MYALGIA,3
TW,NEOPLASM,3
TW,PALPITATIONS,3
TW,PANCREATITIS ACUTE,3
TW,PEPTIC ULCER PERFORATION,3
TW,PERICARDIAL EFFUSION,3
TW,POLLAKIURIA,3
TW,POSTOPERATIVE WOUND INFECTION,3
TW,PROTEINURIA,3
TW,PULMONARY EMBOLISM,3
TW,RENAL FAILURE,3
TW,RETINAL VEIN OCCLUSION,3
TW,SCIATICA,3
TW,SKIN SWELLING,3
TW,SPINAL PAIN,3
TW,SPUTUM PURULENT,3
TW,SUBARACHNOID HAEMORRHAGE,3
TW,SUBCUTANEOUS ABSCESS,3
TW,THYROID MASS,3
TW,TONSILLITIS,3
TW,TOOTHACHE,3
TW,TREMOR,3
TW,TROPONIN I INCREASED,3
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,3
TW,URETEROLITHIASIS,3
TW,UROSEPSIS,3
TW,VAGINAL HAEMORRHAGE,3
TW,VERTIGO,3
TW,ABDOMINAL ABSCESS,2
TW,ABNORMAL FAECES,2
TW,ACUTE CORONARY SYNDROME,2
TW,ACUTE HEPATIC FAILURE,2
TW,ADENOMYOSIS,2
TW,ADRENAL INSUFFICIENCY,2
TW,ALANINE AMINOTRANSFERASE ABNORMAL,2
TW,ANAL FISTULA,2
TW,ANKYLOSING SPONDYLITIS,2
TW,APPENDICITIS,2
TW,ARTERIOSCLEROSIS,2
TW,ATELECTASIS,2
TW,BILE DUCT OBSTRUCTION,2
TW,BILIARY TRACT INFECTION,2
TW,BLADDER CANCER,2
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,2
TW,BLOOD BILIRUBIN INCREASED,2
TW,BLOOD CALCIUM ABNORMAL,2
TW,BLOOD PRESSURE DECREASED,2
TW,BLOOD SODIUM DECREASED,2
TW,BLOOD URIC ACID INCREASED,2
TW,BLOOD URINE PRESENT,2
TW,BRAIN OEDEMA,2
TW,BREAST CANCER IN SITU,2
TW,BRONCHITIS,2
TW,BURSITIS,2
TW,CALCULUS URINARY,2
TW,CARDIAC FAILURE CONGESTIVE,2
TW,CEREBRAL INFARCTION,2
TW,CEREBROVASCULAR DISORDER,2
TW,CHROMATURIA,2
TW,CHRONIC HEPATITIS,2
TW,CHRONIC KIDNEY DISEASE,2
TW,COMPLEMENT FACTOR C3 DECREASED,2
TW,CRYPTOCOCCOSIS,2
TW,CYSTITIS,2
TW,DECREASED IMMUNE RESPONSIVENESS,2
TW,DECUBITUS ULCER,2
TW,DEVICE RELATED INFECTION,2
TW,DIARRHOEA INFECTIOUS,2
TW,DIVERTICULITIS,2
TW,DOUBLE STRANDED DNA ANTIBODY POSITIVE,2
TW,DRY MOUTH,2
TW,ENDOMETRIOSIS,2
TW,ESCHERICHIA BACTERAEMIA,2
TW,EYELID OEDEMA,2
TW,FACIAL PARALYSIS,2
TW,FEBRILE NEUTROPENIA,2
TW,FOLLICULITIS,2
TW,FRACTURE DISPLACEMENT,2
TW,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
TW,GASTRIC PERFORATION,2
TW,GASTRITIS EROSIVE,2
TW,GENERALISED OEDEMA,2
TW,GOITRE,2
TW,HAEMORRHAGE,2
TW,HEPATIC CIRRHOSIS,2
TW,HEPATIC ENCEPHALOPATHY,2
TW,HEPATIC ENZYME INCREASED,2
TW,HEPATIC FIBROSIS,2
TW,HEPATIC STEATOSIS,2
TW,HEPATITIS B SURFACE ANTIGEN POSITIVE,2
TW,HEPATITIS C VIRUS TEST POSITIVE,2
TW,HIV TEST POSITIVE,2
TW,HYPERNATRAEMIA,2
TW,HYPERSENSITIVITY,2
TW,HYPOGLYCAEMIA,2
TW,HYPOVOLAEMIC SHOCK,2
TW,ILEUS PARALYTIC,2
TW,INFECTIOUS COLITIS,2
TW,INFLAMMATORY MARKER INCREASED,2
TW,INJECTION SITE PAIN,2
TW,INJECTION SITE REACTION,2
TW,INTENTIONAL UNDERDOSE,2
TW,INTESTINAL OBSTRUCTION,2
TW,JOINT DISLOCATION,2
TW,JOINT RANGE OF MOTION DECREASED,2
TW,JOINT WARMTH,2
TW,LARGE INTESTINE POLYP,2
TW,LIGAMENT INJURY,2
TW,LIVER DISORDER,2
TW,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,2
TW,LYMPHADENOPATHY,2
TW,LYMPHOCYTE COUNT ABNORMAL,2
TW,MALIGNANT NEOPLASM OF RENAL PELVIS,2
TW,MATERNAL EXPOSURE DURING PREGNANCY,2
TW,MEAN CELL HAEMOGLOBIN INCREASED,2
TW,MEAN CELL VOLUME ABNORMAL,2
TW,MENINGITIS,2
TW,MULTI-ORGAN FAILURE,2
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
TW,MUSCULOSKELETAL DISCOMFORT,2
TW,NASAL CONGESTION,2
TW,NEPHRITIS,2
TW,NERVE INJURY,2
TW,OVARIAN CANCER,2
TW,OVARIAN NEOPLASM,2
TW,PANCREATITIS,2
TW,PANCYTOPENIA,2
TW,PERITONITIS,2
TW,PLATELET COUNT INCREASED,2
TW,PNEUMONIA ASPIRATION,2
TW,POOR QUALITY SLEEP,2
TW,POST PROCEDURAL HAEMORRHAGE,2
TW,PREMATURE BABY,2
TW,PSEUDOMONAS INFECTION,2
TW,PULMONARY CONGESTION,2
TW,PULMONARY TUBERCULOSIS,2
TW,PURULENT DISCHARGE,2
TW,PUSTULAR PSORIASIS,2
TW,PYELONEPHRITIS,2
TW,RASH ERYTHEMATOUS,2
TW,RECTAL CANCER,2
TW,RED BLOOD CELL SEDIMENTATION RATE DECREASED,2
TW,RED BLOOD CELLS URINE POSITIVE,2
TW,RENAL ATROPHY,2
TW,RENAL CANCER,2
TW,RENAL CYST,2
TW,RHEUMATOID FACTOR INCREASED,2
TW,SCRATCH,2
TW,SKIN ABRASION,2
TW,SMALL INTESTINAL OBSTRUCTION,2
TW,SOMNOLENCE,2
TW,SPINAL COLUMN STENOSIS,2
TW,SPINAL CORD COMPRESSION,2
TW,SPLENOMEGALY,2
TW,SWELLING FACE,2
TW,SYNOVIAL CYST,2
TW,THROMBOCYTOPENIA,2
TW,THYROID CANCER,2
TW,TOOTH DISORDER,2
TW,TRANSIENT GLOBAL AMNESIA,2
TW,ULCER,2
TW,ULNA FRACTURE,2
TW,UNDERDOSE,2
TW,URINARY RETENTION,2
TW,UVEITIS,2
TW,VASCULITIS,2
TW,VIRAL INFECTION,2
TW,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
TW,WOUND INFECTION BACTERIAL,2
TW,WOUND INFECTION STAPHYLOCOCCAL,2
TW,ABDOMINAL HERNIA,1
TW,ABDOMINAL INFECTION,1
TW,ABDOMINAL MASS,1
TW,ABDOMINAL TENDERNESS,1
TW,ABDOMINAL WALL WOUND,1
TW,ABSCESS,1
TW,ACCIDENTAL OVERDOSE,1
TW,ACNE,1
TW,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TW,ACUTE KIDNEY INJURY,1
TW,ACUTE PULMONARY OEDEMA,1
TW,ADENOCARCINOMA GASTRIC,1
TW,ADENOMA BENIGN,1
TW,ADRENAL DISORDER,1
TW,ALPHA 1 FOETOPROTEIN INCREASED,1
TW,AMMONIA ABNORMAL,1
TW,AMNESIA,1
TW,AMPULLA OF VATER STENOSIS,1
TW,AMYLASE ABNORMAL,1
TW,ANAL HAEMORRHAGE,1
TW,ANAL SQUAMOUS CELL CARCINOMA,1
TW,ANEURYSM,1
TW,ANGINA PECTORIS,1
TW,ANGIODYSPLASIA,1
TW,ANIMAL BITE,1
TW,ANTINUCLEAR ANTIBODY POSITIVE,1
TW,ANURIA,1
TW,AORTIC ARTERIOSCLEROSIS,1
TW,AORTIC DISORDER,1
TW,AORTIC DISSECTION,1
TW,AORTIC VALVE CALCIFICATION,1
TW,ARTERIAL DISORDER,1
TW,ARTERIOVENOUS FISTULA OCCLUSION,1
TW,ARTHRITIS BACTERIAL,1
TW,ARTHRITIS INFECTIVE,1
TW,ARTHROPOD STING,1
TW,ATAXIA,1
TW,ATRIAL FIBRILLATION,1
TW,BACILLUS BACTERAEMIA,1
TW,BACTERIAL INFECTION,1
TW,BACTERIAL SEPSIS,1
TW,BAND NEUTROPHIL COUNT INCREASED,1
TW,BAND NEUTROPHIL PERCENTAGE INCREASED,1
TW,BARRETT^S OESOPHAGUS,1
TW,BENIGN BREAST NEOPLASM,1
TW,BENIGN NEOPLASM OF SPINAL CORD,1
TW,BILE DUCT STONE,1
TW,BILIARY DILATATION,1
TW,BILIRUBIN CONJUGATED INCREASED,1
TW,BLADDER DILATATION,1
TW,BLINDNESS,1
TW,BLOOD ALBUMIN ABNORMAL,1
TW,BLOOD BILIRUBIN ABNORMAL,1
TW,BLOOD CALCIUM DECREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
TW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL,1
TW,BLOOD CREATININE DECREASED,1
TW,BLOOD CULTURE POSITIVE,1
TW,BLOOD FIBRINOGEN ABNORMAL,1
TW,BLOOD IMMUNOGLOBULIN G INCREASED,1
TW,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TW,BLOOD LACTIC ACID ABNORMAL,1
TW,BLOOD OSMOLARITY ABNORMAL,1
TW,BLOOD OSMOLARITY DECREASED,1
TW,BLOOD POTASSIUM ABNORMAL,1
TW,BLOOD POTASSIUM DECREASED,1
TW,BLOOD PRESSURE FLUCTUATION,1
TW,BLOOD PRESSURE SYSTOLIC INCREASED,1
TW,BODY TEMPERATURE INCREASED,1
TW,BONE EROSION,1
TW,BRAIN NEOPLASM MALIGNANT,1
TW,BRAIN STEM HAEMORRHAGE,1
TW,BREAST CALCIFICATIONS,1
TW,BREAST CANCER STAGE I,1
TW,BREAST FIBROMA,1
TW,BREATH SOUNDS ABNORMAL,1
TW,BRONCHIAL HYPERREACTIVITY,1
TW,BUTTERFLY RASH,1
TW,C-REACTIVE PROTEIN ABNORMAL,1
TW,C-REACTIVE PROTEIN DECREASED,1
TW,CAESAREAN SECTION,1
TW,CALCULUS URETERIC,1
TW,CARBON DIOXIDE INCREASED,1
TW,CARCINOEMBRYONIC ANTIGEN INCREASED,1
TW,CARCINOMA IN SITU,1
TW,CARDIAC DISCOMFORT,1
TW,CARDIAC DISORDER,1
TW,CARDIAC HYPERTROPHY,1
TW,CARDIOGENIC SHOCK,1
TW,CARDIOMYOPATHY,1
TW,CARDIOVASCULAR DISORDER,1
TW,CARPAL TUNNEL SYNDROME,1
TW,CENTRAL NERVOUS SYSTEM INFECTION,1
TW,CEREBRAL ANEURYSM PERFORATION,1
TW,CEREBRAL ATROPHY,1
TW,CEREBRAL ISCHAEMIA,1
TW,CEREBRAL THROMBOSIS,1
TW,CERVICAL VERTEBRAL FRACTURE,1
TW,CERVIX CARCINOMA STAGE 0,1
TW,CHEST INJURY,1
TW,CHOLANGIOCARCINOMA,1
TW,CHOLECYSTITIS ACUTE,1
TW,CHOLERA,1
TW,CHRONIC RESPIRATORY DISEASE,1
TW,CLAVICLE FRACTURE,1
TW,COLD SWEAT,1
TW,COLITIS ULCERATIVE,1
TW,COLON CANCER STAGE 0,1
TW,COMPARTMENT SYNDROME,1
TW,COMPLEMENT FACTOR C4 INCREASED,1
TW,COMPLEX PARTIAL SEIZURES,1
TW,COMPLICATION ASSOCIATED WITH DEVICE,1
TW,CONCUSSION,1
TW,CRANIOPHARYNGIOMA,1
TW,CUTANEOUS TUBERCULOSIS,1
TW,CYST,1
TW,CYST RUPTURE,1
TW,CYSTIC LYMPHANGIOMA,1
TW,CYSTITIS HAEMORRHAGIC,1
TW,CYTOMEGALOVIRUS INFECTION,1
TW,DAYDREAMING,1
TW,DEAFNESS,1
TW,DEEP VEIN THROMBOSIS,1
TW,DELIRIUM,1
TW,DEMENTIA,1
TW,DEMYELINATION,1
TW,DENGUE FEVER,1
TW,DEPRESSION,1
TW,DERMATITIS ALLERGIC,1
TW,DERMATITIS CONTACT,1
TW,DERMATITIS EXFOLIATIVE,1
TW,DEVICE BREAKAGE,1
TW,DIABETES MELLITUS,1
TW,DIABETIC KETOACIDOSIS,1
TW,DIFFUSE LARGE B-CELL LYMPHOMA,1
TW,DIPLEGIA,1
TW,DIVERTICULAR PERFORATION,1
TW,DRESSLER^S SYNDROME,1
TW,DRUG DOSE OMISSION,1
TW,DRUG RESISTANCE,1
TW,DUODENAL NEOPLASM,1
TW,DUODENAL ULCER HAEMORRHAGE,1
TW,DYSPHONIA,1
TW,DYSSTASIA,1
TW,DYSTROPHIC CALCIFICATION,1
TW,EAR INFECTION,1
TW,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
TW,END STAGE RENAL DISEASE,1
TW,ENDOMETRIAL CANCER,1
TW,ENDOMETRIAL CANCER RECURRENT,1
TW,ENTERITIS,1
TW,ENTERITIS INFECTIOUS,1
TW,EPSTEIN-BARR VIRUS INFECTION,1
TW,EPSTEIN-BARR VIRUS TEST POSITIVE,1
TW,ESCHERICHIA INFECTION,1
TW,EXCORIATION,1
TW,EXTRA DOSE ADMINISTERED,1
TW,EXTRADURAL HAEMATOMA,1
TW,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
TW,EXTRAPULMONARY TUBERCULOSIS,1
TW,EYE PAIN,1
TW,EYE SWELLING,1
TW,FACE INJURY,1
TW,FAECES HARD,1
TW,FALLOPIAN TUBE NEOPLASM,1
TW,FEAR OF INJECTION,1
TW,FEELING COLD,1
TW,FIBRIN D DIMER INCREASED,1
TW,FIBROADENOMA OF BREAST,1
TW,FIBROUS HISTIOCYTOMA,1
TW,FISTULA DISCHARGE,1
TW,FLATULENCE,1
TW,FOOD ALLERGY,1
TW,FOREARM FRACTURE,1
TW,FUNCTIONAL GASTROINTESTINAL DISORDER,1
TW,FUNGAL INFECTION,1
TW,GALACTOSTASIS,1
TW,GALLBLADDER CANCER,1
TW,GALLBLADDER ENLARGEMENT,1
TW,GALLBLADDER NECROSIS,1
TW,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
TW,GASTRIC BYPASS,1
TW,GASTRIC ULCER HAEMORRHAGE,1
TW,GASTRODUODENAL ULCER,1
TW,GASTROENTERITIS SALMONELLA,1
TW,GASTROINTESTINAL DISORDER,1
TW,GASTROINTESTINAL MUCOSAL DISORDER,1
TW,GASTROINTESTINAL NEOPLASM,1
TW,GASTROINTESTINAL OEDEMA,1
TW,GENERAL PHYSICAL HEALTH DETERIORATION,1
TW,GENITAL NEOPLASM MALIGNANT FEMALE,1
TW,GINGIVAL BLEEDING,1
TW,GINGIVAL CANCER,1
TW,GINGIVAL INFLAMMATION,1
TW,GINGIVAL SWELLING,1
TW,GINGIVAL ULCERATION,1
TW,GLOMERULAR FILTRATION RATE INCREASED,1
TW,GLOMERULONEPHRITIS CHRONIC,1
TW,GLOMERULOSCLEROSIS,1
TW,GOUTY ARTHRITIS,1
TW,GRANULOCYTOPENIA,1
TW,GRANULOMA,1
TW,HAEMANGIOMA OF LIVER,1
TW,HAEMATOCRIT ABNORMAL,1
TW,HAEMOGLOBIN ABNORMAL,1
TW,HAEMOLYTIC ANAEMIA,1
TW,HAEMORRHAGE SUBCUTANEOUS,1
TW,HAEMORRHAGIC OVARIAN CYST,1
TW,HAEMOTHORAX,1
TW,HAND DEFORMITY,1
TW,HAPTOGLOBIN DECREASED,1
TW,HEART RATE INCREASED,1
TW,HEART RATE IRREGULAR,1
TW,HEART VALVE INCOMPETENCE,1
TW,HEAT ILLNESS,1
TW,HELICOBACTER INFECTION,1
TW,HEMIPARESIS,1
TW,HEMIPLEGIA,1
TW,HEPATIC CALCIFICATION,1
TW,HEPATIC CYST,1
TW,HEPATIC FUNCTION ABNORMAL,1
TW,HEPATIC HAEMORRHAGE,1
TW,HEPATIC LESION,1
TW,HEPATITIS B DNA ASSAY POSITIVE,1
TW,HEPATITIS B REACTIVATION,1
TW,HEPATITIS B VIRUS TEST POSITIVE,1
TW,HEPATITIS C,1
TW,HEPATITIS C RNA,1
TW,HEPATITIS C RNA INCREASED,1
TW,HEPATITIS FULMINANT,1
TW,HERNIA,1
TW,HERPES SIMPLEX ENCEPHALITIS,1
TW,HERPES VIRUS INFECTION,1
TW,HISTIOCYTIC NECROTISING LYMPHADENITIS,1
TW,HLA MARKER STUDY POSITIVE,1
TW,HODGKIN^S DISEASE STAGE II,1
TW,HUMAN POLYOMAVIRUS INFECTION,1
TW,HYPERCALCAEMIA,1
TW,HYPERKALAEMIA,1
TW,HYPERLIPIDAEMIA,1
TW,HYPEROSMOLAR STATE,1
TW,HYPERPYREXIA,1
TW,HYPERSOMNIA,1
TW,HYPERTHYROIDISM,1
TW,HYPOACUSIS,1
TW,HYPOCALCAEMIA,1
TW,HYPOGLYCAEMIC COMA,1
TW,HYPOPHAGIA,1
TW,HYPOPHARYNGEAL CANCER,1
TW,HYPOPHARYNGEAL CANCER STAGE IV,1
TW,HYPOTHYROIDISM,1
TW,IDIOPATHIC PNEUMONIA SYNDROME,1
TW,IGA NEPHROPATHY,1
TW,ILEUS,1
TW,IMMUNODEFICIENCY,1
TW,IMMUNOSUPPRESSION,1
TW,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
TW,INFECTIOUS PLEURAL EFFUSION,1
TW,INFLAMMATION OF WOUND,1
TW,INFLUENZA A VIRUS TEST POSITIVE,1
TW,INFLUENZA B VIRUS TEST POSITIVE,1
TW,INFLUENZA VIRUS TEST POSITIVE,1
TW,INJECTION SITE ERYTHEMA,1
TW,INJECTION SITE HAEMORRHAGE,1
TW,INJECTION SITE HYPERSENSITIVITY,1
TW,INJECTION SITE PRURITUS,1
TW,INJECTION SITE SWELLING,1
TW,INTENTIONAL PRODUCT USE ISSUE,1
TW,INTERFERON GAMMA RELEASE ASSAY POSITIVE,1
TW,INTERMITTENT CLAUDICATION,1
TW,INTERVERTEBRAL DISC COMPRESSION,1
TW,INTERVERTEBRAL DISC DEGENERATION,1
TW,INTERVERTEBRAL DISC DISORDER,1
TW,INTESTINAL ISCHAEMIA,1
TW,INTESTINAL PERFORATION,1
TW,INTESTINAL POLYP,1
TW,INTRACRANIAL ANEURYSM,1
TW,INTRAOCULAR PRESSURE INCREASED,1
TW,IRIDOCYCLITIS,1
TW,ISCHAEMIC CARDIOMYOPATHY,1
TW,JAW FRACTURE,1
TW,JOINT ABSCESS,1
TW,JOINT DESTRUCTION,1
TW,KLEBSIELLA SEPSIS,1
TW,LATENT TUBERCULOSIS,1
TW,LENS DISLOCATION,1
TW,LEUKOPENIA,1
TW,LIMB CRUSHING INJURY,1
TW,LIPOMA,1
TW,LIPOSARCOMA,1
TW,LIVER FUNCTION TEST INCREASED,1
TW,LOW BIRTH WEIGHT BABY,1
TW,LOW DENSITY LIPOPROTEIN INCREASED,1
TW,LOWER RESPIRATORY TRACT INFECTION,1
TW,LOWER RESPIRATORY TRACT INFLAMMATION,1
TW,LUNG CANCER METASTATIC,1
TW,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,1
TW,LUNG NEOPLASM,1
TW,LYMPHOID TISSUE HYPERPLASIA,1
TW,MACULE,1
TW,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
TW,MEAN CELL HAEMOGLOBIN DECREASED,1
TW,MEAN CELL VOLUME DECREASED,1
TW,MENIERE^S DISEASE,1
TW,MENINGITIS TUBERCULOUS,1
TW,MENORRHAGIA,1
TW,METABOLIC ACIDOSIS,1
TW,METASTASES TO BONE,1
TW,METASTASES TO CENTRAL NERVOUS SYSTEM,1
TW,METASTASES TO LIVER,1
TW,METASTASES TO LUNG,1
TW,METASTASES TO LYMPH NODES,1
TW,METASTASES TO PLEURA,1
TW,METASTATIC NEOPLASM,1
TW,MICTURITION DISORDER,1
TW,MITRAL VALVE PROLAPSE,1
TW,MOBILITY DECREASED,1
TW,MONOCYTE COUNT ABNORMAL,1
TW,MULTIPLE SYSTEM ATROPHY,1
TW,MUSCLE SPASMS,1
TW,MUSCULOSKELETAL DISORDER,1
TW,MUSCULOSKELETAL STIFFNESS,1
TW,MYELOPATHY,1
TW,MYOSITIS,1
TW,NAIL DYSTROPHY,1
TW,NASAL OBSTRUCTION,1
TW,NASOPHARYNGEAL CANCER,1
TW,NECK INJURY,1
TW,NECK MASS,1
TW,NECK PAIN,1
TW,NECROTISING FASCIITIS,1
TW,NEOPLASM PROSTATE,1
TW,NEPHROPATHY,1
TW,NEURODEGENERATIVE DISORDER,1
TW,NEUTROPHIL PERCENTAGE ABNORMAL,1
TW,NON-SMALL CELL LUNG CANCER,1
TW,NONINFECTIVE GINGIVITIS,1
TW,NOSOCOMIAL INFECTION,1
TW,OBESITY,1
TW,OBSTRUCTIVE UROPATHY,1
TW,OCCULT BLOOD,1
TW,OCCULT BLOOD POSITIVE,1
TW,OCCUPATIONAL EXPOSURE TO TOXIC AGENT,1
TW,OCULAR HYPERAEMIA,1
TW,OEDEMATOUS KIDNEY,1
TW,OESOPHAGEAL CANCER METASTATIC,1
TW,OESOPHAGEAL CANDIDIASIS,1
TW,OESOPHAGEAL CARCINOMA,1
TW,OESOPHAGEAL DISORDER,1
TW,OESOPHAGEAL PAPILLOMA,1
TW,OESOPHAGEAL STENOSIS,1
TW,ORAL CANDIDIASIS,1
TW,ORAL NEOPLASM,1
TW,OSTEOMYELITIS,1
TW,OSTEOPENIA,1
TW,OVARIAN MASS,1
TW,OVERDOSE,1
TW,OXYGEN CONSUMPTION DECREASED,1
TW,OXYGEN SATURATION DECREASED,1
TW,PAIN IN JAW,1
TW,PALLOR,1
TW,PANCREATIC CARCINOMA,1
TW,PANCREATIC CYST,1
TW,PANCREATIC NEOPLASM,1
TW,PANCREATITIS RELAPSING,1
TW,PAPILLARY THYROID CANCER,1
TW,PAPULE,1
TW,PARATHYROID GLAND ENLARGEMENT,1
TW,PAROTID GLAND ENLARGEMENT,1
TW,PAROVARIAN CYST,1
TW,PATELLA FRACTURE,1
TW,PCO2 DECREASED,1
TW,PENILE SQUAMOUS CELL CARCINOMA,1
TW,PERIARTHRITIS,1
TW,PERITONEAL HAEMORRHAGE,1
TW,PHARYNGEAL OEDEMA,1
TW,PHARYNGITIS,1
TW,PITUITARY HAEMORRHAGE,1
TW,PITUITARY TUMOUR,1
TW,PLACENTA PRAEVIA,1
TW,PNEUMOCYSTIS JIROVECII INFECTION,1
TW,PNEUMOMEDIASTINUM,1
TW,PNEUMONIA ACINETOBACTER,1
TW,PNEUMONIA BACTERIAL,1
TW,PNEUMONIA CRYPTOCOCCAL,1
TW,PNEUMONIA HAEMOPHILUS,1
TW,PNEUMONIA INFLUENZAL,1
TW,PNEUMONIA STAPHYLOCOCCAL,1
TW,PNEUMONITIS,1
TW,PNEUMOTHORAX,1
TW,PO2 INCREASED,1
TW,POLYNEUROPATHY,1
TW,POLYP,1
TW,PRECANCEROUS MUCOSAL LESION,1
TW,PREMATURE LABOUR,1
TW,PREMATURE RUPTURE OF MEMBRANES,1
TW,PRODUCT QUALITY ISSUE,1
TW,PRODUCT USE IN UNAPPROVED INDICATION,1
TW,PROSTATIC DISORDER,1
TW,PROTEIN URINE PRESENT,1
TW,PSYCHOTIC DISORDER,1
TW,PUBIS FRACTURE,1
TW,PULSELESS ELECTRICAL ACTIVITY,1
TW,RADICULOPATHY,1
TW,RADIUS FRACTURE,1
TW,RASH PUSTULAR,1
TW,RECTAL ADENOCARCINOMA,1
TW,RECTAL POLYP,1
TW,RED BLOOD CELL COUNT ABNORMAL,1
TW,RED BLOOD CELLS URINE,1
TW,RED CELL DISTRIBUTION WIDTH ABNORMAL,1
TW,RENAL FAILURE CHRONIC,1
TW,RENAL FUNCTION TEST ABNORMAL,1
TW,RENAL NEOPLASM,1
TW,RENAL PAIN,1
TW,RESPIRATORY DISTRESS,1
TW,RETINAL DETACHMENT,1
TW,SALIVARY GLAND DISORDER,1
TW,SALIVARY GLAND PAIN,1
TW,SALMONELLOSIS,1
TW,SARCOMA OF SKIN,1
TW,SCOLIOSIS,1
TW,SCROTAL OEDEMA,1
TW,SECOND PRIMARY MALIGNANCY,1
TW,SENSITIVITY TO WEATHER CHANGE,1
TW,SINUSITIS,1
TW,SJOGREN^S SYNDROME,1
TW,SKIN DISORDER,1
TW,SKIN INFECTION,1
TW,SKIN INJURY,1
TW,SKIN MASS,1
TW,SKIN PLAQUE,1
TW,SLEEP APNOEA SYNDROME,1
TW,SLEEP DISORDER,1
TW,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
TW,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
TW,SPINAL CORD DISORDER,1
TW,SPINAL CORD INJURY CERVICAL,1
TW,SPINAL CORD NEOPLASM,1
TW,SPINAL DEFORMITY,1
TW,SPINAL DISORDER,1
TW,SPINAL FRACTURE,1
TW,SPUTUM CULTURE POSITIVE,1
TW,SQUAMOUS CELL CARCINOMA,1
TW,STAPHYLOCOCCUS TEST POSITIVE,1
TW,STERNAL FRACTURE,1
TW,STRESS,1
TW,STRESS FRACTURE,1
TW,SUBCUTANEOUS EMPHYSEMA,1
TW,SUBDURAL HAEMATOMA,1
TW,SUDDEN DEATH,1
TW,SUICIDE ATTEMPT,1
TW,SUPERINFECTION,1
TW,SYNOVIAL FLUID WHITE BLOOD CELLS POSITIVE,1
TW,T-CELL LYMPHOMA,1
TW,TACHYCARDIA,1
TW,TENDERNESS,1
TW,TENDON INJURY,1
TW,TENDON RUPTURE,1
TW,TENOSYNOVITIS,1
TW,THERAPEUTIC RESPONSE DECREASED,1
TW,THROAT CANCER,1
TW,THROAT IRRITATION,1
TW,THROMBOTIC MICROANGIOPATHY,1
TW,THYROID ADENOMA,1
TW,THYROID NEOPLASM,1
TW,TONSIL CANCER,1
TW,TORSADE DE POINTES,1
TW,TOXIC EPIDERMAL NECROLYSIS,1
TW,TUBULOINTERSTITIAL NEPHRITIS,1
TW,TUMOUR HAEMORRHAGE,1
TW,UPPER RESPIRATORY TRACT INFECTION,1
TW,UPPER-AIRWAY COUGH SYNDROME,1
TW,URETERAL NEOPLASM,1
TW,URETERIC OBSTRUCTION,1
TW,URETERIC STENOSIS,1
TW,URETHRAL ABSCESS,1
TW,URETHRAL OBSTRUCTION,1
TW,URINARY INCONTINENCE,1
TW,URINARY SEDIMENT PRESENT,1
TW,URINARY TRACT DISORDER,1
TW,URINE ABNORMALITY,1
TW,URINE LEUKOCYTE ESTERASE POSITIVE,1
TW,URINE OSMOLARITY DECREASED,1
TW,URINE SODIUM ABNORMAL,1
TW,URTICARIA,1
TW,UTERINE CANCER,1
TW,UTERINE CYST,1
TW,UTERINE HAEMORRHAGE,1
TW,UTEROVAGINAL PROLAPSE,1
TW,VAGINAL CELLULITIS,1
TW,VARICOSE VEIN,1
TW,VASCULAR CALCIFICATION,1
TW,VASCULAR OCCLUSION,1
TW,VERTIGO POSITIONAL,1
TW,VISUAL IMPAIRMENT,1
TW,VITH NERVE PARALYSIS,1
TW,WEIGHT INCREASED,1
TW,WOUND HAEMORRHAGE,1
TW,WOUND SECRETION,1
TW,XEROPHTHALMIA,1
TH,INFECTION,4
TH,CONDITION AGGRAVATED,3
TH,COUGH,2
TH,DYSPNOEA,2
TH,MYOCARDIAL INFARCTION,2
TH,PNEUMONIA,2
TH,SKIN INFECTION,2
TH,SUBCUTANEOUS ABSCESS,2
TH,TUBERCULOSIS,2
TH,URINARY TRACT INFECTION,2
TH,ACUTE MYOCARDIAL INFARCTION,1
TH,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TH,ACUTE RESPIRATORY FAILURE,1
TH,ALANINE AMINOTRANSFERASE INCREASED,1
TH,ANIMAL BITE,1
TH,ARTHRITIS BACTERIAL,1
TH,ASPARTATE AMINOTRANSFERASE INCREASED,1
TH,CARDIAC FAILURE,1
TH,DECREASED APPETITE,1
TH,DRUG INEFFECTIVE,1
TH,EAR SWELLING,1
TH,EOSINOPHILIA,1
TH,EOSINOPHILIC PNEUMONIA,1
TH,EXTERNAL EAR DISORDER,1
TH,EYE INFECTION FUNGAL,1
TH,GASTROENTERITIS,1
TH,HEPATIC STEATOSIS,1
TH,HEPATITIS B,1
TH,HISTIOCYTOSIS HAEMATOPHAGIC,1
TH,INFECTION PARASITIC,1
TH,INFLUENZA,1
TH,LUNG NEOPLASM MALIGNANT,1
TH,MYCOBACTERIAL INFECTION,1
TH,NEOPLASM MALIGNANT,1
TH,PLEURAL EFFUSION,1
TH,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TH,PNEUMONIA ASPIRATION,1
TH,POLYARTHRITIS,1
TH,PSORIASIS,1
TH,PULMONARY OEDEMA,1
TH,PUNCTURE SITE DISCHARGE,1
TH,PYREXIA,1
TH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
TH,SARCOIDOSIS,1
TH,SCROTAL DISORDER,1
TH,SCROTAL ERYTHEMA,1
TH,SEROMA,1
TH,SIALOADENITIS,1
TH,SINUSITIS,1
TH,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TH,TUBERCULOSIS GASTROINTESTINAL,1
TH,WEIGHT DECREASED,1
TT,PULMONARY EMBOLISM,1
TT,STAPHYLOCOCCAL INFECTION,1
TN,DYSPNOEA,4
TN,BREAST CANCER,3
TN,HYPERSENSITIVITY,3
TN,BRONCHITIS,2
TN,INFLUENZA,2
TN,TOXIC SKIN ERUPTION,2
TN,ABDOMINAL PAIN,1
TN,ACUTE PULMONARY OEDEMA,1
TN,ADENOCARCINOMA GASTRIC,1
TN,ALOPECIA,1
TN,ALVEOLITIS ALLERGIC,1
TN,ANGIOEDEMA,1
TN,ARTHROPATHY,1
TN,ATAXIA,1
TN,BLINDNESS,1
TN,BLOOD GLUCOSE FLUCTUATION,1
TN,BLOOD IMMUNOGLOBULIN E INCREASED,1
TN,BLOOD IMMUNOGLOBULIN G INCREASED,1
TN,BRONCHIECTASIS,1
TN,C-REACTIVE PROTEIN INCREASED,1
TN,CELL DEATH,1
TN,CHEST PAIN,1
TN,CONDITION AGGRAVATED,1
TN,CONFUSIONAL STATE,1
TN,CONGENITAL INTESTINAL MALFORMATION,1
TN,COUGH,1
TN,CROHN^S DISEASE,1
TN,CUTANEOUS LEISHMANIASIS,1
TN,DEATH,1
TN,DELUSION,1
TN,DIZZINESS,1
TN,EXPOSURE VIA FATHER,1
TN,FALL,1
TN,FOETAL GROWTH RESTRICTION,1
TN,FUNGAL INFECTION,1
TN,GASTROENTERITIS,1
TN,HALLUCINATION,1
TN,HEPATOMEGALY,1
TN,HYPERPHAGIA,1
TN,JAUNDICE,1
TN,KNEE ARTHROPLASTY,1
TN,LEFT VENTRICULAR FAILURE,1
TN,LUNG DISORDER,1
TN,LUNG INFECTION,1
TN,LYMPHOCYTOSIS,1
TN,MADAROSIS,1
TN,MENINGITIS,1
TN,MENTAL DISORDER,1
TN,METASTASES TO LIVER,1
TN,MICROALBUMINURIA,1
TN,MICTURITION URGENCY,1
TN,MOTION SICKNESS,1
TN,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
TN,MYDRIASIS,1
TN,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
TN,OEDEMA PERIPHERAL,1
TN,PANCREATITIS,1
TN,PARAESTHESIA,1
TN,PARAESTHESIA ORAL,1
TN,PARESIS,1
TN,PHLEBITIS,1
TN,POLYNEUROPATHY,1
TN,PREMATURE BABY,1
TN,PRURITUS,1
TN,PSORIASIS,1
TN,PSORIATIC ARTHROPATHY,1
TN,RASH,1
TN,RASH ERYTHEMATOUS,1
TN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
TN,RENAL CANCER,1
TN,RETINOPATHY,1
TN,RHEUMATOID ARTHRITIS,1
TN,SCIATICA,1
TN,SENSORY DISTURBANCE,1
TN,SMALL CELL CARCINOMA,1
TN,SMALL CELL LUNG CANCER,1
TN,THERAPEUTIC RESPONSE UNEXPECTED,1
TN,TINNITUS,1
TN,TUBERCULOSIS,1
TN,URTICARIA,1
TN,VISUAL ACUITY REDUCED,1
TN,WEIGHT INCREASED,1
TR,PAIN,151
TR,INFLUENZA,134
TR,INJECTION SITE PAIN,103
TR,DRUG INEFFECTIVE,78
TR,INJECTION SITE SWELLING,75
TR,ARTHRALGIA,63
TR,INJECTION SITE ERYTHEMA,58
TR,CONDITION AGGRAVATED,57
TR,ASTHENIA,52
TR,INJECTION SITE PRURITUS,51
TR,PAIN IN EXTREMITY,44
TR,GAIT DISTURBANCE,43
TR,COUGH,40
TR,BACK PAIN,38
TR,ARTHROPATHY,37
TR,PYREXIA,35
TR,URINARY TRACT INFECTION,34
TR,DYSPNOEA,33
TR,FALL,33
TR,JOINT SWELLING,33
TR,NAUSEA,33
TR,INJECTION SITE BRUISING,32
TR,NEPHROLITHIASIS,31
TR,TOOTH INFECTION,31
TR,PNEUMONIA,28
TR,FEAR,27
TR,MUSCLE SPASMS,27
TR,WEIGHT INCREASED,26
TR,INJECTION SITE HAEMORRHAGE,25
TR,UVEITIS,25
TR,HYPERSENSITIVITY,24
TR,LOCAL SWELLING,24
TR,MUSCULOSKELETAL STIFFNESS,23
TR,PHARYNGITIS,23
TR,BLOOD TEST ABNORMAL,22
TR,LUNG INFECTION,22
TR,PERIPHERAL SWELLING,22
TR,ANKYLOSING SPONDYLITIS,21
TR,FATIGUE,21
TR,MYOCARDIAL INFARCTION,21
TR,UPPER RESPIRATORY TRACT INFECTION,21
TR,BLOOD PRESSURE INCREASED,20
TR,DIARRHOEA,20
TR,HYPERTENSION,20
TR,PRURITUS,20
TR,RHEUMATOID ARTHRITIS,20
TR,HEPATIC ENZYME INCREASED,19
TR,BRONCHITIS,18
TR,HYPOAESTHESIA,18
TR,INTERVERTEBRAL DISC PROTRUSION,18
TR,TUBERCULOSIS,18
TR,WEIGHT DECREASED,18
TR,WOUND,18
TR,NASOPHARYNGITIS,17
TR,C-REACTIVE PROTEIN INCREASED,16
TR,HEADACHE,16
TR,SWELLING,16
TR,ERYTHEMA,15
TR,LUNG DISORDER,15
TR,VERTIGO,15
TR,VOMITING,15
TR,CONTUSION,14
TR,INFLAMMATION,14
TR,PSORIASIS,14
TR,ABDOMINAL PAIN,13
TR,ANAEMIA,13
TR,ASTHMA,13
TR,INFECTION,13
TR,PRURITUS GENERALISED,13
TR,STRESS,13
TR,MOBILITY DECREASED,12
TR,OROPHARYNGEAL PAIN,12
TR,RASH,12
TR,ROAD TRAFFIC ACCIDENT,12
TR,UPPER LIMB FRACTURE,12
TR,ABDOMINAL PAIN UPPER,11
TR,DEATH,11
TR,MEMORY IMPAIRMENT,11
TR,MENTAL DISORDER,11
TR,OEDEMA PERIPHERAL,11
TR,PULMONARY MASS,11
TR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,11
TR,RENAL FAILURE,11
TR,TOOTHACHE,11
TR,CHOLELITHIASIS,10
TR,DECREASED APPETITE,10
TR,DISEASE PROGRESSION,10
TR,INJECTION SITE VESICLES,10
TR,LOSS OF CONSCIOUSNESS,10
TR,TOOTH ABSCESS,10
TR,ABDOMINAL DISTENSION,9
TR,ABORTION,9
TR,BONE DISORDER,9
TR,BURNING SENSATION,9
TR,CATARACT,9
TR,CYST,9
TR,INJECTION SITE REACTION,9
TR,MENSTRUATION IRREGULAR,9
TR,NECK PAIN,9
TR,ORAL HERPES,9
TR,OSTEOPOROSIS,9
TR,PULMONARY OEDEMA,9
TR,TREMOR,9
TR,VASCULAR OCCLUSION,9
TR,ABASIA,8
TR,ALOPECIA,8
TR,BLOOD GLUCOSE INCREASED,8
TR,BONE PAIN,8
TR,DENTAL CARIES,8
TR,HYPERHIDROSIS,8
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,8
TR,INJECTION SITE INDURATION,8
TR,JOINT DISLOCATION,8
TR,LOWER LIMB FRACTURE,8
TR,LYMPHADENOPATHY,8
TR,OEDEMA,8
TR,SINUSITIS,8
TR,SYNCOPE,8
TR,TOOTH DISORDER,8
TR,ANXIETY,7
TR,BLISTER,7
TR,CARDIAC FAILURE,7
TR,DISEASE RECURRENCE,7
TR,DIZZINESS,7
TR,EMBOLISM,7
TR,FEELING HOT,7
TR,GENERALISED ERYTHEMA,7
TR,HAEMORRHAGE,7
TR,HIP FRACTURE,7
TR,IMMUNE SYSTEM DISORDER,7
TR,JOINT STIFFNESS,7
TR,MOVEMENT DISORDER,7
TR,MUSCULOSKELETAL PAIN,7
TR,NERVOUSNESS,7
TR,OSTEOLYSIS,7
TR,PRODUCTIVE COUGH,7
TR,WALKING DISABILITY,7
TR,ACNE,6
TR,BLADDER CANCER,6
TR,BLOOD UREA INCREASED,6
TR,CARDIAC DISORDER,6
TR,CEREBRAL HAEMORRHAGE,6
TR,DIABETES MELLITUS,6
TR,DRUG EFFECT INCOMPLETE,6
TR,FEELING ABNORMAL,6
TR,FOOT FRACTURE,6
TR,GASTRIC HAEMORRHAGE,6
TR,HEPATIC STEATOSIS,6
TR,IMMUNODEFICIENCY,6
TR,INJECTION SITE WARMTH,6
TR,LOCALISED INFECTION,6
TR,MUSCULAR WEAKNESS,6
TR,NEOPLASM MALIGNANT,6
TR,NODULE,6
TR,RENAL DISORDER,6
TR,RENAL PAIN,6
TR,RESTLESSNESS,6
TR,SKIN DISORDER,6
TR,SOMNOLENCE,6
TR,SWELLING FACE,6
TR,ABDOMINAL DISCOMFORT,5
TR,AMNESIA,5
TR,ANGINA PECTORIS,5
TR,BALANCE DISORDER,5
TR,CHEST PAIN,5
TR,DECREASED IMMUNE RESPONSIVENESS,5
TR,DEPRESSED MOOD,5
TR,DIPLOPIA,5
TR,DRUG DEPENDENCE,5
TR,DYSPHAGIA,5
TR,DYSPHONIA,5
TR,FEAR OF INJECTION,5
TR,FRACTURE,5
TR,INSOMNIA,5
TR,NERVE COMPRESSION,5
TR,OVARIAN CYST,5
TR,PNEUMONITIS,5
TR,PSORIATIC ARTHROPATHY,5
TR,RENAL CYST,5
TR,SKIN WOUND,5
TR,WOUND INFECTION,5
TR,XEROPHTHALMIA,5
TR,ANAPHYLACTIC REACTION,4
TR,ANGIOEDEMA,4
TR,APHTHOUS STOMATITIS,4
TR,ARRHYTHMIA,4
TR,ARTHRITIS,4
TR,BLINDNESS,4
TR,BLOOD CHOLESTEROL INCREASED,4
TR,BLOOD COUNT ABNORMAL,4
TR,BLOOD PRESSURE DECREASED,4
TR,BONE DEFORMITY,4
TR,CEREBROVASCULAR ACCIDENT,4
TR,DEEP VEIN THROMBOSIS,4
TR,DERMAL CYST,4
TR,DRY SKIN,4
TR,DYSSTASIA,4
TR,EYE DISORDER,4
TR,FAMILIAL MEDITERRANEAN FEVER,4
TR,FOOT DEFORMITY,4
TR,GALLBLADDER DISORDER,4
TR,HAEMATURIA,4
TR,HAEMOPTYSIS,4
TR,HAEMORRHOIDS,4
TR,HEMIPLEGIA,4
TR,HEPATIC ENZYME ABNORMAL,4
TR,HEPATOMEGALY,4
TR,HYPOTENSION,4
TR,IMMUNOSUPPRESSION,4
TR,INCREASED APPETITE,4
TR,INFLAMMATORY MARKER INCREASED,4
TR,INFLUENZA LIKE ILLNESS,4
TR,INTRACRANIAL PRESSURE INCREASED,4
TR,IRON DEFICIENCY,4
TR,JAUNDICE,4
TR,KIDNEY INFECTION,4
TR,KNEE DEFORMITY,4
TR,LIMB DEFORMITY,4
TR,LUNG NEOPLASM MALIGNANT,4
TR,MALAISE,4
TR,MATERNAL EXPOSURE DURING PREGNANCY,4
TR,MENINGITIS TUBERCULOUS,4
TR,PHARYNGEAL OEDEMA,4
TR,PRODUCT QUALITY ISSUE,4
TR,PRODUCT USE ISSUE,4
TR,PROTEINURIA,4
TR,PULMONARY EMBOLISM,4
TR,RECTAL HAEMORRHAGE,4
TR,RENAL IMPAIRMENT,4
TR,RHEUMATIC DISORDER,4
TR,RHINORRHOEA,4
TR,SECRETION DISCHARGE,4
TR,SKIN EXFOLIATION,4
TR,TACHYCARDIA,4
TR,TENDON RUPTURE,4
TR,THERAPEUTIC RESPONSE UNEXPECTED,4
TR,THROAT IRRITATION,4
TR,TINNITUS,4
TR,VISION BLURRED,4
TR,ABSCESS,3
TR,ACCIDENT AT HOME,3
TR,APPENDICITIS,3
TR,BLOOD CREATININE INCREASED,3
TR,BLOOD URINE PRESENT,3
TR,BONE MARROW FAILURE,3
TR,BOREDOM,3
TR,BREAST MASS,3
TR,CARDIAC VALVE DISEASE,3
TR,CARDIOMEGALY,3
TR,CARDIOVASCULAR DISORDER,3
TR,CHEST DISCOMFORT,3
TR,CHONDROPATHY,3
TR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
TR,COELIAC DISEASE,3
TR,CROHN^S DISEASE,3
TR,DEAFNESS,3
TR,DEPRESSION,3
TR,EAR DISORDER,3
TR,EAR INFECTION,3
TR,EAR PAIN,3
TR,EAR SWELLING,3
TR,EYE INFECTION,3
TR,FEELING COLD,3
TR,FLATULENCE,3
TR,FUNGAL SKIN INFECTION,3
TR,GASTRIC ULCER,3
TR,GASTROENTERITIS,3
TR,GASTROINTESTINAL DISORDER,3
TR,GASTROINTESTINAL HAEMORRHAGE,3
TR,GASTROINTESTINAL INFECTION,3
TR,GENERALISED OEDEMA,3
TR,GROIN PAIN,3
TR,HAEMATEMESIS,3
TR,HEPATIC FAILURE,3
TR,HEPATITIS C,3
TR,HYPOGLYCAEMIA,3
TR,HYPOKINESIA,3
TR,INFECTION SUSCEPTIBILITY INCREASED,3
TR,INGUINAL HERNIA,3
TR,INJECTION SITE HYPERSENSITIVITY,3
TR,INTENTIONAL PRODUCT MISUSE,3
TR,INTESTINAL POLYP,3
TR,IRIDOCYCLITIS,3
TR,JOINT RANGE OF MOTION DECREASED,3
TR,LEIOMYOMA,3
TR,LEUKAEMIA,3
TR,LEUKOPENIA,3
TR,LIMB DISCOMFORT,3
TR,LIVER DISORDER,3
TR,LIVER FUNCTION TEST ABNORMAL,3
TR,LOWER RESPIRATORY TRACT INFECTION,3
TR,LUNG ADENOCARCINOMA,3
TR,MULTIPLE SCLEROSIS,3
TR,MUSCLE STRAIN,3
TR,MUSCULOSKELETAL DISORDER,3
TR,NASAL SEPTUM DEVIATION,3
TR,OCULAR HYPERAEMIA,3
TR,OLIGOHYDRAMNIOS,3
TR,OTITIS MEDIA,3
TR,PALPITATIONS,3
TR,PAPILLARY THYROID CANCER,3
TR,PARAESTHESIA,3
TR,PARALYSIS,3
TR,PARKINSON^S DISEASE,3
TR,POSTOPERATIVE WOUND INFECTION,3
TR,PROCEDURAL PAIN,3
TR,PROSTATOMEGALY,3
TR,PULPITIS DENTAL,3
TR,RASH ERYTHEMATOUS,3
TR,RASH GENERALISED,3
TR,RESPIRATORY FAILURE,3
TR,SARCOIDOSIS,3
TR,SEPSIS,3
TR,SKIN CANCER,3
TR,SKIN DISCOLOURATION,3
TR,SKIN FISSURES,3
TR,SKIN LESION,3
TR,SPINAL FRACTURE,3
TR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
TR,TONSILLAR HYPERTROPHY,3
TR,UMBILICAL HERNIA,3
TR,UTERINE CANCER,3
TR,UTERINE DISORDER,3
TR,UTERINE LEIOMYOMA,3
TR,ABDOMINAL RIGIDITY,2
TR,ABORTION SPONTANEOUS,2
TR,ACCIDENT AT WORK,2
TR,ACUTE LYMPHOCYTIC LEUKAEMIA,2
TR,ACUTE PROMYELOCYTIC LEUKAEMIA,2
TR,ADENOIDAL DISORDER,2
TR,AGITATION,2
TR,ALANINE AMINOTRANSFERASE INCREASED,2
TR,ANKLE FRACTURE,2
TR,ANURIA,2
TR,AORTITIS,2
TR,APHONIA,2
TR,APNOEA,2
TR,ARTHRITIS INFECTIVE,2
TR,ARTICULAR CALCIFICATION,2
TR,BACK DISORDER,2
TR,BACTERIAL TEST POSITIVE,2
TR,BEHCET^S SYNDROME,2
TR,BLOOD INSULIN INCREASED,2
TR,BLOOD PRESSURE FLUCTUATION,2
TR,BONE EROSION,2
TR,BONE MARROW OEDEMA,2
TR,BRAIN INJURY,2
TR,BRAIN NEOPLASM,2
TR,BREAST CYST,2
TR,BRUCELLOSIS,2
TR,BURSITIS,2
TR,C-REACTIVE PROTEIN DECREASED,2
TR,CALCULUS BLADDER,2
TR,CALCULUS URETERIC,2
TR,CARDIAC DISCOMFORT,2
TR,CARDIAC HYPERTROPHY,2
TR,CHRONIC GASTRITIS,2
TR,COLON CANCER,2
TR,CONSTIPATION,2
TR,CORONARY ARTERY OCCLUSION,2
TR,CYSTOCELE,2
TR,DEFORMITY,2
TR,DEHYDRATION,2
TR,DERMATITIS BULLOUS,2
TR,DEVICE FAILURE,2
TR,DIABETES INSIPIDUS,2
TR,DIARRHOEA HAEMORRHAGIC,2
TR,DISCOMFORT,2
TR,DRUG ABUSER,2
TR,DRY MOUTH,2
TR,DRY THROAT,2
TR,DYSPEPSIA,2
TR,DYSPNOEA EXERTIONAL,2
TR,DYSURIA,2
TR,ENTERITIS INFECTIOUS,2
TR,EPILEPSY,2
TR,EPISTAXIS,2
TR,ERYSIPELAS,2
TR,EXOSTOSIS,2
TR,EXPOSURE DURING PREGNANCY,2
TR,EXPOSURE VIA PARTNER,2
TR,EYE HAEMORRHAGE,2
TR,EYE OEDEMA,2
TR,EYE PAIN,2
TR,FACE OEDEMA,2
TR,FACIAL PAIN,2
TR,FACIAL PARALYSIS,2
TR,FISTULA,2
TR,FUNGAL INFECTION,2
TR,FURUNCLE,2
TR,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,2
TR,GENERAL PHYSICAL HEALTH DETERIORATION,2
TR,GENITAL ULCERATION,2
TR,GINGIVAL BLEEDING,2
TR,GINGIVITIS,2
TR,GOITRE,2
TR,GOUT,2
TR,HAEMATOCHEZIA,2
TR,HAEMOGLOBIN DECREASED,2
TR,HAND DEFORMITY,2
TR,HEART VALVE INCOMPETENCE,2
TR,HEPATIC INFECTION,2
TR,HEPATITIS B,2
TR,HEPATOTOXICITY,2
TR,HERNIA,2
TR,HIP ARTHROPLASTY,2
TR,HIP DEFORMITY,2
TR,HORMONE LEVEL ABNORMAL,2
TR,HYPERMETROPIA,2
TR,HYPOACUSIS,2
TR,HYPOXIA,2
TR,INJECTION SITE ABSCESS,2
TR,INJECTION SITE EXTRAVASATION,2
TR,INJECTION SITE INFECTION,2
TR,INTRACRANIAL ANEURYSM,2
TR,JOINT EFFUSION,2
TR,LACRIMATION INCREASED,2
TR,LIGAMENT SPRAIN,2
TR,LIP SWELLING,2
TR,LUNG CYST,2
TR,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
TR,MEASLES,2
TR,MELANOCYTIC NAEVUS,2
TR,MENISCUS INJURY,2
TR,MENORRHAGIA,2
TR,MENSTRUATION DELAYED,2
TR,METRORRHAGIA,2
TR,MUSCULOSKELETAL CHEST PAIN,2
TR,MUSCULOSKELETAL DISCOMFORT,2
TR,MYALGIA,2
TR,MYOPATHY,2
TR,NASAL DISORDER,2
TR,NASAL TURBINATE HYPERTROPHY,2
TR,NASOPHARYNGEAL CANCER,2
TR,NECK MASS,2
TR,NERVE INJURY,2
TR,NO ADVERSE EVENT,2
TR,OESOPHAGEAL ULCER,2
TR,ONYCHOMYCOSIS,2
TR,OPEN ANGLE GLAUCOMA,2
TR,PALATAL DISORDER,2
TR,PANCREATITIS,2
TR,PANNICULITIS,2
TR,PARAESTHESIA ORAL,2
TR,PERITONSILLAR ABSCESS,2
TR,PLATELET COUNT INCREASED,2
TR,PLEURAL EFFUSION,2
TR,POISONING,2
TR,POLYNEUROPATHY,2
TR,POLYP,2
TR,POST PROCEDURAL HAEMORRHAGE,2
TR,PREMATURE BABY,2
TR,PROCEDURAL HAEMORRHAGE,2
TR,PRURITUS GENITAL,2
TR,PULMONARY TUBERCULOSIS,2
TR,RASH MACULAR,2
TR,RECTAL CANCER,2
TR,RENAL HAEMORRHAGE,2
TR,RESPIRATORY TRACT INFECTION,2
TR,SCAN ABNORMAL,2
TR,SENSORY LOSS,2
TR,SIGNET-RING CELL CARCINOMA,2
TR,SKIN TIGHTNESS,2
TR,SLEEP DISORDER,2
TR,SPEECH DISORDER,2
TR,STOMACH MASS,2
TR,SUBCUTANEOUS ABSCESS,2
TR,SYNOVIAL CYST,2
TR,TENSION,2
TR,THROMBOCYTOPENIA,2
TR,THYROID CANCER,2
TR,THYROID NEOPLASM,2
TR,TONSILLITIS,2
TR,TOOTH FRACTURE,2
TR,UPPER-AIRWAY COUGH SYNDROME,2
TR,URINARY INCONTINENCE,2
TR,URINARY TRACT DISORDER,2
TR,URTICARIA,2
TR,UTERINE CYST,2
TR,UTERINE HAEMORRHAGE,2
TR,UTERINE INFLAMMATION,2
TR,VARICELLA,2
TR,VARICOSE VEIN,2
TR,VASCULAR INJURY,2
TR,VASCULITIS,2
TR,VISUAL ACUITY REDUCED,2
TR,VISUAL IMPAIRMENT,2
TR,VOCAL CORD DISORDER,2
TR,WHEEZING,2
TR,WHITE BLOOD CELL COUNT INCREASED,2
TR,WRIST FRACTURE,2
TR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
TR,ABDOMINAL ADHESIONS,1
TR,ABORTION THREATENED,1
TR,ACCIDENT,1
TR,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
TR,ACUTE MYELOID LEUKAEMIA,1
TR,ADENOCARCINOMA GASTRIC,1
TR,ADRENAL CYST,1
TR,ADVERSE DRUG REACTION,1
TR,ADVERSE EVENT,1
TR,AFFECTIVE DISORDER,1
TR,AGGRESSION,1
TR,ALLERGIC COUGH,1
TR,AMENORRHOEA,1
TR,AMOEBIC DYSENTERY,1
TR,ANAL ABSCESS,1
TR,ANAL FISSURE,1
TR,ANAPHYLACTIC SHOCK,1
TR,ANGER,1
TR,ANGIOGRAM,1
TR,ANTINUCLEAR ANTIBODY POSITIVE,1
TR,ANTIPHOSPHOLIPID SYNDROME,1
TR,AORTIC OCCLUSION,1
TR,APHAGIA,1
TR,APHASIA,1
TR,APPENDICITIS PERFORATED,1
TR,APPENDIX DISORDER,1
TR,ARTERIAL RUPTURE,1
TR,ARTERIOSCLEROSIS,1
TR,ASCITES,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASPERGILLOMA,1
TR,ASPHYXIA,1
TR,ASTHENOPIA,1
TR,AUTOIMMUNE THYROIDITIS,1
TR,B-CELL LYMPHOMA,1
TR,BACK INJURY,1
TR,BACTERIAL PYELONEPHRITIS,1
TR,BASAL CELL CARCINOMA,1
TR,BEDRIDDEN,1
TR,BENIGN INTRACRANIAL HYPERTENSION,1
TR,BENIGN NEOPLASM OF ADRENAL GLAND,1
TR,BENIGN PROSTATIC HYPERPLASIA,1
TR,BENIGN SOFT TISSUE NEOPLASM,1
TR,BLADDER DISORDER,1
TR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TR,BLOOD CHOLESTEROL ABNORMAL,1
TR,BLOOD CREATINE INCREASED,1
TR,BLOOD DISORDER,1
TR,BLOOD GLUCOSE ABNORMAL,1
TR,BLOOD PRESSURE ABNORMAL,1
TR,BLOOD PRESSURE DIASTOLIC INCREASED,1
TR,BLOOD TRIGLYCERIDES INCREASED,1
TR,BLOOD URIC ACID INCREASED,1
TR,BLOOD URINE,1
TR,BONE LESION,1
TR,BONE LOSS,1
TR,BONE MARROW DISORDER,1
TR,BONE SWELLING,1
TR,BREAST CALCIFICATIONS,1
TR,BREAST CANCER FEMALE,1
TR,BREAST DISORDER,1
TR,CACHEXIA,1
TR,CALCIFICATION METASTATIC,1
TR,CALCINOSIS,1
TR,CALCULUS URINARY,1
TR,CAPILLARY FRAGILITY,1
TR,CARDIAC ARREST,1
TR,CARDIOVASCULAR INSUFFICIENCY,1
TR,CAROTID ARTERY DISEASE,1
TR,CAROTID ARTERY OCCLUSION,1
TR,CARTILAGE ATROPHY,1
TR,CARTILAGE INJURY,1
TR,CELLULITIS,1
TR,CEREBRAL ISCHAEMIA,1
TR,CERVICAL VERTEBRAL FRACTURE,1
TR,CERVICITIS,1
TR,CERVIX CARCINOMA STAGE II,1
TR,CHAPPED LIPS,1
TR,CHEST X-RAY ABNORMAL,1
TR,CHOLECYSTITIS,1
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 1,1
TR,COAGULOPATHY,1
TR,COLD SWEAT,1
TR,COLITIS ULCERATIVE,1
TR,COMPLEMENT FACTOR C3 INCREASED,1
TR,COMPLEMENT FACTOR C4 INCREASED,1
TR,CONFUSIONAL STATE,1
TR,CORONARY ARTERY DISEASE,1
TR,CRYING,1
TR,CUSHING^S SYNDROME,1
TR,DEAFNESS NEUROSENSORY,1
TR,DEMENTIA ALZHEIMER^S TYPE,1
TR,DENTAL IMPLANTATION,1
TR,DEPENDENCE,1
TR,DERMATITIS EXFOLIATIVE,1
TR,DEVICE BREAKAGE,1
TR,DIALYSIS RELATED COMPLICATION,1
TR,DIFFUSE ALVEOLAR DAMAGE,1
TR,DIPLEGIA,1
TR,DROWNING,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG EFFECT DELAYED,1
TR,DRUG HYPERSENSITIVITY,1
TR,DRUG INTOLERANCE,1
TR,DRUG PRESCRIBING ERROR,1
TR,DRUG-INDUCED LIVER INJURY,1
TR,EAR DISCOMFORT,1
TR,EAR PRURITUS,1
TR,ECZEMA,1
TR,EMOTIONAL DISORDER,1
TR,END STAGE RENAL DISEASE,1
TR,ENDOMETRIAL HYPERPLASIA,1
TR,ENDOMETRIAL HYPERTROPHY,1
TR,ENTERITIS,1
TR,ENZYME LEVEL INCREASED,1
TR,EOSINOPHIL COUNT DECREASED,1
TR,EOSINOPHILIA,1
TR,EOSINOPHILIC COLITIS,1
TR,ERECTILE DYSFUNCTION,1
TR,ERUCTATION,1
TR,EXERCISE TOLERANCE DECREASED,1
TR,EYE INFECTION FUNGAL,1
TR,EYE IRRITATION,1
TR,EYE SWELLING,1
TR,EYELID OEDEMA,1
TR,EYELID PTOSIS,1
TR,FACE INJURY,1
TR,FALSE POSITIVE TUBERCULOSIS TEST,1
TR,FEEDING DISORDER,1
TR,FEELING OF DESPAIR,1
TR,FEMORAL NECK FRACTURE,1
TR,FEMUR FRACTURE,1
TR,FIBROCYSTIC BREAST DISEASE,1
TR,FINGER DEFORMITY,1
TR,FLUID RETENTION,1
TR,FOETAL DEATH,1
TR,FOETAL DISORDER,1
TR,FOETAL GROWTH RESTRICTION,1
TR,FOOD POISONING,1
TR,FORMICATION,1
TR,FRACTURED COCCYX,1
TR,GALACTORRHOEA,1
TR,GANGRENE,1
TR,GASTRIC CANCER,1
TR,GASTRIC DISORDER,1
TR,GASTRITIS EROSIVE,1
TR,GASTROINTESTINAL BACTERIAL INFECTION,1
TR,GASTROINTESTINAL INFLAMMATION,1
TR,GENERAL PHYSICAL CONDITION ABNORMAL,1
TR,GENITAL BURNING SENSATION,1
TR,GESTATIONAL DIABETES,1
TR,GINGIVAL ABSCESS,1
TR,GINGIVAL PAIN,1
TR,GINGIVAL RECESSION,1
TR,GLOMERULAR FILTRATION RATE DECREASED,1
TR,GLOMERULONEPHRITIS,1
TR,HAEMARTHROSIS,1
TR,HAEMATOCRIT DECREASED,1
TR,HAEMORRHAGIC CYST,1
TR,HAEMORRHOID INFECTION,1
TR,HAEMORRHOIDAL HAEMORRHAGE,1
TR,HAIR COLOUR CHANGES,1
TR,HEAD DISCOMFORT,1
TR,HEAD INJURY,1
TR,HEAD TITUBATION,1
TR,HEART VALVE STENOSIS,1
TR,HEMIPARESIS,1
TR,HEPATIC NEOPLASM,1
TR,HEPATITIS A,1
TR,HEPATITIS B CORE ANTIBODY POSITIVE,1
TR,HEPATITIS B SURFACE ANTIGEN POSITIVE,1
TR,HEPATITIS TOXIC,1
TR,HERPES SIMPLEX,1
TR,HERPES VIRUS INFECTION,1
TR,HERPES ZOSTER,1
TR,HICCUPS,1
TR,HISTIOCYTOSIS HAEMATOPHAGIC,1
TR,HOUSE DUST ALLERGY,1
TR,HYDROCEPHALUS,1
TR,HYPERLIPIDAEMIA,1
TR,HYPERTENSIVE CRISIS,1
TR,HYPERTHYROIDISM,1
TR,HYPONATRAEMIA,1
TR,ILEAL ULCER,1
TR,ILLUSION,1
TR,INCISION SITE OEDEMA,1
TR,INCISION SITE PAIN,1
TR,INCONTINENCE,1
TR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
TR,INFERTILITY,1
TR,INFERTILITY FEMALE,1
TR,INFUSION RELATED REACTION,1
TR,INFUSION SITE VESICLES,1
TR,INGROWING NAIL,1
TR,INGROWN HAIR,1
TR,INJECTION SITE ANAESTHESIA,1
TR,INJECTION SITE CELLULITIS,1
TR,INJECTION SITE DRYNESS,1
TR,INJECTION SITE INFLAMMATION,1
TR,INJECTION SITE INJURY,1
TR,INJECTION SITE MASS,1
TR,INJECTION SITE NODULE,1
TR,INJURY,1
TR,INNER EAR DISORDER,1
TR,INTERMITTENT CLAUDICATION,1
TR,INTERSTITIAL LUNG DISEASE,1
TR,INTESTINAL CYST,1
TR,INTESTINAL MASS,1
TR,INTESTINAL OBSTRUCTION,1
TR,INTESTINAL PERFORATION,1
TR,INTRAUTERINE INFECTION,1
TR,IRON DEFICIENCY ANAEMIA,1
TR,JAUNDICE NEONATAL,1
TR,JOINT DESTRUCTION,1
TR,JOINT TUBERCULOSIS,1
TR,JUGULAR VEIN THROMBOSIS,1
TR,JUVENILE IDIOPATHIC ARTHRITIS,1
TR,KNEE ARTHROPLASTY,1
TR,KYPHOSIS,1
TR,LACERATION,1
TR,LANGUAGE DISORDER,1
TR,LEUKOCYTOSIS,1
TR,LIMB INJURY,1
TR,LIP DRY,1
TR,LIPIDOSIS,1
TR,LIPOMA,1
TR,LIVER INJURY,1
TR,LOOSE TOOTH,1
TR,LUMBAR VERTEBRAL FRACTURE,1
TR,LUNG ABSCESS,1
TR,LYMPHADENITIS,1
TR,LYMPHANGITIS,1
TR,LYMPHOEDEMA,1
TR,LYMPHOMA,1
TR,MALNUTRITION,1
TR,MASS,1
TR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
TR,MEAN CELL HAEMOGLOBIN DECREASED,1
TR,MEAN CELL VOLUME ABNORMAL,1
TR,MEDICAL DEVICE COMPLICATION,1
TR,MEDICATION ERROR,1
TR,MENINGIOMA,1
TR,MESOTHELIOMA MALIGNANT,1
TR,METASTATIC NEOPLASM,1
TR,METATARSALGIA,1
TR,MIDDLE INSOMNIA,1
TR,MIGRAINE,1
TR,MOUTH HAEMORRHAGE,1
TR,MOUTH SWELLING,1
TR,MULTI-ORGAN FAILURE,1
TR,MULTIPLE FRACTURES,1
TR,MULTIPLE-DRUG RESISTANCE,1
TR,MUSCLE ATROPHY,1
TR,MUSCLE RUPTURE,1
TR,MYCOSIS FUNGOIDES,1
TR,MYOPIA,1
TR,NAIL DISCOLOURATION,1
TR,NAIL DISORDER,1
TR,NASAL OBSTRUCTION,1
TR,NASAL POLYPS,1
TR,NECK DEFORMITY,1
TR,NEOPLASM SKIN,1
TR,NEURITIS,1
TR,NEUROENDOCRINE TUMOUR,1
TR,NEUROPATHY PERIPHERAL,1
TR,NEUTROPENIA,1
TR,NEUTROPHIL COUNT INCREASED,1
TR,NIGHT SWEATS,1
TR,NORMAL NEWBORN,1
TR,NOSOCOMIAL INFECTION,1
TR,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
TR,OBSESSIVE THOUGHTS,1
TR,OCULAR ICTERUS,1
TR,ODYNOPHAGIA,1
TR,ONYCHOLYSIS,1
TR,ORAL DISCOMFORT,1
TR,ORAL FUNGAL INFECTION,1
TR,ORAL PAPULE,1
TR,ORGANISING PNEUMONIA,1
TR,OROPHARYNGEAL DISCOMFORT,1
TR,OSTEITIS,1
TR,OSTEOARTHRITIS,1
TR,OSTEOMYELITIS,1
TR,OSTEONECROSIS,1
TR,OSTEOSCLEROSIS,1
TR,OTITIS EXTERNA,1
TR,OVERDOSE,1
TR,OXYGEN SATURATION DECREASED,1
TR,PANCREATIC NEOPLASM,1
TR,PANIC ATTACK,1
TR,PANOPHTHALMITIS,1
TR,PAPILLOEDEMA,1
TR,PARAESTHESIA MUCOSAL,1
TR,PARAPLEGIA,1
TR,PARONYCHIA,1
TR,PATELLA FRACTURE,1
TR,PELVIC FRACTURE,1
TR,PERIPHERAL ARTERY THROMBOSIS,1
TR,PERITONITIS,1
TR,PERONEAL NERVE PALSY,1
TR,PHARYNGEAL ERYTHEMA,1
TR,PHARYNGEAL HAEMORRHAGE,1
TR,PHARYNGEAL MASS,1
TR,PHILADELPHIA CHROMOSOME POSITIVE,1
TR,PHLEBITIS,1
TR,PIGMENTATION DISORDER,1
TR,PILONIDAL CYST,1
TR,PLANTAR FASCIITIS,1
TR,PLASMA CELL MYELOMA,1
TR,PLATELET COUNT DECREASED,1
TR,PLEURAL FIBROSIS,1
TR,PLEURISY,1
TR,PLEURITIC PAIN,1
TR,PNEUMONIA ASPIRATION,1
TR,PNEUMOTHORAX,1
TR,POLYMYOSITIS,1
TR,POST PROCEDURAL INFECTION,1
TR,POST PROCEDURAL SWELLING,1
TR,POSTOPERATIVE ABSCESS,1
TR,PREMATURE DELIVERY,1
TR,PREMATURE LABOUR,1
TR,PRESBYOPIA,1
TR,PRESCRIBED UNDERDOSE,1
TR,PRESYNCOPE,1
TR,PROCEDURAL COMPLICATION,1
TR,PROCTALGIA,1
TR,PRODUCT PREPARATION ERROR,1
TR,PRODUCT USE IN UNAPPROVED INDICATION,1
TR,PROSTATE CANCER,1
TR,PROTEIN TOTAL INCREASED,1
TR,PROTEIN URINE PRESENT,1
TR,PROTHROMBIN TIME PROLONGED,1
TR,PULMONARY ALVEOLAR HAEMORRHAGE,1
TR,PULMONARY FUNCTION TEST DECREASED,1
TR,PULMONARY HAEMORRHAGE,1
TR,PULMONARY SARCOIDOSIS,1
TR,RASH PUSTULAR,1
TR,RED BLOOD CELLS URINE,1
TR,RED CELL DISTRIBUTION WIDTH INCREASED,1
TR,REFLUX GASTRITIS,1
TR,RENAL AMYLOIDOSIS,1
TR,RENAL CANCER,1
TR,RENAL CELL CARCINOMA,1
TR,RENAL INJURY,1
TR,RENAL TUBERCULOSIS,1
TR,RENAL VEIN THROMBOSIS,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DISTRESS,1
TR,RESPIRATORY TRACT HAEMORRHAGE,1
TR,RETINAL TEAR,1
TR,RETINAL VEIN THROMBOSIS,1
TR,RHEUMATOID FACTOR INCREASED,1
TR,RHEUMATOID LUNG,1
TR,RIB FRACTURE,1
TR,SAPHO SYNDROME,1
TR,SCAB,1
TR,SEIZURE,1
TR,SENSORY DISTURBANCE,1
TR,SEPTIC SHOCK,1
TR,SKELETAL INJURY,1
TR,SKIN BURNING SENSATION,1
TR,SKIN INFECTION,1
TR,SKIN PAPILLOMA,1
TR,SKIN ULCER,1
TR,SKIN WRINKLING,1
TR,SLEEP APNOEA SYNDROME,1
TR,SOLAR LENTIGO,1
TR,SPINAL COMPRESSION FRACTURE,1
TR,SPINAL CORD COMPRESSION,1
TR,SPINAL DEFORMITY,1
TR,SPINAL PAIN,1
TR,SPONDYLITIS,1
TR,SQUAMOUS CELL CARCINOMA,1
TR,SQUAMOUS CELL CARCINOMA OF LUNG,1
TR,STAB WOUND,1
TR,STATUS EPILEPTICUS,1
TR,STOMATITIS,1
TR,STREPTOCOCCUS TEST POSITIVE,1
TR,SUBCLAVIAN VEIN THROMBOSIS,1
TR,SUICIDE ATTEMPT,1
TR,SUSPECTED COUNTERFEIT PRODUCT,1
TR,SWOLLEN TONGUE,1
TR,SYNOVITIS,1
TR,TESTIS CANCER,1
TR,THERAPY NON-RESPONDER,1
TR,THROMBOSIS,1
TR,THYROID DISORDER,1
TR,THYROIDITIS,1
TR,TONGUE INJURY,1
TR,TONSILLAR DISORDER,1
TR,TOOTH EROSION,1
TR,TOOTH EXTRACTION,1
TR,TOXIC GOITRE,1
TR,TOXIC SKIN ERUPTION,1
TR,TRACHEAL OBSTRUCTION,1
TR,TRANSIENT ISCHAEMIC ATTACK,1
TR,TREATMENT NONCOMPLIANCE,1
TR,TUBERCULIN TEST POSITIVE,1
TR,TUBERCULOSIS GASTROINTESTINAL,1
TR,TYMPANIC MEMBRANE PERFORATION,1
TR,TYPE I HYPERSENSITIVITY,1
TR,TYPE IV HYPERSENSITIVITY REACTION,1
TR,ULTRASOUND BREAST ABNORMAL,1
TR,UMBILICAL CORD ABNORMALITY,1
TR,UMBILICAL CORD AROUND NECK,1
TR,URETHRAL HAEMORRHAGE,1
TR,URINE ANALYSIS ABNORMAL,1
TR,URINE OUTPUT DECREASED,1
TR,UTERINE MASS,1
TR,UTERINE POLYP,1
TR,UTERINE PROLAPSE,1
TR,UTERINE SCAR,1
TR,VAGINAL DISCHARGE,1
TR,VAGINAL HAEMORRHAGE,1
TR,VARICOSE VEIN OPERATION,1
TR,VASCULAR PAIN,1
TR,VASCULAR RUPTURE,1
TR,VASOCONSTRICTION,1
TR,VEIN DISORDER,1
TR,VENA CAVA THROMBOSIS,1
TR,VENOUS OCCLUSION,1
TR,VENTRICULAR SEPTAL DEFECT,1
TR,VITAMIN B12 DECREASED,1
TR,VITAMIN B12 DEFICIENCY,1
TR,VITAMIN D INCREASED,1
TR,WEIGHT BEARING DIFFICULTY,1
TR,WEIGHT LOSS POOR,1
TR,WHITE BLOOD CELL COUNT DECREASED,1
TR,YELLOW SKIN,1
UA,BACK PAIN,1
AE,COUGH,6
AE,PYREXIA,6
AE,CATARACT,4
AE,INFLUENZA,4
AE,RASH,4
AE,DYSPNOEA,3
AE,OROPHARYNGEAL PAIN,3
AE,VOMITING,3
AE,ABORTION MISSED,2
AE,ARTHRALGIA,2
AE,CONDITION AGGRAVATED,2
AE,DIABETES MELLITUS,2
AE,DIZZINESS,2
AE,DRUG INEFFECTIVE,2
AE,HYPERTENSION,2
AE,LEUKOPENIA,2
AE,PAIN,2
AE,RENAL IMPAIRMENT,2
AE,THROMBOCYTOPENIA,2
AE,ABASIA,1
AE,ABORTION SPONTANEOUS,1
AE,ABORTION SPONTANEOUS INCOMPLETE,1
AE,ALOPECIA,1
AE,ANAEMIA,1
AE,APHAGIA,1
AE,APHONIA,1
AE,ARTHRITIS,1
AE,ARTHROPATHY,1
AE,ASTHMA,1
AE,ATRIAL FIBRILLATION,1
AE,BACTERIAL INFECTION,1
AE,BASELINE FOETAL HEART RATE VARIABILITY DISORDER,1
AE,BLOOD CREATINE INCREASED,1
AE,BLOOD PRESSURE INCREASED,1
AE,BRAIN NEOPLASM BENIGN,1
AE,CARDIAC DISORDER,1
AE,CARDIOMEGALY,1
AE,CELLULITIS,1
AE,CHEST DISCOMFORT,1
AE,CHEST PAIN,1
AE,CHILLS,1
AE,COELIAC DISEASE,1
AE,COLON CANCER,1
AE,CONFUSIONAL STATE,1
AE,CONGENITAL ANOMALY,1
AE,DEATH,1
AE,DEHYDRATION,1
AE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AE,DIARRHOEA,1
AE,DRUG ERUPTION,1
AE,DRUG INTOLERANCE,1
AE,EPISTAXIS,1
AE,EXPOSURE DURING PREGNANCY,1
AE,FALL,1
AE,FATIGUE,1
AE,FEAR OF INJECTION,1
AE,FOETAL EXPOSURE DURING PREGNANCY,1
AE,FOOT FRACTURE,1
AE,HAEMOPTYSIS,1
AE,HAEMORRHAGIC DISORDER,1
AE,HUMAN CHORIONIC GONADOTROPIN DECREASED,1
AE,HYPERSENSITIVITY,1
AE,HYPOTENSION,1
AE,IMMUNODEFICIENCY,1
AE,INCISION SITE PAIN,1
AE,INFECTION,1
AE,INFLUENZA LIKE ILLNESS,1
AE,INJECTION SITE PAIN,1
AE,INJECTION SITE RASH,1
AE,INJECTION SITE REACTION,1
AE,JOINT SWELLING,1
AE,LEUKOCYTOSIS,1
AE,LIVER FUNCTION TEST INCREASED,1
AE,LOWER RESPIRATORY TRACT INFECTION,1
AE,LYMPHOCYTOSIS,1
AE,MALAISE,1
AE,MENORRHAGIA,1
AE,MUCOSAL ULCERATION,1
AE,MULTI-ORGAN FAILURE,1
AE,NAUSEA,1
AE,NEPHROLITHIASIS,1
AE,NEUTROPHIL COUNT DECREASED,1
AE,OCULAR TOXICITY,1
AE,OEDEMA MOUTH,1
AE,OEDEMA PERIPHERAL,1
AE,OSTEOPOROSIS,1
AE,PANCYTOPENIA,1
AE,PERICARDITIS,1
AE,PERIPHERAL ISCHAEMIA,1
AE,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
AE,PIGMENTATION DISORDER,1
AE,PNEUMONIA,1
AE,POST PROCEDURAL SWELLING,1
AE,PRODUCT QUALITY ISSUE,1
AE,PSORIASIS,1
AE,PULMONARY HAEMORRHAGE,1
AE,RASH MACULAR,1
AE,RAYNAUD^S PHENOMENON,1
AE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AE,RENAL FAILURE ACUTE,1
AE,ROAD TRAFFIC ACCIDENT,1
AE,SEPSIS,1
AE,SINUSITIS,1
AE,SKIN ULCER,1
AE,SPINAL FRACTURE,1
AE,SPLENOMEGALY,1
AE,SPONDYLOARTHROPATHY,1
AE,STREPTOCOCCAL INFECTION,1
AE,THYROID NEOPLASM,1
AE,TYPE I HYPERSENSITIVITY,1
AE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AE,UPPER LIMB FRACTURE,1
AE,URINE OUTPUT DECREASED,1
AE,URTICARIA,1
AE,VASCULITIS,1
AE,VERTIGO,1
AE,WHITE BLOOD CELL COUNT DECREASED,1
AE,WRIST FRACTURE,1
GB,LOWER RESPIRATORY TRACT INFECTION,995
GB,DEATH,461
GB,MALAISE,386
GB,RHEUMATOID ARTHRITIS,198
GB,CONDITION AGGRAVATED,196
GB,ARTHROPATHY,193
GB,PNEUMONIA,169
GB,INFECTION,159
GB,DRUG INEFFECTIVE,155
GB,FALL,153
GB,URINARY TRACT INFECTION,139
GB,HEADACHE,136
GB,DYSPNOEA,131
GB,PAIN,130
GB,ARTHRALGIA,127
GB,MYOCARDIAL INFARCTION,119
GB,COUGH,114
GB,NASOPHARYNGITIS,110
GB,PAIN IN EXTREMITY,99
GB,CELLULITIS,92
GB,NAUSEA,89
GB,INJECTION SITE REACTION,88
GB,DIARRHOEA,84
GB,FATIGUE,81
GB,NEOPLASM MALIGNANT,81
GB,SEPSIS,74
GB,JOINT SWELLING,73
GB,CEREBROVASCULAR ACCIDENT,72
GB,RASH,68
GB,INJECTION SITE ERYTHEMA,67
GB,DIZZINESS,62
GB,PERIPHERAL SWELLING,62
GB,PYREXIA,60
GB,MUSCULOSKELETAL DISORDER,57
GB,VOMITING,56
GB,OROPHARYNGEAL PAIN,55
GB,LUNG NEOPLASM MALIGNANT,52
GB,BREAST CANCER,47
GB,MOBILITY DECREASED,47
GB,BACK PAIN,46
GB,ARTHRITIS,45
GB,INFLUENZA,45
GB,PRODUCTIVE COUGH,45
GB,CHEST PAIN,44
GB,UPPER LIMB FRACTURE,43
GB,CATARACT,42
GB,HIP FRACTURE,41
GB,ANXIETY,40
GB,DEPRESSED MOOD,40
GB,FEELING ABNORMAL,40
GB,PSORIASIS,40
GB,CHOLELITHIASIS,39
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,38
GB,INJECTION SITE PRURITUS,38
GB,INJECTION SITE PAIN,37
GB,MUSCULOSKELETAL STIFFNESS,37
GB,PROSTATE CANCER,37
GB,LIVER FUNCTION TEST ABNORMAL,36
GB,PULMONARY FIBROSIS,36
GB,VIRAL INFECTION,36
GB,HYPERTENSION,35
GB,MUSCULOSKELETAL PAIN,35
GB,SQUAMOUS CELL CARCINOMA,35
GB,ERYTHEMA,34
GB,HAEMORRHAGE,34
GB,INJECTION SITE BRUISING,34
GB,WHITE BLOOD CELL COUNT DECREASED,34
GB,WOUND INFECTION,34
GB,LOCALISED INFECTION,32
GB,LOWER LIMB FRACTURE,32
GB,PRODUCT USE ISSUE,32
GB,PRURITUS,32
GB,LETHARGY,31
GB,TOOTH ABSCESS,31
GB,GAIT DISTURBANCE,30
GB,ABDOMINAL PAIN UPPER,29
GB,ACUTE KIDNEY INJURY,29
GB,BREAST CANCER FEMALE,29
GB,CHEST DISCOMFORT,29
GB,CONFUSIONAL STATE,29
GB,INJECTION SITE SWELLING,29
GB,RENAL IMPAIRMENT,29
GB,CARDIAC FAILURE,28
GB,SYNCOPE,28
GB,MEMORY IMPAIRMENT,27
GB,MUSCULAR WEAKNESS,27
GB,NEUTROPHIL COUNT DECREASED,27
GB,ABDOMINAL PAIN,26
GB,DRUG DOSE OMISSION,26
GB,PSORIATIC ARTHROPATHY,26
GB,ATRIAL FIBRILLATION,25
GB,BLOOD PRESSURE INCREASED,25
GB,DIVERTICULITIS,25
GB,KIDNEY INFECTION,25
GB,LOSS OF CONSCIOUSNESS,25
GB,MYOCARDIAL ISCHAEMIA,25
GB,DEPRESSION,24
GB,HERNIA,24
GB,HYPERSENSITIVITY,24
GB,NECK PAIN,24
GB,NEPHROLITHIASIS,24
GB,RENAL FAILURE,24
GB,HYPOAESTHESIA,23
GB,INJECTION SITE RASH,23
GB,UVEITIS,23
GB,ABORTION SPONTANEOUS,22
GB,CARDIAC DISORDER,22
GB,HOSPITALISATION,22
GB,LUNG INFECTION,22
GB,PARAESTHESIA,22
GB,PULMONARY EMBOLISM,22
GB,TOOTH DISORDER,22
GB,ANGINA PECTORIS,21
GB,DEEP VEIN THROMBOSIS,21
GB,DEMENTIA,21
GB,INFECTED SKIN ULCER,21
GB,PLEURAL EFFUSION,21
GB,RENAL DISORDER,21
GB,SKIN ULCER,21
GB,SPUTUM DISCOLOURED,21
GB,TUBERCULOSIS,21
GB,C-REACTIVE PROTEIN INCREASED,20
GB,DISEASE RECURRENCE,20
GB,PALPITATIONS,20
GB,PHARYNGITIS,20
GB,CHILLS,19
GB,DECREASED IMMUNE RESPONSIVENESS,19
GB,HAEMOGLOBIN DECREASED,19
GB,LUNG DISORDER,19
GB,SINUSITIS,19
GB,SWELLING FACE,19
GB,WHEEZING,19
GB,WHITE BLOOD CELL COUNT INCREASED,19
GB,BLISTER,18
GB,HEPATIC FAILURE,18
GB,INFLUENZA LIKE ILLNESS,18
GB,LIMB INJURY,18
GB,MOUTH ULCERATION,18
GB,OSTEOARTHRITIS,18
GB,RASH PRURITIC,18
GB,THROMBOSIS,18
GB,ACCIDENT,17
GB,ASTHENIA,17
GB,ASTHMA,17
GB,DIABETES MELLITUS,17
GB,DRUG ERUPTION,17
GB,RHINORRHOEA,17
GB,WOUND,17
GB,BLEPHARITIS,16
GB,FEMUR FRACTURE,16
GB,LYMPHADENOPATHY,16
GB,METASTASES TO BONE,16
GB,OVERDOSE,16
GB,PLEURISY,16
GB,PULMONARY HYPERTENSION,16
GB,RESPIRATORY FAILURE,16
GB,SOMNOLENCE,16
GB,VISUAL IMPAIRMENT,16
GB,ARTHRITIS BACTERIAL,15
GB,BASAL CELL CARCINOMA,15
GB,BLOOD TEST ABNORMAL,15
GB,CARDIAC ARREST,15
GB,EXFOLIATIVE RASH,15
GB,INFLAMMATION,15
GB,INSOMNIA,15
GB,IRIDOCYCLITIS,15
GB,METASTASES TO LIVER,15
GB,MULTI-ORGAN FAILURE,15
GB,PLATELET COUNT DECREASED,15
GB,RASH MACULAR,15
GB,SPINAL FRACTURE,15
GB,TRANSIENT ISCHAEMIC ATTACK,15
GB,ABDOMINAL DISCOMFORT,14
GB,ABSCESS,14
GB,ANAPHYLACTIC REACTION,14
GB,ANKYLOSING SPONDYLITIS,14
GB,BLADDER NEOPLASM,14
GB,DRUG EFFECT INCOMPLETE,14
GB,EYE DISORDER,14
GB,FOOT FRACTURE,14
GB,GASTROINTESTINAL CARCINOMA,14
GB,HYPERCALCAEMIA,14
GB,HYPERHIDROSIS,14
GB,IMPAIRED HEALING,14
GB,LUMBAR VERTEBRAL FRACTURE,14
GB,LUNG ADENOCARCINOMA,14
GB,PANCREATITIS,14
GB,PULMONARY OEDEMA,14
GB,RESPIRATORY TRACT INFECTION,14
GB,STAPHYLOCOCCAL INFECTION,14
GB,TREMOR,14
GB,ULCER,14
GB,WEIGHT DECREASED,14
GB,APHASIA,13
GB,ARTHRITIS INFECTIVE,13
GB,CEREBRAL HAEMORRHAGE,13
GB,CIRCULATORY COLLAPSE,13
GB,DECREASED APPETITE,13
GB,DRY MOUTH,13
GB,EYE SWELLING,13
GB,HYPOTENSION,13
GB,INJECTION SITE MASS,13
GB,JOINT DISLOCATION,13
GB,LUNG CANCER METASTATIC,13
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
GB,NON-HODGKIN^S LYMPHOMA,13
GB,RENAL CANCER,13
GB,RENAL CYST,13
GB,RIB FRACTURE,13
GB,SKIN DISORDER,13
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,13
GB,ALANINE AMINOTRANSFERASE INCREASED,12
GB,BALANCE DISORDER,12
GB,BLADDER CANCER,12
GB,BLOOD ALBUMIN DECREASED,12
GB,BRONCHOPNEUMONIA,12
GB,COLON CANCER,12
GB,GASTRIC ULCER,12
GB,GASTROINTESTINAL DISORDER,12
GB,INGROWING NAIL,12
GB,INTERSTITIAL LUNG DISEASE,12
GB,MUSCLE SPASMS,12
GB,PNEUMONIA ASPIRATION,12
GB,PULMONARY MASS,12
GB,RASH GENERALISED,12
GB,SKIN REACTION,12
GB,SLEEP DISORDER,12
GB,TONSILLITIS,12
GB,URTICARIA,12
GB,ADVERSE EVENT,11
GB,BRONCHIECTASIS,11
GB,CEREBRAL HYPOPERFUSION,11
GB,DRUG HYPERSENSITIVITY,11
GB,EAR INFECTION,11
GB,EYE PAIN,11
GB,HAEMATURIA,11
GB,HOT FLUSH,11
GB,INVASIVE DUCTAL BREAST CARCINOMA,11
GB,JAUNDICE,11
GB,JOINT STIFFNESS,11
GB,LACERATION,11
GB,LIVER DISORDER,11
GB,LIVER FUNCTION TEST INCREASED,11
GB,MENORRHAGIA,11
GB,NEUTROPENIA,11
GB,ORAL HERPES,11
GB,PELVIC FRACTURE,11
GB,PERICARDIAL EFFUSION,11
GB,PNEUMONITIS,11
GB,POST PROCEDURAL INFECTION,11
GB,RASH ERYTHEMATOUS,11
GB,RENAL FAILURE CHRONIC,11
GB,SCAR,11
GB,SKIN CANCER,11
GB,SWOLLEN TONGUE,11
GB,ULCERATIVE KERATITIS,11
GB,ABASIA,10
GB,ACUTE MYOCARDIAL INFARCTION,10
GB,AMYLOIDOSIS,10
GB,BLOOD DISORDER,10
GB,BRAIN NEOPLASM,10
GB,CARDIAC FAILURE CONGESTIVE,10
GB,COMA,10
GB,CONTUSION,10
GB,DEMYELINATION,10
GB,DISCOMFORT,10
GB,DRUG EFFECT DELAYED,10
GB,DYSPEPSIA,10
GB,DYSPHONIA,10
GB,EYE INFECTION,10
GB,FEELING HOT,10
GB,GALLBLADDER DISORDER,10
GB,GINGIVITIS,10
GB,HAEMATOCHEZIA,10
GB,HEART RATE INCREASED,10
GB,HEMIPARESIS,10
GB,HERPES ZOSTER,10
GB,IMMUNE SYSTEM DISORDER,10
GB,LYMPHOMA,10
GB,MASS,10
GB,NERVOUS SYSTEM DISORDER,10
GB,NODULE,10
GB,ORAL INFECTION,10
GB,POSTOPERATIVE WOUND INFECTION,10
GB,RECTAL HAEMORRHAGE,10
GB,SKIN LESION,10
GB,STRESS,10
GB,VISION BLURRED,10
GB,VISUAL ACUITY REDUCED,10
GB,ANGIOEDEMA,9
GB,BLOOD SODIUM DECREASED,9
GB,CROHN^S DISEASE,9
GB,FOOT DEFORMITY,9
GB,FURUNCLE,9
GB,GASTRIC CANCER,9
GB,GASTROINTESTINAL HAEMORRHAGE,9
GB,HEART RATE IRREGULAR,9
GB,IMMUNOSUPPRESSION,9
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
GB,INTERVERTEBRAL DISCITIS,9
GB,METASTATIC NEOPLASM,9
GB,OSTEONECROSIS OF JAW,9
GB,PALLOR,9
GB,PRODUCT QUALITY ISSUE,9
GB,RED BLOOD CELL COUNT DECREASED,9
GB,ROAD TRAFFIC ACCIDENT,9
GB,SENSORY DISTURBANCE,9
GB,SKIN INFECTION,9
GB,TOOTH INFECTION,9
GB,ADENOCARCINOMA OF COLON,8
GB,ALOPECIA,8
GB,BREAST CANCER METASTATIC,8
GB,CEREBRAL DISORDER,8
GB,CYSTITIS,8
GB,DIPLOPIA,8
GB,DYSPNOEA EXERTIONAL,8
GB,FRUSTRATION TOLERANCE DECREASED,8
GB,GASTRIC INFECTION,8
GB,GASTROENTERITIS,8
GB,GRIP STRENGTH DECREASED,8
GB,IMMUNODEFICIENCY,8
GB,INJECTION SITE WARMTH,8
GB,IRITIS,8
GB,JOINT INJURY,8
GB,LIP SWELLING,8
GB,MEDICATION ERROR,8
GB,METASTASES TO LUNG,8
GB,OVARIAN CANCER,8
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,8
GB,PNEUMOTHORAX,8
GB,PROCEDURAL PAIN,8
GB,PRODUCT USE IN UNAPPROVED INDICATION,8
GB,PROTEINURIA,8
GB,PRURITUS GENERALISED,8
GB,RHEUMATIC DISORDER,8
GB,RHINITIS,8
GB,SKIN DISCOLOURATION,8
GB,SKIN IRRITATION,8
GB,SPINAL DISORDER,8
GB,SWELLING,8
GB,UPPER RESPIRATORY TRACT INFECTION,8
GB,VARICELLA,8
GB,WEIGHT BEARING DIFFICULTY,8
GB,ABSCESS LIMB,7
GB,ACUTE PSYCHOSIS,7
GB,BODY TEMPERATURE INCREASED,7
GB,DELUSION,7
GB,DISTURBANCE IN ATTENTION,7
GB,EYE CONTUSION,7
GB,FACE INJURY,7
GB,FOOD POISONING,7
GB,HERPES OPHTHALMIC,7
GB,INTERVERTEBRAL DISC PROTRUSION,7
GB,INTESTINAL OBSTRUCTION,7
GB,JUVENILE IDIOPATHIC ARTHRITIS,7
GB,LEUKAEMIA,7
GB,LICHENOID KERATOSIS,7
GB,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,7
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,7
GB,OEDEMA PERIPHERAL,7
GB,OESOPHAGEAL CARCINOMA,7
GB,OSTEOMYELITIS,7
GB,OSTEOPOROSIS,7
GB,OTITIS MEDIA,7
GB,PHARYNGEAL OEDEMA,7
GB,POST PROCEDURAL COMPLICATION,7
GB,PROSTATIC DISORDER,7
GB,PULMONARY THROMBOSIS,7
GB,RESPIRATORY DISORDER,7
GB,SEIZURE,7
GB,SLUGGISHNESS,7
GB,SUICIDAL IDEATION,7
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,7
GB,TYPE 2 DIABETES MELLITUS,7
GB,ABDOMINAL DISTENSION,6
GB,ABDOMINAL PAIN LOWER,6
GB,ACUTE MYELOID LEUKAEMIA,6
GB,ADENOVIRUS INFECTION,6
GB,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,6
GB,ANAEMIA,6
GB,ARTHROPOD BITE,6
GB,B-CELL LYMPHOMA,6
GB,BILIARY SEPSIS,6
GB,BLINDNESS,6
GB,BLOOD CREATININE INCREASED,6
GB,BLOOD MAGNESIUM DECREASED,6
GB,BURNING SENSATION,6
GB,CANDIDA INFECTION,6
GB,CARPAL TUNNEL SYNDROME,6
GB,CERVICAL VERTEBRAL FRACTURE,6
GB,COLD SWEAT,6
GB,COLITIS,6
GB,CONVULSION,6
GB,DEAFNESS,6
GB,DEHYDRATION,6
GB,DRY EYE,6
GB,DYSARTHRIA,6
GB,DYSGEUSIA,6
GB,EMOTIONAL DISTRESS,6
GB,EPILEPSY,6
GB,EPSTEIN-BARR VIRUS INFECTION,6
GB,ESCHERICHIA INFECTION,6
GB,EYE HAEMORRHAGE,6
GB,FINE MOTOR SKILL DYSFUNCTION,6
GB,GALLBLADDER PAIN,6
GB,GASTRIC DISORDER,6
GB,GASTROENTERITIS NOROVIRUS,6
GB,GRAFT VERSUS HOST DISEASE IN LIVER,6
GB,HAEMATOCRIT DECREASED,6
GB,HAEMOPTYSIS,6
GB,HODGKIN^S DISEASE,6
GB,INJECTION SITE INFECTION,6
GB,LARGE INTESTINE PERFORATION,6
GB,LIMB DISCOMFORT,6
GB,LOCAL SWELLING,6
GB,MALIGNANT MELANOMA,6
GB,MENINGITIS,6
GB,MENSTRUAL DISORDER,6
GB,MENTAL DISORDER,6
GB,MUSCULOSKELETAL CHEST PAIN,6
GB,NASAL CONGESTION,6
GB,NASAL DRYNESS,6
GB,NEUTROPHIL COUNT INCREASED,6
GB,ORAL CANDIDIASIS,6
GB,PARONYCHIA,6
GB,PERITONITIS,6
GB,POLLAKIURIA,6
GB,RECTAL CANCER,6
GB,RENAL FAILURE ACUTE,6
GB,RENAL NEOPLASM,6
GB,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,6
GB,SPEECH DISORDER,6
GB,SUBCUTANEOUS ABSCESS,6
GB,TOXICITY TO VARIOUS AGENTS,6
GB,UTERINE DISORDER,6
GB,VERTIGO,6
GB,WEIGHT INCREASED,6
GB,WOUND SECRETION,6
GB,WRIST FRACTURE,6
GB,ALVEOLITIS,5
GB,ANAL HAEMORRHAGE,5
GB,ANKLE FRACTURE,5
GB,AORTIC ANEURYSM,5
GB,APPENDIX DISORDER,5
GB,ASPERGILLUS INFECTION,5
GB,BACK DISORDER,5
GB,BLOOD COUNT ABNORMAL,5
GB,BLOOD CREATININE DECREASED,5
GB,BLOOD IRON DECREASED,5
GB,BRONCHIAL CARCINOMA,5
GB,CEREBELLAR INFARCTION,5
GB,CERVIX CARCINOMA STAGE 0,5
GB,CHRONIC KIDNEY DISEASE,5
GB,CRYING,5
GB,CYST,5
GB,DEVICE RELATED INFECTION,5
GB,DIVERTICULAR PERFORATION,5
GB,DRUG ADMINISTRATION ERROR,5
GB,DYSURIA,5
GB,EAR PAIN,5
GB,ECZEMA,5
GB,ENCEPHALOPATHY,5
GB,EPISTAXIS,5
GB,EYE INFLAMMATION,5
GB,FEMORAL NECK FRACTURE,5
GB,FLUSHING,5
GB,FOREIGN BODY SENSATION IN EYES,5
GB,GASTROINTESTINAL MOTILITY DISORDER,5
GB,GINGIVAL PAIN,5
GB,GUILLAIN-BARRE SYNDROME,5
GB,HEARING IMPAIRED,5
GB,HEPATIC CANCER,5
GB,HEPATIC FUNCTION ABNORMAL,5
GB,HIATUS HERNIA,5
GB,HYPERSOMNIA,5
GB,HYPOACUSIS,5
GB,HYPOGAMMAGLOBULINAEMIA,5
GB,IDIOPATHIC PULMONARY FIBROSIS,5
GB,INJECTION SITE INFLAMMATION,5
GB,INTERNAL HAEMORRHAGE,5
GB,INTESTINAL PERFORATION,5
GB,INTRADUCTAL PROLIFERATIVE BREAST LESION,5
GB,INVASIVE LOBULAR BREAST CARCINOMA,5
GB,JOINT RANGE OF MOTION DECREASED,5
GB,LIVER INJURY,5
GB,LUPUS-LIKE SYNDROME,5
GB,MATERNAL EXPOSURE DURING PREGNANCY,5
GB,MELANOCYTIC NAEVUS,5
GB,MIGRAINE,5
GB,NEOPLASM,5
GB,NIGHT SWEATS,5
GB,OESOPHAGEAL ADENOCARCINOMA,5
GB,OPHTHALMIC HERPES SIMPLEX,5
GB,PANCREAS INFECTION,5
GB,PANCREATIC CARCINOMA,5
GB,PANCREATIC CARCINOMA METASTATIC,5
GB,PANCREATITIS ACUTE,5
GB,PANIC ATTACK,5
GB,PAPILLARY THYROID CANCER,5
GB,PARKINSON^S DISEASE,5
GB,PLATELET COUNT ABNORMAL,5
GB,POST INFLAMMATORY PIGMENTATION CHANGE,5
GB,PSYCHOTIC DISORDER,5
GB,RASH PAPULAR,5
GB,RESPIRATORY TRACT CONGESTION,5
GB,SEPTIC SHOCK,5
GB,SKIN EXFOLIATION,5
GB,SQUAMOUS CELL CARCINOMA OF LUNG,5
GB,SUPRAVENTRICULAR TACHYCARDIA,5
GB,TACHYCARDIA,5
GB,TEARFULNESS,5
GB,THIRST,5
GB,THROAT TIGHTNESS,5
GB,THROMBOCYTOPENIA,5
GB,TONSILLAR ULCER,5
GB,UROSEPSIS,5
GB,VASCULAR DEMENTIA,5
GB,VIITH NERVE PARALYSIS,5
GB,ABNORMAL LOSS OF WEIGHT,4
GB,ADRENAL INSUFFICIENCY,4
GB,AGGRESSION,4
GB,ANAL CANCER,4
GB,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,4
GB,ARTERIOSCLEROSIS CORONARY ARTERY,4
GB,AUTOIMMUNE HEPATITIS,4
GB,BACTERIAL SEPSIS,4
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,4
GB,BONE DISORDER,4
GB,BRONCHITIS,4
GB,CARDIO-RESPIRATORY ARREST,4
GB,CATHETER SITE CELLULITIS,4
GB,CHOLECYSTITIS,4
GB,COLITIS ULCERATIVE,4
GB,CONJUNCTIVITIS,4
GB,CONSTIPATION,4
GB,CUSHINGOID,4
GB,DECUBITUS ULCER,4
GB,DEVICE RELATED SEPSIS,4
GB,DIFFUSE LARGE B-CELL LYMPHOMA,4
GB,DIVERTICULUM,4
GB,DRUG EFFECT DECREASED,4
GB,DRY SKIN,4
GB,DRY THROAT,4
GB,EMPHYSEMA,4
GB,FEAR OF INJECTION,4
GB,GASTROENTERITIS VIRAL,4
GB,GLAUCOMA,4
GB,GOUT,4
GB,HAEMATEMESIS,4
GB,HEART VALVE INCOMPETENCE,4
GB,HEPATIC CIRRHOSIS,4
GB,HYPERTHYROIDISM,4
GB,IMMOBILE,4
GB,INFECTED BITE,4
GB,INJECTION SITE IRRITATION,4
GB,LEFT VENTRICULAR DYSFUNCTION,4
GB,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,4
GB,LYMPHOCYTE COUNT DECREASED,4
GB,METASTASIS,4
GB,MIGRAINE WITH AURA,4
GB,NECROTISING FASCIITIS,4
GB,NO ADVERSE EVENT,4
GB,NON-SMALL CELL LUNG CANCER,4
GB,OCULAR HYPERAEMIA,4
GB,ORAL PAIN,4
GB,PLASMA CELL MYELOMA,4
GB,PLEURITIC PAIN,4
GB,POOR QUALITY SLEEP,4
GB,SCAR PAIN,4
GB,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,4
GB,TOOTH LOSS,4
GB,URINARY RETENTION,4
GB,VITAMIN D DECREASED,4
GB,ABDOMINAL SEPSIS,3
GB,ABDOMINAL WOUND DEHISCENCE,3
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,3
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,3
GB,ADRENAL ATROPHY,3
GB,AGITATION,3
GB,ANAL ABSCESS,3
GB,ANAL CANCER METASTATIC,3
GB,ANEURYSM,3
GB,AORTIC VALVE DISEASE MIXED,3
GB,APOPTOSIS,3
GB,ARRHYTHMIA,3
GB,ATYPICAL MYCOBACTERIAL INFECTION,3
GB,BACTERIAL INFECTION,3
GB,BILIRUBIN CONJUGATED INCREASED,3
GB,BLADDER CANCER STAGE 0_ WITH CANCER IN SITU,3
GB,BLADDER TRANSITIONAL CELL CARCINOMA,3
GB,BLOOD CALCIUM DECREASED,3
GB,BLOOD PHOSPHORUS DECREASED,3
GB,BLOOD PRESSURE ABNORMAL,3
GB,BLOOD UREA INCREASED,3
GB,BONE PAIN,3
GB,BREAST ABSCESS,3
GB,BURSITIS,3
GB,CARDIOMEGALY,3
GB,CEREBRAL INFARCTION,3
GB,CHRONIC GRAFT VERSUS HOST DISEASE,3
GB,CHRONIC MYELOID LEUKAEMIA,3
GB,CLAVICLE FRACTURE,3
GB,CLOSTRIDIUM DIFFICILE INFECTION,3
GB,COMA SCALE ABNORMAL,3
GB,COMPLETED SUICIDE,3
GB,CONCOMITANT DISEASE PROGRESSION,3
GB,CORONARY ARTERY DISEASE,3
GB,DEFAECATION URGENCY,3
GB,DERMATITIS BULLOUS,3
GB,DIABETIC ULCER,3
GB,DISSEMINATED TUBERCULOSIS,3
GB,DYSSTASIA,3
GB,EMPYEMA,3
GB,ENCEPHALITIS,3
GB,ENCEPHALOMYELITIS,3
GB,ENDOCARDITIS,3
GB,EYE PRURITUS,3
GB,FEEDING DISORDER,3
GB,FEELING COLD,3
GB,FEELING OF BODY TEMPERATURE CHANGE,3
GB,FLUID RETENTION,3
GB,FREQUENT BOWEL MOVEMENTS,3
GB,GANGRENE,3
GB,GENERAL PHYSICAL HEALTH DETERIORATION,3
GB,GINGIVAL BLEEDING,3
GB,GRAFT VERSUS HOST DISEASE IN SKIN,3
GB,HAEMODYNAMIC INSTABILITY,3
GB,HAEMORRHOIDS,3
GB,IDIOPATHIC PNEUMONIA SYNDROME,3
GB,INCREASED TENDENCY TO BRUISE,3
GB,INJECTION SITE HAEMORRHAGE,3
GB,INJECTION SITE RECALL REACTION,3
GB,INTENTIONAL PRODUCT MISUSE,3
GB,INTERNATIONAL NORMALISED RATIO INCREASED,3
GB,INTRAOCULAR PRESSURE TEST ABNORMAL,3
GB,IRON DEFICIENCY ANAEMIA,3
GB,JOINT EFFUSION,3
GB,LACRIMATION INCREASED,3
GB,LEFT VENTRICULAR FAILURE,3
GB,LEUKOPENIA,3
GB,LUNG NEOPLASM,3
GB,LYMPHOEDEMA,3
GB,LYMPHOPENIA,3
GB,MACULAR DEGENERATION,3
GB,MALABSORPTION,3
GB,MALIGNANT NEOPLASM PROGRESSION,3
GB,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,3
GB,MEAN CELL HAEMOGLOBIN INCREASED,3
GB,METASTASES TO LYMPH NODES,3
GB,MONOCYTE COUNT DECREASED,3
GB,MOTOR NEURONE DISEASE,3
GB,MOVEMENT DISORDER,3
GB,MYALGIA,3
GB,MYELITIS,3
GB,NASAL DISCOMFORT,3
GB,NEOPLASM SKIN,3
GB,NEPHROPATHY,3
GB,NERVE INJURY,3
GB,NEUROENDOCRINE TUMOUR,3
GB,NEUROLOGICAL SYMPTOM,3
GB,NEUTROPENIC SEPSIS,3
GB,OEDEMA,3
GB,PANIC REACTION,3
GB,PARAESTHESIA ORAL,3
GB,PERIPHERAL VASCULAR DISORDER,3
GB,PHARYNGEAL DISORDER,3
GB,PNEUMONIA KLEBSIELLA,3
GB,POSTMENOPAUSAL HAEMORRHAGE,3
GB,POSTOPERATIVE WOUND COMPLICATION,3
GB,POSTURING,3
GB,PROTEIN TOTAL DECREASED,3
GB,PULMONARY CONGESTION,3
GB,PYODERMA GANGRENOSUM,3
GB,RALES,3
GB,RENAL CELL CARCINOMA,3
GB,SECRETION DISCHARGE,3
GB,SINUS DISORDER,3
GB,SMALL CELL LUNG CANCER METASTATIC,3
GB,SUICIDE ATTEMPT,3
GB,T-CELL LYMPHOMA,3
GB,TESTIS CANCER,3
GB,THERAPY NON-RESPONDER,3
GB,THROAT CANCER,3
GB,TOOTHACHE,3
GB,TROPONIN T INCREASED,3
GB,TYMPANIC MEMBRANE PERFORATION,3
GB,UMBILICAL HERNIA,3
GB,UNRESPONSIVE TO STIMULI,3
GB,UTERINE CANCER,3
GB,VAGINAL HAEMORRHAGE,3
GB,VASCULITIS,3
GB,VITAMIN B COMPLEX DEFICIENCY,3
GB,VULVAL CANCER,3
GB,WOUND SEPSIS,3
GB,ABDOMINAL HERNIA OBSTRUCTIVE,2
GB,ABDOMINOPLASTY,2
GB,ABNORMAL BEHAVIOUR,2
GB,ACNE,2
GB,ACTINIC KERATOSIS,2
GB,AKINESIA,2
GB,ALCOHOL POISONING,2
GB,AMNESIA,2
GB,ANAL HYPOAESTHESIA,2
GB,ANAL SQUAMOUS CELL CARCINOMA,2
GB,ANAPHYLACTIC SHOCK,2
GB,ANIMAL BITE,2
GB,ANIMAL SCRATCH,2
GB,ANTINUCLEAR ANTIBODY POSITIVE,2
GB,APPARENT DEATH,2
GB,APPENDICITIS,2
GB,ASCITES,2
GB,ATAXIA,2
GB,ATELECTASIS,2
GB,ATRIAL FLUTTER,2
GB,ATYPICAL PNEUMONIA,2
GB,AUTISM,2
GB,BACK INJURY,2
GB,BEDRIDDEN,2
GB,BENIGN NEOPLASM,2
GB,BENIGN NEOPLASM OF THYROID GLAND,2
GB,BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC,2
GB,BLINDNESS UNILATERAL,2
GB,BLOOD BILIRUBIN INCREASED,2
GB,BLOOD GLUCOSE ABNORMAL,2
GB,BLOOD URINE PRESENT,2
GB,BONE MARROW FAILURE,2
GB,BRAIN INJURY,2
GB,BURN INFECTION,2
GB,CARDIOVASCULAR DISORDER,2
GB,CATARRH,2
GB,CERVICAL DYSPLASIA,2
GB,CERVIX CARCINOMA,2
GB,CHEST INJURY,2
GB,CHOLECYSTITIS INFECTIVE,2
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
GB,COELIAC DISEASE,2
GB,COLITIS ISCHAEMIC,2
GB,COLON CANCER STAGE 0,2
GB,COLORECTAL CANCER METASTATIC,2
GB,CONGESTIVE CARDIOMYOPATHY,2
GB,CONTRAINDICATED DRUG ADMINISTERED,2
GB,CORONARY ARTERY OCCLUSION,2
GB,DEMENTIA ALZHEIMER^S TYPE,2
GB,DENTAL CARIES,2
GB,DERMATITIS,2
GB,DERMATITIS ALLERGIC,2
GB,DEVICE OCCLUSION,2
GB,DISEASE PROGRESSION,2
GB,DISSEMINATED INTRAVASCULAR COAGULATION,2
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
GB,DRUG PRESCRIBING ERROR,2
GB,EAR DISORDER,2
GB,EATING DISORDER,2
GB,ECTOPIC PREGNANCY,2
GB,ELDERLY,2
GB,EMOTIONAL DISORDER,2
GB,ENDOMETRIAL ADENOCARCINOMA,2
GB,ENDOPHTHALMITIS,2
GB,ENTERITIS INFECTIOUS,2
GB,ERYSIPELAS,2
GB,ERYTHEMA MULTIFORME,2
GB,ERYTHRODERMIC PSORIASIS,2
GB,ESCHERICHIA URINARY TRACT INFECTION,2
GB,ESSENTIAL HYPERTENSION,2
GB,EXCORIATION,2
GB,EXERCISE TOLERANCE DECREASED,2
GB,EXTRADURAL ABSCESS,2
GB,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),2
GB,EYE ULCER,2
GB,EYELID PTOSIS,2
GB,FACIAL PARALYSIS,2
GB,FAECES DISCOLOURED,2
GB,FAILURE TO THRIVE,2
GB,FIBROMYALGIA,2
GB,FISTULA,2
GB,FOLLICULITIS,2
GB,FOOD ALLERGY,2
GB,FUNGAL INFECTION,2
GB,GALACTORRHOEA,2
GB,GALLBLADDER CANCER,2
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
GB,GASTRIC ULCER HAEMORRHAGE,2
GB,GASTRITIS,2
GB,GASTROINTESTINAL INFECTION,2
GB,GENITAL HYPOAESTHESIA,2
GB,GESTATIONAL DIABETES,2
GB,GLOMERULAR FILTRATION RATE ABNORMAL,2
GB,GLOSSODYNIA,2
GB,GRAFT VERSUS HOST DISEASE,2
GB,GROIN ABSCESS,2
GB,GROWTH RETARDATION,2
GB,HAEMORRHAGE SUBCUTANEOUS,2
GB,HALLUCINATION,2
GB,HAND FRACTURE,2
GB,HEAD DISCOMFORT,2
GB,HEAD INJURY,2
GB,HELICOBACTER INFECTION,2
GB,HEPATIC ENZYME INCREASED,2
GB,HEPATIC INFECTION,2
GB,HEPATIC LESION,2
GB,HEPATITIS,2
GB,HEPATITIS ALCOHOLIC,2
GB,HUMERUS FRACTURE,2
GB,HYPERREFLEXIA,2
GB,HYPERTENSIVE HEART DISEASE,2
GB,HYPOPHAGIA,2
GB,HYPOTONIA,2
GB,HYPOXIA,2
GB,ILL-DEFINED DISORDER,2
GB,INCORRECT PRODUCT STORAGE,2
GB,INDURATION,2
GB,INFECTED BITES,2
GB,INFECTION SUSCEPTIBILITY INCREASED,2
GB,INFECTIVE EXACERBATION OF BRONCHIECTASIS,2
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
GB,INFLAMMATORY BOWEL DISEASE,2
GB,INGUINAL MASS,2
GB,INJECTION SITE DISCOLOURATION,2
GB,INJURY,2
GB,INTENTIONAL OVERDOSE,2
GB,INTERVERTEBRAL DISC DEGENERATION,2
GB,INTERVERTEBRAL DISC SPACE NARROWING,2
GB,INTESTINAL ISCHAEMIA,2
GB,INTESTINAL ULCER,2
GB,INTRACRANIAL PRESSURE INCREASED,2
GB,INVASIVE BREAST CARCINOMA,2
GB,IRRITABILITY,2
GB,IRRITABLE BOWEL SYNDROME,2
GB,LARGE INTESTINE POLYP,2
GB,LIP AND/OR ORAL CAVITY CANCER,2
GB,LIP DRY,2
GB,LIPOMA,2
GB,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,2
GB,LOWER RESPIRATORY TRACT INFECTION VIRAL,2
GB,LOWER RESPIRATORY TRACT INFLAMMATION,2
GB,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,2
GB,MALIGNANT NEOPLASM OF EYELID,2
GB,MALIGNANT PLEURAL EFFUSION,2
GB,MALNUTRITION,2
GB,MASTITIS,2
GB,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
GB,MENTAL IMPAIRMENT,2
GB,METASTASES TO ADRENALS,2
GB,METASTASES TO SPINE,2
GB,METASTATIC GASTRIC CANCER,2
GB,METASTATIC SQUAMOUS CELL CARCINOMA,2
GB,MICROANGIOPATHY,2
GB,MICTURITION URGENCY,2
GB,MITRAL VALVE DISEASE,2
GB,MOUTH SWELLING,2
GB,MULTIPLE SCLEROSIS,2
GB,MYASTHENIA GRAVIS,2
GB,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
GB,MYELODYSPLASTIC SYNDROME,2
GB,NAIL DISORDER,2
GB,NASAL DISORDER,2
GB,NASOPHARYNGEAL CANCER,2
GB,NECK MASS,2
GB,NEPHROTIC SYNDROME,2
GB,NERVE ROOT COMPRESSION,2
GB,NERVOUSNESS,2
GB,NEUROGENIC BLADDER,2
GB,NEUTRALISING ANTIBODIES POSITIVE,2
GB,NOSOCOMIAL INFECTION,2
GB,OBSTRUCTIVE AIRWAYS DISORDER,2
GB,OESTROGEN RECEPTOR POSITIVE BREAST CANCER,2
GB,OPTIC NEURITIS,2
GB,ORAL DISORDER,2
GB,ORAL MUCOSAL BLISTERING,2
GB,ORGAN FAILURE,2
GB,OSTEOSARCOMA,2
GB,OVARIAN CANCER METASTATIC,2
GB,OVARIAN CYST,2
GB,OVARIAN DISORDER,2
GB,OXYGEN SATURATION DECREASED,2
GB,PANCYTOPENIA,2
GB,PAPILLOEDEMA,2
GB,PARALYSIS,2
GB,PATHOLOGICAL FRACTURE,2
GB,PENILE SQUAMOUS CELL CARCINOMA,2
GB,PERIPHERAL ARTHRITIS,2
GB,PERIPHERAL ISCHAEMIA,2
GB,PERSONALITY CHANGE,2
GB,PHAEOCHROMOCYTOMA,2
GB,PHARYNGEAL HAEMORRHAGE,2
GB,PHLEBITIS,2
GB,PHOTOPHOBIA,2
GB,PHOTOSENSITIVITY REACTION,2
GB,POLYP,2
GB,POST PROCEDURAL DISCHARGE,2
GB,PREMATURE BABY,2
GB,PROCTALGIA,2
GB,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
GB,PSEUDOMONAS INFECTION,2
GB,PSEUDOMYXOMA PERITONEI,2
GB,PSYCHOMOTOR HYPERACTIVITY,2
GB,PUBIS FRACTURE,2
GB,PULMONARY ARTERY THROMBOSIS,2
GB,PULMONARY PAIN,2
GB,PULMONARY SARCOIDOSIS,2
GB,PYELONEPHRITIS,2
GB,PYOMETRA,2
GB,RAYNAUD^S PHENOMENON,2
GB,RENAL CANCER METASTATIC,2
GB,RENAL INJURY,2
GB,RESPIRATORY RATE INCREASED,2
GB,RETINAL DETACHMENT,2
GB,SCAB,2
GB,SCHIZOPHRENIA,2
GB,SCIATICA,2
GB,SEASONAL ALLERGY,2
GB,SENSORY LOSS,2
GB,SEXUAL DYSFUNCTION,2
GB,SKIN BURNING SENSATION,2
GB,SKIN FISSURES,2
GB,SKIN HAEMORRHAGE,2
GB,SKIN PAPILLOMA,2
GB,SMALL CELL LUNG CANCER,2
GB,SMALL FIBRE NEUROPATHY,2
GB,SMALL INTESTINE CARCINOMA,2
GB,SPINAL CORD COMPRESSION,2
GB,SPINDLE CELL SARCOMA,2
GB,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,2
GB,STAPHYLOCOCCAL SEPSIS,2
GB,STILL^S DISEASE,2
GB,STOMATITIS,2
GB,STREPTOCOCCAL INFECTION,2
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,2
GB,TACHYPNOEA,2
GB,TEMPORAL ARTERITIS,2
GB,TENDON RUPTURE,2
GB,TESTICULAR MASS,2
GB,THERAPY PARTIAL RESPONDER,2
GB,THERMAL BURN,2
GB,THYROID DISORDER,2
GB,TIBIA FRACTURE,2
GB,TINNITUS,2
GB,TONGUE DISORDER,2
GB,TONSIL CANCER,2
GB,TUBULOINTERSTITIAL NEPHRITIS,2
GB,UTERINE LEIOMYOMA,2
GB,VAGINAL PROLAPSE,2
GB,VARICOSE VEIN,2
GB,VASCULITIC RASH,2
GB,VITAMIN B12 DEFICIENCY,2
GB,VITREOUS DETACHMENT,2
GB,VOCAL CORD PARALYSIS,2
GB,WITHDRAWAL SYNDROME,2
GB,WOUND HAEMORRHAGE,2
GB,WOUND INFECTION STAPHYLOCOCCAL,2
GB,YELLOW SKIN,2
GB,ABDOMINAL ABSCESS,1
GB,ABDOMINAL ADHESIONS,1
GB,ABDOMINAL INFECTION,1
GB,ABNORMAL DREAMS,1
GB,ABNORMAL SENSATION IN EYE,1
GB,ABORTION INDUCED,1
GB,ABSCESS INTESTINAL,1
GB,ACARODERMATITIS,1
GB,ACCIDENT AT HOME,1
GB,ACCIDENTAL DEATH,1
GB,ACCIDENTAL EXPOSURE TO PRODUCT,1
GB,ACROCHORDON,1
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
GB,ACUTE CORONARY SYNDROME,1
GB,ACUTE INTERSTITIAL PNEUMONITIS,1
GB,ACUTE LYMPHOCYTIC LEUKAEMIA,1
GB,ACUTE RESPIRATORY FAILURE,1
GB,ADENOCARCINOMA,1
GB,ADENOCARCINOMA GASTRIC,1
GB,ADENOCARCINOMA OF APPENDIX,1
GB,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
GB,ALCOHOLISM,1
GB,ALOPECIA AREATA,1
GB,ALOPECIA TOTALIS,1
GB,ALVEOLITIS ALLERGIC,1
GB,ANAEMIA OF CHRONIC DISEASE,1
GB,ANAL ULCER,1
GB,ANAPLASTIC ASTROCYTOMA,1
GB,ANASTOMOTIC COMPLICATION,1
GB,ANGER,1
GB,ANGINA BULLOSA HAEMORRHAGICA,1
GB,ANGINA UNSTABLE,1
GB,ANGIOPATHY,1
GB,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
GB,ANGLE CLOSURE GLAUCOMA,1
GB,ANTIPHOSPHOLIPID SYNDROME,1
GB,AORTIC DISSECTION RUPTURE,1
GB,AORTIC STENOSIS,1
GB,AORTIC VALVE DISEASE,1
GB,AORTIC VALVE INCOMPETENCE,1
GB,AORTIC VALVE STENOSIS,1
GB,APATHY,1
GB,APHAGIA,1
GB,APNOEA,1
GB,APPENDICITIS PERFORATED,1
GB,ARTERIOVENOUS MALFORMATION,1
GB,ASBESTOSIS,1
US,INJECTION SITE PAIN,29662
US,INJECTION SITE ERYTHEMA,22751
US,ARTHRALGIA,19545
US,DRUG INEFFECTIVE,19042
US,PAIN,15492
US,PAIN IN EXTREMITY,12928
US,INJECTION SITE SWELLING,12721
US,PSORIASIS,12468
US,INJECTION SITE PRURITUS,12440
US,INJECTION SITE REACTION,11165
US,INJECTION SITE BRUISING,10334
US,FATIGUE,9761
US,DRUG DOSE OMISSION,9643
US,HEADACHE,9531
US,NASOPHARYNGITIS,9325
US,RHEUMATOID ARTHRITIS,8794
US,MALAISE,7944
US,SINUSITIS,6919
US,JOINT SWELLING,6521
US,COUGH,6074
US,DRUG EFFECT INCOMPLETE,5963
US,NAUSEA,5624
US,INJECTION SITE WARMTH,5592
US,CONDITION AGGRAVATED,5354
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5106
US,BACK PAIN,5061
US,MUSCULOSKELETAL STIFFNESS,4997
US,INJECTION SITE HAEMORRHAGE,4960
US,DRUG EFFECT DECREASED,4660
US,PERIPHERAL SWELLING,4452
US,MOBILITY DECREASED,4367
US,INJECTION SITE RASH,4338
US,RASH,4237
US,PRURITUS,3808
US,PYREXIA,3784
US,INFLUENZA,3733
US,FEELING ABNORMAL,3721
US,MUSCULOSKELETAL PAIN,3717
US,GAIT DISTURBANCE,3675
US,DIARRHOEA,3535
US,THERAPEUTIC RESPONSE DECREASED,3485
US,UNEVALUABLE EVENT,3478
US,ARTHRITIS,3422
US,BRONCHITIS,3398
US,OROPHARYNGEAL PAIN,3368
US,ERYTHEMA,3320
US,DIZZINESS,3287
US,PNEUMONIA,3223
US,INJECTION SITE URTICARIA,3204
US,INFECTION,3170
US,FALL,2965
US,DEVICE ISSUE,2935
US,DYSPNOEA,2882
US,ASTHENIA,2681
US,LOCAL SWELLING,2668
US,HYPERSENSITIVITY,2642
US,CONTUSION,2636
US,INTENTIONAL PRODUCT MISUSE,2536
US,VOMITING,2507
US,JOINT STIFFNESS,2462
US,PSORIATIC ARTHROPATHY,2421
US,INJECTION SITE MASS,2362
US,URINARY TRACT INFECTION,2360
US,UNDERDOSE,2303
US,HYPOAESTHESIA,2292
US,UPPER RESPIRATORY TRACT INFECTION,2274
US,INJECTION SITE DISCOLOURATION,2211
US,INCORRECT PRODUCT STORAGE,2208
US,RHINORRHOEA,2166
US,ARTHROPATHY,2143
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2121
US,INJECTION SITE INDURATION,2069
US,SWELLING,2058
US,DRUG HYPERSENSITIVITY,1998
US,ALOPECIA,1926
US,PARAESTHESIA,1880
US,URTICARIA,1833
US,NECK PAIN,1832
US,MEMORY IMPAIRMENT,1831
US,SURGERY,1815
US,INSOMNIA,1806
US,HERPES ZOSTER,1772
US,ACCIDENTAL EXPOSURE TO PRODUCT,1760
US,NASAL CONGESTION,1740
US,MUSCLE SPASMS,1706
US,WEIGHT INCREASED,1640
US,ADVERSE EVENT,1622
US,ANXIETY,1577
US,INFLAMMATION,1535
US,TREATMENT FAILURE,1527
US,WEIGHT DECREASED,1494
US,ABDOMINAL DISCOMFORT,1456
US,RESPIRATORY TRACT CONGESTION,1428
US,ABDOMINAL PAIN UPPER,1410
US,STRESS,1398
US,INFLUENZA LIKE ILLNESS,1379
US,OEDEMA PERIPHERAL,1370
US,ADVERSE DRUG REACTION,1321
US,KNEE ARTHROPLASTY,1317
US,CHEST PAIN,1301
US,MYALGIA,1297
US,DEATH,1287
US,INJECTION SITE EXTRAVASATION,1286
US,SKIN PLAQUE,1264
US,DEPRESSION,1253
US,CHILLS,1249
US,RASH PRURITIC,1237
US,INJECTION SITE DISCOMFORT,1186
US,VISUAL IMPAIRMENT,1183
US,MIGRAINE,1168
US,THERAPY NON-RESPONDER,1157
US,MUSCULAR WEAKNESS,1115
US,FEELING HOT,1108
US,SKIN DISCOLOURATION,1095
US,RASH ERYTHEMATOUS,1077
US,EAR INFECTION,1074
US,PRODUCTIVE COUGH,1072
US,HEPATIC ENZYME INCREASED,1071
US,MUSCULOSKELETAL DISORDER,1060
US,STAPHYLOCOCCAL INFECTION,1042
US,SKIN EXFOLIATION,1035
US,NO THERAPEUTIC RESPONSE,1024
US,OSTEOARTHRITIS,1019
US,INCORRECT DOSE ADMINISTERED,1013
US,NODULE,1000
US,HYPERHIDROSIS,998
US,IMPAIRED HEALING,984
US,HYPERTENSION,980
US,DRY SKIN,968
US,LOCALISED INFECTION,954
US,CELLULITIS,943
US,DECREASED APPETITE,942
US,BURNING SENSATION,915
US,VISION BLURRED,899
US,HYPOACUSIS,876
US,SINUS CONGESTION,869
US,DYSPHONIA,864
US,ABDOMINAL PAIN,861
US,THROAT IRRITATION,836
US,SOMNOLENCE,833
US,LIMB DISCOMFORT,826
US,SINUS DISORDER,825
US,HOSPITALISATION,814
US,TREMOR,789
US,CHEST DISCOMFORT,788
US,SNEEZING,788
US,FIBROMYALGIA,784
US,PRURITUS GENERALISED,783
US,FUNGAL INFECTION,768
US,BLISTER,766
US,CYSTITIS,761
US,LACERATION,759
US,DIABETES MELLITUS,733
US,ASTHMA,730
US,NERVOUSNESS,722
US,VIRAL INFECTION,720
US,LYMPHADENOPATHY,719
US,PHARYNGITIS STREPTOCOCCAL,719
US,BLOOD PRESSURE INCREASED,709
US,HIP ARTHROPLASTY,707
US,CATARACT,706
US,SKIN DISORDER,705
US,JOINT RANGE OF MOTION DECREASED,698
US,FOOT DEFORMITY,696
US,ILL-DEFINED DISORDER,689
US,SLEEP DISORDER,665
US,DRY MOUTH,656
US,PRODUCT STORAGE ERROR,653
US,TOOTH DISORDER,652
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,650
US,FINGER DEFORMITY,647
US,CEREBROVASCULAR ACCIDENT,642
US,DISCOMFORT,635
US,WHITE BLOOD CELL COUNT DECREASED,634
US,TOOTH INFECTION,620
US,GRIP STRENGTH DECREASED,613
US,RASH MACULAR,600
US,CONSTIPATION,599
US,GASTROENTERITIS VIRAL,599
US,INJURY ASSOCIATED WITH DEVICE,598
US,ANAEMIA,589
US,INCREASED TENDENCY TO BRUISE,589
US,DEVICE MALFUNCTION,586
US,EAR PAIN,583
US,ANKYLOSING SPONDYLITIS,577
US,MUSCULOSKELETAL DISCOMFORT,577
US,HAND DEFORMITY,575
US,DIVERTICULITIS,574
US,MYOCARDIAL INFARCTION,573
US,SKIN ULCER,567
US,RESPIRATORY TRACT INFECTION,560
US,NEUROPATHY PERIPHERAL,557
US,RASH GENERALISED,555
US,NEPHROLITHIASIS,553
US,SWELLING FACE,553
US,GASTROINTESTINAL DISORDER,550
US,BONE PAIN,548
US,CONFUSIONAL STATE,547
US,DRY EYE,547
US,RASH PAPULAR,542
US,ADVERSE REACTION,541
US,BREAST CANCER,536
US,FEAR OF INJECTION,534
US,DYSPEPSIA,523
US,HOT FLUSH,523
US,BLOOD GLUCOSE INCREASED,519
US,SKIN HAEMORRHAGE,517
US,ABASIA,512
US,EXTRA DOSE ADMINISTERED,508
US,ACTIVITIES OF DAILY LIVING IMPAIRED,507
US,EPISTAXIS,507
US,INTERVERTEBRAL DISC PROTRUSION,502
US,ROAD TRAFFIC ACCIDENT,501
US,LIMB INJURY,500
US,EYE DISORDER,499
US,CARDIAC DISORDER,497
US,INJECTION SITE VESICLES,497
US,PARANASAL SINUS HYPERSECRETION,497
US,LOWER RESPIRATORY TRACT INFECTION,488
US,DEHYDRATION,479
US,GASTROOESOPHAGEAL REFLUX DISEASE,476
US,ORAL HERPES,476
US,INJECTION SITE IRRITATION,470
US,JOINT INJURY,469
US,TOOTHACHE,464
US,ACNE,463
US,PALPITATIONS,462
US,ABDOMINAL DISTENSION,459
US,ARTHROPOD BITE,459
US,BALANCE DISORDER,456
US,KIDNEY INFECTION,452
US,LUNG DISORDER,447
US,SEPSIS,441
US,STOMATITIS,439
US,EYE PAIN,432
US,IMMUNE SYSTEM DISORDER,432
US,LOSS OF CONSCIOUSNESS,432
US,SKIN LESION,432
US,WOUND,432
US,LABORATORY TEST ABNORMAL,429
US,KNEE OPERATION,422
US,SINUS HEADACHE,420
US,NIGHT SWEATS,418
US,INJECTION SITE INFLAMMATION,416
US,SPINAL PAIN,412
US,MASS,408
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,407
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,400
US,SYSTEMIC LUPUS ERYTHEMATOSUS,398
US,LARYNGITIS,397
US,AMNESIA,390
US,SPINAL OPERATION,390
US,DYSGEUSIA,388
US,DRUG INTOLERANCE,387
US,TOOTH ABSCESS,386
US,BACK DISORDER,385
US,NEOPLASM MALIGNANT,382
US,CARPAL TUNNEL SYNDROME,381
US,LUNG INFECTION,381
US,DYSSTASIA,377
US,LETHARGY,374
US,WHEEZING,374
US,TENDERNESS,373
US,VERTIGO,373
US,EYE SWELLING,372
US,JOINT EFFUSION,371
US,DRUG EFFECT DELAYED,366
US,INJECTION SITE NODULE,364
US,HEART RATE INCREASED,363
US,ROTATOR CUFF SYNDROME,363
US,VISUAL ACUITY REDUCED,359
US,LIVER FUNCTION TEST ABNORMAL,358
US,SCRATCH,356
US,DYSPHAGIA,354
US,FURUNCLE,353
US,OCULAR HYPERAEMIA,351
US,SECRETION DISCHARGE,345
US,THROMBOSIS,344
US,LACRIMATION INCREASED,342
US,HEAD DISCOMFORT,340
US,DEVICE FAILURE,337
US,PAIN IN JAW,336
US,EXOSTOSIS,335
US,INJECTION SITE MACULE,335
US,SCAB,335
US,LIVER DISORDER,334
US,SKIN FISSURES,334
US,CYST,333
US,TOOTH EXTRACTION,332
US,HAEMORRHAGE,330
US,BONE DISORDER,329
US,DISABILITY,329
US,OSTEOPOROSIS,323
US,CRYING,321
US,DEPRESSED MOOD,318
US,INJECTION SITE RECALL REACTION,318
US,ATRIAL FIBRILLATION,317
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,317
US,UPPER LIMB FRACTURE,315
US,EYE PRURITUS,314
US,SEASONAL ALLERGY,312
US,THERAPEUTIC RESPONSE UNEXPECTED,312
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,311
US,TOOTH FRACTURE,311
US,FEELING COLD,306
US,FOOT OPERATION,304
US,MATERNAL EXPOSURE DURING PREGNANCY,303
US,DYSURIA,301
US,GASTRIC DISORDER,301
US,MUSCULOSKELETAL CHEST PAIN,300
US,PLATELET COUNT DECREASED,299
US,CARDIAC FAILURE CONGESTIVE,297
US,FOOT FRACTURE,297
US,MENISCUS INJURY,294
US,SCAR,293
US,NEURALGIA,291
US,SCIATICA,291
US,HYPOTENSION,287
US,WHITE BLOOD CELL COUNT INCREASED,287
US,EYE INFECTION,285
US,JOINT CREPITATION,282
US,POLLAKIURIA,281
US,BURSITIS,279
US,DECREASED IMMUNE RESPONSIVENESS,279
US,NERVE COMPRESSION,279
US,RESPIRATORY DISORDER,277
US,WALKING AID USER,276
US,UPPER-AIRWAY COUGH SYNDROME,274
US,FLUSHING,273
US,RENAL FAILURE,270
US,SKIN CANCER,269
US,HIP FRACTURE,265
US,SPINAL FUSION SURGERY,265
US,SPEECH DISORDER,263
US,TINNITUS,262
US,PREGNANCY,260
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,258
US,INJURY,258
US,RENAL DISORDER,258
US,BLOOD CHOLESTEROL INCREASED,253
US,BLOOD PRESSURE ABNORMAL,253
US,BACTERIAL INFECTION,248
US,PULMONARY MASS,248
US,DRUG ADMINISTRATION ERROR,247
US,JOINT LOCK,247
US,INTERVERTEBRAL DISC DEGENERATION,246
US,OVERDOSE,246
US,PAIN OF SKIN,244
US,SKIN MASS,244
US,APHONIA,243
US,SKIN INFECTION,243
US,SPUTUM DISCOLOURED,242
US,FLUID RETENTION,238
US,JOINT DESTRUCTION,238
US,IMPAIRED WORK ABILITY,237
US,ORAL PAIN,236
US,POST PROCEDURAL INFECTION,233
US,IRRITABILITY,232
US,MOUTH ULCERATION,229
US,SJOGREN^S SYNDROME,229
US,LIVER FUNCTION TEST INCREASED,228
US,HYPERSOMNIA,226
US,ANKLE FRACTURE,225
US,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,224
US,CROHN^S DISEASE,223
US,FEAR,223
US,PHARYNGITIS,223
US,ABORTION SPONTANEOUS,221
US,BLOOD TEST ABNORMAL,221
US,DENTAL CARIES,220
US,ECZEMA,220
US,LYMPHOMA,218
US,JUVENILE IDIOPATHIC ARTHRITIS,217
US,HEAD INJURY,216
US,MALIGNANT MELANOMA,216
US,EAR DISCOMFORT,215
US,SKIN BURNING SENSATION,215
US,INJECTION SITE HYPERSENSITIVITY,212
US,MUSCLE TIGHTNESS,212
US,TENDONITIS,212
US,LIMB OPERATION,211
US,NEEDLE ISSUE,210
US,PROSTATE CANCER,209
US,FLATULENCE,208
US,SPINAL COLUMN STENOSIS,207
US,SPINAL DISORDER,204
US,INCREASED UPPER AIRWAY SECRETION,203
US,SEIZURE,203
US,PAPULE,202
US,TUBERCULOSIS,202
US,COLITIS,201
US,DISTURBANCE IN ATTENTION,201
US,LIP SWELLING,201
US,RUBBER SENSITIVITY,201
US,CHONDROPATHY,200
US,DEAFNESS,200
US,EYE IRRITATION,200
US,LOWER LIMB FRACTURE,200
US,PHARYNGEAL OEDEMA,200
US,LIGAMENT SPRAIN,199
US,NAIL DISORDER,198
US,SYNOVITIS,198
US,THERAPY CESSATION,197
US,SYNCOPE,195
US,UVEITIS,195
US,BEDRIDDEN,194
US,SKIN IRRITATION,193
US,RASH PUSTULAR,192
US,MUSCLE TWITCHING,191
US,SHOULDER OPERATION,191
US,INJECTION SITE INJURY,189
US,BLOOD GLUCOSE DECREASED,187
US,RIB FRACTURE,187
US,BASAL CELL CARCINOMA,186
US,JOINT DISLOCATION,186
US,OSTEOMYELITIS,186
US,SPINAL FRACTURE,186
US,BLINDNESS,185
US,CLOSTRIDIUM DIFFICILE INFECTION,183
US,PULMONARY EMBOLISM,183
US,TENDON RUPTURE,183
US,STREPTOCOCCAL INFECTION,182
US,ULCER,182
US,DERMATITIS CONTACT,181
US,ARTHRITIS INFECTIVE,180
US,HEARING IMPAIRED,179
US,LUNG NEOPLASM MALIGNANT,179
US,GENERAL SYMPTOM,178
US,CONJUNCTIVITIS,177
US,JOINT WARMTH,177
US,DEVICE LEAKAGE,176
US,GOUT,176
US,CATARACT OPERATION,175
US,GENERAL PHYSICAL HEALTH DETERIORATION,175
US,PANIC ATTACK,175
US,BLOOD URINE PRESENT,174
US,HAEMOGLOBIN DECREASED,174
US,HYSTERECTOMY,173
US,MUSCLE STRAIN,173
US,IRITIS,171
US,SKIN REACTION,171
US,FACIAL PAIN,170
US,MACULE,170
US,RENAL IMPAIRMENT,170
US,MULTIPLE SCLEROSIS,169
US,OEDEMA,169
US,CANDIDA INFECTION,168
US,JOINT ARTHROPLASTY,168
US,SLEEP APNOEA SYNDROME,167
US,WOUND INFECTION,167
US,SHOULDER ARTHROPLASTY,166
US,VULVOVAGINAL MYCOTIC INFECTION,165
US,PULMONARY FIBROSIS,163
US,NERVE INJURY,161
US,PALLOR,161
US,PARANASAL SINUS DISCOMFORT,159
US,POST PROCEDURAL COMPLICATION,159
US,TRANSIENT ISCHAEMIC ATTACK,159
US,IRRITABLE BOWEL SYNDROME,158
US,PLEURAL EFFUSION,158
US,RHEUMATOID NODULE,158
US,WRIST FRACTURE,158
US,HEPATITIS C,157
US,CAESAREAN SECTION,156
US,CHOLECYSTECTOMY,156
US,CHONDROLYSIS,156
US,DRUG DISPENSING ERROR,156
US,PUSTULAR PSORIASIS,156
US,DEVICE DIFFICULT TO USE,155
US,HAEMATOCHEZIA,155
US,NERVOUS SYSTEM DISORDER,155
US,GALLBLADDER DISORDER,153
US,GROIN PAIN,153
US,HERNIA,153
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,153
US,PULMONARY CONGESTION,153
US,C-REACTIVE PROTEIN INCREASED,152
US,HYPERAESTHESIA,152
US,VAGINAL HAEMORRHAGE,152
US,EMOTIONAL DISORDER,151
US,BODY TEMPERATURE INCREASED,150
US,CARDIAC FAILURE,150
US,THROAT TIGHTNESS,150
US,BLOOD GLUCOSE ABNORMAL,149
US,FEMUR FRACTURE,149
US,ANIMAL BITE,148
US,CHOLELITHIASIS,148
US,POOR QUALITY SLEEP,148
US,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,148
US,UPPER RESPIRATORY TRACT CONGESTION,147
US,HIP SURGERY,146
US,BLOOD POTASSIUM DECREASED,145
US,SYNOVIAL CYST,145
US,ABSCESS,144
US,PHOTOPHOBIA,144
US,SKIN ATROPHY,144
US,IMMUNOSUPPRESSION,142
US,SWOLLEN TONGUE,142
US,ENDODONTIC PROCEDURE,140
US,ACCIDENT,139
US,MENTAL DISORDER,139
US,PHOTOSENSITIVITY REACTION,139
US,TACHYCARDIA,139
US,BLOOD COUNT ABNORMAL,138
US,BACK INJURY,137
US,MOOD SWINGS,137
US,RED BLOOD CELL COUNT DECREASED,137
US,TUBERCULIN TEST POSITIVE,137
US,GASTROINTESTINAL INFECTION,136
US,HEPATIC STEATOSIS,136
US,SUICIDAL IDEATION,136
US,DRY THROAT,135
US,INFLAMMATORY MARKER INCREASED,135
US,MOOD ALTERED,135
US,WHEELCHAIR USER,135
US,VITAMIN D DECREASED,133
US,DEVICE USE ERROR,132
US,PROCEDURAL PAIN,132
US,THYROID DISORDER,132
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,131
US,GLAUCOMA,131
US,PANCREATITIS,131
US,MENORRHAGIA,128
US,SUNBURN,128
US,LUPUS-LIKE SYNDROME,127
US,ROTATOR CUFF REPAIR,126
US,CONVULSION,125
US,CORRECTIVE LENS USER,125
US,EAR CONGESTION,125
US,COLD SWEAT,124
US,RECTAL HAEMORRHAGE,124
US,OSTEOPENIA,123
US,INJECTION SITE PAPULE,121
US,LYME DISEASE,121
US,PREMATURE BABY,121
US,CARDIAC OPERATION,120
US,DERMATITIS,120
US,SLUGGISHNESS,120
US,TRIGGER FINGER,120
US,COLON CANCER,119
US,BREAST MASS,118
US,AUTOIMMUNE DISORDER,117
US,DEMENTIA,117
US,EAR DISORDER,117
US,LIGAMENT RUPTURE,117
US,THERAPEUTIC RESPONSE DELAYED,117
US,URINARY INCONTINENCE,117
US,COLITIS ULCERATIVE,116
US,GALLBLADDER OPERATION,116
US,MEDICATION ERROR,116
US,RHEUMATOID FACTOR INCREASED,116
US,GINGIVAL PAIN,115
US,PERIPHERAL COLDNESS,115
US,FRUSTRATION TOLERANCE DECREASED,114
US,HYPOTHYROIDISM,114
US,SKIN WARM,114
US,VITAMIN D DEFICIENCY,114
US,DISORIENTATION,113
US,DYSPNOEA EXERTIONAL,113
US,THERMAL BURN,113
US,ANAPHYLACTIC REACTION,112
US,BLOOD DISORDER,112
US,SPINAL OSTEOARTHRITIS,112
US,LATENT TUBERCULOSIS,111
US,ONYCHOMYCOSIS,111
US,DRUG RESISTANCE,110
US,RETCHING,110
US,ALANINE AMINOTRANSFERASE INCREASED,109
US,EYE INFLAMMATION,109
US,GAIT INABILITY,109
US,HYPOKINESIA,109
US,NASAL DISCHARGE DISCOLOURATION,109
US,WEIGHT BEARING DIFFICULTY,109
US,ABDOMINAL PAIN LOWER,108
US,TYPE 2 DIABETES MELLITUS,108
US,ANGER,107
US,EATING DISORDER,107
US,INTERSTITIAL LUNG DISEASE,107
US,INTESTINAL OBSTRUCTION,107
US,MACULAR DEGENERATION,107
US,PREMATURE DELIVERY,107
US,SENSITIVITY TO WEATHER CHANGE,107
US,THINKING ABNORMAL,107
US,FEELING JITTERY,106
US,SKIN INJURY,106
US,TENDON DISORDER,106
US,WHITE BLOOD CELL COUNT ABNORMAL,106
US,ATYPICAL PNEUMONIA,105
US,HYPERKERATOSIS,105
US,INTERVERTEBRAL DISC DISORDER,105
US,ORAL INFECTION,105
US,THERAPEUTIC RESPONSE SHORTENED,105
US,FEELING OF BODY TEMPERATURE CHANGE,104
US,GASTRITIS,104
US,GENERALISED OEDEMA,104
US,BLOOD CREATININE INCREASED,103
US,BREAST PAIN,103
US,DIPLOPIA,103
US,DYSKINESIA,103
US,HEPATIC ENZYME ABNORMAL,103
US,NASAL DISCOMFORT,103
US,SKIN PAPILLOMA,103
US,SQUAMOUS CELL CARCINOMA,103
US,HEART RATE IRREGULAR,102
US,HEPATIC CIRRHOSIS,102
US,IMMUNODEFICIENCY,102
US,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,102
US,DEEP VEIN THROMBOSIS,101
US,FRUSTRATION,101
US,NECK SURGERY,101
US,BLADDER CANCER,100
US,BLOOD PRESSURE DECREASED,100
US,BODY TEMPERATURE ABNORMAL,100
US,MUSCLE DISORDER,100
US,PRESYNCOPE,100
US,RESTLESS LEGS SYNDROME,100
US,CHROMATURIA,99
US,HAEMATOMA,99
US,HAND FRACTURE,99
US,HYPOPHAGIA,99
US,NAIL DISCOLOURATION,99
US,EYE DISCHARGE,98
US,GINGIVITIS,98
US,MENTAL IMPAIRMENT,98
US,OXYGEN SATURATION DECREASED,98
US,PLEURISY,98
US,AGITATION,97
US,FUNGAL SKIN INFECTION,97
US,ORAL CANDIDIASIS,97
US,PLANTAR FASCIITIS,97
US,TENDON PAIN,97
US,HALLUCINATION,96
US,HIATUS HERNIA,96
US,SKIN SWELLING,96
US,TONSILLITIS,96
US,BLOOD IRON DECREASED,94
US,COLONOSCOPY,94
US,GINGIVAL BLEEDING,94
US,JOINT FLUID DRAINAGE,94
US,MENSTRUAL DISORDER,94
US,CONCUSSION,93
US,EMOTIONAL DISTRESS,92
US,GLOSSODYNIA,92
US,INDURATION,92
US,INJECTION SITE PARAESTHESIA,92
US,DYSARTHRIA,91
US,FAECES DISCOLOURED,91
US,ORAL DISORDER,91
US,TOOTH LOSS,91
US,ARTHROPOD STING,90
US,CORONARY ARTERY OCCLUSION,90
US,GASTROINTESTINAL HAEMORRHAGE,90
US,HAEMOPTYSIS,90
US,EYE OPERATION,89
US,GASTRIC INFECTION,89
US,INCREASED APPETITE,89
US,ORAL MUCOSAL BLISTERING,89
US,HYPOAESTHESIA ORAL,88
US,SKIN ABRASION,88
US,MIDDLE EAR EFFUSION,87
US,MUSCLE ATROPHY,87
US,COGNITIVE DISORDER,86
US,GASTRIC ULCER,86
US,VARICOSE VEIN,86
US,DENTAL OPERATION,85
US,HERNIA REPAIR,85
US,OBESITY,85
US,APHASIA,84
US,IMPAIRED DRIVING ABILITY,84
US,ONYCHOCLASIS,84
US,RAYNAUD^S PHENOMENON,84
US,SENSORY DISTURBANCE,84
US,ONYCHOMADESIS,83
US,MELANOCYTIC NAEVUS,81
US,MULTIPLE ALLERGIES,81
US,RESTLESSNESS,81
US,ASPARTATE AMINOTRANSFERASE INCREASED,80
US,DEVICE RELATED INFECTION,80
US,MICTURITION URGENCY,80
US,PNEUMOTHORAX,80
US,SCOLIOSIS,80
US,ARRHYTHMIA,79
US,INJECTION SITE HYPOAESTHESIA,79
US,NASAL DRYNESS,79
US,OVERWEIGHT,79
US,VAGINAL INFECTION,79
US,BLADDER DISORDER,78
US,DEMENTIA ALZHEIMER^S TYPE,78
US,HAEMORRHOIDS,78
US,INGROWING NAIL,78
US,LEUKOPENIA,78
US,PELVIC PAIN,78
US,VEIN DISORDER,78
US,EYELID OEDEMA,77
US,HERPES VIRUS INFECTION,77
US,INJECTION SITE INFECTION,77
US,SKIN INDURATION,77
US,STENT PLACEMENT,77
US,THYROID CANCER,77
US,ORAL SURGERY,76
US,THIRST,76
US,GENERALISED ERYTHEMA,75
US,HORDEOLUM,75
US,SQUAMOUS CELL CARCINOMA OF SKIN,75
US,INFECTIOUS MONONUCLEOSIS,74
US,MOVEMENT DISORDER,74
US,URINE ODOUR ABNORMAL,74
US,EMPHYSEMA,73
US,ERUCTATION,73
US,FOOD ALLERGY,73
US,VASCULITIS,73
US,ANIMAL SCRATCH,72
US,CARPAL TUNNEL DECOMPRESSION,72
US,CARTILAGE INJURY,72
US,FORMICATION,72
US,OVARIAN CYST,72
US,BLOOD BLISTER,71
US,BUNION,71
US,HEART RATE DECREASED,71
US,LIMB DEFORMITY,71
US,PARAESTHESIA ORAL,71
US,POSTOPERATIVE WOUND INFECTION,71
US,BLOOD SODIUM DECREASED,70
US,GINGIVAL SWELLING,70
US,HAEMORRHAGIC DIATHESIS,70
US,PULMONARY OEDEMA,70
US,BRAIN NEOPLASM,69
US,EXPIRED PRODUCT ADMINISTERED,69
US,FREQUENT BOWEL MOVEMENTS,69
US,LYMPH NODE PAIN,69
US,ORAL DISCOMFORT,69
US,PELVIC FRACTURE,69
US,PURULENT DISCHARGE,69
US,RHINITIS,69
US,SENSITIVITY OF TEETH,69
US,FOLLICULITIS,68
US,FOOD POISONING,68
US,PRODUCT QUALITY ISSUE,68
US,RHEUMATOID LUNG,68
US,TENDON INJURY,68
US,VITREOUS FLOATERS,68
US,CHRONIC SINUSITIS,67
US,COMA,67
US,SARCOIDOSIS,67
US,ANTIBIOTIC THERAPY,66
US,BONE LOSS,66
US,PHARYNGEAL DISORDER,66
US,TEMPOROMANDIBULAR JOINT SYNDROME,66
US,WRIST SURGERY,66
US,CORONARY ARTERY BYPASS,65
US,GINGIVAL DISORDER,65
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,65
US,NIGHTMARE,65
US,RASH MACULO-PAPULAR,65
US,RESPIRATORY FAILURE,65
US,SENSATION OF FOREIGN BODY,65
US,ABNORMAL DREAMS,64
US,BLEPHAROSPASM,64
US,CHOKING,64
US,CHRONIC KIDNEY DISEASE,64
US,DEFORMITY,64
US,INVESTIGATION,64
US,KNEE DEFORMITY,64
US,LARGE INTESTINE POLYP,64
US,NECK MASS,64
US,NEUTROPENIA,64
US,UTERINE LEIOMYOMA,64
US,ARTHRODESIS,63
US,CARDIAC PACEMAKER INSERTION,63
US,DENTAL IMPLANTATION,63
US,DRUG PRESCRIBING ERROR,63
US,HAIR TEXTURE ABNORMAL,63
US,INJECTION SITE CELLULITIS,63
US,INJECTION SITE HAEMATOMA,63
US,MOTOR DYSFUNCTION,63
US,OCULAR DISCOMFORT,63
US,PARKINSON^S DISEASE,63
US,SPONDYLITIS,63
US,HIDRADENITIS,62
US,RENAL PAIN,62
US,SENSORY LOSS,62
US,STRESS FRACTURE,62
US,DISEASE PROGRESSION,61
US,RENAL CANCER,61
US,SENSATION OF HEAVINESS,61
US,SKIN TIGHTNESS,61
US,TOE OPERATION,61
US,ARTHRITIS BACTERIAL,60
US,DRUG TOLERANCE,60
US,ENERGY INCREASED,60
US,INTERVERTEBRAL DISC OPERATION,60
US,MENOPAUSE,60
US,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,60
US,VIITH NERVE PARALYSIS,60
US,ABNORMAL BEHAVIOUR,59
US,ANKLE OPERATION,59
US,BLOOD CHOLESTEROL ABNORMAL,59
US,DYSGRAPHIA,59
US,GASTRIC BYPASS,59
US,GUTTATE PSORIASIS,59
US,HEPATIC FAILURE,59
US,NASAL ULCER,59
US,THROMBOCYTOPENIA,59
US,TINEA PEDIS,59
US,AORTIC ANEURYSM,58
US,DENTAL CARE,58
US,EXCORIATION,58
US,HAEMATURIA,58
US,INJECTION SITE SCAR,58
US,TIBIA FRACTURE,58
US,TREATMENT NONCOMPLIANCE,58
US,CORONARY ARTERY DISEASE,57
US,NAIL INFECTION,57
US,RENAL FUNCTION TEST ABNORMAL,57
US,SUBCUTANEOUS ABSCESS,57
US,ANGIOEDEMA,56
US,BLOOD TRIGLYCERIDES INCREASED,56
US,CERVICAL VERTEBRAL FRACTURE,56
US,CHEILITIS,56
US,CORONARY ARTERIAL STENT INSERTION,56
US,ESCHERICHIA INFECTION,56
US,LEUKAEMIA,56
US,LYMPHOEDEMA,56
US,NEOPLASM,56
US,PERICARDITIS,56
US,RASH VESICULAR,56
US,STAPHYLOCOCCAL SKIN INFECTION,56
US,ULCER HAEMORRHAGE,56
US,VAGINAL DISCHARGE,56
US,VULVOVAGINAL PRURITUS,56
US,WOUND SECRETION,56
US,APHAGIA,55
US,BREAKTHROUGH PAIN,55
US,DEMYELINATION,55
US,EYE HAEMORRHAGE,55
US,HELICOBACTER INFECTION,55
US,INFECTION SUSCEPTIBILITY INCREASED,55
US,JAW DISORDER,55
US,MOUTH SWELLING,55
US,OVARIAN CANCER,55
US,PRODUCT USE ISSUE,55
US,WOUND INFECTION STAPHYLOCOCCAL,55
US,ABDOMINAL HERNIA,54
US,ACCIDENT AT WORK,54
US,BREAST CANCER FEMALE,54
US,BUTTERFLY RASH,54
US,DERMATITIS ALLERGIC,54
US,EXPOSURE DURING BREAST FEEDING,54
US,INCISION SITE INFECTION,54
US,NASAL DISORDER,54
US,PERICARDIAL EFFUSION,54
US,POOR PERIPHERAL CIRCULATION,54
US,TEMPERATURE INTOLERANCE,54
US,THYROID NEOPLASM,54
US,UMBILICAL HERNIA,54
US,UTERINE CANCER,54
US,ABSCESS LIMB,53
US,CARDIAC ARREST,53
US,INCORRECT DOSAGE ADMINISTERED,53
US,NON-HODGKIN^S LYMPHOMA,53
US,PULMONARY THROMBOSIS,53
US,URINARY RETENTION,53
US,BONE GRAFT,52
US,BRONCHITIS CHRONIC,52
US,CARDIAC FLUTTER,52
US,DECREASED ACTIVITY,52
US,FEEDING DISORDER,52
US,FULL BLOOD COUNT DECREASED,52
US,INFECTED CYST,52
US,LUMBAR SPINAL STENOSIS,52
US,OPTIC NEURITIS,52
US,OTORRHOEA,52
US,PARONYCHIA,52
US,TONGUE DISCOLOURATION,52
US,AGEUSIA,51
US,APPENDICITIS,51
US,DIZZINESS POSTURAL,51
US,EXFOLIATIVE RASH,51
US,FLANK PAIN,51
US,GESTATIONAL DIABETES,51
US,PIGMENTATION DISORDER,51
US,PRECANCEROUS SKIN LESION,51
US,SEPTIC SHOCK,51
US,SINUS OPERATION,51
US,STRESS AT WORK,51
US,TONGUE DISORDER,51
US,WRIST DEFORMITY,51
US,EAR PRURITUS,50
US,EAR SWELLING,50
US,ELBOW OPERATION,50
US,EXPOSURE TO COMMUNICABLE DISEASE,50
US,HUNGER,50
US,POLYP,50
US,COSTOCHONDRITIS,49
US,HEART RATE ABNORMAL,49
US,INFECTED BITES,49
US,MENINGITIS,49
US,SPINAL LAMINECTOMY,49
US,COELIAC DISEASE,48
US,INCORRECT DOSE ADMINISTERED BY DEVICE,48
US,INGUINAL HERNIA,48
US,INTRAOCULAR PRESSURE INCREASED,48
US,NAIL PITTING,48
US,NECK INJURY,48
US,PHARYNGEAL ERYTHEMA,48
US,SKIN HYPERTROPHY,48
US,TYPE 1 DIABETES MELLITUS,48
US,BLINDNESS UNILATERAL,47
US,BLOOD CALCIUM INCREASED,47
US,BUNION OPERATION,47
US,COAGULOPATHY,47
US,CREPITATIONS,47
US,DIVERTICULUM,47
US,INJECTION SITE OEDEMA,47
US,INTESTINAL PERFORATION,47
US,MUSCLE RUPTURE,47
US,PROCEDURAL COMPLICATION,47
US,SCLERITIS,47
US,ACUTE KIDNEY INJURY,46
US,ASTHENOPIA,46
US,BOWEL MOVEMENT IRREGULARITY,46
US,C-REACTIVE PROTEIN ABNORMAL,46
US,GASTROENTERITIS,46
US,GASTROINTESTINAL PAIN,46
US,GLUCOSE TOLERANCE IMPAIRED,46
US,HAEMATOCRIT DECREASED,46
US,HEPATIC CANCER,46
US,INCORRECT DRUG ADMINISTRATION DURATION,46
US,MUSCLE INJURY,46
US,OSTEONECROSIS,46
US,PARALYSIS,46
US,TRANSAMINASES INCREASED,46
US,CARDIAC MURMUR,45
US,CARDIAC VALVE DISEASE,45
US,COCCIDIOIDOMYCOSIS,45
US,DEVICE DEFECTIVE,45
US,NASAL SEPTUM DEVIATION,45
US,RENAL CYST,45
US,SPINAL COMPRESSION FRACTURE,45
US,APPENDICECTOMY,44
US,APPETITE DISORDER,44
US,BODY HEIGHT DECREASED,44
US,BONE SWELLING,44
US,DEVICE BREAKAGE,44
US,DRUG ERUPTION,44
US,HYPERLIPIDAEMIA,44
US,INJECTION SITE DRYNESS,44
US,LABYRINTHITIS,44
US,MENSTRUATION IRREGULAR,44
US,PETECHIAE,44
US,PRE-ECLAMPSIA,44
US,PULMONARY HYPERTENSION,44
US,RETINAL DETACHMENT,44
US,TENDON OPERATION,44
US,ANGINA PECTORIS,43
US,CATHETERISATION CARDIAC,43
US,HAIR DISORDER,43
US,HEPATITIS,43
US,LIP BLISTER,43
US,MILIARIA,43
US,ORAL FUNGAL INFECTION,43
US,PANCREATIC CARCINOMA,43
US,PAROSMIA,43
US,PERSONALITY CHANGE,43
US,SKIN SENSITISATION,43
US,ANTINUCLEAR ANTIBODY POSITIVE,42
US,BONE EROSION,42
US,CHOLECYSTITIS INFECTIVE,42
US,CONTRAINDICATED PRODUCT ADMINISTERED,42
US,EXPOSURE TO TOXIC AGENT,42
US,HUMERUS FRACTURE,42
US,IMPAIRED GASTRIC EMPTYING,42
US,LIPOMA,42
US,LOCAL REACTION,42
US,LOOSE TOOTH,42
US,TONGUE ULCERATION,42
US,VASCULAR INJURY,42
US,WEIGHT FLUCTUATION,42
US,WOUND HAEMORRHAGE,42
US,APPARENT DEATH,41
US,GENITAL HERPES,41
US,HAEMOGLOBIN ABNORMAL,41
US,HEPATITIS B,41
US,HERPES SIMPLEX,41
US,HYPOGLYCAEMIA,41
US,LOWER EXTREMITY MASS,41
US,MASTITIS,41
US,PAINFUL RESPIRATION,41
US,ROSACEA,41
US,THYROID FUNCTION TEST ABNORMAL,41
US,AGGRESSION,40
US,CARDIOMYOPATHY,40
US,ENDOMETRIOSIS,40
US,HYPERTHYROIDISM,40
US,INCONTINENCE,40
US,INJECTION SITE DISCHARGE,40
US,LARGE INTESTINE PERFORATION,40
US,LIVER INJURY,40
UY,BLADDER NEOPLASM,1
UY,CARDIOPULMONARY FAILURE,1
UY,COLON NEOPLASM,1
UY,PERITONITIS,1
UY,SEPTIC SHOCK,1
UY,UTERINE INFECTION,1
VE,DEATH,32
VE,MYOCARDIAL INFARCTION,21
VE,RESPIRATORY ARREST,18
VE,INFLUENZA,14
VE,URINARY TRACT INFECTION,10
VE,CEREBROVASCULAR ACCIDENT,9
VE,DRUG INEFFECTIVE,8
VE,FALL,8
VE,GALLBLADDER DISORDER,8
VE,HYPERSENSITIVITY,7
VE,TUBERCULOSIS,7
VE,ARTHROPATHY,6
VE,CARDIAC ARREST,6
VE,DIARRHOEA,6
VE,HYPERTENSION,6
VE,ARTHRALGIA,5
VE,BRONCHITIS,5
VE,VOMITING,5
VE,CELLULITIS,4
VE,COUGH,4
VE,EYE DISORDER,4
VE,HAEMORRHAGE,4
VE,PNEUMONIA,4
VE,RESPIRATORY TRACT INFECTION,4
VE,ARTHRITIS BACTERIAL,3
VE,ARTHRITIS INFECTIVE,3
VE,ASTHMA,3
VE,BACTERIAL INFECTION,3
VE,DECREASED IMMUNE RESPONSIVENESS,3
VE,DEHYDRATION,3
VE,DENGUE FEVER,3
VE,DIABETES MELLITUS,3
VE,ERYTHEMA NODOSUM,3
VE,FATIGUE,3
VE,HAEMOGLOBIN DECREASED,3
VE,HEADACHE,3
VE,HEPATITIS A,3
VE,INFECTION,3
VE,INJECTION SITE ERYTHEMA,3
VE,JOINT INJURY,3
VE,LEUKAEMIA,3
VE,LUNG DISORDER,3
VE,POISONING,3
VE,PROSTATE CANCER,3
VE,PYREXIA,3
VE,RENAL DISORDER,3
VE,ROAD TRAFFIC ACCIDENT,3
VE,SEPSIS,3
VE,TACHYCARDIA,3
VE,ABDOMINAL DISCOMFORT,2
VE,ADVERSE DRUG REACTION,2
VE,ALOPECIA,2
VE,ARTHRITIS,2
VE,BACK DISORDER,2
VE,BLISTER,2
VE,BLOOD PRESSURE INCREASED,2
VE,BONE DISORDER,2
VE,BRONCHOPNEUMONIA,2
VE,CATARACT,2
VE,COLON CANCER,2
VE,CYSTITIS,2
VE,DEPRESSION,2
VE,DISEASE PROGRESSION,2
VE,DIZZINESS,2
VE,GAIT DISTURBANCE,2
VE,GASTRIC CANCER,2
VE,GENERALISED OEDEMA,2
VE,HERPES SIMPLEX,2
VE,HIP FRACTURE,2
VE,HYPERTENSIVE CRISIS,2
VE,IMMUNOSUPPRESSION,2
VE,INTESTINAL OBSTRUCTION,2
VE,JOINT SWELLING,2
VE,KIDNEY INFECTION,2
VE,LIVER DISORDER,2
VE,LOWER LIMB FRACTURE,2
VE,NEOPLASM MALIGNANT,2
VE,NEPHROLITHIASIS,2
VE,NEURALGIA,2
VE,PAIN,2
VE,PAIN IN EXTREMITY,2
VE,PERIPHERAL SWELLING,2
VE,PROSTATE INFECTION,2
VE,PSORIATIC ARTHROPATHY,2
VE,PULMONARY OEDEMA,2
VE,SKIN ULCER,2
VE,SYNCOPE,2
VE,TENDON RUPTURE,2
VE,TOOTH DISORDER,2
VE,TREMOR,2
VE,TUBERCULIN TEST POSITIVE,2
VE,ABASIA,1
VE,ABDOMINAL PAIN,1
VE,ABDOMINAL PAIN UPPER,1
VE,ABNORMAL SENSATION IN EYE,1
VE,ABORTION SPONTANEOUS,1
VE,ABSCESS,1
VE,ABSCESS ORAL,1
VE,ACCIDENT,1
VE,ANAL FISTULA,1
VE,ANXIETY,1
VE,AORTIC ANEURYSM,1
VE,APHONIA,1
VE,ARTERIOSCLEROSIS,1
VE,ARTHROPOD BITE,1
VE,ASTHENIA,1
VE,BACK PAIN,1
VE,BEDRIDDEN,1
VE,BENIGN BREAST NEOPLASM,1
VE,BLOOD GLUCOSE DECREASED,1
VE,BLOOD INSULIN INCREASED,1
VE,BLOOD PRESSURE ABNORMAL,1
VE,BLOOD PRESSURE DECREASED,1
VE,BONE CANCER,1
VE,BONE DECALCIFICATION,1
VE,BONE PAIN,1
VE,BREAST CANCER FEMALE,1
VE,BREAST CYST,1
VE,BREAST SWELLING,1
VE,BRONCHIECTASIS,1
VE,BRONCHOSPASM,1
VE,BURNS SECOND DEGREE,1
VE,CAESAREAN SECTION,1
VE,CARDIAC DISORDER,1
VE,CARDIAC FAILURE,1
VE,CEREBRAL INFARCTION,1
VE,CERVICAL DYSPLASIA,1
VE,CHIKUNGUNYA VIRUS INFECTION,1
VE,CHILLS,1
VE,CHOKING,1
VE,COLITIS,1
VE,CONTUSION,1
VE,CONVERSION DISORDER,1
VE,CONVULSION,1
VE,CORONARY ARTERY BYPASS,1
VE,CRITICAL ILLNESS,1
VE,DECREASED APPETITE,1
VE,DEMENTIA ALZHEIMER^S TYPE,1
VE,DEVICE DISLOCATION,1
VE,DEVICE FAILURE,1
VE,DIABETIC KETOACIDOSIS,1
VE,DISEASE COMPLICATION,1
VE,DISEASE RECURRENCE,1
VE,DIVERTICULITIS,1
VE,DRUG EFFECT DECREASED,1
VE,DYSPEPSIA,1
VE,DYSPNOEA,1
VE,EAR HAEMORRHAGE,1
VE,EAR SWELLING,1
VE,EPISTAXIS,1
VE,EUSTACHIAN TUBE DYSFUNCTION,1
VE,EYE PAIN,1
VE,EYE PRURITUS,1
VE,FEELING ABNORMAL,1
VE,FEELING COLD,1
VE,FEELING HOT,1
VE,FEMORAL NECK FRACTURE,1
VE,FEMUR FRACTURE,1
VE,FOOT DEFORMITY,1
VE,FOOT FRACTURE,1
VE,FRACTURE,1
VE,FUNGAL SKIN INFECTION,1
VE,GALLBLADDER PAIN,1
VE,GASTRIC DISORDER,1
VE,GASTRIC HAEMORRHAGE,1
VE,GASTRIC ULCER PERFORATION,1
VE,GENERAL PHYSICAL HEALTH DETERIORATION,1
VE,GRANULOMA,1
VE,GROIN ABSCESS,1
VE,HAEMOLYTIC ANAEMIA,1
VE,HAEMORRHOIDS,1
VE,HAND DEFORMITY,1
VE,HEAD INJURY,1
VE,HEMIPARESIS,1
VE,HEPATIC CIRRHOSIS,1
VE,HEPATIC STEATOSIS,1
VE,HEPATOMEGALY,1
VE,HERNIA,1
VE,HERPES ZOSTER,1
VE,HIP DEFORMITY,1
VE,HODGKIN^S DISEASE,1
VE,HYPERHIDROSIS,1
VE,HYPERTENSIVE CARDIOMYOPATHY,1
VE,IMMUNE SYSTEM DISORDER,1
VE,IMMUNODEFICIENCY,1
VE,IMPAIRED WORK ABILITY,1
VE,INFECTED SKIN ULCER,1
VE,INGUINAL HERNIA,1
VE,INJECTION SITE HYPERSENSITIVITY,1
VE,INJECTION SITE INFECTION,1
VE,INJECTION SITE PRURITUS,1
VE,INJECTION SITE REACTION,1
VE,INJECTION SITE SWELLING,1
VE,JOINT EFFUSION,1
VE,KNEE DEFORMITY,1
VE,LIMB DISCOMFORT,1
VE,LIPOMA,1
VE,LIVER INJURY,1
VE,LOCALISED INFECTION,1
VE,LUNG NEOPLASM MALIGNANT,1
VE,LUPUS-LIKE SYNDROME,1
VE,MENTAL DISORDER,1
VE,MIGRAINE,1
VE,MOBILITY DECREASED,1
VE,MOUTH HAEMORRHAGE,1
VE,MOUTH ULCERATION,1
VE,MULTIPLE SCLEROSIS,1
VE,MUMPS,1
VE,MUSCULAR WEAKNESS,1
VE,MYALGIA,1
VE,MYCOSIS FUNGOIDES,1
VE,MYELODYSPLASTIC SYNDROME,1
VE,NAIL DISORDER,1
VE,NASAL DISCOMFORT,1
VE,NAUSEA,1
VE,NECK PAIN,1
VE,NEOPLASM,1
VE,NERVOUS SYSTEM DISORDER,1
VE,NO ADVERSE EVENT,1
VE,OCCULT BLOOD,1
VE,OCULAR DISCOMFORT,1
VE,OCULAR HYPERAEMIA,1
VE,ODYNOPHAGIA,1
VE,OROPHARYNGEAL PAIN,1
VE,OSTEOARTHRITIS,1
VE,PALPITATIONS,1
VE,PARAESTHESIA,1
VE,PARKINSON^S DISEASE,1
VE,PERITONITIS,1
VE,PLASMA CELL MYELOMA,1
VE,PLATELET COUNT DECREASED,1
VE,PLEURAL EFFUSION,1
VE,PRODUCT USE IN UNAPPROVED INDICATION,1
VE,PROSTATIC DISORDER,1
VE,PROSTHESIS USER,1
VE,PRURITUS,1
VE,PRURITUS GENERALISED,1
VE,PSORIASIS,1
VE,PSYCHOTIC DISORDER,1
VE,PULMONARY FIBROSIS,1
VE,PULMONARY MYCOSIS,1
VE,PULMONARY THROMBOSIS,1
VE,PURULENT DISCHARGE,1
VE,QUALITY OF LIFE DECREASED,1
VE,RASH GENERALISED,1
VE,RENAL FAILURE,1
VE,RESPIRATORY DISTRESS,1
VE,RESPIRATORY FAILURE,1
VE,RETINAL DETACHMENT,1
VE,RETINAL HAEMORRHAGE,1
VE,RHEUMATOID ARTHRITIS,1
VE,RHEUMATOID FACTOR INCREASED,1
VE,SCLERODERMA,1
VE,SEPTIC SHOCK,1
VE,SKIN PAPILLOMA,1
VE,SPONDYLITIS,1
VE,SPONDYLOARTHROPATHY,1
VE,SUBCUTANEOUS ABSCESS,1
VE,SWEAT GLAND DISORDER,1
VE,SWELLING,1
VE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
VE,TENDONITIS,1
VE,TENOSYNOVITIS,1
VE,TENSION,1
VE,TESTIS CANCER,1
VE,THROAT IRRITATION,1
VE,THROMBOPHLEBITIS,1
VE,THYROID CANCER,1
VE,TIBIA FRACTURE,1
VE,TINEA PEDIS,1
VE,TOOTH INFECTION,1
VE,TOXICITY TO VARIOUS AGENTS,1
VE,TUMOUR INVASION,1
VE,TUMOUR MARKER INCREASED,1
VE,ULCER,1
VE,UMBILICAL HERNIA,1
VE,UNEVALUABLE EVENT,1
VE,UPPER LIMB FRACTURE,1
VE,UROSEPSIS,1
VE,UTERINE CANCER,1
VE,VAGINAL HAEMORRHAGE,1
VE,VASCULITIS,1
VE,VERTIGO,1
VE,WRIST FRACTURE,1
VE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
